Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ZNF595	FLJ31740	ENSG00000272602	"Zinc finger protein 595"	Q8IYB9	4	53286-88208	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 60.5"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 106.0;K-562: 249.2;SH-SY5Y: 159.9"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"				"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.63e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.46e-2)"	8.0	8.4	4.3	7.1	4.3	8.9	9.9	12.1	6.9	8.7	1.6	6.5	4.3	10.7	6.0	5.2	7.7	5.1	4.8	4.2	5.4	4.9	6.3	7.2	10.2	6.5	5.0	14.7	10.1	5.4	4.2	60.5	7.1	7.4	6.1	10.1	5.6	4.3	5.3	7.4	6.1	10.9	3.7	9.5	6.3	8.7	4.5	10.6	10.3	6.6	10.1	5.9	7.3	6.2	4.0	13.8	8.9	8.3	50.4	61.9	68.3	4.8	4.4	5.3	6.9	6.6	5.7	106.0	7.9	4.0	9.0	3.0	50.3	4.7	7.8	8.5	7.2	0.4	0.1	0.0	3.2	0.1	26.8	6.8	6.1	5.2	5.5	5.7	4.4	47.9	249.2	1.1	4.3	30.5	0.3	29.6	15.6	0.0	6.2	0.1	2.0	0.1	7.7	4.5	7.3	159.9	6.1	7.0	2.8	35.3	50.3	17.1	29.3	5.4	39.3	3.2	6.1	0.4	53.4	12.6	0.2	0.1	18.0	5.9	2.7	16.0	8.5	3.5	3.9	16.3	4.7	5.8	4.3	17.3	6.4	6.3	4.5	23.3	3.2	15.7	4.0	4.9	4.3	4.3	12.1	6.9	4.2	5.4	6.5	5.0	7.1	3.7	4.5	6.2	9.1	6.4	11.7	10.7	11.3	4.6	10.1	4.3	6.8	8.7	5.0	6.5	5.6	8.6	12.5	3.7	2.1	10.5	10.8	2.9	15.6	8.1	5.4	2.0	7.6	9.9	0.0	1.7	21.9	4.4	9.8	8.2	3.1	2.6	7.6	18.8	10.8	3.8	4.0	3.3	24.0	3.4	2.0	1.8	4.2	6.1	11.1	2.7	5.4	22.5	1.6	11.8	33.0	24.1	34.9	3.1	2.9	9.1	13.2	6.4	3.0	4.6	2.3	6.8	0.0	9.7	5.7	16.0	16.8	2.6	4.5	8.5	5.0	9.3	3.4	6.6
ZNF718	FLJ90036	ENSG00000250312	"Zinc finger protein 718"	Q3SXZ3	4	124501-202303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 37.5;Excitatory neurons: 40.1;Inhibitory neurons: 58.2;Microglial cells: 47.8;Oligodendrocyte precursor cells: 62.8;Oligodendrocytes: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 19.3"															NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.96e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.67e-6)"	"unprognostic (1.39e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.92e-1)"	1.9	3.0	1.8	2.2	1.8	3.0	2.6	3.4	2.5	3.3	0.5	2.5	1.7	2.2	2.1	1.8	2.9	2.0	1.9	1.3	2.3	2.5	1.4	2.0	3.8	2.0	2.5	3.5	2.5	2.7	2.0	2.8	2.4	3.0	2.2	2.7	2.2	2.2	0.9	3.0	1.9	1.9	1.5	2.9	1.9	2.0	2.4	4.6	4.7	1.8	3.4	2.0	2.3	2.7	0.0	0.9	5.4	0.0	3.3	6.2	1.3	6.9	0.9	4.3	3.3	5.9	7.7	8.5	4.0	2.5	7.6	2.0	4.4	3.2	5.8	0.0	1.6	0.0	1.5	0.0	4.1	0.1	0.1	3.2	2.8	4.3	0.6	3.9	2.9	2.4	4.1	0.1	7.6	4.4	0.8	5.3	6.6	0.0	2.4	19.3	2.1	4.7	3.5	2.1	7.3	1.7	3.5	1.2	4.2	4.3	12.5	1.6	2.1	3.2	4.0	4.1	5.1	0.0	0.0	13.3	0.0	0.0	4.0	2.6	1.3	5.7	2.2	1.8	2.1	2.0	1.9	1.4	2.4	2.2	2.2	2.1	1.6	5.4	1.1	2.4	1.6	1.2	1.8	1.8	3.4	2.5	1.3	2.3	2.0	2.5	2.4	1.5	2.4	2.7	4.0	3.2	3.6	37.5	6.5	2.0	2.2	1.4	4.6	8.4	3.5	3.0	2.4	0.0	5.1	0.0	2.1	1.9	7.6	1.2	0.0	3.1	0.3	1.0	3.7	3.4	1.2	9.7	40.1	1.4	1.4	3.6	4.1	1.6	5.7	6.6	6.1	0.9	1.4	8.4	58.2	0.7	0.0	1.6	1.9	0.7	3.7	2.9	3.6	47.8	1.7	2.6	15.5	62.8	85.0	1.6	0.1	4.5	4.6	0.9	0.5	1.4	2.6	5.1	0.0	4.4	3.8	2.4	4.1	3.0	0.9	1.4	5.5	4.0	0.8	1.4
ZNF732	FLJ59067	ENSG00000186777	"Zinc finger protein 732"	B4DXR9	4	270675-305474	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 2.7;Inhibitory neurons: 1.9;Spermatocytes: 5.0;Spermatogonia: 8.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NTERA-2: 7.7"															NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (7.83e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.99e-4)"	"unprognostic (7.60e-3)"	"unprognostic (8.13e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.44e-3)"	"unprognostic (3.60e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.40e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-1)"	0.1	0.1	0.1	0.2	0.7	0.0	0.4	0.3	0.4	0.6	0.0	0.4	0.0	0.4	0.0	0.3	0.5	0.1	0.2	0.2	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.7	0.3	0.1	0.8	0.2	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.6	0.2	0.1	0.0	0.4	0.2	1.5	0.1	0.0	0.4	0.0	0.7	0.4	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.7	0.0	1.8	0.0	0.0	0.0	0.6	0.9	0.0	1.8	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.2	0.0	0.0	1.6	0.0	0.6	0.3	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	8.4	0.6	0.3	0.0	0.0	0.3	0.0	0.1
ZNF141	"D4S90, pHZ-44"	ENSG00000131127	"Zinc finger protein 141"	Q15928	4	337814-384868	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.76e-4)"	4.7	13.9	8.6	3.3	9.1	1.3	4.8	12.5	12.1	8.8	9.1	5.3	2.4	5.1	4.2	4.2	6.9	1.5	5.1	8.9	8.6	6.1	6.1	6.5	5.1	8.1	8.2	15.6	5.5	3.2	8.5	2.3	8.3	7.6	2.5	13.7	5.9	2.5	2.5	4.8	6.2	1.2	7.6	7.1	4.4	5.6	8.5	3.3	7.5	1.1	4.3	5.5	6.7	9.2	0.1	1.3	5.0	2.0	1.4	1.9	1.3	1.5	0.9	2.1	3.0	4.4	2.6	0.3	1.2	1.2	2.5	2.1	0.0	1.2	2.8	0.0	1.2	0.1	2.3	0.2	1.0	0.1	4.8	2.2	1.3	2.1	0.9	1.1	0.5	1.0	0.1	0.2	2.1	1.4	4.3	6.3	5.4	0.5	2.3	0.1	0.0	0.5	1.5	2.7	5.0	2.5	1.8	0.7	1.3	2.6	2.2	4.8	0.4	0.3	1.6	1.2	1.5	0.1	0.2	0.2	0.0	0.0	0.9	0.5	0.5	1.0	1.3	0.6	1.3	1.2	1.1	1.1	1.0	1.8	1.6	1.3	0.9	1.4	0.9	0.7	0.9	0.5	8.6	9.1	12.5	12.1	8.9	8.6	8.1	8.2	8.3	7.6	8.5	9.2	9.5	6.4	7.7	14.7	28.3	3.7	3.3	2.0	6.2	24.0	5.2	5.8	5.3	8.6	4.2	14.7	14.6	3.5	11.2	2.6	5.9	3.5	7.9	4.5	9.3	9.6	6.0	8.4	9.9	2.9	3.0	9.7	4.6	5.6	5.7	22.8	3.9	2.0	2.3	33.7	11.6	2.7	2.0	2.2	6.0	6.1	11.1	12.2	3.6	15.0	5.5	7.9	16.5	15.1	16.3	2.9	1.0	6.0	7.2	2.8	3.3	1.7	4.8	18.1	26.3	9.8	21.3	10.6	9.7	3.3	4.1	4.1	13.5	15.3	4.5	2.2
ZNF721	KIAA1982	ENSG00000182903	"Zinc finger protein 721"	Q8TF20	4	425815-499156	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065313			Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Centriolar satellite"	"HPA065313: AB_2685464"	"unprognostic (2.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (2.76e-4)"	12.5	10.9	8.3	14.4	9.2	18.0	18.8	18.9	12.7	12.1	4.4	10.9	10.5	12.9	14.2	10.4	14.7	10.0	8.2	9.2	8.7	11.8	12.8	12.6	22.6	5.0	5.2	15.3	15.1	15.5	11.2	10.0	6.1	11.5	12.0	19.9	11.1	10.0	10.5	18.5	11.4	10.3	4.6	14.9	12.9	14.2	7.1	19.1	16.8	16.1	22.0	10.9	11.9	12.5	17.2	10.4	20.2	25.0	14.5	19.9	12.7	15.2	13.1	16.4	14.5	15.4	17.1	28.8	16.3	14.9	23.6	11.3	20.9	19.0	22.0	10.4	24.4	51.0	10.7	10.4	14.2	21.5	2.4	17.5	16.3	18.0	27.3	25.6	17.1	40.4	29.9	19.7	23.0	16.4	35.3	32.4	32.1	11.3	22.1	28.6	30.1	16.4	17.9	22.8	29.6	18.9	20.2	11.6	19.3	17.3	21.2	22.4	22.0	14.5	5.3	11.5	27.3	22.7	22.2	68.7	11.1	5.2	13.9	8.0	8.3	12.9	12.1	8.7	12.2	16.6	13.3	12.0	8.4	15.9	20.8	16.5	11.4	13.5	8.2	10.3	16.7	7.3	8.3	9.2	18.9	12.7	9.2	8.7	5.0	5.2	6.1	4.6	7.1	12.5	44.4	25.6	31.9	29.7	44.9	21.0	26.4	18.6	25.6	38.0	25.0	27.3	16.7	25.8	24.8	18.4	31.3	16.9	33.0	10.9	15.6	12.9	34.5	29.6	31.9	30.7	12.7	33.2	37.6	14.9	10.6	26.0	29.0	29.0	26.0	32.0	28.5	17.6	10.9	23.5	30.1	16.4	4.1	18.8	19.1	12.3	19.6	18.8	12.4	11.2	14.8	24.7	46.4	24.6	32.7	13.8	11.3	12.0	23.4	27.8	12.4	14.5	24.9	35.1	19.7	30.5	20.1	35.2	34.3	23.1	23.2	17.4	40.9	29.5	15.8	31.0
PIGG	"FLJ20265, GPI7, LAS21"	ENSG00000174227	"Phosphatidylinositol glycan anchor biosynthesis class G"	Q5H8A4	4	499210-540200	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015997	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA015997: AB_2164679"	"unprognostic (3.87e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.61e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.97e-2)"	12.7	13.7	6.0	11.4	6.7	9.4	12.8	6.0	6.9	10.6	7.8	12.9	14.2	11.5	20.5	11.4	11.6	12.9	8.1	7.5	5.5	9.5	8.9	11.6	13.4	6.7	6.1	15.4	14.1	17.5	15.2	12.6	7.0	12.1	12.0	10.7	14.7	11.2	8.1	20.3	13.5	9.8	6.0	13.1	13.2	8.8	6.8	10.8	14.9	4.1	11.3	12.9	11.5	10.3	18.7	20.2	18.2	15.2	33.0	23.1	28.7	24.0	28.8	25.1	29.7	21.5	42.4	7.8	17.4	30.8	46.0	25.0	17.2	23.5	23.1	7.3	19.1	19.4	24.7	17.0	22.6	27.3	27.6	26.2	38.9	23.2	12.7	27.4	19.4	14.9	21.4	16.5	22.6	11.6	15.3	23.9	29.6	20.2	28.2	16.9	11.2	11.5	24.2	25.4	18.2	23.2	17.7	18.3	17.6	17.3	29.2	24.1	30.0	25.6	12.0	13.3	37.7	13.5	19.4	12.3	21.7	19.9	32.7	20.5	5.1	4.2	5.9	6.5	6.7	3.5	4.5	5.7	8.1	2.8	4.8	3.9	3.8	7.8	4.9	7.2	8.3	3.9	6.0	6.7	6.0	6.9	7.5	5.5	6.7	6.1	7.0	6.0	6.8	10.3	14.4	16.0	12.6	21.9	12.6	8.9	10.9	17.7	12.5	10.8	11.4	9.3	8.6	7.2	23.0	9.2	4.2	16.7	14.8	14.9	0.0	15.8	2.4	16.4	15.4	13.1	10.8	11.2	23.2	17.8	14.8	10.2	22.4	20.2	12.7	19.8	8.9	10.1	9.1	8.4	15.1	8.5	16.2	11.5	6.5	0.7	13.7	9.5	8.8	24.4	13.6	11.6	17.5	16.6	26.0	18.4	12.8	12.8	14.9	13.7	13.1	5.6	19.9	10.5	19.7	10.4	11.5	9.9	8.2	10.1	6.3	23.1	14.2	13.0	9.7	14.2
TMEM271		ENSG00000273238	"Transmembrane protein 271"	A0A286YF58	4	573880-576295	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 23.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.7;NB-4: 1.5;NTERA-2: 2.6;SCLC-21H: 5.7;U-2 OS: 1.4;U-251 MG: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA					"Cluster 7: SCLC-21H - Neuronal signaling"									"unprognostic (4.13e-3)"						"unprognostic (6.97e-3)"				"unprognostic (2.65e-2)"			0.0	0.9	13.2	0.0	12.4	0.0	0.0	0.2	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	11.2	0.0	0.0	0.0	0.0	4.0	5.1	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	3.7	0.0	0.0	2.4	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0		7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	1.5	2.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	12.4	0.2	23.3	18.0	11.2	4.0	5.1	2.7	2.4	6.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625573-670782	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 385.0"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 460.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.9	2.2	13.5	5.5	25.7	8.4	4.1	8.2	22.3	2.5	1.9	1.7	1.2	2.7	4.0	1.7	10.2	3.7	5.9	11.2	22.6	4.9	1.0	4.6	14.3	22.8	19.9	2.8	1.8	8.2	4.1	3.1	25.5	2.8	1.3	385.0	3.8	3.0	1.1	2.1	3.0	2.5	9.3	10.1	2.9	4.4	24.1	12.2	12.0	0.1	9.3	3.8	1.4	39.3	0.1	0.0	1.2	0.5	0.3	0.4	0.4	0.0	0.1	0.8	2.0	0.0	0.1	0.3	11.5	0.3	0.9	0.1	2.5	0.6	0.0	0.1	0.0	1.0	0.3	0.1	5.8	0.2	0.4	0.7	0.0	3.5	0.0	0.8	1.1	17.3	0.1	1.0	0.1	0.3	31.3	0.1	9.4	0.7	0.0	16.8	0.2	0.2	2.1	1.3	20.2	11.9	0.0	0.3	0.1	4.2	0.6	0.0	0.4	0.2	1.2	0.2	0.4	7.7	24.0	0.3	0.3	0.3	0.2	16.8	5.4	0.9	14.0	7.7	12.6	12.8	9.3	9.8	8.5	21.4	14.6	15.8	1.4	14.4	8.1	18.2	15.5	9.4	13.5	25.7	8.2	22.3	11.2	22.6	22.8	19.9	25.5	9.3	24.1	39.3	0.5	3.2	5.0	4.2	6.4	0.4	2.1	1.2	2.8	20.7	3.9	2.4	4.4	0.0	3.5	0.0	83.4	0.1	8.4	0.2	1.9	6.9	0.4	7.0	2.2	2.9	1.8	7.4	40.3	0.6	0.3	1.3	1.5	2.5	3.8	5.4	2.2	0.0	11.3	11.8	27.3	0.5	4.1	5.1	1.4	0.3	1.5	3.3	3.6	4.7	6.2	31.1	7.2	10.1	33.9	0.8	0.2	1.5	7.5	1.9	0.0	8.4	11.2	460.1	0.0	1.6	1.1	4.3	11.0	1.9	0.3	0.3	5.9	3.5	0.4	1.3
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674330	"Metabolic proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2048.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 886.5;Distal tubular cells: 1729.5;Proximal tubular cells: 2485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	360.1	412.7	940.1	212.2	960.8	312.4	277.4	981.5	1172.2	263.3	926.5	555.7	460.3	237.4	242.7	511.9	218.8	94.5	1507.7	932.5	968.9	572.0	591.7	235.6	174.6	980.1	955.6	257.5	330.9	774.8	312.8	144.8	972.5	262.0	331.4	336.4	304.8	220.4	2048.3	297.8	436.7	172.8	952.6	281.3	414.9	130.6	960.4	315.7	270.1	1688.5	223.8	293.5	323.8	998.1	542.0	560.8	781.7	599.5	622.4	544.4	390.7	561.8	445.4	407.4	359.4	525.4	548.4	299.0	472.8	612.4	683.8	361.8	668.9	924.1	241.4	249.9	1082.7	854.6	1107.9	1435.2	659.0	1118.6	368.0	721.6	533.5	472.2	491.0	665.5	503.3	608.1	756.0	314.4	464.7	904.5	972.6	1337.3	861.9	1071.7	1438.9	584.4	555.0	620.7	863.9	1053.2	667.7	530.1	401.6	525.0	620.2	502.7	590.4	695.7	580.2	348.0	340.7	308.2	730.9	739.7	1273.2	947.0	528.0	712.7	391.3	1049.3	1044.5	1188.8	742.1	920.0	776.3	1470.4	909.2	839.0	1067.0	1131.6	837.1	811.9	962.2	943.5	822.7	1179.7	1086.3	1456.6	940.1	960.8	981.5	1172.2	932.5	968.9	980.1	955.6	972.5	952.6	960.4	998.1	311.8	153.8	199.7	0.0	88.6	0.0	0.0	0.0	0.0	0.0	461.7	421.8	0.0	0.0	121.9	886.5	0.0	404.9	188.8	0.0	1729.5	467.4	0.0	468.6	315.6	125.1	0.0	0.0	0.0	692.9	335.8	139.4	0.0	484.2	122.4	311.8	0.0	0.0	676.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.6	0.0	0.0	278.1	0.0	0.0	0.0	0.0	509.6	0.0	0.0	50.1	0.0	0.0	2485.3	183.6	0.0	0.0	0.0	156.7	0.0	0.0	0.0	0.0	274.9	97.8	146.6	0.0	0.0
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 66.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.3;Proximal enterocytes: 55.5;Rod photoreceptor cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 60.4"					"Not detected"	"Not detected"			"HPA037381, HPA039262"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: AB_2676418"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	17.9	21.4	21.8	7.0	21.8	11.4	16.6	21.9	36.0	10.6	19.4	20.7	20.7	7.4	17.8	20.0	7.9	8.3	10.4	21.0	20.4	19.4	22.2	11.0	11.0	22.8	21.1	7.7	9.9	15.3	13.7	5.1	22.3	18.2	13.0	66.1	13.3	8.9	24.6	18.6	25.2	5.6	20.9	16.1	12.3	22.2	21.9	10.0	13.6	8.3	10.3	11.2	13.3	23.5	4.3	6.9	24.8	13.2	60.4	41.2	11.9	10.2	13.6	10.2	9.3	8.4	17.7	4.9	4.8	16.6	7.3	6.2	4.0	7.0	3.0	9.2	5.0	7.4	11.7	7.9	21.0	11.3	6.5	31.3	6.5	8.1	8.4	14.8	6.3	10.4	7.7	6.5	12.7	8.0	6.1	7.8	5.2	8.8	10.4	5.4	5.3	3.0	16.9	19.9	11.3	6.4	3.4	8.5	7.2	8.0	13.7	10.2	10.4	8.7	1.6	7.5	6.0	24.7	5.3	2.9	9.5	10.1	4.6	15.5	8.2	1.5	3.3	5.5	4.2	8.7	5.6	2.0	7.7	12.7	6.7	6.8	5.8	18.4	12.3	14.5	2.6	5.8	21.8	21.8	21.9	36.0	21.0	20.4	22.8	21.1	22.3	20.9	21.9	23.5	4.5	0.0	11.9	2.3	11.7	12.0	6.8	12.8	18.2	6.3	12.9	14.5	1.4	7.2	5.7	7.3	20.9	7.3	9.2	22.7	11.7	9.6	22.2	9.1	6.9	5.9	5.4	4.2	1.4	4.7	5.4	7.5	13.7	5.3	13.9	4.9	10.4	18.3	22.7	11.8	1.3	11.4	6.1	21.2	8.6	87.3	7.2	12.4	7.2	1.0	22.8	22.2	13.4	0.5	1.6	6.1	13.2	3.8	5.1	8.3	55.5	42.6	8.2	74.3	6.6	21.7	5.6	14.1	4.4	21.2	13.4	5.5	5.9	14.7	15.4	9.7
SLC49A3	"FLJ22269, LP2561, MFSD7"	ENSG00000169026	"Solute carrier family 49 member 3"	Q6UXD7	4	681829-689271	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.8;Breast glandular cells: 14.6;Collecting duct cells: 14.7;Ductal cells: 19.2;Extravillous trophoblasts: 33.9;Hofbauer cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.7;CAPAN-2: 5.8;SK-BR-3: 8.2;T-47d: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043593	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"			"HPA043593: AB_10959611"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.11e-1)"	8.2	3.2	2.4	4.4	2.1	3.5	9.0	2.7	3.0	4.5	3.5	4.2	5.9	3.4	4.2	4.4	3.3	3.7	8.3	1.7	2.3	8.3	5.8	8.1	3.0	3.2	2.2	1.2	4.8	4.6	1.9	2.7	3.0	5.0	2.3	12.6	8.4	2.1	3.0	10.2	5.9	2.1	2.7	8.5	8.4	8.9	3.5	0.6	8.5	1.9	1.7	4.3	4.9	2.9	0.1	0.1	2.7	1.9	1.9	3.7	8.7	1.0	0.0	0.7	0.6	0.4	5.8	0.1	0.2	4.5	0.4	0.2	0.0	0.0	0.2	0.6	0.6	1.6	0.7	0.2	0.8	0.0	1.2	2.5	0.0	3.4	0.0	0.0	1.3	0.3	0.4	0.5	0.0	0.1	0.1	0.7	0.3	0.4	0.5	0.0	0.3	0.6	0.0	0.3	0.9	0.7	0.0	8.2	0.5	0.5	25.8	1.6	0.3	0.8	0.3	0.4	0.3	2.8	1.6	0.1	0.3	0.7	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.4	0.2	0.0	0.1	0.3	2.4	2.1	2.7	3.0	1.7	2.3	3.2	2.2	3.0	2.7	3.5	2.9	12.8	3.2	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.6	8.4	0.0	0.0	1.8	14.7	0.0	0.7	3.1	0.0	1.9	19.2	0.0	2.1	6.0	4.3	0.0	0.0	0.0	0.4	33.9	4.3	0.0	4.1	0.0	0.8	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	4.9	0.7	0.5	0.0	0.0
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA061879: AB_2684631"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.25e-4)"	32.7	45.1	17.9	15.5	18.5	30.1	34.7	30.6	19.5	41.9	16.7	31.7	22.6	35.3	8.7	35.5	33.6	14.0	27.2	18.9	17.0	31.7	29.7	34.7	18.3	18.1	17.2	50.4	27.8	7.8	31.4	19.8	17.5	38.3	10.3	13.3	37.4	9.7	18.4	53.3	36.2	10.7	16.2	51.0	32.1	23.3	17.9	18.6	34.6	11.4	11.8	27.2	39.4	24.1	22.1	19.6	35.3	40.4	15.8	16.2	43.3	29.2	15.9	23.5	23.7	21.5	23.8	15.7	19.1	28.3	23.8	14.9	16.5	23.7	17.8	20.8	17.9	22.6	24.2	38.4	19.3	15.5	28.9	20.5	31.0	20.5	9.3	15.4	30.5	28.2	31.5	12.6	23.3	24.6	41.8	54.6	23.4	14.9	35.0	41.0	22.4	10.1	14.1	35.6	50.2	37.9	15.2	16.1	16.1	22.7	31.5	21.8	36.9	22.8	18.4	19.2	38.1	30.1	27.6	24.6	18.0	24.5	43.0	3.4	7.1	3.1	3.3	5.1	2.8	4.2	2.0	2.1	3.2	5.0	2.5	1.7	4.5	4.7	2.2	4.6	3.3	2.3	17.9	18.5	30.6	19.5	18.9	17.0	18.1	17.2	17.5	16.2	17.9	24.1	29.5	12.8	28.8	19.6	12.5	25.4	17.3	17.2	25.0	12.3	28.3	21.3	21.7	17.2	21.8	9.2	12.5	13.4	13.5	21.4	3.9	20.6	52.0	17.7	28.7	27.8	19.2	9.1	18.1	19.8	30.0	17.8	35.2	21.2	16.5	22.4	25.4	15.3	12.2	6.7	18.6	21.7	20.3	15.1	21.0	54.4	16.4	20.1	23.2	23.4	14.3	9.1	16.5	27.2	22.8	32.7	19.3	15.4	22.9	24.0	19.1	9.4	14.0	8.5	6.6	18.8	18.8	19.0	25.6	22.5	28.7	23.7	13.3	20.8	20.2	38.2
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826129	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 273.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.5;Bipolar cells: 33.4;Endothelial cells: 29.6;Excitatory neurons: 44.2;Inhibitory neurons: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 84.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	17.2	13.4	26.1	1.2	43.0	0.1	18.2	59.7	273.5	16.9	0.0	5.0	1.0	10.8	0.1	5.7	16.4	0.4	11.5	18.5	72.8	10.9	8.3	9.4	0.8	135.5	25.1	9.4	3.2	1.4	12.8	0.3	128.2	13.8	0.2	5.7	9.6	0.7	4.1	3.4	5.1	0.4	13.9	27.2	4.9	8.6	124.2	3.6	7.5	0.2	0.2	8.3	12.9	89.9	5.7	0.5	0.1	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	16.3	1.7	4.2	1.9	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.4	0.0	1.8	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.3	0.0	2.5	2.3	0.0	2.6	4.4	2.6	0.1	0.0	1.6	0.0	0.4	84.3	11.8	0.4	5.5	0.0	0.2	8.5	0.3	0.1	0.0	0.5	0.1	0.1	0.2	4.7	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	26.1	43.0	59.7	273.5	18.5	72.8	135.5	25.1	128.2	13.9	124.2	89.9	45.5	0.0	0.0	5.9	0.4	1.0	3.2	0.4	1.8	33.4	7.8	8.1	3.6	0.0	1.9	0.0	4.2	0.1	2.8	2.5	1.9	1.2	1.4	1.1	5.4	29.6	21.5	0.0	44.2	0.8	3.2	1.8	2.6	1.4	0.0	0.3	14.3	4.8	0.2	18.5	90.7	2.1	0.0	0.3	1.9	2.3	1.8	0.5	1.8	8.4	0.0	16.8	0.0	8.0	4.7	0.8	5.2	0.0	0.6	2.6	0.3	1.2	0.0	21.7	0.0	0.4	2.3	4.3	9.8	0.2	1.1	1.0	1.6	0.8	2.7	1.3
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	31.9	40.7	21.1	25.9	22.5	35.5	34.0	20.1	29.7	42.7	20.1	56.3	51.2	41.9	8.0	49.7	43.0	17.7	25.4	21.5	17.8	55.0	47.7	46.0	25.6	28.7	19.8	40.5	53.1	22.7	37.1	15.6	22.1	41.8	14.8	9.4	71.0	13.3	31.4	40.4	57.4	9.8	17.7	61.5	54.2	45.8	20.6	21.6	38.5	6.6	12.9	38.7	39.3	20.5	36.0	28.3	16.9	29.0	16.6	14.2	43.6	33.0	19.7	22.3	18.5	35.9	49.8	30.4	20.9	20.1	40.3	29.7	17.7	27.4	10.5	30.7	27.9	35.3	29.5	27.5	31.1	36.2	53.0	20.5	23.2	22.7	11.0	14.2	24.7	35.3	38.4	37.4	15.2	34.7	61.6	92.1	30.4	38.2	46.3	50.2	19.4	27.4	18.2	28.8	29.0	31.3	19.3	24.2	23.3	14.1	39.2	30.7	40.8	30.9	18.0	31.8	45.1	59.5	41.3	33.8	34.9	43.7	29.0	3.0	10.3	12.8	8.8	9.8	7.6	4.9	5.8	6.1	6.5	3.9	3.3	4.8	7.4	4.8	24.6	7.6	5.6	9.4	21.1	22.5	20.1	29.7	21.5	17.8	28.7	19.8	22.1	17.7	20.6	20.5	24.7	25.6	33.2	34.0	33.9	17.0	15.3	17.9	14.8	27.2	25.3	17.7	12.2	18.6	28.2	25.8	64.6	19.0	46.2	131.3	9.8	18.8	99.1	32.2	21.6	26.7	29.4	26.1	25.7	28.0	17.5	19.5	93.8	52.5	18.3	31.2	18.5	31.6	36.6	11.8	23.5	66.5	26.4	35.9	18.4	134.7	25.1	35.5	16.0	59.0	28.8	16.3	35.0	9.0	24.4	37.6	71.1	18.8	26.1	28.4	65.8	31.0	33.8	26.9	19.7	17.9	18.0	32.9	27.4	19.9	22.3	31.1	34.6	41.6	65.0	44.6
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.5	28.2	13.0	8.1	13.3	12.9	17.5	15.7	24.6	14.7	12.2	15.5	8.9	17.3	6.0	14.2	14.9	10.0	19.6	12.9	13.1	16.4	33.5	16.1	16.1	14.6	13.1	12.2	23.3	9.2	30.9	7.4	14.5	19.0	3.6	10.2	21.4	8.7	19.7	17.0	17.5	6.4	11.4	26.1	19.3	13.2	12.7	8.9	21.0	4.5	6.1	16.1	13.5	13.5	4.9	9.5	5.1	7.0	23.7	12.3	11.8	13.0	8.6	7.3	10.8	4.2	20.5	4.0	7.5	12.8	12.8	8.4	4.7	9.5	3.1	9.2	11.9	8.3	14.9	4.3	13.7	4.6	14.8	17.5	11.3	6.4	4.3	5.1	4.6	8.1	8.2	30.0	6.4	16.2	11.3	17.4	3.2	5.8	24.8	7.5	3.1	11.5	7.0	5.0	14.0	12.9	8.6	5.5	7.8	2.5	24.3	11.3	6.6	13.7	3.0	16.8	9.1	23.0	5.9	7.4	13.2	9.4	11.3	36.8	32.2	27.2	20.6	41.1	13.3	19.4	17.3	15.5	29.4	21.6	12.6	17.6	27.8	17.0	39.7	47.1	18.5	21.2	13.0	13.3	15.7	24.6	12.9	13.1	14.6	13.1	14.5	11.4	12.7	13.5	17.0	12.8	8.9	26.8	20.7	6.2	8.1	21.0	12.5	26.8	15.2	14.4	10.4	8.6	17.1	14.7	4.2	24.1	19.2	13.7	1.9	8.8	6.1	11.6	12.2	10.2	16.2	3.0	42.8	11.4	10.1	16.6	17.9	11.3	7.0	10.8	10.8	24.5	15.2	47.1	37.8	9.6	34.6	14.5	9.1	4.0	12.5	15.8	19.6	15.0	9.6	38.6	15.5	25.1	29.1	7.9	16.1	16.1	16.7	6.1	16.6	8.0	13.6	28.7	13.1	10.1	12.3	24.0	14.1	12.3	7.7	18.9	15.3	29.2	7.6	8.4
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.5;Intestinal goblet cells: 21.6;Paneth cells: 33.1;Proximal enterocytes: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.5	8.2	11.7	9.2	11.4	9.8	6.7	15.4	15.8	9.0	3.6	20.0	22.2	7.9	2.6	10.8	7.6	5.1	6.0	14.0	10.9	8.3	8.1	9.5	11.0	14.3	8.6	6.5	9.9	3.7	10.5	3.2	10.1	9.3	6.5	1.0	9.4	4.0	3.6	13.2	23.6	2.7	6.1	15.4	8.4	9.0	11.8	7.5	8.7	1.3	4.4	8.4	9.7	7.0	5.7	9.1	3.9	13.2	4.7	3.8	14.5	10.7	6.0	6.0	5.9	6.5	11.1	7.6	8.8	6.8	12.2	6.5	2.2	7.5	1.4	6.0	6.9	11.8	10.3	11.6	8.0	5.1	15.2	7.2	12.5	4.9	2.3	5.1	7.3	15.6	9.1	0.9	4.7	8.6	10.7	29.6	6.9	15.9	15.3	17.0	1.1	0.9	6.5	7.9	2.4	6.6	3.7	4.1	11.3	3.0	9.9	12.3	10.8	10.3	4.8	11.7	7.2	20.2	9.4	6.0	8.9	10.9	9.5	2.9	0.5	1.3	2.0	0.5	0.9	0.5	0.7	1.7	0.4	0.4	0.7	1.3	0.3	2.4	0.4	0.8	0.5	0.8	11.7	11.4	15.4	15.8	14.0	10.9	14.3	8.6	10.1	6.1	11.8	7.0	4.3	3.2	3.1	8.5	3.6	2.8	1.3	2.9	1.2	3.6	3.5	3.9	3.0	4.3	2.9	3.7	4.2	0.5	15.1	33.5	0.0	3.0	0.6	2.6	3.3	3.3	7.7	5.7	12.4	4.9	2.1	2.9	3.1	4.1	0.0	6.2	2.5	5.8	2.5	3.3	11.8	21.6	0.0	4.1	2.3	1.3	4.1	4.6	3.6	5.6	4.5	3.0	10.3	3.0	3.2	5.7	33.1	2.6	4.6	3.1	29.1	0.9	4.4	1.0	0.0	2.6	2.8	3.2	4.3	2.9	3.8	0.7	6.7	3.6	14.5	3.8
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113564	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Spermatocytes: 52.3;Spermatogonia: 42.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.3;ovarian cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;HeLa: 39.4;JURKAT: 18.0;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057527	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA057527: AB_2683457"	"unprognostic (2.75e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	1.5	1.2	1.0	0.7	1.5	2.0	1.6	4.4	1.1	1.5	1.1	1.7	0.4	1.0	1.0	1.2	2.1	0.8	0.7	1.0	0.8	4.5	0.2	1.4	1.0	0.8	0.6	5.0	9.2	1.3	7.4	0.3	0.9	1.8	0.6	1.3	1.7	0.5	0.5	1.9	1.1	0.8	0.9	1.1	1.0	3.0	0.8	0.8	3.2	0.6	0.7	0.9	1.8	1.0	11.8	0.7	0.1	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	5.3	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.0	18.0	0.1	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	3.8	0.0	22.6	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.5	0.2	1.2	0.2	0.4	0.6	1.1	0.3	0.0	0.1	0.0	0.1	0.2	0.3	1.0	1.5	4.4	1.1	1.0	0.8	0.8	0.6	0.9	0.9	0.8	1.0	1.1	3.2	6.9	1.3	1.3	2.8	5.6	1.5	13.6	3.0	3.9	4.8	0.6	1.5	6.8	0.0	2.1	0.0	1.1	0.5	62.6	3.8	3.9	0.5	2.5	0.8	4.9	0.0	4.7	0.9	0.2	11.7	1.1	1.1	4.5	1.9	0.4	0.0	0.6	0.0	1.7	2.8	0.0	0.8	1.8	7.5	8.4	1.8	0.0	2.8	0.9	5.1	2.1	0.0	4.4	0.8	1.6	0.7	0.8	4.6	0.7	8.9	2.2	6.4	0.0	6.8	1.7	52.3	42.4	4.5	3.1	0.3	1.8	2.1	1.2	4.5
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 187.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 255.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 255.9"	"Group enriched"	"Detected in many"	5	"HHSteC: 303.8;HSkMC: 546.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	66.2	40.4	4.0	18.8	7.7	19.5	50.6	15.6	3.9	161.4	3.5	51.5	18.5	187.1	4.4	40.6	49.7	32.2	35.5	3.5	0.8	37.1	79.1	63.0	3.9	2.9	1.7	34.4	18.7	0.9	15.1	19.2	3.5	111.8	7.2	0.7	28.8	8.4	19.1	38.3	63.5	42.7	0.2	26.9	43.8	4.7	1.8	1.8	16.3	6.6	1.0	68.4	94.0	1.5	0.4	0.6	0.0	0.0	10.2	79.0	3.0	6.2	5.0	0.8	1.0	0.0	0.1	1.8	9.7	26.9	0.9	45.0	0.0	0.2	0.0	0.3	0.1	0.2	3.0	12.7	303.8	0.2	1.5	546.6	0.0	0.6	0.0	0.0	0.0	4.1	0.3	9.2	0.0	0.3	5.3	12.2	3.5	9.7	0.7	1.0	3.3	7.9	0.0	0.0	1.7	1.1	1.1	0.0	2.9	1.7	0.4	1.5	0.1	0.2	0.9	20.5	0.0	1.3	2.7	0.6	0.1	6.5	0.0	3.7	0.9	1.0	255.9	1.1	5.5	0.7	33.1	105.8	0.4	1.0	14.4	96.8	9.8	50.4	2.2	42.9	0.1	123.2	4.0	7.7	15.6	3.9	3.5	0.8	2.9	1.7	3.5	0.2	1.8	1.5	9.8	0.0	5.6	1.3	6.6	36.8	2.0	82.5	2.2	3.7	5.1	3.8	4.0	24.3	43.0	1.8	0.0	3.4	427.0	9.7	1.9	3.8	0.2	12.7	256.6	5.7	13.8	4.0	8.4	1.3	355.8	257.7	10.7	6.6	6.3	0.2	15.4	40.4	12.8	0.0	0.6	9.7	73.2	5.8	15.4	0.5	29.8	9.5	26.6	6.5	9.2	0.9	1096.8	0.5	0.7	1.5	6.7	9.4	64.0	15.8	16.3	28.3	32.6	0.4	6.6	22.5	89.9	0.2	0.5	21.3	21.5	38.9	100.8	8.1	7.9	13.2
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211445-1249953	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	76.1	88.1	92.3	86.1	91.2	71.5	72.7	96.6	104.3	94.7	73.6	94.6	91.0	98.4	47.5	85.0	89.2	61.4	100.0	92.7	98.1	88.4	109.2	82.6	108.7	99.2	94.1	93.5	141.1	58.8	140.0	45.7	94.6	94.8	41.9	38.8	90.9	50.8	170.1	74.3	97.1	48.1	77.1	118.7	79.5	47.3	90.0	98.1	86.2	91.5	62.4	87.5	79.8	89.8	108.5	156.8	118.4	146.6	81.5	58.6	101.7	83.4	76.8	101.8	102.8	135.0	255.1	131.0	93.8	97.5	156.6	84.1	72.3	109.9	30.4	101.0	86.6	119.1	185.6	177.1	135.7	108.4	163.3	101.3	82.5	86.5	49.8	97.8	76.8	147.1	138.1	219.6	56.9	178.1	351.4	338.3	140.5	87.8	148.4	244.4	71.4	173.2	65.8	135.9	222.0	138.1	79.6	85.2	114.5	70.9	187.2	164.5	99.7	168.5	94.2	97.8	182.1	157.7	164.3	155.2	133.4	166.4	135.6	12.6	15.6	17.4	31.8	23.1	24.0	20.1	22.3	27.4	20.6	19.3	17.1	25.1	12.7	23.9	23.9	34.6	20.9	16.1	92.3	91.2	96.6	104.3	92.7	98.1	99.2	94.1	94.6	77.1	90.0	89.8	33.3	41.7	39.0	17.9	36.8	34.2	21.1	22.1	13.1	32.1	52.0	39.5	54.9	37.1	19.2	36.8	4.2	25.4	72.4	57.2	11.7	29.4	4.0	34.0	46.4	35.7	46.1	42.3	19.4	40.6	32.0	37.5	37.8	41.6	24.1	31.2	45.0	85.0	43.0	40.4	21.2	49.7	20.3	72.9	31.8	5.5	45.1	37.7	46.2	21.5	45.9	46.8	82.4	19.6	17.7	45.0	35.7	35.7	42.0	36.9	42.8	37.4	25.7	17.8	6.6	31.2	32.9	10.8	13.4	30.3	37.8	19.8	41.1	32.0	57.5	27.9
MAEA	"EMP, GID9, HLC-10, p44EMLP"	ENSG00000090316	"Macrophage erythroblast attacher, E3 ubiquitin ligase"	Q7L5Y9	4	1289887-1340147	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	28.5	44.2	21.9	23.5	21.3	18.3	28.8	19.8	24.0	32.6	25.9	39.7	33.5	34.4	10.9	46.7	29.2	17.5	38.6	21.1	27.2	40.9	32.3	24.0	24.3	25.7	23.0	34.9	35.4	30.7	38.9	17.2	26.3	29.2	14.2	8.8	35.7	21.5	37.1	41.2	35.7	14.9	18.1	40.0	37.1	26.8	23.2	20.7	33.9	19.2	15.7	30.7	33.5	20.0	58.1	66.9	47.6	47.7	31.5	31.1	61.4	57.4	30.6	47.1	42.2	70.5	73.5	52.5	43.6	42.4	85.5	42.0	46.1	72.2	19.1	42.4	52.2	49.2	74.1	68.1	37.1	55.8	50.9	38.8	38.6	37.8	23.6	31.8	38.0	50.4	70.4	41.6	41.3	61.5	84.2	86.5	62.2	63.4	72.9	81.0	38.1	47.8	50.3	68.2	84.7	57.8	51.1	39.3	41.5	26.3	71.5	48.4	52.8	85.9	36.0	39.0	96.1	50.5	83.4	58.1	59.0	51.3	48.2	74.9	49.9	70.9	59.2	52.6	83.5	47.6	47.1	56.4	47.1	38.1	41.4	42.5	117.9	45.5	77.3	33.0	59.8	59.1	21.9	21.3	19.8	24.0	21.1	27.2	25.7	23.0	26.3	18.1	23.2	20.0	22.0	19.2	25.0	28.4	21.6	18.7	15.7	33.9	8.0	28.1	22.5	25.3	35.5	14.3	24.3	16.5	20.9	48.2	29.7	41.2	46.9	43.4	8.0	21.9	25.2	24.4	20.4	26.3	19.6	30.3	46.4	25.0	25.5	25.0	10.8	30.4	19.6	15.0	39.6	21.9	23.2	33.1	30.5	29.2	15.9	9.8	35.4	23.2	28.4	14.0	46.3	22.3	28.8	22.6	20.0	40.3	31.3	37.2	23.5	22.7	30.4	36.4	17.9	19.1	13.1	24.9	27.9	36.6	44.0	19.3	19.9	95.2	29.7	59.6	38.1	21.8
UVSSA	KIAA1530	ENSG00000163945	"UV stimulated scaffold protein A"	Q2YD98	4	1345691-1395989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050824, HPA053496"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA050824: AB_2681251, HPA053496: AB_2682170"	"unprognostic (6.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.85e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.76e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (6.87e-4)"	4.2	4.3	3.5	5.5	4.1	8.0	4.4	3.4	5.1	4.5	5.5	4.7	5.5	5.0	6.0	4.2	6.4	3.4	2.9	3.3	3.1	3.2	3.9	6.0	3.8	5.7	3.9	5.5	6.7	2.6	9.3	2.8	4.7	4.1	3.5	4.7	5.7	2.7	4.6	9.2	5.3	2.5	3.0	5.6	5.5	9.4	5.4	3.8	7.1	1.5	3.4	4.7	4.5	7.5	3.7	4.1	6.1	5.7	7.0	9.0	4.6	3.4	2.9	3.0	2.6	3.4	7.5	2.7	6.5	3.4	7.9	4.4	3.8	3.9	2.6	3.7	1.6	6.4	7.9	4.0	2.7	3.9	7.6	2.6	7.8	3.4	4.4	3.4	5.0	4.6	6.2	8.9	3.7	2.1	5.8	8.1	6.0	2.9	5.2	5.0	3.1	3.4	2.7	5.4	4.4	5.8	2.6	3.0	3.8	5.3	8.0	2.2	9.5	11.4	2.8	4.2	5.9	13.4	9.0	6.1	8.5	4.4	6.9	0.1	0.6	0.9	0.6	0.5	0.3	0.4	0.5	0.5	1.0	0.4	0.4	0.3	1.0	3.3	0.8	0.8	0.2	0.5	3.5	4.1	3.4	5.1	3.3	3.1	5.7	3.9	4.7	3.0	5.4	7.5	20.7	6.4	26.2	16.3	11.5	5.5	5.2	3.4	5.7	18.2	13.7	10.7	3.6	7.2	8.8	16.5	41.7	3.4	17.1	10.3	3.9	8.0	7.6	23.7	23.1	9.1	6.0	7.4	6.9	8.5	2.9	10.3	21.9	20.1	8.8	16.7	5.3	12.5	6.8	30.3	9.3	10.9	8.2	10.8	6.3	7.3	5.3	13.4	5.4	14.0	7.6	9.0	7.2	5.5	16.5	10.1	6.7	3.8	12.6	5.0	10.7	4.8	23.6	25.3	0.0	13.1	11.4	23.2	9.4	8.0	6.1	3.7	12.0	12.8	6.5	4.5
NKX1-1	"HSPX153, SAX2"	ENSG00000235608	"NK1 homeobox 1"	Q15270	4	1402932-1406442	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029367	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA						"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM53A	DNTNP	ENSG00000174137	"Family with sequence similarity 53 member A"	Q6NSI3	4	1617915-1684261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.8;Oligodendrocytes: 14.8;Spermatocytes: 14.6;Spermatogonia: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.8;SCLC-21H: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036452, HPA058138"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA036452: AB_10671841, HPA058138: AB_2683619"	"unprognostic (8.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.15e-3)"	1.2	1.1	1.5	0.4	2.3	0.6	1.1	1.7	1.7	1.2	0.6	1.2	0.2	1.3	1.7	0.8	1.2	0.5	0.8	1.0	1.6	1.0	1.8	0.6	0.5	2.9	2.4	1.3	1.5	0.5	5.6	0.2	2.5	0.9	0.0	0.0	1.2	0.4	1.1	1.4	0.8	0.4	1.8	1.0	1.2	12.8	2.3	0.3	3.7	0.2	0.2	1.1	0.8	3.8	0.6	0.1	0.7	1.4	0.2	0.9	0.5	2.5	1.5	1.7	1.3	0.4	0.8	1.8	1.4	0.5	0.7	0.2	0.0	0.3	0.5	0.3	0.6	0.4	0.2	0.4	1.7	0.0	0.6	0.8	1.5	0.6	1.9	0.4	0.4	2.8	1.1	0.2	0.6	0.5	0.5	1.7	0.6	0.3	3.8	0.5	0.2	0.0	0.5	0.5	4.4	2.4	1.2	0.1	2.1	0.4	1.8	0.7	0.4	0.2	0.1	0.8	0.4	0.3	1.0	0.5	0.0	0.6	3.2	0.0	0.3	0.3	0.1	0.9	0.3	0.5	0.2	0.2	0.7	0.5	1.1	0.0	0.0	0.2	0.4	1.7	0.3	0.3	1.5	2.3	1.7	1.7	1.0	1.6	2.9	2.4	2.5	1.8	2.3	3.8	1.0	0.0	0.0	0.7	0.5	1.3	0.4	0.5	1.2	0.7	0.9	0.5	3.6	1.5	0.2	1.8	0.0	0.1	0.1	0.4	1.9	0.6	12.8	0.3	0.7	0.7	0.0	1.3	2.0	1.0	0.0	0.8	1.1	0.8	0.0	0.9	1.1	0.7	0.2	0.0	1.9	0.1	0.0	0.6	0.7	2.0	0.6	0.6	0.0	1.0	0.6	0.2	0.0	2.5	14.8	0.5	0.1	0.4	0.2	0.4	0.0	0.5	0.3	0.4	0.0	1.3	1.9	14.6	11.0	1.6	0.4	0.0	0.7	1.2	0.4	0.2
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TMEM129	D4S2561E	ENSG00000168936	"Transmembrane protein 129, E3 ubiquitin ligase"	A0AVI4	4	1715952-1721358	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.22e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (9.64e-8)"	"unprognostic (1.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.36e-3)"	20.8	33.7	30.2	11.0	31.2	6.1	20.6	30.2	30.7	23.7	37.1	34.4	22.0	27.8	10.1	25.0	26.7	11.8	38.6	27.9	28.1	41.2	46.9	21.7	13.0	35.0	32.6	25.8	36.9	33.2	43.0	10.2	29.5	29.6	8.5	6.4	32.9	19.1	30.9	20.3	26.1	9.5	33.2	25.9	31.6	15.4	32.2	8.1	35.5	18.7	8.2	27.0	19.8	30.1	16.1	18.4	15.0	22.4	27.0	15.7	17.3	12.7	20.4	13.0	13.9	13.6	38.8	20.9	14.9	13.7	23.1	15.8	7.7	16.2	2.2	14.5	23.1	11.9	13.9	17.5	22.0	16.4	19.9	26.1	34.2	7.1	6.5	30.1	20.3	19.4	13.2	15.1	12.4	12.6	22.4	26.5	23.3	17.6	22.4	14.3	7.9	26.0	32.6	17.6	34.7	21.4	10.9	19.0	17.3	5.3	39.3	7.5	14.0	15.0	11.3	13.3	12.5	37.7	12.1	10.0	17.3	22.2	16.4	0.1	1.7	0.0	1.6	1.1	1.4	0.7	1.4	1.2	1.6	0.9	1.0	0.7	0.3	1.0	1.2	3.7	0.7	1.1	30.2	31.2	30.2	30.7	27.9	28.1	35.0	32.6	29.5	33.2	32.2	30.1	13.2	22.4	9.3	17.0	11.4	5.1	15.2	9.6	13.6	27.2	15.4	13.0	12.9	18.6	6.6	23.9	6.2	20.9	26.8	28.8	25.4	20.4	1.1	7.9	8.2	12.4	13.1	8.6	7.3	19.6	7.8	17.4	12.8	8.4	10.2	14.7	15.4	19.9	17.9	25.2	9.0	26.5	14.2	11.7	4.9	3.1	30.4	8.7	10.6	13.1	7.2	39.6	25.7	8.0	11.9	14.1	14.9	36.1	13.1	16.8	24.0	18.4	7.9	19.7	13.1	21.9	17.1	7.1	5.6	13.7	9.5	5.5	12.1	22.7	33.8	11.3
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 148.3;esophagus: 139.7;skin 1: 271.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA		2500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.6	1.6	118.0	1.5	140.6	1.4	5.5	115.6	104.0	23.7	37.4	12.2	19.5	1.5	2.8	139.7	2.2	7.9	4.8	100.8	107.6	39.3	40.7	7.4	0.4	144.7	129.2	0.5	76.4	0.2	16.1	9.3	109.8	13.8	5.2	0.2	20.2	15.0	1.3	271.5	14.7	0.4	108.9	4.0	7.8	17.6	148.3	1.7	1.5	0.9	11.1	23.1	60.9	81.2	0.0	3.8	19.5	5.6	0.0	0.3	22.1	2.4	0.3	0.8	0.4	48.2	1.0	0.0	17.8	0.7	0.7	34.9	5.5	0.3	0.3	0.2	19.3	14.2	3.9	80.6	0.1	0.0	0.6	0.0	10.9	0.2	0.1	0.1	0.1	2.3	16.7	0.1	0.0	23.9	0.8	0.5	36.1	19.5	0.1	1.2	1.0	0.3	2.8	64.1	5.7	1.6	1.9	4.0	0.0	22.2	20.4	2.5	1.0	0.0	2.1	0.5	1.6	0.1	0.0	0.0	0.2	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.0	140.6	115.6	104.0	100.8	107.6	144.7	129.2	109.8	108.9	148.3	81.2	2.2	0.0	32.5	410.4	1.1	103.8	4.1	29.8	23.9	0.0	4.8	1.5	3.1	91.5	37.6	14.7	0.0	0.5	1.6	36.1	0.0	5.0	7.9	3.0	1.7	3.4	4.2	0.0	0.5	0.7	12.0	3.2	3.6	4.0	0.0	0.1	16.1	30.4	0.6	0.0	1.3	20.7	4.1	1.2	6.5	1.3	0.6	0.6	12.4	14.0	0.6	0.1	0.0	34.2	2.2	0.4	18.0	0.4	0.0	4.2	21.2	9.9	9.8	0.6	0.0	0.7	2.9	0.4	25.9	55.0	88.7	0.8	0.7	0.1	17.0	12.8
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856156	"Human disease related genes, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	13.6	16.3	14.3	7.9	13.7	7.7	10.8	11.7	14.6	8.2	10.8	20.3	13.9	8.4	3.2	23.8	8.0	4.5	19.6	13.4	13.2	13.3	16.4	8.9	7.0	12.7	13.5	9.2	12.5	11.4	8.8	4.9	11.9	8.4	10.7	4.5	9.6	4.2	18.7	15.9	11.7	5.1	12.2	10.7	13.8	14.5	15.0	25.7	10.7	10.9	7.9	8.4	10.6	11.6	22.9	38.1	11.6	36.1	17.4	12.2	20.7	22.1	10.7	21.8	16.9	35.5	24.7	37.5	15.4	23.3	34.0	22.7	29.8	31.2	13.2	25.1	31.1	38.4	30.9	25.6	22.6	39.3	30.3	19.9	22.0	24.9	21.8	10.1	19.0	22.6	51.5	22.9	15.3	25.1	57.3	44.7	30.5	24.7	43.2	32.4	16.2	21.9	17.0	31.3	29.5	26.0	25.2	31.5	13.3	10.0	29.7	20.3	28.8	24.8	14.8	21.1	37.3	19.8	32.7	29.3	22.0	33.8	20.2	3.9	3.7	2.0	5.8	5.0	5.7	4.2	4.9	4.9	4.1	3.6	3.2	4.6	0.5	5.9	5.1	12.9	4.2	2.1	14.3	13.7	11.7	14.6	13.4	13.2	12.7	13.5	11.9	12.2	15.0	11.6	12.2	16.0	11.5	15.0	19.2	40.0	40.7	13.4	8.0	19.4	19.7	10.5	23.3	11.5	14.0	27.6	33.3	17.5	24.9	116.1	31.3	25.5	32.2	9.1	19.4	16.7	15.6	20.4	14.3	31.3	22.6	17.0	32.1	14.7	10.2	17.9	16.1	33.3	21.5	15.2	12.4	29.5	12.2	18.4	19.8	45.1	20.2	13.0	19.6	4.7	13.9	12.7	28.8	9.5	13.2	42.4	52.7	16.6	17.8	58.8	48.8	46.1	5.6	28.4	13.1	23.8	16.1	54.2	44.4	25.2	51.1	15.2	16.7	21.9	53.2	48.4
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871393-1982207	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 20.3;Granulosa cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	10.1	8.4	12.7	16.5	13.0	54.9	9.9	23.6	15.2	9.4	0.8	19.6	18.6	10.7	7.3	13.6	8.4	8.3	15.8	11.8	11.5	9.8	8.3	12.6	25.4	9.8	8.6	7.7	13.5	12.0	13.8	12.2	12.0	9.7	22.5	28.5	11.6	8.4	16.7	11.6	18.3	12.4	4.4	14.1	12.5	37.2	12.6	59.8	17.4	13.7	24.3	9.7	9.2	14.9	124.0	58.6	168.3	71.2	17.5	26.5	44.2	98.2	85.4	115.2	128.8	44.6	141.4	117.5	31.4	78.0	158.5	50.2	114.4	74.3	195.0	58.3	47.7	151.3	81.7	25.5	18.6	89.5	74.9	9.9	19.8	101.2	89.9	60.1	92.2	123.4	81.7	132.2	95.8	42.1	243.3	99.7	68.8	60.1	77.1	137.8	106.7	42.9	45.4	57.4	115.6	82.7	78.4	29.2	31.7	71.4	68.9	52.2	64.9	109.0	87.4	72.8	188.1	54.1	72.9	113.7	66.0	81.9	108.0	4.0	1.1	1.3	1.0	0.8	1.1	0.9	1.5	1.2	1.2	1.7	1.1	0.8	3.4	1.2	0.5	2.1	2.9	0.7	12.7	13.0	23.6	15.2	11.8	11.5	9.8	8.6	12.0	4.4	12.6	14.9	12.6	12.8	18.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	15.3	9.1	0.0	0.0	8.1	12.9	0.0	15.7	7.2	0.0	3.9	10.4	0.0	13.0	11.7	6.3	0.0	0.0	0.0	7.1	10.0	6.0	0.0	20.3	2.5	69.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	5.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	4.9	0.0	0.0	4.0	7.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.4	5.2	3.7	0.0	0.0
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982717-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	9.3	7.8	7.5	10.8	8.6	14.2	6.0	8.0	11.5	7.1	6.1	9.4	13.4	11.3	6.3	9.5	12.4	5.7	6.3	8.0	6.9	6.8	5.8	6.6	10.8	8.7	8.9	15.5	16.7	10.1	3.0	10.3	6.8	8.9	4.7	7.0	18.2	8.4	12.0	12.8	13.4	5.7	8.1	12.1	12.7	16.5	7.4	9.4	7.4	4.6	7.4	6.8	1.8	9.5	27.2	24.6	21.0	38.8	8.5	8.9	41.6	14.3	10.1	16.9	13.4	41.1	45.7	47.8	20.1	9.3	21.0	25.2	21.3	17.9	8.2	24.5	33.2	31.5	18.0	39.4	12.4	33.1	30.9	7.6	15.6	11.3	12.0	12.5	13.0	26.6	60.5	22.3	7.4	31.7	63.8	94.4	60.8	23.2	36.5	57.6	18.3	30.2	12.1	22.5	57.1	35.7	16.4	19.3	24.4	13.0	37.1	24.5	14.7	17.0	19.2	19.8	31.9	47.2	52.7	53.6	19.4	34.5	21.4	7.0	14.4	14.9	15.4	16.9	18.5	16.3	17.9	13.9	13.9	24.0	15.0	12.0	5.3	15.4	14.0	17.3	22.1	13.1	7.5	8.6	8.0	11.5	8.0	6.9	8.7	8.9	6.8	8.1	7.4	9.5	11.1	12.8	17.9	30.7	18.5	32.6	18.6	20.3	17.6	19.2	17.6	19.3	4.6	14.3	19.1	12.9	39.6	27.9	16.2	14.6	9.8	18.7	24.0	25.2	17.7	13.2	16.2	17.2	55.9	13.6	28.1	14.7	13.3	28.5	9.5	23.3	11.4	8.3	16.4	37.0	40.9	17.8	14.2	10.1	12.1	7.4	15.5	11.3	14.2	13.1	19.6	18.1	19.6	31.7	30.2	16.2	18.7	13.2	14.0	23.6	17.5	8.9	17.3	21.9	0.0	15.4	15.2	32.9	39.4	29.8	38.2	28.5	18.8	15.8	20.1	27.0
C4orf48		ENSG00000243449	"Chromosome 4 open reading frame 48"	Q5BLP8	4	2041993-2043970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.9;choroid plexus: 62.6;pituitary gland: 74.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 412.4;Paneth cells: 484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 158.3;NB-4: 117.3;PC-3: 343.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052447	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA052447: AB_2681837"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.17e-3)"	13.5	18.3	50.0	4.6	68.4	2.7	9.6	71.0	66.6	5.2	62.6	20.4	2.7	5.5	0.2	4.3	7.8	0.4	8.2	49.4	60.8	20.2	4.0	7.9	1.3	81.5	63.2	6.6	18.9	2.4	74.5	2.1	58.6	7.1	0.9	0.2	9.2	1.4	1.2	3.1	16.3	0.6	67.8	18.5	11.9	56.1	60.3	0.3	9.3	0.0	0.6	6.8	2.9	97.9	33.4	27.1	5.3	24.9	2.4	3.9	35.3	31.2	6.0	5.6	5.3	18.6	19.6	4.4	29.2	1.2	10.4	9.2	0.6	3.5	1.7	20.1	158.3	10.5	15.8	10.7	5.2	21.7	70.3	3.0	5.9	1.2	0.0	1.8	5.9	17.9	35.1	0.1	3.9	20.6	24.6	117.3	15.8	1.8	343.1	56.1	8.3	11.2	5.0	12.3	42.7	60.0	15.3	0.7	47.7	0.5	8.3	10.3	26.5	14.7	31.9	11.0	35.3	23.8	22.4	0.4	14.6	13.2	20.8	88.5	451.6	431.5	123.6	325.6	127.5	187.7	157.2	138.3	270.0	167.9	89.1	92.9	349.2	29.6	290.7	301.1	199.8	192.8	50.0	68.4	71.0	66.6	49.4	60.8	81.5	63.2	58.6	67.8	60.3	97.9	13.3	0.0	1.9	8.8	58.1	21.9	6.6	13.2	7.4	12.0	147.0	139.8	10.6	20.0	14.2	200.5	0.0	8.0	52.8	412.4	70.5	320.8	97.1	326.7	92.6	42.1	235.1	30.7	5.6	222.7	116.5	47.7	35.7	107.3	107.5	209.0	123.1	11.9	235.5	18.5	8.2	154.2	44.7	272.1	113.3	350.5	19.3	158.9	327.3	7.5	205.2	78.8	20.6	6.0	41.1	198.2	484.2	28.2	84.1	10.9	223.7	7.9	28.8	15.0	13.1	1.7	53.2	99.7	193.2	5.7	10.1	13.1	73.9	50.9	117.1	11.1
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.5	0.7	56.1	0.1	46.4	0.0	1.6	42.9	99.0	0.0	0.6	0.2	0.1	0.3	1.3	0.1	0.9	0.1	0.8	45.8	29.0	5.3	0.0	0.0	0.2	52.3	46.4	0.2	2.3	0.9	1.8	0.1	57.5	1.0	0.1	3.7	2.3	1.6	5.7	1.0	0.2	0.2	33.0	0.3	0.4	9.0	88.8	0.2	0.3	2.5	0.0	0.0	0.0	38.9	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	56.1	46.4	42.9	99.0	45.8	29.0	52.3	46.4	57.5	33.0	88.8	38.9	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;testis: 2.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Excitatory neurons: 77.7;Inhibitory neurons: 42.7;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 26.8;Spermatocytes: 23.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	2.4	0.6	0.3	0.0	0.4	0.0	1.0	0.2	0.5	0.3	0.0	0.3	0.1	0.3	0.7	0.1	0.4	0.3	0.3	0.3	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.2	0.4	0.1	0.4	0.1	0.0	0.6	0.0	0.2	0.5	0.2	0.4	0.3	0.3	0.1	0.0	0.3	0.3	2.6	0.1	0.1	0.3	0.1	0.1	0.2	0.2	0.4	0.0	0.6	0.0	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	32.3	1.0	0.9	1.0	0.6	0.6	4.2	3.0	1.5	3.6	1.5	1.7	0.0	0.0	0.2	0.6	0.2	3.9	0.4	8.3	4.2	2.0	1.9	4.8	0.8	77.7	1.0	0.3	2.0	1.5	2.1	0.0	5.5	3.3	1.1	0.7	3.3	42.7	0.0	2.0	1.3	1.0	14.1	4.4	1.3	0.0	15.0	0.7	2.5	1.0	22.1	26.8	0.5	1.1	3.8	1.5	1.0	0.3	0.8	1.9	3.8	0.0	2.9	1.1	23.4	10.4	0.5	1.6	0.0	1.8	4.1	0.3	1.3
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2078998-2242276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040649, HPA048190"	Approved		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	9.6	8.6	3.5	7.5	3.5	27.5	8.9	9.0	4.6	8.1	1.9	8.3	6.5	7.3	4.9	8.0	7.2	4.2	5.8	3.4	3.2	6.2	7.4	9.0	10.2	3.4	3.4	7.3	10.5	4.0	5.6	6.5	3.3	8.5	5.3	5.8	8.5	4.5	7.4	8.9	9.2	4.7	2.3	12.0	9.0	10.7	3.4	8.6	7.4	4.6	8.3	7.1	7.7	4.3	9.8	4.7	14.2	13.0	5.5	8.5	12.8	14.3	6.0	12.7	10.6	9.5	12.5	18.9	6.5	5.7	14.3	9.3	11.9	7.2	15.9	6.8	6.9	12.5	13.1	7.0	4.5	11.6	11.2	4.3	10.2	11.0	5.8	6.6	10.3	8.8	22.0	21.2	12.5	5.4	19.6	19.5	11.2	8.5	12.3	13.9	12.4	10.4	6.3	6.7	18.4	10.0	10.1	7.6	8.4	10.5	15.7	7.8	8.5	18.1	7.8	11.1	17.0	11.2	10.6	16.9	8.8	16.8	12.0	9.6	4.2	12.2	7.9	5.8	10.1	5.5	8.2	8.9	3.8	9.1	9.5	8.9	4.7	10.7	6.9	6.8	12.0	6.6	3.5	3.5	9.0	4.6	3.4	3.2	3.4	3.4	3.3	2.3	3.4	4.3	15.5	3.2	4.8	0.0	15.8	12.6	5.0	6.4	15.4	11.9	9.3	8.8	5.8	7.2	10.3	3.7	12.5	7.3	24.0	3.9	1.9	7.4	11.8	8.9	11.8	9.4	7.2	23.1	0.0	5.7	11.7	9.6	4.6	8.3	13.3	12.1	6.8	3.7	7.2	25.2	0.0	6.4	12.2	5.4	9.3	6.4	9.9	10.4	12.4	0.0	7.9	6.5	16.5	0.0	0.0	5.3	1.8	8.6	22.5	5.1	5.8	2.6	5.4	12.5	0.0	12.3	17.7	34.4	25.3	10.5	7.7	5.1	26.5	10.1	5.8	3.0
MXD4	"bHLHc12, MAD4, MST149, MSTP149"	ENSG00000123933	"MAX dimerization protein 4"	Q14582	4	2247432-2262109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 169.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053363			Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA053363: AB_2682128"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.54e-2)"	"prognostic favorable (2.21e-5)"	"unprognostic (1.64e-1)"	"unprognostic (5.94e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.12e-2)"	38.6	42.0	43.9	11.3	39.8	29.8	35.9	62.1	58.4	31.1	38.2	35.2	18.3	37.1	11.6	21.0	27.9	15.1	36.2	40.9	37.7	38.8	20.6	38.5	20.2	40.6	40.5	23.2	25.3	12.4	63.5	14.3	39.7	33.0	7.2	5.9	35.0	25.0	24.1	25.9	28.6	14.0	37.5	57.6	31.2	22.1	41.2	23.2	33.4	14.4	9.1	25.1	19.4	39.6	2.3	8.3	12.9	15.5	44.2	32.6	3.0	16.4	16.6	12.0	12.2	2.0	7.1	7.1	36.1	25.0	6.4	11.2	3.7	13.0	3.1	6.3	39.5	1.3	29.0	23.6	32.4	5.5	14.5	51.1	22.9	3.9	6.1	26.5	28.9	10.3	9.8	11.6	11.3	16.2	12.6	31.6	5.1	9.6	36.4	8.5	4.4	15.1	14.2	13.0	20.8	38.7	15.4	7.5	12.3	15.7	35.2	34.4	68.7	13.3	5.3	9.9	3.7	17.6	13.2	2.8	18.2	4.9	4.0	7.2	2.7	3.4	3.3	3.0	2.7	2.2	3.0	3.3	2.5	2.0	1.5	1.5	1.1	2.0	3.0	7.2	4.0	1.4	43.9	39.8	62.1	58.4	40.9	37.7	40.6	40.5	39.7	37.5	41.2	39.6	169.7	19.2	19.9	48.0	37.9	19.1	15.3	13.6	7.4	81.6	67.8	67.1	18.4	17.2	16.1	60.7	87.6	44.3	129.6	47.9	15.6	16.5	10.1	39.6	81.9	54.7	33.6	20.6	11.6	18.3	48.4	53.6	23.0	42.8	24.1	37.9	103.5	35.5	50.3	65.6	20.5	55.9	10.2	72.9	27.5	28.8	33.2	58.8	23.2	27.2	21.6	67.9	68.0	19.1	19.7	17.5	31.8	56.4	54.0	28.7	44.0	22.1	13.4	97.1	26.3	39.6	48.5	7.0	37.0	17.3	26.3	32.7	54.7	100.5	38.2	13.1
ZFYVE28	"KIAA1643, lst-2"	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418651	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	5.5	8.7	4.6	3.1	7.5	2.1	5.4	49.9	18.0	5.5	0.5	8.0	6.1	4.8	1.6	4.7	5.4	3.4	3.9	7.3	0.3	8.7	6.5	6.2	4.0	9.4	6.9	4.5	5.0	4.3	10.8	1.0	7.4	4.0	2.8	4.0	5.5	2.8	2.9	5.4	8.8	1.5	1.0	6.7	7.2	8.1	5.0	2.6	7.7	1.8	2.0	4.8	4.6	6.2	0.9	1.2	0.2	4.2	2.4	0.8	0.2	2.1	3.5	1.1	0.3	0.1	7.6	0.0	2.2	3.7	2.9	4.4	1.4	0.3	0.7	11.7	1.5	0.3	5.3	0.3	4.8	0.8	12.6	3.3	0.7	1.3	0.1	7.7	3.5	1.1	2.2	9.2	1.0	2.6	0.1	14.2	0.2	2.4	9.3	0.0	0.0	4.7	1.7	0.6	6.6	0.5	2.1	0.1	1.2	0.1	2.8	0.3	0.6	2.0	0.1	6.2	0.2	14.8	11.7	0.2	6.0	2.8	2.0	0.4	0.2	0.0	1.9	0.0	0.8	0.4	1.0	1.3	0.3	1.8	1.3	1.4	0.0	0.2	0.1	0.1	1.9	0.5	4.6	7.5	49.9	18.0	7.3	0.3	9.4	6.9	7.4	1.0	5.0	6.2	12.2	0.0	1.7	41.4	3.7	5.9	3.4	2.1	5.7	12.2	7.6	6.2	3.4	7.2	2.9	11.0	18.8	0.3	25.4	32.3	7.9	3.4	29.1	5.1	4.8	8.0	2.4	1.3	133.9	2.3	0.3	3.6	11.7	6.3	8.9	2.6	5.3	3.7	1.9	8.4	93.2	7.8	2.0	2.2	33.0	8.9	1.5	5.1	7.2	32.8	4.0	1.6	48.4	23.6	36.4	2.6	16.8	2.2	9.8	1.7	18.1	4.2	3.0	17.8	0.0	2.3	3.0	3.1	8.0	6.2	4.8	0.3	31.6	8.2	6.6	5.4
CFAP99		ENSG00000206113	"Cilia and flagella associated protein 99"		4	2418974-2462942	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"brain: 4.8;choroid plexus: 5.8;fallopian tube: 3.9;retina: 1.5;testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Early spermatids: 11.6;Endometrial ciliated cells: 13.6;Late spermatids: 11.2;Rod photoreceptor cells: 5.5;Spermatocytes: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA071642			Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA071642: "	"unprognostic (7.54e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.93e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.49e-1)"	0.0	0.8	0.5	0.0	0.5	0.0	0.0	0.8	0.3	0.2	5.8	0.0	0.0	0.2	0.1	0.0	3.9	0.0	0.0	0.9	0.8	0.2	0.1	0.6	0.0	3.2	4.8	0.0	0.3	0.0	0.8	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	5.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	0.3	0.9	0.8	3.2	4.8	1.8	2.0	1.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.0	1.8	3.7	4.2	0.0	0.0	0.0	0.0	0.2	11.6	13.6	0.2	0.1	0.0	0.0	1.2	0.6	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	1.5	2.9	5.5	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536647-2732573	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	14.3	11.7	9.7	7.6	9.3	13.0	13.2	15.1	11.5	14.8	9.6	13.4	7.9	13.8	6.8	9.6	12.9	6.0	9.7	9.5	9.7	11.9	11.6	10.1	9.6	9.8	9.0	15.0	11.1	9.2	15.5	7.6	9.3	12.1	6.0	8.9	10.1	7.0	15.1	13.2	12.3	8.0	6.9	12.0	10.5	21.1	10.5	12.4	12.2	8.7	6.7	11.5	11.2	11.8	8.7	10.7	20.0	11.3	12.0	12.2	10.5	13.1	11.3	12.7	10.8	10.9	13.9	17.1	7.7	14.7	15.7	7.4	14.0	9.4	10.8	10.3	8.9	25.7	14.3	11.5	14.4	15.8	17.2	13.3	9.8	12.7	13.0	11.6	12.8	10.0	18.2	18.5	10.8	9.4	25.5	25.6	15.9	8.9	11.8	24.7	10.3	8.4	8.7	11.1	17.1	14.6	11.2	7.8	11.3	10.9	14.3	15.9	17.4	19.2	11.3	10.5	17.5	18.0	14.5	16.1	10.7	12.8	13.8	3.3	0.9	0.8	0.8	0.6	0.6	0.6	0.7	1.2	0.6	0.9	0.7	1.1	1.8	1.3	3.1	1.7	0.6	0.5	9.7	9.3	15.1	11.5	9.5	9.7	9.8	9.0	9.3	6.9	10.5	11.8	21.8	12.8	18.2	62.7	11.2	9.4	6.7	6.5	9.1	25.7	10.5	9.0	14.7	4.3	15.6	1.8	47.9	7.3	20.0	12.9	1.9	9.4	8.9	19.8	21.8	19.4	14.4	17.9	62.4	7.5	7.1	13.2	15.8	27.1	8.8	30.2	11.0	6.3	8.7	15.2	70.8	11.1	8.2	7.6	11.6	13.4	17.1	15.9	14.2	51.5	11.1	15.8	11.3	45.8	58.3	10.1	11.0	14.7	12.4	11.3	11.4	2.8	5.6	26.2	6.6	20.5	17.5	36.2	32.4	9.6	9.9	5.6	14.4	13.6	9.6	9.2
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756342	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	30.0	19.9	15.8	16.5	16.6	23.9	26.3	16.3	18.5	20.9	15.7	32.1	17.7	20.2	6.4	27.2	18.1	10.6	31.4	14.8	15.9	37.1	30.1	29.9	17.6	18.0	16.9	18.8	22.8	5.5	19.7	15.7	17.0	24.5	10.5	2.6	19.2	9.2	41.5	19.6	39.4	9.9	16.9	31.2	27.8	22.9	17.3	10.8	22.3	13.6	15.9	30.2	20.8	16.3	24.4	32.6	10.1	15.4	31.5	21.6	43.7	25.8	22.9	23.6	22.9	37.2	38.5	22.1	28.7	28.3	52.9	15.8	18.3	29.8	13.8	17.2	23.0	26.4	19.9	41.9	39.0	21.9	32.2	27.9	26.5	26.1	23.5	18.1	33.9	19.8	27.4	30.4	16.5	50.6	29.0	53.6	26.6	35.9	55.0	18.9	15.3	11.6	25.5	26.9	15.1	17.0	20.2	21.0	29.6	17.2	23.0	32.0	40.0	18.2	20.1	29.0	40.4	31.3	22.8	16.0	33.3	39.1	20.2	7.6	8.9	27.1	7.4	13.9	8.1	9.6	11.3	12.5	8.7	14.4	9.2	7.6	8.4	5.7	14.8	4.0	13.3	6.3	15.8	16.6	16.3	18.5	14.8	15.9	18.0	16.9	17.0	16.9	17.3	16.3	48.2	6.4	9.8	3.6	40.7	61.3	49.3	42.5	19.4	2.0	25.3	17.8	13.2	7.2	19.0	14.7	2.1	52.4	44.6	56.0	13.7	58.2	2.3	26.0	26.4	46.7	19.2	8.2	1.1	59.6	106.1	28.4	28.5	33.3	13.3	21.4	41.0	16.7	34.5	0.0	0.7	38.0	24.4	21.2	112.7	7.5	21.5	34.6	26.6	3.7	71.8	12.4	48.4	0.5	3.4	71.8	63.0	17.7	21.2	86.6	174.3	46.8	13.0	6.8	19.7	18.7	38.0	23.6	62.4	28.1	79.0	95.6	44.9	17.1	38.0	84.7
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793071-2841098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036789, HPA036790"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA036789: , HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	15.3	6.8	17.2	30.0	20.6	48.2	7.9	20.1	16.6	7.0	6.8	12.3	11.4	6.8	9.8	7.1	8.9	8.7	6.7	14.4	22.3	13.1	12.1	17.0	23.2	34.0	30.5	5.8	9.6	4.8	5.0	12.8	25.2	5.3	9.1	5.2	10.4	8.3	16.9	39.7	16.0	10.5	21.5	43.9	16.7	5.2	36.1	8.4	4.7	4.8	13.3	12.3	9.7	14.8	11.2	5.2	7.4	8.7	4.6	14.6	7.2	16.8	13.0	11.1	10.9	6.9	31.6	18.0	20.5	14.2	9.7	5.6	0.3	10.5	7.5	12.2	6.8	41.4	15.2	6.1	17.1	15.4	29.1	27.7	10.5	7.1	5.9	11.8	25.7	13.7	2.5	37.2	15.0	9.6	2.7	24.3	13.3	21.6	13.3	0.6	7.4	9.9	20.1	16.1	25.4	16.4	12.8	10.7	10.3	6.8	15.7	30.8	35.4	12.1	8.9	4.2	13.8	19.5	10.6	4.3	14.1	40.2	14.4	4.1	21.0	13.6	13.8	36.5	8.2	3.0	3.8	8.8	15.9	6.9	1.9	5.0	33.8	8.3	44.6	6.7	6.9	12.1	17.2	20.6	20.1	16.6	14.4	22.3	34.0	30.5	25.2	21.5	36.1	14.8	27.6	3.2	5.8	40.5	19.5	38.1	10.0	35.3	8.6	0.8	19.8	10.0	8.3	7.2	25.3	40.5	0.0	1.3	43.7	42.5	3.9	6.3	8.5	9.7	11.0	31.3	10.2	14.9	0.4	22.0	1.2	11.3	18.3	22.0	9.5	11.6	33.9	59.0	49.3	0.0	2.7	14.2	30.5	81.5	63.3	10.8	13.7	71.9	19.6	18.7	48.9	23.7	57.7	2.5	0.5	25.3	27.1	10.1	18.1	16.1	23.7	43.7	12.3	6.4	39.5	5.2	16.0	1.9	3.7	18.6	83.4	4.2	22.0	25.5	15.4	20.1
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
MFSD10	"IT10C3, TETRAN"	ENSG00000109736	"Major facilitator superfamily domain containing 10"	Q14728	4	2930561-2934834	"Predicted membrane proteins"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 251.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 275.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043209	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA043209: AB_2678364"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.76e-2)"	"unprognostic (9.43e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (8.32e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.00e-2)"	35.2	20.2	15.8	9.9	16.4	66.1	30.5	13.6	24.1	43.1	19.3	30.3	12.3	34.7	3.3	27.6	36.9	12.5	26.5	16.1	14.4	33.6	10.8	36.9	13.2	16.9	14.7	41.6	29.0	3.6	28.7	11.5	14.7	34.3	3.8	1.1	30.4	11.3	14.0	22.0	31.0	7.6	13.2	36.1	31.6	15.6	17.6	6.3	37.6	3.4	6.3	34.6	32.8	14.3	50.4	46.2	13.3	33.7	21.7	15.5	36.0	45.1	21.9	21.5	24.6	24.7	117.3	8.8	23.7	28.4	40.0	45.9	12.1	65.6	5.8	56.9	40.7	19.1	39.2	25.9	36.5	59.9	27.1	23.5	37.5	24.5	15.4	33.4	24.7	20.0	26.4	18.0	16.5	53.8	16.9	275.6	43.0	38.9	54.5	20.7	6.4	41.8	32.9	30.6	34.2	40.7	10.8	31.5	49.1	13.5	82.9	112.9	37.1	17.7	30.4	22.2	36.6	12.2	5.8	13.8	50.0	153.3	27.8	64.7	55.0	117.4	73.0	71.2	62.6	45.1	46.8	82.1	57.4	35.2	23.3	41.1	44.2	45.9	95.8	45.7	34.4	42.6	15.8	16.4	13.6	24.1	16.1	14.4	16.9	14.7	14.7	13.2	17.6	14.3	64.6	38.5	29.1	17.6	41.3	31.4	78.8	251.5	28.5	9.2	56.3	68.1	5.0	28.6	123.2	46.0	8.4	67.4	71.0	37.8	3.9	96.0	11.7	41.5	33.4	41.1	28.2	13.3	21.5	45.9	93.0	42.9	33.6	44.3	32.4	50.7	45.7	3.1	69.6	15.2	14.8	37.2	93.6	49.3	36.7	18.8	36.4	45.6	42.7	9.4	62.1	11.0	64.9	9.5	8.8	86.0	51.5	22.6	28.1	92.1	60.0	17.9	104.9	10.0	92.1	27.0	56.6	15.5	16.1	26.9	26.9	83.7	62.4	44.7	49.4	100.5
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	"G protein-coupled receptor kinase 4"	P32298	4	2963571-3040760	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3;testis: 42.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 123.0;Early spermatids: 357.7;Late spermatids: 500.3;Spermatocytes: 180.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057023	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA057023: AB_2683313"	"unprognostic (1.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"	2.8	3.3	6.2	1.1	6.2	1.3	2.4	19.3	8.4	3.0	0.3	2.8	1.0	2.7	2.3	1.8	2.1	2.4	4.9	6.5	5.7	2.2	2.0	2.0	1.2	6.0	5.5	3.5	5.4	4.4	6.2	1.6	5.7	2.0	1.4	10.1	2.9	2.1	4.8	2.3	1.4	2.1	3.6	1.4	3.0	42.3	6.4	1.6	3.3	4.4	1.2	2.3	2.2	7.2	2.3	0.8	2.7	7.9	6.3	6.1	1.6	4.3	1.9	2.4	2.1	2.3	0.7	5.1	1.9	7.1	4.8	0.7	3.6	3.6	2.1	3.4	3.4	5.6	3.2	2.6	3.8	2.3	1.9	4.1	5.7	4.3	2.0	2.7	4.7	5.5	5.4	6.6	5.8	2.6	4.8	4.8	2.1	3.3	6.0	6.1	3.4	2.1	2.3	2.9	15.2	4.8	2.7	1.2	4.1	1.9	6.0	3.5	5.5	6.6	1.7	4.5	4.0	6.5	4.0	3.8	3.3	5.0	2.2	2.1	0.3	0.6	0.3	0.7	0.4	0.3	0.2	0.2	0.1	0.3	0.5	0.4	1.1	0.5	0.2	0.7	0.1	0.4	6.2	6.2	19.3	8.4	6.5	5.7	6.0	5.5	5.7	3.6	6.4	7.2	3.9	3.2	7.4	34.6	2.1	11.2	3.2	5.0	7.4	57.1	5.0	5.5	11.4	4.3	5.6	3.7	123.0	2.1	4.7	0.8	13.7	2.7	357.7	4.2	7.2	4.2	10.3	8.6	53.9	3.8	5.3	8.7	5.1	3.8	5.7	75.0	6.1	3.0	3.4	18.5	71.1	2.4	4.1	2.9	4.6	500.3	13.1	3.1	7.2	9.4	3.0	11.4	2.1	48.2	29.3	2.1	0.4	8.2	5.3	1.8	2.0	5.0	1.2	58.2	6.6	8.4	5.7	180.4	22.3	6.5	11.4	3.0	4.0	34.6	1.3	2.4
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3041363-3243960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	8.3	9.3	10.5	8.2	11.7	8.1	7.6	7.8	14.2	6.1	8.2	8.1	6.0	7.1	8.3	10.4	6.7	5.1	7.1	15.7	3.5	7.9	8.9	10.1	11.5	8.7	5.2	7.2	21.3	12.3	9.0	6.9	7.8	7.0	6.5	10.3	7.2	5.8	15.3	15.1	9.7	5.8	3.0	11.5	8.9	10.1	6.8	11.3	9.1	12.4	8.8	7.3	7.0	11.0	19.5	14.2	17.6	10.3	30.9	20.2	17.7	9.0	10.4	13.0	12.6	17.3	12.2	28.6	8.9	20.9	21.6	10.7	20.6	15.3	12.0	7.8	15.4	27.4	18.0	18.8	7.5	17.7	37.9	11.1	9.5	25.4	10.7	9.3	14.3	13.0	17.7	9.9	11.4	17.9	22.4	17.1	21.2	9.7	20.7	17.7	16.9	5.7	14.2	18.1	18.5	13.9	15.0	5.7	14.6	12.9	16.1	10.8	20.6	16.8	11.1	12.4	19.0	7.6	8.8	22.9	13.4	16.4	13.3	0.0	0.7	0.9	1.0	1.1	0.7	0.8	0.8	1.3	1.1	0.6	0.4	0.7	0.1	0.9	1.5	0.7	1.2	0.7	10.5	11.7	7.8	14.2	15.7	3.5	8.7	5.2	7.8	3.0	6.8	11.0	15.8	25.6	14.8	41.1	20.7	13.8	8.0	12.4	9.1	48.1	20.4	15.4	10.4	17.2	14.6	14.7	181.4	11.8	26.1	22.4	5.9	12.0	9.4	23.1	20.8	17.2	18.5	18.5	88.8	17.5	11.7	13.9	20.9	25.3	11.4	54.9	22.1	17.1	26.7	45.4	75.1	13.3	4.1	23.4	15.4	10.3	16.1	25.4	8.8	40.3	18.2	20.8	24.7	59.8	52.4	20.0	21.2	11.7	15.3	15.7	20.9	12.2	12.0	50.7	13.1	19.2	13.6	13.0	21.3	21.9	20.0	8.3	19.5	16.8	20.9	11.6
MSANTD1	"C4orf44, LOC345222"	ENSG00000188981	"Myb/SANT DNA binding domain containing 1"	Q6ZTZ1	4	3244369-3271738	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;testis: 3.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 38.5;Late spermatids: 28.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (7.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.24e-1)"	0.3	0.2	2.4	0.1	2.9	0.1	0.3	0.8	2.3	0.5	0.0	0.4	0.1	0.3	0.2	0.4	0.3	0.0	0.3	2.2	4.4	0.5	0.5	0.5	0.1	0.9	1.4	0.4	1.0	0.0	1.1	0.0	1.0	0.6	0.0	0.7	0.3	0.0	0.7	0.3	0.4	0.0	0.0	0.8	0.8	3.8	4.5	0.0	1.0	0.0	0.0	0.4	0.4	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.9	0.8	2.3	2.2	4.4	0.9	1.4	1.0	0.0	4.5	0.8	0.5	0.0	0.0	1.3	0.1	1.0	0.1	0.1	0.0	2.4	0.5	0.3	1.4	0.0	0.1	0.0	4.2	0.1	0.5	0.1	1.9	0.0	38.5	0.7	0.3	0.3	0.0	0.0	3.0	6.8	0.5	0.2	0.0	0.8	0.0	2.2	0.0	0.2	0.3	1.7	3.0	0.2	0.0	0.0	0.7	28.4	0.0	0.3	0.0	1.9	0.0	0.8	1.0	1.0	1.8	0.3	1.1	0.4	0.0	0.2	0.0	0.3	0.2	2.0	0.0	0.4	0.3	4.5	1.3	0.4	0.3	0.0	0.2	0.1	0.1	0.1
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	8.4	6.5	13.6	2.9	46.6	2.3	8.7	10.2	20.5	16.1	10.5	8.3	4.8	8.6	4.7	30.4	9.9	3.9	6.7	12.9	8.5	11.1	17.3	10.6	3.5	9.5	8.5	12.5	4.9	3.3	13.8	3.7	8.2	16.6	1.9	3.8	9.4	4.7	12.3	20.7	6.2	2.6	7.8	6.0	6.7	10.3	8.7	3.6	8.0	4.6	3.3	10.4	20.2	10.5	4.8	6.0	11.9	8.6	3.9	3.1	4.9	5.1	4.1	5.2	3.8	4.9	2.8	1.1	3.1	4.5	7.6	4.6	2.3	16.3	1.7	0.1	1.9	0.5	3.6	12.0	3.5	0.3	6.5	2.6	10.9	2.7	3.6	4.6	11.5	4.2	5.6	0.2	4.8	4.1	0.8	13.1	5.6	2.7	5.7	12.3	4.6	4.0	2.7	14.1	13.3	13.8	3.2	2.2	11.4	2.9	5.4	8.2	8.7	10.0	6.5	2.0	5.5	5.9	4.9	2.7	5.9	7.2	7.3	0.4	0.3	0.0	0.2	1.1	0.0	0.0	0.2	0.1	0.4	0.2	0.3	0.1	0.4	0.0	1.1	0.2	0.2	0.2	13.6	46.6	10.2	20.5	12.9	8.5	9.5	8.5	8.2	7.8	8.7	10.5	16.1	6.4	6.4	66.9	2.6	84.4	142.0	69.3	71.2	17.3	11.0	14.9	8.6	8.6	28.6	5.5	29.2	6.2	1.3	6.4	3.9	10.4	5.0	22.8	13.3	26.6	14.9	4.8	44.3	10.4	1.3	14.6	7.7	11.8	14.0	57.7	27.8	28.8	20.8	10.1	170.1	10.8	8.2	12.4	11.3	5.5	14.9	21.7	17.8	47.8	7.8	29.3	2.1	71.4	25.5	14.7	2.7	7.9	0.8	53.9	6.0	23.9	34.6	18.9	0.0	12.5	12.7	24.0	15.3	84.4	110.0	6.7	4.3	11.8	9.0	153.8
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441968-3449486	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"liver: 217.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 85.6;Hepatocytes: 72.0;Late spermatids: 165.9"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	9300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	1.5	0.0	2.3	0.0	0.1	2.2	2.6	0.5	0.7	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.1	1.3	0.6	0.6	217.1	0.1	0.0	0.9	0.6	0.1	0.1	0.0	0.7	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	3.8	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	2.2	2.6	1.3	0.6	0.9	0.6	0.9	0.5	0.8	0.6	0.1	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.6	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.0	4.4	2.2	72.0	0.0	3.3	3.9	0.0	0.0	3.2	0.0	165.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	0.3	0.0	0.0	1.2	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	21.5	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3503612-3532446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 584.3;Syncytiotrophoblasts: 693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"		NA	NA		810000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	6.6	9.0	6.6	2.6	10.3	6.0	6.4	8.6	7.6	8.9	10.7	7.6	3.3	8.6	3.2	5.8	7.5	1.9	19.3	5.8	8.1	12.7	9.6	8.5	2.1	8.0	6.9	9.5	14.4	7.7	14.4	6.3	7.9	8.2	1.7	2.8	10.1	4.1	8.9	6.3	6.7	1.9	5.2	8.6	9.2	9.2	7.5	1.6	8.9	2.4	1.4	7.3	6.3	6.3	3.7	7.4	5.7	8.2	5.5	2.9	12.5	5.9	4.8	4.3	3.1	14.9	7.0	2.1	6.0	4.2	7.0	6.2	3.4	5.8	2.4	1.6	7.9	2.9	7.8	10.4	4.2	4.7	12.5	4.0	4.3	3.9	1.9	4.7	5.2	3.9	5.1	7.0	3.6	5.9	3.1	18.4	4.9	5.1	7.8	4.3	4.2	7.1	4.8	8.6	5.6	4.6	7.4	3.0	8.1	3.4	6.7	8.6	5.6	5.1	4.7	4.1	8.2	4.2	2.9	2.8	5.9	13.3	7.2	21.9	23.2	60.1	9.3	19.7	8.1	9.9	8.6	8.8	13.3	10.0	9.4	8.6	20.5	11.7	19.1	10.2	11.5	27.3	6.6	10.3	8.6	7.6	5.8	8.1	8.0	6.9	7.9	5.2	7.5	6.3	95.0	109.0	90.9	21.2	78.0	67.8	174.6	267.7	52.9	70.6	75.3	84.2	165.9	108.7	158.7	195.0	45.9	584.3	75.8	147.7	50.9	159.3	40.4	85.5	229.6	88.2	82.6	35.7	22.5	107.9	184.0	152.5	79.0	71.2	81.1	102.3	62.4	92.6	243.1	38.7	20.6	121.6	164.8	100.5	80.2	60.0	126.2	154.2	147.7	16.9	107.1	140.0	91.6	28.1	16.7	95.4	153.4	151.6	205.2	124.5	204.6	273.7	144.8	86.2	78.9	82.8	108.1	272.5	161.4	40.7	61.4	693.5	86.0	99.9	109.9	140.5
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 84.9;endometrium 1: 57.6"	"Cell type enriched"	"Detected in some"	5	"Endometrial stromal cells: 135.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 22.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"basal ganglia: 34.3"	HPA057688	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	17.9	3.7	7.6	0.5	22.3	0.0	8.2	3.7	8.8	84.9	3.2	3.1	0.4	57.6	2.2	2.0	22.7	0.4	7.6	6.8	5.5	32.9	0.6	4.1	0.7	5.4	5.7	8.3	3.8	0.2	4.8	3.6	7.1	22.4	0.2	0.8	1.2	18.6	3.5	7.4	3.2	2.1	3.8	22.0	2.4	3.7	8.6	0.4	1.4	1.8	0.1	4.2	14.1	6.4	0.0	4.6	0.1	0.1	0.5	0.0	0.2	0.5	0.0	0.1	0.0	2.4	1.4	0.0	2.3	0.4	0.8	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	13.3	0.6	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	21.9	0.0	0.0	7.4	8.6	0.0	0.0	6.8	0.0	0.0	0.4	8.0	9.7	3.0	0.0	0.1	1.9	7.0	0.1	0.0	0.0	5.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	22.3	3.7	8.8	6.8	5.5	5.4	5.7	7.1	3.8	8.6	6.4	26.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.2	1.7	0.8	0.9	1.0	2.8	0.0	12.9	0.0	0.9	0.1	0.1	3.9	0.4	0.0	4.7	135.9	5.4	0.0	0.0	1.2	0.0	0.2	1.4	0.0	2.4	0.0	10.7	1.1	0.0	0.3	3.3	0.6	0.2	0.0	0.0	0.7	0.4	1.5	0.6	0.0	1.0	0.0	5.8	0.0	0.0	0.2	0.1	0.0	3.8	0.0	0.3	0.0	2.4	0.0	0.1	0.0	0.9	5.8	0.1	1.6	0.0	0.0	1.6	0.6	0.0	0.1	0.2
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188726-4226929	"Predicted membrane proteins, Transporters"	"Biomineralization, Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035599	Uncertain					NA	NA						"Cluster 25: Spermatids - Spermatogenesis"			"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM128	MGC13159	ENSG00000132406	"Transmembrane protein 128"	Q5BJH2	4	4235542-4248223	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044809	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA044809: AB_10963539"	"unprognostic (4.97e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	22.5	27.2	21.7	15.4	24.0	8.4	33.0	24.0	34.8	25.3	21.9	23.1	20.7	27.3	47.0	20.4	29.2	16.9	22.9	21.1	23.8	33.5	19.7	25.0	23.3	25.2	23.5	36.6	21.4	44.7	17.8	26.9	24.9	26.8	24.9	16.2	22.0	25.5	14.4	22.5	19.4	16.4	24.6	22.2	23.7	25.3	23.2	23.6	37.2	15.3	23.2	17.9	18.4	29.1	15.7	12.0	43.7	33.3	34.8	29.0	31.1	33.2	37.2	34.8	33.0	13.5	60.9	9.1	17.0	29.6	33.0	13.3	21.1	22.5	33.0	25.0	13.1	17.1	8.8	19.0	48.9	41.4	30.0	40.6	38.7	13.5	27.0	31.1	20.9	29.9	24.7	17.9	40.7	17.1	34.0	55.3	36.3	22.8	23.4	13.2	17.5	19.7	52.9	24.4	24.5	39.6	13.5	12.9	41.2	28.6	44.4	40.5	20.5	32.8	13.8	30.9	35.0	49.8	43.9	30.6	34.2	28.6	40.7	25.7	36.5	42.8	36.3	50.4	45.8	38.1	43.9	36.2	38.1	34.3	59.0	49.9	17.4	45.6	45.0	61.5	36.7	37.9	21.7	24.0	24.0	34.8	21.1	23.8	25.2	23.5	24.9	24.6	23.2	29.1	20.7	12.8	22.7	8.8	13.8	17.8	20.3	63.5	12.0	9.9	25.5	22.0	9.1	24.3	30.5	31.3	2.1	45.3	17.3	24.2	29.4	28.7	25.9	16.3	19.6	18.6	17.3	15.2	11.1	23.7	44.4	23.1	7.1	14.6	15.8	14.3	27.8	18.2	30.2	13.5	12.3	23.2	28.5	23.5	14.0	8.9	40.7	14.9	39.2	10.3	25.2	26.4	23.7	14.1	24.5	18.2	33.9	37.6	5.7	24.0	24.9	38.3	32.6	11.7	46.0	18.9	20.3	76.7	34.4	12.8	25.1	43.8	16.3	17.0	17.7	20.6
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290154	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	14.8	8.4	7.8	19.8	8.4	20.4	11.2	8.2	13.0	10.0	7.1	10.8	8.8	9.1	5.7	15.9	10.4	8.2	15.6	8.0	9.0	8.8	10.4	11.8	24.3	9.0	8.6	12.4	9.6	5.3	8.4	11.1	8.9	7.8	10.1	11.1	7.3	6.7	21.2	9.2	9.3	9.0	7.9	18.7	7.9	102.1	8.5	12.8	6.7	11.7	17.8	18.8	10.8	9.3	59.9	30.8	26.7	39.3	22.9	26.0	46.1	53.2	18.1	53.7	37.1	97.1	75.6	158.9	37.5	23.0	86.2	37.0	100.6	55.4	69.8	28.6	74.8	159.2	29.5	109.0	38.7	184.4	41.4	20.5	34.4	61.8	103.9	13.9	47.2	89.1	217.9	51.2	37.8	60.5	63.4	236.6	134.0	62.1	99.2	96.2	48.6	76.4	24.4	40.7	63.4	27.4	29.0	31.0	55.8	34.0	32.3	54.4	44.7	53.3	42.7	70.2	169.1	36.2	59.1	250.4	36.5	154.7	44.2	37.3	26.4	24.4	73.5	26.8	85.5	21.7	48.2	80.3	19.5	15.0	22.1	47.9	7.6	30.3	39.2	14.3	25.4	30.2	7.8	8.4	8.2	13.0	8.0	9.0	9.0	8.6	8.9	7.9	8.5	9.3	29.1	16.0	23.5	6.8	26.9	120.1	59.2	19.9	27.9	10.1	15.7	32.9	20.9	14.3	25.6	1.8	8.4	47.7	128.9	11.5	9.8	24.9	223.1	17.7	29.4	32.3	10.7	46.3	3.6	19.8	55.6	31.9	9.7	12.7	21.5	31.5	14.3	11.2	35.8	15.2	4.2	16.1	4.1	30.4	34.0	113.4	34.2	44.7	21.4	2.8	35.2	14.1	197.8	6.0	9.3	30.0	11.4	26.7	36.1	117.5	3.0	7.4	19.2	30.2	39.5	34.4	27.9	718.6	36.6	36.0	115.8	20.2	135.3	46.8	28.9	64.1
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	2.3	1.8	0.8	2.2	0.7	5.1	2.4	1.0	1.6	2.4	1.1	2.1	1.6	2.2	2.4	1.8	1.9	1.9	2.3	0.8	0.8	1.8	1.9	2.4	3.0	0.9	0.7	3.7	2.9	2.1	3.1	2.0	1.2	2.8	1.6	3.4	2.2	2.2	2.9	2.2	1.9	2.3	0.4	3.5	1.7	4.0	1.0	2.0	2.9	2.1	3.0	2.4	2.1	2.3	1.4	2.2	2.7	4.6	3.6	3.7	3.2	1.6	3.2	3.6	2.8	1.9	2.6	4.9	1.7	1.9	4.4	2.3	4.8	2.8	3.7	1.6	1.9	5.7	1.5	2.8	2.8	3.5	2.0	2.4	2.3	3.3	2.1	2.0	3.6	5.2	3.0	2.6	3.4	2.2	6.9	6.7	4.7	2.0	3.0	4.1	3.6	3.1	1.4	2.4	3.3	3.2	3.7	1.4	3.7	3.6	2.0	3.3	3.6	3.2	1.4	2.0	3.7	3.1	3.3	4.3	2.3	2.9	3.2	2.9	2.0	9.8	4.6	2.1	3.8	1.6	2.6	4.5	1.5	2.4	2.9	3.4	4.6	2.8	1.8	0.3	2.6	1.5	0.8	0.7	1.0	1.6	0.8	0.8	0.9	0.7	1.2	0.4	1.0	2.3	3.1	0.0	1.1	3.9	5.3	2.5	1.9	1.8	2.2	2.9	2.2	3.4	1.9	1.5	2.1	1.8	4.2	2.0	5.8	0.8	0.0	1.9	2.7	1.2	2.7	3.1	1.2	3.6	11.5	2.6	1.5	3.1	2.0	1.3	1.3	5.4	3.9	2.2	1.8	1.7	12.5	1.8	2.0	3.1	2.4	0.7	1.5	2.7	3.6	4.7	4.5	1.7	9.2	11.6	10.0	1.1	2.9	2.2	6.6	2.1	1.8	0.9	1.3	8.2	0.0	2.2	2.1	9.7	5.5	1.7	2.6	1.5	6.3	4.6	1.6	1.2
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.7;pituitary gland: 135.1;skin 1: 120.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2"	"Cancer enriched"	"Detected in many"	4	"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6"	"Lineage enriched"	"Detected in many"	57	"T-cells: 61.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"				"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	5.0	25.3	29.0	4.2	33.1	1.0	6.0	59.6	50.7	17.1	5.3	7.9	6.8	7.8	2.1	30.7	20.1	1.3	5.9	18.4	95.7	4.4	0.5	1.5	3.2	57.1	64.8	46.3	1.8	0.1	135.1	18.3	58.8	22.8	7.1	32.3	6.7	18.2	0.7	120.9	5.8	6.9	24.2	2.2	8.0	16.0	45.4	9.5	0.5	3.0	3.5	13.3	30.1	24.2	0.2	0.1	0.8	0.5	0.0	0.0	14.6	0.3	0.0	0.2	0.0	1.3	0.4	0.0	10.4	0.5	3.3	2.4	84.7	5.5	0.4	0.0	3.0	0.0	0.2	0.0	4.1	0.0	0.0	0.1	12.0	0.0	2.3	0.0	14.6	22.3	0.0	0.1	1.3	0.0	6.8	0.5	10.1	0.1	0.4	0.1	0.0	0.4	0.0	4.8	168.6	82.5	0.6	0.2	80.9	7.0	0.9	0.3	204.6	0.0	13.0	0.2	0.3	0.1	0.4	75.9	0.1	0.2	0.4	0.2	0.1	0.1	45.2	0.1	61.9	0.1	42.2	37.1	0.1	0.1	10.4	27.6	1.0	0.9	0.2	0.1	4.5	15.7	29.0	33.1	59.6	50.7	18.4	95.7	57.1	64.8	58.8	24.2	45.4	24.2	1.6	9.6	0.0	5.9	0.4	86.8	83.4	47.9	31.3	222.4	0.7	24.3	0.0	0.0	13.2	0.0	4.2	120.2	6.0	0.0	0.0	0.0	31.2	10.3	1.4	2.1	2.4	0.0	16.6	0.0	15.2	24.9	0.0	16.4	1.3	128.8	1.8	0.0	8.2	8.4	32.2	0.0	4.1	0.0	13.6	44.2	3.1	1.3	291.7	6.5	0.4	6.4	20.6	1.5	4.0	0.1	0.2	5.7	0.7	19.9	0.0	20.4	1.7	24.3	0.0	0.2	10.8	2.9	14.4	44.8	178.2	76.8	17.0	96.0	0.3	77.0
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 119.9"	"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 191.1;Glandular and luminal cells: 249.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Plasma membrane"		"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.84e-4)"	"prognostic favorable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.69e-4)"	10.6	16.0	8.4	10.9	9.4	12.0	10.9	8.9	10.4	119.9	14.5	12.8	18.1	53.9	8.2	10.7	48.6	14.0	13.0	7.9	9.9	29.2	15.7	10.8	13.2	9.4	8.9	11.3	22.5	16.9	14.6	12.8	10.1	10.6	13.4	8.3	12.1	8.9	16.5	12.0	15.6	15.7	8.2	10.6	18.5	30.5	10.2	9.4	11.3	9.9	12.4	11.0	11.8	9.3	26.6	16.7	19.3	20.0	16.2	23.7	26.1	30.1	26.9	27.6	22.8	35.5	37.3	35.1	69.7	27.1	24.9	13.9	34.6	17.2	27.0	15.1	18.6	22.0	22.3	43.4	24.2	38.6	17.8	22.2	14.7	23.4	16.9	15.4	23.5	27.5	21.7	30.0	19.9	14.0	35.6	27.2	26.0	21.3	36.1	31.4	14.6	28.2	28.2	15.6	24.7	22.0	22.2	14.7	26.4	16.5	21.6	18.3	27.2	16.7	18.4	15.4	32.1	21.6	35.4	40.1	20.4	29.3	21.0	10.6	15.6	10.8	15.1	16.0	18.2	16.7	14.0	13.7	23.8	14.4	11.7	13.4	3.1	16.9	20.6	37.6	14.3	14.0	8.4	9.4	8.9	10.4	7.9	9.9	9.4	8.9	10.1	8.2	10.2	9.3	17.5	32.1	9.0	52.5	15.8	7.9	8.3	20.3	9.6	39.3	14.4	11.6	20.4	18.6	25.3	20.2	20.9	31.0	27.9	33.8	70.5	32.5	80.6	191.1	38.4	14.8	4.9	15.6	40.2	27.9	19.0	18.5	23.9	249.4	8.2	21.6	6.8	10.8	28.1	10.1	48.0	22.8	32.6	13.7	12.4	76.5	14.0	21.3	14.2	48.7	26.5	25.8	16.5	37.7	56.4	36.5	28.8	14.7	20.4	15.7	32.8	25.2	34.5	17.7	6.6	13.1	18.1	94.9	35.7	13.1	9.7	31.7	18.9	27.2	20.0	13.9
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859665-4863936	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 57.0;choroid plexus: 98.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 47.9;EFO-21: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	18.4	6.0	12.2	0.7	11.8	0.2	12.8	12.2	16.9	57.0	98.0	1.8	0.5	17.5	0.3	0.9	9.6	1.3	10.3	18.8	12.2	2.9	0.5	4.3	0.6	17.2	11.8	3.5	2.3	0.4	21.1	4.1	11.8	5.5	0.1	0.6	8.8	3.6	20.1	5.2	1.1	3.2	15.1	4.5	2.0	0.7	13.0	0.2	9.2	2.0	0.4	11.2	14.5	12.3	2.5	1.5	0.5	2.8	8.0	5.1	8.9	6.1	2.8	3.5	1.7	47.9	15.3	0.3	21.4	4.4	17.0	0.1	10.6	0.0	1.2	2.0	12.2	0.1	8.0	17.4	0.6	0.1	1.4	1.0	0.8	2.6	0.9	1.1	0.8	4.1	7.9	0.3	1.9	1.2	1.3	2.4	0.2	0.7	11.1	6.4	6.4	0.6	0.2	1.5	0.4	0.3	5.4	0.3	4.0	0.8	0.9	2.1	2.0	4.1	9.1	13.0	9.9	1.0	0.9	5.7	2.6	3.1	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	12.2	11.8	12.2	16.9	18.8	12.2	17.2	11.8	11.8	15.1	13.0	12.3	118.4	0.0	0.0	17.3	0.5	7.1	2.4	0.3	4.6	0.8	8.6	24.3	5.5	0.0	0.0	0.0	4.2	0.3	1.6	3.9	0.0	0.2	0.4	364.0	35.7	48.1	0.0	0.0	1.1	0.9	0.1	34.8	1.1	462.0	0.0	1.1	5.7	0.2	0.5	0.0	1.2	2.5	0.0	0.6	8.8	0.0	1.2	4.4	16.0	3.7	0.0	0.7	0.0	1.0	0.3	0.3	0.1	0.4	1.6	3.3	0.6	0.5	0.0	0.7	0.0	13.6	18.2	0.8	1.5	2.6	4.7	0.3	4.8	14.6	2.6	2.0
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.1;Endothelial cells: 32.0;Erythroid cells: 86.6;Fibroblasts: 16.8;Hofbauer cells: 15.5;Microglial cells: 23.4"	"Group enriched"	"Detected in many"	5	"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"NK-cell: 27.0"	"Lineage enriched"	"Detected in many"	11	"NK-cells: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 194.1;HUVEC TERT2: 152.3;NB-4: 382.2;WM-115: 89.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		270000	"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.8	1.9	2.1	1.8	2.5	13.9	6.9	2.8	3.9	12.9	3.1	5.5	0.6	9.5	1.3	4.8	7.9	4.6	1.5	2.6	2.7	1.0	0.3	4.9	4.5	4.2	3.0	1.7	1.2	1.2	1.6	46.0	3.9	10.8	1.4	0.2	4.3	14.4	0.5	3.2	2.4	4.0	3.3	1.2	4.7	0.3	3.4	4.5	5.8	0.2	4.9	12.0	7.3	4.8	0.1	0.0	0.1	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.1	0.1	0.0	0.9	0.0	0.0	5.0	0.0	2.7	0.0	0.0	152.3	0.0	0.0	7.5	0.0	0.0	0.0	382.2	0.7	0.0	0.0	5.7	7.7	0.2	0.0	0.0	0.1	8.8	0.3	0.0	24.5	0.2	0.0	0.0	52.7	0.0	34.6	0.1	0.0	1.0	0.2	0.4	0.0	4.8	89.6	2.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.1	27.0	0.0	0.4	0.0	0.9	2.1	2.5	2.8	3.9	2.6	2.7	4.2	3.0	3.9	3.3	3.4	4.8	14.1	0.0	0.5	0.0	1.2	2.8	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.2	0.4	0.3	0.3	32.0	0.0	86.6	0.0	0.0	0.4	16.8	0.0	0.3	8.9	0.2	0.7	0.0	15.5	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	4.7	8.8	23.4	0.6	0.0	3.1	0.5	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.1	0.0	0.3	1.6	0.5	0.5	8.6	0.0	0.6
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051480-5500994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;lymphoid tissue: 19.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015820			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA015820: AB_1858913"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	3.5	0.3	2.3	1.2	7.8	1.5	4.3	1.9	2.3	3.3	1.5	1.1	0.5	3.5	0.3	1.2	1.3	1.4	0.4	2.1	4.5	15.0	0.1	0.9	1.8	3.7	3.9	0.6	1.8	0.3	0.4	3.2	3.7	0.6	1.1	0.8	1.0	0.9	1.3	2.4	1.1	2.5	3.6	0.2	6.0	4.5	3.5	19.5	1.7	1.7	1.0	3.1	1.5	3.6	0.0	14.0	0.8	0.0	0.6	1.0	0.0	9.7	1.1	6.3	0.2	0.1	0.0	0.0	2.1	19.7	27.5	0.1	1.5	0.0	2.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.2	27.5	1.4	0.0	0.1	3.4	0.0	0.0	2.0	4.1	0.0	0.0	25.2	0.1	0.0	6.2	0.0	0.4	0.0	0.0	0.1	8.5	0.6	0.0	0.0	7.1	0.2	2.8	43.8	0.0	0.9	0.1	0.0	0.1	0.0	112.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	7.8	1.9	2.3	2.1	4.5	3.7	3.9	3.7	3.6	3.5	3.6	3.6	0.0	1.1	1.6	0.0	2.3	0.2	0.0	0.0	0.0	4.2	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	17.6	1.1	108.2	0.2	0.1	3.2	0.0	0.0	3.7	0.0	0.1	5.5	4.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	14.4	0.0	0.0	0.0	1.2	39.3	1.5	1.1	5.4	27.2	0.5	0.0	0.0	169.4	1.3	0.4	0.0	1.2	0.0	0.1	0.0	18.9	0.0	0.0	0.0	0.6	0.4	1.2	5.5	0.0	1.0	0.0	0.2	0.4	0.0	0.1
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Microtubules, Cytokinetic bridge"	"Nucleoplasm, Cytosol"	"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	4.8	0.7	1.3	1.5	1.4	0.1	3.6	1.2	1.1	6.0	2.3	3.7	0.6	4.7	1.7	2.2	4.7	2.7	3.1	1.3	1.4	2.6	0.7	2.1	1.9	1.6	1.5	7.8	1.7	3.1	1.1	1.3	1.2	3.2	0.6	0.3	2.8	2.0	1.1	3.8	2.0	2.3	1.4	1.0	2.1	1.6	1.5	1.0	3.8	1.9	1.7	4.1	4.4	1.3	0.0	2.7	0.0	6.6	8.4	9.3	0.0	4.1	9.7	3.6	6.0	0.0	0.0	5.2	0.0	3.3	2.0	2.8	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	5.9	4.6	4.6	10.6	0.0	3.9	0.0	0.0	0.2	5.3	0.0	0.0	0.0	3.9	0.0	0.0	8.6	8.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.5	6.7	0.0	0.0	2.4	0.0	4.1	4.7	1.2	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.4	1.2	1.1	1.3	1.4	1.6	1.5	1.2	1.4	1.5	1.3	0.6	0.0	0.5	17.6	0.8	2.2	4.9	2.3	12.0	0.0	0.9	2.2	1.0	1.5	1.3	0.0	0.0	8.3	1.7	0.0	0.0	1.9	2.2	0.7	5.6	1.2	0.0	0.4	0.3	0.5	0.3	8.9	0.5	1.7	2.5	4.7	1.4	0.1	0.5	0.0	0.3	0.0	0.0	0.3	1.2	0.9	11.5	0.8	0.0	6.5	0.0	1.9	1.0	1.0	0.3	0.6	0.0	7.9	1.7	2.8	0.0	0.9	1.0	0.1	0.0	14.7	3.2	1.8	2.1	4.4	0.9	1.4	2.8	3.4	0.0	1.4
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711201-5814305	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Microglial cells: 10.3;Skeletal myocytes: 10.5"	"Cancer enhanced"	"Detected in all"		"renal cancer: 16.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 62.3;hTERT-HME1: 60.7;hTERT-RPE1: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (9.47e-5)"	6.6	3.3	2.2	3.0	2.4	0.1	5.4	1.5	1.4	10.3	4.4	8.4	1.9	13.7	8.3	8.1	13.9	14.1	7.2	1.6	2.1	26.0	2.8	8.3	2.8	3.7	2.4	33.5	9.3	18.8	1.9	3.6	1.7	11.4	3.4	1.7	9.6	9.8	1.4	7.8	3.0	11.7	2.5	3.0	4.6	3.5	2.7	4.2	9.4	3.3	2.8	7.0	6.0	1.3	7.5	9.4	5.1	13.4	32.6	46.7	1.8	16.3	62.3	18.6	23.9	0.0	0.0	0.0	5.1	26.2	31.0	8.7	5.4	13.5	15.2	12.4	3.7	0.0	5.6	2.5	24.1	0.0	1.4	23.2	19.4	24.8	60.7	53.0	13.1	0.0	0.1	0.1	43.6	0.0	0.0	0.0	5.6	0.0	8.6	11.4	14.1	0.2	6.4	1.3	2.9	8.7	0.0	0.0	6.4	4.9	3.4	0.6	22.9	15.8	3.0	11.3	14.5	9.9	8.6	0.8	45.2	0.0	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	1.5	1.4	1.6	2.1	3.7	2.4	1.7	2.5	2.7	1.3	0.5	3.2	2.3	26.4	0.1	3.4	1.9	3.6	2.2	0.5	0.5	1.1	2.0	1.5	2.2	3.7	0.0	0.1	0.0	0.0	1.9	0.6	0.5	0.8	6.6	0.7	0.0	0.4	1.2	0.0	0.0	6.5	1.5	4.5	0.0	1.5	0.7	0.8	0.0	0.0	1.1	0.0	2.0	0.0	1.0	0.2	0.9	0.2	5.4	10.3	0.0	2.0	0.0	2.0	0.1	0.3	0.0	0.7	0.4	0.9	0.0	1.5	1.5	0.1	0.0	10.5	2.6	0.0	0.0	2.0	2.8	0.1	0.9	2.4	0.0	1.2
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.7;pituitary gland: 67.3;retina: 57.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.9;Excitatory neurons: 40.8;Horizontal cells: 210.3;Inhibitory neurons: 44.5;Muller glia cells: 78.4"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.0;HAP1: 117.2;NTERA-2: 84.3;REH: 229.4;RH-30: 129.6;SCLC-21H: 167.2;SH-SY5Y: 105.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	9.8	53.0	2.7	55.9	0.1	0.9	45.0	58.0	9.6	10.7	4.4	1.3	21.9	0.1	2.7	4.9	5.1	2.8	59.7	57.9	2.1	0.3	5.7	1.9	31.0	35.2	7.9	5.7	0.7	67.3	5.4	41.0	3.2	1.6	57.6	2.7	3.1	0.5	3.7	2.9	14.5	30.8	1.1	3.7	3.0	47.1	1.2	2.4	1.1	1.0	2.6	2.9	38.2	1.3	2.7	81.0	2.8	0.1	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	27.2	1.9	117.2	0.0	0.0	2.2	0.9	0.0	4.0	0.6	1.4	0.1	0.7	1.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.3	1.3	0.0	0.4	0.0	84.3	0.0	2.6	229.4	129.6	20.2	0.0	0.2	167.2	105.8	0.0	0.6	1.4	54.2	0.8	0.1	6.8	3.8	27.3	2.3	2.6	14.8	2.2	0.1	9.8	0.9	69.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	55.9	45.0	58.0	59.7	57.9	31.0	35.2	41.0	30.8	47.1	38.2	1.0	0.0	1.1	23.8	0.0	0.4	0.0	1.5	0.0	148.9	0.0	0.0	1.5	0.0	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.1	2.2	0.4	13.6	6.3	2.4	1.3	40.8	0.0	0.2	3.5	3.1	0.5	0.0	2.4	0.0	0.0	0.5	210.3	44.5	0.0	0.0	0.0	0.0	5.5	0.6	0.2	1.8	6.5	0.0	78.4	0.0	33.2	2.9	0.4	0.0	0.4	0.0	0.4	0.0	0.0	0.0	22.8	6.6	0.4	6.2	1.0	12.4	1.1	0.1	0.3	0.2	1.5	0.0	0.1
C4orf50	FLJ46481	ENSG00000181215	"Chromosome 4 open reading frame 50"	Q6ZRC1	4	5897373-6200555	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	22	"brain: 4.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 12.7;Inhibitory neurons: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (7.02e-3)"	"unprognostic (6.55e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.35e-2)"	"unprognostic (9.94e-5)"	"unprognostic (4.31e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.88e-6)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.68e-2)"	0.0	0.0	2.7	0.0	4.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	0.0	2.6	2.5	0.5	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.7	5.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.0	1.1	0.4	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0
JAKMIP1	"FLJ31564, Gababrbp, JAMIP1, MARLIN1"	ENSG00000152969	"Janus kinase and microtubule interacting protein 1"	Q96N16	4	6026199-6200591	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;pituitary gland: 10.2;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.6;dendritic cells: 17.6;Excitatory neurons: 82.9;Inhibitory neurons: 53.6;Muller glia cells: 61.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"gdT-cell: 25.3;MAIT T-cell: 11.2;memory CD4 T-cell: 11.2;memory CD8 T-cell: 22.6;naive CD8 T-cell: 10.1;T-reg: 36.7"	"Lineage enriched"	"Detected in many"	33	"T-cells: 36.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;JURKAT: 14.3;MOLT-4: 45.2;SCLC-21H: 18.6;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044570	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044570: AB_2678995"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.86e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.25e-4)"	"unprognostic (7.14e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-8)"	"unprognostic (1.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.96e-3)"	0.3	4.8	21.4	1.0	31.1	1.3	0.1	5.0	30.4	0.2	0.1	1.0	0.2	0.1	0.1	0.3	0.2	0.5	0.1	21.6	22.0	0.2	0.3	0.9	3.0	9.0	13.5	0.5	0.6	0.0	10.2	0.0	12.8	4.2	0.2	17.0	0.7	0.1	0.1	0.1	1.1	0.2	7.1	2.6	0.6	5.2	16.2	0.3	0.7	0.0	0.6	0.7	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.4	45.2	0.0	3.4	0.0	2.6	2.3	0.0	0.7	0.0	0.0	18.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.3	0.0	11.2	0.3	11.2	22.6	0.0	0.2	0.8	10.1	0.1	1.1	0.0	0.1	36.7	5.4	21.4	31.1	5.0	30.4	21.6	22.0	9.0	13.5	12.8	7.1	16.2	20.3	0.2	0.0	0.0	35.6	0.8	0.0	0.0	0.0	0.0	1.5	0.2	0.1	0.8	0.0	0.0	0.0	2.1	0.0	17.6	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.4	82.9	0.0	0.0	0.5	2.6	0.8	0.0	0.2	0.0	0.0	0.1	3.3	53.6	0.0	0.0	1.3	0.5	2.4	0.0	0.5	0.0	7.5	0.3	61.2	12.3	7.1	3.1	0.1	0.0	0.0	2.3	1.3	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.9	4.6	0.0	0.1	0.0	16.2	0.4	0.0	0.0
AC092442.1		ENSG00000284684	"Novel protein"		4	6064977-6070162	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	16	"brain: 6.0"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	7	"amygdala: 1.8;basal ganglia: 6.0;cerebral cortex: 3.7;hippocampal formation: 1.9;hypothalamus: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"																								0.0	0.0	1.8	0.0	6.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	6.0	0.0	3.7	1.9	2.4	0.1	0.1	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	0.8	6.2	72.9	0.6	86.7	0.0	1.4	42.1	106.2	18.0	0.0	1.1	0.8	27.0	7.4	35.9	9.9	0.4	2.5	85.7	44.5	0.3	0.1	0.1	0.3	52.5	52.7	0.6	0.7	1.5	22.6	0.1	55.1	5.0	0.3	10.9	5.3	14.5	0.8	34.0	1.2	11.9	62.3	0.3	0.8	7.3	66.9	2.7	0.1	0.9	3.1	0.9	11.5	91.2	31.4	46.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	19.0	0.0	68.4	13.7	20.0	0.7	0.0	0.0	2.4	0.0	3.2	3.7	0.7	0.0	0.1	6.6	11.4	0.0	0.0	0.0	0.1	4.2	0.0	0.1	6.6	36.2	0.0	0.1	2.2	0.6	38.9	0.0	0.0	1.2	0.0	0.1	39.1	7.5	1.5	0.1	0.0	1.1	18.9	0.1	0.0	0.2	22.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.9	86.7	42.1	106.2	85.7	44.5	52.5	52.7	55.1	62.3	66.9	91.2	0.2	0.0	0.0	61.0	0.0	14.7	0.4	0.8	4.6	11.0	1.9	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	67.4	0.8	5.7	0.6	0.0	0.0	203.3	0.2	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	3.3	82.8	0.0	0.0	0.0	1.1	182.5	6.8	0.0	0.0	4.7	0.0	6.5	0.0	14.1	94.6	2.4	0.0	4.5	0.0	1.3	0.0	0.2	0.0	3.1	0.0	0.0	2.5	2.3	1.6	6.5	22.0	0.0	0.2	0.1	0.0	0.2
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575189-6623362	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA		15000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	20.0	13.6	12.9	13.8	18.2	14.8	16.4	7.7	14.3	17.6	26.0	14.5	13.4	18.6	14.1	11.3	17.7	15.9	22.6	13.2	15.6	15.1	23.7	18.2	13.5	13.0	13.2	26.6	22.0	9.2	17.9	12.9	11.8	18.0	7.9	5.2	16.7	11.5	4.7	13.6	15.8	10.3	10.6	17.7	20.1	4.4	15.0	9.0	23.2	4.7	8.5	19.3	15.9	11.9	17.5	15.6	2.9	21.0	44.7	30.9	19.7	35.0	40.5	16.8	22.9	9.0	32.3	8.7	16.5	38.2	39.2	17.4	1.0	11.1	9.2	10.4	8.8	11.7	10.9	10.2	19.5	22.0	51.8	41.0	10.9	13.4	3.6	30.3	19.7	10.8	5.1	21.9	22.1	10.8	10.9	13.9	3.8	21.8	11.9	10.7	14.4	10.4	8.8	17.4	5.0	5.5	23.4	13.9	8.9	10.0	27.7	29.1	36.3	30.3	9.1	38.2	22.5	9.0	8.4	4.2	35.4	25.5	26.7	15.4	9.0	14.3	11.7	13.2	8.9	4.2	7.0	10.7	8.6	4.4	6.3	8.2	11.0	6.8	17.5	3.3	10.7	11.0	12.9	18.2	7.7	14.3	13.2	15.6	13.0	13.2	11.8	10.6	15.0	11.9	9.8	16.0	18.9	7.8	11.6	5.0	5.5	4.9	11.4	8.9	8.2	5.6	17.0	20.0	11.1	11.0	6.2	13.5	12.9	18.3	1.9	9.7	0.6	18.7	15.8	8.2	7.8	5.7	9.4	10.7	10.2	18.4	11.7	36.8	10.8	11.1	17.5	44.1	20.9	10.1	8.3	11.0	2.0	30.2	8.2	1.1	19.6	18.0	3.6	8.4	11.2	13.0	5.2	6.0	8.9	10.1	9.0	24.5	15.1	7.1	11.7	4.2	9.5	7.4	13.1	7.5	8.5	1.1	0.6	8.0	3.8	8.5	15.6	4.4	8.9	4.6
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
AC093323.1		ENSG00000170846	"Novel protein, similar to Morf4 family associated protein 1"	B2RBV5	4	6663396-6676755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 12.7;Cytotrophoblasts: 18.9;Distal tubular cells: 13.7;Glandular and luminal cells: 13.7;Granulosa cells: 12.2;Theca cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"									NA	NA					"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (9.08e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.33e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-3)"	1.7	3.0	3.4	2.5	3.6	3.6	3.8	2.4	3.7	1.8	2.5	3.2	1.5	3.5	3.6	2.2	2.3	2.2	2.3	3.5	4.5	2.8	2.9	2.7	4.1	2.3	2.8	3.9	2.1	3.2		2.5	2.7	3.6	4.1	2.0	3.2	2.5	4.3	6.9	2.3	2.5	2.6	4.2	4.2	2.6	4.9	3.2	2.0	4.3	4.4	2.1		2.8	4.0	5.0	7.4	7.6	3.5	4.5	7.0	6.0	2.6	4.7	3.8	5.8	5.7	3.8	3.1	2.9	4.8	5.1	5.8	4.2	8.0	1.6	8.2	16.5	7.6	4.4	1.2	17.6	10.0	2.0	3.8	4.6	4.2	6.6	3.1	7.3	12.3	1.3	4.0	7.9	12.0	16.1	7.7	6.0	7.6	5.6	4.9	1.9	1.6	2.8	16.6	5.8	5.1	3.2	2.6	2.6	16.1	5.4	4.2	3.5	0.0	2.6	8.3	2.5	5.8	1.3	1.0	19.3	5.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	3.6	2.4	3.7	3.5	4.5	2.3	2.8	2.7	2.6	4.9	2.8	4.3	6.4	12.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.6	9.8	0.0	0.0	4.3	5.5	0.0	18.9	7.2	0.0	13.7	2.1	0.0	9.8	11.0	2.2	0.0	0.0	0.0	3.2	7.0	3.4	0.0	13.7	1.3	12.2	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.3	3.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.6	5.2	19.5	0.0	0.0
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
MRFAP1L1	MGC9651	ENSG00000178988	"Morf4 family associated protein 1 like 1"	Q96HT8	4	6707701-6709865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"				"unprognostic (5.77e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.40e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.80e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (5.26e-5)"	32.9	41.7	67.7	31.8	69.7	19.0	52.2	68.8	88.8	45.6	56.5	38.7	25.3	47.0	50.0	40.3	41.3	33.3	52.4	67.4	69.6	42.5	55.6	36.1	53.4	67.4	68.1	51.6	30.1	46.0	39.2	40.1	67.6	49.3	32.9	52.4	48.1	40.4	49.6	38.4	33.4	36.9	70.4	43.7	39.8	20.3	69.3	47.9	41.0	50.7	46.4	42.6	39.3	69.7	60.3	37.0	82.4	66.1	82.2	69.8	51.9	54.5	88.8	66.3	62.2	40.2	78.6	70.7	53.8	66.5	88.3	42.4	66.0	79.4	72.2	48.7	46.1	96.4	67.8	95.3	51.3	66.6	53.4	72.9	92.3	59.2	59.4	61.7	63.7	48.2	98.3	55.9	65.5	74.8	94.6	133.6	84.5	59.9	87.1	59.5	99.6	59.8	90.6	51.2	94.4	73.4	44.5	44.9	92.0	48.8	83.8	68.2	56.9	55.5	47.2	41.7	76.1	83.9	133.5	53.7	54.3	103.2	53.6	288.6	44.5	170.5	144.0	44.8	142.1	89.5	134.7	149.5	57.0	85.2	134.2	137.9	94.7	127.1	55.0	54.3	143.1	119.5	67.7	69.7	68.8	88.8	67.4	69.6	67.4	68.1	67.6	70.4	69.3	69.7	17.4	32.1	51.8	9.8	36.7	34.0	24.1	31.9	47.3	28.2	26.5	23.5	53.5	42.9	39.6	18.4	16.7	42.5	37.0	11.2	23.5	23.1	3.4	22.2	34.4	29.8	18.6	40.0	12.5	18.5	31.8	33.5	25.0	24.3	34.7	21.4	28.2	44.0	22.2	53.8	11.3	16.5	36.7	26.0	22.2	3.8	30.7	17.8	26.6	12.2	22.4	45.9	54.6	9.0	14.4	21.8	14.2	28.2	38.1	31.2	12.7	32.1	49.2	21.8	26.3	24.1	24.2	33.3	32.2	40.9	37.4	29.7	49.0	25.7	14.6	24.9
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716174-6717664	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	8.6	11.7	8.0	7.9	8.2	9.8	8.9	8.3	8.7	9.4	9.1	8.9	9.2	9.9	7.1	11.1	9.3	6.5	8.0	8.3	7.7	10.0	11.3	6.3	12.1	8.1	8.2	12.0	7.9	5.6	7.2	7.7	8.3	9.4	5.7	4.3	8.2	6.4	10.8	8.6	11.4	5.1	8.4	13.1	8.8	6.3	8.3	8.9	7.6	5.7	8.6	9.6	8.6	8.6	15.3	10.3	15.2	15.6	11.7	15.0	30.5	12.0	13.2	11.0	9.7	9.2	16.0	14.4	12.6	10.9	15.5	10.1	8.6	14.0	8.4	11.7	14.1	22.0	10.3	23.2	14.3	10.8	19.7	14.2	13.6	8.7	7.5	10.8	10.3	12.3	29.3	12.6	11.6	15.1	17.6	37.5	19.7	11.2	20.0	17.9	16.8	13.0	15.3	13.3	13.1	17.5	9.9	7.1	22.7	11.6	22.4	20.8	11.6	10.0	8.9	11.8	15.4	18.8	19.8	19.4	11.2	19.6	16.3	2.5	2.7	14.0	4.4	4.6	4.5	6.3	5.4	4.8	3.6	5.2	8.4	4.5	1.4	2.5	3.1	3.4	5.1	1.7	8.0	8.2	8.3	8.7	8.3	7.7	8.1	8.2	8.3	8.4	8.3	8.6	18.7	6.4	5.9	3.9	40.8	23.6	35.2	4.9	26.7	29.1	25.2	27.8	5.3	21.5	5.7	23.9	6.2	65.1	49.5	21.7	25.4	9.7	2.5	28.6	28.0	20.2	11.4	26.5	6.8	7.0	93.1	27.8	21.9	25.3	3.8	18.7	32.5	23.6	35.8	30.3	6.6	22.8	4.1	24.0	22.2	1.6	32.3	16.6	30.2	5.6	18.1	38.4	60.8	4.5	8.3	9.9	33.9	22.6	19.7	40.3	33.9	51.3	4.6	24.7	6.6	26.6	20.0	16.0	14.3	23.1	24.9	63.3	47.7	39.1	24.2	34.8
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	13.0	12.0	18.6	8.5	19.9	16.2	13.3	20.2	20.9	12.0	17.8	14.0	8.5	15.4	12.6	20.6	15.3	12.4	33.2	18.0	22.3	18.8	15.0	12.0	7.5	18.2	22.5	13.1	10.6	23.9	10.3	10.4	19.8	14.7	12.3	24.7	8.9	14.6	32.5	7.6	11.5	13.1	20.1	12.9	10.9	12.0	23.4	11.7	15.1	51.1	8.6	10.4	9.8	21.0	13.7	13.0	26.7	16.7	18.8	20.2	14.0	17.4	18.1	12.0	10.1	8.2	11.3	9.0	5.8	19.7	18.5	7.0	13.7	7.7	15.5	5.1	5.6	26.7	11.1	11.0	9.9	11.6	33.6	13.6	17.7	13.4	7.4	15.4	12.6	8.9	20.3	7.6	15.4	6.7	22.3	11.7	14.1	10.2	14.3	15.7	27.3	4.2	20.3	12.8	20.2	13.1	12.9	11.4	12.1	18.3	14.5	21.1	16.0	11.0	12.8	9.8	15.2	13.1	14.1	7.0	13.5	12.2	30.3	2.0	2.0	5.7	2.1	1.4	2.9	1.3	1.6	2.5	1.3	1.3	1.5	1.6	10.6	1.8	2.1	2.0	1.6	0.9	18.6	19.9	20.2	20.9	18.0	22.3	18.2	22.5	19.8	20.1	23.4	21.0	27.6	32.1	39.2	62.3	19.1	12.7	27.4	12.9	24.5	77.2	29.0	20.6	132.1	10.0	29.0	12.9	37.5	14.7	23.6	47.9	41.1	23.4	45.0	74.4	28.0	20.6	25.1	49.9	123.8	11.7	7.7	27.7	44.9	38.7	12.6	16.3	15.0	42.9	11.2	99.3	120.7	20.9	30.5	23.9	11.8	64.2	24.8	28.4	7.2	73.1	34.8	49.7	27.8	90.0	138.0	21.8	24.8	33.1	24.2	28.0	29.6	24.6	58.0	44.6	26.3	39.4	31.6	31.6	22.4	19.2	11.1	22.4	27.4	27.0	17.5	35.7
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7043001	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 65.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 5.3"									HPA047546	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	2.0	2.0	0.5	2.4	1.3	1.2	2.4	2.1	1.1	6.0	0.8	0.9	0.8	0.7	1.3	10.7	0.8	0.6	2.5	2.1	1.4	0.5	1.7	0.8	3.4	3.7	0.7	1.3	1.0	3.3	0.5	3.0	1.0	0.6	1.8	1.0	1.1	1.1	1.7	0.8	0.6	2.7	0.8	1.1	65.4	2.6	0.7	1.5	0.7	0.6	0.7	0.9	1.9	1.0	2.7	1.4	1.1	1.8	1.2	0.3	2.7	1.6	3.0	1.8	0.9	2.4	0.6	0.7	1.5	3.9	1.2	0.5	1.2	0.9	0.1	0.4	0.6	1.1	0.7	0.9	0.8	1.5	1.1	1.3	1.8	0.2	0.3	1.2	1.9	0.4	0.2	1.9	2.4	1.6	1.0	0.5	0.9	1.6	0.6	0.9	0.1	5.3	1.0	3.8	0.8	2.2	1.0	0.5	1.3	1.0	1.5	1.3	2.5	0.7	1.5	2.1	0.0	0.1	0.5	1.9	0.0	0.8	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.5	0.1	0.1	1.0	0.0	0.0	0.1	2.0	2.4	2.4	2.1	2.5	2.1	3.4	3.7	3.0	2.7	2.6	1.9	3.1	0.0	4.8	0.0	1.0	0.6	0.8	2.8	0.6	4.0	3.7	3.2	0.9	0.0	6.9	3.7	12.5	0.6	0.7	2.5	1.9	2.2	76.7	59.7	4.0	2.3	5.4	0.0	0.0	1.1	0.6	1.5	0.5	2.4	0.0	0.6	2.9	0.9	1.2	0.0	0.0	1.9	4.1	2.2	0.9	93.4	3.1	1.7	1.8	0.0	1.1	6.9	0.0	0.0	0.0	1.7	2.7	4.1	0.1	1.2	0.2	4.5	53.4	19.6	0.0	4.6	2.3	30.6	3.6	1.2	1.0	0.5	0.8	2.7	0.8	0.9
TADA2B	MGC21874	ENSG00000173011	"Transcriptional adaptor 2B"	Q86TJ2	4	7041899-7057952	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 40.4;Rod photoreceptor cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035770	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA035770: AB_10603993"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.17e-11)"	"unprognostic (5.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (1.59e-4)"	10.9	16.3	7.7	13.1	8.1	35.4	10.5	9.3	10.4	10.6	8.3	12.7	13.4	11.8	8.1	14.6	12.2	10.2	20.6	11.0	6.5	12.3	15.7	11.7	17.8	8.7	7.0	19.3	30.2	16.7	9.1	10.8	8.6	12.8	10.3	20.2	24.4	13.0	52.0	12.1	13.0	11.6	6.4	15.3	14.6	15.5	8.2	12.0	16.4	42.4	12.6	11.5	9.2	8.3	11.5	17.2	11.8	14.0	12.8	14.5	11.3	16.5	16.9	20.9	12.8	17.0	16.8	15.2	9.6	18.4	27.8	9.2	16.3	8.7	13.4	9.0	12.5	15.5	10.5	12.9	15.6	17.9	24.3	10.5	18.2	13.9	16.1	14.4	9.8	13.9	17.6	23.9	15.8	11.0	21.8	15.3	14.0	15.3	26.4	14.0	24.1	8.0	19.1	15.9	19.2	13.8	14.2	12.6	16.6	9.5	19.0	26.6	15.3	13.2	10.2	16.1	22.9	21.6	19.5	19.7	10.9	9.7	13.7	0.7	1.3	6.9	2.7	1.7	1.9	2.5	1.7	2.6	1.2	1.7	2.3	1.7	4.4	1.5	2.1	1.3	2.0	1.2	7.7	8.1	9.3	10.4	11.0	6.5	8.7	7.0	8.6	6.4	8.2	8.3	7.1	9.6	15.0	7.2	9.0	4.6	2.7	3.3	0.6	27.1	12.4	8.0	12.7	4.3	9.1	7.3	31.3	3.6	14.2	10.6	5.9	4.5	2.9	8.6	9.0	6.4	7.2	2.1	5.0	9.3	2.9	8.0	8.2	8.7	9.5	6.3	4.2	16.7	5.7	40.4	5.2	9.5	4.1	8.8	4.2	4.8	16.8	7.0	7.2	1.9	8.1	10.4	6.2	5.0	3.7	7.9	7.8	12.8	5.1	5.8	8.7	7.6	7.1	38.3	0.0	12.4	5.2	6.1	4.5	3.6	5.8	4.4	10.1	12.5	6.9	5.4
GRPEL1	"FLJ25609, GrpE, hMGE"	ENSG00000109519	"GrpE like 1, mitochondrial"	Q9HAV7	4	7058895-7068064	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036647	Supported		Supported	Mitochondria		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036647: AB_10672359"	"unprognostic (6.13e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (9.61e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.30e-2)"	15.4	35.9	12.7	7.7	13.2	24.9	11.2	14.2	16.4	7.2	14.2	10.1	9.0	7.0	8.4	10.9	8.4	7.5	23.1	13.1	13.6	20.7	32.4	7.7	10.2	14.0	13.5	10.4	10.1	13.1	6.9	7.8	14.4	7.9	9.7	12.4	8.6	7.9	26.8	10.7	7.8	8.3	13.8	10.4	11.1	12.8	13.7	7.6	8.9	29.7	11.3	15.2	7.6	14.1	21.7	20.0	11.3	22.3	21.3	17.9	13.9	27.9	22.2	30.8	22.6	35.5	27.5	46.4	18.3	21.4	47.7	21.5	45.0	32.0	35.9	11.2	28.2	49.8	17.6	38.7	24.9	50.7	24.2	17.8	41.4	27.3	32.8	15.7	27.4	30.8	29.7	18.9	36.7	21.9	40.3	62.5	16.9	38.8	65.7	26.6	42.1	19.5	31.0	22.4	31.6	15.3	21.9	21.5	24.3	11.4	19.3	29.2	23.8	20.5	12.7	29.5	49.3	20.3	31.1	31.0	27.9	32.6	16.5	12.0	25.2	41.1	22.8	27.6	31.9	27.3	24.4	25.9	36.3	21.6	30.8	23.9	8.4	26.2	22.7	22.0	26.6	27.2	12.7	13.2	14.2	16.4	13.1	13.6	14.0	13.5	14.4	13.8	13.7	14.1	52.5	25.6	32.1	1.6	40.7	133.4	134.8	68.5	60.9	27.8	44.0	43.6	96.1	34.3	43.1	38.6	10.4	69.3	52.9	35.3	133.1	75.0	60.3	35.0	41.7	51.5	18.5	34.5	4.5	47.7	80.3	46.5	26.0	38.0	58.2	23.2	25.0	109.4	60.3	28.6	5.1	34.1	52.9	29.0	74.7	84.9	28.0	41.7	64.0	2.8	54.0	26.4	17.5	3.0	6.5	91.4	27.6	29.0	27.0	116.5	49.2	203.1	36.2	28.0	0.0	38.1	56.3	51.7	55.0	58.1	125.2	86.1	61.6	92.0	47.0	120.3
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071818			Approved	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA071818: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	2.4	1.1	13.4	3.4	18.3	1.7	1.6	11.6	15.9	8.5	0.0	4.5	1.4	4.7	3.8	2.2	3.3	3.6	2.0	12.1	11.3	9.0	4.6	4.4	0.8	18.6	17.6	5.8	0.7	0.0	2.7	0.2	14.7	5.2	1.1	12.9	1.0	2.4	1.1	1.8	2.6	6.2	11.3	0.4	1.6	1.6	14.1	3.1	3.1	1.2	1.2	3.0	3.7	22.9	0.8	1.1	1.3	0.2	0.1	0.0	0.0	0.2	0.1	1.6	0.4	0.2	0.6	0.0	7.6	5.0	1.3	19.6	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.3	0.2	0.0	14.5	0.2	4.3	6.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.4	0.0	0.9	0.0	1.6	9.1	0.2	0.0	0.8	0.7	14.1	0.0	0.0	0.8	0.0	8.4	0.0	4.9	1.4	0.0	0.1	0.0	0.0	0.0	1.6	8.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	18.3	11.6	15.9	12.1	11.3	18.6	17.6	14.7	11.3	14.1	22.9	0.1	3.2	11.3	107.1	0.0	0.1	0.3	4.6	0.0	70.3	0.1	2.4	2.0	0.0	6.9	5.5	0.0	0.0	0.3	0.0	0.0	0.2	2.2	0.4	0.4	0.3	0.0	0.0	41.4	0.0	0.0	5.0	0.0	0.9	0.0	5.4	0.4	1.6	0.2	1.7	24.3	0.0	2.0	0.3	0.0	11.6	12.8	0.4	1.8	8.4	0.1	33.0	1.0	8.0	76.2	1.1	0.0	7.9	0.1	0.4	0.4	1.4	2.0	2.7	0.0	0.9	1.0	0.1	0.3	0.0	0.4	0.0	0.3	1.5	0.0	0.6
PSAPL1		ENSG00000178597	"Prosaposin like 1"	Q6NUJ1	4	7430285-7434930	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"skin 1: 98.5;stomach 1: 38.6"	"Cell type enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 41.8"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA		31000		"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.3	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	98.5	0.0	0.0	0.0	0.0	38.6	3.4	0.1	0.2	0.0	0.0	3.1	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0
AFAP1	"AFAP, AFAP-110"	ENSG00000196526	"Actin filament associated protein 1"	Q8N556	4	7758714-7939926	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 170.5;Extravillous trophoblasts: 116.3;Inhibitory neurons: 117.2;Late spermatids: 373.8;Oligodendrocyte precursor cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"TIME: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015642, CAB024712"	Enhanced		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Actin filaments, Cytosol"	"Focal adhesion sites"	"CAB024712: , HPA015642: AB_1844632"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.44e-2)"	12.6	3.1	7.0	8.7	5.8	0.7	9.7	4.5	6.9	8.7	2.9	17.6	5.6	15.4	2.0	11.0	8.5	9.4	10.8	5.8	4.5	4.9	1.2	8.5	4.4	3.7	2.7	7.1	3.8	14.7	7.9	12.6	2.8	7.7	9.8	3.4	8.6	10.2	3.5	5.3	7.7	15.4	3.4	4.0	6.7	22.0	3.5	3.1	7.4	2.4	4.8	14.2	8.3	3.5	31.9	23.2	16.2	12.9	15.4	27.8	21.3	46.4	68.1	43.6	40.0	7.4	7.2	0.1	15.2	75.5	72.3	15.1	8.6	18.7	28.6	0.9	5.7	0.0	33.2	4.5	43.0	0.0	0.4	17.2	13.8	54.4	35.5	72.2	53.0	4.8	0.7	6.8	23.0	10.3	0.6	0.0	7.0	13.2	44.3	0.0	12.1	1.5	4.7	4.1	31.8	53.0	15.9	10.9	12.4	21.4	4.1	0.3	126.7	53.0	11.8	69.6	23.0	0.0	0.2	0.0	18.9	0.1	61.9	0.0	0.4	2.9	0.4	0.1	0.5	0.0	0.6	0.6	0.0	0.0	1.2	0.5	1.0	0.0	0.0	0.0	0.5	0.7	7.0	5.8	4.5	6.9	5.8	4.5	3.7	2.7	2.8	3.4	3.5	3.5	22.5	6.4	2.0	4.6	0.2	2.9	9.7	16.2	7.4	1.2	10.2	8.9	5.9	10.0	12.7	11.0	4.2	5.6	2.3	14.8	0.0	19.2	170.5	7.5	17.6	20.1	14.5	0.0	24.7	7.7	116.3	21.1	11.2	8.8	0.0	4.4	14.3	0.0	8.5	0.0	117.2	20.6	0.0	0.3	3.6	373.8	11.1	6.0	1.8	30.9	0.6	10.2	0.0	125.2	5.4	29.9	8.6	12.4	0.6	13.5	6.4	4.2	6.4	0.7	6.6	8.0	13.4	12.5	10.0	6.2	4.3	8.8	7.3	2.6	13.9	9.9
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 204.8;tongue: 73.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 93.2;Inhibitory neurons: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 13.8;SiHa: 5.9;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	7.3	4.0	2.7	1.6	11.0	0.1	5.1	0.0	9.9	2.5	0.0	2.3	0.5	1.2	0.7	13.1	1.8	1.3	7.1	2.7	10.4	7.0	0.9	3.3	1.0	1.4	0.0	0.6	3.4	1.3	6.8	0.6	1.1	1.5	1.7	5.0	5.4	0.5	204.8	6.9	1.6	1.9	0.0	20.5	1.4	1.0	1.4	1.7	3.0	73.5	2.2	1.9	4.1	0.0	1.1	0.0	0.2	1.6	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.5	3.1	0.3	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.7	2.1	0.1	0.0	1.2	2.9	0.9	0.2	1.0	0.7	0.2	0.0	13.8	1.0	5.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.7	11.0	0.0	9.9	2.7	10.4	1.4	0.0	1.1	0.0	1.4	0.0	4.4	0.0	1.1	9.4	0.5	2.5	0.1	0.1	0.6	6.4	0.4	0.3	4.7	1.5	0.3	3.7	0.0	0.0	0.6	7.9	0.0	3.5	2.2	5.2	0.7	3.5	10.7	0.0	93.2	4.3	0.6	0.9	2.6	0.2	2.5	0.5	0.7	0.4	0.1	11.8	67.6	3.8	0.0	0.6	0.7	5.1	0.0	0.3	0.0	2.8	0.0	3.1	0.0	16.1	17.6	3.5	5.1	3.8	0.1	0.3	14.3	0.6	1.7	3.2	6.6	7.0	3.5	0.2	2.0	2.0	6.3	0.0	0.7	4.0	5.8	0.3
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	8.4	3.5	4.0	8.7	4.3	4.6	5.6	4.1	5.6	2.9	5.2	2.8	0.9	2.1	0.7	8.4	3.0	5.4	3.6	3.6	7.3	19.2	9.6	9.0	9.1	10.5	6.0	1.2	6.3	0.7	2.5	3.0	8.5	4.7	1.0	1.3	4.6	2.7	1.5	2.7	4.9	2.0	9.2	14.1	6.0	0.6	8.4	28.0	4.6	0.7	4.5	4.4	5.8	11.8	3.9	6.1	0.1	0.0	0.0	0.5	4.1	0.4	0.2	0.5	0.8	3.2	2.2	5.2	5.2	0.0	0.8	2.0	0.0	12.4	0.0	14.2	0.2	0.0	6.1	5.7	4.3	0.1	0.8	0.2	15.3	0.3	9.9	0.5	25.8	3.2	0.8	7.3	0.4	4.1	41.8	3.4	0.0	2.3	5.1	3.1	0.7	1.6	0.4	1.0	0.1	3.1	1.7	0.4	26.8	1.0	0.0	1.0	14.2	0.0	3.0	19.0	0.2	0.0	1.0	4.7	0.2	1.9	4.1	0.0	9.9	1.3	0.7	8.8	0.9	4.9	1.7	1.1	7.7	6.8	0.9	0.7	0.3	0.3	12.3	17.7	2.5	4.3	4.0	4.3	4.1	5.6	3.6	7.3	10.5	6.0	8.5	9.2	8.4	11.8	12.6	0.0	5.8	1.3	18.1	0.8	10.5	6.9	0.6	1.0	0.8	1.4	3.3	4.3	4.1	25.8	0.0	2.1	18.2	2.5	7.9	3.6	0.5	0.9	0.3	12.6	1.2	3.2	0.2	5.6	3.4	1.6	32.6	2.2	17.2	0.3	27.5	8.6	22.7	23.5	0.1	2.5	14.2	33.7	16.7	1.5	0.6	35.7	0.0	17.8	15.6	13.3	7.2	0.5	0.1	9.3	4.5	0.7	17.1	8.3	0.1	17.2	2.0	0.9	0.0	0.6	1.2	0.0	0.3	2.5	0.6	3.0	11.7	2.5	1.8	15.3
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269754-8307098	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 194.9"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 158.8;Leydig cells: 43.5;Peritubular cells: 42.9;Skeletal myocytes: 99.0;Theca cells: 25.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 67.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"U-2197: 182.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	68.0	6.0	0.9	8.7	1.3	13.4	50.4	0.9	1.3	35.4	5.0	33.9	8.7	42.4	10.6	15.1	26.2	35.5	194.9	0.9	1.0	6.2	3.2	38.0	1.2	1.0	1.0	93.0	6.8	0.4	15.7	20.4	1.0	26.3	4.8	0.1	22.8	6.7	32.1	28.1	16.9	11.8	1.0	2.9	21.9	4.3	1.7	2.2	26.0	12.9	0.7	62.4	32.6	0.7	0.0	1.0	1.4	0.0	5.8	10.8	0.3	2.4	0.2	2.8	0.6	0.1	0.1	0.0	13.6	6.4	1.4	0.1	1.2	0.0	0.9	0.0	2.3	1.3	13.9	0.0	6.1	0.0	0.6	1.2	0.0	4.2	0.0	1.7	9.8	0.0	0.3	0.0	10.2	0.0	0.2	36.5	6.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	15.8	0.3	26.4	0.5	0.2	28.8	0.1	1.1	8.1	1.4	4.7	182.1	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.9	1.3	0.9	1.0	1.0	1.0	1.0	1.0	1.7	0.7	12.6	0.0	0.0	0.0	0.0	5.2	0.5	0.0	0.6	0.0	0.5	0.9	16.5	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.1	1.2	0.3	8.1	5.3	0.0	0.0	0.0	0.0	4.2	158.8	0.5	0.3	0.0	6.0	3.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	8.6	1.4	43.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.4	0.4	0.0	0.1	0.0	0.0	0.0	99.0	10.6	0.4	0.7	0.6	5.3	1.4	0.9	25.2	0.0	0.2
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Supported	Peroxisomes		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	7.7	8.8	5.8	6.4	5.2	4.4	12.2	3.8	7.2	9.5	5.9	8.4	8.9	5.6	4.3	26.6	6.6	5.9	16.2	5.3	4.9	6.5	14.9	7.2	6.6	5.9	4.6	7.5	12.0	7.1	4.5	8.4	4.7	10.5	6.3	3.8	15.4	8.4	6.4	12.5	8.9	11.4	4.2	5.3	10.1	2.9	5.0	4.6	8.5	5.6	8.5	10.1	13.7	7.1	8.9	9.6	10.5	14.1	11.0	18.7	17.2	11.1	15.1	18.5	16.1	4.8	11.7	11.9	11.7	22.8	25.0	5.4	4.6	14.4	14.3	4.1	4.5	5.2	8.2	14.8	18.3	10.7	9.4	18.9	12.1	16.7	6.5	13.3	22.1	13.1	7.0	10.6	16.1	8.2	11.4	15.6	5.9	11.3	16.4	11.8	17.3	14.3	11.2	12.4	5.1	11.7	14.2	7.2	7.3	8.6	7.2	14.9	21.7	18.2	5.9	7.5	11.8	7.9	5.6	5.4	23.2	13.1	11.8	0.1	13.2	3.3	6.1	15.2	6.3	5.4	7.1	7.8	17.8	4.9	6.5	6.7	3.1	9.5	14.4	21.4	10.4	9.4	5.8	5.2	3.8	7.2	5.3	4.9	5.9	4.6	4.7	4.2	5.0	7.1	6.2	6.4	5.9	14.7	4.8	4.5	7.6	12.3	8.6	8.2	11.6	7.6	9.4	10.0	9.8	11.0	33.3	23.9	7.7	10.9	3.9	17.3	4.4	13.1	4.2	5.6	1.8	3.0	13.2	13.7	9.3	6.6	10.2	10.0	0.0	21.7	4.6	14.2	10.2	1.7	14.2	4.9	14.2	4.1	4.4	3.3	6.8	5.3	5.4	6.5	7.6	3.8	2.1	12.5	14.5	16.9	7.4	11.3	5.6	9.1	18.3	8.2	11.2	18.6	0.0	3.8	6.9	2.4	2.3	14.1	5.8	74.6	6.0	6.0	7.5	11.4
TRMT44	"C4orf23, FLJ35725, METTL19, TRM44"	ENSG00000155275	"TRNA methyltransferase 44 homolog"	Q8IYL2	4	8436140-8493531	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045461	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA045461: AB_10961276"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.34e-3)"	5.8	3.5	2.0	3.9	2.5	7.1	6.9	2.6	2.8	5.1	0.7	4.9	3.6	6.2	4.4	6.6	5.4	3.4	4.6	2.2	0.9	3.2	4.2	4.2	5.0	0.9	0.6	7.6	4.5	4.2	3.2	4.9	1.2	4.8	3.2	3.7	5.5	3.8	5.9	9.0	3.6	4.4	0.6	4.0	5.3	4.9	1.3	3.7	4.5	2.6	5.2	5.0	5.6	2.6	5.2	5.1	6.4	7.5	6.5	6.3	15.2	5.9	4.2	7.6	6.7	6.8	7.0	6.9	3.1	2.3	6.4	4.1	9.3	5.4	6.7	3.7	5.9	6.9	8.9	5.1	6.0	11.4	4.9	3.9	7.7	5.8	6.3	6.4	8.1	4.8	10.2	7.2	5.0	3.2	9.5	8.3	7.4	6.5	8.5	6.9	6.9	4.9	6.6	6.0	6.9	4.7	3.8	3.4	5.5	7.2	2.9	4.7	5.2	4.6	2.5	4.4	9.3	8.4	6.0	6.2	5.1	10.7	4.7	0.1	0.3	0.0	0.6	0.3	0.3	0.2	0.5	0.6	0.5	0.5	0.7	0.2	0.0	0.2	0.6	0.4	0.0	0.1	2.0	2.5	2.6	2.8	2.2	0.9	0.9	0.6	1.2	0.6	1.3	2.6	4.4	9.6	7.3	12.7	4.9	6.8	4.2	3.1	2.8	7.8	6.8	5.1	3.3	7.2	3.2	7.3	25.0	10.2	4.1	2.6	5.9	5.0	3.8	16.2	13.0	4.7	1.8	1.7	21.3	4.5	6.2	7.5	14.8	25.6	5.1	18.8	5.0	3.8	4.6	3.3	18.4	2.0	2.0	3.1	2.4	2.8	5.9	3.7	1.8	8.4	4.1	2.6	3.1	8.5	12.3	4.5	7.2	3.8	5.3	5.3	3.0	2.7	8.1	10.8	0.0	6.3	6.5	9.2	5.8	8.2	5.8	16.3	5.2	4.8	3.8	7.6
GPR78		ENSG00000155269	"G protein-coupled receptor 78"	Q96P69	4	8558725-8619761	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1.4;placenta: 3.0"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 5.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 25.8"									HPA013209	Uncertain					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA013209: AB_10601657"	"unprognostic (6.41e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.70e-2)"		"unprognostic (3.82e-4)"	"unprognostic (6.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.88e-15)"	"unprognostic (5.55e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.90e-3)"	"unprognostic (8.15e-2)"	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	4.9	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 144.3"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 1.5;Fibroblasts: 8.5;Microglial cells: 2.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 73.6;BJ: 39.7;BJ hTERT+: 51.7;hTERT-RPE1: 30.6;RH-30: 57.6;U-2197: 46.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	11.1	1.8	0.3	2.7	1.0	0.0	11.8	0.5	2.9	33.3	2.3	4.6	0.8	14.6	9.1	7.4	19.9	30.7	2.8	0.8	0.4	2.0	1.4	7.1	2.8	0.7	0.5	144.3	3.2	1.8	5.2	42.1	0.8	5.9	1.8	0.1	1.5	24.2	0.2	13.8	2.6	8.4	1.2	1.4	3.3	3.1	0.3	1.5	7.8	0.0	1.0	23.0	25.1	0.9	26.1	0.4	0.0	1.6	5.0	0.5	73.6	39.7	51.7	14.5	5.8	1.7	0.7	0.0	3.7	21.3	0.3	0.0	0.0	0.0	5.4	0.0	2.9	0.0	0.3	0.7	4.4	0.0	0.0	9.2	0.0	0.0	0.0	30.6	0.0	0.0	1.2	0.0	0.9	6.1	0.0	0.1	9.2	0.2	22.0	0.1	57.6	0.0	0.0	1.1	0.1	0.1	1.4	0.5	0.1	8.3	0.3	0.0	0.0	2.0	2.6	46.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.5	2.9	0.8	0.4	0.7	0.5	0.8	1.2	0.3	0.9	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.6	8.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0
HMX1	"H6, NKX5-3"	ENSG00000215612	"H6 family homeobox 1"	Q9NP08	4	8846076-8871839	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cataract, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.6;retina: 2.3;testis: 1.3"	"Group enriched"	"Detected in some"	13	"Horizontal cells: 267.5;Muller glia cells: 247.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;EFO-21: 2.9;HEK 293: 5.5;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (6.11e-2)"				"unprognostic (1.63e-2)"	"unprognostic (2.97e-1)"				"unprognostic (6.35e-2)"		"unprognostic (7.94e-2)"		"unprognostic (9.36e-2)"	"unprognostic (1.97e-1)"			0.0	0.0	1.2	0.0	1.0	0.0	0.0	1.6	1.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	1.6	1.2	1.0	1.0	1.5	1.6	1.4	1.1	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.1	0.6	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	267.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	247.9	0.0	6.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.1	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"	D6RGX4	4	9170409-9176730	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA							Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L10		ENSG00000231396	"Ubiquitin specific peptidase 17 like family member 10"	C9JJH3	4	9210657-9212249	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17 like family member 11"	C9JVI0	4	9215405-9216997	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"brain: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	3.2	0.0	1.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	2.4	1.4	3.4	2.4	1.0	3.6	0.2	2.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L12		ENSG00000227551	"Ubiquitin specific peptidase 17 like family member 12"	C9JPN9	4	9220152-9221744	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L13		ENSG00000232399	"Ubiquitin specific peptidase 17 like family member 13"	C9JLJ4	4	9224896-9226488	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17 like family member 15"	C9J2P7	4	9234385-9236046	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	87	"brain: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	7.1	0.0	3.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	3.8	0.0	0.0	0.0	0.0	10.4	0.9	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	3.5	0.0	7.6	6.8	3.8	10.4	0.9	12.3	0.9	12.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L17		ENSG00000249104	"Ubiquitin specific peptidase 17 like family member 17"	D6RBQ6	4	9243879-9245471	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L18		ENSG00000250844	"Ubiquitin specific peptidase 17 like family member 18"	D6R9N7	4	9248630-9250222	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L19		ENSG00000248920	"Ubiquitin specific peptidase 17 like family member 19"	D6RCP7	4	9253378-9254970	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L20		ENSG00000250745	"Ubiquitin specific peptidase 17 like family member 20"	D6RJB6	4	9258124-9259716	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"brain: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA045642: AB_2679403"																		0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.0	1.2	1.0	1.7	0.7	0.7	0.3	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L21		ENSG00000249811	"Ubiquitin specific peptidase 17 like family member 21"	D6R901	4	9262872-9264464	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17 like family member 22"	D6RA61	4	9267619-9269211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	1.2	0.8	0.6	1.3	0.1	1.8	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L23		ENSG00000250913	"Ubiquitin specific peptidase 17 like family member 23"	D6RBM5	4	9272364-9272914	"Enzymes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L24		ENSG00000232264	"Ubiquitin specific peptidase 17 like family member 24"	Q0WX57	4	9325165-9326757	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L25		ENSG00000230430	"Ubiquitin specific peptidase 17 like family member 25"	Q0WX57	4	9329911-9331503	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L26		ENSG00000229579	"Ubiquitin specific peptidase 17 like family member 26"	Q0WX57	4	9334658-9336250	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L5		ENSG00000227140	"Ubiquitin specific peptidase 17 like family member 5"	A8MUK1	4	9339403-9340995	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L27		ENSG00000235780	"Ubiquitin specific peptidase 17 like family member 27"	Q0WX57	4	9344148-9345740	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L28		ENSG00000231051	"Ubiquitin specific peptidase 17 like family member 28"	Q0WX57	4	9348893-9350485	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L29		ENSG00000231637	"Ubiquitin specific peptidase 17 like family member 29"	Q0WX57	4	9353638-9355230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L30		ENSG00000228856	"Ubiquitin specific peptidase 17 like family member 30"	Q0WX57	4	9363129-9364721	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"epididymis: 167.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 1.2;pons: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"TIME: 2.1"														"Secreted in other tissues"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"																				"unprognostic (2.11e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	14.9	0.0	167.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	14.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	1.2	0.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.3;liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 27.4;Proximal tubular cells: 72.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 36.9;myeloid DC: 30.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 30.5;monocytes: 36.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	1.6	2.6	1.0	2.0	1.2	2.1	4.2	1.3	1.2	2.5	2.7	1.8	10.7	1.4	2.4	5.2	3.5	2.4	2.3	1.1	1.6	29.3	21.4	4.2	2.0	2.3	1.5	1.6	1.0	2.4	1.4	7.6	2.0	3.5	1.6	1.2	16.6	18.8	0.5	2.2	8.4	2.0	1.8	1.8	1.0	0.7	2.0	4.2	2.7	0.5	1.4	6.4	4.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.1	0.0	0.3	2.4	0.0	3.5	0.7	0.0	7.3	0.0	48.1	0.0	8.2	0.3	0.0	0.0	23.6	1.6	0.1	6.3	3.4	19.9	0.0	4.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.3	2.4	0.0	0.4	0.1	1.5	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.1	0.0	36.9	0.9	0.3	7.6	0.3	0.3	0.3	0.1	30.5	0.1	0.2	0.1	1.1	0.2	0.9	12.2	0.2	9.1	1.0	1.2	1.3	1.2	1.1	1.6	2.3	1.5	2.0	1.8	2.0	3.0	1.4	0.0	0.0	8.1	1.3	0.9	13.4	27.4	6.2	0.0	4.6	6.1	2.4	0.0	5.7	3.7	2.1	18.7	0.5	1.7	3.9	0.5	5.1	4.1	2.1	1.5	0.0	1.3	4.4	1.1	1.8	1.6	1.1	11.5	1.3	0.5	2.2	5.2	10.3	0.0	5.6	0.9	10.2	8.7	3.7	3.4	0.0	8.8	0.0	15.9	4.4	1.2	1.0	10.6	1.1	0.6	0.5	0.4	0.3	2.0	8.1	72.6	3.0	0.4	0.0	4.6	1.6	1.1	1.9	5.4	0.6	8.5	0.9	0.7	2.5	7.7
DRD5	"DRD1B, DRD1L2"	ENSG00000169676	"Dopamine receptor D5"	P21918	4	9781634-9784009	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Dystonia, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6;stomach 1: 4.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Horizontal cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 7.0"	HPA048930	Supported					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048930: AB_2680562"		"unprognostic (2.03e-2)"			"unprognostic (2.63e-1)"	"unprognostic (9.73e-2)"		"unprognostic (4.27e-2)"		"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-4)"	"unprognostic (5.09e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.36e-3)"	0.0	0.0	3.2	1.4	6.6	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	0.0	0.4	0.0	2.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	4.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.6	0.0	3.3	1.6	1.6	2.0	1.1	2.2	1.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1232.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		63000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	133.7	77.7	60.2	194.5	58.1	150.9	107.8	56.8	65.4	147.1	104.2	200.8	149.1	261.1	91.0	165.1	179.5	117.4	134.2	69.7	69.7	119.4	84.2	142.8	174.6	68.4	69.7	120.5	63.7	89.6	58.4	105.4	68.6	124.5	141.5	93.0	124.9	173.7	94.8	110.4	148.3	214.6	63.1	110.0	131.7	131.9	62.6	188.0	109.8	89.5	149.6	203.0	139.3	68.8	249.5	246.9	213.2	179.4	160.1	265.9	336.9	612.9	561.7	542.9	423.1	296.4	303.3	173.6	193.3	744.4	579.3	158.8	237.3	451.0	582.4	270.7	82.8	494.1	244.6	213.8	377.9	159.4	538.6	256.7	228.4	552.9	276.3	418.7	599.3	301.6	151.6	273.3	540.7	142.8	700.1	229.0	253.4	200.7	250.4	327.8	197.7	146.7	344.9	394.7	72.4	80.5	265.6	141.3	257.3	282.9	120.1	173.9	909.9	415.7	174.6	345.7	548.0	173.4	296.4	225.5	439.7	240.4	522.9	177.4	115.7	213.6	172.3	195.9	134.4	81.6	143.8	173.0	141.4	61.1	145.6	156.9	201.5	129.0	246.9	154.5	214.9	298.4	60.2	58.1	56.8	65.4	69.7	69.7	68.4	69.7	68.6	63.1	62.6	68.8	66.5	35.3	52.9	10.1	77.0	145.3	204.6	103.5	46.7	22.0	65.9	68.7	62.9	52.9	87.4	104.8	41.7	172.5	126.7	347.1	86.1	282.5	500.8	72.2	63.8	103.6	109.2	56.8	4.7	211.3	302.4	68.7	118.3	111.7	82.4	78.7	84.3	71.8	249.2	33.7	8.4	152.6	138.4	159.4	135.8	1232.1	46.9	174.9	80.0	15.0	303.7	82.6	147.2	11.6	9.6	322.8	244.4	92.2	78.3	150.7	169.0	113.1	73.5	28.0	98.6	46.1	168.1	81.6	64.3	74.9	137.0	231.6	132.2	77.2	172.8	193.6
ZNF518B	KIAA1729	ENSG00000178163	"Zinc finger protein 518B"	Q9C0D4	4	10439880-10457426	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031215, HPA031216"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA031215: AB_10600200, HPA031216: AB_10601449"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.89e-3)"	6.3	4.4	4.7	6.4	5.2	3.9	7.0	7.8	4.7	3.7	4.9	3.9	3.7	4.9	3.6	4.2	2.9	4.3	6.4	5.6	6.4	3.3	2.2	4.3	6.7	2.5	4.0	7.8	1.5	3.7	2.9	7.0	3.6	6.9	2.9	7.0	7.4	7.1	6.0	3.7	5.0	5.6	3.9	6.7	3.5	9.0	7.7	8.6	7.9	8.7	8.7	4.2	3.7	4.0	8.2	5.5	20.8	6.1	2.7	3.9	0.1	9.1	2.3	5.7	6.6	0.0	0.0	0.1	9.2	13.7	16.1	0.2	4.8	10.4	12.6	0.0	8.8	26.2	0.0	0.0	11.9	0.0	11.2	11.7	6.0	9.0	0.0	11.6	19.6	19.3	28.9	0.0	4.7	0.0	18.2	0.6	20.4	4.1	12.5	15.5	8.6	3.0	0.3	11.2	15.5	4.6	4.3	0.0	2.8	16.6	3.4	7.0	14.9	0.0	18.7	0.1	8.8	10.7	8.5	15.1	1.1	1.4	1.1	2.2	2.0	9.6	2.1	1.9	2.6	7.9	3.3	2.4	3.5	3.5	3.4	3.2	4.9	5.0	4.7	1.2	2.6	1.7	4.7	5.2	7.8	4.7	5.6	6.4	2.5	4.0	3.6	3.9	7.7	4.0	15.7	3.2	6.3	4.2	12.1	15.9	22.8	8.0	8.6	9.6	5.7	5.1	26.3	4.3	9.5	0.0	10.4	8.9	3.7	3.6	3.9	2.5	13.1	5.0	9.2	13.1	1.2	4.6	12.1	4.0	9.3	11.9	4.6	10.2	16.5	22.5	12.8	1.8	9.2	11.8	10.6	3.5	14.2	10.2	8.0	20.8	16.1	7.3	1.8	7.5	6.5	6.1	6.2	4.5	3.5	1.6	3.3	21.4	5.3	20.0	6.2	1.3	6.7	10.3	0.0	6.7	8.6	13.7	11.2	6.8	14.2	9.2	8.1	19.7	4.3	19.5
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429564	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ovary: 31.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 112.0;granulocytes: 96.3;Granulosa cells: 285.0;Peritubular cells: 90.3;Urothelial cells: 92.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.4"	"Group enriched"	"Detected in some"	36	"memory B-cell: 14.9;naive B-cell: 26.6;plasmacytoid DC: 42.3"	"Group enriched"	"Detected in many"	108	"B-cells: 26.6;dendritic cells: 42.3"	"Cell line enhanced"	"Detected in some"		"A-431: 5.8;CAPAN-2: 20.6;HaCaT: 6.0;RPTEC TERT1: 13.2;RT4: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.6	2.5	2.3	2.7	1.9	2.0	1.9	25.4	6.9	2.4	0.0	2.1	3.7	3.4	1.3	11.6	4.4	12.7	1.9	1.6	4.7	5.9	0.4	1.8	2.3	4.7	3.3	31.9	1.0	0.1	4.7	0.7	3.8	2.0	1.1	1.0	5.6	1.5	0.4	0.5	2.9	0.9	4.4	3.3	6.5	1.3	5.8	1.3	1.6	0.2	1.2	14.5	2.6	6.1	5.8	1.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.6	0.0	0.4	0.0	0.0	6.0	0.0	2.8	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.1	1.6	2.2	1.2	0.0	0.0	13.2	14.5	4.6	0.0	0.0	0.1	0.4	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	14.9	0.0	0.0	0.7	26.6	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.1	2.3	1.9	25.4	6.9	1.6	4.7	4.7	3.3	3.8	4.4	5.8	6.1	3.5	3.2	5.8	0.0	13.1	9.1	13.5	70.1	5.2	3.7	2.4	9.3	3.2	32.9	112.0	20.2	4.2	0.5	21.6	5.2	0.0	25.0	1.7	3.6	1.0	28.9	2.4	0.0	13.4	2.1	42.1	13.2	23.9	14.9	96.3	285.0	25.0	0.4	37.6	1.7	35.0	7.2	71.2	3.5	3.7	2.0	8.7	12.5	1.8	6.5	4.9	32.9	8.2	24.1	0.7	51.9	6.5	90.3	0.0	5.6	2.7	19.1	61.2	2.6	0.0	0.5	17.5	5.4	5.6	36.6	8.1	1.4	1.4	68.5	4.3	92.9
RAB28		ENSG00000157869	"RAB28, member RAS oncogene family"	P51157	4	13361354-13484365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 119.9;Inhibitory neurons: 140.4;Spermatocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044575	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044575: AB_10959460"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.31e-3)"	"prognostic favorable (1.61e-4)"	17.1	18.9	22.9	12.8	25.2	19.3	20.3	39.5	29.2	15.3	24.9	16.2	11.0	22.5	18.8	12.0	21.9	15.5	30.4	23.7	29.5	16.4	11.9	16.1	18.3	22.3	26.7	22.4	10.0	23.9	19.3	19.5	24.7	16.2	18.1	55.4	12.1	16.0	7.2	19.9	11.3	17.3	24.3	17.2	14.5	37.7	29.6	18.4	19.5	13.3	16.7	13.2	13.3	28.9	22.0	11.4	36.3	18.6	18.7	34.8	19.0	19.7	22.7	21.7	28.9	11.3	22.7	26.0	12.5	19.3	46.0	11.1	31.4	17.6	39.3	16.7	15.7	18.6	20.1	10.8	18.3	21.2	10.9	16.0	23.3	19.8	18.7	26.5	23.9	32.9	37.0	97.1	30.4	8.8	45.3	52.7	50.7	16.4	19.9	28.6	22.8	21.5	18.7	11.9	28.7	17.3	17.0	12.2	28.1	28.2	13.7	23.8	16.5	28.8	12.6	23.8	30.7	24.0	18.0	34.6	25.7	38.3	38.6	21.0	16.2	26.1	16.5	15.6	17.0	18.4	15.3	16.2	16.8	17.9	20.3	16.5	15.1	20.6	14.4	12.9	17.2	10.6	22.9	25.2	39.5	29.2	23.7	29.5	22.3	26.7	24.7	24.3	29.6	28.9	17.8	6.4	6.4	81.0	22.3	27.4	26.7	38.7	22.2	31.0	15.6	14.0	18.2	2.8	16.7	7.3	33.3	23.3	15.1	7.9	19.6	12.9	19.1	19.6	17.7	18.4	10.3	9.9	119.9	14.2	22.7	27.5	11.7	8.2	5.1	12.4	12.8	6.8	17.0	32.0	140.4	11.0	32.6	15.1	18.2	20.6	18.6	14.2	30.2	49.6	16.7	44.5	19.6	97.0	79.8	11.2	7.8	24.0	19.2	21.4	6.3	18.8	36.5	44.1	19.7	24.1	20.1	123.9	63.7	20.6	30.0	27.9	21.3	10.6	11.6	19.0
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13544508	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 18.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.2;Cardiomyocytes: 4.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.3;NB-4: 11.3;NTERA-2: 6.2;THP-1: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm		"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.0	18.7	0.6	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.1	0.6	0.0	0.0	0.4	1.0	0.0	0.1	0.2	0.0	0.1	1.8	1.4	0.0	2.3	1.8	0.7	0.0	0.0	0.2	0.4	0.0	0.0	1.4	0.0	0.0	0.4	2.0	1.8	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	4.3	0.0	0.0	0.0	2.2	0.6	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.5	1.4	0.0	0.6	0.0	0.3	11.3	6.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.9	6.6	0.0	0.5	2.5	0.1	0.4	1.7	0.0	0.0	0.4	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627725	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	15.9	10.6	11.8	17.6	12.8	41.6	16.2	17.5	15.0	14.3	10.1	16.1	10.8	16.6	16.8	12.8	14.8	12.4	11.9	11.2	14.4	13.5	11.1	12.9	21.8	13.5	12.3	23.0	13.7	22.6	9.1	16.6	13.1	12.3	12.5	22.0	14.5	12.7	11.3	17.7	18.8	11.8	10.6	21.9	14.2	16.7	12.9	25.3	13.7	14.1	20.8	12.7	14.0	15.7	17.6	23.2	22.7	16.3	27.0	28.4	17.4	20.0	21.0	16.3	18.1	17.6	18.7	23.6	8.9	22.0	30.2	11.7	18.7	19.9	31.2	16.3	10.7	33.2	31.0	21.6	16.6	50.5	26.4	22.9	22.1	33.7	25.9	22.3	17.0	16.4	23.8	27.4	20.6	10.5	26.2	33.4	29.2	11.3	19.9	19.8	33.6	9.6	30.6	17.5	13.5	24.6	22.0	7.7	18.2	24.3	9.1	19.3	38.9	25.1	13.2	15.6	26.7	32.3	20.3	29.0	24.6	23.4	20.3	2.5	1.1	2.3	1.1	1.1	0.9	1.3	0.7	0.8	0.7	1.5	1.0	0.8	9.2	0.6	0.7	1.9	0.7	0.4	11.8	12.8	17.5	15.0	11.2	14.4	13.5	12.3	13.1	10.6	12.9	15.7	113.2	83.3	95.8	72.1	93.7	26.3	22.6	17.4	33.0	170.8	39.6	67.8	88.5	51.5	49.7	36.8	89.6	16.5	105.8	31.0	3.9	30.2	20.8	135.4	108.7	68.7	34.7	57.4	56.1	25.3	18.6	60.0	29.6	193.7	63.3	110.1	41.0	32.7	21.5	161.5	62.8	29.1	6.1	41.5	29.0	17.6	50.4	70.9	24.9	56.2	64.1	87.6	57.7	57.8	96.5	33.2	23.8	57.9	68.4	24.8	22.4	7.6	40.0	198.3	46.0	103.4	78.8	83.1	32.1	29.7	28.8	18.6	73.5	106.7	24.3	27.4
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002481-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 127.6;Oligodendrocytes: 406.5;Suprabasal keratinocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA072513: AB_2686529"	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	9.6	6.0	13.2	5.1	21.9	26.5	12.3	18.8	21.9	9.8	5.6	11.5	8.4	7.4	8.3	13.3	6.0	9.5	7.3	14.6	15.0	12.0	17.6	8.4	5.6	22.4	16.6	6.3	4.4	16.3	4.2	6.4	20.7	8.4	9.7	16.1	8.1	10.7	5.8	23.5	8.7	8.6	18.7	5.8	10.7	37.9	17.3	4.5	4.8	6.2	6.4	8.0	13.2	45.5	2.9	18.1	1.9	0.7	13.1	26.2	3.6	10.8	6.7	5.8	4.6	0.3	4.2	1.9	2.1	10.1	11.8	3.5	3.9	2.6	3.6	4.8	1.5	0.5	16.3	3.5	6.1	1.0	2.6	12.3	12.5	15.6	14.7	8.7	6.1	0.3	0.4	13.2	26.9	1.5	0.2	4.7	1.7	5.9	2.8	0.3	1.8	0.8	57.3	2.6	1.7	11.1	3.1	2.4	10.6	8.7	1.5	12.2	11.7	24.0	2.1	15.3	6.1	9.0	1.3	1.0	19.3	10.6	9.5	0.0	0.2	0.6	0.1	0.1	0.5	0.0	0.2	0.1	0.2	0.1	0.3	0.1	1.1	0.5	0.1	0.1	0.1	0.1	13.2	21.9	18.8	21.9	14.6	15.0	22.4	16.6	20.7	18.7	17.3	45.5	24.9	32.1	14.2	55.8	8.1	85.8	12.2	6.8	58.1	8.6	31.2	17.8	22.3	12.8	9.3	31.3	27.1	1.4	10.7	26.4	1.9	4.6	64.5	38.4	9.9	14.7	10.2	3.8	58.2	4.9	1.8	13.4	15.3	50.7	10.8	1.8	13.2	23.8	11.2	15.2	127.6	13.1	4.1	14.1	31.0	20.3	6.2	20.3	53.4	39.4	6.6	8.5	3.1	89.5	406.5	7.0	16.9	8.2	17.5	11.8	18.7	14.8	5.1	19.3	0.0	20.7	16.5	16.6	4.6	77.0	129.4	1.4	11.0	3.6	8.1	17.0
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446167	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Fibroblasts: 32.3;Leydig cells: 22.7;Peritubular cells: 31.6;Skeletal myocytes: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 4.2;ASC TERT1: 2.8;HSkMC: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	7.8	1.4	1.2	1.6	1.2	0.0	4.7	1.2	2.6	23.1	0.0	8.6	1.2	16.5	10.2	6.0	6.3	14.0	7.0	0.8	1.8	5.5	1.2	10.8	1.2	1.1	1.8	20.9	0.8	0.1	1.1	7.2	0.9	9.5	4.2	0.1	2.5	3.2	0.6	3.2	3.8	12.0	0.6	9.7	9.0	1.7	1.8	0.4	3.8	6.6	0.5	10.3	10.3	1.3	0.0	0.0	0.0	0.0	4.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.6	0.8	1.8	1.1	1.8	0.9	0.6	1.8	1.3	1.2	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	15.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.1	0.2	6.5	0.5	0.0	0.0	1.0	0.0	0.3	32.3	0.0	0.6	0.0	2.0	0.0	0.0	0.1	1.7	4.4	0.0	0.0	0.0	3.2	0.5	22.7	0.3	5.4	6.5	0.0	0.3	0.0	2.5	0.7	0.0	0.0	31.6	0.2	0.1	0.0	2.8	0.0	1.2	6.6	15.2	9.9	0.0	0.1	0.6	3.0	0.0	0.7	5.7	0.0	0.1
CC2D2A	"JBTS9, KIAA1345, MKS6"	ENSG00000048342	"Coiled-coil and C2 domain containing 2A"	Q9P2K1	4	15469865-15601552	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 84.7"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044124	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA044124: AB_10969197"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.01e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.42e-9)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.18e-2)"	8.3	9.3	13.5	2.7	13.0	2.7	8.8	14.2	16.5	14.2	22.1	17.3	4.9	12.8	11.1	8.3	34.2	12.4	7.4	13.2	13.5	23.6	2.9	10.7	2.0	13.7	14.6	11.7	5.1	10.0	12.7	8.5	12.6	10.0	5.9	84.7	3.3	12.5	2.5	2.3	5.0	15.4	12.0	3.3	8.2	4.9	14.7	1.2	8.2	11.1	1.4	9.3	6.4	12.7	5.4	11.3	15.6	7.0	18.4	34.4	3.8	6.8	11.5	12.7	15.5	5.1	13.2	0.5	7.3	13.1	27.7	3.4	13.1	8.7	15.9	0.0	7.3	5.5	10.1	7.1	13.5	0.5	0.1	25.0	22.8	20.7	15.5	23.3	5.9	0.2	14.7	0.4	24.4	3.9	0.2	0.9	25.9	0.2	23.3	3.5	4.9	1.1	32.1	2.6	9.7	11.1	4.3	3.1	32.2	14.6	4.9	1.3	2.2	20.2	12.0	8.6	14.4	0.4	0.5	0.3	24.3	0.3	13.1	1.9	2.4	0.2	0.4	1.6	0.6	0.3	0.3	0.1	3.8	0.3	0.2	0.4	4.8	0.9	0.8	0.2	0.9	0.6	13.5	13.0	14.2	16.5	13.2	13.5	13.7	14.6	12.6	12.0	14.7	12.7	8.4	12.8	14.6	39.8	0.7	2.2	5.6	5.7	14.2	15.1	6.5	9.0	22.9	10.0	23.5	25.8	569.2	10.2	0.3	0.8	33.2	6.6	12.0	96.8	14.0	7.0	6.0	2.7	20.9	0.9	3.1	18.7	4.1	9.0	0.0	15.2	8.9	1.6	5.0	8.4	43.4	0.9	8.2	5.7	4.6	6.7	9.3	4.4	12.4	16.9	1.2	18.4	0.0	62.8	19.5	1.0	0.5	16.6	1.3	4.4	2.1	57.1	128.4	136.4	6.6	14.7	17.7	2.6	0.7	6.4	1.3	1.5	1.9	12.9	2.9	4.0
FBXL5	"FBL4, FBL5, FLR1"	ENSG00000118564	"F-box and leucine rich repeat protein 5"	Q9UKA1	4	15604381-15681679	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 407.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 108.2;granulocytes: 407.0;monocytes: 225.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002484	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002484: "	"unprognostic (1.53e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.70e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.18e-2)"	72.8	50.9	49.0	40.2	53.9	110.9	51.9	56.3	65.5	53.8	50.3	51.3	29.8	42.1	63.5	43.0	46.1	51.6	49.5	48.1	51.2	128.0	77.4	48.8	35.3	49.9	52.6	41.5	32.7	59.4	44.4	37.1	50.1	51.5	36.2	48.0	36.9	56.4	80.1	36.3	31.7	55.1	50.9	45.1	41.5	68.0	52.2	46.3	70.6	85.5	32.6	53.9	37.7	55.2	23.3	17.8	42.3	23.9	65.0	63.9	13.4	30.4	37.2	32.7	45.9	14.3	34.1	18.1	14.2	36.4	57.8	8.5	21.9	36.5	50.3	17.7	11.2	17.8	12.9	16.9	65.3	21.7	16.4	59.0	48.4	30.4	46.9	74.9	86.8	15.7	15.2	14.8	99.1	10.5	41.3	33.4	22.3	19.1	15.8	29.5	43.0	14.8	51.8	32.9	20.4	19.2	28.4	10.0	32.8	57.7	16.2	35.8	20.8	37.8	10.7	26.0	38.0	20.1	22.2	16.8	32.4	37.7	46.6	204.3	225.4	115.2	46.2	112.9	44.9	33.5	42.5	44.7	108.2	31.3	44.0	44.8	407.0	42.4	101.7	16.6	40.6	206.8	49.0	53.9	56.3	65.5	48.1	51.2	49.9	52.6	50.1	50.9	52.2	55.2	37.0	44.8	62.0	63.6	31.3	27.3	37.2	40.5	62.0	52.3	34.6	28.2	88.1	41.5	46.9	36.8	6.2	53.3	38.9	24.4	78.2	29.2	80.3	32.5	41.2	42.5	25.9	29.9	73.6	23.3	41.8	47.0	36.2	42.1	39.9	38.6	40.0	69.1	48.5	40.4	78.7	20.1	32.6	109.9	28.4	52.9	39.7	81.1	30.2	63.7	138.4	36.2	44.3	65.9	120.2	18.8	20.4	58.3	39.1	30.8	37.2	252.3	61.9	41.1	59.2	42.1	46.2	188.5	73.5	63.1	26.1	26.4	45.4	38.4	25.6	32.7
FAM200B	C4orf53	ENSG00000237765	"Family with sequence similarity 200 member B"	P0CF97	4	15681662-15690447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 406.9;Late spermatids: 306.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017855	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA017855: AB_1847703"	"unprognostic (7.38e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.82e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (4.39e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.35e-5)"	6.4	6.8	12.8	5.1	13.7	3.7	7.2	13.7	17.2	6.8	9.7	5.1	6.6	6.4	9.3	4.7	6.2	5.0	5.2	12.8	13.4	10.3	8.9	4.2	5.5	12.0	13.0	8.5	5.5	5.8	6.5	6.5	12.1	6.1	5.6	8.9	4.6	6.0	5.5	4.8	5.7	3.8	12.4	5.4	4.4	4.8	15.0	9.6	8.9	6.6	3.9	4.1	4.9	15.0	6.3	9.2	14.6	8.0	10.2	13.5	5.2	7.7	4.3	10.0	9.0	6.8	4.3	7.4	3.9	8.4	13.1	4.4	14.5	7.4	15.6	3.7	8.0	5.7	12.3	10.7	8.1	5.4	2.4	7.9	8.4	9.7	6.1	16.9	5.7	4.7	7.6	4.4	22.1	3.6	5.6	5.9	19.4	3.6	7.3	5.0	22.5	1.1	9.2	4.9	20.0	11.0	5.6	1.6	13.6	12.8	3.3	6.6	8.1	10.3	8.1	8.4	10.5	2.1	4.6	3.5	6.4	7.2	23.5	3.7	6.7	6.8	1.4	3.0	1.9	0.8	1.7	1.3	3.3	1.3	2.9	2.3	15.1	1.1	2.4	1.1	2.1	3.7	12.8	13.7	13.7	17.2	12.8	13.4	12.0	13.0	12.1	12.4	15.0	15.0	35.2	28.9	47.5	16.0	21.7	53.8	61.8	80.0	76.8	53.4	72.8	96.1	94.9	78.6	52.4	77.3	12.5	72.4	34.8	54.3	406.9	50.1	224.1	64.6	46.1	42.9	66.0	27.1	23.4	58.7	60.2	59.0	17.9	62.9	13.3	64.5	44.3	91.9	68.2	53.8	23.5	68.5	97.6	77.3	48.6	306.0	93.8	60.4	62.2	5.6	84.7	133.3	59.8	10.6	39.4	51.9	79.3	70.0	8.5	45.4	105.2	233.8	55.1	21.1	46.0	48.1	56.7	113.4	38.0	45.4	51.1	34.6	38.8	71.2	66.7	64.7
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 139.8;intestine: 48.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.8;Macrophages: 33.3;monocytes: 80.1;Proximal enterocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 257.7;neutrophil: 292.7"	"Group enriched"	"Detected in many"	95	"dendritic cells: 78.9;granulocytes: 292.7;monocytes: 257.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 76.0;TIME: 40.4;U-937: 52.5;WM-115: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		190000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	21.2	2.7	1.9	13.7	2.1	139.8	9.4	2.1	4.7	11.0	1.6	8.3	48.6	6.3	2.9	4.6	7.9	18.2	19.1	2.1	2.0	17.0	8.5	12.7	7.1	1.9	1.4	9.3	3.1	1.7	1.3	13.7	2.2	3.7	9.7	1.0	3.9	4.6	2.7	5.0	29.3	9.7	0.8	18.6	3.2	2.7	3.0	3.9	4.9	6.8	3.5	16.8	7.4	3.3	0.6	10.5	1.2	1.0	28.8	7.0	1.6	21.0	2.1	20.4	22.2	0.3	12.1	0.8	1.9	12.2	0.6	0.3	3.3	0.5	17.2	0.8	0.7	5.6	0.8	0.6	6.7	7.2	15.1	5.7	1.5	12.9	1.0	0.9	3.0	5.0	0.7	0.5	12.5	0.3	2.3	4.3	2.7	0.9	2.2	0.8	1.8	0.5	0.5	0.6	1.4	4.3	0.4	0.7	14.2	1.2	0.5	76.0	40.4	0.6	1.0	7.9	1.1	0.6	0.2	0.7	2.7	52.5	44.8	41.8	257.7	20.8	1.1	97.4	1.7	2.2	0.9	0.8	78.9	0.9	1.1	0.7	292.7	0.4	73.9	26.6	1.0	109.8	1.9	2.1	2.1	4.7	2.1	2.0	1.9	1.4	2.2	0.8	3.0	3.3	5.4	3.2	3.7	1.3	0.3	4.6	0.8	0.1	1.8	0.6	1.2	2.0	1.5	2.8	1.0	1.8	0.0	16.0	5.5	3.7	1.9	4.4	4.4	8.0	9.9	3.8	1.2	2.5	0.7	2.5	24.0	22.5	0.0	16.2	15.9	20.6	6.4	2.1	40.8	0.0	0.7	8.1	0.0	26.3	11.5	1.2	3.1	33.3	14.2	3.7	80.1	0.6	3.1	0.5	3.6	1.1	11.9	2.2	0.4	0.6	79.0	9.6	3.0	0.2	6.6	3.9	15.5	2.5	1.4	1.7	3.0	7.1	1.8	1.4	23.2	3.3
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.3"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	2.5	13.1	3.8	13.6	2.0	2.7	2.5	0.7	0.9	4.5	5.8	0.9	1.2	1.1	3.0	1.9	3.8	3.5	6.6	0.8	3.3	6.3	23.4	3.3	5.5	0.7	0.3	0.1	1.8	0.5	3.4	13.2	3.5	0.2	2.6	19.7	21.4	0.3	5.3	1.4	2.8	17.0	3.0	1.0	3.9	63.3	2.0	3.4	18.0	6.8	0.5	4.6	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	2.5	3.8	2.7	2.5	3.5	6.6	3.3	5.5	3.4	2.8	3.9	4.6	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935577-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 117.1;esophagus: 421.8;vagina: 172.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1044.3;Basal respiratory cells: 596.2;Squamous epithelial cells: 528.5;Suprabasal keratinocytes: 786.2;Urothelial cells: 303.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 117.5;head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 556.3;HBEC3-KT: 968.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.6	0.1	0.0	1.7	0.0	0.1	13.5	0.0	0.0	117.1	0.0	22.1	1.8	0.5	0.1	421.8	1.2	0.3	0.2	0.0	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	1.1	0.0	1.7	15.6	0.0	59.7	0.1	0.1	91.2	7.0	1.1	0.0	0.1	2.0	0.0	0.0	0.3	0.7	0.0	38.4	14.9	172.3	0.0	150.7	10.5	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	189.0	0.0	10.9	0.0	0.2	556.3	0.0	968.2	0.0	0.0	1.2	0.0	2.0	0.0	0.2	0.0	0.4	0.1	141.0	0.0	17.7	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	7.9	75.2	0.0	0.0	0.0	93.4	6.7	0.0	0.0	0.2	0.0	0.2	0.0	0.9	0.5	0.1	0.2	0.3	0.0	0.3	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	8.4	0.0	0.3	1044.3	182.5	596.2	217.4	0.0	11.8	3.2	0.1	0.0	223.2	0.0	0.0	0.2	0.2	49.6	0.0	49.7	0.0	52.8	3.3	6.3	0.0	0.0	0.0	7.5	2.4	6.2	0.0	65.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.1	42.7	0.0	60.6	0.0	0.0	0.9	74.7	0.0	0.6	0.0	1.0	0.0	0.0	139.1	50.8	0.0	0.0	90.8	0.7	0.0	56.8	0.0	0.0	0.0	10.4	0.0	0.0	528.5	786.2	2.3	2.1	0.0	26.1	303.6
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960245-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.0;bone marrow: 54.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 486.6;NK-cells: 1627.2"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 551.3;memory CD8 T-cell: 332.1"	"Lineage enriched"	"Detected in many"	8	"T-cells: 551.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.9;T-47d: 3.2;WM-115: 1.3"														"Secreted to blood"	NA	NA	346000000	36000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	29.0	1.5	0.9	0.4	1.0	54.6	12.7	0.8	1.5	0.6	0.8	11.8	0.1	0.5	7.2	0.6	0.7	0.9	23.6	1.0	1.1	0.5	1.2	8.5	2.9	0.9	0.8	0.4	0.2	0.3	0.2	0.5	0.9	1.4	0.9	1.1	8.6	0.9	1.1	21.0	2.0	0.3	0.8	14.0	1.7	8.6	0.9	5.3	1.1	3.6	1.0	2.8	1.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.9	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	3.5	0.8	2.4	551.3	1.3	5.2	0.8	128.6	332.1	0.9	0.4	47.3	314.1	8.4	64.9	1.6	2.1	0.9	371.2	0.9	1.0	0.8	1.5	1.0	1.1	0.9	0.8	0.9	0.8	0.9	0.9	2.6	0.0	5.3	0.0	2.6	9.6	0.0	0.2	0.0	0.0	1.5	1.7	1.5	5.7	1.4	5.5	8.4	0.6	486.6	0.1	0.0	0.7	1.3	0.9	0.1	2.2	0.0	3.6	0.0	0.0	0.0	19.9	0.5	0.3	3.8	60.3	6.1	0.6	0.0	0.0	0.0	0.4	0.0	4.9	12.0	3.0	0.0	2.2	46.2	0.0	5.8	1.4	1627.2	0.0	0.1	0.2	0.0	0.4	17.5	0.0	0.0	1.3	1.3	0.4	0.0	1.8	2.5	0.7	0.1	0.1	7.7	1.0	167.2	0.2	0.1	0.0
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 272.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004922, CAB011525, HPA031053"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.3	0.3	4.1	6.2	3.0	4.0	27.7	2.7	3.5	44.9	2.0	30.7	12.4	6.0	4.3	5.1	5.4	30.9	6.7	3.3	2.8	20.9	1.8	3.1	0.0	3.8	4.3	0.1	14.4	0.0	0.1	30.1	3.6	2.8	16.7	272.9	57.9	7.1	1.0	0.9	22.9	3.5	2.8	0.2	24.8	8.0	5.0	0.1	4.8	0.0	0.1	4.2	0.2	3.1	0.0	0.0	37.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	70.6	28.9	0.6	62.2	0.0	0.0	0.1	7.3	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	97.4	0.0	0.0	1.4	0.1	0.0	91.1	0.1	12.0	3.6	0.0	2.4	1.9	3.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.0	2.7	3.5	3.3	2.8	3.8	4.3	3.6	2.8	5.0	3.1	0.2	3.2	4.8	1.3	0.3	0.0	0.1	7.2	0.0	14.8	38.2	30.0	8.6	31.5	29.9	82.8	581.7	0.6	1.0	39.3	0.0	64.1	31.4	71.1	1.7	5.1	44.4	2.1	0.9	15.5	0.1	4.4	31.6	14.8	0.0	3.8	0.7	0.1	0.1	10.1	5.4	15.0	34.6	0.0	0.0	44.3	3.1	0.7	0.0	27.2	0.6	47.5	0.0	45.8	1.2	38.2	28.3	6.4	0.4	1.5	18.8	3.6	144.8	311.3	0.0	0.8	3.1	2.1	1.0	0.7	0.0	0.1	0.7	0.3	26.0	4.1
TAPT1	FLJ90013	ENSG00000169762	"Transmembrane anterior posterior transformation 1"	Q6NXT6	4	16160505-16227410	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis"	"Developmental protein, Receptor"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Late spermatids: 163.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042567	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	"Nucleoplasm, Cytosol"	"HPA042567: AB_2678055"	"unprognostic (2.34e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (9.75e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.30e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (7.07e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (9.00e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.25e-3)"	"prognostic favorable (4.18e-4)"	7.4	15.1	17.5	6.0	18.6	25.7	10.0	17.3	22.3	8.2	15.1	8.9	6.4	10.0	9.2	6.1	9.5	6.7	9.1	17.1	17.0	12.4	30.5	11.9	9.6	18.6	17.4	8.1	8.1	13.0	8.5	6.8	18.4	7.4	8.2	24.7	7.6	6.4	35.5	7.7	7.5	9.3	17.4	8.5	7.9	11.1	17.5	12.2	11.5	19.9	8.1	7.6	6.9	19.5	4.9	3.6	6.0	7.0	8.9	6.8	2.5	7.8	6.0	7.4	8.1	4.9	8.5	31.7	8.3	5.0	10.8	4.0	5.2	4.0	9.3	2.9	6.3	6.2	5.0	5.2	8.4	12.6	6.2	4.2	7.7	7.3	5.3	9.1	3.8	19.3	9.7	14.5	7.2	3.5	18.7	10.1	4.0	9.3	8.4	45.0	8.4	5.8	12.0	5.1	10.0	8.0	7.4	6.2	9.5	4.1	11.5	12.3	7.1	6.2	4.1	4.2	10.3	13.9	12.2	24.2	12.4	30.9	7.3	1.1	0.3	0.0	0.2	0.2	0.0	1.0	0.7	0.4	0.5	2.5	0.9	0.7	0.6	0.3	0.3	0.8	0.5	0.3	17.5	18.6	17.3	22.3	17.1	17.0	18.6	17.4	18.4	17.4	17.5	19.5	12.0	32.1	62.6	47.3	20.2	9.1	6.3	4.2	4.0	24.5	15.0	9.9	14.3	10.0	8.7	7.3	114.7	4.2	16.2	11.1	3.9	6.7	79.0	14.2	12.6	12.8	14.4	16.6	42.6	8.2	3.1	10.2	8.6	12.0	2.5	17.5	8.6	46.0	4.2	70.7	43.6	9.8	4.1	10.3	18.9	163.1	9.9	11.1	16.0	45.0	6.5	33.1	8.2	60.8	68.2	9.5	9.4	15.1	8.9	7.1	10.7	8.7	14.4	62.4	6.6	17.0	11.5	33.3	5.7	7.1	8.0	7.0	10.8	16.5	9.0	6.6
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 752.2;choroid plexus: 301.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 337.6;Muller glia cells: 387.2;Oligodendrocytes: 481.3;Proximal tubular cells: 527.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	66.6	74.3	515.1	10.2	720.1	15.1	26.4	696.9	571.9	15.8	301.8	21.2	25.6	16.5	40.1	15.6	17.3	17.7	43.4	457.6	578.5	110.1	197.2	23.3	11.9	663.0	752.2	18.3	28.8	49.9	32.7	11.8	688.6	28.7	17.0	40.1	36.3	19.5	108.6	16.2	23.9	17.9	524.9	14.3	23.7	12.4	602.6	13.6	22.1	61.2	13.3	14.5	15.1	663.7	33.1	62.5	30.2	35.8	66.1	32.3	41.5	43.2	22.3	47.5	41.6	52.2	46.4	12.2	28.0	30.3	50.8	18.4	40.3	58.4	33.7	35.3	7.3	34.8	33.4	128.3	37.3	46.2	2.9	40.8	35.6	31.6	40.3	25.9	24.5	33.2	37.0	29.0	50.6	19.2	65.0	77.8	44.8	36.7	45.4	27.0	21.0	52.2	48.2	17.5	47.1	64.3	31.9	6.7	156.6	35.0	15.7	19.0	37.7	23.6	41.1	26.5	38.2	43.1	67.7	85.3	52.0	43.1	41.7	0.3	38.9	3.0	31.3	61.3	29.8	18.6	33.1	32.3	48.3	18.3	37.4	32.6	1.1	29.8	48.4	115.1	20.3	34.4	515.1	720.1	696.9	571.9	457.6	578.5	663.0	752.2	688.6	524.9	602.6	663.7	20.3	28.9	31.5	10.7	14.8	20.0	21.3	32.2	18.8	36.2	37.6	28.3	74.4	50.1	19.5	38.6	8.4	69.6	22.8	13.7	109.5	41.1	1.0	11.8	19.1	17.2	174.3	30.1	23.1	23.4	34.2	27.1	27.5	17.8	25.4	42.3	20.7	337.6	80.3	82.4	21.9	31.1	34.6	38.1	23.9	4.8	22.7	32.2	152.9	12.2	23.4	387.2	16.5	15.1	481.3	16.9	11.6	38.0	23.6	23.2	41.4	527.2	6.2	31.4	26.3	27.5	25.4	3.3	58.9	29.7	16.1	18.3	18.5	90.0	35.7	17.3
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA042407	Uncertain					NA	NA									"HPA042407: AB_10806237"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
MED28	"DKFZP434N185, EG1, magicin"	ENSG00000118579	"Mediator complex subunit 28"	Q9H204	4	17614641-17634105	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035900, HPA035901"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035900: AB_10673223, HPA035901: AB_2674853"	"unprognostic (1.14e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.07e-3)"	6.9	5.6	8.8	7.5	9.3	12.2	9.2	9.4	8.8	12.2	8.8	9.8	5.9	11.5	9.7	7.9	10.6	5.2	6.4	8.4	9.4	7.7	6.2	9.7	10.8	9.4	8.8	14.8	7.3	6.6	10.3	8.5	8.4	9.1	6.9	11.7	9.2	7.3	12.6	10.2	9.6	7.2	8.6	10.2	8.7	6.0	9.6	11.2	9.8	5.9	11.1	9.1	9.9	11.9	4.6	2.9	23.2	11.7	10.0	7.8	9.4	6.5	7.7	8.6	7.8	8.1	10.9	12.6	4.5	6.0	7.6	4.5	14.1	7.0	8.6	5.0	7.0	22.2	10.1	12.3	7.0	15.7	10.7	7.6	9.6	5.4	4.5	9.0	7.5	18.0	20.0	11.3	7.7	4.5	23.3	27.0	16.1	9.1	4.8	17.8	8.5	5.9	8.2	6.8	16.6	8.3	5.7	4.9	5.7	13.6	9.3	16.0	9.4	5.6	3.9	4.0	6.2	8.4	4.0	16.1	5.1	14.9	6.1	5.2	6.6	6.5	4.5	5.2	4.4	5.5	4.9	4.2	6.4	5.6	6.4	5.0	9.0	5.5	4.4	4.4	4.2	7.5	8.8	9.3	9.4	8.8	8.4	9.4	9.4	8.8	8.4	8.6	9.6	11.9	45.7	19.2	27.6	4.9	67.6	92.2	114.0	86.2	46.1	42.6	54.9	65.8	19.5	38.6	55.2	22.0	16.7	114.5	69.9	25.9	84.1	61.6	11.6	31.2	47.3	63.9	44.3	93.2	5.1	53.8	167.8	57.9	19.4	35.5	59.1	78.4	52.5	31.5	93.9	33.7	5.8	41.2	65.1	74.1	103.0	20.4	56.5	61.7	60.5	5.6	115.4	58.9	94.7	9.5	8.9	57.2	47.4	47.0	33.0	110.2	33.6	58.8	40.6	35.1	32.9	50.5	74.7	76.0	100.5	46.0	93.5	134.6	61.3	62.7	47.5	104.6
FAM184B	KIAA1276	ENSG00000047662	"Family with sequence similarity 184 member B"	Q9ULE4	4	17629306-17781621	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.0;retina: 1.7;skeletal muscle: 4.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.0;Horizontal cells: 32.0;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 27.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044119, HPA048458"	Enhanced					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA044119: AB_2678817, HPA048458: AB_2680401"	"unprognostic (1.20e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.13e-4)"	"unprognostic (2.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-4)"	0.0	0.1	1.8	0.1	1.9	0.2	0.1	1.2	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.7	0.3	0.0	0.0	0.1	2.0	1.6	0.0	0.0	0.1	0.0	0.0	1.8	0.1	0.2	1.7	0.1	0.0	4.2	0.2	0.0	0.0	1.0	0.1	0.0	0.1	1.6	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.9	1.2	2.0	1.9	1.7	2.0	1.6	1.8	1.0	1.6	1.6	1.1	0.0	2.0	4.2	3.8	4.5	5.2	0.2	2.8	33.0	2.7	2.0	0.6	2.8	0.8	0.0	14.6	4.8	1.7	2.4	0.0	1.1	0.8	1.1	2.2	2.7	4.2	2.7	15.5	1.0	3.9	2.8	0.0	2.8	13.4	3.6	0.4	2.4	1.2	32.0	23.0	1.8	0.0	2.2	8.2	1.7	11.5	1.5	3.6	1.9	0.0	19.8	2.1	75.9	7.1	1.5	0.5	7.5	0.4	7.0	0.0	1.1	0.2	27.1	0.0	9.7	2.2	9.1	9.5	0.9	9.7	5.3	4.8	3.4	0.6	5.4
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.40e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favorable (7.67e-4)"	9.6	8.2	4.5	8.0	7.0	18.1	13.0	6.4	6.7	12.8	2.9	10.4	7.9	13.8	10.2	7.9	11.9	6.6	8.4	4.2	7.4	9.2	4.8	9.1	11.9	6.1	5.8	19.4	11.3	12.3	13.3	9.8	5.7	10.6	9.5	13.3	10.9	7.9	8.2	15.0	10.2	8.9	4.5	8.9	8.8	10.9	7.8	12.0	10.1	4.4	11.4	10.0	10.2	9.4	21.7	4.6	24.3	25.5	6.8	11.9	13.2	13.9	16.3	16.2	19.1	13.1	17.2	24.2	10.8	12.9	13.1	10.7	14.4	14.7	23.9	8.3	13.2	34.2	16.0	21.5	16.3	30.4	13.4	15.5	11.8	20.6	20.3	10.8	11.3	23.6	37.4	39.3	9.4	8.2	33.4	29.0	20.0	6.3	13.1	35.0	27.8	15.7	7.1	16.9	36.0	28.9	14.8	3.9	16.9	12.2	14.3	8.1	14.5	18.7	14.7	20.8	17.8	17.3	7.4	29.4	15.4	20.6	12.8	7.8	1.4	2.1	2.5	1.6	3.3	2.0	2.7	2.8	0.9	2.9	3.4	3.2	1.0	2.1	1.1	1.8	2.1	1.3	4.5	7.0	6.4	6.7	4.2	7.4	6.1	5.8	5.7	4.5	7.8	9.4	11.6	19.2	24.8	13.1	17.6	25.4	24.3	9.4	25.6	12.2	16.3	16.9	21.9	12.8	14.4	9.2	6.2	17.6	27.0	8.6	13.7	9.9	19.6	12.9	18.4	13.0	17.5	21.7	20.2	7.7	10.0	15.9	14.3	13.3	17.1	24.8	11.4	6.4	7.7	15.2	20.2	12.5	14.2	11.9	11.3	11.5	21.1	9.4	10.6	15.0	10.2	27.5	7.2	29.1	36.7	11.8	7.6	22.2	27.6	14.6	9.2	5.1	17.1	14.6	13.1	21.7	16.2	28.8	17.3	19.5	21.2	12.3	20.3	19.0	13.9	19.2
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810979-17844865	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.9;lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.6"	"Low region specificity"	"Detected in all"			HPA039613	Uncertain					NA	Yes		9500	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	0.7	0.5	0.1	4.1	0.1	13.9	0.9	0.5	0.1	0.7	0.2	3.0	3.8	0.6	0.0	3.5	0.2	0.9	0.3	0.0	0.2	0.2	0.7	0.6	8.7	0.6	1.2	0.2	0.2	0.1	0.1	3.0	0.7	0.3	2.4	0.3	0.7	0.0	0.2	3.5	3.2	1.0	1.2	2.1	1.9	5.6	0.3	15.8	0.3	0.1	8.7	1.2	1.0	0.2	45.1	28.3	63.8	42.2	4.0	7.8	23.1	56.8	22.2	55.0	55.8	36.3	26.8	66.8	11.3	16.0	47.6	19.9	54.5	22.1	74.8	30.5	27.0	53.6	37.3	29.8	0.2	38.4	20.3	1.5	1.5	40.7	18.6	8.8	27.9	28.9	53.1	74.1	55.0	13.4	44.1	36.9	32.8	26.1	27.9	42.8	57.4	28.0	16.6	13.9	50.0	29.7	51.2	10.9	15.7	27.2	25.6	21.3	23.2	52.5	23.6	30.0	78.9	23.2	23.3	56.1	21.7	39.1	35.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.1	0.1	0.5	0.1	0.0	0.2	0.6	1.2	0.7	1.2	0.3	0.2	0.3	0.0	1.1	0.0	3.3	2.4	0.6	1.9	1.2	0.2	0.6	0.6	0.2	0.0	0.8	0.0	0.0	11.7	1.6	2.9	0.0	0.1	15.8	0.9	1.9	1.7	1.8	59.3	0.2	0.0	26.6	3.8	7.1	2.3	1.3	14.2	2.2	0.5	9.5	0.0	0.4	3.1	2.0	2.6	2.9	9.5	0.6	3.7	1.8	1.0	0.7	0.3	3.1	0.5	0.5	0.2	0.1	0.0	20.4	0.4	0.2	0.0	0.0	0.2	0.0	0.2	4.3	63.7	24.3	11.0	1.1	2.2	3.7	0.7	5.6	1.3
LCORL	"FLJ30696, MLR1"	ENSG00000178177	"Ligand dependent nuclear receptor corepressor like"	Q8N3X6	4	17841199-18021876	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 133.6;Microglial cells: 135.9;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 164.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028794, HPA028795, HPA060033"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192"	"unprognostic (1.06e-1)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (3.22e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.90e-4)"	"unprognostic (3.46e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	2.6	3.7	2.8	3.0	3.6	3.7	2.8	6.4	3.4	2.6	2.1	3.2	5.8	3.0	2.8	2.5	2.0	3.4	1.6	2.3	6.9	4.0	3.4	2.8	3.6	3.4	5.0	4.1	3.3	4.6	1.6	3.9	3.6	2.7	3.6	6.5	2.3	2.1	2.8	4.9	7.0	2.7	3.4	3.4	4.5	5.8	6.3	3.9	3.7	2.9	2.7	2.7	1.9	5.5	5.3	3.4	11.5	5.1	7.1	10.5	2.8	5.9	6.3	5.0	6.7	2.1	7.0	11.4	2.7	3.5	8.8	2.2	4.9	2.2	5.4	1.6	3.7	9.7	5.6	2.4	4.6	7.5	6.7	6.0	2.9	3.3	8.1	7.9	7.1	6.9	5.6	12.1	6.3	1.7	7.3	13.0	5.3	4.1	5.3	7.8	9.1	6.1	7.1	3.0	8.7	10.2	4.8	2.7	3.3	5.2	5.0	4.3	5.8	7.9	4.6	6.7	11.5	12.0	6.2	9.6	6.5	7.9	7.1	7.6	3.3	3.3	2.2	3.5	1.7	2.8	1.3	1.3	2.8	3.5	1.5	2.2	2.5	2.3	3.0	2.3	2.2	1.3	2.8	3.6	6.4	3.4	2.3	6.9	3.4	5.0	3.6	3.4	6.3	5.5	16.9	12.8	15.6	65.6	18.2	23.8	4.4	7.9	17.1	18.4	13.0	9.0	9.4	34.3	9.5	7.3	41.7	8.8	20.9	16.1	9.8	12.3	33.2	14.0	13.1	23.4	35.4	10.1	69.2	10.9	9.0	10.2	14.8	11.8	19.6	26.5	12.8	13.6	16.4	20.2	133.6	23.5	8.2	18.9	29.2	20.1	14.6	23.5	3.6	135.9	21.0	10.4	13.4	117.1	164.2	12.4	16.1	7.5	40.7	10.1	34.1	14.6	15.9	22.5	19.7	13.6	12.8	52.2	16.3	13.6	19.0	9.9	11.6	19.8	16.5	6.3
SLIT2	"SLIL3, Slit-2"	ENSG00000145147	"Slit guidance ligand 2"	O94813	4	20251905-20620561	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 256.7;Inhibitory neurons: 544.9;Oligodendrocytes: 157.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 98.0;BJ hTERT+: 200.8;BJ hTERT+ SV40 Large T+: 97.8;fHDF/TERT166: 117.8;HBF TERT88: 112.0;HEK 293: 88.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007590, HPA019511, HPA023088"	Uncertain				"Secreted in other tissues"	NA	NA		77000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227"	"unprognostic (1.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (4.93e-3)"	"unprognostic (6.80e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.16e-4)"	8.0	24.9	3.2	3.3	6.4	0.0	9.4	0.0	14.0	24.0	11.7	11.5	2.4	16.4	9.9	5.8	13.1	9.4	7.8	6.6	20.5	12.3	2.0	34.9	1.8	7.9	3.1	4.3	2.8	1.5	8.8	25.2	4.5	12.6	5.4	13.2	6.1	15.7	2.9	3.8	4.8	24.9	0.4	14.2	9.0	1.3	17.6	2.4	9.2	5.1	1.2	13.1	13.9	2.4	0.1	0.0	54.6	0.0	37.8	34.8	1.7	98.0	200.8	97.8	36.9	0.4	0.1	0.0	3.4	117.8	0.2	1.2	15.7	7.9	112.0	0.2	88.3	0.0	0.4	0.0	7.2	0.9	0.0	8.5	0.0	63.6	18.6	2.1	35.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	1.7	0.0	6.3	61.2	0.5	0.0	1.0	0.1	3.5	0.8	0.0	0.2	0.4	1.9	0.2	0.2	2.0	34.9	5.0	35.0	54.2	0.0	0.1	0.0	0.9	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	6.4	0.0	14.0	6.6	20.5	7.9	3.1	4.5	0.4	17.6	2.4	1.6	0.0	9.0	10.1	0.0	8.0	2.0	0.1	0.6	47.6	1.0	0.6	5.2	1.5	1.3	0.0	0.0	1.1	0.0	0.6	1.9	1.7	0.6	6.4	1.9	2.0	1.2	0.0	256.7	0.5	1.2	58.8	0.0	7.1	2.5	1.3	4.2	0.2	1.9	0.0	544.9	0.0	0.0	1.0	9.7	1.7	26.4	0.7	8.8	31.9	0.0	1.3	0.0	43.7	157.9	0.2	0.0	26.7	0.1	3.7	0.0	11.5	7.4	2.1	6.6	3.2	6.4	0.2	1.7	1.2	6.7	2.1	1.1	20.3	0.1	1.9
PACRGL	"C4orf28, MGC29898"	ENSG00000163138	"Parkin coregulated like"	Q8N7B6	4	20696282-20752907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 211.7;Late spermatids: 88.4;Oligodendrocytes: 66.9;Spermatocytes: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054666			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Vesicles"		"HPA054666: AB_2682564"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.90e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (4.85e-4)"	7.6	8.5	9.6	5.7	10.1	4.0	16.0	3.6	11.9	8.2	16.6	8.5	6.6	12.9	14.3	9.2	13.5	9.6	9.2	11.9	11.4	8.2	4.5	7.3	7.9	6.5	7.3	13.5	7.0	11.1	8.0	7.4	5.4	10.5	8.6	15.0	7.0	10.1	7.2	14.7	7.8	10.1	6.5	7.1	7.7	28.1	12.1	5.4	15.1	8.1	6.3	9.2	7.7	12.1	12.5	8.9	16.8	12.1	23.7	21.9	8.0	15.9	11.9	13.4	17.5	8.9	28.2	11.9	11.5	8.7	24.1	6.4	9.3	10.9	24.3	4.3	8.6	8.4	16.1	13.7	11.8	17.6	8.9	14.4	18.8	17.9	17.4	14.5	14.9	12.2	13.9	7.6	12.7	9.1	18.1	17.0	20.3	11.0	12.3	9.4	18.4	7.4	12.9	7.8	25.4	17.9	12.5	5.6	12.2	9.4	11.5	10.0	12.0	14.4	13.5	20.0	22.6	8.0	2.5	11.3	21.7	10.9	25.5	0.0	1.5	0.7	1.3	2.4	2.9	2.0	1.4	1.3	2.7	1.8	2.2	1.5	0.6	2.3	2.0	3.5	1.9	1.4	9.6	10.1	3.6	11.9	11.9	11.4	6.5	7.3	5.4	6.5	12.1	12.1	6.7	9.6	6.4	37.9	4.9	13.6	10.6	6.8	13.1	5.8	8.2	7.0	5.4	8.6	8.6	7.3	4.2	5.5	4.9	5.5	7.9	9.7	211.7	15.8	8.6	7.4	9.0	5.7	48.0	9.1	6.9	9.7	6.6	4.8	2.5	7.9	7.5	3.1	4.2	5.0	44.9	5.9	6.1	4.9	4.0	88.4	13.1	4.6	5.4	31.9	3.3	9.7	3.1	35.7	66.9	8.7	9.1	12.4	2.1	9.7	5.5	6.2	27.1	12.1	13.1	9.2	7.3	90.6	30.3	9.0	10.5	5.9	3.6	9.3	6.7	8.0
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728606-21948772	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.5;retina: 18.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	0.6	2.2	11.9	1.3	16.4	0.0	0.6	13.8	24.5	11.0	0.0	6.9	1.2	6.2	0.6	4.0	2.5	1.1	0.5	17.8	12.8	8.2	0.2	0.5	0.0	7.0	7.9	1.3	0.5	0.0	4.2	1.0	13.7	0.5	4.1	18.1	0.5	0.3	0.3	0.5	3.8	6.0	4.3	0.3	0.8	0.4	9.0	0.0	6.4	0.0	0.0	1.0	1.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	16.4	13.8	24.5	17.8	12.8	7.0	7.9	13.7	4.3	9.0	10.6	0.0	0.0	0.0	148.2	0.1	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.5	0.0	0.0	14.7	0.0	0.1	0.0	0.3	62.6	0.1	9.8	0.2	2.1	1.6	0.0	0.0	9816.7	0.0	0.0	3.1	0.0	0.2	0.0	12.3	1.1	0.2	0.2	0.0	1982.4	0.6	0.0	0.0	0.0	4.2	0.0	0.5	3.6	119.9	0.6	45.9	0.0	5175.8	91.4	0.0	7.8	0.0	0.0	0.0	0.4	15.2	0.0	12.6	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.1	0.1	14.5	0.7	0.1
ADGRA3	"FLJ38547, GPR125, PGR21"	ENSG00000152990	"Adhesion G protein-coupled receptor A3"	Q8IWK6	4	22345071-22516066	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 221.7;Hepatocytes: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008904	Uncertain				"Intracellular and membrane"	NA	NA		280000	"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA008904: AB_1849258"	"unprognostic (3.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-3)"	8.1	9.5	22.9	3.7	21.5	1.9	10.9	21.6	19.2	10.9	43.8	17.1	7.2	15.1	9.6	5.2	21.6	7.6	10.8	21.8	27.2	10.4	58.3	5.0	1.2	24.5	34.7	8.9	12.5	12.2	7.3	9.2	24.2	12.0	17.1	5.9	8.2	11.5	17.6	4.4	7.0	14.0	26.8	2.7	9.6	6.8	25.6	5.1	25.1	11.4	2.6	5.7	4.9	24.1	19.6	14.4	36.5	30.6	29.0	13.0	32.7	23.5	25.7	15.5	8.4	16.5	38.1	3.0	11.7	11.2	21.5	21.1	23.2	33.4	22.1	0.0	16.3	1.7	11.3	37.0	9.7	17.1	0.0	12.3	40.9	10.1	17.5	29.5	23.7	12.2	17.9	0.6	26.1	8.7	15.3	0.5	40.3	18.3	14.6	70.7	74.6	4.9	18.8	19.9	27.1	31.3	9.8	0.8	16.7	25.1	10.1	14.8	0.5	23.2	16.6	10.6	22.4	2.7	0.0	0.1	12.7	12.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.9	21.5	21.6	19.2	21.8	27.2	24.5	34.7	24.2	26.8	25.6	24.1	2.4	3.2	4.1	221.7	1.1	0.0	13.4	0.0	11.4	11.8	12.0	14.6	14.5	21.5	5.0	16.5	20.9	21.8	2.3	18.8	0.0	18.4	7.9	50.1	23.2	3.1	12.2	9.1	12.3	11.8	7.9	10.2	10.2	41.4	0.0	28.5	6.1	120.4	3.4	0.0	18.9	18.8	0.0	5.4	0.0	7.4	9.6	1.8	0.0	9.4	0.4	6.2	0.0	54.3	3.5	20.3	12.2	9.8	0.2	21.0	10.6	5.4	2.2	13.5	0.0	25.7	8.0	1.3	7.2	2.5	0.0	7.3	1.3	11.7	22.2	11.1
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1098.2;Inhibitory neurons: 1704.4;Oligodendrocyte precursor cells: 890.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"A-431: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.07e-3)"	2.3	2.9	4.2	0.6	3.2	0.0	1.6	7.6	13.0	3.3	33.9	7.4	7.6	0.9	1.5	3.3	1.5	2.6	36.3	3.1	10.7	29.0	44.6	3.1	0.2	4.1	4.1	1.2	3.8	38.5	4.8	0.1	2.6	3.3	9.1	4.2	29.3	3.0	29.5	8.2	6.6	1.9	2.4	0.8	4.3	4.5	7.2	2.3	17.7	37.2	0.4	1.1	1.0	4.1	88.6	0.0	1.6	0.0	2.6	0.0	0.0	0.0	1.9	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	4.5	10.7	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.7	0.0	12.3	0.1	4.0	0.2	2.8	0.0	3.5	4.2	0.5	1.4	0.0	0.7	0.7	0.0	1.6	8.1	0.1	0.1	1.6	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.2	7.6	13.0	3.1	10.7	4.1	4.1	2.6	2.4	7.2	4.1	2.5	19.2	2.6	240.6	0.9	0.9	4.1	7.4	1.2	7.0	2.7	1.5	90.9	47.1	6.3	36.8	39.6	0.0	0.0	36.0	52.8	12.0	78.3	7.2	1.3	0.8	26.7	0.0	1098.2	0.0	0.0	2.4	4.1	9.7	1.3	0.2	1.1	88.8	0.0	0.0	1704.4	17.0	38.7	2.5	0.3	69.7	0.9	0.6	7.2	24.4	0.1	6.4	0.0	890.2	28.8	0.6	7.3	2.2	1.8	1.4	32.0	26.8	4.8	1.9	0.0	37.1	5.1	0.8	0.6	2.6	1.1	0.0	1.0	1.9	21.9	1.5
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 436.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 498.5;Leydig cells: 424.1;Peritubular cells: 365.6;Smooth muscle cells: 428.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.2;BJ: 38.1;PC-3: 55.1;RPTEC TERT1: 231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	510000000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	221.4	20.4	14.3	26.1	20.9	0.0	134.2	15.8	23.8	226.5	436.1	122.7	18.2	151.6	10.4	62.1	177.6	22.4	150.1	47.1	14.1	124.1	16.5	155.0	10.6	22.9	23.4	59.7	86.7	2.6	19.8	39.8	17.5	131.3	13.4	1.9	70.9	23.4	22.0	91.9	65.2	37.1	16.4	24.8	102.1	74.1	19.0	5.8	176.6	22.9	7.0	178.3	170.4	13.6	0.0	0.0	0.0	0.0	66.2	17.3	2.0	38.1	16.7	2.3	1.4	0.5	0.0	0.0	11.8	8.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	16.8	0.0	15.8	0.0	17.9	0.1	0.0	1.1	0.0	0.0	0.1	0.3	1.1	8.0	0.0	55.1	0.0	0.0	0.6	231.3	0.8	0.2	0.2	0.0	1.2	0.0	2.1	32.8	0.0	0.0	8.7	1.0	1.6	0.4	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	20.9	15.8	23.8	47.1	14.1	22.9	23.4	17.5	16.4	19.0	13.6	46.1	12.8	18.1	7.2	1.0	90.8	65.5	0.6	10.2	0.4	21.7	22.1	23.0	144.4	7.6	90.1	0.0	211.4	1.8	25.6	15.6	63.6	18.7	81.9	45.8	21.0	34.6	0.0	0.1	1.8	17.0	498.5	5.1	80.3	0.0	0.1	15.4	0.2	17.3	0.0	0.1	51.9	0.0	0.3	115.5	33.9	424.1	3.2	80.0	3.7	0.0	20.7	0.0	0.5	0.7	3.5	89.3	365.6	1.1	80.4	0.0	142.7	0.1	1.4	197.2	6.5	428.9	73.2	4.4	6.1	70.3	190.0	7.6	6.1	51.8	9.6
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	9.7	5.3	11.0	6.2	12.1	2.0	11.9	7.8	13.1	10.4	7.5	11.1	3.7	10.4	6.3	4.6	10.1	6.8	8.4	12.1	10.7	8.4	8.7	8.9	2.2	9.1	9.2	10.6	19.1	8.1	7.2	8.4	9.2	11.4	5.9	8.5	18.8	6.7	7.0	6.6	5.9	10.2	7.9	4.9	13.1	3.7	12.3	2.5	8.8	7.6	2.2	9.0	7.0	11.5	6.0	2.3	4.8	0.8	7.5	13.4	1.3	8.4	13.4	6.9	7.9	0.1	6.9	0.0	3.9	17.0	7.8	1.1	1.4	1.0	4.5	0.0	0.0	0.0	0.4	0.5	6.2	0.0	0.0	9.3	6.5	4.1	0.0	18.8	5.6	0.0	0.0	1.2	4.2	6.3	0.0	0.1	5.3	0.6	5.3	0.0	0.0	0.4	12.5	4.2	5.3	0.1	3.2	5.5	17.8	5.1	9.3	13.8	12.0	10.0	0.9	7.5	7.3	0.1	0.0	0.0	30.6	1.4	6.8	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.5	11.0	12.1	7.8	13.1	12.1	10.7	9.1	9.2	9.2	7.9	12.3	11.5	14.3	0.0	9.5	23.5	0.4	6.2	7.2	2.7	6.8	11.9	11.7	6.9	5.7	5.7	3.7	7.3	10.4	7.1	0.1	2.3	0.0	6.6	1.1	7.4	6.6	13.6	1.8	2.7	30.2	10.4	1.5	8.1	6.6	7.8	0.0	8.3	10.4	6.4	12.2	5.0	39.8	11.9	0.0	9.7	2.1	1.7	10.8	8.1	8.8	16.9	6.7	9.1	0.0	27.6	20.9	8.7	5.6	11.7	1.1	11.0	0.7	2.3	3.1	11.6	6.6	12.5	9.7	1.6	2.8	1.7	3.1	10.7	0.7	2.0	5.2	6.7
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030946	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"parathyroid gland: 127.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Inhibitory neurons: 33.3;Oligodendrocyte precursor cells: 10.1;Skeletal myocytes: 8.6;Smooth muscle cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.2;HAP1: 5.2;RPMI-8226: 13.3;SCLC-21H: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Uncertain	Centrosome	"Secreted to blood"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	3.4	1.6	2.7	7.5	3.5	0.0	0.8	5.7	4.1	1.5	1.0	3.1	0.7	6.7	2.7	1.4	7.8	7.1	3.3	1.9	9.2	4.3	0.3	1.0	2.9	12.0	13.1	2.1	1.7	127.8	0.3	3.9	6.7	0.5	1.6	2.3	0.3	1.2	0.2	0.3	1.8	13.6	4.0	0.9	1.4	0.7	4.2	2.3	1.1	0.4	8.4	3.0	0.7	3.3	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	1.2	13.3	0.5	0.0	18.2	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.3	2.0	0.0	0.8	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.5	5.7	4.1	1.9	9.2	12.0	13.1	6.7	4.0	4.2	3.3	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	2.0	2.1	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.7	0.0	4.8	1.7	33.3	0.0	0.0	0.6	0.5	0.1	0.6	1.0	0.0	2.8	0.0	0.5	0.0	10.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.6	8.5	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160550	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"RNA-binding, Transferase, tRNA-binding"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 26.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA070409: AB_2686265"	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	4.7	3.5	2.1	1.7	2.1	0.7	4.4	2.0	3.0	4.2	1.6	5.3	4.8	3.8	2.6	3.2	3.8	2.5	2.7	2.0	2.1	8.2	26.1	3.9	2.1	2.2	2.0	4.9	7.4	3.3	3.0	2.8	2.1	3.4	2.7	1.5	3.9	2.0	3.4	5.2	7.6	1.3	2.0	5.6	5.0	4.0	2.1	5.2	4.8	2.6	2.0	3.8	3.5	2.3	1.7	1.0	3.0	1.3	3.9	4.9	2.5	1.1	1.9	2.6	2.3	0.6	2.6	2.9	1.4	1.0	2.6	1.3	3.5	1.2	2.0	1.9	1.3	2.5	1.0	1.8	4.0	2.0	3.3	4.0	4.2	1.0	3.7	3.1	2.5	4.3	7.0	2.5	1.6	0.7	4.4	6.2	2.1	1.8	2.5	1.3	4.3	1.7	3.7	0.7	1.6	2.4	1.3	1.4	4.7	1.9	1.5	5.5	1.0	1.4	0.7	0.7	1.7	2.3	6.2	1.6	1.4	5.4	1.8	0.0	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	2.1	2.1	2.0	3.0	2.0	2.1	2.2	2.0	2.1	2.0	2.1	2.3	5.7	0.0	7.2	9.4	6.6	2.4	1.7	3.9	2.8	3.0	5.5	4.3	5.3	22.8	4.3	16.5	0.0	5.5	4.1	10.2	7.9	5.4	30.0	7.3	6.2	6.1	6.1	8.2	5.3	4.7	3.5	4.8	8.2	5.4	3.8	7.9	6.1	42.6	6.1	5.0	7.2	7.7	4.1	8.1	4.5	18.1	3.4	6.6	3.6	14.0	8.0	3.2	4.1	16.1	18.5	5.4	6.0	6.4	6.9	2.7	20.0	20.9	10.2	2.4	0.0	4.9	4.4	26.0	18.3	5.3	3.3	5.9	6.2	7.6	7.8	1.1
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25160663-25279204	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004099	Enhanced		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	7.9	8.9	3.4	14.0	3.9	14.1	16.5	3.6	4.5	11.4	5.8	18.7	39.0	8.0	5.8	16.7	8.7	8.3	4.5	3.2	4.1	12.9	57.9	16.5	18.1	4.3	3.6	5.2	9.5	7.7	3.4	12.0	4.5	11.4	20.4	4.9	23.5	7.9	2.4	13.1	31.6	9.1	4.5	13.5	22.7	12.1	3.7	19.7	24.1	4.8	18.9	14.3	8.1	5.3	33.8	9.9	16.7	14.6	18.2	33.9	31.3	50.8	48.6	48.4	58.1	14.0	37.7	86.3	11.5	45.3	37.5	14.7	37.3	24.6	41.7	28.9	12.2	30.4	23.3	26.1	14.2	61.9	21.0	21.6	17.9	18.6	19.2	12.9	28.0	27.0	20.7	76.2	37.0	18.8	58.3	39.7	23.6	40.5	13.6	34.4	58.1	47.5	32.2	32.2	28.9	6.2	24.5	17.1	12.0	17.0	25.7	27.3	33.8	31.8	8.4	18.3	32.5	76.3	49.5	77.4	34.5	45.4	30.6	5.3	1.1	3.4	1.5	1.2	1.0	1.4	1.5	1.5	0.8	1.2	1.2	1.4	1.7	0.9	0.9	1.5	3.5	0.6	3.4	3.9	3.6	4.5	3.2	4.1	4.3	3.6	4.5	4.5	3.7	5.3	5.6	6.4	18.5	21.5	14.9	15.0	15.8	9.9	8.0	2.1	8.4	5.3	0.0	5.7	12.2	9.2	0.0	21.6	6.7	20.2	5.9	5.5	1.0	10.0	3.4	7.1	8.4	25.7	8.7	7.1	12.6	6.1	16.3	8.5	0.0	3.5	6.8	40.4	10.3	1.7	13.7	13.7	8.2	15.4	13.9	1.0	4.4	8.6	5.4	11.2	10.3	0.7	4.1	30.2	20.1	5.8	8.2	4.5	27.4	14.1	16.8	20.3	10.4	3.4	0.0	5.3	7.2	9.6	10.3	18.3	15.6	13.5	10.3	4.4	13.9	18.2
ZCCHC4	"FLJ23024, HSPC052, ZGRF4"	ENSG00000168228	"Zinc finger CCHC-type containing 4"	Q9H5U6	4	25312774-25370383	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 19.6;Oligodendrocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035575, HPA035576"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Golgi apparatus"		"HPA035575: AB_2674682, HPA035576: AB_10671516"	"unprognostic (5.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.07e-2)"	4.5	3.6	2.8	3.5	3.6	3.8	5.0	3.7	3.5	4.3	3.5	3.9	3.8	5.2	4.0	3.3	4.3	3.3	4.6	2.7	3.0	3.8	3.5	3.6	5.2	3.3	3.1	6.1	3.4	6.0	2.7	3.3	3.4	3.9	4.0	4.8	3.9	3.9	7.4	4.3	4.0	3.7	3.0	4.4	3.4	4.4	3.3	4.8	4.5	5.5	4.5	4.1	3.6	4.3	4.5	2.8	9.1	4.2	6.9	8.8	8.1	11.4	12.1	13.1	15.0	4.4	11.9	7.5	3.1	7.0	12.9	3.5	8.9	8.3	18.2	1.8	4.8	7.0	5.8	7.4	8.8	11.6	4.9	7.0	9.2	12.5	9.8	7.8	6.3	11.4	12.7	3.6	11.3	3.4	12.0	15.2	12.5	7.4	6.0	8.0	13.9	4.6	7.1	4.7	8.4	5.8	4.9	4.1	7.4	8.8	6.0	6.9	5.0	11.0	4.6	7.2	15.7	7.2	9.6	11.0	11.8	11.0	10.8	1.4	1.9	0.6	3.0	2.4	4.4	3.5	3.9	3.8	2.8	3.6	3.7	4.1	1.1	4.4	2.3	2.1	4.3	2.3	2.8	3.6	3.7	3.5	2.7	3.0	3.3	3.1	3.4	3.0	3.3	4.3	5.9	0.0	5.8	12.1	7.6	3.7	4.0	4.3	6.8	3.7	3.0	2.9	6.4	1.5	5.5	0.0	2.1	5.9	4.2	2.1	3.9	3.8	1.5	5.5	5.1	4.6	2.4	2.1	10.7	2.3	4.5	4.8	3.1	3.9	1.3	6.4	2.2	3.1	5.1	3.3	15.5	3.6	6.1	4.4	2.2	0.5	4.1	3.3	3.6	5.6	2.6	5.5	5.2	19.6	23.6	2.9	3.9	5.3	3.7	2.7	5.7	4.5	8.2	5.2	0.0	5.2	5.7	9.0	9.1	4.9	3.4	3.7	5.4	4.0	4.4	2.5
ANAPC4	APC4	ENSG00000053900	"Anaphase promoting complex subunit 4"	Q9UJX5	4	25377263-25418498	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 266.1;Glandular and luminal cells: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032519, HPA038395, HPA038396"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Intermediate filaments"		"CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356"	"unprognostic (1.36e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (5.73e-7)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.18e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (1.12e-6)"	13.4	15.7	14.1	15.6	15.0	18.5	15.8	14.5	19.1	23.5	15.1	15.6	11.8	26.7	18.1	13.5	35.1	11.8	11.6	14.6	14.1	15.1	13.0	13.8	20.6	14.1	13.9	18.6	15.8	15.5	12.9	15.5	14.1	16.6	16.7	16.6	12.9	21.2	13.8	14.7	15.8	13.9	14.3	19.2	14.1	10.8	14.7	16.1	13.7	8.5	18.3	18.8	14.3	16.7	21.5	12.4	21.4	22.4	22.0	24.4	30.5	25.0	18.5	23.2	22.3	20.0	33.4	34.9	13.1	21.4	29.5	16.9	22.9	21.1	26.5	12.5	17.5	33.9	23.2	18.9	14.8	26.7	26.6	18.9	15.6	20.5	12.4	16.4	20.4	30.4	49.7	10.2	29.8	16.7	34.6	43.5	29.7	18.9	15.2	24.4	35.7	25.7	19.6	23.0	23.8	14.3	18.7	11.0	16.1	21.8	16.4	28.3	20.9	19.7	12.4	15.3	29.1	13.4	25.3	33.3	21.4	37.6	19.0	2.4	7.4	14.9	9.6	8.8	13.1	8.6	8.7	11.4	6.5	6.9	7.7	9.8	3.0	10.3	12.5	4.2	11.6	6.4	14.1	15.0	14.5	19.1	14.6	14.1	14.1	13.9	14.1	14.3	14.7	16.7	11.1	9.6	14.5	26.8	15.2	12.9	16.5	13.1	14.2	12.9	7.6	7.5	14.0	14.3	17.2	7.3	10.4	56.9	17.5	8.9	5.9	10.3	4.3	266.1	20.6	11.1	12.6	10.3	28.8	12.0	14.2	16.3	17.3	79.0	25.3	15.3	15.0	7.1	17.5	21.9	38.4	8.4	10.2	13.7	8.0	3.4	10.2	13.7	17.8	18.7	15.0	12.2	16.5	34.2	49.0	8.9	6.5	15.1	19.5	4.9	9.8	7.0	45.9	13.9	19.7	15.7	16.3	13.4	15.4	13.0	9.2	23.8	19.7	12.7	11.8	7.8
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747433-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 128.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 82.1"	"Group enriched"	"Detected in many"	4	"memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2"	"Group enriched"	"Detected in many"	4	"B-cells: 42.0;dendritic cells: 38.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 287.9;OE19: 217.9;U-698: 187.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 100.4"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	9.3	5.5	8.7	61.5	11.3	13.6	9.3	82.1	11.1	54.0	8.7	72.1	82.0	7.9	68.8	8.7	11.0	53.6	5.3	12.5	4.2	14.5	11.6	40.7	124.8	2.8	5.2	5.6	48.5	45.5	3.7	37.5	4.7	18.9	68.8	35.2	38.3	4.0	2.9	2.9	72.4	7.8	2.9	63.2	104.8	6.6	8.2	18.7	10.9	2.8	128.3	42.4	2.2	5.9	21.5	23.0	16.7	5.6	2.7	3.3	2.6	10.4	28.3	7.9	25.2	14.6	97.0	287.9	48.9	72.0	66.7	13.3	12.4	45.1	10.6	15.7	7.2	3.3	35.4	19.6	70.0	40.1	2.0	5.7	35.8	27.8	10.9	31.3	105.7	5.8	19.3	0.3	5.6	16.2	0.1	2.8	48.2	217.9	20.1	1.5	91.3	40.6	60.9	71.2	41.0	8.0	69.2	1.0	7.1	23.0	3.3	49.0	46.6	0.5	32.6	0.6	30.6	1.8	0.5	187.9	125.0	16.7	19.3	0.9	0.2	0.0	5.7	0.0	6.8	42.0	7.0	6.4	1.4	41.8	3.0	4.8	0.7	8.0	0.3	38.2	9.6	3.3	8.7	11.3	82.1	11.1	12.5	4.2	2.8	5.2	4.7	2.9	8.2	5.9	13.2	12.8	36.0	57.1	114.7	0.9	3.4	16.8	1.2	4.0	1.6	0.9	1.8	61.5	51.9	3.7	0.0	30.7	71.0	46.3	0.0	64.9	60.8	6.0	1.5	11.5	11.5	10.5	40.1	33.2	1.3	2.5	71.9	19.3	2.5	3.4	13.6	4.2	4.9	0.0	26.6	92.6	22.4	23.1	4.6	78.3	1.5	14.4	8.8	4.7	14.6	33.2	10.3	128.7	1.4	38.3	22.6	0.4	271.7	13.6	46.9	10.7	24.2	32.8	0.0	0.8	4.7	0.7	2.5	0.7	1.6	16.4	27.8	0.2	36.8	6.1
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted to blood"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	27.9	36.7	36.7	16.6	37.7	13.1	27.2	38.1	50.2	22.2	39.8	30.9	39.9	23.9	72.2	15.7	23.8	23.9	46.8	36.5	38.4	46.0	38.2	19.7	30.4	36.9	36.1	33.9	43.4	28.2	17.6	14.1	36.9	23.9	25.5	29.9	35.1	17.5	95.9	13.9	35.1	17.8	37.9	23.6	38.6	20.5	36.8	17.4	31.4	61.4	24.8	28.8	19.1	39.2	29.9	24.5	32.3	31.3	34.9	75.4	43.0	28.4	34.3	24.0	30.4	21.9	51.6	48.8	48.1	31.7	49.6	8.5	37.9	36.3	33.4	27.9	30.1	28.3	16.4	42.0	59.1	34.0	18.0	53.9	71.6	30.6	46.1	46.7	18.7	32.5	45.9	15.5	29.6	19.1	37.0	57.5	61.0	39.6	36.1	30.1	42.0	31.7	53.5	21.6	41.3	38.4	18.3	12.7	66.0	35.2	26.3	47.5	31.4	25.8	30.5	29.3	36.8	30.2	26.9	52.6	39.2	35.6	33.4	30.6	31.5	15.9	26.2	37.7	34.5	47.3	37.5	33.2	36.9	47.9	50.4	41.1	16.3	35.6	29.4	38.3	42.9	31.7	36.7	37.7	38.1	50.2	36.5	38.4	36.9	36.1	36.9	37.9	36.8	39.2	21.5	9.6	41.6	9.4	48.0	21.9	30.4	89.4	26.7	7.7	49.8	63.1	61.8	61.5	59.0	36.8	8.4	63.7	22.5	50.9	131.0	70.0	11.5	34.7	30.6	23.1	19.3	9.2	3.8	62.5	59.7	40.0	31.6	34.6	10.8	37.1	21.8	66.5	69.7	1.7	4.6	64.0	59.0	62.9	32.1	23.1	37.6	44.5	44.4	4.7	42.9	95.3	38.1	9.5	7.9	46.2	44.6	48.2	38.4	38.9	130.1	166.5	47.0	22.2	72.3	26.8	35.8	44.5	36.4	27.3	19.5	43.8	29.8	71.2	65.4	30.8
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 422.1;Oligodendrocytes: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA000251: , HPA060647: AB_2684337"	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	40.9	18.3	28.1	33.0	44.2	51.3	28.4	34.2	38.5	31.9	27.7	33.2	20.2	36.4	18.0	28.5	23.6	25.5	21.8	29.0	37.6	21.4	17.9	31.3	27.5	41.7	38.5	34.2	22.3	26.2	12.9	54.4	39.0	28.0	28.1	33.1	19.3	22.5	21.7	26.0	22.7	38.0	32.2	25.7	25.4	28.7	36.4	27.8	24.8	28.9	26.5	31.8	21.7	58.9	68.2	19.1	60.0	39.0	91.5	138.8	44.9	54.4	47.0	50.9	60.1	14.5	36.4	56.0	34.1	36.2	39.5	12.2	51.9	33.4	98.1	30.4	28.4	42.5	24.2	27.9	47.9	76.9	35.9	64.0	28.5	104.9	39.7	70.3	28.5	34.3	43.0	21.5	93.2	20.1	54.5	76.4	163.5	20.3	30.3	48.0	112.4	25.4	26.8	22.4	84.5	36.5	28.0	20.6	24.3	54.4	22.0	53.3	38.5	50.5	25.2	86.3	51.9	40.2	51.9	55.7	132.3	86.3	43.4	23.8	94.6	112.9	31.4	77.8	42.6	37.2	49.8	34.1	136.4	33.4	41.4	35.9	220.5	70.9	77.1	31.5	68.1	68.6	28.1	44.2	34.2	38.5	29.0	37.6	41.7	38.5	39.0	32.2	36.4	58.9	72.5	48.1	66.8	62.0	54.6	152.8	86.2	104.6	55.8	94.6	48.9	51.2	44.2	62.9	83.3	46.0	129.3	102.7	47.3	26.6	74.3	64.3	44.4	54.5	96.3	73.2	78.4	46.9	81.7	65.4	74.4	129.0	29.0	62.8	57.0	130.7	65.3	53.1	365.2	85.8	85.9	51.0	59.0	208.5	422.1	56.7	135.5	234.2	80.0	60.9	125.1	95.0	44.3	215.1	378.1	76.5	35.1	84.2	54.9	113.7	44.9	55.4	67.5	102.9	85.5	71.7	95.8	134.7	158.4	45.9	109.3	83.9	102.8	57.0	47.0	75.7
CCKAR		ENSG00000163394	"Cholecystokinin A receptor"	P32238	4	26481396-26490484	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;gallbladder: 29.2;stomach 1: 16.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Group enriched"	"Detected in some"	5	"hypothalamus: 5.1;midbrain: 6.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 7.2"	"Region enhanced"	"Detected in all"		"midbrain: 12.6"	HPA073900			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA073900: "	"unprognostic (7.48e-2)"				"unprognostic (3.70e-2)"	"unprognostic (7.13e-2)"					"unprognostic (3.08e-2)"	"unprognostic (3.36e-1)"		"unprognostic (3.79e-1)"				0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	29.2	0.0	0.6	5.1	0.1	0.0	0.0	0.0	0.8	6.9	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.5	0.1	1.1	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.4	0.6	5.1	0.8	6.9	0.6	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26756223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Excitatory neurons: 106.6;Inhibitory neurons: 95.3;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	3.4	5.8	5.2	2.5	4.5	1.6	4.3	5.3	5.1	7.4	10.7	4.4	1.8	7.6	7.0	2.9	7.7	7.5	5.7	4.2	6.2	17.3	2.9	4.3	2.2	7.1	6.2	8.8	3.0	14.6	5.0	3.8	7.0	5.2	3.0	9.2	3.2	6.3	3.1	2.2	1.7	8.7	4.8	2.8	3.1	4.9	5.7	17.4	7.8	5.0	2.6	4.8	3.0	6.0	2.4	1.9	8.5	5.3	11.5	18.5	2.4	11.1	8.2	4.9	4.8	4.1	5.8	5.6	9.5	15.0	15.2	1.0	4.8	5.6	4.7	1.7	2.2	1.4	6.6	1.2	6.3	3.2	1.4	9.3	4.5	9.4	5.7	19.7	6.7	7.2	5.3	0.0	77.1	0.1	6.3	3.5	3.9	3.2	9.2	4.7	8.4	0.6	18.9	2.5	8.4	3.2	5.3	1.2	5.5	6.9	2.1	1.2	6.5	6.2	1.7	4.7	2.8	1.2	3.1	2.6	22.1	1.7	6.4	1.1	0.5	1.8	4.2	0.6	5.1	1.6	3.2	4.7	0.9	2.0	2.4	2.9	0.0	4.5	0.6	1.7	1.7	1.3	5.2	4.5	5.3	5.1	4.2	6.2	7.1	6.2	7.0	4.8	5.7	6.0	6.0	3.2	4.1	66.9	8.2	3.6	5.3	7.6	7.4	7.4	5.7	5.3	6.4	1.5	2.5	20.2	14.6	4.0	18.1	1.0	5.9	4.8	11.1	15.7	18.9	6.8	9.5	2.1	106.6	3.1	2.2	9.3	6.1	9.0	8.9	9.3	7.1	1.9	1.6	5.0	95.3	2.1	10.2	2.4	2.7	3.1	9.0	2.4	10.6	42.2	0.8	7.4	13.4	102.5	72.4	2.6	0.4	9.1	5.5	1.9	0.6	19.2	17.4	19.3	0.0	9.5	11.1	25.6	8.9	3.1	4.5	1.9	14.4	13.1	1.6	2.3
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857601-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 84.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 187.7;U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	11.2	7.5	11.5	16.9	14.3	17.3	11.6	11.1	14.3	11.0	84.2	11.5	16.6	10.8	22.5	6.2	12.3	19.8	6.9	17.7	12.4	13.0	9.9	15.1	25.4	12.7	12.2	18.8	14.2	8.4	13.7	10.3	12.5	13.9	14.4	18.8	12.9	7.3	8.2	13.9	15.0	10.2	9.7	22.1	14.9	7.4	13.7	20.8	10.6	6.5	23.4	13.9	7.7	14.3	10.0	14.1	13.9	17.5	14.7	9.2	12.7	24.0	7.7	12.6	15.1	12.4	34.4	44.5	13.6	9.4	13.1	11.9	10.4	28.3	13.4	13.4	16.2	13.0	26.3	11.9	11.7	23.3	13.5	12.1	13.7	16.9	8.8	16.3	15.4	17.7	14.1	8.8	31.0	11.9	17.2	22.9	15.2	20.8	18.9	187.7	26.0	10.9	10.6	22.3	24.3	8.8	16.9	12.3	6.6	9.9	7.6	19.8	16.3	17.1	11.1	11.8	15.7	23.7	20.8	90.6	18.4	24.8	28.0	12.9	1.7	1.4	3.9	1.4	2.6	4.1	4.2	3.3	1.3	4.8	4.5	3.5	3.0	1.8	6.5	5.0	2.2	1.3	11.5	14.3	11.1	14.3	17.7	12.4	12.7	12.2	12.5	9.7	13.7	14.3	55.8	12.8	26.9	123.7	57.1	16.4	14.1	42.4	17.6	39.0	18.7	16.3	8.8	22.8	30.6	33.1	81.3	11.9	62.7	17.3	13.7	10.5	9.8	18.0	19.9	49.3	45.7	14.9	69.9	20.1	6.9	20.2	26.0	14.7	36.8	32.4	32.2	11.2	7.4	30.3	68.1	30.8	46.8	20.4	16.2	8.3	15.2	29.2	8.8	58.1	18.9	19.2	65.9	101.0	87.5	12.7	15.9	7.2	37.1	10.9	19.4	5.1	112.4	61.1	19.7	22.5	18.3	19.9	24.0	7.8	15.5	4.9	48.3	37.0	14.4	12.9
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Group enriched"	"Detected in many"	8	"Astrocytes: 311.8;Excitatory neurons: 1152.0;Inhibitory neurons: 882.3;Oligodendrocyte precursor cells: 917.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.4;RH-30: 120.4;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		340000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	1.8	3.2	10.5	5.2	14.6	0.0	3.0	0.0	33.7	23.9	0.0	19.2	3.2	16.9	25.1	14.3	9.7	8.1	19.1	23.7	50.1	2.0	1.0	2.9	1.4	13.0	14.3	4.7	0.9	1.1	0.2	0.2	14.3	10.6	7.8	3.4	0.8	18.2	0.6	11.6	5.0	22.1	3.9	18.6	11.4	1.0	46.3	1.4	4.1	0.4	1.2	16.3	5.9	11.8	0.0	1.1	14.4	20.1	29.5	28.5	0.0	3.8	0.0	1.9	0.9	1.9	26.5	0.0	0.1	0.2	0.0	15.3	1.3	38.5	3.4	0.0	43.4	0.1	26.8	0.0	30.4	0.6	0.0	17.2	8.8	1.0	10.7	17.5	7.5	0.0	0.0	0.0	9.0	0.1	0.0	0.1	8.8	9.3	4.0	0.0	120.4	0.0	0.9	65.2	0.9	0.2	0.4	1.2	1.3	8.2	1.8	6.9	0.0	24.1	6.2	6.7	0.0	0.0	0.0	0.0	18.8	0.1	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	14.6	0.0	33.7	23.7	50.1	13.0	14.3	14.3	3.9	46.3	11.8	1.1	0.0	0.0	311.8	0.3	85.0	92.4	25.7	46.7	46.8	0.7	9.0	83.2	0.0	13.7	64.4	0.0	0.1	0.0	0.3	0.0	0.6	16.9	66.8	8.4	7.6	0.0	0.0	1152.0	0.7	0.1	24.0	20.9	60.4	1.3	0.8	19.2	0.1	0.3	10.1	882.3	0.5	4.1	1.0	3.5	10.4	0.3	1.3	21.4	43.1	0.0	1.3	0.0	917.3	26.4	26.5	0.0	28.6	1.3	26.1	0.0	0.2	27.0	3.4	0.0	51.3	11.0	1.1	2.7	18.5	38.6	0.1	1.8	1.7	0.3	50.3
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244514	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.9;brain: 92.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 285.4;Late spermatids: 167.5;Oligodendrocytes: 781.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.7;hTCEpi: 12.7;MOLT-4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Actin filaments"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	4.5	2.2	28.9	10.0	70.4	39.9	5.1	19.9	39.5	3.5	0.0	5.3	8.9	3.3	3.8	13.1	3.3	9.3	1.5	24.5	21.5	3.7	9.4	13.4	15.7	34.1	38.8	1.5	7.0	5.4	2.9	3.5	32.6	2.2	5.6	1.4	4.6	2.9	0.7	16.1	8.9	4.3	18.3	11.5	6.1	6.2	32.1	24.6	23.2	0.8	11.0	9.9	6.3	92.8	8.6	0.7	0.8	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	4.2	13.7	4.1	3.2	0.4	0.0	3.2	1.3	6.7	0.0	0.0	7.6	0.1	2.9	0.2	1.6	5.5	0.0	0.4	12.7	0.0	2.7	4.9	0.0	11.1	0.2	0.7	0.0	3.6	12.8	4.5	1.0	6.0	2.6	6.5	0.0	4.7	9.3	8.7	7.3	0.0	0.4	2.1	2.7	0.4	5.6	1.6	0.0	2.3	7.5	0.0	1.1	0.0	0.0	8.0	0.9	6.1	1.9	0.0	0.5	0.0	3.8	1.8	3.5	1.8	2.1	2.7	0.3	0.9	0.7	1.9	0.4	6.7	4.7	1.2	1.1	0.6	28.9	70.4	19.9	39.5	24.5	21.5	34.1	38.8	32.6	18.3	32.1	92.8	18.6	153.8	23.3	285.4	46.1	39.1	32.9	13.5	21.6	0.8	11.2	7.0	2.1	17.2	33.2	7.3	0.0	0.2	100.4	15.5	7.9	7.9	123.6	31.4	3.0	15.8	3.0	8.6	140.8	10.0	0.4	9.4	20.4	50.0	9.5	5.9	3.3	4.2	8.7	0.0	29.9	11.3	6.1	33.2	24.9	167.5	2.8	35.1	5.4	40.3	26.7	5.4	95.8	161.4	781.2	21.5	23.3	0.7	43.0	30.0	17.4	5.8	18.0	1.2	0.0	8.1	3.6	4.2	3.0	37.0	67.5	0.8	90.7	0.1	6.9	44.1
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281616-36347511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.8;fallopian tube: 13.7;lung: 3.5;lymphoid tissue: 4.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 37.9;Early spermatids: 87.2;Endometrial ciliated cells: 109.2;NK-cells: 53.5;Respiratory ciliated cells: 199.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (9.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.45e-5)"	"unprognostic (5.12e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.05e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.12e-3)"	0.2	0.1	2.5	1.2	1.8	0.5	0.1	1.0	0.4	0.5	1.5	0.1	0.4	0.6	0.2	0.3	13.7	0.6	0.1	2.1	2.5	0.0	0.3	3.5	4.0	11.8	11.2	0.0	0.1	0.0	0.0	0.0	6.3	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.5	0.1	10.6	2.2	0.5	1.2	1.6	0.3	0.2	0.0	1.3	0.3	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.3	1.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.4	2.5	1.8	1.0	0.4	2.1	2.5	11.8	11.2	6.3	10.6	1.6	4.9	0.4	3.2	4.1	0.7	1.4	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.4	0.0	24.2	0.0	0.0	0.0	37.9	0.0	0.0	0.1	87.2	109.2	0.6	0.1	0.0	0.8	0.2	0.0	0.0	0.4	3.1	1.7	1.3	0.0	0.0	0.1	0.1	0.0	0.2	0.0	8.2	0.8	0.0	24.1	0.3	1.2	0.0	1.9	0.1	0.0	53.5	0.0	2.9	0.1	0.0	0.0	12.4	0.1	0.0	0.2	199.1	0.0	0.0	0.5	0.9	1.8	0.3	0.5	0.1	0.0	27.4	0.0	0.0	0.1
NWD2	KIAA1239	ENSG00000174145	"NACHT and WD repeat domain containing 2"	Q9ULI1	4	37244743-37449463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;brain: 5.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 91.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046911	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046911: AB_2679861"	"unprognostic (1.14e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.53e-1)"		"unprognostic (5.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.26e-2)"	2.4	0.0	1.0	0.0	5.9	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.9	0.0	2.7	1.6	1.1	0.2	4.7	2.5	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.0	4.5	1.9	0.1	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453925-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.6"	"Group enriched"	"Detected in some"	5	"OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	3.4	0.3	2.7	3.0	2.9	3.8	3.8	5.3	4.3	10.2	5.9	25.5	17.7	6.7	0.2	2.1	2.8	9.2	0.4	3.5	4.2	12.4	36.0	3.7	0.5	4.9	4.9	0.2	24.9	16.0	1.2	7.6	4.2	1.7	23.7	4.6	28.2	6.8	0.2	1.6	19.6	4.0	4.5	0.3	20.7	1.4	4.9	0.2	1.5	0.4	4.3	8.8	2.9	4.1	0.1	0.2	3.2	0.3	0.0	0.0	4.2	0.7	0.0	0.0	0.0	12.6	5.2	0.1	3.0	0.0	0.1	0.4	0.2	0.8	0.1	0.0	0.4	0.0	8.3	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	14.3	0.2	0.2	0.5	64.6	1.7	0.1	7.8	0.2	12.7	81.0	0.9	0.3	0.5	32.6	1.0	4.0	113.1	0.7	0.6	0.4	4.5	0.2	1.6	0.2	0.1	0.5	0.0	6.9	5.6	0.9	1.4	2.1	0.6	0.2	0.4	0.2	0.3	0.4	0.2	0.5	0.5	0.8	8.6	0.8	0.1	1.6	0.7	0.3	2.7	2.9	5.3	4.3	3.5	4.2	4.9	4.9	4.2	4.5	4.9	4.1	0.3	0.0	12.6	45.4	0.7	0.3	7.8	4.9	0.0	0.6	7.1	3.9	0.2	27.1	10.1	11.0	0.0	6.7	0.2	61.3	11.7	25.2	1.2	9.5	0.4	0.9	9.6	0.0	2.3	51.8	4.7	0.3	33.6	5.5	0.0	0.0	0.0	13.1	0.7	0.0	2.4	28.0	4.1	0.0	0.3	2.4	0.0	0.2	3.6	22.5	0.6	5.3	0.0	46.8	1.8	53.6	67.2	0.0	0.0	7.8	52.3	9.2	12.3	1.0	0.0	0.2	0.9	0.3	0.2	0.5	0.0	47.5	0.4	0.1	31.8	19.1
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Microglial cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 59.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	13.5	2.4	10.6	4.9	15.5	25.6	7.8	20.1	14.9	5.1	9.3	8.3	6.2	5.5	2.7	6.4	5.1	6.1	6.0	8.0	13.3	3.9	4.8	6.6	4.7	29.7	19.3	3.5	2.3	1.5	1.4	6.1	27.7	3.0	6.6	3.1	3.5	3.8	15.8	12.4	5.5	6.0	24.4	7.3	12.3	1.6	20.1	3.7	12.5	4.3	4.8	7.8	4.1	39.7	4.8	5.1	12.9	11.1	10.8	6.2	10.8	8.0	6.9	5.5	7.2	16.8	5.7	1.3	5.7	6.9	9.8	4.3	4.1	7.2	9.6	0.2	2.1	1.8	4.7	18.2	8.1	6.0	4.5	10.6	10.2	7.5	8.2	3.4	24.9	3.3	3.1	5.0	6.4	4.4	7.5	8.3	3.2	6.9	1.5	2.5	45.0	2.2	13.2	5.9	2.9	8.5	6.1	6.6	10.6	3.2	18.0	3.2	29.6	13.8	8.7	10.1	9.5	2.5	2.6	7.3	11.7	12.8	11.4	0.8	15.2	27.4	5.1	5.7	6.3	0.7	6.2	4.9	8.5	0.2	5.3	7.0	59.3	7.7	5.5	9.8	5.5	5.1	10.6	15.5	20.1	14.9	8.0	13.3	29.7	19.3	27.7	24.4	20.1	39.7	30.5	9.6	3.1	16.3	2.9	3.3	2.5	1.7	10.8	0.4	8.1	9.5	2.1	5.7	3.9	0.0	0.0	1.4	9.8	8.4	0.0	3.1	6.5	5.5	9.9	14.4	1.2	3.4	3.3	8.6	3.6	10.7	22.4	2.4	2.5	0.5	6.4	0.9	2.6	3.3	2.4	1.6	0.0	3.2	2.7	8.1	3.7	9.2	1.8	36.5	4.1	4.0	0.0	22.6	12.5	10.3	2.9	6.0	15.5	2.7	6.7	0.2	3.3	1.4	13.1	18.8	16.4	0.8	0.3	5.5	4.7	5.2	10.6	5.1	1.1	3.8
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826660-37862937	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 334.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1700000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	8.2	11.2	3.2	9.5	3.2	10.1	8.8	4.6	4.5	10.9	4.5	9.8	7.6	10.1	4.9	36.6	7.9	11.3	5.6	4.9	3.1	8.0	14.8	6.9	10.0	3.4	3.0	6.9	4.4	8.4	3.0	11.7	3.6	7.8	9.0	18.2	7.7	5.2	1.2	17.5	7.8	13.7	3.5	8.3	6.1	5.3	3.1	10.2	9.7	1.9	22.7	18.9	16.4	3.7	27.4	9.5	14.6	16.6	10.2	12.4	19.8	32.6	18.9	27.8	26.4	18.0	19.2	38.0	15.5	17.8	34.9	13.8	36.0	32.0	65.1	23.0	21.0	40.1	15.2	12.3	23.2	44.2	26.5	17.0	36.0	22.0	18.6	16.2	41.6	31.2	53.6	6.2	24.3	15.6	49.8	49.6	17.3	19.2	15.5	35.8	23.1	14.8	15.7	52.3	31.8	10.8	17.5	23.3	12.0	19.5	21.5	45.4	37.0	19.7	24.9	27.3	67.1	14.0	38.4	40.3	10.9	56.2	32.9	19.8	27.5	67.2	9.8	22.4	11.5	9.4	8.0	11.1	31.9	5.5	7.7	9.8	33.6	28.1	18.2	7.1	14.9	17.0	3.2	3.2	4.6	4.5	4.9	3.1	3.4	3.0	3.6	3.5	3.1	3.7	16.9	0.0	8.2	5.2	13.8	14.7	14.3	32.9	17.6	7.8	12.6	6.9	4.5	14.3	23.1	3.7	0.0	31.9	11.9	10.6	5.9	16.0	0.9	9.0	12.7	22.9	7.2	8.0	8.3	11.8	37.8	10.3	5.6	14.7	12.7	56.4	42.5	9.7	37.9	6.7	5.6	9.2	4.1	24.4	15.2	2.0	8.4	24.5	5.4	4.7	46.1	334.1	13.4	8.0	0.9	14.5	6.7	9.8	10.5	17.7	6.9	10.4	9.8	16.0	13.1	5.8	23.8	0.6	2.1	42.5	32.1	79.8	14.7	19.8	12.9	20.4
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891084-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 310.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	32.0	10.9	21.6	38.3	19.8	64.2	23.0	14.6	19.7	50.4	44.7	123.8	30.7	139.8	46.4	22.9	61.1	44.6	56.1	26.8	12.3	83.5	26.2	32.4	53.8	17.8	14.3	24.7	28.3	134.2	16.8	41.3	15.4	22.7	28.3	9.6	20.5	40.2	110.0	12.2	35.3	91.2	14.4	39.8	34.3	48.1	13.0	59.0	56.7	149.9	41.3	51.6	23.8	16.8	23.2	26.1	46.7	50.5	16.4	45.3	40.2	61.9	103.6	57.3	58.0	15.0	73.8	118.6	15.0	41.5	72.1	1.0	35.8	45.0	87.6	9.4	20.2	45.9	17.1	31.6	26.2	85.7	50.0	55.4	8.9	35.3	24.4	47.7	89.4	81.6	57.0	19.8	60.3	17.7	119.5	80.5	26.3	3.6	23.6	104.9	75.8	34.7	47.3	42.4	40.7	36.5	23.0	21.1	25.6	104.9	20.5	65.4	61.4	75.1	84.3	19.0	91.4	48.1	63.7	310.4	32.8	76.9	68.2	2.9	7.6	23.2	3.8	25.2	6.2	7.1	3.7	3.1	7.4	9.0	3.3	4.2	20.5	9.7	28.2	6.2	3.3	3.9	21.6	19.8	14.6	19.7	26.8	12.3	17.8	14.3	15.4	14.4	13.0	16.8	38.3	12.8	6.7	50.9	42.0	7.9	14.0	5.0	4.6	12.4	15.1	9.8	73.9	22.8	8.3	27.6	0.0	20.1	30.7	26.0	76.3	13.8	27.6	19.4	27.6	39.9	44.3	11.6	75.9	40.8	27.6	15.5	7.1	25.8	2.5	24.3	27.8	19.8	31.0	10.1	37.7	11.9	36.7	68.6	21.4	50.2	23.3	52.2	10.6	91.8	51.0	9.8	25.7	45.8	9.2	38.7	17.6	19.9	40.7	37.3	13.1	77.3	14.8	1.1	39.5	17.4	79.5	13.0	19.4	3.4	8.7	29.1	32.0	7.4	11.9	35.9
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960398-37961128	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.7;Early spermatids: 5.2;Langerhans cells: 12.9;Smooth muscle cells: 3.7;Spermatocytes: 4.3;Suprabasal keratinocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"		"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	0.2	0.0	0.5	0.2	0.7	1.1	0.1	0.6	1.0	0.4	0.2	1.4	0.0	0.5	0.3	0.1	0.5	0.2	1.0	1.0	0.0	0.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.4	0.3	0.1	0.0	0.1	0.2	0.7	0.1	0.4	0.3	0.1	0.9	0.3	0.0	0.1	0.1	0.2	0.6	0.2	0.6	0.3	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.6	1.0	1.0	0.0	0.3	0.1	0.4	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.8	4.7	0.7	0.7	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.6	1.5	0.0	0.0	0.0	5.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.6	12.9	0.5	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.6	3.7	4.3	0.2	0.0	2.8	0.0	0.6	0.0	0.2	0.4
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664197-38701517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049512: AB_2680799, HPA065054: AB_2685415"	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	27.9	23.8	13.8	22.1	18.4	95.0	20.8	16.5	14.9	30.1	14.1	44.5	38.0	28.0	14.1	56.3	20.2	33.5	14.8	14.6	14.1	16.1	44.2	23.9	16.4	19.8	17.9	44.7	33.4	31.0	11.3	31.5	18.4	23.3	47.4	16.6	31.2	19.7	14.5	65.4	38.7	25.7	15.7	29.2	46.0	5.2	16.1	13.1	28.1	17.9	19.6	42.1	39.2	21.3	21.1	14.1	51.8	10.6	23.3	34.5	16.8	11.3	32.5	7.4	9.2	13.3	37.3	0.0	15.7	24.4	21.6	22.3	14.9	19.8	11.9	0.3	11.5	20.1	20.7	28.5	23.8	5.0	0.2	31.3	53.3	10.8	20.0	14.0	29.0	7.6	58.0	9.7	12.0	4.7	5.4	8.8	12.2	42.6	10.1	7.2	25.2	22.8	26.4	49.1	14.9	19.4	12.3	9.6	24.4	20.8	6.0	6.9	46.2	24.6	14.4	42.2	12.4	13.7	4.6	0.1	10.2	14.9	10.7	10.8	4.4	17.0	6.3	7.6	4.5	5.3	7.0	5.7	3.4	4.2	9.7	5.6	13.4	3.0	12.5	0.8	8.3	2.4	13.8	18.4	16.5	14.9	14.6	14.1	19.8	17.9	18.4	15.7	16.1	21.3	108.7	22.4	29.5	20.9	78.6	121.5	150.9	82.2	99.0	42.8	38.5	29.7	16.2	77.2	76.6	31.3	31.3	27.4	137.3	219.5	11.7	88.3	1.1	87.3	70.8	86.7	86.5	239.3	11.6	86.2	21.8	70.0	230.4	168.2	19.7	35.0	65.7	57.2	56.3	35.3	27.9	170.3	91.6	87.9	78.6	4.1	51.9	94.9	49.8	45.0	64.4	46.7	143.2	36.2	47.8	113.6	145.5	48.2	105.2	143.9	124.6	24.3	39.4	38.1	26.3	55.5	42.6	1.1	5.0	191.6	222.5	27.4	84.3	62.4	128.4	308.7
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 9.4;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.0;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.0"	"Group enriched"	"Detected in some"	53	"Daudi: 68.6;REH: 22.9;U-698: 24.7"					"Low region specificity"	"Detected in many"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.9	0.3	1.0	15.8	0.9	1.4	0.8	1.0	1.2	0.2	0.5	1.4	1.2	0.4	0.4	0.5	0.5	1.3	0.1	0.9	1.2	0.2	0.4	0.8	42.3	1.9	1.5	0.0	0.1	0.1	0.2	0.2	2.0	1.0	1.9	0.1	1.4	0.4	0.2	0.5	10.0	0.3	2.0	24.3	2.9	0.1	1.4	5.1	0.4	0.1	47.9	2.7	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.4	0.0	0.1	0.0	24.7	0.0	0.1	0.0	0.3	0.4	0.9	0.0	2.8	0.0	39.0	0.0	0.0	6.4	24.0	0.1	0.1	1.3	0.1	3.6	7.2	0.0	1.8	1.0	0.9	1.0	1.2	0.9	1.2	1.9	1.5	2.0	2.0	1.4	2.2	0.2	0.0	1.1	0.0	57.2	0.4	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.2	2.7	0.3	0.0	0.0	0.9	0.0	0.2	1.3	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.0	1.9	0.8	0.0	0.0	4.5	0.0	16.9	1.0	0.2	0.0	4.5	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;lymphoid tissue: 26.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 15.4;Hofbauer cells: 14.9;Kupffer cells: 34.9;Macrophages: 32.7;Microglial cells: 29.0;monocytes: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 128.5"	"Group enriched"	"Detected in all"	6	"granulocytes: 128.5;monocytes: 42.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.3;HUVEC TERT2: 12.6;RPMI-8226: 14.4;U-698: 20.6;U-937: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	8.8	4.1	1.9	26.9	2.1	34.3	7.3	2.3	1.8	4.6	2.8	4.9	6.5	6.0	2.1	3.3	6.0	9.6	2.3	1.8	2.4	4.4	8.8	10.8	16.2	4.9	3.2	10.2	5.1	1.6	1.0	10.0	5.2	3.5	6.8	1.4	9.0	3.7	0.5	1.8	6.2	9.8	3.9	24.9	6.4	1.3	4.1	8.1	1.6	3.4	19.7	8.0	1.1	6.7	0.2	2.0	0.1	0.0	0.3	1.5	0.0	0.0	0.5	0.1	1.1	0.2	5.4	11.3	1.1	0.0	5.3	0.3	0.1	1.4	0.3	1.3	0.5	1.4	0.5	0.0	0.1	2.1	0.6	0.4	0.3	0.5	0.0	0.4	12.6	0.2	1.6	3.3	1.7	0.0	0.5	4.6	0.0	0.0	0.0	7.7	0.1	14.4	1.3	0.0	0.0	1.5	0.0	0.1	0.5	0.1	0.1	2.7	3.3	1.1	0.5	0.1	0.7	1.2	0.2	20.6	2.8	7.7	0.3	0.1	22.0	8.3	3.0	30.8	2.3	6.5	3.2	2.5	13.8	5.6	3.1	1.8	128.5	5.6	42.7	4.5	1.3	9.0	1.9	2.1	2.3	1.8	1.8	2.4	4.9	3.2	5.2	3.9	4.1	6.7	1.0	0.0	1.5	1.0	15.4	0.3	0.6	3.0	1.8	0.3	2.9	1.1	0.2	0.0	4.4	1.8	0.0	0.1	8.6	0.6	1.9	5.5	0.0	6.1	0.7	2.6	0.0	0.8	0.7	4.4	0.2	3.1	2.0	4.7	3.8	0.1	0.4	2.5	14.9	0.0	1.6	0.4	2.0	34.9	14.6	0.2	0.0	32.7	0.0	29.0	19.2	1.9	6.2	3.5	2.2	2.0	0.3	2.6	2.1	1.1	0.6	1.1	7.8	0.2	0.0	3.9	0.5	0.1	0.3	0.8	0.6	0.1	6.1	2.6	1.4	1.4
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Enzymes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 13.6;Hofbauer cells: 7.2;Kupffer cells: 12.2;Langerhans cells: 6.6;Macrophages: 11.6;Microglial cells: 20.6;monocytes: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 13.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.3;GAMG: 13.5;RPMI-8226: 10.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	1.6	1.6	1.2	10.3	1.1	6.6	1.4	1.4	1.1	1.0	1.4	1.6	1.6	1.0	0.5	1.4	1.2	3.5	0.6	1.1	1.9	0.5	2.0	2.6	10.8	2.6	1.9	1.3	0.4	0.5	0.4	2.6	3.0	0.9	2.1	0.1	2.0	0.5	0.3	0.7	4.4	2.0	2.7	9.7	2.2	0.3	2.8	2.0	0.6	1.3	13.8	3.2	0.8	4.4	1.6	6.1	0.2	0.1	0.3	6.8	0.0	1.7	7.3	0.7	2.4	0.0	13.3	7.5	2.8	0.3	13.5	0.7	0.1	1.3	1.1	0.0	0.5	3.4	7.3	0.2	0.4	3.9	5.5	2.9	1.4	2.9	1.6	0.2	1.5	1.1	3.9	2.3	3.3	0.0	0.0	6.7	0.2	0.0	1.0	3.7	3.2	10.8	0.4	0.1	0.0	0.1	0.2	0.0	1.0	0.3	0.3	2.0	2.1	2.3	7.8	0.9	2.7	0.1	0.0	6.1	5.3	4.4	1.7	0.0	2.6	0.8	0.2	2.5	0.0	1.7	0.1	0.1	1.8	1.0	0.2	0.1	13.4	0.3	1.3	1.2	0.3	0.7	1.2	1.1	1.4	1.1	1.1	1.9	2.6	1.9	3.0	2.7	2.8	4.4	0.6	0.0	0.0	0.3	13.6	0.6	1.2	0.3	0.0	0.6	1.2	0.8	1.2	0.0	0.2	0.0	0.0	0.0	2.2	0.2	0.0	0.5	0.0	0.5	0.7	1.1	0.0	0.4	0.2	0.2	0.2	0.9	0.0	1.2	2.5	0.3	0.4	0.2	7.2	0.0	0.9	0.1	0.0	12.2	6.6	0.0	0.6	11.6	0.0	20.6	14.0	0.2	1.0	0.5	0.3	0.3	0.1	0.7	3.7	0.9	0.2	0.0	1.3	0.8	0.0	0.9	0.5	0.2	0.0	0.2	0.9	0.3	1.7	1.4	0.1	0.8
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		96000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	28.4	48.1	7.9	23.6	11.8	2.0	20.2	7.8	9.2	48.4	23.7	34.6	22.9	29.2	17.8	35.1	19.5	36.4	23.7	9.9	11.4	11.8	54.2	21.2	8.9	13.7	12.5	41.5	25.6	22.4	18.5	35.6	11.2	35.5	33.7	3.1	61.2	27.8	16.6	15.6	24.4	61.7	9.0	8.8	34.4	12.5	12.1	4.3	17.6	22.7	19.5	35.6	26.4	13.4	43.5	30.7	18.5	21.9	197.4	204.7	6.1	167.9	244.1	69.7	105.8	8.1	33.0	0.0	23.0	273.8	118.8	11.9	0.1	53.7	80.1	0.2	4.6	3.1	30.3	40.6	70.6	0.1	5.8	122.1	17.0	101.2	23.3	157.2	101.4	0.1	3.4	0.2	102.9	11.0	0.1	2.3	3.8	18.3	15.6	0.8	90.9	3.2	23.4	8.7	0.7	9.4	33.8	0.7	33.8	42.8	20.8	3.8	156.3	75.4	34.8	95.3	39.5	0.7	0.2	0.3	123.3	3.3	63.0	0.6	3.2	0.0	0.1	3.6	0.0	0.4	0.1	0.1	2.6	0.1	0.1	0.1	2.4	0.0	1.4	0.3	0.0	0.9	7.9	11.8	7.8	9.2	9.9	11.4	13.7	12.5	11.2	9.0	12.1	13.4	28.1	16.0	13.2	5.9	2.2	12.2	47.4	43.7	15.4	0.3	29.9	21.2	17.2	14.3	56.0	7.3	0.0	2.2	0.2	46.8	9.8	45.6	1.0	17.5	88.6	35.2	15.7	3.6	1.0	61.0	47.0	94.9	35.7	39.1	1.3	30.4	31.1	68.3	16.1	0.0	1.8	78.7	83.4	7.2	15.0	6.3	110.9	8.7	21.4	17.8	6.4	12.2	0.0	14.6	31.0	47.6	41.6	116.2	8.5	92.6	39.0	11.7	47.8	1.2	19.7	49.4	44.3	1.2	5.5	23.6	10.2	3.4	3.1	94.1	32.0	82.7
TMEM156	FLJ23235	ENSG00000121895	"Transmembrane protein 156"	Q8N614	4	38966744-39032922	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 26.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 99.8;Microglial cells: 68.4;NK-cells: 28.8;Plasma cells: 123.1;T-cells: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 74.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.6;GAMG: 29.6;HBEC3-KT: 84.8;hTERT-HME1: 64.0;NB-4: 35.2;PC-3: 37.3;U-698: 45.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"				"prognostic favorable (4.09e-4)"	"unprognostic (7.36e-3)"	"unprognostic (3.31e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.17e-2)"	"unprognostic (8.73e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.92e-4)"	"unprognostic (9.06e-2)"	0.4	1.7	1.7	9.0	1.6	1.9	1.1	2.0	1.8	0.5	1.7	1.7	1.8	0.5	0.2	0.5	0.5	1.9	0.3	1.9	1.9	0.5	2.8	0.9	23.6	2.7	2.2	0.4	0.3	0.2	0.1	0.1	2.8	0.6	1.9	0.5	0.9	0.5	0.5	0.4	5.1	0.4	2.3	11.1	2.6	0.2	1.9	5.1	0.4	0.0	26.8	3.0	0.2	3.4	2.4	23.9	0.2	0.2	0.0	0.6	0.2	0.1	6.4	0.0	0.0	0.2	0.3	39.6	0.3	0.0	29.6	0.2	0.2	84.8	0.3	0.4	0.0	2.1	7.7	0.5	13.3	16.8	0.3	0.1	4.2	1.7	64.0	4.9	7.3	6.5	5.8	0.2	2.8	0.2	3.1	35.2	0.1	0.9	37.3	0.8	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.1	1.2	17.9	2.9	0.5	0.2	0.7	0.2	0.1	45.3	5.0	15.2	0.1	16.8	0.8	48.6	12.2	0.3	14.3	74.8	20.7	12.2	8.4	59.9	8.0	10.4	1.8	12.5	0.3	12.4	15.4	8.3	1.7	1.6	2.0	1.8	1.9	1.9	2.7	2.2	2.8	2.3	1.9	3.4	0.6	0.0	1.8	0.7	99.8	0.5	0.8	0.5	0.0	0.6	2.3	2.4	0.3	17.2	1.9	0.0	0.0	0.1	22.1	0.0	0.0	0.5	1.3	0.3	1.1	3.3	0.0	4.2	0.6	0.0	1.2	0.8	1.5	0.2	0.0	0.0	2.9	0.4	1.6	1.7	0.7	0.2	2.0	22.8	2.7	2.8	0.0	8.4	10.6	68.4	2.7	0.1	28.8	0.5	2.5	1.1	0.0	0.0	123.1	0.8	0.0	0.4	1.5	0.5	0.0	1.4	0.6	0.8	0.1	0.0	0.6	0.3	30.2	0.1	0.3	0.8
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 186.3;Microglial cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 323.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	41.4	22.4	53.9	32.3	53.8	9.0	18.7	44.8	56.5	17.0	29.4	44.4	12.7	19.1	13.5	32.0	9.4	23.1	14.4	49.8	50.0	25.0	42.3	20.2	33.7	53.5	50.2	18.4	11.3	12.9	7.5	28.0	53.0	35.9	16.1	11.8	10.2	66.0	10.7	6.1	13.2	46.1	56.7	21.0	13.1	11.0	55.2	14.6	21.5	18.9	38.9	34.8	9.5	52.6	56.7	78.2	40.9	30.2	22.9	58.5	59.1	44.2	323.1	36.6	35.4	64.6	40.4	86.4	52.4	45.5	192.7	3.3	50.7	112.3	46.6	8.8	10.1	36.8	71.4	46.5	195.6	10.9	11.9	74.5	61.9	55.5	137.7	134.1	73.7	13.8	28.2	17.0	87.1	23.8	11.5	19.6	12.6	14.3	75.5	20.9	53.7	2.1	31.3	23.0	2.8	29.7	25.0	8.0	21.8	49.0	19.3	22.9	94.2	96.8	65.4	25.5	53.8	19.3	18.7	79.0	78.6	28.3	22.9	5.4	2.2	0.4	0.7	3.2	1.1	5.1	1.4	0.8	2.5	3.7	1.1	0.5	2.3	1.0	1.4	0.9	0.2	0.8	53.9	53.8	44.8	56.5	49.8	50.0	53.5	50.2	53.0	56.7	55.2	52.6	74.9	16.0	1.1	45.7	38.0	3.7	9.4	22.9	7.4	18.8	16.5	11.2	4.5	17.2	33.7	11.0	4.2	1.0	6.3	0.3	17.6	39.3	2.8	4.0	11.1	43.6	1.2	10.9	46.1	21.0	57.9	12.6	3.1	5.3	2.5	9.5	22.9	35.6	13.3	70.7	186.3	0.4	12.2	25.4	25.8	6.6	8.1	28.6	17.8	190.2	27.5	12.1	7.2	69.9	79.0	24.3	0.1	13.9	43.0	31.5	2.0	21.8	32.7	3.4	0.0	14.2	17.3	9.8	5.6	3.3	3.4	5.7	10.7	32.4	0.7	14.1
WDR19	"DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182504-39285810	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.3;ASC TERT1: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	7.5	8.0	3.1	5.3	2.5	3.7	9.2	5.3	3.8	10.5	10.8	6.8	1.9	16.0	13.3	3.9	20.3	8.4	4.2	2.3	2.5	8.8	6.3	8.8	4.7	5.3	3.6	17.9	5.4	8.1	9.1	6.2	2.9	7.7	4.2	13.0	5.7	8.4	2.3	5.5	4.7	9.1	3.5	4.6	6.2	14.0	2.7	6.9	16.7	2.4	4.9	6.2	6.8	3.6	6.1	5.2	10.3	12.1	45.3	47.0	4.7	7.5	17.2	8.1	10.6	2.8	6.5	10.4	4.1	7.8	17.2	4.0	10.9	5.4	8.6	0.5	8.5	2.2	10.3	6.1	16.1	9.6	2.6	30.5	11.1	11.9	7.2	24.6	10.7	11.0	8.7	9.1	9.9	2.1	7.7	8.1	3.5	3.7	5.6	8.2	10.4	4.2	7.0	2.9	11.5	10.4	10.2	2.4	6.1	13.1	5.5	3.6	7.9	7.9	5.3	17.5	7.8	7.2	7.6	7.6	11.9	3.3	3.7	0.1	0.3	0.2	0.3	0.5	0.3	0.8	0.5	0.6	0.3	1.2	0.5	0.6	0.3	0.8	0.5	0.1	0.3	0.2	3.1	2.5	5.3	3.8	2.3	2.5	5.3	3.6	2.9	3.5	2.7	3.6	5.5	12.8	9.3	26.1	5.4	4.8	4.9	4.6	2.2	10.1	7.3	7.4	4.5	2.8	9.4	18.4	10.4	1.2	1.8	0.7	0.0	5.5	5.1	32.3	14.6	6.7	2.4	4.0	61.8	3.6	3.2	10.8	2.0	12.0	2.5	13.4	4.2	10.0	3.2	25.2	82.5	2.0	12.2	3.2	3.6	3.4	16.4	3.0	1.8	19.7	1.8	6.7	1.0	18.1	19.7	2.9	0.2	18.8	3.9	3.0	0.3	4.0	46.6	21.7	0.0	10.9	7.9	33.8	10.2	3.9	4.7	1.4	2.9	13.1	1.1	1.9
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.6;liver: 17.7;pancreas: 6.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000	"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.6	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.2	17.7	1.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.3	2.8	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452587-39458931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 2512.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	1868.9	1181.0	377.9	809.5	384.9	2487.2	2132.6	378.2	2512.5	2407.6	382.9	1776.6	737.5	1418.3	2338.6	1568.7	1896.6	785.0	1168.4	368.3	462.3	1318.1	1056.3	1130.2	613.9	381.0	381.1	3607.4	2794.6	510.7	1060.0	419.0	382.5	1562.6	605.5	314.2	1387.6	681.5	1550.4	2153.4	1327.8	551.1	407.5	1400.1	1484.5	386.8	388.4	43.6	1072.2	1767.5	705.8	1675.7	1773.4	395.9	52.4	41.7	2173.3	48.2	57.0	90.0	72.9	1109.3	1618.3	1306.1	981.0	131.1	1243.5	2771.5	93.8	1081.2	1040.1	1169.0	67.3	79.3	1422.3	964.2	2080.2	80.0	415.4	131.2	81.3	153.2	711.1	113.8	3249.4	56.1	1445.8	1907.5	69.6	70.4	2126.4	1196.8	60.9	69.4	1556.5	163.4	1954.7	1523.9	57.6	1417.2	2327.7	76.3	1656.7	63.7	74.3	915.0	31.6	899.8	115.5	1976.1	1864.0	98.7	63.2	51.1	72.1	1486.9	134.2	1806.3	2754.2	2483.9	1456.9	1717.2	56.6	447.2	556.1	171.7	664.4	585.3	1320.8	1566.4	1311.6	919.0	779.1	1361.8	1804.5	1436.1	94.8	927.3	456.8	1013.2	1101.2	2263.3	377.9	384.9	378.2	2512.5	368.3	462.3	381.0	381.1	382.5	407.5	388.4	395.9	1634.0	663.4	908.4	2.3	3629.4	4132.6	5621.6	3089.9	1994.2	406.0	4149.6	3833.2	428.0	2051.8	1359.8	709.9	160.6	3011.2	2723.2	1300.0	2733.2	2184.8	1549.9	1126.9	2738.2	2121.2	1850.2	1755.0	3.0	4399.8	5910.8	1698.9	828.7	1534.0	913.2	2226.7	2439.5	1991.3	2775.3	198.5	3.2	3581.7	1053.8	3282.8	3322.0	1707.8	4819.6	2242.3	1851.6	2.8	4568.2	1398.0	3045.4	3.0	3.6	3145.0	2925.6	2394.1	1420.3	4718.4	2823.2	3698.3	656.7	581.0	1512.0	3760.1	2630.9	684.0	593.6	2325.1	4675.5	3400.0	2937.1	2567.2	3793.6	5564.6
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39459004-39485109	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.0;Late spermatids: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	5.4	7.5	5.9	3.0	6.5	6.6	5.7	7.6	9.8	5.1	5.9	6.4	5.5	4.6	5.3	6.7	6.1	3.6	11.1	6.2	6.7	8.7	8.6	2.9	5.1	6.3	6.4	10.0	6.8	6.5	4.0	3.3	6.8	4.1	6.4	5.4	4.3	3.1	27.2	5.7	5.2	5.2	5.5	3.6	6.3	9.8	6.2	4.3	4.2	21.0	4.2	5.8	4.7	8.3	5.7	4.5	5.4	5.2	11.5	11.4	4.8	6.6	3.7	6.1	4.1	6.8	7.8	20.8	7.3	2.5	15.2	4.9	15.9	9.1	8.0	2.4	4.0	8.8	2.3	7.0	10.4	19.1	5.5	10.8	14.6	7.1	22.4	13.4	7.0	12.7	21.1	5.2	7.5	3.6	10.9	24.9	7.3	15.3	14.2	9.1	15.2	12.9	7.1	2.9	6.0	4.8	3.8	4.9	22.5	7.6	5.6	8.8	2.6	4.7	10.6	6.3	15.5	9.9	15.8	14.3	7.2	22.2	4.0	2.5	6.4	3.9	5.7	7.6	12.7	10.0	8.1	8.0	6.2	7.6	16.2	11.6	3.4	7.7	5.6	5.5	5.7	4.7	5.9	6.5	7.6	9.8	6.2	6.7	6.3	6.4	6.8	5.5	6.2	8.3	11.0	9.6	12.6	14.0	12.9	9.7	11.6	17.4	12.0	25.8	15.7	17.3	20.1	17.2	12.7	18.4	10.4	24.0	22.6	12.9	21.5	13.2	86.0	11.2	15.8	10.3	18.1	12.4	11.9	6.4	18.2	10.4	9.2	10.3	17.7	19.0	11.4	19.0	17.5	10.1	18.8	13.5	18.3	13.5	7.8	100.1	10.2	11.4	1.8	6.5	17.6	15.4	16.5	14.6	22.9	10.3	10.1	12.4	5.8	6.6	18.3	32.6	14.1	26.7	0.0	10.8	20.5	64.9	25.1	13.7	9.2	9.6	14.2	19.0	18.4	8.8
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
SMIM14	"C4orf34, FLJ13289"	ENSG00000163683	"Small integral membrane protein 14"	Q96QK8	4	39546336-39638902	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 553.9;Intestinal goblet cells: 408.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 269.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051299	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051299: AB_2681429"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.48e-2)"	"prognostic favorable (3.00e-6)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-3)"	21.7	45.5	12.6	22.4	15.7	4.7	33.2	15.0	14.8	36.2	14.8	41.4	17.7	19.2	38.4	20.0	27.5	19.8	10.2	13.3	17.4	22.9	118.4	22.4	38.9	15.6	15.1	23.2	24.3	25.4	17.5	8.4	16.6	35.6	36.8	12.3	40.8	19.8	6.7	14.3	21.1	14.5	16.7	27.2	46.6	14.2	15.9	15.5	27.9	9.4	45.2	19.4	14.5	19.4	12.4	20.9	9.9	9.6	64.4	71.8	17.7	16.9	21.5	7.4	10.8	6.8	44.2	269.3	15.8	19.2	11.8	4.6	2.0	3.6	6.1	7.1	2.2	0.3	8.9	12.2	22.0	1.8	2.8	27.4	13.1	7.6	4.9	26.4	11.3	11.8	2.9	8.6	12.5	38.4	2.9	4.8	4.7	54.2	14.4	11.9	0.5	3.0	15.5	10.8	7.5	9.4	19.0	25.1	6.8	3.9	25.1	4.0	37.8	17.0	3.8	22.1	2.9	28.0	6.4	1.1	27.9	3.4	6.7	53.5	52.7	28.0	20.7	46.0	22.6	103.9	14.5	18.4	55.9	107.1	11.0	16.2	37.3	40.4	49.1	100.1	9.1	44.5	12.6	15.7	15.0	14.8	13.3	17.4	15.6	15.1	16.6	16.7	15.9	19.4	55.3	57.7	124.4	29.4	228.9	49.3	76.5	83.4	42.7	80.6	150.3	96.6	17.0	65.8	143.4	104.8	35.5	38.3	74.9	242.2	84.1	86.9	238.5	115.3	65.6	45.8	106.1	25.3	34.0	144.8	49.6	108.6	85.1	73.4	45.7	19.2	57.1	553.9	43.6	92.5	52.4	408.8	126.1	79.8	85.1	31.5	113.1	62.6	46.2	36.5	108.0	109.7	36.0	29.1	85.5	226.2	132.4	124.5	19.8	199.0	75.0	117.9	225.3	48.5	59.2	56.5	58.8	66.2	25.0	95.0	59.8	104.1	28.8	65.7	118.3	124.0
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698109-39782792	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		390000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	29.9	19.4	13.5	23.4	17.5	21.4	21.7	20.9	24.5	16.0	9.2	35.8	31.2	17.8	17.7	26.2	12.7	12.9	18.4	18.3	14.9	26.7	45.4	16.4	20.1	12.9	14.0	13.6	13.2	20.4	15.8	24.4	13.1	19.8	24.2	21.0	16.9	14.9	37.3	22.6	24.8	17.2	7.8	18.0	31.8	16.5	14.2	22.4	23.8	25.6	18.0	20.2	17.2	16.0	91.3	90.7	49.3	45.6	29.8	28.7	82.8	122.8	26.4	32.8	34.0	138.0	91.1	114.3	105.2	35.0	79.8	39.0	95.4	54.7	51.9	76.1	70.0	145.7	88.9	121.6	38.4	159.0	79.6	27.1	60.2	46.0	49.0	35.2	43.3	49.3	152.9	39.6	33.9	86.6	111.5	89.9	67.7	54.4	69.8	66.3	144.0	44.2	46.0	123.9	103.9	47.4	91.7	34.5	58.9	54.1	44.4	58.2	116.9	49.9	105.7	60.0	114.5	55.3	174.0	121.4	26.9	101.4	59.5	19.6	18.1	24.8	14.4	16.9	13.4	20.7	15.0	13.8	19.7	14.7	11.2	12.6	15.1	14.0	25.4	27.6	16.0	10.5	13.5	17.5	20.9	24.5	18.3	14.9	12.9	14.0	13.1	7.8	14.2	16.0	63.2	57.7	63.1	69.2	53.0	122.9	65.5	74.3	59.7	62.2	65.3	52.5	72.3	52.9	66.7	49.7	29.2	84.5	76.5	143.7	66.5	83.5	144.9	72.0	82.3	65.6	59.7	85.8	115.9	89.4	168.7	59.2	68.3	90.9	34.8	40.1	63.5	113.6	80.2	104.3	113.8	74.5	65.1	77.1	91.8	202.4	65.3	76.5	56.9	89.0	104.0	87.1	56.7	87.0	118.2	139.6	94.3	56.4	55.5	111.4	75.3	98.0	60.7	42.9	39.5	61.8	121.1	145.2	55.1	74.3	137.9	147.5	61.3	54.8	74.1	107.0
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	19.4	16.2	13.3	23.2	15.0	29.4	24.3	19.7	18.1	20.6	17.0	23.0	19.7	19.9	20.2	25.8	15.9	16.5	14.5	13.4	13.9	22.0	33.4	22.7	33.2	15.1	13.6	23.6	21.0	29.7	10.6	22.9	15.5	18.5	23.9	20.9	20.1	15.9	17.7	24.3	19.4	19.4	14.2	21.4	20.6	14.0	14.2	42.0	28.5	19.6	34.7	22.8	15.9	23.5	54.8	40.0	50.3	53.4	47.5	47.5	40.2	43.4	40.9	50.1	49.6	39.2	60.2	106.6	46.5	51.6	79.5	29.4	86.9	50.5	71.7	36.1	33.2	73.1	47.6	41.3	47.5	90.2	60.1	31.5	55.9	53.3	78.2	44.5	64.7	62.1	88.0	43.8	52.0	38.5	113.2	78.8	28.6	51.4	26.7	104.3	89.6	38.9	48.2	54.6	69.5	41.2	59.9	40.7	39.0	37.5	41.4	78.7	61.5	56.4	58.6	41.2	74.3	37.0	69.7	112.3	40.1	90.6	45.3	2.3	1.2	1.9	2.3	1.6	3.0	2.0	2.2	2.5	1.8	2.5	2.6	2.1	0.4	3.0	1.1	2.2	2.0	1.0	13.3	15.0	19.7	18.1	13.4	13.9	15.1	13.6	15.5	14.2	14.2	23.5	36.2	86.6	70.3	75.7	52.3	56.6	37.0	29.3	51.8	32.7	42.6	30.1	40.5	32.9	45.8	22.0	60.5	32.4	50.8	39.2	7.9	22.0	9.7	34.9	50.0	40.7	30.5	69.6	120.5	25.8	39.1	36.8	41.3	52.8	29.1	45.1	40.0	58.2	30.9	13.5	115.3	36.3	28.5	46.6	54.5	10.0	32.9	44.6	46.2	119.9	38.7	13.3	42.2	98.5	138.0	38.9	28.2	33.1	52.8	53.7	28.5	27.4	25.5	27.9	32.9	36.3	31.1	44.2	48.5	66.9	68.2	38.7	49.9	30.9	40.4	59.6
N4BP2	B3BP	ENSG00000078177	"NEDD4 binding protein 2"	Q86UW6	4	40056850-40158252	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036770, HPA042607, HPA072549"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: "	"unprognostic (5.03e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.45e-1)"	1.0	0.7	1.4	2.5	1.2	4.1	2.9	1.8	1.6	2.5	1.7	2.2	2.4	3.4	1.9	1.8	1.8	1.6	1.1	0.7	4.2	1.5	5.8	1.6	3.6	2.1	1.7	3.0	4.2	1.4	1.2	3.6	0.7	2.4	2.2	2.2	3.5	0.9	0.7	1.9	2.2	0.8	1.4	1.9	1.9	1.8	4.0	11.3	3.5	1.0	4.1	2.1	1.4	0.5	2.0	2.0	12.0	1.9	0.8	3.8	9.5	2.2	2.5	1.3	2.7	3.9	4.0	10.7	4.3	2.1	2.2	1.5	7.7	2.4	3.0	3.4	2.3	4.8	1.5	1.8	1.9	13.0	11.2	4.3	3.3	2.1	4.6	0.4	3.3	10.0	10.8	4.5	2.5	1.9	26.8	6.4	6.0	1.6	1.7	15.4	14.1	2.5	1.0	4.7	4.7	8.3	2.2	1.6	2.1	7.8	1.5	3.8	4.5	1.5	7.3	0.9	1.7	7.4	8.0	7.3	1.4	4.8	3.0	5.1	0.8	0.4	1.7	0.9	1.8	1.2	2.3	1.3	1.4	1.7	3.4	1.9	0.2	8.2	0.9	6.5	1.1	0.9	1.4	1.2	1.8	1.6	0.7	4.2	2.1	1.7	0.7	1.4	4.0	0.5	9.6	22.4	24.4	19.2	18.2	12.0	14.3	5.1	18.8	33.0	12.3	11.2	12.3	11.5	13.2	22.0	27.1	44.2	36.7	9.0	0.0	6.0	4.7	17.6	15.1	11.4	19.3	22.5	16.5	12.6	12.9	15.5	12.2	20.7	5.1	36.1	6.8	20.7	12.4	72.3	47.2	17.1	10.2	16.3	24.6	4.3	9.9	24.0	7.2	36.5	17.9	12.4	27.8	44.2	3.1	11.4	10.8	3.8	36.0	12.4	7.3	3.6	8.7	22.6	13.1	17.9	6.3	22.0	24.3	13.0	13.1	27.0	28.4	30.4	8.5	9.2
RHOH	"ARHH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.9;lymphoid tissue: 98.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	2.2	0.9	0.7	36.4	0.6	62.9	13.2	0.5	0.8	2.9	0.6	6.3	4.8	1.6	0.9	2.9	1.5	6.4	0.7	0.6	0.8	1.2	2.7	5.7	86.0	1.1	1.3	0.9	1.4	0.4	0.7	0.9	0.9	2.7	5.6	0.0	3.9	0.9	0.6	1.2	20.6	1.5	1.0	42.6	8.2	0.7	0.8	98.2	1.8	0.3	85.2	10.6	1.6	1.0	0.2	0.4	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	126.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	2.6	0.0	18.8	0.1	0.0	0.0	21.1	92.5	1.5	0.0	0.0	0.0	0.1	0.1	123.7	1.4	1.2	0.0	0.0	179.4	13.3	2.3	0.0	0.4	19.1	0.3	4.3	0.0	0.0	0.1	0.1	0.3	0.8	0.2	0.1	5.7	0.5	0.5	0.0	0.5	0.1	0.2	65.5	56.8	116.3	0.1	4.4	0.1	210.3	1.1	168.7	112.2	0.8	99.3	164.3	176.9	151.1	1.9	212.1	274.3	220.5	8.4	74.2	1.2	26.1	268.4	124.1	0.7	0.6	0.5	0.8	0.6	0.8	1.1	1.3	0.9	1.0	0.8	1.0	2.9	3.2	9.9	0.3	273.0	7.1	1.4	0.3	1.8	0.0	11.1	6.7	1.1	1.5	2.9	0.0	0.0	0.1	90.5	0.3	0.0	0.1	0.6	0.6	0.5	2.3	0.0	23.4	0.3	0.0	0.2	3.6	9.7	1.0	141.8	0.0	1.8	0.2	2.2	0.0	0.3	0.4	0.0	4.4	16.2	0.7	0.0	28.4	56.9	8.4	11.3	0.0	64.9	0.5	0.1	0.0	0.1	0.0	183.1	1.4	0.0	0.4	1.0	0.0	0.0	2.0	2.0	0.3	0.2	0.3	7.0	0.3	223.6	0.1	0.3	2.0
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335333-40355217	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"breast cancer: 2.5;glioma: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 15.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Not detected"	"Not detected"									NA	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.1	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBM47	"FLJ20273, NET18"	ENSG00000163694	"RNA binding motif protein 47"	A0AV96	4	40423267-40630875	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 442.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 136.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006347	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006347: AB_2181208"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-16)"	"unprognostic (1.62e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.77e-2)"	9.3	49.7	2.2	20.3	1.9	9.6	24.7	1.8	3.0	15.3	44.9	61.0	68.4	3.5	23.1	42.2	17.7	17.9	1.3	2.8	2.3	67.6	34.5	21.0	8.2	6.0	3.2	2.2	25.9	27.8	3.2	20.1	4.9	33.2	50.5	0.4	59.4	13.4	0.5	9.0	64.1	4.7	4.1	14.7	64.6	6.7	5.7	4.4	49.5	1.1	11.4	22.6	15.5	6.8	31.9	47.8	0.0	1.8	0.2	0.0	134.0	0.8	1.6	0.1	0.6	28.3	63.5	0.2	23.0	1.2	3.8	14.2	0.9	11.8	0.3	0.2	7.6	0.0	3.1	7.9	0.6	0.3	0.3	0.8	6.0	0.1	0.1	1.8	0.0	0.0	1.8	7.0	0.1	18.1	0.2	1.1	13.5	56.7	2.4	0.2	0.0	34.7	46.8	41.6	1.6	0.3	17.3	58.4	0.3	14.8	23.9	9.0	0.0	0.5	1.9	0.3	1.0	23.5	37.7	4.1	5.0	3.9	0.2	0.5	45.5	0.5	0.2	33.1	0.3	5.9	0.2	0.1	34.4	5.4	0.4	0.1	136.2	0.5	26.2	14.1	0.2	16.9	2.2	1.9	1.8	3.0	2.8	2.3	6.0	3.2	4.9	4.1	5.7	6.8	1.1	80.1	116.6	0.7	21.2	58.9	75.2	42.9	95.0	0.1	145.7	63.5	1.9	75.8	92.2	112.2	0.0	99.6	16.3	442.8	64.6	90.6	1.3	132.6	9.5	6.0	121.9	2.5	2.5	115.4	84.3	7.7	174.8	143.7	7.0	8.7	23.6	140.4	92.6	1.7	1.9	234.2	59.0	138.8	92.8	2.6	2.5	119.9	37.4	82.4	80.6	0.3	1.0	2.5	0.8	108.0	228.1	1.2	40.1	164.7	218.1	143.6	118.3	0.1	0.0	1.4	5.1	2.6	10.4	178.1	75.4	262.6	4.8	16.9	203.8	295.4
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749925-40811184	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.5;Late spermatids: 75.6;Respiratory ciliated cells: 36.4;Spermatocytes: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;CAPAN-2: 5.5;Karpas-707: 4.0;MCF7: 2.6;SuSa: 3.0;T-47d: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.6	0.9	0.6	1.0	0.6	0.6	3.8	0.4	0.4	2.5	7.2	2.8	1.7	2.2	2.7	1.8	6.8	1.2	2.1	0.5	1.5	4.7	0.4	3.3	0.3	1.8	2.4	2.3	7.2	3.3	3.6	1.3	1.5	4.5	2.4	0.7	4.8	1.5	0.0	1.5	2.1	1.2	1.2	2.7	3.2	16.5	2.0	0.3	4.7	0.2	0.3	1.3	1.2	0.8	2.6	0.1	1.2	0.0	0.0	0.0	1.7	0.0	0.2	0.1	0.1	1.0	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.6	0.1	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.4	0.7	0.6	1.5	0.3	1.7	0.0	3.0	3.9	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.4	0.5	1.5	1.8	2.4	1.5	1.2	2.0	0.8	0.1	9.6	7.8	3.6	4.3	1.1	3.1	1.5	2.2	0.1	8.6	7.1	3.5	0.0	10.5	9.2	0.0	9.2	0.1	2.7	9.8	5.8	47.5	20.7	0.9	0.6	8.3	0.4	0.7	5.4	3.6	1.2	4.6	5.4	0.0	8.5	0.7	0.2	3.8	0.0	0.9	7.1	4.1	0.8	0.4	75.6	1.5	2.2	0.0	8.4	1.0	2.1	0.0	18.1	1.3	4.7	2.7	0.0	0.3	4.5	2.2	5.5	36.4	0.1	0.0	0.4	0.8	38.9	11.4	8.2	1.0	4.5	0.7	3.4	7.7	5.7
APBB2	"FE65L, FE65L1, MGC35575"	ENSG00000163697	"Amyloid beta precursor protein binding family B member 2"	Q92870	4	40810027-41216714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 586.1;Oligodendrocytes: 803.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"naive B-cell: 5.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 138.7;TIME: 192.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023542	Approved		Approved	Mitochondria		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA023542: AB_1844909"	"unprognostic (4.43e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (5.91e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.19e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.61e-1)"	41.6	9.1	23.1	5.4	42.3	8.6	25.1	38.1	24.5	16.1	3.7	13.9	8.3	14.0	5.9	8.9	13.1	16.1	21.5	20.6	30.6	16.5	14.7	18.6	7.4	42.9	39.6	32.1	10.8	8.5	8.5	17.6	39.5	8.7	7.7	15.7	8.6	9.8	28.7	12.6	7.0	14.9	25.2	14.8	11.3	8.5	36.7	13.2	33.6	21.7	5.6	10.7	13.1	72.9	19.4	9.4	20.6	28.8	64.9	50.7	45.2	38.5	45.8	14.0	24.5	34.1	40.2	33.9	20.7	16.5	44.5	5.6	36.5	49.4	25.0	1.1	7.3	0.4	23.5	21.1	65.0	19.2	1.1	76.7	24.6	42.5	43.0	58.2	138.7	19.0	1.1	0.7	86.1	16.3	6.3	3.6	17.1	9.8	17.9	50.9	58.6	38.4	19.9	8.9	27.2	15.4	11.7	6.6	6.9	23.7	17.2	2.2	192.3	20.1	59.5	13.8	61.1	8.1	18.5	41.2	20.7	30.8	24.6	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	5.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	23.1	42.3	38.1	24.5	20.6	30.6	42.9	39.6	39.5	25.2	36.7	72.9	58.8	80.1	14.5	46.7	5.0	10.7	3.8	10.4	7.4	7.6	25.5	13.6	22.5	12.8	6.3	9.2	6.2	14.4	0.5	5.2	7.9	3.8	14.5	5.6	32.8	39.4	3.0	5.3	121.3	6.4	2.8	25.2	12.8	7.5	1.3	13.5	47.2	13.8	3.2	62.2	171.3	4.0	16.2	4.0	6.7	23.1	35.8	2.5	7.2	164.9	0.1	9.3	0.0	586.1	803.4	6.2	6.7	37.2	0.2	2.7	5.5	6.3	4.0	7.6	59.2	43.2	51.4	3.8	10.8	7.3	11.9	6.0	1.2	24.0	7.4	3.6
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 203.9;tongue: 277.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 650.7;Excitatory neurons: 434.8;Inhibitory neurons: 551.3;Oligodendrocytes: 1102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 1.3"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 106.2;HeLa: 180.0;hTERT-RPE1: 146.9;RT4: 181.0;SiHa: 102.5;WM-115: 144.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"		NA	NA		5600	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Actin filaments"		"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavorable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	42.6	36.4	70.3	4.9	111.3	0.2	22.0	92.2	88.0	11.4	13.5	9.2	4.5	6.4	5.8	17.2	17.3	21.7	96.2	68.6	82.1	29.0	11.8	121.5	2.4	93.9	103.9	35.6	10.5	71.7	16.2	9.5	98.6	55.5	7.4	35.7	72.4	24.7	203.9	12.2	7.2	10.3	90.8	107.8	10.0	9.5	88.8	7.3	41.1	277.5	3.3	25.3	7.6	135.4	2.4	26.7	40.3	2.7	0.1	0.1	3.9	33.9	17.1	33.2	16.7	4.1	10.5	0.1	106.2	90.5	1.0	18.8	23.1	15.6	37.2	0.2	3.1	0.1	180.0	0.2	33.4	0.0	0.2	0.6	44.5	0.0	10.3	146.9	3.3	0.0	0.0	0.1	9.6	14.9	0.1	0.1	2.8	5.8	2.9	0.0	49.2	0.7	27.9	181.0	37.9	76.8	102.5	40.2	0.6	32.2	3.0	0.2	0.1	0.4	38.6	9.3	26.0	0.1	0.1	0.3	2.6	0.0	144.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	111.3	92.2	88.0	68.6	82.1	93.9	103.9	98.6	90.8	88.8	135.4	101.4	650.7	211.5	205.3	0.8	39.0	50.9	5.9	33.6	32.1	80.0	32.3	242.4	28.6	90.1	95.6	37.5	16.4	0.4	4.8	21.5	40.3	107.7	31.0	10.6	77.6	9.6	0.0	434.8	14.0	45.7	51.8	16.3	44.3	5.1	13.8	128.5	11.5	13.0	0.0	551.3	11.7	6.1	13.3	30.9	29.0	1.8	5.2	14.2	121.8	19.5	82.6	0.0	64.8	1102.9	5.5	9.3	7.5	0.3	103.3	4.4	10.6	75.7	69.7	0.0	37.5	12.9	5.0	15.6	25.2	30.5	46.1	2.8	67.9	5.5	52.8
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.6;brain: 15.2"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 10.1;pons: 15.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	15.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM33	"FLJ10525, Pom33"	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935129-41960803	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	12.4	16.1	8.0	19.4	10.5	14.9	16.0	13.1	11.4	11.4	16.0	18.7	21.1	11.1	25.5	21.2	12.3	17.2	10.5	9.6	12.8	24.2	39.9	15.1	17.0	15.5	13.5	10.5	18.2	30.1	11.0	20.0	14.7	17.2	21.3	13.0	17.9	11.8	8.4	11.9	16.9	11.3	14.1	13.9	19.1	9.9	12.1	14.9	23.8	12.4	20.1	21.8	10.8	18.8	36.9	42.4	36.7	51.3	46.7	31.8	44.9	49.5	53.9	41.5	47.5	52.4	123.4	64.8	74.7	41.5	85.5	57.4	124.4	65.0	56.1	17.1	26.2	80.7	49.7	45.9	54.4	108.7	67.6	33.4	69.0	52.5	78.3	26.5	32.7	37.3	86.8	24.7	57.4	32.6	96.5	67.9	67.2	58.1	50.0	42.7	57.8	51.6	58.2	53.5	40.8	58.4	40.5	38.0	62.4	35.3	42.9	37.4	53.0	48.3	65.0	48.9	89.5	44.5	76.9	77.4	51.7	88.4	71.2	41.2	32.1	21.7	14.9	31.0	17.6	13.0	15.3	14.2	22.9	12.0	13.6	15.0	43.2	16.5	35.2	17.9	19.0	16.4	8.0	10.5	13.1	11.4	9.6	12.8	15.5	13.5	14.7	14.1	12.1	18.8	25.1	60.9	34.3	20.9	25.0	73.3	35.7	42.4	24.5	19.2	36.9	16.4	18.0	27.1	40.5	55.2	16.7	56.3	35.2	58.9	23.5	44.6	2.9	26.9	31.2	25.9	35.0	25.0	33.6	38.1	49.3	30.5	36.2	33.4	38.7	23.1	24.7	84.4	57.3	28.6	32.8	40.4	34.6	67.5	51.0	4.7	20.2	55.7	56.9	11.2	55.9	33.9	16.5	32.6	40.3	54.1	47.4	23.3	32.5	73.7	41.6	41.1	29.7	20.4	26.3	26.5	55.6	31.0	28.7	47.5	66.9	133.1	28.3	39.7	43.0	64.5
DCAF4L1	WDR21B	ENSG00000182308	"DDB1 and CUL4 associated factor 4 like 1"	Q3SXM0	4	41981756-41986465	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 24.7"	"Group enriched"	"Detected in some"	9	"Early spermatids: 35.4;Spermatocytes: 89.6;Spermatogonia: 128.4"	"Cancer enriched"	"Detected in single"	49	"testis cancer: 8.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.1"									CAB073535	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB073535: "	"unprognostic (6.24e-2)"	"unprognostic (7.52e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.64e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-4)"	0.2	0.2	0.5	0.2	0.5	0.1	0.1	0.7	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.4	0.3	0.4	0.4	0.3	0.1	0.4	0.3	0.1	0.1	0.0	0.8	0.0	0.5	0.2	0.0	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.3	0.6	0.1	24.7	0.5	0.0	0.2	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.2	0.6	0.7	0.1	0.0	0.7	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.2	1.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.6	0.2	0.9	0.1	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.7	0.7	0.4	0.3	0.4	0.3	0.5	0.3	0.5	0.6	0.8	0.0	0.0	0.7	0.5	0.4	0.3	0.2	0.0	1.2	0.9	0.5	1.2	1.5	0.3	0.0	0.0	0.2	0.6	0.3	0.0	0.3	35.4	0.9	0.9	0.9	0.0	0.4	1.4	0.6	0.3	0.5	0.0	1.2	0.0	0.1	0.0	0.6	0.3	0.0	0.8	0.4	2.0	2.2	0.3	8.6	1.2	0.8	3.6	0.0	0.7	0.7	2.1	0.5	0.6	0.9	0.1	0.4	0.9	1.2	0.2	0.1	0.5	1.6	0.0	2.9	0.7	89.6	128.4	0.6	0.9	0.5	0.6	0.2	0.7	0.6
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990502-42090461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004014	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	8.8	15.4	11.4	6.9	12.4	5.8	13.8	12.0	16.1	11.8	12.2	13.4	12.6	10.3	16.0	9.3	9.9	8.6	21.1	12.8	11.9	30.5	14.2	8.9	7.4	11.1	11.3	11.1	12.9	22.7	14.6	9.4	11.6	13.6	13.9	19.8	12.2	10.0	14.7	9.6	11.6	8.5	10.9	7.9	12.9	6.8	11.5	9.1	17.3	20.5	7.8	9.5	8.0	11.7	12.7	6.2	20.3	23.2	15.3	21.3	11.4	17.3	20.8	14.8	17.5	6.4	16.2	13.0	12.2	20.0	19.1	6.3	17.3	14.3	21.1	4.4	10.2	14.9	10.7	10.9	27.1	20.8	10.3	17.0	14.4	12.7	16.5	23.8	16.3	12.9	20.4	6.0	26.2	6.1	12.0	19.6	15.6	19.7	8.5	5.9	18.4	10.8	30.2	10.6	22.5	25.3	12.3	13.5	15.9	14.3	17.2	15.5	17.7	17.4	10.1	17.6	20.3	11.9	9.5	12.3	23.8	17.4	15.5	3.1	1.8	1.0	1.2	2.3	1.3	1.3	1.3	1.5	2.5	1.1	1.7	1.4	0.8	2.1	1.9	1.8	1.6	1.4	11.4	12.4	12.0	16.1	12.8	11.9	11.1	11.3	11.6	10.9	11.5	11.7	19.7	48.1	44.5	48.3	26.5	15.2	22.8	24.7	24.5	34.9	30.3	16.9	90.7	32.9	33.8	38.6	25.0	44.4	11.4	33.8	103.7	35.9	7.1	27.3	29.2	22.1	33.5	32.2	70.0	36.4	34.0	27.7	37.8	26.8	34.2	33.3	21.4	25.4	24.2	50.5	74.7	36.7	30.5	22.2	21.1	8.7	20.8	23.8	24.9	43.1	28.0	29.7	9.2	63.3	84.7	34.3	17.4	22.6	35.8	27.1	25.5	111.7	43.6	39.3	6.6	29.3	28.1	16.1	18.0	40.8	22.7	49.4	21.2	44.8	38.3	24.2
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;prostate: 3.3;testis: 9.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.7	1.1	0.7	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.3	1.1	0.0	0.1	0.2	2.1	1.2	3.6	0.1	0.0	0.0	1.0	0.3	2.8	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	1.2	0.2	9.4	0.7	1.1	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.3	1.3	1.1	1.2	3.6	2.8	0.1	0.7	0.4	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397488-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.3;heart muscle: 15.5;kidney: 21.4"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 43.0;Fibroblasts: 19.4;Hepatic stellate cells: 55.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 7.6;renal cancer: 7.8"	"Group enriched"	"Detected in all"	4	"midbrain: 13.3;thalamus: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AN3-CA: 219.6;PC-3: 130.4"	"Region enriched"	"Detected in many"	23	"olfactory bulb: 51.7"	"Region enriched"	"Detected in many"	8	"spinal cord: 21.4"	HPA054754			Approved	"Lipid droplets,Cytosol"		NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.1	1.8	1.8	1.8	1.6	0.0	2.3	1.1	1.6	0.7	1.2	6.2	2.2	0.2	0.3	1.7	0.5	1.0	15.5	1.0	2.2	21.4	0.6	5.7	7.0	1.7	13.3	0.3	0.2	0.2	0.6	0.0	2.6	0.8	3.0	0.1	0.6	1.0	1.6	0.5	10.4	4.3	1.4	0.4	2.9	0.6	10.1	0.1	5.0	1.4	0.8	3.5	1.3	1.2	0.0	0.0	0.0	219.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.1	0.0	0.0	23.3	0.0	0.0	0.0	2.6	0.0	0.1	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	1.2	0.0	10.1	0.0	130.4	0.2	0.0	0.0	9.0	0.0	0.1	0.3	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.1	1.6	1.0	2.2	1.7	13.3	2.6	1.4	10.1	1.2	4.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	3.7	0.0	0.0	0.1	0.1	43.0	0.0	0.0	0.1	2.5	3.7	0.0	5.3	0.0	0.0	0.0	19.4	0.5	0.1	0.0	1.1	55.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.0	3.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	2.4	0.0	0.1	0.0	0.2	1.4	0.5	0.4	0.1	0.0	0.0	0.0	2.4	0.1	0.0
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
GRXCR1	"DFNB25, PPP1R88"	ENSG00000215203	"Glutaredoxin and cysteine rich domain containing 1"	A8MXD5	4	42892713-43030658	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"seminal vesicle: 2.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 3.2;Spermatocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040824	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA040824: AB_10794863"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCTD8		ENSG00000183783	"Potassium channel tetramerization domain containing 8"	Q6ZWB6	4	44173903-44448809	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;retina: 6.8"	"Group enriched"	"Detected in some"	4	"Astrocytes: 169.4;Excitatory neurons: 223.7;Inhibitory neurons: 445.3;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 610.8"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.2;NTERA-2: 1.5;SCLC-21H: 5.7;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031562	Enhanced		Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA031562: AB_10602609"	"unprognostic (1.49e-2)"	"unprognostic (7.70e-3)"		"unprognostic (1.53e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.77e-2)"		"unprognostic (1.48e-1)"		"unprognostic (7.85e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.44e-1)"	1.5	0.2	5.4	0.0	9.6	0.0	0.0	26.0	7.0	1.0	3.6	0.9	0.0	1.4	0.2	0.1	0.2	0.3	0.2	6.4	11.5	0.8	0.0	0.1	0.0	9.2	12.7	1.5	0.6	1.0	0.0	0.0	10.2	0.4	0.1	6.8	0.4	0.9	1.5	0.1	0.1	0.5	14.6	0.0	1.5	1.3	8.2	0.0	3.0	1.1	0.0	0.1	0.3	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.6	26.0	7.0	6.4	11.5	9.2	12.7	10.2	14.6	8.2	16.3	0.1	0.0	0.0	169.4	0.0	0.0	0.6	0.0	1.8	2.6	1.3	0.3	0.3	4.3	0.0	3.7	4.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	3.5	1.0	0.0	0.0	223.7	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.4	0.0	0.1	0.0	445.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	71.2	0.0	4.4	0.0	322.7	610.8	0.2	0.0	0.0	0.0	1.2	0.0	1.9	0.0	17.1	0.0	1.7	0.2	0.1	1.6	1.0	0.0	0.1	0.0	10.0	0.0	0.1
YIPF7	"FinGER9, FLJ39576"	ENSG00000177752	"Yip1 domain family member 7"	Q8N8F6	4	44622065-44678556	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 84.9;tongue: 27.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Cardiomyocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 4.8;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.0;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA030642	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA030642: AB_10601027"	"unprognostic (9.41e-4)"	"unprognostic (2.27e-1)"		"unprognostic (2.90e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.34e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.98e-2)"	0.0	0.1	1.0	0.0	1.0	0.0	0.1	5.4	1.3	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.0	0.8	1.0	1.2	0.1	0.0	0.0	0.1	0.8	1.1	0.2	0.3	0.0	0.2	0.0	1.0	0.3	0.0	0.3	0.3	0.2	84.9	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.9	0.0	0.1	27.9	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	1.0	5.4	1.3	1.0	1.2	0.8	1.1	1.0	0.9	0.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678420-44700928	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	5.2	4.1	2.5	3.9	3.2	6.3	5.2	4.3	3.6	3.5	0.6	5.7	4.6	4.8	3.8	5.2	4.1	2.7	6.1	3.3	2.5	6.9	7.1	3.1	4.7	1.6	1.9	4.9	3.7	4.3	2.4	3.7	1.9	4.9	5.9	6.7	4.0	3.5	15.8	5.0	6.3	3.5	2.4	4.8	7.9	5.9	2.2	4.4	5.3	17.0	4.6	3.9	3.8	4.4	11.9	6.0	10.9	13.9	4.4	9.0	24.0	16.1	8.2	16.2	12.4	10.5	8.3	25.8	12.3	7.7	14.9	9.2	18.7	18.2	18.2	8.7	12.2	30.7	5.3	7.2	14.3	33.4	12.7	9.2	8.1	12.1	10.5	7.6	11.8	15.0	31.7	4.9	13.2	5.9	19.1	7.0	7.0	8.5	13.8	13.5	22.5	11.0	4.8	4.6	14.8	11.1	10.1	4.2	11.2	8.4	6.8	9.6	11.7	11.0	12.7	14.8	19.1	17.9	17.4	18.3	11.9	19.7	9.6	0.5	2.2	2.3	2.0	2.9	2.6	2.1	2.1	1.8	2.1	1.7	1.9	2.0	0.0	2.3	1.9	2.3	3.6	1.9	2.5	3.2	4.3	3.6	3.3	2.5	1.6	1.9	1.9	2.4	2.2	4.4	7.2	6.4	9.5	9.8	11.6	4.0	9.6	6.0	5.2	10.5	9.8	7.5	22.8	7.2	9.1	7.3	2.1	13.1	10.1	11.5	13.7	10.3	2.0	12.0	14.3	8.1	11.4	14.9	20.3	10.2	17.6	9.7	18.3	8.8	1.3	16.6	7.9	13.9	12.1	11.8	19.5	12.4	4.1	11.7	5.4	2.9	5.6	9.0	7.2	9.4	9.2	9.2	14.4	18.6	19.0	16.4	6.6	7.2	13.9	9.8	11.3	12.2	16.7	10.3	0.0	6.8	10.0	12.3	14.6	14.9	7.1	13.4	9.5	18.9	13.3	10.6
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		820000	"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	13.1	12.6	9.6	9.8	10.8	8.4	14.5	21.9	13.3	13.9	7.5	12.3	7.9	16.6	14.0	10.1	12.6	10.5	17.5	10.8	9.9	13.8	4.0	10.0	12.6	9.5	9.8	22.6	8.2	13.0	12.8	6.7	9.9	14.7	8.2	18.5	9.2	15.2	11.3	9.7	8.5	16.5	10.4	11.8	9.1	11.6	9.8	13.2	18.1	10.1	10.5	12.0	10.0	12.5	15.7	10.9	11.4	9.7	17.8	24.7	3.9	27.1	30.3	17.9	16.7	5.6	19.1	13.6	15.5	23.4	29.8	5.3	10.6	26.3	19.7	18.4	11.9	19.3	16.6	9.2	18.8	20.8	17.7	28.5	18.1	17.9	13.1	22.6	26.5	18.1	12.2	17.9	33.6	0.7	25.2	11.6	5.5	10.4	19.5	16.3	24.3	8.0	17.3	9.5	19.5	15.8	12.1	7.0	27.2	5.4	14.9	12.1	25.9	23.7	22.6	38.5	31.6	23.0	38.7	19.7	38.6	14.3	21.3	9.3	2.4	5.0	9.7	3.6	11.2	12.2	9.0	9.3	3.7	10.5	11.2	10.8	1.1	9.8	4.9	2.8	10.7	4.7	9.6	10.8	21.9	13.3	10.8	9.9	9.5	9.8	9.9	10.4	9.8	12.5	18.4	9.6	4.6	17.0	19.8	12.5	8.9	18.6	8.0	15.6	9.2	8.1	14.1	2.8	9.4	14.7	8.4	1.2	15.7	3.0	15.6	13.3	30.3	7.9	21.9	14.4	6.7	6.5	29.1	15.1	1.1	22.0	7.1	8.5	15.8	8.5	11.4	1.6	4.8	13.5	29.2	4.4	18.3	3.7	8.7	5.0	16.1	4.2	8.8	8.4	4.3	19.8	13.4	31.2	20.4	14.2	2.9	23.7	6.3	5.2	2.9	13.2	8.0	18.2	13.1	14.3	20.0	34.4	29.9	5.7	10.7	0.5	13.7	20.0	4.4	5.2
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor subunit gamma1"	Q8N1C3	4	46035769-46124054	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 44.7"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 135.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		0.1	0.1	21.6	0.0	20.6	0.0	0.0	19.0	27.3	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.4	31.7	0.0	0.0	0.0	0.0	24.8	38.0	1.2	0.0	0.0	0.6	0.0	23.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.2	44.7	0.0	0.1	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	20.6	19.0	27.3	19.4	31.7	24.8	38.0	23.9	21.1	44.7	23.1	0.3	0.0	0.0	135.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.2	0.0	15.4	0.0	2.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.6	0.0	1.8	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor subunit alpha2"	P47869	4	46243548-46475230	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.5;epididymis: 8.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 425.4;Excitatory neurons: 156.2;Inhibitory neurons: 111.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 4.2;U-87 MG: 2.1;WM-115: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	1.2	0.3	20.2	0.4	29.9	0.2	1.3	2.6	31.5	0.5	0.0	3.0	0.9	0.4	8.8	0.7	0.0	0.5	0.2	29.4	16.0	6.3	0.4	0.1	0.3	0.3	1.9	0.7	0.1	0.0	0.5	0.4	0.0	0.1	2.1	2.4	0.2	0.7	0.1	0.2	6.0	0.2	1.3	1.2	0.5	0.5	13.8	0.4	0.1	0.1	0.4	0.2	0.7	8.8	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	4.2	0.2	0.0	0.2	0.6	0.0	2.1	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	29.9	2.6	31.5	29.4	16.0	0.3	1.9	0.0	1.3	13.8	8.8	4.9	0.0	0.0	425.4	0.0	0.1	0.0	0.0	1.2	15.3	0.2	0.0	0.6	0.0	0.0	40.5	4.2	0.0	0.0	23.1	3.9	0.0	9.1	1.2	31.7	1.0	31.8	0.0	156.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	111.6	3.4	0.0	0.0	0.0	17.1	0.6	0.1	1.8	16.9	0.0	0.2	0.0	13.0	5.5	0.0	4.7	0.0	0.0	0.0	38.1	0.1	0.0	1.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.0	2.7	0.0
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909245	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	70	"testis: 85.8"	"Group enriched"	"Detected in some"	9	"Early spermatids: 519.2;Late spermatids: 211.0;Spermatocytes: 391.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Karpas-707: 33.9"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"										"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.0	9.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	391.5	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA4		ENSG00000109158	"Gamma-aminobutyric acid type A receptor subunit alpha4"	P48169	4	46918900-46993581	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 7.5;heart muscle: 2.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 124.9;Inhibitory neurons: 160.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	149	"REH: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"						"unprognostic (2.78e-2)"		"unprognostic (6.57e-3)"	"unprognostic (2.46e-1)"			"unprognostic (2.23e-1)"		"unprognostic (3.17e-1)"			"unprognostic (1.11e-1)"	"unprognostic (6.91e-2)"			0.0	0.0	1.8	0.0	7.5	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.5	4.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	7.5	0.0	6.8	4.0	2.6	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	21.5	0.0	0.5	0.0	0.0	0.6	0.3	0.0	0.6	15.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	124.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	160.1	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	8.4	0.0	6.1	0.0	3.5	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.4	3.8	0.1	0.4	0.1	0.0	0.0	0.0	0.9	0.0
GABRB1		ENSG00000163288	"Gamma-aminobutyric acid type A receptor subunit beta1"	P18505	4	46993723-47426447	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 26.3"	"Group enriched"	"Detected in some"	15	"Astrocytes: 926.2;Excitatory neurons: 440.3;Inhibitory neurons: 507.4;Oligodendrocyte precursor cells: 266.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.1;U-87 MG: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.11e-2)"		"unprognostic (7.56e-3)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"			"unprognostic (1.11e-1)"		"unprognostic (4.98e-3)"		"unprognostic (8.16e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.34e-1)"		0.0	0.2	19.1	0.0	24.8	0.0	0.0	0.3	26.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	3.6	26.2	24.6	0.3	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.3	1.5	0.1	0.6	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	26.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	24.8	0.3	26.3	26.2	24.6	0.5	7.4	0.6	1.1	26.1	2.3	0.0	0.0	0.0	926.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.1	1.2	0.0	440.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	507.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.1	32.9	0.0	266.9	16.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.3	1.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0
COMMD8	FLJ20502	ENSG00000169019	"COMM domain containing 8"	Q9NX08	4	47450787-47463702	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035887	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA035887: AB_10600702"	"unprognostic (9.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (2.71e-5)"	"unprognostic (1.06e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.13e-2)"	13.4	15.5	9.7	20.3	9.8	21.4	13.6	10.0	14.6	11.8	13.0	17.7	18.4	10.4	22.6	24.1	11.3	13.7	27.2	9.5	12.2	45.3	12.7	13.5	30.4	9.9	10.3	10.2	10.4	26.8	13.4	19.0	10.0	10.6	18.1	13.5	8.4	10.0	8.8	17.5	19.0	15.0	10.4	18.1	14.3	24.1	10.3	21.6	21.3	12.6	25.4	16.8	11.8	10.3	32.6	17.6	15.2	7.8	31.6	44.8	21.1	47.8	31.5	30.7	41.5	29.9	37.4	51.7	39.0	45.3	69.4	17.0	49.4	39.1	55.0	30.8	22.1	29.8	17.7	23.2	43.0	73.6	36.8	38.7	51.6	29.2	32.3	28.5	39.5	33.7	22.5	20.6	75.8	18.1	44.1	59.4	10.4	21.8	22.8	21.8	34.7	11.2	88.1	26.3	29.8	15.2	19.9	16.1	39.6	26.5	29.5	48.0	32.7	43.6	41.8	39.2	57.9	21.6	27.6	42.1	47.3	95.2	32.2	114.3	58.2	68.9	44.6	80.4	48.1	48.1	40.5	44.9	74.0	43.4	37.5	43.2	29.0	57.4	89.4	34.3	51.2	71.4	9.7	9.8	10.0	14.6	9.5	12.2	9.9	10.3	10.0	10.4	10.3	10.3	31.3	22.4	16.5	3.3	41.6	22.6	11.4	60.5	21.6	18.2	12.8	16.6	46.1	18.6	32.6	29.5	4.2	86.6	39.1	20.9	107.6	42.8	68.4	43.0	21.6	26.7	21.0	14.5	5.5	46.3	116.3	28.6	16.8	19.2	33.0	11.3	22.5	12.7	90.9	6.7	7.3	19.4	42.7	54.4	42.1	18.9	54.3	50.7	12.4	4.7	82.0	37.2	72.1	2.5	5.3	25.1	23.8	40.6	22.9	8.6	28.0	231.8	57.4	23.8	19.7	16.9	29.9	141.5	59.0	37.3	30.0	105.8	53.9	36.9	28.8	10.2
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485275-47593486	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"basophil: 84.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 84.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.6"					"Low region specificity"	"Detected in all"			HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	4.9	6.0	2.6	5.0	2.9	1.3	4.2	1.9	2.7	7.0	15.9	3.7	3.9	7.4	7.2	10.2	4.7	7.4	4.2	1.8	4.1	10.2	2.4	6.1	6.2	3.1	3.7	8.1	4.5	10.4	3.1	14.9	2.9	4.6	3.8	4.1	3.4	6.4	1.0	9.9	4.5	9.7	2.4	10.0	5.1	2.0	5.0	4.5	9.1	2.7	7.9	7.3	6.5	2.9	2.6	1.8	4.0	2.8	11.1	12.0	0.7	17.9	21.5	8.4	15.1	9.4	15.4	8.1	6.5	29.1	14.3	4.6	41.6	15.0	12.9	3.2	3.2	6.5	2.8	0.5	9.8	2.1	3.9	10.3	11.2	16.4	10.9	27.5	14.4	4.0	0.1	4.3	23.2	1.0	4.4	1.2	1.4	0.0	2.2	4.9	9.0	0.1	15.0	3.1	2.6	4.9	8.4	2.1	5.2	8.7	3.8	2.1	21.9	20.7	4.1	1.9	7.8	1.9	1.5	0.0	10.2	11.9	6.8	84.3	3.1	0.4	1.1	5.0	1.9	2.7	0.5	0.8	4.0	6.7	0.1	0.9	1.5	2.3	6.9	2.4	0.8	1.6	2.6	2.9	1.9	2.7	1.8	4.1	3.1	3.7	2.9	2.4	5.0	2.9	22.9	9.6	7.5	39.2	27.8	19.2	9.2	21.9	23.9	12.2	6.7	8.4	4.9	4.3	8.5	16.5	31.3	48.5	17.1	1.6	1.9	5.5	4.4	4.8	29.5	16.1	9.6	4.0	25.7	4.6	11.0	22.4	14.3	7.0	2.5	21.3	18.2	6.6	13.0	13.5	42.8	4.6	18.3	21.7	7.9	1.5	62.1	17.7	7.2	47.8	15.7	21.9	15.5	52.3	24.1	2.7	3.4	25.2	23.0	5.7	1.9	9.2	6.2	9.2	26.3	12.8	23.6	0.6	2.8	35.4	27.0	176.8	15.5	51.7	4.1	8.1
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
NFXL1	HOZFP	ENSG00000170448	"Nuclear transcription factor, X-box binding like 1"	Q6ZNB6	4	47847233-47914667	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 213.2;Spermatocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059132	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA059132: AB_2683917"	"unprognostic (5.37e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.26e-3)"	"unprognostic (8.48e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.72e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.01e-2)"	3.0	2.2	1.6	4.4	1.8	4.2	6.4	3.2	1.9	5.4	1.1	3.7	4.6	5.3	10.9	3.8	5.4	3.3	1.8	1.3	1.6	4.1	3.9	3.0	4.1	1.9	1.9	6.1	4.6	6.6	3.2	3.8	1.9	5.0	4.8	3.7	5.2	4.4	2.7	3.9	3.9	5.0	2.0	3.7	4.8	13.7	2.3	4.3	10.1	2.8	4.6	4.3	3.6	1.8	7.0	4.4	4.8	9.9	8.9	14.6	16.2	4.7	6.7	7.6	9.3	7.4	15.6	5.5	8.8	3.1	14.6	7.1	12.4	9.4	8.9	4.3	4.8	6.0	8.7	13.6	11.5	14.8	11.5	9.6	12.3	5.2	30.7	8.9	6.6	11.5	10.8	6.7	7.8	7.0	11.7	6.9	11.6	9.7	6.7	10.3	9.2	9.3	9.6	13.2	15.1	7.3	3.5	9.8	6.8	9.1	6.8	4.2	5.5	9.8	6.2	4.6	10.6	10.8	7.0	11.2	5.7	8.2	8.8	0.0	0.5	0.6	0.7	0.7	0.9	0.8	1.0	0.8	0.5	0.8	1.1	1.0	1.9	0.4	0.4	0.6	0.7	0.6	1.6	1.8	3.2	1.9	1.3	1.6	1.9	1.9	1.9	2.0	2.3	1.8	6.9	6.4	8.7	15.0	6.3	5.4	4.0	5.2	7.4	19.6	10.0	7.0	213.2	11.5	9.9	7.3	10.4	5.6	10.5	6.2	11.7	9.2	36.9	15.7	16.7	7.8	11.4	6.9	35.6	7.1	11.5	27.3	7.1	18.4	2.5	10.9	7.9	7.5	4.8	8.4	35.0	11.2	12.2	6.5	4.3	20.2	12.8	9.9	1.8	17.8	7.3	11.0	8.2	33.7	30.7	7.4	4.7	10.1	13.8	7.0	6.5	4.2	9.9	16.5	0.0	8.1	9.1	81.1	27.2	9.9	4.3	6.7	6.8	5.5	8.1	5.2
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.8;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 42.0;Collecting duct cells: 42.3;Distal enterocytes: 56.2;Squamous epithelial cells: 44.4;Undifferentiated cells: 38.6;Urothelial cells: 55.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.3;CAPAN-2: 11.6;HaCaT: 15.3;HBEC3-KT: 11.1;RT4: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036765	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.3	0.1	0.1	1.7	0.3	0.2	3.6	0.3	0.3	2.0	0.3	14.1	5.4	0.3	7.3	21.8	2.1	1.4	0.1	0.1	0.4	3.3	16.2	0.4	0.1	0.2	0.2	0.0	1.9	3.7	0.6	1.8	0.2	2.1	13.3	1.8	5.1	1.2	1.6	25.7	7.1	0.5	0.1	0.2	7.1	0.6	1.0	0.3	1.6	0.1	3.0	7.7	4.8	0.1	13.3	0.2	0.0	0.0	0.0	0.0	2.1	2.4	2.3	1.8	3.2	7.8	11.6	0.0	1.7	0.0	3.3	15.3	2.2	11.1	4.7	0.1	2.8	0.0	0.1	0.5	0.0	0.1	0.1	0.1	4.0	0.2	2.6	3.1	0.6	0.8	0.1	0.0	2.6	5.1	0.1	0.1	1.9	9.1	3.4	0.0	0.0	0.0	6.4	17.9	1.1	0.3	1.2	4.3	1.9	1.0	2.7	0.0	5.0	0.1	4.5	0.0	0.3	0.1	0.2	0.0	0.2	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.1	0.4	0.2	0.2	0.2	0.1	1.0	0.1	0.3	9.6	6.1	0.0	0.4	14.4	42.0	6.4	4.6	0.2	9.9	5.0	2.8	4.3	12.6	42.3	0.0	2.1	0.2	56.2	0.0	15.7	0.7	7.3	1.1	1.1	11.5	0.0	0.9	6.7	1.4	1.5	11.2	14.2	0.0	0.3	0.4	18.5	0.4	0.0	1.0	27.5	4.1	1.2	2.1	0.3	0.0	0.6	1.8	1.0	0.6	0.7	0.0	0.5	0.1	16.1	31.2	0.0	1.4	27.4	31.8	1.0	3.2	5.1	0.0	1.9	2.8	1.3	2.8	44.4	33.0	3.6	1.0	0.1	38.6	55.2
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 264.4"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1139.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	3.3	0.4	0.5	0.8	1.4	0.3	1.5	1.6	0.9	1.0	0.6	3.6	2.2	0.4	9.3	9.0	4.1	1.1	0.4	0.7	0.8	2.4	23.5	0.3	0.1	0.4	0.3	0.1	0.8	4.1	0.3	1.0	0.4	2.6	2.4	264.4	4.3	1.7	5.0	5.1	6.3	0.3	0.1	3.4	2.8	0.4	0.7	0.3	0.7	1.3	0.5	3.7	1.9	0.6	2.3	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	2.0	9.2	0.1	0.5	0.0	2.7	1.4	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.0	0.8	0.7	0.5	0.2	0.9	0.0	0.1	0.4	1.1	2.2	0.1	0.0	0.1	0.4	7.2	0.3	0.0	0.2	0.5	0.1	0.2	0.9	0.0	0.3	0.2	3.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	0.5	1.4	1.6	0.9	0.7	0.8	0.4	0.3	0.4	0.1	0.7	0.6	7.3	0.0	0.0	0.7	0.1	0.1	1.8	0.5	0.6	97.7	8.7	1.8	0.7	5.7	3.4	62.5	91.8	0.0	0.0	10.6	0.0	10.1	0.4	2.5	0.4	8.7	0.0	2.7	1.2	6.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	38.0	1.7	45.4	1.1	4.0	0.0	0.8	0.0	0.1	0.3	0.5	0.0	7.5	0.0	163.9	0.0	0.0	0.2	2.1	16.4	0.0	0.0	3.7	24.5	0.4	0.8	1139.7	0.0	0.6	17.1	0.6	1.3	10.3	2.7	0.3	0.2	0.1	4.7	35.1
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134250	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.4;lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 84.1;NK-cells: 288.4;T-cells: 52.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 152.3"	"Group enriched"	"Detected in many"	19	"NK-cells: 152.3;T-cells: 54.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.1;HMC-1: 14.0;U-266/70: 6.8;U-266/84: 9.2;WM-115: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	0.9	1.0	0.1	7.8	0.0	5.6	0.9	0.0	0.4	0.8	0.3	1.5	1.8	1.0	12.4	1.5	2.0	2.2	0.6	0.0	0.5	1.1	2.1	2.8	15.8	1.2	0.2	0.2	0.8	0.4	0.7	1.9	1.5	0.5	1.4	2.0	1.4	0.5	0.6	2.2	5.6	0.4	0.2	10.6	1.1	1.1	0.8	5.7	1.2	0.0	10.8	2.2	0.9	0.2	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	6.1	0.0	1.8	0.0	0.2	0.3	0.0	0.1	0.6	0.3	0.1	3.1	0.0	0.0	0.0	0.4	14.0	0.0	0.0	0.1	0.0	0.9	0.2	0.6	0.2	0.1	0.8	0.0	0.0	2.8	0.0	0.8	1.0	0.4	0.0	0.0	1.7	1.6	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.1	6.8	9.2	0.6	0.0	0.5	32.0	5.4	0.1	1.0	42.0	0.2	54.8	0.2	21.1	20.2	0.2	0.1	53.2	37.0	2.4	152.3	0.3	0.6	17.6	36.3	0.1	0.0	0.0	0.4	0.0	0.5	1.2	0.2	1.5	0.2	0.8	0.2	0.7	0.0	1.8	0.3	3.2	0.4	0.6	0.0	0.6	0.5	0.8	0.4	1.1	1.5	0.0	0.0	4.2	0.4	84.1	0.2	1.9	1.5	10.1	2.0	0.4	0.9	0.0	10.7	21.5	0.0	0.1	0.6	0.0	5.5	1.3	0.1	3.6	1.5	1.6	0.0	3.3	0.2	0.0	6.9	0.4	2.8	0.3	1.9	1.8	3.7	1.6	1.4	288.4	0.5	0.5	0.1	0.1	0.0	8.9	0.6	0.4	0.5	0.0	0.4	0.0	1.2	0.1	1.0	0.8	0.8	1.1	0.5	52.3	0.1	0.4	0.8
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269838	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 20.7;eosinophil: 13.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	0.9	1.7	0.1	2.1	0.2	6.1	1.4	0.1	0.4	1.2	1.0	1.3	1.6	1.1	4.2	3.4	1.9	1.1	1.3	0.0	0.4	1.1	2.5	2.0	3.1	1.1	0.3	0.4	0.8	1.2	0.6	1.1	1.1	0.5	1.3	1.8	2.3	1.0	0.6	3.6	1.5	0.8	0.3	1.7	1.1	1.2	0.7	2.0	1.3	0.5	3.3	1.0	1.6	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	2.2	1.3	2.7	0.0	2.2	1.9	2.0	0.0	0.1	0.6	1.1	0.0	1.8	0.1	0.8	13.5	1.0	0.1	0.0	2.2	20.3	0.0	0.3	1.7	0.0	1.4	0.0	0.6	7.5	0.5	4.1	1.0	1.3	4.9	0.4	1.4	0.8	3.1	2.7	0.0	3.4	0.9	0.0	0.2	0.6	0.3	0.5	1.1	0.7	4.2	0.0	0.0	0.0	2.8	0.0	20.3	15.4	2.6	0.0	3.0	0.1	20.7	0.6	13.3	0.1	0.7	0.3	1.0	0.2	0.5	1.5	0.7	0.5	0.5	0.5	3.6	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.0	0.4	1.1	0.3	1.1	0.3	0.7	0.2	0.6	6.4	6.8	0.7	6.8	2.5	1.7	0.2	2.8	0.9	1.7	1.1	1.8	7.2	2.6	0.0	0.0	1.5	3.3	2.1	0.0	1.7	6.4	13.9	1.5	1.2	3.0	12.6	6.7	1.1	0.1	0.8	0.0	25.1	19.6	0.7	0.0	2.9	4.9	0.0	1.6	1.4	4.1	4.6	1.8	2.6	0.0	5.9	1.8	10.3	1.7	6.6	0.0	0.5	0.2	1.0	0.6	0.4	15.4	1.3	3.0	2.0	0.2	3.1	6.6	1.8	0.8	0.7	1.4	9.8	3.0	0.8	3.4	0.3	2.1	1.6
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341529-48426201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		210000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	24.9	12.6	7.0	14.6	6.6	15.5	17.0	10.5	9.0	21.4	9.0	27.3	13.4	23.6	18.6	38.7	25.7	18.5	40.6	6.1	7.2	18.6	26.7	21.0	16.5	6.9	7.1	22.2	15.1	29.6	7.8	22.2	6.8	25.8	24.0	15.8	19.1	30.2	71.8	32.5	16.3	35.4	6.0	16.3	18.2	40.3	8.1	24.4	20.0	98.8	21.0	26.3	21.9	8.5	32.8	12.7	22.2	22.0	33.9	41.6	15.6	49.3	62.3	43.0	44.5	12.6	26.8	19.4	29.7	56.7	76.7	21.2	91.5	46.1	75.6	16.1	9.5	34.1	17.5	14.4	36.5	31.5	33.4	35.4	67.1	50.0	58.0	32.2	25.8	17.1	22.3	21.1	43.7	16.5	36.4	25.9	9.4	25.7	18.2	20.6	43.1	12.4	38.0	35.4	14.7	18.7	20.0	14.8	21.2	20.4	18.6	22.2	33.0	46.8	44.2	29.9	50.5	28.6	32.1	16.3	36.8	35.2	34.5	9.5	6.5	7.7	6.6	4.7	7.2	5.1	8.1	9.9	6.6	7.5	6.6	7.1	5.8	8.8	7.3	2.3	5.7	3.6	7.0	6.6	10.5	9.0	6.1	7.2	6.9	7.1	6.8	6.0	8.1	8.5	37.2	54.5	38.7	43.8	27.9	84.2	50.6	32.6	38.7	15.8	26.5	19.4	79.6	18.6	32.3	27.6	14.6	29.3	31.7	35.0	21.5	29.9	162.4	145.1	64.7	28.8	25.2	16.6	47.0	34.9	29.1	31.9	28.5	57.4	21.6	20.3	21.8	33.0	21.6	35.3	47.3	34.5	22.4	20.5	31.0	319.2	27.4	29.2	19.6	38.4	37.5	20.7	28.8	54.3	43.1	32.2	27.9	36.9	26.2	53.9	23.4	26.4	85.1	41.0	32.9	54.1	43.1	98.7	48.8	55.0	91.5	75.5	35.0	32.8	25.6	58.3
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489526	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 36.8"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 16.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 1.8;glioma: 5.9"	"Region enhanced"	"Detected in many"		"midbrain: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7"	HPA028835	Uncertain	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.1	2.7	0.5	0.2	1.8	1.1	0.1	0.0	4.6	0.9	0.0	1.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.2	9.0	0.2	0.1	0.2	0.0	8.6	36.8	0.1	0.1	0.0	6.7	0.0	23.3	0.2	0.1	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.6	0.1	0.5	0.4	3.8	0.0	0.4	0.0	0.0	0.1	0.6	2.6	0.0	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	9.2	0.0	0.1	0.0	2.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	32.1	0.4	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	4.6	0.2	9.0	8.6	36.8	23.3	0.6	3.8	2.6	0.4	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.2	0.4	0.0	3.0	0.6	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	16.2	0.0	0.0	0.0	0.4	2.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.7	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ZAR1	Z3CXXC6	ENSG00000182223	"Zygote arrest 1"	Q86SH2	4	48490252-48494389	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Inhibitory neurons: 1.9;Late spermatids: 8.6;Oligodendrocyte precursor cells: 3.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"midbrain: 2.1"							NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"					"unprognostic (9.71e-2)"	"unprognostic (2.58e-1)"		"unprognostic (4.59e-3)"	"unprognostic (2.47e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-1)"				"unprognostic (1.08e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.32e-5)"	"unprognostic (4.51e-1)"	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.0	0.0	1.1	0.0	3.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497357-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.5"	"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 1148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	8.8	5.4	12.2	13.2	43.5	15.0	7.9	26.6	22.6	8.4	0.8	37.9	10.4	8.4	3.7	6.6	6.1	8.3	8.6	12.1	19.9	8.4	5.7	9.7	13.4	34.8	23.4	7.9	5.6	20.3	2.7	10.5	31.2	6.5	36.7	29.2	6.8	6.6	4.5	10.2	12.8	9.2	22.2	10.8	10.7	6.3	25.7	16.7	7.9	12.0	13.1	10.2	3.4	81.5	19.7	11.6	26.8	16.4	11.3	16.1	14.5	18.1	17.4	17.6	21.2	9.4	14.7	25.0	14.3	19.3	32.9	11.8	17.8	28.1	37.9	14.3	6.1	45.6	11.3	4.3	7.0	31.6	16.8	11.6	10.5	24.0	24.9	16.4	26.4	21.3	14.8	9.2	22.9	9.6	34.5	10.9	4.6	8.9	9.8	25.4	35.0	4.7	15.7	20.8	23.1	9.9	17.7	5.2	9.9	12.8	6.8	19.6	40.3	19.8	25.5	10.1	35.3	12.4	17.5	22.1	16.6	20.6	19.8	13.5	0.9	1.8	2.0	1.4	1.6	1.5	1.8	1.7	1.0	1.2	2.0	1.9	2.8	2.7	1.0	1.7	1.3	0.7	12.2	43.5	26.6	22.6	12.1	19.9	34.8	23.4	31.2	22.2	25.7	81.5	87.1	38.5	33.1	92.1	50.1	47.3	24.3	32.0	38.7	45.3	23.7	17.0	33.5	18.6	28.9	16.5	135.5	23.6	59.9	122.8	3.9	13.8	11.6	48.2	29.0	74.8	79.5	80.6	110.1	11.6	21.5	23.7	128.4	56.8	46.9	25.6	48.9	15.2	19.4	47.1	172.5	195.1	38.7	30.1	34.0	3.9	17.1	40.1	26.6	214.5	35.1	32.8	63.8	146.8	1148.7	28.8	87.3	18.4	38.6	43.4	50.4	8.4	21.0	105.6	19.7	31.2	37.3	12.8	10.9	37.3	49.3	10.8	54.4	15.6	93.9	53.3
OCIAD1	"Asrij, FLJ20455, OCIA, TPA018"	ENSG00000109180	"OCIA domain containing 1"	Q9NX40	4	48805212-48861817	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044803	Approved		Approved	Mitochondria		NA	NA		21000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA044803: AB_10961287"	"unprognostic (8.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.82e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.10e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.34e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	129.5	184.0	161.1	99.4	170.6	107.7	153.9	154.6	212.9	150.3	173.5	161.1	155.8	138.0	192.2	118.1	167.2	124.6	219.3	177.3	177.0	238.1	326.5	124.1	127.3	161.1	153.1	159.1	156.1	248.7	109.9	118.4	157.6	145.9	159.9	143.7	161.9	148.1	255.0	107.1	134.6	133.3	163.1	105.1	141.3	91.0	165.8	133.6	239.4	255.9	133.9	136.3	72.3	172.6	165.2	118.2	231.7	162.8	230.8	283.0	178.6	253.1	393.8	261.1	311.3	110.6	473.2	190.4	241.5	238.0	311.4	141.7	229.4	250.4	296.2	149.4	152.7	293.4	105.7	88.1	336.5	309.1	300.9	292.0	353.5	208.3	258.4	315.4	270.0	173.9	339.8	104.1	300.0	107.7	261.4	287.6	195.2	211.7	110.4	169.6	216.9	203.1	502.9	154.5	139.8	261.0	120.4	101.1	306.5	179.8	212.8	271.5	196.9	176.1	200.7	120.7	333.1	256.3	380.4	283.1	223.2	251.0	220.2	47.8	60.2	76.5	62.6	68.0	90.8	74.1	73.1	79.2	75.4	64.9	90.2	80.5	48.3	95.4	86.5	85.2	68.5	73.5	161.1	170.6	154.6	212.9	177.3	177.0	161.1	153.1	157.6	163.1	165.8	172.6	176.7	160.3	124.5	85.8	107.1	79.7	111.3	243.3	102.4	126.6	96.7	119.6	152.3	102.9	169.4	121.4	66.7	170.5	103.1	140.0	137.0	140.0	34.3	147.3	120.5	120.2	130.1	89.8	125.1	128.3	168.8	124.4	84.1	110.5	141.8	102.6	118.9	167.3	152.7	89.2	137.2	131.3	124.1	94.0	77.2	35.5	132.3	106.1	87.2	76.8	107.2	206.1	121.5	106.1	158.1	130.7	122.5	139.2	115.3	104.2	164.1	178.9	151.2	111.6	124.9	121.3	112.7	188.3	88.3	94.1	75.9	164.7	109.8	197.2	142.7	100.4
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 155.4"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 325.2;U-251 MG: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	9.2	20.4	14.1	22.1	13.1	16.3	23.4	10.3	15.3	19.8	14.1	54.7	122.3	20.7	46.9	25.8	22.4	32.4	14.3	17.8	15.6	155.4	129.5	19.0	34.6	13.1	13.2	8.7	26.9	44.4	33.6	8.6	11.7	23.8	49.9	26.9	40.2	29.2	4.4	20.0	88.4	15.0	11.6	12.6	85.0	6.3	13.7	53.6	37.4	3.9	40.3	28.1	12.0	12.7	208.9	108.5	1.6	0.0	0.0	0.0	2.7	53.3	23.9	28.4	26.9	0.0	249.4	35.7	230.1	30.5	248.0	65.5	29.7	325.2	29.1	83.8	22.6	0.1	78.6	0.1	25.6	101.7	0.3	14.7	150.8	0.1	61.1	81.4	115.5	140.2	0.1	17.6	30.3	78.3	172.2	70.2	102.5	234.2	145.2	38.5	0.1	59.4	288.7	135.0	230.3	69.5	75.4	25.5	5.4	0.8	26.2	25.2	195.6	0.2	215.1	1.2	399.5	49.5	59.6	113.3	163.0	0.3	0.4	208.4	3.5	69.1	101.6	1.5	136.9	168.0	191.0	147.3	18.1	156.7	247.2	165.0	11.2	156.0	1.3	122.4	338.7	137.7	14.1	13.1	10.3	15.3	17.8	15.6	13.1	13.2	11.7	11.6	13.7	12.7	135.9	28.9	70.6	2.0	102.5	109.0	146.6	401.4	81.4	17.6	152.7	190.6	39.2	194.5	224.2	176.6	29.2	46.2	66.3	359.7	217.2	510.5	1.4	197.5	22.9	103.3	306.4	38.9	10.1	570.2	11.4	14.9	157.5	190.8	36.8	75.3	31.1	193.9	44.3	1.7	11.6	301.3	341.8	6.4	27.0	2.5	5.0	21.7	65.8	5.6	15.9	49.9	82.4	2.5	1.8	1277.4	311.6	21.4	53.5	180.1	702.0	1384.9	171.4	77.6	0.0	3.7	41.8	2.6	3.2	105.2	131.4	15.3	129.8	52.1	188.6	239.2
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 111.9;Oligodendrocytes: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	14.0	17.8	14.5	7.3	14.1	2.8	9.8	14.4	20.3	13.3	8.1	15.0	5.9	13.6	11.5	10.4	12.7	11.4	12.1	13.4	17.3	14.9	28.9	9.1	7.5	16.0	16.2	16.0	9.1	9.5	15.7	6.9	17.2	12.0	8.5	15.7	13.4	16.9	11.8	7.7	9.7	17.3	14.2	9.4	13.3	17.0	18.9	6.5	13.2	11.4	6.1	16.9	10.9	16.4	10.6	18.9	25.5	36.7	25.6	27.5	9.8	31.1	23.2	18.0	15.9	11.8	12.1	8.1	20.1	35.2	23.5	11.2	31.0	19.8	27.8	4.9	9.5	13.8	14.9	28.7	54.9	20.4	17.9	25.1	23.7	19.6	17.9	27.0	19.2	7.4	15.6	5.9	35.3	15.2	24.1	13.6	14.5	21.1	15.1	11.4	12.2	4.4	23.1	12.4	14.4	15.6	13.1	17.8	28.9	13.9	18.4	12.3	28.8	24.0	19.7	19.7	25.7	11.1	18.1	7.3	16.6	18.8	14.4	6.8	3.6	8.8	5.7	3.3	8.5	3.6	6.4	6.5	2.5	2.4	6.0	6.8	1.4	3.7	2.4	1.5	3.2	4.4	14.5	14.1	14.4	20.3	13.4	17.3	16.0	16.2	17.2	14.2	18.9	16.4	13.1	6.4	14.1	86.2	9.7	37.2	19.2	16.5	16.5	23.3	18.1	11.7	40.6	14.3	13.2	16.5	16.7	5.0	9.8	14.9	13.7	10.6	76.3	10.7	16.1	17.9	6.7	11.8	90.9	12.2	8.5	23.1	21.9	10.0	13.3	18.9	17.2	35.8	8.2	30.3	88.6	7.2	12.2	7.3	18.4	111.9	14.9	7.2	32.0	51.5	5.3	14.9	15.5	69.4	131.4	13.3	10.9	25.9	6.3	17.2	8.9	24.1	18.1	17.8	0.0	13.4	20.8	24.6	25.5	17.3	33.2	3.4	11.1	12.4	8.9	15.0
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.5;skeletal muscle: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.9;Distal enterocytes: 9.0;Excitatory neurons: 9.4;Gastric mucus-secreting cells: 6.1;Inhibitory neurons: 7.3;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 8.8;Paneth cells: 7.3;Proximal enterocytes: 21.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;CAPAN-2: 2.0;OE19: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.4	0.3	0.9	0.9	1.0	0.0	0.3	1.3	1.4	0.6	0.5	6.1	22.5	0.5	0.2	0.1	0.5	1.8	1.0	1.0	0.8	1.1	0.5	0.2	0.1	1.2	0.8	0.4	0.3	0.3	2.4	0.0	1.2	0.5	5.8	0.8	0.3	0.2	8.0	0.2	18.7	0.6	0.8	0.3	5.0	0.8	1.1	0.1	0.2	2.1	0.0	0.5	0.3	1.2	0.0	0.0	0.1	0.2	0.6	1.5	0.0	0.2	0.4	0.1	0.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.3	1.4	1.0	0.8	1.2	0.8	1.2	0.8	1.1	1.2	0.2	0.0	0.0	5.9	0.1	0.0	0.0	0.2	0.0	1.6	0.1	0.4	1.1	1.5	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.2	1.3	0.4	0.2	0.1	0.0	0.0	9.4	1.2	0.0	0.6	6.1	0.2	0.0	0.1	0.7	0.1	0.0	0.0	7.3	4.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.9	0.6	0.1	0.0	8.0	8.8	0.5	7.3	0.4	0.0	0.0	21.8	0.4	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1
SGCB	"A3b, LGMD2E, SGC"	ENSG00000163069	"Sarcoglycan beta"	Q16585	4	52020706-52038299	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 105.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 203.7"	"Cancer enhanced"	"Detected in all"		"glioma: 56.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.7"	"Low region specificity"	"Detected in all"							"HPA011422, HPA058656"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA011422: AB_1856795, HPA058656: AB_2683790"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.53e-6)"	"unprognostic (3.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (7.61e-4)"	32.7	21.6	27.1	9.5	30.3	0.5	14.7	28.0	32.2	23.4	21.4	32.9	13.1	28.1	11.1	21.9	20.5	19.5	57.2	25.3	27.7	35.0	10.8	15.2	6.1	29.7	28.4	20.1	6.5	47.0	13.9	24.2	30.3	25.0	16.2	16.6	13.5	27.2	105.7	7.2	14.9	37.3	29.0	11.1	14.0	16.0	28.3	5.6	9.2	81.3	4.5	20.4	15.7	33.4	11.4	13.7	27.8	10.6	104.7	78.5	10.1	62.8	79.9	34.5	36.2	3.7	14.9	3.0	11.8	82.9	53.5	5.5	20.9	23.1	36.7	18.8	7.8	0.2	11.8	6.8	42.8	6.8	3.6	86.8	15.9	29.9	17.3	89.8	46.1	10.7	0.1	0.1	74.5	4.4	15.1	0.1	10.0	4.6	20.4	0.0	14.8	0.2	29.2	3.8	16.2	28.4	39.9	1.9	14.1	31.0	5.2	4.1	47.0	50.8	17.0	24.1	56.6	14.9	20.4	5.5	37.5	2.4	59.7	0.3	1.0	0.0	2.1	0.5	2.1	2.6	2.5	2.3	0.5	2.3	1.7	2.2	0.5	0.3	0.4	1.0	4.2	1.0	27.1	30.3	28.0	32.2	25.3	27.7	29.7	28.4	30.3	29.0	28.3	33.4	38.9	32.1	13.1	15.3	6.6	13.4	25.8	70.2	9.6	22.0	8.6	19.7	88.8	25.8	19.6	12.9	6.2	5.7	2.8	15.6	1.9	28.7	61.1	32.6	48.1	27.2	16.3	0.0	17.3	51.8	49.8	64.6	12.8	29.7	2.5	16.7	36.0	15.7	2.8	28.6	21.2	4.2	8.2	2.1	8.7	203.7	38.8	2.7	26.6	24.4	1.9	23.6	1.0	38.7	38.1	53.8	6.0	91.4	4.6	11.7	32.6	64.6	20.4	16.5	46.0	102.8	59.8	12.2	17.4	8.0	10.5	6.3	7.3	14.2	15.1	13.5
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.3;testis: 28.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	2.4	0.7	2.2	0.0	6.3	1.3	1.0	10.7	15.6	4.1	2.1	4.2	2.0	4.6	68.3	6.7	1.8	2.5	2.7	5.3	5.4	8.0	0.3	6.8	8.3	1.8	2.0	4.5	4.9	1.9	5.5	4.2	5.6	0.1	10.1	5.6	0.8	6.6	2.2	3.1	6.0	0.6	4.9	28.8	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.8	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	1.3	1.0	2.5	2.7	6.8	8.3	5.5	6.0	2.6	3.8	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590960-52659301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 150.8;Early spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.4	8.6	30.4	3.3	31.2	2.9	6.4	27.4	31.5	7.6	22.4	3.9	4.4	6.5	5.4	11.5	7.0	5.3	28.6	30.8	33.3	9.9	2.9	3.9	3.7	27.9	33.9	11.0	5.2	10.4	4.6	5.3	26.7	6.9	4.0	11.5	8.3	6.7	14.5	7.5	4.2	5.0	30.4	3.3	6.0	12.3	32.5	3.4	9.3	12.5	5.5	6.0	7.4	26.8	8.1	5.7	18.0	13.3	19.1	23.8	19.8	13.0	10.5	9.5	7.9	11.5	6.2	5.4	14.9	13.0	13.4	4.7	31.6	15.1	17.2	4.7	11.1	8.4	5.3	12.8	19.1	11.2	9.4	20.4	13.9	9.7	9.1	18.4	14.2	7.4	8.3	7.4	20.3	7.4	4.8	5.9	13.3	9.0	6.8	12.0	13.1	1.1	20.3	14.8	10.8	12.9	6.4	21.5	12.9	17.1	7.9	8.2	13.3	9.2	20.1	10.9	19.9	7.5	3.7	4.2	14.2	6.7	11.6	0.7	0.4	0.1	0.7	0.4	0.5	0.4	1.2	0.6	0.9	0.4	0.2	0.2	0.1	0.4	0.3	1.4	0.4	0.3	30.4	31.2	27.4	31.5	30.8	33.3	27.9	33.9	26.7	30.4	32.5	26.8	10.0	6.4	7.2	24.2	6.4	5.4	11.2	15.2	26.2	150.8	13.7	11.7	44.9	14.3	16.4	14.7	4.2	12.1	10.7	5.2	21.5	10.8	229.8	18.4	34.9	12.5	4.2	6.7	32.6	12.0	12.5	17.8	17.3	15.6	0.0	22.9	13.6	6.8	5.8	35.3	24.3	5.9	10.2	8.4	4.6	34.1	28.9	7.9	8.8	21.5	12.9	30.0	5.2	30.2	12.6	12.5	9.9	36.1	9.5	21.1	3.9	17.1	23.8	8.7	6.6	16.2	15.9	3.2	14.4	25.9	8.2	7.7	8.0	18.3	7.1	17.7
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751586	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.9;placenta: 10.8"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.4;Extravillous trophoblasts: 102.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;hTCEpi: 32.5;RPTEC TERT1: 24.2"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		6000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.1	0.5	1.0	0.2	0.7	0.0	0.9	0.7	1.2	0.8	0.7	0.2	0.2	0.6	0.6	1.2	0.5	0.2	2.6	0.8	0.8	3.5	0.1	0.6	0.2	0.9	0.7	1.3	0.5	12.9	0.0	10.8	1.0	0.4	0.4	0.0	0.4	0.8	0.0	0.3	0.1	0.2	0.9	0.5	0.4	0.7	0.8	0.0	0.4	0.0	0.4	0.5	0.6	1.0	7.6	0.3	1.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	46.9	9.9	0.0	1.0	0.1	0.7	0.5	0.0	3.4	0.0	0.0	0.4	0.0	0.1	0.5	0.6	0.0	0.0	2.1	32.5	0.0	4.8	0.0	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	3.1	3.0	1.4	0.0	0.0	0.0	24.2	0.7	2.0	0.4	3.1	1.3	0.0	4.7	4.1	0.7	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.7	1.2	0.8	0.8	0.9	0.7	1.0	0.9	0.8	1.0	0.1	0.0	0.0	0.0	0.5	0.5	1.8	2.3	2.2	0.0	2.2	1.9	2.9	0.0	0.6	7.3	0.0	74.4	0.0	0.1	0.0	2.5	4.2	0.6	0.9	1.3	0.0	0.0	0.4	0.8	102.9	1.5	0.0	1.7	0.0	2.6	0.0	0.0	7.4	0.0	0.2	0.3	2.0	0.0	0.0	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	3.7	0.0	3.0	0.1	0.0	0.0	0.2	0.5	0.2	0.4	2.8	0.1	17.4	0.0	0.2	0.4	1.4
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862317-52866835	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.6;ovary: 66.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	2.0	2.0	3.1	0.5	3.8	0.0	1.1	2.8	5.8	4.5	0.1	0.9	0.0	9.8	2.7	0.5	4.1	0.9	14.7	5.2	3.2	17.9	0.6	1.0	0.8	0.3	0.4	66.4	0.9	7.9	0.7	4.7	0.2	2.0	0.1	0.3	1.4	9.1	0.4	3.8	0.9	1.9	0.2	27.6	4.1	5.9	1.4	0.1	1.0	0.1	0.9	2.2	4.9	3.2	0.3	0.0	5.9	0.0	5.2	2.4	14.1	0.1	0.1	0.3	0.0	11.1	0.0	0.0	0.5	0.0	0.1	0.0	0.7	3.5	0.0	0.0	1.4	0.5	0.0	0.0	1.0	0.0	0.4	2.5	6.2	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.0	1.3	1.1	0.0	15.2	1.3	0.2	0.0	6.8	0.0	10.2	1.5	3.2	38.5	0.2	2.6	1.3	10.1	1.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	3.1	3.8	2.8	5.8	5.2	3.2	0.3	0.4	0.2	0.2	1.4	3.2	1.1	6.4	0.0	0.3	0.9	0.9	1.5	2.8	0.0	4.9	7.5	6.5	5.3	0.0	1.8	33.1	0.0	102.6	1.5	7.1	0.0	1.5	0.4	1.6	6.9	1.2	0.0	0.0	2.7	0.5	62.2	4.6	9.7	2.7	0.0	26.6	1.1	0.0	8.0	0.0	1.1	3.6	0.0	0.3	1.7	3.3	24.2	0.8	0.0	4.7	0.6	1.9	0.0	0.5	0.9	0.5	5.6	68.4	0.1	0.5	1.6	0.1	0.1	1.2	0.0	5.8	5.7	4.6	10.9	1.2	0.4	23.1	0.9	6.1	2.8	0.2
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366066	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 63.0;Excitatory neurons: 126.2;Inhibitory neurons: 131.6;Microglial cells: 82.4;Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	7.3	9.0	5.7	7.3	6.2	7.6	7.3	5.5	6.6	6.2	4.8	6.3	5.6	6.9	3.3	8.5	4.6	4.5	6.4	5.6	6.8	7.1	5.6	5.2	7.4	6.5	6.0	6.6	6.1	5.6	5.8	6.0	6.8	4.4	6.2	4.0	5.5	5.1	7.6	7.2	4.3	7.5	5.6	5.8	5.8	2.8	6.9	6.5	5.2	6.2	7.9	6.0	6.6	8.3	13.5	12.2	6.8	16.0	22.2	22.3	8.3	30.0	22.6	10.3	8.7	8.7	16.6	25.7	22.8	57.7	11.1	8.1	22.2	26.2	19.6	7.7	13.0	14.1	12.1	10.6	10.3	18.3	24.8	15.5	15.6	19.9	7.8	9.9	18.2	6.5	24.4	14.3	17.7	15.2	25.0	10.8	4.3	37.6	15.0	15.4	6.6	26.8	11.4	8.7	19.5	11.3	6.8	25.0	13.7	7.9	9.8	8.2	16.3	22.1	14.2	25.7	22.3	16.5	9.8	29.7	15.1	20.7	65.0	0.1	7.2	1.8	9.2	12.2	9.5	8.0	7.4	10.6	19.6	6.4	10.9	10.1	1.4	17.9	13.5	12.7	7.1	11.1	5.7	6.2	5.5	6.6	5.6	6.8	6.5	6.0	6.8	5.6	6.9	8.3	5.4	0.0	3.1	63.0	10.3	3.7	5.4	5.8	8.0	4.1	3.9	3.4	2.9	11.5	3.5	3.7	6.2	8.4	5.4	3.5	1.9	3.8	2.9	2.6	8.4	4.2	1.2	5.5	126.2	5.1	6.7	7.3	5.6	3.6	12.7	5.9	4.2	6.0	5.3	5.0	131.6	3.5	2.0	2.5	3.1	1.5	6.5	10.0	5.4	82.4	2.7	2.7	3.1	182.0	153.7	2.5	2.8	5.7	14.3	2.8	2.4	8.5	4.3	3.3	0.0	5.3	3.8	5.4	3.5	10.5	5.4	4.2	6.8	16.4	4.9	3.5
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377641-53460862	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	19.1	15.7	5.8	14.8	5.9	31.8	17.0	11.3	8.7	18.4	1.2	14.3	11.7	17.9	12.7	15.9	16.0	11.0	13.0	4.9	9.9	13.3	13.7	14.2	20.2	4.8	5.1	22.0	9.7	16.4	9.7	21.1	4.9	12.3	15.1	17.0	14.7	11.4	25.8	17.9	14.4	15.9	4.6	14.8	14.4	31.4	7.0	29.4	14.6	11.7	23.3	17.5	16.2	8.7	43.7	29.5	51.8	32.6	36.4	31.9	63.5	52.8	64.0	45.1	35.0	43.2	37.8	79.5	42.6	47.2	44.4	26.7	55.6	37.9	55.8	27.0	31.0	60.0	25.5	40.7	51.2	95.4	53.6	31.2	35.6	51.6	49.8	42.0	32.3	47.7	71.3	34.3	34.1	33.3	88.5	44.4	35.9	53.7	28.8	79.2	22.0	36.9	33.9	34.7	40.8	41.5	37.6	40.3	65.1	47.0	25.2	33.6	33.9	44.2	39.7	39.9	67.2	43.3	27.8	100.8	38.4	59.2	84.3	45.2	23.3	51.4	32.5	25.0	38.8	34.8	33.0	32.9	31.9	32.3	36.6	32.3	28.3	50.7	37.0	46.5	45.9	33.1	5.8	5.9	11.3	8.7	4.9	9.9	4.8	5.1	4.9	4.6	7.0	8.7	36.1	25.6	25.4	47.0	50.4	38.7	46.6	41.5	30.1	41.2	24.0	25.4	14.4	21.5	34.1	27.6	18.8	58.7	54.0	26.9	37.2	45.8	10.3	37.6	51.1	33.4	36.6	29.2	78.8	34.9	52.2	41.9	29.6	41.6	49.4	40.0	28.5	21.2	33.2	77.4	78.7	27.0	32.6	19.8	24.6	15.2	66.8	32.2	32.0	60.9	41.3	48.6	29.9	137.7	91.4	36.9	33.3	53.4	40.3	36.5	25.2	23.3	44.8	30.3	39.5	38.9	46.9	118.5	87.6	31.8	34.1	86.3	49.8	56.8	29.4	38.5
AC058822.1		ENSG00000282278	"Novel FIP1L1-PDGFRA fusion protein"		4	53377839-54295272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.7;BJ hTERT+: 10.2;fHDF/TERT166: 17.2;HSkMC: 9.8;U-138 MG: 5.4;U-2197: 7.7"									HPA058202			Supported	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA058202: AB_2683636"																		0.9	0.0	1.0	2.0	1.5	0.0	0.0	0.4	1.7	0.3	1.5	0.4	0.5	0.3	0.0	1.3	0.1	0.4	1.6	0.9	0.7	0.3	0.3	0.8	0.0	1.6	0.7	1.2	0.8	0.0	0.0	1.2	1.3	0.2	0.0	0.8	0.0	0.0	0.3	0.0	1.0	0.9	0.5	0.2	0.8	2.2	0.5	0.1	0.0	2.0	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.8	4.7	0.0	1.5	10.2	0.0	0.1	0.9	0.0	0.0	0.0	17.2	0.0	0.0	1.5	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.8	0.0	3.8	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.1	5.4	0.1	7.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.5	0.4	1.7	0.9	0.7	1.6	0.7	1.3	0.5	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 2.7;basal ganglia: 6.0;cerebral cortex: 10.3;hippocampal formation: 7.5;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	21.9	2.5	2.7	2.1	6.0	1.0	14.3	0.1	10.3	6.1	0.0	6.7	9.4	4.2	0.6	24.4	6.4	5.5	8.7	7.5	0.1	10.6	4.4	2.7	2.1	0.0	0.1	2.1	16.3	11.9	4.3	24.6	0.4	5.9	6.9	3.8	25.1	7.2	5.9	11.8	9.0	3.0	0.0	0.9	9.5	4.4	0.6	3.3	17.9	12.0	4.1	4.3	7.9	3.1	1.4	0.5	1.6	0.9	2.7	5.8	8.0	1.2	0.6	0.0	0.0	2.9	8.9	1.7	1.1	4.3	0.4	1.4	0.0	0.2	0.0	0.4	4.6	2.2	1.5	1.5	1.3	2.4	0.7	4.4	0.2	0.3	0.0	1.9	2.7	0.8	1.9	0.8	6.4	4.5	2.2	1.7	4.3	17.7	0.7	1.2	0.6	0.7	5.6	8.2	2.2	2.1	0.6	10.8	0.9	9.1	5.7	1.1	7.8	10.0	2.6	3.1	1.6	3.6	0.5	1.1	8.7	2.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.2	0.2	0.0	2.7	6.0	0.1	10.3	7.5	0.1	0.0	0.1	0.4	0.0	0.6	3.1	77.5	0.0	3.9	4.9	1.7	8.2	18.0	14.5	24.5	7.5	13.3	7.1	1.6	12.8	15.5	7.3	6.2	30.6	1.5	18.5	19.6	13.7	171.7	37.7	7.6	16.0	13.8	3.6	123.8	11.7	22.1	4.8	14.3	83.0	2.5	1.5	2.9	6.2	2.5	42.1	42.2	13.4	14.2	0.3	2.1	47.9	4.4	1.3	5.4	11.2	0.4	2.2	2.1	43.7	4.0	12.3	26.5	8.6	0.9	8.5	14.5	2.9	17.9	5.8	0.0	10.0	2.2	0.9	2.6	32.2	11.9	14.9	1.9	1.4	14.2	15.2
CHIC2	BTL	ENSG00000109220	"Cysteine rich hydrophobic domain 2"	Q9UKJ5	4	54009789-54064605	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 348.7;Suprabasal keratinocytes: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 365.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA026784, HPA076603"	Uncertain		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"		"HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317"	"unprognostic (4.56e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.47e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.40e-2)"	20.8	15.9	9.1	12.9	8.5	27.1	18.1	12.6	9.6	16.0	12.1	12.4	12.3	12.3	10.3	27.4	12.1	20.5	15.1	8.6	9.2	14.2	20.3	19.7	14.7	8.6	8.5	13.0	9.9	6.5	9.3	13.5	9.0	12.9	8.9	5.9	15.2	5.7	9.8	27.5	13.2	10.5	7.8	17.3	12.9	39.6	9.2	21.9	11.9	6.6	13.3	15.1	18.1	9.7	25.4	4.6	12.8	11.9	21.5	16.8	13.1	34.6	36.1	20.1	20.3	18.1	22.0	21.4	29.5	22.0	17.2	7.7	17.9	25.1	22.0	11.9	9.5	11.7	4.2	13.6	65.1	19.2	23.4	22.6	19.8	30.3	45.3	38.3	30.0	22.2	13.0	15.4	40.6	7.1	22.3	30.7	8.7	11.2	16.9	14.3	7.3	8.4	23.3	8.1	19.7	18.3	8.3	12.2	26.6	18.3	6.1	26.8	51.3	25.2	19.9	36.6	21.4	18.4	9.5	17.2	18.7	18.7	18.7	365.5	79.3	171.5	60.1	64.7	57.7	41.3	60.0	68.6	55.9	40.1	54.6	59.6	325.0	74.2	68.3	47.0	81.5	77.9	9.1	8.5	12.6	9.6	8.6	9.2	8.6	8.5	9.0	7.8	9.2	9.7	58.1	6.4	7.3	35.6	42.5	348.7	95.5	61.0	68.3	8.1	61.6	33.5	4.1	15.7	25.9	7.3	8.4	27.8	57.8	27.2	17.6	42.8	55.4	64.1	58.0	64.3	25.8	72.6	39.7	28.0	38.7	80.8	32.6	34.2	36.3	36.8	38.6	23.9	24.7	13.5	40.2	21.9	40.7	36.4	144.2	13.4	17.1	50.3	67.6	49.6	32.6	9.0	28.8	74.4	23.2	61.8	42.1	24.5	40.2	85.1	41.9	29.2	56.0	7.2	19.7	53.9	45.1	163.5	89.9	97.4	373.8	47.7	65.8	39.8	21.0	135.9
GSX2	Gsh2	ENSG00000180613	"GS homeobox 2"	Q9BZM3	4	54099523-54102498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"glioma: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 43: Cardiomyocytes - Nuclear processes"								"unprognostic (4.48e-2)"						"unprognostic (1.05e-1)"				"unprognostic (7.01e-2)"	"unprognostic (1.89e-1)"		0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.6	0.2	0.2	0.2	0.2	0.4	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346213-55373100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 79.6"					"Low region specificity"	"Detected in all"			HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	12.5	12.0	10.4	2.5	11.5	3.7	12.2	11.0	12.4	12.9	9.2	7.3	3.8	6.8	4.2	26.1	5.6	10.3	9.3	10.7	10.1	9.6	14.5	10.5	2.5	11.0	11.2	3.1	20.2	7.0	5.9	4.0	10.8	7.4	4.1	1.5	16.4	2.9	6.3	15.4	7.0	2.6	10.9	6.8	9.7	3.3	10.9	6.0	7.6	5.4	6.0	10.0	14.7	12.7	9.7	4.3	10.3	10.1	29.4	20.4	5.6	10.4	9.3	2.4	5.4	6.5	19.5	21.2	11.7	11.0	11.1	7.0	5.3	7.9	3.9	6.6	17.1	12.3	5.2	15.8	9.2	23.7	6.1	17.6	14.5	5.4	5.3	7.8	14.4	38.5	21.2	47.7	21.1	10.8	36.0	10.3	13.0	53.2	9.3	11.4	3.3	14.0	12.8	7.9	16.0	9.1	10.7	79.6	8.3	9.0	9.4	17.9	8.3	25.0	4.7	2.0	8.1	28.6	15.8	7.9	34.1	29.5	25.9	25.6	35.8	11.7	16.1	56.5	18.6	12.5	12.0	15.2	30.2	12.7	10.2	14.4	1.8	8.6	59.5	61.7	12.5	23.1	10.4	11.5	11.0	12.4	10.7	10.1	11.0	11.2	10.8	10.9	10.9	12.7	25.4	9.6	15.9	4.6	7.8	13.6	13.3	245.5	5.2	4.9	43.8	29.3	5.3	34.3	245.2	5.5	4.2	27.0	21.2	12.2	3.9	93.4	3.2	51.2	31.0	19.6	12.0	14.9	11.1	105.4	106.0	16.2	13.3	105.9	14.0	6.7	17.5	18.6	63.4	10.1	17.1	22.6	57.0	32.4	34.1	0.5	1.8	27.6	24.9	4.7	31.3	21.9	18.6	8.5	23.4	155.5	10.0	5.7	16.8	17.5	9.4	18.4	195.0	3.9	13.1	13.3	28.2	3.5	20.1	32.7	29.7	7.5	7.2	15.4	23.3	108.6
AC064824.1		ENSG00000288695	"Novel protein, SRD5A3-RP11-177J6.1 readthrough"		4	55346228-55388368	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.9;skeletal muscle: 2.9"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.5;JURKAT: 2.1;U-266/70: 1.9"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 40: NK-cells - Unknown function"		"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"																						0.1	0.0	1.2	0.1	1.8	0.0	0.4	1.2	1.6	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.1	0.5	0.2	1.2	1.0	0.1	0.1	0.2	0.1	1.2	1.5	0.1	0.3	0.1		0.1	1.5	0.2	0.1	0.6	0.2	0.2	2.9	0.5	0.0	0.2	1.1	0.2	0.2	0.6	1.2	0.4	0.0	1.6	0.1	0.2		1.9	0.0	0.3	0.2	0.2	1.5	0.7	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.5	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.4	0.2	0.5	0.2	0.0	0.2	0.2	0.2	2.1	0.4	0.8	0.2	0.2	1.2	0.2	0.4	0.3	0.1	0.4	0.0	0.2	0.1	0.0	0.4	0.1	0.1	0.9	0.2	0.1	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.9	0.6	0.0	0.3	0.6	0.6	0.0	0.1	0.0	0.2	0.7	0.0	0.3	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.1	0.3	1.2	1.8	1.2	1.6	1.2	1.0	1.2	1.5	1.5	1.1	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 1021.6;Urothelial cells: 601.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	53.4	61.3	39.2	42.6	75.1	11.3	35.2	62.0	70.8	45.9	36.0	32.4	32.0	34.0	31.1	55.8	31.6	46.0	37.3	40.8	51.1	41.6	19.3	52.7	32.6	84.8	72.0	22.3	40.1	32.3	24.0	60.5	78.9	37.8	33.3	15.0	40.4	30.6	17.1	26.2	27.9	40.0	54.5	37.0	39.2	13.7	65.8	24.0	37.8	17.2	42.5	78.8	42.7	117.4	74.6	30.4	47.1	50.2	143.5	105.4	50.0	138.6	212.7	98.0	106.7	34.2	108.3	76.9	98.3	85.9	56.2	53.8	50.0	56.8	98.9	43.8	46.4	66.0	50.1	66.6	89.1	92.1	75.1	109.1	72.7	55.9	37.3	82.4	113.2	25.6	112.8	47.8	116.5	54.5	73.0	76.5	51.7	97.8	70.6	52.0	35.5	42.1	148.6	70.2	48.3	64.7	69.8	261.0	85.8	46.3	41.2	65.3	98.3	83.1	49.6	37.0	102.5	44.4	38.5	48.3	98.9	77.2	67.9	23.7	40.4	26.0	15.2	35.7	17.0	19.0	14.3	17.8	36.5	11.5	12.1	14.4	28.6	18.1	35.9	28.4	18.3	30.2	39.2	75.1	62.0	70.8	40.8	51.1	84.8	72.0	78.9	54.5	65.8	117.4	119.6	54.5	52.4	42.7	87.9	245.1	277.8	295.0	147.4	50.6	85.8	42.7	32.2	71.4	214.9	79.1	81.3	112.5	97.7	42.4	17.6	171.1	32.1	123.6	99.1	108.0	50.4	79.1	58.2	163.5	157.2	110.4	76.0	173.8	21.0	57.6	113.8	18.4	105.7	28.6	71.5	69.4	77.3	97.9	145.7	24.7	58.7	109.5	88.9	59.0	117.5	53.2	123.6	71.4	1021.6	248.0	48.6	63.6	117.1	239.3	51.3	50.0	125.2	91.9	98.6	92.2	129.0	37.8	24.6	169.4	268.8	80.6	81.6	90.6	61.6	601.6
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55546909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	5.5	6.1	3.7	4.2	4.2	1.3	5.9	8.9	5.4	8.0	5.5	5.1	4.9	6.9	5.7	9.2	5.3	4.3	7.5	4.7	5.3	6.5	5.5	4.6	2.9	2.8	3.7	6.2	5.1	10.3	5.5	5.5	3.3	6.2	5.7	11.6	4.6	6.1	9.8	6.8	5.6	7.1	3.8	4.5	6.9	14.1	3.8	3.0	10.1	9.2	3.7	5.6	6.8	5.0	20.0	9.1	7.5	11.6	11.8	11.5	3.6	18.7	16.4	12.9	12.7	5.1	14.8	5.1	9.9	22.8	10.3	15.9	9.5	15.4	23.2	6.9	3.1	4.4	9.4	6.7	10.3	7.0	4.7	6.7	15.8	18.8	18.7	10.4	13.1	4.6	10.1	10.1	21.3	10.6	4.0	4.1	5.0	16.3	9.4	2.5	8.7	3.3	11.0	10.9	7.6	6.2	13.5	16.7	8.9	6.2	5.7	4.2	17.1	18.4	19.5	6.0	26.6	9.1	7.5	3.1	15.6	5.8	14.6	0.0	0.7	0.2	0.7	0.7	1.3	0.4	0.9	0.8	1.1	0.7	0.4	0.6	0.2	0.9	0.7	0.5	0.9	0.4	3.7	4.2	8.9	5.4	4.7	5.3	2.8	3.7	3.3	3.8	3.8	5.0	32.2	41.7	27.7	49.3	15.2	31.1	21.8	28.5	27.9	63.4	21.5	14.9	55.2	14.3	27.4	14.7	43.8	11.3	11.9	21.5	1.9	13.6	34.5	34.2	39.9	32.1	39.7	3.8	95.9	16.5	6.8	28.0	25.0	32.0	3.8	16.6	28.9	27.7	11.6	33.7	114.6	18.5	18.3	17.0	26.1	16.9	23.9	16.9	10.6	70.3	14.0	26.7	19.6	82.0	93.1	28.3	13.2	36.1	18.5	34.0	29.6	19.7	25.2	41.4	13.1	36.5	28.2	64.9	72.5	55.1	37.5	5.2	14.0	21.7	15.6	51.6
PDCL2	GCPHLP	ENSG00000163440	"Phosducin like 2"	Q8N4E4	4	55556519-55592245	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	197	"testis: 65.1"	"Group enriched"	"Detected in some"	19	"Early spermatids: 1285.9;Late spermatids: 634.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0;testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HaCaT: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048260, HPA072384"	Enhanced		Approved	Microtubules,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Microtubules	Centrosome	"HPA048260: AB_2680333, HPA072384: "		"unprognostic (5.93e-3)"		"unprognostic (1.19e-7)"		"unprognostic (1.04e-1)"				"unprognostic (3.01e-3)"				"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.41e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	65.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1285.9	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	634.7	7.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	13.1	0.0	0.1	40.4	50.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.2;skin 1: 38.5;vagina: 30.7"	"Group enriched"	"Detected in many"	4	"Squamous epithelial cells: 212.4;Suprabasal keratinocytes: 73.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 90.2;HaCaT: 382.6;K-562: 311.3;Karpas-707: 135.7"	"Group enriched"	"Detected in some"	8	"hypothalamus: 1.1;pons and medulla: 4.5"	"Low region specificity"	"Detected in some"			HPA025926	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.4	0.7	0.5	9.7	1.5	0.6	1.1	12.3	0.0	1.4	0.8	0.1	0.0	100.2	0.2	0.0	0.2	0.3	2.8	0.2	0.0	0.8	0.5	1.1	2.6	0.1	0.1	0.0	2.3	0.8	0.8	0.2	0.8	0.1	14.3	0.2	0.1	38.5	1.4	0.2	3.0	0.1	4.0	2.2	6.8	1.7	2.5	0.0	7.7	0.1	30.7	0.4	41.3	0.3	22.1	5.6	0.0	0.0	0.0	0.0	0.0	2.9	7.8	0.3	61.5	90.2	8.6	0.0	8.5	382.6	46.1	3.3	2.3	5.6	25.1	0.6	36.0	0.0	0.0	0.0	0.3	0.0	4.2	0.0	3.0	10.0	0.4	6.4	311.3	135.7	0.3	9.9	1.2	0.2	11.7	7.5	11.4	0.2	0.0	0.5	1.9	0.4	19.5	49.0	30.9	0.8	0.1	4.2	20.9	0.1	2.7	0.2	27.5	0.3	54.5	39.1	0.3	0.0	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.6	1.1	0.3	2.8	1.1	2.6	0.8	3.0	6.8	0.4	0.0	0.0	2.3	0.0	0.6	16.3	0.6	16.2	4.0	0.2	0.9	1.3	0.1	0.0	8.0	0.0	0.0	2.0	0.0	0.6	0.0	0.1	0.4	3.9	0.3	0.7	0.0	14.5	0.2	0.2	0.1	4.4	29.6	5.8	1.3	0.9	0.0	0.1	0.3	0.0	17.2	0.8	20.3	0.0	1.6	0.3	0.0	0.2	3.6	0.0	0.1	2.0	0.0	1.0	0.2	2.4	0.2	0.0	1.2	0.4	0.0	0.0	7.0	0.0	0.0	0.0	1.2	5.8	10.0	212.4	73.6	0.1	0.7	0.2	2.6	12.0
EXOC1L		ENSG00000250821	"Exocyst complex component 1 like"	A0A1B0GW35	4	55819790-55837489	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"Theca cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 1.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.8"	"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"																					0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853648-55905086	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	19.7	16.5	18.1	17.3	20.4	12.7	20.0	20.4	20.0	18.9	18.7	18.0	16.8	16.6	20.4	29.3	16.5	15.5	16.5	18.3	20.0	15.9	10.2	17.4	18.3	21.1	19.2	15.1	12.9	20.5	14.5	20.8	20.3	14.3	19.1	18.5	17.4	12.8	13.6	28.1	16.2	15.7	20.4	20.8	15.6	16.9	20.1	13.9	16.3	13.5	20.0	16.2	20.1	25.1	21.8	12.4	21.9	25.3	36.9	45.9	14.6	30.2	30.1	24.1	25.1	8.6	37.1	20.9	20.6	32.6	29.1	25.4	18.0	23.9	34.5	11.1	12.4	19.4	14.8	10.1	34.7	21.3	26.4	37.4	32.1	25.1	27.6	31.2	39.9	16.0	28.3	20.1	53.0	13.8	15.6	21.5	13.9	31.2	23.4	18.0	16.4	17.1	26.9	23.6	16.2	28.7	18.0	29.2	25.5	18.5	18.6	22.6	48.5	29.7	24.2	25.8	26.3	23.9	12.7	18.4	38.6	23.4	28.8	21.3	14.6	13.1	6.5	19.0	8.8	8.4	9.2	9.5	14.3	8.3	8.3	6.0	19.5	12.5	23.6	6.4	11.6	7.9	18.1	20.4	20.4	20.0	18.3	20.0	21.1	19.2	20.3	20.4	20.1	25.1	44.7	41.7	38.0	77.4	24.5	34.8	14.8	34.0	22.2	48.8	26.4	21.2	29.1	17.2	35.6	22.0	31.3	60.8	21.4	38.3	19.6	23.6	45.3	41.0	47.5	39.0	22.2	19.6	72.6	20.0	31.6	28.9	22.4	37.2	36.7	35.5	40.0	12.3	40.9	28.6	86.5	28.8	24.4	37.7	47.4	16.7	21.5	37.8	40.9	56.2	38.7	40.3	22.6	73.4	138.0	36.2	32.4	23.7	19.0	17.4	37.6	21.9	44.7	32.5	32.9	25.9	27.9	47.6	31.6	42.5	39.9	51.2	27.8	44.6	28.7	26.8
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033361	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.3;monocytes: 64.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (6.11e-5)"	2.6	1.6	1.0	7.2	1.3	10.1	2.8	2.1	1.6	3.5	1.9	2.4	3.1	7.6	2.1	2.0	3.3	3.1	1.4	1.2	1.3	4.0	1.3	3.2	10.2	1.7	1.5	5.0	1.7	2.0	1.2	5.9	1.7	2.3	3.2	3.7	1.5	1.6	0.8	3.9	3.3	5.0	1.0	5.7	2.2	6.4	2.0	9.5	2.6	1.3	7.6	2.9	2.2	1.9	8.9	4.8	13.0	12.3	2.6	5.0	5.5	8.6	6.1	7.7	9.0	5.2	9.0	23.7	6.4	3.8	6.0	4.0	13.8	5.2	14.6	6.5	8.4	8.3	7.6	4.9	2.9	15.2	12.6	3.9	4.1	9.9	7.0	3.4	6.5	11.9	15.4	11.0	8.1	5.2	21.3	9.5	8.3	4.4	4.9	15.4	6.1	4.8	5.6	6.4	9.3	9.6	7.7	5.2	6.4	7.8	6.9	9.7	6.5	10.4	17.0	12.5	15.1	5.9	4.4	15.7	5.2	11.8	13.1	9.9	2.1	2.9	3.0	2.8	2.8	3.0	3.9	2.9	1.5	5.6	5.0	3.1	4.3	4.7	3.2	5.6	2.7	1.4	1.0	1.3	2.1	1.6	1.2	1.3	1.7	1.5	1.7	1.0	2.0	1.9	16.3	6.4	12.4	7.8	30.2	9.1	8.2	6.3	7.4	12.6	5.6	6.6	8.5	2.8	9.4	7.3	10.4	20.0	27.3	5.2	3.9	9.4	92.3	23.1	14.6	18.2	5.4	28.2	10.0	5.4	16.3	11.5	3.1	13.0	14.5	38.2	12.5	1.7	10.4	26.9	10.4	5.5	6.1	12.9	11.3	19.4	5.9	19.2	5.4	19.7	64.5	4.3	32.0	8.0	13.9	15.6	6.7	8.2	16.7	5.2	3.0	10.0	17.4	24.5	6.6	16.2	11.2	57.3	38.7	6.8	6.7	9.6	20.0	34.6	5.7	6.3
CRACD	"CRAD, KIAA1211"	ENSG00000109265	"Capping protein inhibiting regulator of actin dynamics"	Q6ZU35	4	56049073-56328625	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;intestine: 19.7;testis: 29.6"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.7;SH-SY5Y: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		59000		"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	0.5	2.3	6.6	3.1	9.6	3.9	0.3	8.7	5.6	1.6	0.0	9.5	13.8	3.5	4.2	0.5	2.9	11.3	0.8	5.7	12.8	0.7	0.6	1.0	2.2	18.8	13.3	1.2	1.8	6.3	0.9	0.6	19.1	1.7	8.1	4.1	1.0	3.5	0.0	0.5	19.7	4.4	8.7	2.5	2.7	29.6	11.9	0.6	0.1	0.2	1.9	1.3	1.2	6.2	0.0	2.9	11.2	0.9	0.3	0.0	4.1	0.1	0.4	0.5	1.2	3.4	0.4	10.2	0.3	0.0	9.1	0.0	9.6	0.2	0.3	0.9	5.6	5.7	5.1	0.5	1.6	4.8	0.8	0.4	0.2	0.0	0.1	3.6	5.3	9.1	0.0	9.8	0.1	1.4	7.1	0.4	6.0	8.7	7.2	6.8	6.1	0.2	0.1	2.6	26.7	56.7	1.0	0.3	6.9	9.4	2.4	0.5	2.1	0.3	2.8	0.7	2.6	9.7	6.9	0.1	2.8	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	9.6	8.7	5.6	5.7	12.8	18.8	13.3	19.1	8.7	11.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AASDH	"ACSF4, LYS2, NRPS998"	ENSG00000157426	"Aminoadipate-semialdehyde dehydrogenase"	Q4L235	4	56338287-56387508	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036472, HPA036473"	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA036472: AB_2675142, HPA036473: AB_10673656"	"unprognostic (1.95e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.85e-3)"	4.3	4.9	3.9	4.7	4.6	4.5	8.4	6.1	4.2	5.8	4.0	4.5	4.5	6.4	8.1	4.6	7.0	4.4	3.7	3.6	4.2	6.7	6.5	4.5	6.4	4.5	4.5	8.4	3.8	7.2	4.2	5.0	4.6	6.4	5.8	11.8	5.6	5.4	4.2	7.1	4.2	5.7	4.1	5.9	4.7	5.0	4.3	6.2	7.1	4.2	6.7	4.3	4.3	5.3	5.0	3.3	8.6	6.6	12.8	14.7	5.3	6.2	7.5	6.3	5.4	3.8	10.2	10.9	5.7	6.8	4.8	3.1	6.3	6.3	7.0	4.4	6.3	5.1	6.3	4.9	11.4	9.4	3.7	8.5	10.2	6.7	10.0	9.1	9.8	6.9	11.9	5.4	7.2	4.9	11.1	7.8	4.8	9.1	4.8	8.2	4.2	5.1	9.0	4.2	5.7	5.5	7.1	11.2	7.2	8.1	8.9	6.0	6.7	4.2	5.6	4.4	4.5	4.3	3.6	7.1	6.6	8.4	4.6	0.0	2.0	1.6	2.8	2.5	3.7	2.4	2.8	2.4	2.2	3.0	4.0	3.0	0.4	2.8	1.6	1.9	2.9	1.3	3.9	4.6	6.1	4.2	3.6	4.2	4.5	4.5	4.6	4.1	4.3	5.3	14.1	6.4	16.2	59.4	17.3	10.1	13.9	26.0	13.6	38.7	21.7	21.2	10.1	14.3	17.3	18.4	27.1	40.7	22.8	9.4	25.4	9.9	26.0	22.0	28.6	13.9	12.1	24.0	26.9	7.6	19.4	17.9	14.8	21.0	20.3	26.4	19.6	21.9	15.4	35.3	36.7	14.7	22.4	17.6	8.7	5.2	16.8	12.6	10.6	19.7	21.5	31.3	20.6	36.2	39.1	6.0	13.4	18.0	9.9	14.2	8.0	29.2	11.2	56.4	6.6	22.5	11.9	43.3	35.0	13.6	15.6	23.9	16.5	23.8	15.9	8.1
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No		11000	"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	2.8	6.1	3.8	5.4	4.0	5.6	7.1	3.7	4.7	4.3	3.6	3.9	4.0	4.6	3.4	4.5	4.4	3.0	2.3	4.1	4.0	6.0	6.1	2.2	8.4	3.4	4.0	7.4	5.9	3.9	2.5	6.7	4.3	3.9	4.8	4.4	5.6	3.1	2.9	4.3	3.2	3.6	3.7	4.3	3.5	8.6	4.1	8.3	5.9	2.9	8.0	6.7	2.6	4.2	23.1	19.0	38.0	18.7	12.2	15.7	31.0	25.2	11.1	20.4	21.6	38.1	27.5	80.6	33.4	11.9	19.0	16.8	74.0	25.4	40.7	21.1	32.8	32.6	22.6	42.2	18.4	65.0	19.5	13.6	19.4	29.0	32.4	12.6	21.8	32.5	83.5	43.3	23.2	20.9	80.6	49.1	50.6	52.0	22.4	67.2	24.9	56.9	34.2	16.2	64.0	31.2	20.1	36.3	23.0	35.4	24.5	13.8	15.3	21.2	36.6	21.4	45.0	32.2	34.5	82.9	23.6	40.7	20.1	4.7	1.8	0.9	3.8	2.7	5.9	7.4	5.1	5.2	2.5	6.1	7.7	7.1	0.5	10.2	3.9	3.2	4.3	3.5	3.8	4.0	3.7	4.7	4.1	4.0	3.4	4.0	4.3	3.7	4.1	4.2	4.8	0.0	5.5	16.6	10.7	31.0	16.0	5.6	28.5	8.4	10.1	9.7	3.8	4.3	8.0	3.7	2.1	29.7	10.3	1.5	9.8	3.7	2.6	5.5	14.1	7.8	4.2	14.9	22.9	2.7	25.2	9.4	4.1	6.9	7.0	66.2	5.3	7.1	7.9	38.7	15.8	4.3	4.1	1.6	6.0	2.6	7.8	5.2	8.8	5.6	3.1	6.4	2.1	5.5	9.1	3.3	2.7	5.7	15.3	15.0	0.8	12.7	6.2	4.7	0.0	9.3	10.8	16.4	27.5	18.3	31.8	7.7	10.7	21.9	9.0	8.7
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 157.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		490000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	24.5	40.2	22.7	40.1	26.7	46.8	54.6	28.3	25.0	29.3	21.6	42.8	32.1	29.7	22.1	36.3	35.4	17.8	19.7	20.3	27.8	42.7	109.7	14.1	51.3	26.0	30.1	30.7	21.7	39.5	17.7	45.9	26.1	31.0	54.7	30.4	26.4	25.8	32.4	37.6	30.8	35.7	25.6	18.3	20.7	29.5	26.8	56.4	32.4	24.1	64.5	37.4	25.4	27.2	239.3	175.3	354.3	220.6	74.3	166.1	304.0	201.7	145.1	282.5	276.0	280.5	275.7	548.0	228.3	136.0	154.1	143.6	565.5	293.0	480.8	110.4	198.8	298.7	259.5	313.4	141.8	537.1	127.6	141.9	207.9	301.0	225.0	155.7	235.4	308.6	524.7	198.5	246.8	159.3	621.5	267.2	407.5	454.8	216.5	496.2	151.7	361.5	268.4	164.5	378.8	226.4	198.6	273.7	124.3	287.2	181.2	169.8	127.7	222.6	290.1	221.8	419.0	139.1	128.2	571.1	234.8	385.2	251.0	6.0	5.2	0.4	5.2	8.7	15.0	17.8	14.4	9.2	15.3	11.0	17.4	15.5	1.1	15.9	6.9	17.0	11.2	8.7	22.7	26.7	28.3	25.0	20.3	27.8	26.0	30.1	26.1	25.6	26.8	27.2	16.4	22.4	22.9	17.0	35.7	56.6	71.9	66.0	54.1	27.4	35.8	37.5	23.3	50.1	32.3	33.1	6.2	134.4	15.3	20.5	37.2	45.0	69.4	15.2	49.1	25.1	24.7	80.8	9.1	26.3	157.5	34.2	15.3	23.3	21.0	69.1	13.2	78.7	51.5	28.6	14.6	41.0	34.6	16.1	17.2	10.6	29.8	16.1	17.8	6.5	20.2	14.0	6.2	13.0	12.2	27.4	18.6	23.3	48.1	81.7	15.9	47.7	17.9	24.6	0.0	31.3	29.2	40.0	50.3	53.1	50.4	54.6	16.8	66.4	69.7	48.9
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467617-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA		23000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	37.7	31.6	13.9	41.2	15.0	73.5	49.8	15.1	18.1	41.4	20.5	39.1	29.3	40.8	29.5	42.3	33.0	33.5	25.2	14.2	19.1	33.4	45.4	32.1	49.5	14.9	18.8	45.0	47.7	43.4	16.4	48.3	16.8	31.1	41.1	27.3	43.8	32.7	33.3	34.3	31.6	44.6	15.9	39.1	33.6	27.2	14.9	52.8	54.3	35.7	55.6	46.6	23.7	18.6	109.1	82.0	101.6	98.7	63.2	90.0	98.0	157.2	125.0	129.3	102.7	91.2	120.5	167.6	105.6	132.2	68.2	61.1	126.9	133.4	152.3	44.3	74.0	146.4	90.3	86.0	115.7	284.4	116.3	85.8	175.9	138.0	243.3	112.1	117.1	126.4	216.1	157.0	124.9	84.2	168.6	73.9	88.2	135.1	86.1	149.2	81.9	127.0	88.5	101.7	62.9	104.5	99.8	193.4	88.5	81.3	77.0	102.3	142.7	106.8	143.3	110.4	165.2	111.8	56.9	181.2	114.9	148.3	132.2	43.0	64.3	38.7	50.4	70.8	65.1	52.8	50.9	51.1	82.1	48.5	49.4	49.9	8.4	59.5	57.5	61.4	60.8	58.7	13.9	15.0	15.1	18.1	14.2	19.1	14.9	18.8	16.8	15.9	14.9	18.6	78.5	73.7	72.5	17.0	84.7	97.3	93.7	103.5	47.3	61.6	65.8	80.4	45.2	54.3	87.9	27.6	18.8	120.8	97.0	30.5	66.5	121.1	86.3	38.9	87.2	83.7	53.2	113.8	30.2	131.2	197.3	84.0	39.3	73.3	101.9	94.5	63.9	80.1	100.4	57.2	32.4	94.8	69.2	109.4	78.9	116.1	65.3	83.4	58.7	28.1	122.4	54.5	72.1	29.1	35.6	111.8	48.7	66.5	156.6	131.7	43.5	71.1	54.6	37.7	39.5	92.9	106.7	48.2	86.5	73.2	100.9	166.5	71.1	111.0	89.0	115.2
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56524959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.9"	"Group enriched"	"Detected in many"	17	"Early spermatids: 100.7;Late spermatids: 292.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 2.8;REH: 7.5;SCLC-21H: 7.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria	Nucleoli	"HPA072942: AB_2686561"	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	0.2	1.1	1.2	0.2	1.3	2.2	0.8	1.4	1.6	1.5	4.2	1.2	0.3	1.4	0.4	0.5	0.5	1.0	0.2	1.1	1.4	0.2	0.1	0.2	0.2	2.2	1.4	1.4	0.1	0.1	1.2	0.0	1.3	1.0	0.2	0.4	0.8	1.6	0.2	2.1	0.5	1.7	1.0	0.1	0.4	12.9	1.5	0.4	0.4	0.0	0.2	0.6	1.9	1.3	0.0	0.1	0.3	0.2	0.6	1.7	0.0	0.6	0.3	1.3	1.2	0.1	0.5	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.3	2.8	0.4	1.2	0.1	0.4	1.3	0.0	0.0	0.3	1.1	0.0	0.1	0.0	1.6	0.0	0.8	7.5	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.2	1.3	1.4	1.6	1.1	1.4	2.2	1.4	1.3	1.0	1.5	1.3	0.4	0.0	1.1	0.3	0.0	6.0	1.3	3.6	1.8	0.1	2.6	2.5	0.1	1.5	0.3	1.8	0.0	0.1	0.1	0.0	0.0	0.6	100.7	2.5	2.0	0.7	0.0	0.0	3.3	0.2	0.1	3.0	0.0	2.9	0.0	2.0	0.4	0.0	0.1	0.0	2.4	0.8	0.0	0.8	0.3	292.4	1.5	0.2	5.4	0.0	0.0	0.9	0.0	3.0	1.7	0.8	0.1	1.2	0.0	1.6	0.1	0.7	0.4	0.1	0.0	1.3	0.9	11.5	1.2	0.0	1.6	0.0	0.2	1.6	0.6	0.3
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530606-56603507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 3.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 27.3;Late spermatids: 20.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA066627, HPA068093"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA066627: , HPA068093: AB_2685951"	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.5	0.0	0.1	0.1	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.3	0.0	0.0	0.1	0.0	1.3	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	20.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 716.7;skin 1: 1439.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8"	"Cancer enhanced"	"Detected in many"		"glioma: 43.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 518.2;NK-cell: 781.6"	"Group enriched"	"Detected in all"	15	"NK-cells: 781.6;T-cells: 518.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	9.5	33.7	212.8	27.7	235.6	12.1	112.2	215.4	322.0	250.1	239.2	30.5	17.2	19.1	541.4	716.7	10.5	35.1	48.8	237.4	212.0	24.0	2.9	372.8	18.4	237.6	211.6	9.4	5.3	13.3	11.7	59.6	218.5	26.9	7.0	22.1	172.0	64.7	19.2	1439.9	11.3	115.6	238.8	11.9	33.9	45.3	215.0	15.8	224.5	31.8	190.4	34.1	368.6	234.2	0.0	0.0	0.0	0.0	5.0	15.7	5.9	0.0	0.0	1.4	1.0	0.0	0.0	12.6	0.7	0.3	2.3	2.2	1.4	0.0	1.9	31.2	0.2	0.1	0.0	0.0	2.0	0.0	0.1	2.6	11.9	3.6	0.0	3.4	66.9	0.0	0.0	0.5	3.2	0.5	0.1	1.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	50.5	1.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	76.2	0.0	0.2	0.5	0.1	26.0	0.1	0.1	3.2	0.0	0.0	5.7	1.1	2.0	518.2	3.5	282.0	43.4	123.6	227.6	2.6	36.5	20.9	150.8	11.2	781.6	4.5	3.6	9.1	365.6	212.8	235.6	215.4	322.0	237.4	212.0	237.6	211.6	218.5	238.8	215.0	234.2	14.5	750.0	569.2	38.2	23.3	414.6	42.2	8.7	59.7	3.5	3.4	3.0	14.8	2.8	125.6	1.8	0.0	2.3	345.3	0.8	1.9	0.4	33.3	2.8	4.0	28.7	8.4	30.5	62.2	0.2	5.5	16.7	5.6	5.2	10.1	99.5	5.3	1.2	4.0	0.0	7.9	11.1	4.1	11.4	30.9	45.9	3.1	7.9	35.6	14.0	41.4	166.4	1150.4	7.1	6.7	1.7	0.0	3.0	9.6	31.3	1.2	0.6	12.5	5.6	32.9	3.7	104.8	3.3	15.3	31.6	377.2	321.8	219.9	0.1	1.4	28.8
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor Kazal type 2"	P20155	4	56809860-56821742	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"epididymis: 5310.4"	"Group enriched"	"Detected in many"	10	"Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 146.4"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 146.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 90.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB020824, HPA026813"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favorable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.5	0.1	0.1	1.1	0.2	13.5	1.3	0.1	0.6	1.3	1.8	2.8	1.9	0.3	5310.4	0.2	0.3	0.1	7.4	0.2	0.2	0.3	0.2	0.2	4.7	0.3	0.3	0.4	0.1	0.0	4.2	0.0	0.2	3.5	2.1	0.0	2.0	240.7	1.8	0.5	3.1	0.3	0.2	1.7	3.0	346.1	0.3	3.9	0.6	2.3	4.8	0.5	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.7	2.9	18.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	6.0	0.3	3.0	0.0	0.0	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	90.5	0.4	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.5	0.1	0.6	9.1	5.1	5.4	1.4	10.5	11.1	21.6	0.9	146.4	0.0	0.8	0.3	5.4	0.1	0.2	0.1	0.6	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.1	0.2	0.0	0.0	0.0	7.2	2.0	14.2	1.8	1.8	0.0	0.2	0.6	3.4	0.0	0.2	0.0	0.0	0.0	2.5	1.4	0.0	0.0	1217.2	0.2	0.1	1.6	1.8	32.4	0.3	0.0	0.3	0.8	0.5	0.2	1.3	0.3	0.0	0.0	0.1	0.0	0.2	10.4	0.0	0.0	3.6	1399.4	37.9	2.5	12.4	0.0	1.6	1.5	1.0	0.0	0.1	0.0	13.1	24.5	35.2	9.5	0.4	0.3	0.3	0.0	13.1	0.4	1.9	1989.6	149.9	0.1	0.3	0.0	16.8	0.0	2.6	2.6
REST	"DFNA27, NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966808	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	6.9	5.5	5.7	9.4	6.5	24.8	9.8	6.3	7.5	8.8	9.4	6.9	6.4	9.3	8.9	8.2	7.8	7.9	7.6	5.0	5.2	10.9	11.5	8.0	13.4	8.0	6.6	11.2	7.7	13.8	0.5	9.9	7.8	10.0	7.0	7.5	7.8	8.1	5.2	8.9	6.3	8.0	6.6	10.7	8.2	12.3	6.8	18.1	10.9	6.5	13.6	8.7	2.1	7.4	10.8	13.0	17.4	18.2	13.2	16.0	22.7	15.6	13.8	16.0	14.7	11.5	16.5	24.5	23.5	16.8	10.7	9.8	13.2	16.3	24.4	12.6	8.1	22.0	9.4	12.5	16.2	29.0	13.5	16.5	14.6	15.1	16.0	20.5	20.1	19.0	14.3	26.3	19.0	17.3	31.5	21.3	15.2	12.3	8.9	30.0	14.5	8.1	19.0	18.3	0.3	8.1	17.8	18.8	14.6	24.8	19.3	20.3	28.7	20.4	18.1	12.4	14.2	10.8	7.8	15.1	13.2	16.7	10.8	7.4	2.5	7.2	6.2	3.9	6.2	11.6	6.9	5.9	5.2	21.1	10.8	4.4	2.8	6.1	7.9	6.0	9.4	2.5	5.7	6.5	6.3	7.5	5.0	5.2	8.0	6.6	7.8	6.6	6.8	7.4	38.1	70.5	60.2	18.6	51.1	57.1	51.9	33.3	99.6	1.6	42.6	35.2	50.2	42.9	43.3	29.5	81.3	58.0	65.2	21.4	23.5	58.4	9.7	67.3	64.3	50.5	3.6	54.7	0.1	38.2	57.1	40.8	23.9	63.4	51.4	56.3	47.2	31.0	32.2	0.0	0.2	23.5	44.7	36.2	37.9	11.9	39.4	44.0	21.4	12.2	78.0	45.1	71.1	11.1	21.1	45.8	29.0	36.9	44.3	44.3	22.1	24.4	43.3	36.1	32.9	56.5	56.0	58.3	53.8	55.0	45.7	66.4	66.6	62.3	26.1	48.7
NOA1	"C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3"	ENSG00000084092	"Nitric oxide associated 1"	Q8NC60	4	56963350-56977606	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035838, HPA035839"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA035838: AB_10669531, HPA035839: AB_10669658"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (8.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.27e-2)"	10.4	8.8	6.9	10.3	7.9	17.5	15.5	8.2	7.6	12.3	7.8	15.8	19.5	11.1	11.3	11.3	16.8	9.6	10.9	7.2	6.8	11.0	8.6	9.1	16.7	7.5	6.8	15.1	22.9	10.9	4.1	8.3	7.8	11.3	14.2	6.9	16.0	10.7	21.8	17.8	14.7	10.2	7.4	11.6	13.3	6.7	6.9	17.6	12.0	16.1	17.5	11.4	8.5	8.7	18.9	17.2	12.3	21.9	22.7	40.5	33.9	14.6	26.5	16.7	16.8	30.3	34.4	67.8	24.5	12.5	13.1	19.7	24.2	26.2	15.8	12.4	30.8	16.8	14.2	33.0	17.7	30.8	17.4	37.7	31.4	15.4	26.7	34.9	28.5	28.6	28.9	22.0	22.8	27.9	44.3	41.2	16.2	36.0	26.4	30.5	13.2	25.4	24.1	28.1	28.5	24.3	15.1	60.2	22.5	15.8	26.9	21.6	18.4	13.0	31.2	15.8	27.3	29.5	13.2	34.5	13.2	19.4	17.1	14.2	33.1	16.7	26.2	31.3	40.8	45.6	40.1	33.8	39.4	35.7	48.3	40.6	8.0	48.1	28.3	30.3	52.0	35.8	6.9	7.9	8.2	7.6	7.2	6.8	7.5	6.8	7.8	7.4	6.9	8.7	10.3	3.2	5.8	5.2	21.3	25.4	20.9	31.4	35.9	6.6	24.7	20.6	16.2	17.2	18.4	7.3	4.2	31.5	19.8	10.6	19.6	19.0	27.0	30.9	14.3	13.2	17.5	27.3	6.8	22.8	32.7	15.6	15.3	15.2	8.2	19.1	10.4	5.1	17.8	1.7	6.8	20.6	16.2	20.3	16.2	12.5	16.1	14.2	12.4	1.9	26.9	10.0	25.7	5.0	8.0	16.9	20.3	23.3	14.7	16.7	31.4	14.8	25.0	9.4	13.1	15.5	19.8	13.0	8.9	24.4	24.7	27.9	18.2	30.8	34.5	20.6
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031158	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	28.2	29.1	11.8	38.3	14.0	34.1	34.1	21.0	17.6	32.9	16.9	34.7	32.6	34.9	26.5	30.0	32.9	30.2	48.1	14.2	16.0	35.7	30.0	27.7	49.9	14.1	11.8	31.6	28.3	50.3	17.8	32.9	15.4	32.5	36.3	36.8	30.6	32.4	64.7	28.0	30.9	38.3	12.8	36.5	31.1	39.8	12.8	61.2	37.6	56.7	51.3	42.4	19.8	17.6	78.9	64.3	110.5	98.2	89.3	80.3	61.2	94.6	101.3	98.3	91.1	82.9	80.1	126.5	86.1	94.3	71.4	52.2	140.5	77.2	139.8	54.2	66.3	96.9	70.0	71.5	102.2	156.0	100.6	86.8	76.1	114.3	68.5	81.0	119.5	95.0	145.4	100.0	115.9	56.8	142.3	60.5	92.0	101.5	77.9	105.9	75.7	68.4	66.8	90.7	95.3	106.8	67.5	120.3	89.6	90.7	65.8	88.3	91.2	74.4	95.2	75.8	132.2	77.3	75.5	172.8	82.4	83.1	92.4	51.9	17.0	22.8	27.7	17.0	29.5	27.9	26.6	28.8	22.2	18.9	25.9	30.8	14.4	26.5	19.8	17.6	30.9	19.8	11.8	14.0	21.0	17.6	14.2	16.0	14.1	11.8	15.4	12.8	12.8	17.6	39.5	28.9	52.0	26.8	61.5	41.3	60.9	60.3	39.9	45.5	31.5	26.5	35.7	35.8	56.3	36.8	43.8	49.2	77.1	36.9	19.6	60.9	5.9	53.4	52.7	39.5	29.9	50.5	31.1	55.0	30.7	42.8	59.1	45.8	58.2	36.8	30.7	30.8	29.1	45.4	32.0	36.9	50.8	45.8	36.8	8.8	57.5	42.5	44.4	33.7	74.3	26.7	115.4	23.6	40.4	54.0	36.2	38.0	50.5	59.4	36.6	32.7	80.6	49.0	72.3	46.5	45.7	74.0	63.6	32.7	39.9	41.0	75.2	46.2	35.4	74.6
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	190000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	833.0	374.9	99.4	151.1	124.0	44.2	583.2	112.7	149.7	640.3	1299.1	473.1	105.6	653.2	260.4	115.3	618.1	405.7	1117.2	132.7	143.8	1298.6	283.2	532.4	133.1	185.2	138.7	359.1	270.1	77.2	246.0	66.6	146.4	506.0	83.2	4.7	193.7	659.0	185.6	193.6	259.6	334.9	136.8	436.9	267.4	259.2	187.9	48.9	995.3	91.8	81.9	546.4	494.0	132.6	1.3	4.8	1.1	0.0	134.8	50.4	4.7	693.6	643.1	59.2	19.0	2.8	0.1	0.3	433.7	33.5	35.3	70.2	0.7	111.1	15.7	1.3	5.4	2.5	78.7	0.5	207.7	17.1	17.9	234.7	55.8	96.8	26.2	1471.3	138.2	0.6	0.5	0.9	142.8	0.0	0.5	74.5	5.9	0.0	1.3	13.4	0.4	2.8	682.7	0.0	1.0	1.8	130.2	9.5	0.0	276.3	1.8	64.6	1009.4	60.5	46.4	7.8	114.8	41.1	0.4	1.4	159.2	58.3	1.8	2.0	3.9	21.7	0.1	4.1	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.3	10.8	4.5	0.4	0.1	1.7	99.4	124.0	112.7	149.7	132.7	143.8	185.2	138.7	146.4	136.8	187.9	132.6	2254.8	112.2	20.2	164.9	16.2	238.5	127.2	300.5	24.5	5.9	27.7	53.5	148.2	20.0	90.6	2087.4	22.9	6.6	76.9	1.4	516.5	2455.3	75.9	1235.5	702.2	2740.1	1.2	82.7	0.7	15.1	8.3	1435.9	29.0	381.3	15.8	1205.0	3079.4	16.4	26.5	0.0	3.7	1.0	61.1	101.9	375.7	335.4	11440.4	70.4	944.5	151.8	41.8	17.1	345.0	11.6	0.8	84.6	1.5	11731.6	11.0	113.3	0.0	692.2	731.0	12.5	8184.6	155.0	4434.0	36.6	38.6	9.9	179.1	5.7	51.3	759.1	2.5	64.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"heart muscle: 554.3"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 1775.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"																					0.0	0.3	0.1	0.1	0.3	1.0	0.6	0.8	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.1	554.3	0.1	0.5	0.0	0.0	0.2	0.4	0.3	0.1	0.1	0.5	0.1	0.0	0.1	0.4	1.7	0.0	0.5	0.3	0.0	56.2	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.6	1.9	0.0	0.3	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.3	0.1	0.5	0.3	0.1	0.4	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1775.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.2	0.0	0.0	50.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHA5	"CEK7, EHK1, Hek7, TYRO4"	ENSG00000145242	"EPH receptor A5"	P54756	4	65319563-65670495	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Neurogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 21.3"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 202.5;Inhibitory neurons: 162.8;Oligodendrocyte precursor cells: 96.0"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 10.0;PC-3: 9.4;TIME: 12.6;U-138 MG: 25.5;U-2197: 15.7;U-251 MG: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		33000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.02e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.89e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.60e-1)"		"unprognostic (6.68e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.25e-2)"		"unprognostic (5.88e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.81e-3)"	0.0	0.8	3.3	0.1	5.3	0.0	0.0	0.0	21.3	2.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.8	16.2	2.4	0.0	0.0	0.1	0.0	2.6	1.4	2.3	0.0	0.0	0.7	0.9	4.0	1.5	0.1	1.5	0.3	1.4	0.0	0.2	0.0	0.2	1.8	0.3	0.3	0.7	0.3	0.0	0.9	0.0	0.0	0.1	0.5	3.1	0.0	0.7	0.8	0.0	0.8	0.4	0.0	0.4	1.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	4.4	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.3	0.0	0.0	1.5	2.6	0.0	0.0	0.0	0.1	0.0	9.4	0.0	2.9	0.5	0.0	0.0	1.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	12.6	25.5	3.1	15.7	20.6	0.0	0.0	0.0	2.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.3	0.0	21.3	16.2	2.4	2.6	1.4	4.0	1.8	0.3	3.1	0.0	0.0	0.0	8.5	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	2.2	0.1	0.0	0.0	202.5	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.7	162.8	0.0	0.0	0.0	0.0	15.2	0.9	0.0	3.6	5.6	0.0	5.7	0.0	96.0	4.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.7	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.1
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468762-67545503	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	1.5	1.6	2.5	1.0	3.2	3.6	3.3	5.6	2.6	2.8	0.2	2.0	1.1	3.1	2.3	1.5	2.9	1.1	1.5	2.2	2.0	2.0	1.4	1.5	1.8	1.3	1.8	5.6	3.8	1.5	2.5	1.3	1.7	2.9	1.2	2.7	2.0	1.6	1.1	2.3	1.8	1.5	1.3	2.0	2.1	1.7	1.7	2.0	3.1	1.1	1.5	2.0	2.3	2.8	0.4	0.5	1.6	0.9	1.9	1.1	0.9	0.6	0.5	0.7	0.5	0.7	1.3	2.7	0.8	0.8	0.2	0.8	2.2	0.9	1.2	0.8	0.4	2.1	0.9	0.9	0.6	3.9	0.8	1.4	0.3	0.5	1.3	1.2	0.4	1.8	3.0	1.6	1.1	0.7	5.3	3.5	1.8	0.8	0.3	2.4	4.0	0.9	1.0	0.8	2.8	1.3	1.2	2.5	0.7	1.6	0.7	1.3	0.4	1.0	0.5	0.7	0.5	1.3	0.5	2.7	1.1	2.2	0.6	0.5	0.2	0.5	0.7	0.4	0.3	0.8	0.8	0.9	0.2	1.1	1.2	0.9	0.2	0.5	0.2	0.4	0.4	0.2	2.5	3.2	5.6	2.6	2.2	2.0	1.3	1.8	1.7	1.3	1.7	2.8	53.1	32.1	35.5	38.8	68.4	15.2	25.3	17.7	35.9	53.7	26.0	32.3	24.3	18.6	31.6	16.5	14.6	20.2	75.0	17.7	11.7	13.5	4.1	21.0	39.0	33.7	13.1	31.7	58.5	16.7	12.9	41.3	35.7	25.1	26.6	39.8	23.2	14.1	12.8	52.2	57.0	18.4	18.3	16.7	7.9	5.5	34.8	26.7	16.0	31.9	27.4	31.6	60.8	46.3	74.6	14.6	13.0	25.6	89.1	15.3	24.2	20.4	27.2	29.0	19.7	54.1	34.2	47.2	44.4	34.7	9.2	18.3	69.8	43.3	16.4	23.9
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Group enriched"	"Detected in some"	5	"B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 185.4;U-698: 83.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.4	0.1	0.0	15.5	0.0	5.8	0.8	0.0	0.0	0.3	0.0	2.3	1.8	0.6	1.9	0.7	0.1	1.4	0.2	0.5	0.0	9.2	0.4	1.4	40.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	2.3	0.0	1.3	2.8	0.1	0.1	8.1	0.4	0.0	16.0	2.3	2.7	0.0	6.4	0.4	0.0	51.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.2	0.0	24.7	0.0	5.3	0.1	24.3	0.9	0.1	1.9	88.1	2.0	0.8	1.2	107.8	7.9	0.2	1.0	38.9	0.1	5.2	0.4	4.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	60.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	5.5	0.0	0.0	5.8	0.0	9.8	0.0	13.0	0.1	0.0	0.6	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.0	80.8	0.0	0.4	0.0	0.8	0.0	0.2	0.1	65.1	0.3	0.7	7.1	0.3	1.2	16.0	0.0	0.2	0.0	6.2	0.0	0.3	0.0	0.0	0.4	147.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.1	0.0	4.3	0.1	0.0	0.2
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701155	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	6.7	6.6	5.9	9.9	8.0	17.1	8.3	7.5	7.5	10.6	4.9	7.1	8.1	6.8	6.2	11.4	5.7	8.0	5.3	5.6	7.9	6.3	10.7	7.8	12.4	9.7	8.0	7.7	6.2	7.9	12.0	9.8	10.0	7.7	8.4	14.4	6.7	5.5	5.2	8.4	8.6	8.7	8.4	10.2	9.4	10.0	8.7	10.4	7.9	6.5	13.6	10.2	10.6	16.0	34.4	18.8	30.5	24.0	14.8	17.4	20.6	69.5	27.1	31.1	36.2	19.8	45.1	43.4	24.2	28.7	31.8	19.8	31.9	34.6	46.6	50.0	8.9	27.8	30.7	18.7	12.6	49.3	20.4	12.5	10.9	40.3	24.3	21.2	27.8	21.9	67.2	25.0	37.2	13.0	51.5	11.2	18.0	24.3	22.6	30.0	62.6	16.1	25.3	38.3	14.9	18.8	39.2	27.5	13.0	25.3	18.4	13.0	40.6	28.6	31.9	23.6	30.8	17.8	15.0	43.0	50.9	13.5	28.1	6.4	1.8	2.9	2.4	2.3	2.7	3.0	2.8	3.2	2.2	3.0	2.0	2.4	1.3	5.7	2.6	3.1	2.5	1.4	5.9	8.0	7.5	7.5	5.6	7.9	9.7	8.0	10.0	8.4	8.7	16.0	34.6	25.6	21.7	54.5	46.5	70.1	65.2	43.0	37.5	45.8	30.8	17.0	13.5	10.0	34.6	16.5	54.2	29.2	45.0	34.7	3.9	24.6	2.3	28.6	24.8	39.0	32.3	23.8	66.3	17.1	17.8	26.6	39.8	45.3	31.0	62.3	20.0	20.9	23.2	33.7	78.1	27.0	28.5	29.9	54.0	5.8	21.5	31.4	24.9	37.5	34.6	14.6	26.8	77.9	115.7	53.3	36.6	19.9	44.8	87.0	21.2	15.9	34.9	39.9	19.7	28.0	24.0	57.7	43.9	30.9	46.2	58.8	37.6	40.4	22.8	149.0
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67737118-67754388	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Inhibitory neurons: 1.3;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA013424	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.0	0.7	0.4	0.1	0.7	0.0	0.0	0.2	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.0	0.3	0.8	0.5	0.1	0.1	0.0	5.4	0.0	1.2	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.3	0.9	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	1.0	0.3	0.8	0.8	0.5	1.2	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TMPRSS11D	"ASP, HAT"	ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884002	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"cervix: 51.6;esophagus: 71.8;lymphoid tissue: 34.4;salivary gland: 21.0;vagina: 76.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 24.4;Club cells: 13.8;Inhibitory neurons: 3.9;Oligodendrocyte precursor cells: 5.0;Urothelial cells: 12.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077704	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA077704: "	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.3	2.6	51.6	1.0	0.0	0.0	0.0	0.0	71.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	2.6	2.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	21.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.9	0.2	0.0	0.0	34.4	0.6	76.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.3	2.6	1.1	1.1	2.6	2.0	2.7	0.7	0.9	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.1	24.4	0.6	0.0	0.0	0.0	0.3	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.0	1.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	12.0
TMPRSS11A	"ECRG1, HATL1, HESP"	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909395-67964140	"Enzymes, Predicted membrane proteins, Transporters"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 86.1;lymphoid tissue: 28.4;vagina: 41.7"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 50.7"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	19.9	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.4	12.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	28.4	0.3	41.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.3	0.2	0.3	0.9	0.4	1.1	0.1	0.3	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.2	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.1	0.2	50.7	0.0	0.0	0.0	0.0	0.0	7.2
TMPRSS11F	"FLJ16046, HATL4"	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129869	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.2;skin 1: 9.3;vagina: 4.8"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 6.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026911	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.1	1.0	0.0	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	4.1	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.1	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.9	0.0	0.3	0.0	0.1	0.0	0.5
TMPRSS11B	HATL5	ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245694	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 390.7;lymphoid tissue: 82.2;vagina: 118.3"	"Group enriched"	"Detected in some"	22	"Early spermatids: 10.4;Late spermatids: 14.5;Squamous epithelial cells: 8.2"	"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"					"unprognostic (4.24e-2)"				"prognostic favorable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.2	56.8	0.1	0.0	0.0	0.0	0.0	390.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	58.6	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.2	0.0	0.0	0.0	82.2	0.0	118.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	8.2	0.0	0.0	0.1	0.0	0.0	0.2
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350090	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	43.0	27.0	22.4	19.5	26.5	116.6	43.8	31.9	25.0	52.6	18.6	40.0	15.6	43.6	22.7	48.0	42.3	15.3	34.1	20.9	26.0	38.2	33.1	40.6	28.4	23.6	23.6	68.6	44.5	20.3	41.2	23.8	24.8	37.9	19.6	38.5	42.1	17.6	47.2	51.3	40.5	17.2	23.2	41.9	36.3	31.3	23.1	30.3	42.1	16.7	26.7	37.3	50.5	32.7	31.8	18.4	37.1	22.2	21.7	18.8	30.4	33.8	21.3	20.6	21.5	22.9	27.9	50.8	27.0	17.2	16.7	23.3	35.1	29.4	33.1	38.2	21.3	38.8	27.3	25.6	22.1	41.5	29.0	17.8	31.3	18.5	44.0	26.6	22.6	24.7	37.5	29.0	30.7	23.9	48.9	37.1	27.6	30.4	18.0	42.4	41.6	22.8	32.6	35.6	31.9	24.8	29.5	31.5	25.9	34.3	24.6	28.8	24.1	23.5	24.9	16.4	22.5	30.1	21.8	53.7	15.9	26.6	22.0	69.3	20.3	40.4	24.1	12.7	19.0	36.1	19.6	19.8	12.2	44.8	26.9	22.9	105.4	20.8	27.0	39.3	20.3	9.7	22.4	26.5	31.9	25.0	20.9	26.0	23.6	23.6	24.8	23.2	23.1	32.7	104.6	112.2	129.5	54.9	104.7	119.9	103.6	76.2	88.8	105.8	112.8	107.2	92.6	85.8	125.1	73.5	70.9	73.6	136.8	58.1	52.8	70.2	98.5	131.9	135.3	92.2	85.8	74.7	43.8	57.2	124.8	81.3	54.0	254.8	94.7	86.2	63.5	85.6	43.2	90.9	49.4	77.9	63.1	61.0	75.9	22.0	74.6	84.5	64.0	56.2	67.0	99.2	96.8	59.3	110.1	81.6	56.0	67.7	103.2	121.6	42.0	44.0	113.2	138.4	52.6	122.0	98.8	139.2	95.9	127.1	134.5	119.0	122.0	59.5	66.9	119.8
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447463-68497604	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 89.5;esophagus: 220.2;salivary gland: 56.7;vagina: 156.3"	"Cell type enriched"	"Detected in some"	14	"Ionocytes: 476.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043816, HPA051062"	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA043816: , HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	89.5	0.0	0.0	0.0	0.0	18.2	220.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.0	0.0	56.7	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	24.5	6.5	156.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	12.9	0.7	0.0	0.0	0.5	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	476.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.2	6.6	0.3	1.1	0.7	0.0	0.0	32.6
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 460.0;liver: 136.2"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 130.1;Paneth cells: 35.1;Undifferentiated cells: 100.6"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"memory B-cell: 2.8;naive B-cell: 8.8"	"Lineage enriched"	"Detected in single"	61	"B-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 1.1;RPMI-8226: 1.7"									HPA045108	Supported					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.3	0.0	0.0	38.8	0.0	0.0	0.7	0.0	0.0	1.5	0.0	365.7	364.3	1.4	1.5	0.1	0.2	0.6	0.0	0.0	0.0	0.2	136.2	0.2	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	125.8	0.0	0.2	0.7	0.0	0.0	460.0	9.1	0.1	0.6	0.8	0.0	0.1	0.4	0.0	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	130.1	0.0	0.0	0.0	11.1	0.1	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.3	0.1	35.1	0.0	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	100.6	0.2
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646597-68670652	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 77.7;liver: 291.2"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.7;Hepatocytes: 142.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	21.6	5.1	0.0	0.0	0.0	0.1	77.7	0.0	0.0	0.0	0.0	291.2	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	0.1	17.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	4.4	0.9	0.1	168.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	24.2	3.0	0.2	0.0	0.2	0.0	2.7	0.1	3.6	0.1	0.1	0.0	0.0	0.0	0.0	2.9	142.8	0.0	0.0	0.1	3.3	0.0	3.2	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.6	1.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.9	0.1	0.6	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.9
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 233.7"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	233.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951804	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 31.4;kidney: 21.0;liver: 13.3;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045108	Supported					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.0	13.3	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	91.5	0.0	3.7	0.0	0.0	0.0	89.8	11.7	26.3	0.0	0.0	0.0	0.0	12.2	2.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	53.5	0.0	0.0	0.0	34.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	54.7	0.0	0.0	0.0	248.9	130.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	101.1	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"kidney: 1299.8;liver: 1612.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 310.8"									HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.2	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	32.0	0.0	3.8	68.7	8.9	24.2	0.2	49.9	10.4	0.0	0.0	0.0	1299.8	1612.1	0.4	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.1	0.0	0.3	6.9	0.0	3.6	27.5	0.0	0.3	66.6	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.3	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	41.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.6	0.1	310.8	2.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	43.2	0.0	0.0	0.0	0.2	0.3	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.6	1.6	0.0	0.0	1.2	0.6	0.1	38.6	2.1	125.0	0.0	0.0	0.0	5.7	97.8	6.6	0.3	150.6	14.0	1.0	3.5	2.7	0.4	10.6	0.0	0.1	0.0	234.7	0.0	0.0	8.9	550.8	0.1	0.0	0.3	37.3	0.0	13.8	0.0	0.0	1.8	7.6	3.6	0.0	0.0	0.0	0.0	1.5	0.4	13.0	10.7	0.0	0.0	0.6	70.6	1249.5	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	6.3	0.1	5.9	2.3
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214748	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 239.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 13.7;Cholangiocytes: 7.2"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"basophil: 4.7;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.7"	"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 5: Breast - Unknown function"		"Cluster 35: Glandular cells - Unknown function"			"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.0	0.1	0.0	0.1	239.4	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.9	0.0	0.5	11.4	0.0	0.0	0.0	3.6	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280475-69295050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"breast: 198.5"	"Cell type enriched"	"Detected in single"	16	"Cholangiocytes: 10.0"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	10	"Daudi: 2.9;NB-4: 2.7"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	198.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	107	"liver: 1273.7"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 883.5"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"RH-30: 4.6"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	1.3	1273.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	10.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	11.7	883.5	0.1	0.0	0.1	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	P0DTE4	4	69588417-69653249	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 3.6;kidney: 2.3;liver: 3.6;pituitary gland: 5.6"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 107.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;lung cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA017261, HPA045108"	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	"P0DTE4, P0DTE5"	4	69588417-69639642	"Enzymes, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 6.3;liver: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"					"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860145	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 27.5;liver: 37.2;skin 1: 19.3;vagina: 30.4"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.8;Glandular and luminal cells: 35.1;Hepatocytes: 51.4;Paneth cells: 66.3;Proximal enterocytes: 21.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HHSteC: 71.1;HSkMC: 32.3;hTCEpi: 27.3;HUVEC TERT2: 20.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 7.8"	"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	14.5	0.1	0.0	0.1	0.1	0.1	0.1	0.2	13.5	4.1	0.2	27.5	0.3	1.0	0.8	0.2	0.2	0.0	0.1	0.0	0.3	37.2	2.3	0.0	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.1	0.7	0.1	0.0	6.6	0.4	0.0	19.3	27.3	0.1	0.0	0.0	2.1	0.1	0.1	0.5	0.0	0.0	1.5	0.7	30.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	71.1	0.0	0.0	32.3	27.3	0.0	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	11.9	1.0	8.7	0.0	0.0	0.1	0.0	0.1	1.5	2.8	1.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	65.8	1.3	0.3	0.0	0.0	0.1	1.3	0.1	0.2	0.0	35.1	0.0	0.0	2.5	51.4	0.3	0.0	0.0	4.7	0.0	0.8	0.7	0.0	0.3	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	66.3	0.0	0.0	0.0	21.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	3.4	1.5	0.1	0.0	13.8	0.2
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931068-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"breast: 1391.5"	"Cell type enriched"	"Detected in some"	47	"Breast glandular cells: 8261.0"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			16.0	0.0	0.1	0.5	0.0	0.0	1391.5	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.4	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.2	0.0	0.1	0.0	0.4	0.1	28.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	8261.0	172.2	2.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.1	0.3	0.0	2.1	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.0	0.0
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"breast: 307.2"	"Cell type enriched"	"Detected in some"	97	"Breast glandular cells: 33136.9"	"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"	NA	NA				"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	307.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	33136.9	340.4	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	0.8	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995966-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	925	"salivary gland: 9143.2"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 9.8;Early spermatids: 2.8"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	9.8	0.0	5.6	0.8	0.0	0.1	0.0	0.0	9143.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.8	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028455-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1102	"salivary gland: 136053.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HL-60: 1.7"									CAB073541	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB073541: "																		0.0	0.1	0.7	0.3	1.3	18.9	0.1	2.8	2.3	0.0	0.0	2.4	0.3	0.2	0.4	0.2	0.1	0.1	26.2	0.9	0.0	0.1	0.1	0.2	0.3	0.1	0.0	26.0	123.4	0.1	1.8	13.1	0.2	0.2	3.0	0.7	136053.4	0.1	0.1	10.0	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.2	0.0	0.1	0.1	0.0	1.5	0.4	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.0	1.6	0.2	0.1	0.3	0.1	0.0	1.7	1.1	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.7	0.2	0.2	0.4	0.9	0.4	0.1	0.4	1.0	0.2	0.1	0.1	0.1	0.6	0.4	0.4	0.2	0.3	0.3	0.7	0.4	0.0	0.3	0.6	0.4	0.3	0.5	0.9	0.2	0.3	0.5	0.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.7	1.3	2.8	2.3	0.9	0.0	0.1	0.0	0.2	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050438-70058848	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2602	"salivary gland: 48372.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077315	Approved				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 11: Alveolar cells - Smell perception"			"HPA077315: "									"unprognostic (2.22e-1)"									0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	18.5	0.0	0.0	5.5	0.0	0.0	0.0	0.0	48372.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	959	"salivary gland: 1106.3"	"Group enriched"	"Detected in some"	25	"Early spermatids: 25.5;Late spermatids: 9.8"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1106.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"salivary gland: 371.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 31.7;OE19: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.8	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.3	0.1	3.6	1.0	0.1	0.6	0.2	0.1	0.5	0.0	0.0	0.8	1.2	0.0	2.4	0.3	1.2	0.7	0.0	0.5	3.6	0.5	0.3	0.0	1.8	0.8	0.0	371.5	1.4	0.0	0.0	0.7	7.3	0.0	0.0	9.8	0.0	0.2	0.0	4.1	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.2	0.0	0.1	3.2	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.3	0.4	0.0	1.5	1.3	1.8	0.0	0.4	0.0	0.0	0.0	6.5	0.0	2.3	0.9	0.1	0.0	0.0	0.0	8.2	0.0	0.0	6.6	10.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	4.2	0.5	0.4
FDCSP	"C4orf7, FDC-SP"	ENSG00000181617	"Follicular dendritic cell secreted protein"	Q8NFU4	4	70226124-70235252	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"lymphoid tissue: 3257.5;salivary gland: 6608.7"	"Group enriched"	"Detected in some"	25	"Breast glandular cells: 90.8;Breast myoepithelial cells: 87.9;Ductal cells: 75.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 336.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;GAMG: 7.5;HL-60: 1.5;K-562: 1.4;RH-30: 2.1;U-87 MG: 5.4"					"Not detected"	"Not detected"			"HPA014326, CAB014890"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 35: Glandular cells - Unknown function"			"CAB014890: , HPA014326: AB_1845719"	"unprognostic (1.26e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.73e-3)"	"unprognostic (9.62e-2)"		"prognostic favorable (2.38e-4)"	"unprognostic (5.99e-3)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.79e-1)"		"unprognostic (1.96e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.83e-2)"	4.8	1.8	0.0	313.8	0.0	0.0	183.5	0.0	0.0	0.2	0.2	24.6	1.8	4.8	0.1	13.4	0.9	2.7	1.6	0.0	0.1	0.3	1.9	1.4	1052.7	0.1	0.6	0.5	2.7	0.0	0.5	0.7	0.0	1.6	18.3	0.0	6608.7	0.1	1.4	0.5	49.5	4.2	0.0	33.2	10.1	0.3	0.3	17.2	3.3	0.0	3257.5	11.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	5.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	90.8	87.9	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	75.6	0.0	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 378.1"	"Cell type enriched"	"Detected in some"	48	"Breast glandular cells: 2554.0"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 35.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"	NA	NA				"Cluster 5: Breast - Unknown function"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.0	0.0	0.0	0.0	0.0	0.0	378.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2554.0	52.2	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	3.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0
CABS1	"C4orf35, CLPH, FLJ32897, NYD-SP26"	ENSG00000145309	"Calcium binding protein, spermatid associated 1"	Q96KC9	4	70334981-70337116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 106.3"	"Group enriched"	"Detected in some"	144	"Early spermatids: 1299.5;Late spermatids: 4446.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044016, HPA055352"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA044016: AB_10964494, HPA055352: AB_2682790"															"unprognostic (1.36e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1299.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4446.4	19.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360760-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"salivary gland: 59.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7;liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044567	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMR3B	"P-B, PRL3, PROL3"	ENSG00000171201	"Submaxillary gland androgen regulated protein 3B"	P02814	4	70370093-70390244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	946	"salivary gland: 217144.9"	"Group enriched"	"Detected in some"	55	"Breast glandular cells: 2.3;Early spermatids: 8.4;Late spermatids: 6.0"	"Cancer enriched"	"Detected in some"	22	"breast cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"EFO-21: 4.5"														"Secreted to digestive system"	NA	NA		1900000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 34: Spermatids - Unknown function"																			"unprognostic (3.72e-1)"		0.0	9.1	0.0	0.0	0.0	7.6	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.1	8.9	0.0	0.0	44.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	47.3	229.5	0.0	1.6	23.2	0.0	1.6	0.0	0.0	217144.9	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397931-70410195	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 146.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.5;Breast myoepithelial cells: 3.3;Glandular and luminal cells: 2.1"	"Group enriched"	"Detected in some"	5	"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	NA	NA		63000		"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 35: Glandular cells - Unknown function"			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	875	"salivary gland: 26019.1"	"Cell type enriched"	"Detected in some"	12	"Melanocytes: 12.4"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006411	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									1.2	5.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	2.1	0.0	0.0	6.6	0.0	0.0	1.0	3.7	0.6	0.0	0.0	0.7	6.5	29.7	0.0	1.9	3.2	0.0	0.8	0.0	0.0	26019.1	0.0	2.6	3.6	1.5	0.0	0.0	1.0	1.1	1.5	0.2	0.0	1.3	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.4	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518569-70532743	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 28.3;salivary gland: 6.8;stomach 1: 7.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 14.0;Ionocytes: 4.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 16.7;hTERT-RPE1: 23.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.1	0.3	0.0	0.0	28.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.7	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	23.7	0.1	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.5	14.0	0.0	0.0	0.1	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HEK 293: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Uncertain	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA					"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70646824	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 7.5;heart muscle: 6.5;kidney: 9.0;skeletal muscle: 4.9"	"Group enriched"	"Detected in some"	4	"Melanocytes: 33.8;Plasma cells: 13.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 0.6;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.2;U-266/84: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	7.5	0.0	0.3	2.4	6.5	0.0	0.0	9.0	0.5	0.3	0.0	0.0	0.0	0.0	3.6	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.2	0.2	0.0	0.1	1.7	0.6	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.1	2.8	0.0	3.7	0.0	0.0	0.0	0.0	3.9	1.0	4.4	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.6	0.3	0.1	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	13.4	0.0	0.0	4.1	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	130.2	76.6	0.7	1089.0	0.8	76.3	3028.0	0.4	3.0	205.2	3.1	7979.6	6145.8	94.2	25.0	654.4	115.0	492.4	45.6	0.4	1.4	43.3	116.8	620.2	1033.5	1.9	1.0	183.5	78.3	2.1	2.0	2.4	0.8	90.2	6426.5	0.3	2420.5	258.4	4.2	13.2	4277.1	200.3	7.0	819.4	5916.2	40.0	0.8	155.3	19.4	0.8	1746.7	1059.4	11.6	2.8	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.7	0.8	0.4	3.0	0.4	1.4	1.9	1.0	0.8	7.0	0.8	2.8	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3 small subunit processome component"	Q9NQZ2	4	70688532-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	22.4	22.7	8.9	25.5	9.5	19.1	18.7	9.4	11.3	14.0	10.0	16.9	16.3	16.1	15.0	20.6	16.3	14.6	17.0	9.9	9.8	21.0	27.1	18.6	33.0	9.1	9.3	15.7	14.9	16.3	9.4	16.3	9.1	15.1	16.4	12.0	15.9	13.7	15.9	18.8	21.5	20.2	8.7	34.5	17.8	11.4	9.6	32.1	16.0	13.1	31.5	22.1	12.3	10.0	33.7	32.3	42.4	35.4	58.9	44.3	36.3	68.4	43.9	38.4	37.0	42.4	43.7	147.4	42.1	58.9	43.8	27.7	62.7	93.7	55.4	45.9	35.9	56.1	43.0	45.9	63.9	85.9	47.9	60.4	55.2	47.0	46.0	42.3	52.2	42.3	65.3	48.2	62.8	69.7	79.9	47.8	29.6	68.9	46.7	33.8	58.3	60.5	69.7	53.7	35.5	48.4	29.1	65.4	44.5	46.1	36.1	34.2	58.5	38.8	65.9	37.3	44.3	69.6	55.4	104.8	47.3	41.4	34.8	8.4	10.7	5.6	6.4	12.6	6.8	7.0	5.3	7.4	13.4	6.1	7.7	6.7	0.8	6.8	11.3	13.5	7.3	5.5	8.9	9.5	9.4	11.3	9.9	9.8	9.1	9.3	9.1	8.7	9.6	10.0	19.2	57.7	54.2	4.9	23.7	22.9	44.3	42.2	24.5	19.4	12.3	14.4	20.6	14.3	50.5	12.9	6.2	26.7	30.0	11.8	19.6	29.3	1.1	22.8	29.3	26.7	15.0	16.8	6.2	29.8	14.6	23.6	21.9	25.1	29.2	16.7	16.8	25.1	21.9	16.8	5.9	14.7	30.5	37.8	24.2	2.2	17.4	24.2	12.4	5.6	27.9	26.8	30.9	2.5	8.9	22.6	9.5	25.2	18.5	23.0	15.9	27.9	45.7	22.3	13.1	30.8	48.8	11.5	9.5	23.0	25.6	21.6	24.6	22.2	15.6	29.9
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70808619	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 120.3"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 189.4;Cone photoreceptor cells: 264.8;Excitatory neurons: 192.9;Oligodendrocytes: 197.8;Rod photoreceptor cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA022952: AB_2671005, HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	19.4	34.8	57.1	18.2	63.7	11.6	18.7	63.3	77.0	28.6	27.6	18.9	12.0	29.4	23.3	24.4	18.0	17.7	16.0	63.8	72.0	22.1	22.2	21.9	21.7	77.1	63.0	35.8	19.2	8.2	41.1	17.5	81.5	19.2	16.0	120.3	18.9	15.6	25.6	46.5	15.0	20.8	61.4	25.4	19.1	39.0	63.6	32.5	45.7	11.7	17.3	19.9	25.7	99.3	8.5	5.8	67.0	15.9	30.8	35.2	26.6	26.6	10.2	8.5	9.4	9.9	20.2	33.2	10.8	22.4	19.1	8.4	10.3	11.8	13.6	18.2	13.4	7.2	8.4	11.6	18.0	8.4	4.3	24.7	18.0	11.4	13.3	39.5	18.3	35.4	20.2	32.9	18.8	10.4	52.8	9.6	16.1	14.7	7.3	12.8	21.0	15.2	16.7	8.0	61.7	30.6	9.7	17.0	16.2	25.8	11.7	4.2	15.7	28.8	20.0	8.8	6.2	37.2	18.0	35.7	29.4	6.1	6.0	0.6	3.4	0.3	1.5	4.8	1.9	3.5	1.2	1.3	4.9	2.6	1.2	1.3	0.1	2.6	4.9	6.6	0.5	0.8	57.1	63.7	63.3	77.0	63.8	72.0	77.1	63.0	81.5	61.4	63.6	99.3	31.9	35.3	82.1	189.4	18.7	19.4	23.3	9.9	15.9	126.9	22.1	11.8	19.3	12.8	30.6	23.9	264.8	15.0	19.5	7.5	7.9	14.7	70.0	32.9	63.6	32.6	15.0	7.4	192.9	21.1	7.0	43.7	23.4	36.0	21.0	53.1	32.9	25.7	10.5	139.7	175.0	8.4	14.2	37.3	36.4	122.5	47.2	31.0	42.7	72.1	67.0	43.9	13.4	136.7	197.8	19.1	5.2	50.8	17.2	40.2	11.6	19.6	28.3	198.6	26.3	53.2	35.9	14.8	27.6	36.7	28.8	7.7	11.5	40.9	10.1	19.3
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815783-70839897	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.2"	"Cell type enhanced"	"Detected in all"		"monocytes: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	38.0	61.2	38.4	36.9	37.7	23.7	37.7	42.5	47.1	36.3	58.9	54.6	43.1	32.5	34.0	42.0	43.0	35.2	80.7	41.0	44.5	55.8	54.4	35.5	47.4	40.3	42.3	38.4	62.0	48.8	21.5	43.8	41.6	39.9	62.7	25.4	83.9	35.3	275.2	32.0	41.3	40.0	40.7	34.6	50.8	32.8	40.9	76.0	45.7	155.0	53.7	50.3	25.8	46.1	116.9	78.1	90.0	94.5	93.5	108.1	128.3	138.2	87.3	102.3	83.5	80.5	117.1	167.6	102.9	143.7	53.0	43.4	161.3	108.6	135.9	91.3	52.8	88.4	75.2	112.4	115.1	130.8	48.7	91.9	102.2	103.6	71.6	123.0	106.9	91.9	102.6	94.7	144.2	124.9	217.4	92.0	96.3	127.1	80.9	88.2	139.8	71.6	126.1	144.0	93.4	84.0	65.3	183.6	234.3	104.7	79.8	63.3	98.4	95.1	99.7	79.4	88.7	78.1	66.2	106.4	78.6	83.6	94.5	12.7	17.4	7.7	10.1	12.3	12.2	7.4	14.6	15.5	28.1	6.1	14.4	12.6	2.0	20.0	15.2	27.2	13.3	8.4	38.4	37.7	42.5	47.1	41.0	44.5	40.3	42.3	41.6	40.7	40.9	46.1	27.8	32.1	36.6	19.6	38.0	50.0	53.7	32.9	48.3	18.2	37.7	28.3	135.5	40.0	30.4	27.6	25.0	106.2	57.4	52.9	74.3	70.3	7.6	53.8	40.4	33.0	69.0	41.2	35.1	61.3	141.3	41.2	65.2	44.5	17.2	60.2	35.0	50.9	63.2	28.6	30.5	73.5	36.7	66.3	53.7	6.7	34.8	45.4	62.2	24.4	301.5	23.8	41.2	21.6	28.0	60.1	46.7	39.1	58.7	65.9	47.1	74.1	27.6	19.6	19.7	38.4	46.2	35.0	61.8	69.7	50.4	77.2	45.1	99.0	89.3	67.0
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	7.3	7.5	9.4	9.6	12.0	30.0	8.4	5.4	13.0	7.5	19.4	5.8	4.8	7.8	5.0	7.5	8.9	6.9	8.5	19.1	13.5	22.5	6.5	9.6	11.3	9.7	11.3	7.8	8.6	12.5	4.0	8.8	10.0	9.6	6.3	4.9	8.5	5.4	6.1	8.8	5.4	7.7	12.9	8.8	8.1	6.0	8.1	20.0	11.0	6.3	10.3	6.9	5.3	15.8	8.2	6.6	24.2	19.9	12.9	16.2	20.2	24.2	13.2	13.3	11.5	8.8	15.3	45.6	11.5	21.6	9.1	5.7	15.2	20.3	31.9	25.1	5.5	71.5	7.4	6.8	12.9	15.6	13.8	13.5	10.9	14.9	12.0	14.8	15.9	23.4	45.0	14.5	21.3	8.9	49.2	9.7	8.0	5.3	8.5	15.6	23.5	6.1	22.1	14.1	8.4	16.5	10.6	4.7	32.9	12.9	10.9	10.0	19.3	36.6	18.9	16.8	10.0	9.2	3.4	19.1	12.8	11.5	17.2	0.3	1.2	1.1	0.5	0.6	0.4	0.1	0.2	0.2	1.7	0.2	0.3	0.2	0.1	0.2	0.4	2.1	0.6	0.5	9.4	12.0	5.4	13.0	19.1	13.5	9.7	11.3	10.0	12.9	8.1	15.8	11.1	25.6	19.1	42.4	8.9	17.8	6.0	6.1	18.8	3.3	13.7	8.8	17.4	5.7	10.2	44.1	18.8	5.6	31.5	2.6	9.8	5.4	0.8	27.2	16.0	12.8	37.8	99.1	38.4	4.6	5.6	12.1	7.1	25.6	10.8	24.5	9.7	7.1	11.2	6.7	36.5	8.9	4.1	29.2	39.7	1.6	4.4	33.5	10.6	65.6	45.6	6.0	8.2	41.7	12.1	9.4	2.1	8.6	6.9	11.5	1.4	17.1	16.9	4.5	26.3	8.7	23.0	6.4	9.0	15.1	17.0	5.7	10.3	23.4	6.6	9.4
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 105.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 105.7;Erythroid cells: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 232.9;U-698: 191.8"	"Low region specificity"	"Detected in all"							"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	11.1	15.2	10.1	36.3	11.2	43.9	12.5	9.7	13.6	9.9	11.0	15.7	13.7	13.4	7.2	14.6	9.8	12.4	10.4	10.7	10.7	9.8	9.2	13.4	92.9	10.9	10.4	10.6	8.3	8.8	3.5	15.3	10.8	10.2	18.9	17.1	7.7	7.1	9.5	14.7	15.9	13.9	11.4	32.3	14.2	9.0	9.7	105.8	15.7	12.1	79.6	14.2	6.1	13.4	25.8	17.2	38.5	23.9	12.4	20.4	21.0	65.3	25.6	53.3	43.6	11.3	56.1	232.9	24.7	28.3	31.0	14.8	34.6	21.4	71.0	43.5	16.2	46.6	18.6	20.5	11.8	95.8	58.5	11.2	25.5	32.2	19.5	26.0	31.0	64.4	19.0	93.2	62.0	15.5	126.6	39.5	17.2	45.6	15.6	96.0	74.0	18.6	26.6	18.8	35.1	31.8	24.9	49.6	29.7	17.4	22.3	54.3	22.0	60.1	41.8	47.6	37.1	31.7	21.2	191.8	40.7	60.0	45.0	25.6	17.2	28.9	24.2	20.5	32.0	44.5	33.0	30.6	23.8	41.1	34.2	34.2	8.1	34.4	21.0	63.6	41.2	45.1	10.1	11.2	9.7	13.6	10.7	10.7	10.9	10.4	10.8	11.4	9.7	13.4	16.4	0.0	8.6	6.8	105.7	43.0	10.1	11.9	27.9	16.1	10.4	5.2	6.5	7.2	7.5	12.9	6.2	11.9	97.7	10.4	29.4	19.2	0.7	5.9	7.0	16.3	21.0	284.8	17.1	6.2	19.3	11.0	8.6	7.4	22.9	7.5	22.9	7.2	38.2	18.5	21.0	16.4	22.4	63.2	74.5	2.3	8.4	56.0	46.2	18.7	61.4	15.8	84.5	8.0	11.1	10.5	8.0	10.1	24.6	11.6	7.1	10.0	4.7	10.7	6.6	9.3	15.9	52.0	33.9	28.0	43.3	4.5	62.4	4.8	16.5	8.4
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC vitamin D binding protein"	P02774	4	71741696-71804041	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 8260.1"	"Group enriched"	"Detected in some"	27	"Cholangiocytes: 1552.8;Hepatocytes: 3017.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.0;RH-30: 3.0;SiHa: 1.8;U-698: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	73000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.6	0.1	0.0	495.5	0.1	0.0	0.0	46.1	8260.1	0.0	0.2	0.1	0.1	0.0	44.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	1.8	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1552.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	39.5	0.5	0.1	0.0	2.0	0.0	37.5	0.1	16.2	0.2	0.0	0.0	0.0	0.0	0.0	58.5	3017.1	0.1	0.0	0.1	0.7	0.0	83.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.2;seminal vesicle: 3.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 22.1;Cytotrophoblasts: 6.6;Excitatory neurons: 14.5;Extravillous trophoblasts: 12.3;Muller glia cells: 4.9;Syncytiotrophoblasts: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"GAMG: 28.1;NTERA-2: 9.2;RPTEC TERT1: 11.9;SH-SY5Y: 14.0;U-2 OS: 13.7"	"Region enriched"	"Detected in some"	4	"olfactory bulb: 4.3"	"Low region specificity"	"Detected in all"			HPA026825			Approved	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Actin filaments"	"HPA026825: AB_10603123"	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.1	0.0	1.0	0.2	0.9	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.9	0.0	0.2	0.1	0.0	0.9	1.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	1.6	0.3	0.1	0.2	0.7	0.0	3.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.2	7.2	0.3	0.2	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	14.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.6	0.9	1.1	0.5	0.0	0.3	0.0	0.2	0.5	0.1	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	22.1	0.0	0.5	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.3	0.0	0.0	14.5	0.2	12.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	3.5	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.7	0.0	0.0	9.7	0.0	0.0	0.0	0.1
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569221	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 8.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Excitatory neurons: 50.2;Leydig cells: 19.9;Rod photoreceptor cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;AN3-CA: 7.8;HEL: 14.1;K-562: 12.3;SH-SY5Y: 7.0;U-2 OS: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Intermediate filaments"		"HPA021368: AB_2670681, HPA021369: AB_2670682"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	2.3	0.8	0.5	1.0	2.5	0.8	3.2	0.0	1.5	0.4	0.1	0.3	0.1	1.9	1.7	0.2	2.9	0.6	0.9	1.5	0.6	0.9	0.2	1.1	0.8	0.0	0.2	2.0	0.3	2.7	0.2	0.7	0.1	0.7	0.3	8.4	0.4	1.1	0.2	0.4	0.2	1.7	0.0	0.7	0.5	1.9	0.1	0.6	1.2	0.3	0.3	1.3	0.4	0.4	0.0	0.0	13.2	7.8	0.1	0.3	0.1	0.7	2.1	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.8	0.0	1.8	0.0	1.8	14.1	0.9	0.0	0.2	0.0	0.0	1.7	0.1	0.6	0.1	3.3	0.0	0.0	12.3	0.0	0.0	0.0	1.3	0.0	2.2	0.0	4.0	0.0	2.6	0.0	4.6	0.0	0.5	7.0	0.0	0.6	0.2	1.4	0.1	0.2	0.1	5.6	8.5	0.0	0.7	0.0	0.0	0.0	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	1.5	1.5	0.6	0.0	0.2	0.1	0.0	0.1	0.4	1.8	0.0	3.4	7.5	0.0	0.5	0.9	0.0	0.0	0.9	0.8	3.2	1.2	1.5	1.3	1.8	14.6	0.0	0.0	0.0	0.0	0.0	4.1	2.2	5.1	3.7	0.0	2.5	50.2	0.0	0.3	3.3	0.0	0.7	1.3	1.9	3.9	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.7	1.9	19.9	0.3	0.0	1.0	0.0	1.8	0.0	7.1	1.3	0.0	0.0	4.5	0.0	1.1	0.0	0.3	0.5	12.9	0.0	0.3	1.2	1.2	0.8	0.3	0.0	0.0	0.0	2.8	0.0	0.1
COX18	FLJ38991	ENSG00000163626	"Cytochrome c oxidase assembly factor COX18"	Q8N8Q8	4	73052362-73069755	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046772, HPA049489"	Approved					NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 52: Non-specific - Transcription"			"HPA046772: AB_2679799, HPA049489: AB_2680791"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (9.01e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.22e-7)"	"unprognostic (1.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.22e-3)"	1.5	3.9	0.7	0.4	0.8	0.5	1.4	1.3	1.0	1.3	1.1	1.6	0.6	1.5	0.9	1.4	1.2	0.4	2.7	0.8	0.9	1.7	2.4	1.2	0.7	0.4	0.6	1.5	2.0	0.7	1.3	0.6	0.5	0.9	0.6	1.3	1.9	0.6	2.7	1.3	1.4	0.4	0.3	1.3	1.7	1.3	1.0	0.4	1.1	1.2	0.5	1.2	1.2	0.7	0.6	1.0	1.0	1.0	0.9	0.9	0.8	1.0	0.9	0.4	0.5	0.8	1.1	1.8	0.7	0.6	0.7	0.6	1.0	0.7	0.4	1.4	0.7	0.9	1.3	1.3	0.7	1.5	1.2	1.1	0.7	0.4	0.8	1.1	0.8	1.6	1.4	1.7	0.8	0.5	1.8	1.0	1.5	1.1	1.1	1.0	1.6	2.6	0.8	0.6	1.5	1.0	1.1	0.9	0.4	0.8	0.8	0.8	1.1	1.0	0.8	1.3	0.5	1.7	0.8	1.1	1.2	1.1	0.8	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.1	0.1	0.7	0.8	1.3	1.0	0.8	0.9	0.4	0.6	0.5	0.3	1.0	0.7	5.6	3.2	6.3	7.2	10.1	2.5	3.7	4.5	1.2	11.7	7.1	4.2	13.9	5.7	7.3	9.2	22.9	8.0	9.0	5.5	13.7	6.5	4.0	6.7	8.4	6.7	5.4	7.8	10.5	8.0	8.3	7.0	5.6	7.1	0.0	17.4	11.4	16.7	8.8	20.2	10.6	7.7	4.1	13.9	3.0	2.0	9.0	8.4	5.4	6.5	12.5	6.6	11.3	10.1	13.4	9.3	5.2	9.4	18.1	6.6	6.6	13.0	8.1	14.3	13.1	7.5	6.0	10.2	7.3	5.5	1.4	3.0	8.6	12.7	9.6	3.4
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 961.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	79.7	961.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.6;stomach 1: 34.9"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 2.7"	"Lineage enriched"	"Detected in single"	13	"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.2	0.1	0.0	4.9	0.0	0.1	8.4	0.0	0.2	2.3	5.0	11.9	9.8	0.5	2.8	1.9	2.7	4.4	0.0	0.1	0.2	6.0	2.2	1.3	5.7	0.0	0.8	1.3	16.6	0.7	0.4	7.4	0.0	5.7	12.7	1.6	3.5	3.7	0.0	5.3	12.3	0.3	0.0	0.2	34.9	0.1	0.7	30.6	5.7	0.4	6.9	9.2	1.8	0.1	0.3	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.2	12.0	76.0	1.1	0.0	0.3	3.8	0.0	6.0	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	5.8	0.0	21.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	11.1	0.2	0.0	0.1	0.5	23.5	70.2	2.8	0.0	0.2	1.8	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	20.2	0.1	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.0	0.7	0.1	0.3	12.8	5.1	0.0	25.0	9.8	38.5	70.5	18.8	0.1	25.1	42.2	1.2	21.5	37.7	7.3	0.0	55.7	0.1	81.1	17.6	18.2	0.3	45.4	2.0	0.8	120.3	0.4	0.3	80.9	23.0	1.7	171.8	22.8	1.3	2.2	0.4	4.0	4.4	0.0	0.1	57.9	103.7	0.3	1.0	0.0	0.0	1.2	1.8	0.0	0.6	18.7	0.0	0.0	0.3	67.1	65.8	0.0	21.3	24.6	30.1	37.8	29.8	0.5	0.0	0.0	1.6	0.0	0.2	11.9	1.4	47.2	3.5	0.7	23.2	60.5
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740541-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3301.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"cerebral cortex: 136.1"	"Immune cell enriched"	"Detected in some"	451	"neutrophil: 483.0"	"Lineage enriched"	"Detected in single"	788	"granulocytes: 483.0"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 4072.6;GAMG: 1080.2"					"Not detected"	"Not detected"			HPA057179	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7260		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	67.9	13.5	1.8	209.9	2.8	3301.3	3.6	1.7	136.1	54.5	7.6	10.6	3.6	41.0	0.2	3.7	8.9	177.2	33.8	1.7	1.6	10.8	77.7	91.2	1.2	2.1	1.6	6.0	16.1	1.8	3.2	41.1	15.1	9.6	7.3	0.9	25.4	1.5	1.3	3.2	4.9	12.7	1.9	10.3	8.8	0.7	4.9	15.2	3.4	8.1	8.7	456.7	4.0	1.9	2.7	1.4	0.0	0.1	3.9	19.4	0.2	25.7	4072.6	35.9	117.0	0.2	13.0	0.2	547.6	1.3	1080.2	48.2	0.0	1.0	562.3	1.8	0.2	0.9	0.4	6.5	6.8	41.0	2.5	12.4	1.7	119.0	2.9	12.9	124.9	0.0	1.4	0.8	0.7	0.0	0.0	55.7	0.0	14.7	20.3	0.3	0.5	0.9	317.3	17.2	0.1	0.0	1.9	0.1	61.1	0.8	0.1	5.6	308.3	56.8	5.1	15.1	55.0	0.4	0.7	1.7	252.5	30.9	88.2	1.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	483.0	0.0	0.0	0.0	0.0	0.1	1.8	2.8	1.7	136.1	1.7	1.6	2.1	1.6	15.1	1.9	4.9	1.9	28.6	51.3	254.1	0.0	26.4	0.0	13262.1	0.0	164.4	0.5	40.2	15.4	23.8	127.2	426.5	0.0	0.0	4.3	17.7	14.4	0.0	1695.0	3.2	717.6	257.1	712.2	19.1	8.0	0.0	260.7	5.2	1475.1	54.0	1708.7	51.2	0.5	15.7	3.6	367.1	0.0	0.0	26.4	0.0	543.0	0.0	1.9	0.6	3685.4	0.0	0.0	1178.5	0.5	0.0	0.0	0.0	584.9	0.3	0.4	27.3	8869.1	0.9	1.0	178.6	1.1	39.5	44.3	263.0	0.3	2.5	124.9	0.0	21.3	138.8	0.0	18.5	13149.4
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836640-73849064	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 36.0;lymphoid tissue: 100.8;urinary bladder: 26.5"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 241.2;Basal respiratory cells: 509.4;Cholangiocytes: 317.4;Club cells: 361.3;Ductal cells: 1120.6;Prostatic glandular cells: 245.5;Urothelial cells: 328.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 5.3"	"Immune cell enriched"	"Detected in single"	104	"neutrophil: 10.4"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 53.2;EFO-21: 136.5;hTEC/SVTERT24-B: 28.8;HUVEC TERT2: 84.5;RPTEC TERT1: 98.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.6"	"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	108000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	6.0	0.1	0.5	14.1	0.8	2.1	0.6	0.2	5.3	4.6	2.7	0.9	8.0	0.0	0.1	2.5	2.4	36.0	3.2	0.3	0.6	3.7	6.6	2.7	0.3	0.4	0.4	0.1	5.3	0.0	0.2	0.1	0.6	3.5	0.6	0.0	3.8	10.8	0.0	0.0	10.3	0.3	0.2	100.8	1.2	0.3	0.9	2.6	0.0	0.3	2.8	26.5	5.6	0.3	0.0	0.0	0.5	0.0	4.4	16.6	0.0	3.3	53.2	0.4	0.7	0.0	0.0	0.0	136.5	0.2	5.3	11.8	0.0	0.0	8.1	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	10.1	0.3	28.8	0.0	0.4	84.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	3.9	0.0	0.0	0.0	98.4	1.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	1.4	0.9	0.5	0.0	0.6	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	5.3	0.3	0.6	0.4	0.4	0.6	0.2	0.9	0.3	0.0	3.2	2.0	0.0	0.1	0.4	241.2	509.4	0.0	0.0	2.9	1.3	0.2	317.4	361.3	0.0	0.0	0.0	0.0	0.2	0.0	1120.6	0.0	0.7	0.1	2.0	78.1	0.0	0.0	3.9	0.0	13.2	0.0	1.3	0.0	0.3	0.0	0.6	0.2	0.0	0.0	0.2	97.6	0.3	0.8	0.1	0.0	1.1	0.0	0.0	7.8	0.0	0.0	0.0	0.0	43.5	0.0	0.0	0.0	245.5	0.0	0.3	75.7	0.0	0.0	1.5	18.4	0.0	1.2	0.3	0.1	0.0	0.1	0.0	0.1	328.4
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853296-73854483	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 2.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 10.0;Club cells: 2.6;Enteroendocrine cells: 5.3;Macrophages: 6.4;Theca cells: 2.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"basophil: 14.2;neutrophil: 9.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in single"		"EFO-21: 1.7"									HPA052485	Supported				"Secreted to blood"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.2	0.0	0.0	0.1	0.2	1.2	0.2	0.0	0.3	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.7	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.9	0.0	0.0	2.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.1	0.3	0.0	11.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.1	0.0	10.0	2.6	1.8	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.7	2.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	1.4	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.5
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871308	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 102.2;lymphoid tissue: 196.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16674.3;Club cells: 7384.0;Ionocytes: 4146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	243	"neutrophil: 47.3"	"Lineage enriched"	"Detected in single"	243	"granulocytes: 47.3"	"Group enriched"	"Detected in many"	6	"BJ hTERT+: 748.4;EFO-21: 1906.7;RPTEC TERT1: 682.0"														"Secreted to blood"	NA	NA	384000		"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"prognostic favorable (7.83e-4)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	38.0	6.2	4.3	49.0	4.9	41.6	3.8	3.6	8.1	102.2	4.8	14.6	10.6	2.3	0.1	38.7	14.9	25.7	28.3	3.5	3.7	18.7	10.2	45.2	2.4	4.0	3.7	2.4	25.7	0.4	2.0	5.1	4.3	18.7	16.0	0.4	23.7	9.5	1.7	2.2	26.9	3.0	4.1	196.6	9.1	0.2	5.4	2.9	1.9	1.9	23.6	75.5	25.5	4.2	3.7	4.4	0.0	0.0	4.4	11.7	0.0	20.6	748.4	17.7	18.8	0.2	13.4	0.0	1906.7	1.3	72.5	38.6	0.0	3.5	94.2	2.8	0.0	0.0	1.3	0.0	4.4	0.0	0.0	9.7	1.3	133.2	10.6	1.4	144.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	7.7	5.4	0.0	0.0	0.0	682.0	16.7	0.1	0.0	1.5	0.3	40.4	2.0	0.5	1.9	173.9	0.0	6.6	37.8	1.5	0.0	1.6	3.7	1.9	0.1	26.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	4.3	4.9	3.6	8.1	3.5	3.7	4.0	3.7	4.3	4.1	5.4	4.2	7.9	44.8	273.3	0.0	2.9	126.6	991.1	16674.3	131.5	0.0	61.3	42.9	4.1	413.2	7384.0	5.5	0.0	0.3	1.4	40.3	0.0	1073.2	0.0	152.2	21.5	106.7	635.7	0.0	0.0	42.5	0.7	449.0	20.9	199.0	15.8	1.4	3.9	2.1	26.7	0.0	0.0	31.1	4146.2	10.4	467.3	0.0	0.0	110.8	124.5	0.0	56.9	0.0	0.0	0.0	0.0	232.8	7.6	0.0	0.1	2062.0	19.6	3.1	1219.7	0.0	0.0	152.9	217.7	0.4	0.2	48.7	105.1	0.4	27.8	0.1	66.0	1251.3
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 66.5;lymphoid tissue: 31.5"	"Cell type enriched"	"Detected in some"	23	"Macrophages: 1360.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 2.2"	"Group enriched"	"Detected in many"	12	"basophil: 85.2;neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.8"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000		"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.8	0.2	0.1	0.7	0.3	66.5	0.3	0.1	2.2	0.1	0.7	1.0	0.0	0.1	0.0	0.1	0.3	0.7	0.9	0.1	0.1	0.6	2.2	10.5	0.3	0.3	0.2	0.1	0.3	0.0	0.3	3.0	0.3	0.1	0.8	0.0	0.4	0.1	1.0	0.0	0.2	0.1	0.4	31.5	0.9	0.1	0.2	0.0	0.6	2.5	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.8	0.0	0.0	1.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	3.8	1.4	0.8	1.2	0.8	0.0	0.2	0.0	1.5	0.7	0.7	0.3	43.0	0.1	3.9	5.4	0.6	148.4	0.1	0.3	0.1	2.2	0.1	0.1	0.3	0.2	0.3	0.4	0.2	0.3	0.7	0.0	0.0	0.0	10.8	0.0	0.2	0.4	0.0	0.0	0.1	0.3	0.0	2.8	1.5	1.8	0.0	0.0	4.1	5.3	0.0	6.0	0.0	0.0	0.0	7.1	13.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	24.7	0.2	0.3	0.0	0.0	1.8	0.0	9.5	0.0	0.1	0.0	1360.7	0.0	0.0	59.0	0.0	57.7	0.0	0.0	7.6	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.3	5.8	0.0	7.4	0.2
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73986439-73988190	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 98.7;lymphoid tissue: 53.6"	"Cell type enriched"	"Detected in some"	18	"Macrophages: 1497.3"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	13	"basophil: 394.2;neutrophil: 132.3"	"Lineage enriched"	"Detected in all"	20	"granulocytes: 394.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	2900000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.3	0.5	0.3	0.5	0.4	98.7	0.6	0.3	2.2	0.1	1.0	0.1	0.0	0.1	0.0	0.2	0.8	0.8	1.3	0.2	0.3	0.9	2.9	19.4	0.0	0.5	0.4	0.1	0.1	0.0	0.4	5.2	0.8	0.1	0.0	0.0	0.6	0.0	1.4	0.1	0.0	0.1	0.8	53.6	0.2	0.0	0.7	0.1	1.0	4.2	0.0	8.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	394.2	13.0	9.3	2.0	5.3	2.9	1.5	1.2	0.6	8.0	2.3	4.1	1.0	132.3	1.9	5.0	20.1	2.1	1791.5	0.3	0.4	0.3	2.2	0.2	0.3	0.5	0.4	0.8	0.8	0.7	0.4	0.3	3.2	1.1	0.0	10.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	4.0	1.8	0.0	0.0	9.3	0.1	0.0	4.7	0.0	0.0	0.0	12.3	0.0	2.7	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	36.8	1.1	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	1497.3	0.0	0.0	80.8	0.0	75.2	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998677	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 35.9;salivary gland: 50.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 64.6;Ductal cells: 94.0;Macrophages: 222.6;Pancreatic endocrine cells: 245.4"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 56.2;stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 191.9;EFO-21: 157.0;HSkMC: 111.4;hTEC/SVTERT24-B: 81.6;RPTEC TERT1: 603.6"									HPA065474	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1110000	1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	2.1	0.2	1.5	35.9	0.9	1.2	3.2	0.6	8.8	7.7	0.4	0.7	0.8	0.2	0.0	0.1	0.2	4.8	0.6	0.8	2.6	0.2	1.3	10.0	6.3	1.4	2.1	0.0	0.5	0.0	0.1	0.2	3.1	1.3	0.3	0.0	50.2	0.5	0.1	0.0	2.1	0.2	1.1	2.1	8.5	0.4	5.7	0.6	0.0	0.2	0.6	8.4	0.0	0.7	0.1	191.9	0.7	0.0	0.3	6.9	0.0	3.5	2.9	1.5	3.0	0.6	1.6	0.0	157.0	0.1	34.0	0.4	0.0	0.0	17.6	0.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	111.4	0.0	81.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	603.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	1.0	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.0	1.5	0.9	0.6	8.8	0.8	2.6	1.4	2.1	3.1	1.1	5.7	0.7	0.2	3.2	0.0	0.0	0.0	0.9	0.7	64.6	0.0	0.0	8.0	4.4	1.2	15.7	33.2	0.0	0.0	0.0	0.1	1.3	0.0	94.0	0.7	0.7	0.1	1.8	0.0	0.0	0.3	1.4	0.1	3.6	15.3	1.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.7	4.1	0.3	30.4	0.3	0.0	222.6	0.0	1.0	2.1	0.0	0.0	0.0	0.1	245.4	0.0	0.0	0.3	3.1	0.0	0.1	4.3	0.0	0.0	0.6	4.0	0.1	0.6	0.0	0.3	0.0	0.3	0.0	1.1	2.0
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.8;cervix: 20.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2244.7;Club cells: 738.5;Ionocytes: 724.2;Langerhans cells: 2366.2;Macrophages: 718.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4;stomach cancer: 18.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.5;hTEC/SVTERT24-B: 75.0;RPTEC TERT1: 43.8"														"Secreted to blood"	NA	NA	28700			"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	20.8	1.0	0.7	14.4	0.4	15.8	1.6	0.4	2.2	20.7	0.6	4.1	0.7	0.7	0.0	1.0	1.3	6.9	6.4	0.5	0.6	1.4	3.9	15.8	0.7	0.6	0.6	1.0	1.8	0.1	0.5	0.6	0.5	1.7	9.2	0.1	5.9	0.3	0.5	0.5	2.5	1.6	0.5	2.0	8.9	0.3	2.7	2.0	0.7	1.0	0.7	15.9	0.6	0.7	0.5	3.7	1.5	0.0	0.8	1.4	0.0	5.3	48.5	1.3	2.9	0.1	5.9	0.0	5.2	0.0	17.6	0.2	0.3	1.7	10.5	0.0	0.0	4.1	0.6	0.0	5.7	0.5	0.0	1.1	1.2	75.0	7.3	1.2	1.1	0.8	0.9	0.0	2.1	0.0	1.1	0.2	0.7	7.0	1.5	0.1	1.7	0.0	43.8	1.3	0.0	0.0	0.5	0.0	1.1	0.7	0.2	0.0	2.0	10.5	0.6	5.3	13.7	0.0	0.0	0.0	11.9	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.4	0.4	2.2	0.5	0.6	0.6	0.6	0.5	0.5	2.7	0.7	34.2	99.3	244.9	1.6	10.1	228.4	205.6	2244.7	340.9	0.0	123.0	79.9	14.8	125.8	738.5	5.5	0.0	0.7	5.9	137.1	0.0	217.6	1.7	103.4	24.3	113.7	52.9	0.0	0.0	96.7	1.1	161.0	408.7	157.2	27.3	0.2	15.7	1.4	72.2	0.0	0.0	168.3	724.2	162.9	2366.2	5.6	14.0	718.0	188.5	1.0	28.1	0.0	0.0	0.0	0.0	186.1	33.5	0.4	5.1	225.9	95.7	0.2	144.2	0.0	39.5	78.5	92.6	1.7	8.3	50.3	148.6	8.1	14.0	0.1	197.5	79.7
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097040-74099196	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 509.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1668.3;Basal respiratory cells: 3166.0;Basal squamous epithelial cells: 1671.5;Langerhans cells: 2390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 1.1;non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.1"	"Cell line enriched"	"Detected in many"	8	"GAMG: 430.9"														"Secreted to blood"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"prognostic favorable (5.93e-5)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	95.6	12.5	4.7	28.2	3.7	88.7	39.6	3.3	6.1	61.0	4.0	9.6	3.5	15.1	0.3	12.2	17.4	52.2	49.8	4.3	10.1	14.7	509.9	87.6	12.6	5.8	4.7	9.1	88.3	2.7	7.2	3.8	4.0	13.4	21.1	1.7	20.7	10.0	21.5	3.2	11.0	14.8	4.4	7.8	26.6	1.3	9.7	3.8	6.6	35.6	1.3	82.1	3.4	4.2	1.3	3.8	0.2	0.0	1.3	4.4	0.1	4.2	52.9	2.1	6.2	0.3	8.0	0.0	7.0	0.3	430.9	0.1	0.3	11.2	8.4	0.1	0.2	3.3	5.0	0.0	35.6	1.4	0.0	4.0	38.5	27.2	37.0	1.4	4.6	0.1	0.1	0.0	1.1	0.0	0.5	0.5	0.0	4.6	1.1	0.0	0.0	0.0	26.2	0.0	0.0	0.1	2.5	0.4	1.1	0.4	0.1	0.1	7.1	1.9	0.7	7.7	4.0	0.1	0.1	0.1	30.8	8.9	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	4.7	3.7	3.3	6.1	4.3	10.1	5.8	4.7	4.0	4.4	9.7	4.2	620.7	477.5	1668.3	1.0	15.0	415.5	336.3	3166.0	1671.5	0.0	762.9	283.3	22.9	469.0	957.6	9.2	0.0	3.3	17.9	91.4	0.0	858.1	1.1	489.8	149.1	677.8	132.1	34.7	0.0	603.6	3.1	488.7	206.9	1223.1	85.2	0.1	365.1	325.8	117.3	0.0	0.0	131.6	498.5	291.4	2390.3	0.8	15.8	926.0	277.5	0.0	50.7	0.6	0.0	0.0	0.0	282.5	14.6	0.0	35.3	342.6	57.8	1.1	194.1	0.3	72.3	131.8	288.7	1.1	5.0	440.3	227.7	2.2	36.3	0.6	128.5	119.1
MTHFD2L	MGC72244	ENSG00000163738	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like"	Q9H903	4	74114174-74303099	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035434	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA035434: AB_10601038"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.42e-4)"	"unprognostic (3.45e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.81e-3)"	1.6	3.7	5.6	1.2	5.4	1.7	3.3	3.5	6.5	1.4	1.1	1.6	1.6	1.6	3.4	1.9	1.5	1.1	6.0	4.1	8.5	1.9	7.0	1.3	1.2	5.0	5.0	1.6	1.6	2.5	1.5	1.7	5.1	1.5	1.1	2.6	1.4	1.7	2.7	1.2	1.0	1.2	5.4	1.4	1.4	0.9	5.8	3.4	2.0	3.9	1.1	1.3	1.2	7.6	2.8	2.8	4.0	3.6	1.4	2.1	0.9	3.3	2.6	2.2	2.4	2.2	2.6	3.0	4.5	1.5	1.6	1.7	3.2	2.2	3.3	3.1	2.0	3.7	1.9	2.6	2.4	5.8	0.7	1.5	5.1	3.3	7.9	4.1	4.7	6.7	6.6	3.6	2.7	2.7	10.9	8.3	1.2	4.5	3.1	10.9	2.7	5.1	14.2	1.4	3.7	8.0	1.8	2.8	3.5	4.3	1.5	4.0	4.9	2.5	3.8	4.8	5.6	3.6	5.0	8.8	15.5	1.3	3.8	0.3	0.9	0.4	0.3	0.9	0.3	1.8	0.2	0.4	1.5	0.6	0.8	0.9	0.6	1.1	3.5	1.6	1.4	1.0	5.6	5.4	3.5	6.5	4.1	8.5	5.0	5.0	5.1	5.4	5.8	7.6	23.3	22.4	19.6	57.5	18.9	16.6	63.5	31.1	30.1	0.0	90.5	53.6	24.5	30.0	27.6	49.7	0.0	17.9	17.1	23.3	84.1	24.0	85.7	67.1	11.0	19.9	37.2	44.2	41.2	19.1	8.8	13.5	35.7	50.4	10.2	35.5	25.0	104.7	24.5	0.0	41.0	34.7	69.2	27.3	23.0	23.2	12.8	30.4	16.0	20.6	17.3	0.0	12.3	74.9	73.1	15.6	19.4	8.6	20.9	69.2	18.3	51.3	30.1	0.0	26.3	19.4	21.1	8.1	12.3	44.0	22.6	12.3	11.1	36.8	36.4	71.9
EPGN	"ALGV3072, EPG, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308470-74316789	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 49.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.0;Basal prostatic cells: 7.3;Basal squamous epithelial cells: 25.6;Urothelial cells: 5.1"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 157.9;U-2197: 74.8"	"Not detected"	"Not detected"							HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.6	0.1	0.2	1.6	0.1	0.3	1.4	0.4	0.6	5.2	0.1	0.1	0.1	0.0	1.1	49.0	1.5	0.1	0.8	0.2	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.1	0.1	2.2	0.1	0.5	0.1	0.2	0.0	0.2	3.6	3.1	0.1	3.5	0.1	0.0	0.1	0.3	0.0	1.1	0.1	0.9	0.0	0.0	3.4	1.3	9.6	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.2	0.0	0.0	0.4	0.0	0.8	0.0	0.1	1.8	0.2	3.6	0.0	2.8	0.0	0.0	0.0	0.5	20.2	0.0	0.2	0.0	0.7	0.0	157.9	2.9	11.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.0	0.0	0.3	0.0	3.6	0.4	0.0	0.0	0.3	0.3	0.1	0.0	8.3	3.3	0.0	0.0	0.5	0.0	0.2	0.4	0.1	74.8	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.3	0.3	0.1	0.7	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.4	0.0	0.0	1.5	0.0	0.0	6.0	7.3	0.9	25.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	3.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.0	1.6	0.1	0.2	0.0	0.0	5.1
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365145-74388749	"Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"bone marrow: 129.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 179.1;Kupffer cells: 133.9;Langerhans cells: 171.1;Macrophages: 570.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 270.0;CAPAN-2: 76.7;hTEC/SVTERT24-B: 83.7;U-2197: 181.4;U-87 MG: 307.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000			"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	4.5	0.0	0.3	10.3	0.3	129.0	2.5	0.2	0.5	1.9	0.2	2.0	0.2	0.2	0.2	12.6	0.8	5.7	0.7	0.3	0.1	0.1	0.2	2.7	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.4	0.1	3.4	0.1	1.3	0.0	0.2	9.3	1.6	3.0	0.0	0.5	0.2	0.1	0.6	0.1	0.1	0.0	1.0	4.9	4.0	0.3	1.4	41.1	0.0	0.0	3.8	6.6	0.1	9.2	270.0	2.6	1.6	32.5	76.7	0.0	44.1	0.0	20.1	2.4	0.0	59.3	2.7	0.0	0.0	1.2	1.6	1.2	1.1	0.1	0.1	3.9	20.2	83.7	43.5	0.0	0.0	0.0	0.1	0.5	0.2	0.4	0.1	0.1	0.1	0.2	0.6	0.1	0.0	0.1	0.6	1.6	0.0	0.0	27.0	0.2	0.0	0.0	0.1	0.0	0.0	1.6	0.6	181.4	0.0	0.0	0.0	0.2	307.0	0.0	0.2	0.4	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.1	0.2	0.1	0.4	0.0	0.6	0.3	4.9	6.4	7.2	0.0	5.7	5.4	5.6	179.1	4.0	0.0	24.4	2.3	18.2	5.7	82.4	0.0	0.0	0.4	2.2	56.3	0.0	1.8	3.7	2.4	0.7	2.5	3.6	17.0	0.1	0.2	0.7	4.4	0.5	3.9	7.0	0.1	0.4	1.9	26.8	0.0	1.8	38.2	16.2	133.9	171.1	1.0	0.3	570.7	7.2	0.0	23.2	0.0	0.0	0.0	0.0	0.8	27.1	0.0	11.7	2.5	32.4	0.2	41.9	0.0	0.0	2.5	3.1	0.5	0.3	3.8	9.2	0.7	3.3	0.2	33.1	7.4
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445136-74455005	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.9;placenta: 328.8;urinary bladder: 145.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1119.1;Basal prostatic cells: 1254.3;Macrophages: 1271.1;Paneth cells: 909.8;Urothelial cells: 2102.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 67.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 11.0;eosinophil: 11.8;NK-cell: 3.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 11.8;NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 379.0;HBEC3-KT: 648.1;hTCEpi: 644.0;hTERT-HME1: 1365.7;MCF7: 416.8"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in many"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	48.1	4.6	0.1	36.7	0.1	129.9	61.6	0.1	0.8	19.2	1.8	18.7	3.3	3.7	0.2	43.4	13.2	74.1	20.5	0.3	0.1	2.5	4.0	36.1	1.9	0.3	0.2	12.4	4.5	1.5	9.5	328.8	0.8	6.5	18.9	0.1	11.7	0.7	18.4	15.3	10.2	6.5	0.2	10.0	20.2	9.3	0.4	7.1	5.4	0.8	3.0	145.6	13.8	0.4	15.9	107.3	0.0	0.0	0.9	1.4	0.0	3.2	5.0	0.7	2.9	379.0	59.8	0.0	8.0	0.0	0.0	17.4	0.1	648.1	6.5	0.1	0.0	0.4	2.8	18.0	191.9	2.3	0.4	5.9	644.0	37.8	1365.7	0.9	0.2	0.4	1.6	0.7	14.4	416.8	0.2	0.0	0.0	78.6	42.8	0.0	0.1	0.1	36.4	2.9	0.5	0.2	22.2	1.2	0.0	0.4	11.6	0.1	1.0	0.0	15.3	5.3	0.1	0.9	0.0	0.1	0.0	0.0	1.7	11.0	0.0	11.8	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.3	0.2	0.0	0.1	3.8	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.3	0.2	0.8	0.2	0.4	0.4	670.0	198.7	301.9	0.0	190.7	1119.1	1254.3	73.0	303.9	0.0	801.5	460.2	49.0	62.9	183.9	51.5	0.0	1.8	836.1	878.0	0.0	61.8	70.4	167.7	12.3	32.2	41.6	18.5	0.0	10.2	1.5	80.8	254.9	193.1	680.5	0.9	10.8	4.2	32.2	0.0	0.5	393.5	8.2	250.4	196.4	12.1	0.3	1271.1	33.8	0.0	1.7	0.8	20.6	0.0	0.0	497.1	909.8	1.2	352.1	115.3	55.7	0.7	53.3	0.2	19.7	10.3	20.2	68.3	51.1	194.5	342.4	1.1	473.6	1.2	308.9	2102.9
BTC		ENSG00000174808	Betacellulin	P35070	4	74744759-74794523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.5;Respiratory ciliated cells: 43.1;Skeletal myocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.1;MCF7: 5.8;RPTEC TERT1: 9.5;SK-BR-3: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	314000			"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (7.36e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.76e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.35e-1)"	"prognostic favorable (6.10e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.31e-3)"	2.5	1.7	0.6	1.8	0.8	0.0	4.1	0.2	0.9	2.7	3.9	25.6	4.3	3.2	6.9	11.0	7.6	6.2	0.4	0.9	0.7	4.4	1.1	4.6	0.1	1.0	1.3	0.9	2.9	7.3	1.6	0.4	0.8	4.6	7.4	4.2	6.9	4.4	0.4	13.7	6.8	10.0	0.9	0.1	6.2	0.6	0.7	0.2	5.8	1.0	0.5	4.6	1.9	0.7	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.1	0.0	16.1	0.0	3.3	0.0	2.3	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.2	0.3	0.1	2.6	0.1	0.0	0.0	0.1	0.4	5.8	0.1	0.0	0.0	1.7	2.4	0.0	0.0	0.0	9.5	4.6	0.2	0.0	2.4	6.4	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.3	2.8	0.3	0.0	0.0	2.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.8	0.2	0.9	0.9	0.7	1.0	1.3	0.8	0.9	0.7	0.7	2.9	9.6	10.8	0.0	0.0	0.6	3.9	3.7	0.0	2.4	3.9	1.4	0.9	4.3	12.2	11.0	2.1	0.5	0.0	6.1	0.0	4.1	2.0	18.5	1.3	0.7	12.0	0.0	7.7	5.9	0.0	0.7	8.6	10.7	0.0	6.7	2.9	0.4	0.1	0.0	3.2	9.9	10.2	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	10.4	0.0	2.5	0.3	3.3	4.9	0.0	0.0	4.3	1.7	1.1	43.1	5.7	0.0	18.5	5.6	0.0	0.2	8.4	3.0	0.3	0.2	1.2	7.3	7.6
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
RCHY1	"ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363"	ENSG00000163743	"Ring finger and CHY zinc finger domain containing 1"	Q96PM5	4	75479037-75514764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030338, HPA030339"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Vesicles"	"HPA030338: , HPA030339: AB_10603232"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (3.62e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.89e-5)"	8.6	7.0	9.5	7.9	10.2	17.0	16.8	12.6	13.0	9.0	7.7	12.1	8.7	9.6	6.9	7.2	11.9	6.8	16.8	9.4	10.6	16.2	12.3	10.0	9.5	8.9	10.4	14.5	8.3	12.6	5.8	10.0	9.9	10.9	13.2	14.8	12.9	10.1	16.5	5.6	8.6	11.6	9.9	11.5	8.9	13.6	10.7	12.7	18.9	23.6	12.6	7.6	4.7	10.7	9.8	5.0	14.6	13.8	15.1	13.1	8.4	6.5	15.1	13.2	15.4	13.8	11.9	16.2	12.0	9.4	13.1	5.8	37.6	11.5	19.9	13.4	12.3	21.2	9.2	17.9	13.0	28.9	11.2	12.2	14.1	15.2	14.2	15.9	27.0	20.8	19.9	16.2	30.9	15.8	26.7	11.5	24.5	26.9	8.7	14.2	34.4	13.9	20.4	16.7	22.6	12.4	10.7	24.8	28.2	15.9	14.0	12.9	10.8	8.6	8.5	7.8	11.1	17.0	13.0	22.8	10.5	20.2	14.0	27.5	9.2	9.7	4.3	5.7	7.6	4.6	5.4	5.2	8.0	2.1	3.9	5.5	4.0	5.5	5.6	4.1	5.7	4.7	9.5	10.2	12.6	13.0	9.4	10.6	8.9	10.4	9.9	9.9	10.7	10.7	22.2	19.2	10.3	28.4	25.4	40.7	32.3	47.1	39.3	35.0	38.5	25.9	56.8	24.3	23.5	23.9	20.9	31.6	31.2	21.9	68.4	30.3	37.3	11.9	17.1	22.3	13.8	21.8	31.2	22.5	23.2	24.6	21.9	17.3	5.1	23.8	25.4	23.0	19.0	23.5	32.3	23.4	38.7	37.5	26.8	59.8	22.4	27.4	28.4	22.5	23.9	32.0	24.7	31.7	41.0	26.5	22.6	25.2	19.7	36.6	24.6	69.4	13.5	21.7	32.9	20.9	27.3	72.8	41.7	28.1	31.0	33.8	32.9	35.2	27.6	26.3
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	9.8	11.3	6.8	12.6	12.3	12.6	15.3	14.4	10.0	10.2	8.9	9.9	12.4	16.5	12.7	9.4	10.6	9.1	14.6	7.9	11.5	9.8	12.5	9.4	15.7	11.7	9.6	14.8	8.5	12.4	9.4	9.6	11.0	13.5	11.7	21.7	13.3	10.2	15.3	16.7	13.2	10.7	7.2	12.5	11.0	23.5	10.8	9.2	15.5	13.6	12.1	9.2	8.5	21.0	8.5	6.2	13.4	9.2	14.8	14.9	6.9	19.8	10.1	10.5	10.8	7.3	20.7	11.5	10.0	6.6	11.8	8.8	12.4	8.8	12.8	14.1	8.5	8.8	10.5	9.3	20.0	12.8	9.5	12.3	16.9	11.7	18.3	16.5	5.9	14.8	16.2	25.0	11.3	10.4	11.1	8.2	6.8	12.2	5.8	11.0	14.5	8.5	9.9	6.5	10.0	10.3	9.6	12.6	11.8	11.0	14.1	10.2	6.8	17.5	11.6	20.8	9.8	22.4	12.3	11.5	11.9	9.5	14.9	17.2	8.4	12.7	9.0	7.4	12.2	8.6	10.9	8.6	7.0	10.2	12.2	9.5	18.2	6.9	8.3	5.7	13.3	6.6	6.8	12.3	14.4	10.0	7.9	11.5	11.7	9.6	11.0	7.2	10.8	21.0	11.0	12.8	11.0	21.9	19.8	8.3	14.7	12.7	14.8	20.2	13.0	10.5	17.0	18.6	11.5	22.0	31.3	10.8	13.5	8.9	15.6	8.3	131.8	13.1	13.5	8.5	12.6	12.6	11.0	6.4	8.8	16.0	8.6	8.4	10.8	18.0	9.3	9.8	7.2	16.8	15.6	12.8	6.1	14.0	6.5	23.0	14.0	9.6	7.2	13.1	11.5	13.3	8.2	18.6	35.9	8.0	11.5	11.3	17.5	11.4	16.7	15.7	20.6	18.9	0.0	10.0	13.7	56.0	16.6	12.2	6.8	7.7	18.1	15.5	7.5	7.7
ODAPH	"AI2A4, C4orf26, FLJ23657"	ENSG00000174792	"Odontogenesis associated phosphoprotein"	Q17RF5	4	75556048-75565871	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.7;placenta: 5.8"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 9.2;Syncytiotrophoblasts: 27.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1;urothelial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	33	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 10.7"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 61.3"														"Secreted in other tissues"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (1.13e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-2)"		"unprognostic (1.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.17e-7)"	"unprognostic (8.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.40e-4)"	"unprognostic (6.53e-3)"	0.1	0.1	0.7	0.2	0.7	0.3	0.1	0.9	1.7	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.6	0.1	0.1	0.1	0.2	0.8	0.8	0.1	0.0	0.0	0.4	5.8	0.9	0.1	0.2	0.5	0.1	0.1	0.9	0.3	0.2	0.0	0.6	0.1	0.1	0.4	0.7	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	1.3	0.5	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.3	61.3	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.0	2.8	0.0	2.1	0.3	0.1	0.0	0.1	2.6	0.1	0.9	9.6	0.1	0.1	0.6	0.2	0.0	10.7	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.7	0.7	0.9	1.7	0.6	0.6	0.8	0.8	0.9	0.6	0.7	1.5	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.8	0.0	1.9	0.1	0.0	0.0	3.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	9.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	27.0	0.1	0.1	0.0	0.0
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75576496-75630716	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;choroid plexus: 8.6;retina: 9.6;testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 76.4;Early spermatids: 57.8;Excitatory neurons: 32.8;Inhibitory neurons: 40.9;Oligodendrocytes: 46.4;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HHSteC: 1.9;RPTEC TERT1: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.1	1.0	6.3	0.3	6.7	0.0	0.3	4.1	8.3	0.6	8.6	0.7	0.1	0.6	0.9	0.8	1.6	0.4	0.3	6.5	6.1	5.9	0.0	4.7	0.3	6.0	4.8	1.6	0.5	2.5	1.5	0.0	6.5	0.6	0.9	9.6	0.3	0.6	0.0	0.2	0.1	0.4	4.9	0.1	0.6	11.6	5.8	0.0	3.1	0.0	0.6	0.2	0.3	8.3	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.8	1.0	0.9	0.1	0.5	0.0	0.3	0.0	1.0	0.2	0.0	0.2	0.9	0.1	1.5	0.0	0.1	0.0	1.9	0.0	0.0	0.6	1.0	0.1	0.3	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.2	0.1	1.1	0.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.7	4.1	8.3	6.5	6.1	6.0	4.8	6.5	4.9	5.8	8.3	0.2	25.6	76.4	5.9	0.4	0.1	0.5	0.6	0.6	17.7	0.7	3.0	0.9	1.5	4.7	9.2	4.2	0.1	0.3	3.0	7.9	1.9	57.8	11.6	1.4	0.2	1.8	0.0	32.8	0.2	0.6	1.2	1.1	2.5	1.3	1.0	0.4	0.0	0.1	10.1	40.9	2.3	0.0	0.0	0.4	20.7	1.8	0.5	1.8	3.7	0.0	11.6	0.0	5.5	46.4	0.1	1.0	1.2	0.3	0.2	0.0	29.5	18.6	20.2	0.0	0.4	1.1	101.7	4.1	0.8	0.3	0.3	2.7	0.2	2.7	0.2
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75641849-75724589	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol		NA	NA		47000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	37.6	41.5	32.6	50.9	35.6	69.2	50.3	24.2	48.5	47.2	12.9	61.7	52.4	45.1	32.1	49.5	55.2	49.7	47.8	33.7	51.7	67.5	65.3	46.0	60.2	26.0	28.8	32.0	42.2	56.0	28.2	38.4	32.4	77.8	58.0	46.8	37.0	49.2	115.1	25.5	62.6	55.0	24.0	48.0	47.5	60.5	40.0	66.5	74.6	119.5	61.2	65.8	25.8	30.0	96.8	96.6	160.5	131.1	134.8	136.6	54.1	141.6	144.6	96.2	101.5	128.5	137.1	197.1	125.5	120.1	87.0	68.8	170.1	176.0	136.6	111.4	66.2	185.7	95.7	141.7	119.8	188.4	146.2	109.9	144.4	114.6	122.8	129.1	172.1	114.9	140.9	139.2	150.7	63.0	218.4	63.1	154.1	140.3	36.3	159.8	199.2	96.3	112.3	125.8	124.1	141.1	105.7	151.0	201.9	165.7	75.1	90.9	178.5	95.3	76.5	107.7	81.7	136.2	133.9	195.2	135.5	122.9	122.7	83.1	36.2	62.4	50.0	47.8	76.4	35.1	48.1	55.8	41.1	28.2	46.9	51.5	30.8	59.6	64.1	18.5	44.1	64.1	32.6	35.6	24.2	48.5	33.7	51.7	26.0	28.8	32.4	24.0	40.0	30.0	72.8	54.5	100.7	26.1	126.3	89.0	81.7	53.2	114.4	61.4	71.8	55.2	79.1	20.0	81.0	53.3	50.1	36.4	133.0	92.2	41.1	59.0	213.8	84.7	57.8	69.8	135.4	43.9	70.6	68.9	49.3	56.7	65.2	80.0	105.7	76.7	51.0	77.7	45.7	70.7	74.9	107.9	50.8	75.9	131.3	228.8	26.4	86.1	60.5	30.9	85.3	29.3	53.5	36.7	59.1	94.8	66.6	39.9	117.7	84.5	88.3	104.1	85.8	69.1	19.7	57.2	91.9	63.2	74.8	79.8	77.7	41.3	186.2	99.5	75.6	88.3
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724577-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		170000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	35.0	38.7	13.1	32.3	14.7	13.0	39.0	15.6	19.0	44.3	26.1	33.9	35.6	32.3	64.2	50.1	30.1	32.0	57.4	14.9	16.1	38.7	76.8	30.4	32.5	16.7	14.4	56.9	57.5	37.7	31.5	43.7	16.4	39.9	36.9	39.2	54.7	37.5	219.2	36.2	33.7	35.7	14.9	26.3	40.8	43.1	15.6	30.7	53.4	138.7	39.7	40.2	27.6	19.2	46.8	36.0	49.5	66.7	118.6	155.8	45.5	106.2	129.4	57.2	69.2	36.2	70.4	60.6	64.0	98.0	49.2	52.8	74.9	66.5	85.6	67.2	29.3	41.8	31.4	76.3	93.0	55.8	46.2	89.2	80.6	59.8	116.4	110.6	87.1	41.7	73.7	67.9	85.8	30.9	55.4	29.5	67.9	98.2	21.3	36.3	47.2	49.2	85.5	53.1	39.4	38.3	39.1	82.4	67.3	73.6	60.6	45.1	67.4	52.2	32.2	95.8	40.7	63.6	36.6	29.5	77.6	33.1	63.2	21.9	13.1	11.9	16.4	18.7	22.2	9.8	13.6	15.7	16.8	11.2	13.9	13.8	8.1	22.2	26.9	13.4	15.1	13.7	13.1	14.7	15.6	19.0	14.9	16.1	16.7	14.4	16.4	14.9	15.6	19.2	34.5	60.9	84.5	59.1	43.2	38.0	52.8	59.6	51.2	33.3	35.0	28.4	126.9	28.6	71.7	25.8	43.8	47.9	32.6	32.0	35.2	38.4	11.1	35.7	57.5	36.4	40.1	20.8	70.9	48.6	49.0	62.7	61.2	55.0	48.8	126.2	32.9	62.0	42.8	26.9	68.7	63.7	40.7	38.0	35.1	10.9	78.6	41.3	28.4	60.9	54.8	32.8	45.3	77.4	113.7	48.5	33.4	68.4	106.9	78.2	44.3	50.4	66.4	51.2	39.5	54.0	50.5	73.8	68.2	58.7	40.3	90.6	37.8	36.3	41.9	63.8
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	462	"retina: 238.7"	"Group enriched"	"Detected in some"	25	"Cone photoreceptor cells: 166.8;Rod photoreceptor cells: 576.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	238.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.4	0.0	0.0	0.0	166.8	0.0	0.1	0.1	0.0	0.0	6.3	0.0	0.1	1.5	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	1.9	0.1	14.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	576.7	0.0	0.4	0.1	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913660-75941013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 142.2;Kupffer cells: 115.8;Langerhans cells: 109.9;Proximal enterocytes: 167.7"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 672.4;non-classical monocyte: 583.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 672.4"	"Cell line enhanced"	"Detected in many"		"U-2197: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	19.0	14.6	9.2	30.0	10.0	18.5	37.4	10.9	10.8	23.0	14.1	61.8	30.9	12.9	9.1	28.4	16.4	15.7	19.9	9.5	13.3	40.6	68.4	23.0	48.4	11.2	11.1	8.2	7.6	11.7	7.7	19.4	11.7	70.9	69.9	32.7	31.5	11.4	8.6	22.8	60.7	15.4	9.5	63.8	18.5	3.4	13.2	16.3	15.9	13.0	27.9	20.0	18.4	14.5	11.9	26.6	1.1	0.7	62.4	62.8	1.1	17.5	11.6	11.8	4.0	9.3	41.1	1.0	8.9	43.5	0.4	23.1	34.8	13.4	7.1	17.0	1.3	8.4	19.4	22.6	14.3	31.4	29.6	16.0	10.0	10.3	3.5	18.4	19.1	18.7	9.6	35.9	10.6	43.5	20.2	20.5	13.5	53.4	10.5	13.5	0.4	55.6	12.4	6.7	15.9	2.3	18.1	56.2	5.4	1.8	63.3	54.1	28.8	0.7	1.5	78.6	0.8	8.8	3.8	5.9	14.8	44.5	7.4	48.6	270.1	110.3	62.0	672.4	67.5	58.8	78.4	61.8	143.2	40.4	65.2	54.5	90.3	35.5	583.3	53.2	114.6	233.7	9.2	10.0	10.9	10.8	9.5	13.3	11.2	11.1	11.7	9.5	13.2	14.5	10.6	0.0	7.3	7.2	31.2	11.3	18.8	5.7	4.0	11.5	31.3	14.2	4.4	25.8	10.9	5.5	18.8	24.6	19.5	142.2	13.7	5.7	0.5	12.1	18.1	14.6	48.0	10.8	17.7	8.4	19.2	28.2	3.1	11.9	15.2	3.5	18.5	37.2	39.7	11.8	27.4	45.4	8.2	115.8	109.9	0.0	10.5	80.3	17.8	7.5	77.8	7.7	16.5	5.0	4.8	4.1	46.7	7.5	16.8	55.4	167.7	12.4	27.7	86.9	0.0	31.8	16.7	1.1	0.9	15.9	18.9	13.3	34.8	9.1	24.4	14.0
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Human disease related genes, Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	14.6	13.5	10.5	14.8	10.8	7.2	17.9	8.4	12.3	13.6	8.5	14.3	11.9	17.6	19.0	15.3	12.7	8.7	14.3	10.9	11.0	15.0	15.8	12.6	21.2	9.6	8.9	13.7	17.7	17.7	8.9	12.9	9.3	14.2	15.1	6.8	15.0	16.2	22.9	14.8	11.1	17.1	8.5	15.5	14.0	21.3	11.1	16.4	21.2	16.4	20.2	18.8	11.7	10.2	29.8	11.8	28.5	38.9	33.1	29.8	30.6	41.3	35.9	34.0	29.1	36.6	42.0	46.7	30.2	38.1	32.4	29.7	44.5	40.5	42.3	41.2	23.0	39.9	24.4	30.6	32.7	68.5	43.9	26.4	45.0	36.3	40.4	21.1	30.0	31.2	72.7	37.8	36.4	33.1	69.6	25.1	47.4	48.3	18.1	41.8	53.5	39.3	32.7	32.6	43.3	35.6	28.1	57.0	48.9	31.1	26.4	39.6	29.1	36.6	36.7	44.4	34.8	33.9	37.6	62.0	40.7	31.1	46.0	10.4	14.5	4.1	19.1	19.1	23.8	17.8	23.0	21.1	15.3	20.1	23.0	19.5	2.3	23.4	27.5	13.0	21.5	15.9	10.5	10.8	8.4	12.3	10.9	11.0	9.6	8.9	9.3	8.5	11.1	10.2	36.2	19.2	34.7	15.0	45.7	27.5	26.8	45.1	35.3	21.1	21.3	29.1	12.3	14.3	46.0	22.0	6.2	30.6	35.7	14.5	35.2	37.7	109.0	12.1	29.9	25.2	22.8	35.3	34.0	24.9	32.2	27.4	20.9	18.7	49.4	26.3	18.9	22.1	37.9	13.5	31.8	22.6	36.7	24.3	16.3	106.7	25.4	30.0	24.9	30.9	40.3	23.7	42.2	23.6	29.9	33.4	18.3	33.1	49.0	37.1	17.1	46.6	26.1	20.0	19.7	33.2	38.7	75.6	100.7	47.5	33.1	25.0	38.1	33.2	27.9	22.4
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007509	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 309.9"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 5.0;Hofbauer cells: 6.2;Kupffer cells: 10.3;Macrophages: 12.6;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	902000		"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	5.5	2.0	0.1	65.1	0.2	0.2	17.5	0.1	0.6	4.9	0.3	10.2	3.0	4.8	0.7	5.3	2.8	8.5	5.9	0.1	0.1	8.7	19.1	31.8	309.9	1.8	0.2	3.8	1.4	1.5	1.0	1.7	1.6	3.7	25.3	0.0	19.0	0.7	1.5	2.9	6.0	3.2	0.3	31.2	17.5	6.0	0.2	32.8	7.1	2.5	30.6	11.1	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	1.8	0.2	1.6	0.3	0.2	0.3	3.4	0.0	1.7	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.4	0.0	0.2	1.3	0.1	1.1	2.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	5.0	1.8	6.2	0.0	0.0	0.0	0.0	10.3	3.6	1.3	0.6	12.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	3.5	1.7	8.0	0.0	0.3	0.1	0.5	0.0	0.1	0.4
ART3	ARTC3	ENSG00000156219	"ADP-ribosyltransferase 3 (inactive)"	Q13508	4	76011184-76112802	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 67.3;skeletal muscle: 220.2;testis: 96.4;tongue: 101.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 76.2;Spermatocytes: 262.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"NB-4: 5.5;NTERA-2: 14.1;SK-MEL-30: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		48000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	1.0	0.4	3.4	1.1	4.2	0.0	0.9	6.9	9.4	2.2	4.0	3.7	0.3	0.3	0.5	4.7	0.9	0.2	67.3	4.7	4.6	0.2	0.2	0.4	0.3	3.3	3.3	0.4	7.9	0.1	2.5	0.1	2.8	2.0	2.2	0.2	3.1	1.3	220.2	0.9	2.3	0.4	3.5	2.7	1.9	96.4	2.7	0.6	0.3	101.6	0.1	0.7	1.7	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	14.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	6.9	9.4	4.7	4.6	3.3	3.3	2.8	3.5	2.7	9.9	0.4	0.0	0.0	0.7	0.1	0.5	0.5	1.1	0.0	0.5	0.2	0.3	76.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.3	2.1	0.4	0.8	0.0	0.0	37.9	0.0	0.1	2.6	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.4	13.5	1.8	0.2	1.8	0.0	0.0	0.3	0.0	5.0	7.3	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.3	0.0	21.7	2.7	262.8	24.2	0.0	0.3	0.0	0.2	0.1	0.8	0.4
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021118-76023497	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.7;Glandular and luminal cells: 23.5;Kupffer cells: 41.1;Langerhans cells: 21.4;Macrophages: 45.7;Plasma cells: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 52.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.1;BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;GAMG: 5.1;RPMI-8226: 4.3;RT4: 2.4;THP-1: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	253000		"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.0	5.9	1.4	95.5	1.5	1.2	20.7	0.9	2.6	13.2	1.2	10.7	11.2	7.1	0.7	8.0	4.1	10.6	4.4	1.2	1.0	7.8	29.0	35.1	68.0	7.4	1.2	3.0	0.9	17.1	2.1	10.3	10.8	43.9	15.9	0.4	20.1	1.8	1.2	2.0	11.2	15.8	3.4	20.3	19.2	3.0	2.6	35.2	3.7	1.1	17.3	45.1	3.7	1.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	6.1	2.2	2.2	0.2	0.1	2.0	0.2	0.0	5.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.3	0.1	2.4	0.0	0.0	0.0	0.4	1.3	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.6	0.0	0.0	21.5	0.0	0.0	52.4	0.0	1.4	0.3	0.0	3.5	0.1	0.0	0.0	1.1	0.0	36.9	0.0	0.0	7.6	1.4	1.5	0.9	2.6	1.2	1.0	7.4	1.2	10.8	3.4	2.6	1.5	3.8	0.0	2.2	0.0	2.2	0.9	9.4	52.7	0.6	0.0	2.6	7.0	0.3	1.5	2.8	0.0	0.0	0.1	0.0	2.7	0.0	5.9	2.6	12.5	10.9	8.0	0.0	0.0	0.0	0.0	0.0	6.9	3.1	23.5	1.3	0.0	0.0	0.1	17.3	0.0	0.0	1.0	10.2	41.1	21.4	4.0	0.3	45.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	11.4	6.4	2.6	1.3	0.0	0.0	1.3	12.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.9	1.4
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Human disease related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Basal prostatic cells: 2.6;Basal respiratory cells: 2.9;Distal enterocytes: 2.7;Exocrine glandular cells: 3.6;Macrophages: 4.3;Prostatic glandular cells: 3.7;Proximal enterocytes: 2.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 3.4;BJ hTERT+ SV40 Large T+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 5.3;GAMG: 1.4"					"Region enhanced"	"Detected in single"		"spinal cord: 1.2"	CAB009921	Uncertain				"Secreted to blood"	NA	NA	187000			"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.31e-7)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	1.6	0.4	1.5	11.1	1.3	0.3	3.7	1.1	3.5	2.5	1.0	1.7	0.8	1.5	0.2	1.0	1.6	1.2	1.2	1.2	1.2	1.3	2.4	6.0	11.9	2.3	1.4	0.5	8.9	0.1	0.3	3.6	2.2	5.2	4.3	0.0	3.1	0.3	0.3	0.3	1.2	1.7	1.6	5.8	6.3	0.9	2.0	6.3	1.2	0.0	1.4	4.6	0.6	1.3	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.4	5.1	5.3	0.0	0.1	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	1.1	3.5	1.2	1.2	2.3	1.4	2.2	1.6	2.0	1.3	0.5	3.2	0.0	0.0	0.2	0.1	2.6	2.9	0.0	0.0	0.2	0.3	0.2	1.5	0.2	0.0	0.0	0.0	0.0	2.7	0.0	2.0	0.0	0.7	0.9	2.2	0.0	0.0	0.0	3.6	0.0	0.5	0.0	1.6	0.0	0.0	0.4	0.2	1.8	0.0	0.0	0.1	0.0	2.1	0.3	0.0	0.0	4.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	2.8	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.2	1.4
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158737-76234536	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 12.5;classical monocyte: 14.1;intermediate monocyte: 26.0;myeloid DC: 8.2;non-classical monocyte: 24.9;plasmacytoid DC: 28.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 28.9;granulocytes: 12.5;monocytes: 26.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 499.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA		9200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	60.6	24.0	33.5	27.7	63.5	7.3	56.7	58.9	38.9	60.8	18.9	61.6	39.2	44.1	58.4	33.9	45.4	60.0	61.6	29.6	48.6	46.8	89.9	77.1	20.2	62.2	49.6	58.9	58.9	63.6	11.1	80.2	62.5	72.3	64.0	53.2	80.5	55.4	89.8	26.0	49.1	57.8	60.1	47.0	60.7	19.4	50.7	21.3	65.9	81.3	20.6	65.3	25.1	92.9	39.8	38.4	48.9	97.1	499.7	242.0	35.8	131.5	250.2	114.0	178.2	72.5	112.3	0.0	85.1	262.3	109.6	28.3	28.3	78.9	96.0	138.8	30.1	3.2	32.9	25.3	129.9	19.0	12.1	186.9	72.3	117.3	54.5	268.9	200.6	10.0	15.6	188.6	159.2	58.2	1.6	4.0	9.7	120.3	23.6	23.3	82.7	42.0	64.4	43.6	101.3	110.2	104.7	61.3	115.5	49.3	34.6	17.1	131.3	125.9	48.5	104.7	47.5	167.6	98.8	0.2	158.1	22.2	170.9	12.5	14.1	3.1	2.8	26.0	2.6	3.8	1.9	1.5	8.2	3.0	2.6	4.3	1.9	1.1	24.9	28.9	3.0	6.1	33.5	63.5	58.9	38.9	29.6	48.6	62.2	49.6	62.5	60.1	50.7	92.9	89.0	176.3	52.4	47.3	20.1	24.0	90.5	64.8	34.1	109.6	69.7	36.4	53.0	87.2	52.1	99.3	60.5	35.3	43.6	109.0	7.9	119.9	7.1	50.3	74.0	69.9	102.4	28.6	57.4	72.9	47.5	108.3	40.8	88.8	3.8	84.8	79.6	108.7	143.4	60.6	55.4	77.1	44.7	165.7	27.5	5.6	45.4	76.2	67.6	38.4	43.5	87.2	6.2	106.1	201.1	78.0	68.3	66.5	82.2	133.5	103.2	27.6	54.4	81.7	92.1	91.0	68.1	18.2	16.5	34.8	33.8	59.4	16.3	56.5	55.3	93.4
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283783	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	5	"OE19: 28.0"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	6.2	4.9	7.6	0.4	8.3	1.0	6.8	7.5	8.8	2.9	7.9	2.6	3.2	1.7	11.0	1.3	19.6	4.0	1.9	8.0	8.4	7.3	9.1	4.0	0.5	8.1	8.5	0.8	9.1	7.6	8.5	1.5	7.8	4.2	2.9	8.8	4.4	2.7	6.4	1.3	3.5	1.1	7.8	1.2	5.1	8.0	9.5	0.7	9.7	3.2	0.4	1.9	0.7	9.1	0.6	2.1	2.1	0.6	1.6	0.2	0.5	0.2	2.0	0.4	0.4	2.6	2.2	0.1	0.6	0.7	4.5	0.6	0.9	0.5	0.7	2.1	0.1	0.1	1.3	3.6	0.9	0.5	0.3	1.0	0.5	0.6	0.5	0.9	0.2	0.3	0.2	1.5	0.6	3.1	0.2	0.2	0.4	28.0	1.0	0.3	0.5	0.3	3.4	1.8	3.7	2.9	1.0	1.6	0.3	0.5	1.7	0.2	0.5	0.4	0.5	1.2	0.5	5.5	1.2	0.1	1.6	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	7.6	8.3	7.5	8.8	8.0	8.4	8.1	8.5	7.8	7.8	9.5	9.1	1.6	9.6	2.6	4.2	0.4	0.6	2.5	5.1	0.0	12.9	7.7	9.1	7.9	8.6	8.4	0.0	12.5	3.3	0.1	6.2	9.8	7.5	47.3	34.0	0.6	1.8	7.7	0.8	1.0	7.8	1.6	1.5	3.1	2.0	0.0	1.5	1.8	3.6	0.8	1.7	1.1	5.7	14.2	1.0	0.0	6.2	0.6	0.7	1.8	1.0	0.0	4.7	0.0	0.0	2.9	5.8	3.0	0.4	0.4	2.8	13.0	10.3	91.4	7.4	0.0	2.0	2.2	8.8	4.3	0.3	0.3	3.4	0.2	0.8	3.1	1.9
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 41.5;skeletal muscle: 55.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.4;Alveolar cells type 2: 1.7;Astrocytes: 2.0;Excitatory neurons: 5.1;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.4;Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;OE19: 2.7"									HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	12.5	1.3	1.5	0.4	1.6	1.0	9.3	1.1	2.5	2.0	1.1	9.0	0.1	2.4	1.3	1.6	2.1	0.6	21.2	1.4	2.0	2.4	41.5	8.3	0.4	1.9	1.5	0.9	2.3	0.5	0.7	0.6	1.7	4.3	0.4	1.8	2.3	0.5	55.9	0.9	12.4	0.7	1.6	0.9	2.9	2.3	1.9	0.1	1.3	0.5	0.1	6.7	2.0	2.0	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.2	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.6	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.1	0.1	2.7	0.4	0.0	0.0	0.4	0.0	0.6	0.7	0.5	0.1	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.3	0.1	0.2	0.4	0.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	1.5	1.6	1.1	2.5	1.4	2.0	1.9	1.5	1.7	1.6	1.9	2.0	0.0	6.4	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306733-76311130	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.3;skeletal muscle: 248.5;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 9.1;Ductal cells: 7.9;Glandular and luminal cells: 5.1;Plasma cells: 7.0;Proximal enterocytes: 19.5;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 140.7;U-266/70: 62.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	109.7	5.3	4.3	7.3	4.0	19.9	11.8	3.5	6.3	7.0	2.9	29.0	9.6	9.3	3.2	15.1	13.7	12.8	52.7	4.0	7.0	10.0	130.3	14.1	1.3	6.7	5.4	10.0	12.0	7.9	1.7	16.8	6.2	20.7	26.4	4.0	4.7	13.9	248.5	1.5	26.1	28.0	5.6	2.2	15.5	9.7	5.6	1.3	2.6	154.7	2.1	22.1	4.5	5.6	15.9	9.9	2.0	10.0	46.3	13.9	12.7	21.9	21.6	12.0	12.6	12.6	17.9	0.0	13.1	25.8	26.2	9.2	9.6	6.1	7.4	52.4	3.6	1.7	18.2	16.5	4.8	9.5	10.5	7.1	24.0	10.2	8.2	32.4	0.9	0.0	0.6	140.7	23.7	13.0	0.6	7.4	2.5	24.1	7.2	0.0	3.8	9.9	8.0	17.2	2.6	17.7	12.9	20.2	0.3	5.0	4.9	3.7	3.9	11.6	5.9	29.4	12.5	62.8	17.1	0.0	19.6	7.5	5.4	0.1	2.6	5.7	2.0	3.1	1.1	0.1	2.4	2.4	2.5	0.0	0.5	0.9	0.3	4.4	1.2	0.3	0.8	1.3	4.3	4.0	3.5	6.3	4.0	7.0	6.7	5.4	6.2	5.6	5.6	5.6	0.0	0.0	0.5	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.2	9.1	0.0	7.9	0.0	2.8	1.5	0.1	0.0	0.4	0.0	3.9	1.4	1.0	2.6	5.1	0.0	0.3	0.0	1.5	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	3.3	2.9	0.0	7.0	0.5	19.5	0.3	6.6	0.0	0.0	1.1	3.0	0.2	0.0	1.1	0.0	0.8	0.3	0.3	1.4	0.9
CCDC158	FLJ25770	ENSG00000163749	"Coiled-coil domain containing 158"	Q5M9N0	4	76312997-76421868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 33.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 88.5;Late spermatids: 81.7;Spermatocytes: 66.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (3.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.99e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.68e-1)"	0.5	0.1	0.0	0.0	0.1	0.0	1.1	0.3	0.4	0.1	0.0	0.2	0.0	0.2	0.9	0.1	0.2	0.2	0.3	0.0	0.5	0.5	1.6	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.5	0.0	0.3	0.5	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	33.5	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.5	0.3	0.5	0.3	0.3	0.1	0.4	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.7	1.0	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	88.5	2.3	0.1	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	81.7	0.6	0.3	0.0	0.0	0.0	1.1	0.0	3.0	3.0	0.1	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.3	0.2	66.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SHROOM3	"APXL3, KIAA1481, SHRM, ShrmL"	ENSG00000138771	"Shroom family member 3"	Q8TF72	4	76435229-76783253	"Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 313.1;Distal enterocytes: 154.5;Endometrial ciliated cells: 182.9;Glandular and luminal cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 40.8;AF22: 38.2;BJ hTERT+: 36.9;EFO-21: 39.9;OE19: 40.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047784	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA047784: AB_2680155"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.64e-13)"	"unprognostic (2.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	1.0	2.0	0.4	6.1	1.8	0.1	15.4	12.4	3.4	5.9	18.5	20.0	15.2	3.0	13.9	17.5	15.7	17.8	3.9	0.9	0.0	7.0	6.2	8.5	0.4	6.1	2.1	0.5	6.5	12.9	3.3	4.4	5.9	9.0	17.2	9.7	25.7	6.3	0.1	3.0	14.7	9.7	5.6	6.1	21.9	0.7	0.2	0.9	3.5	0.1	2.4	4.9	2.3	3.0	40.8	7.9	38.2	25.2	0.0	0.6	1.4	12.4	36.9	0.8	1.6	6.8	26.3	0.6	39.9	34.6	3.0	20.4	5.1	17.8	0.7	0.1	6.7	0.0	7.5	0.0	0.2	0.0	0.0	0.3	4.3	1.3	6.7	9.7	0.7	0.3	0.0	9.7	0.8	3.6	0.7	0.1	16.0	40.5	4.7	3.5	6.3	6.3	6.0	0.9	15.0	19.9	5.2	28.2	2.1	23.2	6.8	0.2	0.0	6.5	5.5	0.2	5.4	12.0	13.3	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	12.4	3.4	0.9	0.0	6.1	2.1	5.9	5.6	0.2	3.0	0.6	89.8	53.4	313.1	1.0	0.9	5.8	14.0	2.8	35.8	69.9	46.1	11.0	81.5	40.0	35.0	75.0	0.4	0.6	154.5	0.0	33.6	7.1	182.9	27.1	2.1	86.9	2.7	54.5	36.4	0.7	4.7	103.0	350.1	0.0	11.9	0.7	42.2	0.2	1.7	19.1	104.0	30.5	1.6	0.3	3.2	0.3	1.8	3.6	29.0	1.6	7.2	0.0	6.0	2.1	73.8	92.3	0.0	0.3	35.8	102.7	6.8	65.7	31.1	0.0	0.3	7.4	3.4	2.4	3.5	0.3	0.1	1.7	0.3	70.5	11.9
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894152-76898144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Gastric mucus-secreting cells: 4.6;Squamous epithelial cells: 2.7;Urothelial cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.3;CACO-2: 3.9;OE19: 7.4;RT4: 19.4;T-47d: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.0	0.3	1.2	0.7	1.4	0.0	1.3	0.0	2.8	1.0	0.7	7.7	5.5	0.3	0.8	6.2	1.1	1.3	0.0	1.8	0.1	7.7	19.1	1.6	0.0	0.5	0.0	0.0	5.8	6.9	0.4	0.6	0.6	0.8	6.3	0.2	2.4	2.7	0.0	1.5	8.1	0.2	0.0	0.0	4.6	0.0	0.0	0.2	2.4	0.0	2.3	6.0	2.2	1.1	3.9	0.1	0.3	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.9	2.6	0.0	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.5	19.4	0.1	0.0	0.0	1.7	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.0	2.8	1.8	0.1	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.5	1.9	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	4.6	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.1	1.1	0.9	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.5	6.1
SEPTIN11	"FLJ10849, SEPT11"	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949751-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 90.1;Extravillous trophoblasts: 266.8;Fibroblasts: 40.1;Hofbauer cells: 52.0;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 495.8;fHDF/TERT166: 604.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		2800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	84.8	13.0	34.6	27.5	46.5	7.9	39.3	24.3	51.4	40.4	0.0	50.1	21.8	33.8	18.0	22.5	17.4	45.4	30.8	40.5	13.7	52.4	33.9	40.5	24.1	5.2	8.5	20.0	22.3	17.3	11.3	84.1	4.5	21.0	40.4	22.3	11.6	26.1	26.0	13.3	35.3	40.6	0.0	25.6	25.2	7.8	16.6	12.7	21.1	18.3	22.8	39.3	21.5	50.6	87.6	34.9	328.1	293.8	192.8	152.9	94.6	495.8	382.7	110.6	154.5	64.3	62.9	2.0	100.9	604.4	51.9	36.6	109.8	73.8	171.2	114.0	36.7	171.2	44.6	47.1	168.0	93.0	69.7	195.5	34.4	160.2	59.8	87.7	169.0	34.3	72.0	46.6	331.2	50.4	122.8	3.3	111.1	71.4	18.1	142.6	372.8	10.1	62.6	94.0	112.1	83.6	96.2	54.4	77.9	209.9	49.5	37.3	184.4	368.7	109.4	182.8	93.1	28.5	24.3	1.1	140.5	10.0	76.4	12.2	2.4	32.5	8.1	2.2	5.0	3.6	9.2	11.2	7.8	6.7	3.5	9.4	0.6	38.4	7.4	20.8	5.8	6.6	34.6	46.5	24.3	51.4	40.5	13.7	5.2	8.5	4.5	0.0	16.6	50.6	33.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	90.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	266.8	40.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	60.5	5.6	0.0	0.0	0.0
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047155-77076309	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	176.7	98.4	182.1	109.8	191.0	222.9	183.6	253.4	218.2	234.8	131.4	182.7	100.0	211.0	249.1	177.9	196.5	150.7	195.7	148.1	171.8	183.8	133.7	144.8	185.2	184.0	185.9	341.6	155.2	145.2	71.1	138.0	188.6	198.9	129.8	213.2	183.0	208.9	225.8	136.4	120.8	195.6	167.5	149.1	149.0	131.7	186.1	229.2	273.5	177.8	238.8	186.6	170.5	220.7	163.3	96.0	305.0	268.6	447.6	406.7	117.0	122.5	298.4	189.9	181.5	119.3	240.6	300.1	183.2	309.4	118.9	83.4	211.7	428.9	300.2	214.0	83.7	180.3	102.1	114.0	438.1	312.0	346.4	320.4	502.6	175.1	426.2	542.6	270.1	154.3	157.2	315.9	273.4	187.7	406.3	292.5	135.2	113.9	59.0	250.7	290.0	126.5	283.5	182.7	387.3	211.8	162.9	247.2	209.2	212.6	141.2	131.6	184.6	231.0	137.0	249.0	170.4	173.7	86.1	310.9	195.4	210.6	153.3	160.7	113.2	236.7	95.6	108.0	131.2	148.2	157.0	142.0	119.5	153.7	165.2	143.8	145.8	109.3	134.0	135.3	149.7	100.0	182.1	191.0	253.4	218.2	148.1	171.8	184.0	185.9	188.6	167.5	186.1	220.7	368.4	173.1	231.3	59.7	606.6	422.9	633.0	489.3	578.8	629.5	550.2	523.5	460.5	323.1	238.7	196.8	68.8	273.7	441.5	258.8	794.3	400.9	71.0	250.5	321.3	405.5	412.3	510.9	125.8	334.3	427.4	510.9	220.2	231.2	278.4	300.9	382.7	121.5	337.0	181.7	150.3	346.6	329.6	685.1	676.5	147.5	604.0	490.4	402.0	77.8	613.0	403.2	390.3	52.3	69.1	515.1	317.6	989.2	500.8	854.8	468.4	596.6	161.4	228.7	552.2	373.3	510.8	200.4	745.5	466.1	394.8	379.5	497.3	326.5	345.9	747.1
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157207-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	46.4	23.6	15.5	35.6	18.2	88.0	81.5	64.3	20.8	39.6	8.3	33.5	28.0	39.2	26.7	136.0	18.8	32.8	14.9	17.5	11.4	71.0	11.0	26.3	73.5	13.5	14.7	37.4	14.7	46.3	8.8	64.6	13.5	78.1	34.4	81.2	34.3	31.4	12.3	29.2	25.1	33.8	13.1	48.1	25.4	11.2	15.2	67.3	53.2	34.4	73.5	53.5	37.1	19.2	30.9	3.9	66.5	35.5	43.1	54.9	45.0	25.4	72.6	19.4	36.0	4.6	43.8	61.7	40.0	23.7	18.4	21.7	17.6	83.8	37.2	43.2	11.8	5.2	18.1	9.1	22.4	9.3	62.1	46.9	40.8	9.1	19.9	64.6	29.4	35.9	3.0	36.7	36.0	12.0	42.9	19.7	6.8	15.0	4.1	24.3	64.8	4.1	121.9	84.1	17.7	56.1	30.0	46.7	18.0	39.4	34.9	13.8	27.6	26.3	26.0	19.1	4.2	26.9	21.9	43.8	18.4	14.4	13.4	14.8	1.7	21.0	0.9	2.7	2.1	3.2	1.3	1.0	1.9	6.3	1.0	0.6	8.0	2.1	3.1	2.8	6.1	0.8	15.5	18.2	64.3	20.8	17.5	11.4	13.5	14.7	13.5	13.1	15.2	19.2	25.0	12.8	12.3	14.7	55.8	37.1	29.0	27.8	113.8	112.4	101.1	53.6	4.7	8.6	25.4	55.2	22.9	29.7	35.5	57.6	86.1	33.7	0.8	50.4	44.6	35.7	16.7	1.7	13.8	19.6	98.7	61.5	18.3	107.7	39.3	20.3	35.3	3.9	32.3	25.2	26.7	38.0	50.8	45.3	56.7	2.3	27.7	35.8	56.9	10.3	61.8	28.4	17.5	17.1	13.9	49.2	24.6	27.4	20.5	74.3	29.6	70.9	15.3	46.8	65.7	61.3	41.5	9.2	10.1	40.8	26.7	15.7	31.1	17.1	16.1	57.8
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 523.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 242.2;Breast myoepithelial cells: 72.4;Endometrial stromal cells: 101.0;monocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA052613	Uncertain				"Secreted to blood"	NA	NA	93700			"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favorable (9.12e-4)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	2.6	0.4	0.1	127.7	0.4	0.1	15.4	0.4	0.3	1.4	0.1	13.3	1.9	3.6	1.6	2.4	0.8	5.8	1.2	0.1	0.1	0.6	28.5	2.9	523.1	1.1	0.1	0.7	0.3	0.2	3.1	0.6	0.1	27.3	16.5	0.2	8.5	1.4	0.0	0.6	68.5	1.2	0.4	338.6	34.9	1.5	0.1	16.2	2.4	0.0	441.3	30.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.3	0.1	0.1	1.1	0.1	0.1	0.4	0.1	0.2	0.9	0.0	0.5	1.3	0.3	0.1	15.8	3.9	0.0	0.0	242.2	72.4	0.0	1.5	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.6	101.0	1.7	0.0	10.7	1.9	0.2	0.3	6.3	0.5	1.8	1.3	0.0	3.6	21.3	10.2	0.0	3.9	0.0	0.0	3.4	0.0	0.0	0.0	0.9	0.0	1.9	38.8	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.3	7.8	0.0	0.1	4.5
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 366.6;T-cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	11.8	9.5	6.9	22.4	7.7	29.5	13.4	14.4	8.1	12.4	6.1	12.9	13.1	11.1	9.8	16.6	11.6	14.0	6.1	6.4	10.1	13.2	19.6	11.6	36.1	7.5	7.7	13.6	19.9	17.8	6.0	22.5	7.1	11.7	15.5	12.9	12.6	12.2	7.2	13.7	13.6	14.5	8.2	23.6	14.7	11.2	11.5	49.5	14.4	8.6	38.5	15.7	8.4	9.0	17.0	9.6	12.5	9.1	14.7	13.6	13.1	13.1	17.8	11.9	15.9	3.5	18.3	26.5	15.4	18.9	8.6	10.9	17.5	18.7	14.9	28.4	10.0	25.4	9.8	10.3	9.1	24.0	22.9	8.1	22.7	12.1	24.3	10.9	38.2	21.2	22.7	38.0	13.9	9.0	52.3	14.0	6.2	13.4	3.2	12.4	38.4	21.5	12.5	13.5	16.0	7.2	23.3	20.1	7.9	15.4	6.8	13.7	35.6	10.9	11.5	19.9	7.3	48.1	21.0	35.1	12.3	11.9	8.6	21.4	4.4	10.6	9.4	7.0	9.9	5.5	7.2	7.7	4.4	7.2	6.7	8.2	6.9	8.2	10.3	6.4	6.4	4.1	6.9	7.7	14.4	8.1	6.4	10.1	7.5	7.7	7.1	8.2	11.5	9.0	93.0	22.4	21.0	34.3	101.1	57.9	13.3	15.9	59.2	39.5	30.5	20.8	16.7	31.5	24.0	36.8	39.6	31.1	366.6	16.9	60.7	8.2	4.7	30.1	24.6	54.0	26.3	31.5	74.8	12.4	8.6	25.1	26.5	46.2	38.0	22.1	45.3	32.6	17.1	32.0	70.7	29.8	14.2	41.0	50.1	3.7	18.6	50.0	24.9	105.9	39.2	19.3	128.8	68.9	60.7	11.0	16.1	12.8	178.5	33.9	28.4	26.3	17.0	43.5	32.9	26.6	29.2	49.4	39.9	44.7	66.1	24.4	240.0	37.9	24.1	26.7
MRPL1	BM022	ENSG00000169288	"Mitochondrial ribosomal protein L1"	Q9BYD6	4	77862830-77952785	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043656	Supported		Approved	Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043656: AB_2678601"	"unprognostic (9.03e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.14e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.22e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (7.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"unprognostic (9.17e-3)"	19.4	17.7	17.1	17.4	17.7	26.9	24.4	16.8	20.9	16.5	15.7	28.3	19.5	18.6	21.0	20.5	17.0	11.8	41.7	17.9	18.2	38.1	33.8	13.1	23.6	17.3	17.1	19.0	14.1	21.4	8.1	21.4	17.9	16.0	29.4	14.5	19.3	15.0	67.3	14.6	18.6	21.4	17.1	15.0	17.8	8.8	17.8	19.3	17.7	67.6	24.2	19.8	9.2	17.7	40.5	26.2	47.3	40.7	36.6	47.4	41.2	44.6	28.6	57.4	39.3	55.0	71.6	71.4	53.9	37.1	35.8	32.8	71.1	82.5	75.6	47.6	37.6	61.1	27.6	60.4	47.5	126.2	28.3	37.7	76.7	51.2	53.0	37.8	70.4	50.1	90.3	24.1	73.6	46.0	76.0	84.9	52.0	92.0	34.3	90.7	60.6	41.1	113.3	43.2	52.1	25.9	36.1	88.7	84.5	38.0	43.7	61.0	41.9	37.5	54.3	37.7	65.1	21.1	28.1	74.6	31.9	71.8	49.3	9.0	11.5	7.0	20.6	19.0	20.6	27.8	22.2	23.1	22.1	25.5	26.8	29.5	1.7	23.2	16.9	18.0	25.8	15.4	17.1	17.7	16.8	20.9	17.9	18.2	17.3	17.1	17.9	17.1	17.8	17.7	40.1	25.6	35.7	22.5	45.7	12.7	17.1	68.6	13.6	24.6	31.6	37.2	122.1	57.2	33.5	33.1	18.8	72.7	75.5	22.2	135.0	46.0	15.5	33.9	40.9	34.9	47.9	34.9	45.9	36.7	51.9	27.5	18.8	38.5	42.4	38.7	40.7	134.3	47.7	25.2	39.7	60.5	61.1	25.1	12.7	9.3	31.1	23.5	16.0	35.6	34.1	26.7	64.9	45.2	47.7	28.3	24.9	33.4	38.6	14.7	36.0	144.8	20.6	42.4	39.5	31.4	45.9	21.1	48.0	23.1	12.8	34.9	65.8	61.7	70.9	15.5
FRAS1	"FLJ14927, FLJ22031, KIAA1500"	ENSG00000138759	"Fraser extracellular matrix complex subunit 1"	Q86XX4	4	78057323-78544269	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.8;thyroid gland: 12.0"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 204.9;Inhibitory neurons: 377.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 35.9;Hep G2: 21.9;RH-30: 20.1;SiHa: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051601	Approved				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA051601: AB_2681547"	"unprognostic (1.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (4.69e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.09e-2)"	2.0	0.6	3.4	0.5	5.8	0.0	0.7	0.0	7.9	2.1	4.0	3.5	0.3	2.0	1.9	1.7	1.0	0.9	1.5	3.5	3.3	7.4	0.3	3.4	0.1	3.1	3.3	0.2	5.4	0.6	2.4	5.8	3.0	2.3	1.3	2.2	1.0	0.7	2.7	1.3	1.0	1.4	0.6	0.7	0.9	0.6	13.8	2.6	12.0	2.2	0.2	0.5	1.4	4.9	4.6	6.9	2.7	0.0	7.0	2.9	4.8	1.1	4.1	0.6	0.4	5.4	9.8	0.0	8.2	35.9	0.0	1.3	3.8	2.1	0.1	0.0	3.8	4.2	8.5	21.9	0.8	0.0	0.0	14.1	2.3	0.0	5.2	5.4	0.1	0.3	0.0	0.0	4.1	0.2	0.1	0.0	8.6	3.6	1.3	0.0	20.1	0.0	8.7	9.9	5.0	9.7	21.6	6.7	1.3	12.3	0.0	0.0	0.0	0.0	4.5	2.9	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.8	0.0	7.9	3.5	3.3	3.1	3.3	3.0	0.6	13.8	4.9	0.5	32.1	0.0	9.1	0.1	1.9	2.2	2.5	10.2	10.8	0.8	1.8	7.3	22.8	9.2	29.5	0.0	28.0	0.0	0.8	3.9	7.6	2.1	5.5	1.0	2.0	1.2	0.0	204.9	1.7	1.4	5.3	4.1	13.5	0.0	0.1	1.1	0.2	4.4	0.0	377.7	1.0	0.0	0.0	0.7	2.8	0.6	0.4	1.8	20.6	0.0	0.6	0.0	10.1	5.5	2.7	2.5	0.0	0.0	1.8	1.4	4.3	2.5	2.7	0.0	1.5	3.4	0.8	1.2	10.4	1.3	15.6	0.1	2.8	2.4	0.4
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551747-78610451	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 337.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	320	"neutrophil: 207.7"	"Lineage enriched"	"Detected in single"	327	"granulocytes: 207.7"	"Cell line enhanced"	"Detected in many"		"A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Supported	"Plasma membrane"		NA	NA		6400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	52.9	3.1	16.5	22.7	17.3	337.7	43.8	14.5	28.2	19.6	11.7	27.7	15.8	12.5	3.7	55.2	16.8	17.3	51.2	14.2	21.6	24.9	3.9	144.4	2.4	19.9	16.1	2.5	32.7	34.0	5.9	81.5	20.8	68.0	26.7	1.6	119.5	12.9	28.3	10.0	13.3	20.1	14.6	21.6	90.5	1.9	19.9	7.1	83.7	36.7	12.7	10.2	15.6	14.7	419.5	77.7	1.3	0.9	1.0	0.9	0.6	4.9	0.4	11.0	10.9	403.5	563.7	0.1	334.7	14.4	0.4	161.6	0.1	300.0	16.0	1.4	3.3	36.4	142.0	23.9	45.9	5.9	0.2	2.4	262.6	4.1	566.3	60.1	118.9	9.0	0.7	0.3	1.9	15.9	1.7	0.2	13.0	502.1	55.4	0.0	0.8	0.0	477.8	45.2	0.3	0.3	235.5	58.2	16.6	186.1	9.9	4.3	153.2	0.6	52.6	0.2	93.0	3.1	5.1	2.2	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	207.7	0.1	0.6	0.1	0.0	2.9	16.5	17.3	14.5	28.2	14.2	21.6	19.9	16.1	20.8	14.6	19.9	14.7	322.7	589.7	47.3	0.0	1.1	24.9	81.8	144.9	1.8	0.2	27.6	85.9	8.6	55.8	175.2	38.6	0.0	212.6	1.0	35.4	17.6	434.5	1.1	33.7	4.4	84.6	5.4	3.2	0.9	305.3	106.2	16.9	99.9	58.1	5.1	0.1	23.2	0.6	18.9	0.0	0.3	33.4	122.1	0.3	0.3	0.3	3.1	6.9	5.4	42.2	21.0	1.2	0.0	1.0	0.6	754.2	61.6	0.4	0.6	158.6	11.5	5.5	89.6	0.4	0.0	7.6	18.7	1.1	0.6	21.9	6.7	62.8	2.3	1.3	29.7	46.7
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	"BMP2 inducible kinase"	Q9NSY1	4	78776342-78916365	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 242.9;granulocytes: 129.2;Hofbauer cells: 140.4;Microglial cells: 351.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 50.1;HEL: 73.6;HMC-1: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026436, HPA026451, HPA026501"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles"		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	"unprognostic (7.96e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.74e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.18e-2)"	6.0	4.2	8.5	13.5	8.2	11.9	7.4	7.3	7.2	6.5	3.8	9.5	5.6	4.4	5.4	7.4	6.0	7.4	8.0	7.2	18.6	4.9	6.7	7.7	16.5	12.1	11.2	3.1	3.5	4.3	0.6	9.2	13.5	3.3	11.9	6.5	3.5	3.5	2.2	9.9	6.9	6.6	10.9	12.2	4.7	10.2	9.8	10.9	7.7	4.5	16.3	7.1	1.4	16.5	11.4	3.2	6.0	7.5	12.0	11.1	4.8	10.8	14.4	10.3	13.7	6.4	6.4	13.2	5.6	50.1	9.9	2.9	6.7	8.5	19.4	3.5	2.3	73.6	5.0	3.5	13.2	15.9	80.6	15.9	11.0	16.4	15.6	7.3	14.4	10.0	19.8	36.5	12.1	2.4	9.5	7.4	2.9	8.8	2.1	13.5	10.3	3.7	13.3	5.2	8.4	5.2	14.2	7.8	10.4	7.9	2.7	10.0	14.7	10.6	4.2	18.4	11.9	7.7	3.2	4.8	9.9	21.4	7.7	0.1	0.5	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.4	0.6	0.1	0.0	0.9	0.1	0.8	0.3	0.0	0.1	8.5	8.2	7.3	7.2	7.2	18.6	12.1	11.2	13.5	10.9	9.8	16.5	10.7	28.9	16.2	242.9	31.5	25.0	4.3	5.4	10.2	10.9	27.4	15.2	6.5	2.8	7.7	7.3	4.2	5.0	6.1	24.6	0.0	7.5	15.9	18.6	12.7	17.6	6.7	105.4	53.2	8.8	14.2	13.7	6.6	25.0	129.2	32.1	22.1	19.7	140.4	10.1	59.0	48.2	6.1	65.9	68.2	11.1	8.1	65.4	28.4	351.3	34.6	37.0	1.0	49.3	59.1	14.6	43.0	6.8	7.6	6.3	19.9	18.0	12.3	8.4	6.6	22.3	11.7	26.1	11.2	17.1	31.4	3.4	7.6	5.4	24.0	3.2
PAQR3		ENSG00000163291	"Progestin and adipoQ receptor family member 3"	Q6TCH7	4	78887127-78939438	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.4;Excitatory neurons: 58.1;Late spermatids: 139.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 18: Non-specific - Mitochondria"		"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (7.41e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.27e-1)"	0.5	1.1	0.1	0.1	0.1	0.1	0.5	0.6	0.3	0.2	0.0	1.0	0.2	0.4	0.0	1.1	0.5	0.1	1.6	0.1	0.1	0.9	1.3	0.3	0.2	0.2	0.1	0.2	0.9	0.0	0.4	0.0	0.2	0.2	0.0	0.2	0.5	0.0	0.3	0.6	1.3	0.0	0.4	1.4	0.9	0.6	0.1	0.0	0.4	0.0	0.0	0.3	0.4	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.8	0.3	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.4	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.4	5.6	3.2	8.3	19.2	7.9	17.6	5.2	3.0	6.2	20.0	4.9	4.6	9.6	2.8	5.1	11.0	4.2	9.5	9.9	7.5	0.0	2.9	81.4	17.9	10.2	6.4	8.4	7.8	58.1	3.8	12.3	12.7	1.5	11.8	24.1	5.6	5.0	10.8	4.4	5.0	36.2	12.8	0.0	5.2	8.6	139.2	7.5	6.2	7.2	12.2	4.0	12.8	6.2	15.6	24.2	3.2	8.2	10.5	7.1	5.4	16.7	2.6	6.6	10.7	13.1	11.4	9.3	17.6	17.1	8.6	23.3	13.0	9.8	2.9	5.9	3.2
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N-alpha-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326061	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 2.6;placenta: 4.2;testis: 6.2"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 2.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.6	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	4.2	0.3	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.0	32.9	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.1	0.1	0.2	0.5	0.4	0.3	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	15.9	0.0	0.0	13.3	0.0	0.0	0.0	0.0
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406361-79408228	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	306	"testis: 89.5"	"Group enriched"	"Detected in some"	92	"Early spermatids: 589.0;Late spermatids: 163.3;Spermatocytes: 194.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"SCLC-21H: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060687	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA060687: AB_2684343"															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	89.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	589.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANTXR2	"CMG-2, CMG2, FLJ31074"	ENSG00000163297	"ANTXR cell adhesion molecule 2"	P58335	4	79901146-80125454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.4;HHSteC: 197.9;LHCN-M2: 221.0;U-2197: 176.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		13000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-1)"	60.9	30.0	4.1	35.4	4.1	18.7	18.7	3.6	6.4	52.2	5.0	39.9	23.0	95.4	21.9	24.5	31.2	54.9	31.8	3.6	5.0	17.1	34.4	24.7	16.2	4.7	5.0	75.0	4.6	27.8	1.6	90.0	4.2	110.2	42.7	1.6	10.1	90.3	6.1	6.1	29.6	108.3	5.5	18.3	23.2	8.4	4.0	10.7	4.9	21.7	16.1	53.1	12.0	4.4	15.5	1.9	34.6	6.6	215.4	118.0	3.1	48.3	124.6	17.5	19.9	0.6	11.8	0.0	0.8	76.8	11.4	4.5	4.4	49.7	66.9	2.2	4.2	12.2	1.3	4.8	197.9	51.6	29.5	145.3	15.2	132.7	68.3	150.2	52.6	1.6	27.1	35.8	221.0	0.0	1.1	57.1	5.7	21.7	70.3	2.4	19.8	9.0	12.0	14.4	30.6	41.2	4.9	0.6	8.2	16.3	0.7	11.0	69.8	155.7	9.7	176.7	103.4	3.1	0.0	0.1	78.6	39.4	49.0	72.7	17.5	61.6	12.8	9.5	13.8	23.5	21.4	13.1	32.2	9.4	11.3	5.9	54.4	4.3	18.0	32.2	40.4	14.0	4.1	4.1	3.6	6.4	3.6	5.0	4.7	5.0	4.2	5.5	4.0	4.4	6.4	12.8	10.0	23.5	25.7	7.0	15.5	6.5	4.0	6.9	4.0	2.2	24.9	4.3	10.2	0.0	29.2	18.3	24.9	42.4	3.9	4.2	2.3	7.7	69.3	15.5	18.6	6.3	25.4	6.7	29.0	58.7	4.1	6.1	60.1	8.9	15.0	24.9	17.7	0.0	2.1	15.1	4.1	13.4	28.9	5.3	39.1	28.3	1.8	45.9	53.7	6.9	4.1	19.1	0.8	45.5	28.9	63.9	14.1	13.9	16.9	2.5	4.9	21.4	39.5	32.5	28.5	0.6	2.1	0.9	4.3	6.6	24.4	18.3	13.3	1.6
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 27.2"	"Cell type enriched"	"Detected in many"	9	"Bipolar cells: 271.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.7"	"Low region specificity"	"Detected in all"			HPA057253			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"	Nucleoplasm	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	4.8	2.3	5.1	5.0	10.2	4.0	4.0	0.0	17.0	11.7	0.0	11.4	1.1	9.3	1.9	1.7	5.2	1.7	1.7	13.7	0.0	1.3	0.3	1.6	5.1	0.0	0.0	5.2	0.9	0.0	5.4	4.3	0.0	26.1	1.5	24.1	1.4	27.2	2.2	2.7	5.7	3.8	0.6	1.8	5.0	1.1	0.1	0.7	1.2	0.9	2.4	10.2	9.8	3.2	2.3	0.2	0.7	0.0	2.1	7.2	0.1	5.8	20.5	2.8	3.2	0.0	2.2	0.0	0.0	7.2	1.8	0.7	0.1	2.4	12.1	8.8	1.8	0.8	0.0	0.0	4.1	9.1	2.5	4.4	0.2	11.1	3.2	27.3	0.4	2.4	0.0	3.7	41.7	0.0	4.2	48.2	0.0	0.2	17.0	1.6	0.0	0.2	1.2	0.3	99.3	13.8	0.3	0.0	0.1	0.1	0.0	4.5	8.8	7.1	1.0	5.2	0.4	1.7	0.0	0.0	17.8	4.2	1.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.5	0.5	0.1	0.7	0.3	0.1	0.5	0.2	0.0	0.1	0.2	0.1	5.1	10.2	0.0	17.0	13.7	0.0	0.0	0.0	0.0	0.6	0.1	3.2	0.9	0.0	0.5	2.3	8.2	0.6	3.4	0.4	0.0	271.5	0.1	0.4	1.8	0.0	5.2	1.8	2.1	0.0	2.5	0.0	0.0	0.0	1.5	0.3	6.5	2.2	0.0	2.5	29.9	0.2	0.2	8.8	0.0	0.5	0.0	0.1	0.0	0.0	0.5	3.3	2.0	0.2	2.0	1.2	6.2	6.7	3.1	5.9	1.8	3.7	0.9	6.1	2.1	7.1	17.0	0.7	0.0	3.4	2.7	3.7	0.0	0.2	5.0	11.6	0.0	4.2	2.9	0.3	0.4	0.0	0.1	0.1	5.0	0.1	0.0	0.6
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.7;gallbladder: 3.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 9.4;Microglial cells: 1.9;Proximal tubular cells: 4.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 11.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.1;BJ hTERT+: 120.0;fHDF/TERT166: 88.0;HBF TERT88: 88.0;LHCN-M2: 81.1;U-138 MG: 109.5;U-251 MG: 55.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.6	0.0	0.1	0.0	11.7	1.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	3.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	1.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	6.1	21.8	0.0	64.1	120.0	16.5	12.2	0.0	0.1	0.0	0.0	88.0	1.2	0.1	0.1	22.5	88.0	0.0	1.1	0.2	0.1	0.0	1.7	0.6	0.0	6.3	0.0	48.6	23.0	27.9	5.7	0.0	0.0	0.2	81.1	0.0	0.1	0.3	0.1	0.0	2.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.8	0.0	0.0	0.2	20.9	109.5	4.6	5.4	55.0	0.0	0.0	0.1	6.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.2	0.6	0.0	2.7	0.2	3.0	0.0	0.5	0.5	0.0	0.0	1.1	0.3	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.6	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
CFAP299	C4orf22	ENSG00000197826	"Cilia and flagella associated protein 299"	Q6V702	4	80335730-80963750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 19.8;testis: 27.4"	"Cell type enriched"	"Detected in some"	54	"Endometrial ciliated cells: 54.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.0	0.9	0.0	1.0	0.0	0.1	1.4	0.5	0.7	2.6	0.1	0.1	0.2	0.0	0.0	19.8	0.1	0.0	1.0	1.0	0.3	0.0	1.4	0.1	5.3	3.7	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	27.4	1.2	0.1	0.6	0.0	0.0	0.0	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.7	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.0	1.4	0.5	1.0	1.0	5.3	3.7	2.3	3.5	1.2	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	54.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030708-81057627	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.3;lung: 5.5;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 32.2;Distal enterocytes: 68.9;Granulosa cells: 104.0;Paneth cells: 32.8;Proximal enterocytes: 25.2"	"Group enriched"	"Detected in some"	4	"lung cancer: 4.2;urothelial cancer: 7.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 16.3;RT4: 13.5;SK-BR-3: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	1.5	0.4	0.3	0.3	0.2	0.8	1.2	0.2	0.3	0.4	0.1	9.3	3.2	0.0	0.1	0.0	0.9	2.0	0.0	0.1	0.6	0.1	0.0	5.5	0.3	0.7	0.7	2.5	0.0	0.0	0.0	0.0	0.5	0.2	6.8	0.5	1.3	0.0	0.0	0.3	7.2	0.5	0.6	0.0	1.1	0.1	1.4	0.0	0.0	0.6	1.5	9.5	0.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.5	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.1	0.6	0.7	0.7	0.5	0.6	1.4	0.0	0.0	3.2	32.2	0.0	0.2	0.1	0.5	0.7	0.0	2.2	0.1	0.0	1.3	0.0	15.1	0.0	0.0	0.0	0.0	68.9	0.0	0.0	0.0	0.9	0.1	0.3	0.0	0.0	1.6	0.0	0.0	2.1	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	5.6	5.0	6.1	0.0	1.2	0.0	0.9	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.2	32.8	0.0	0.0	0.5	25.2	0.1	9.4	0.1	0.0	0.3	1.2	0.2	0.3	0.0	0.4	0.0	0.0	0.1	14.1	3.8
PRKG2	"cGKII, PKG2, PRKGR2"	ENSG00000138669	"Protein kinase cGMP-dependent 2"	Q13237	4	81087370-81215117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.1;prostate: 9.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Excitatory neurons: 32.6;Inhibitory neurons: 66.1;Oligodendrocyte precursor cells: 106.6;Proximal enterocytes: 19.7;Smooth muscle cells: 29.8"	"Group enriched"	"Detected in some"	4	"melanoma: 4.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.0;ASC TERT1: 3.8;HEL: 21.2;hTCEpi: 4.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007386, CAB018739"	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"			"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	1.0	0.2	2.1	0.2	1.5	0.5	1.5	0.5	1.7	1.0	0.0	2.4	9.6	0.4	0.3	2.8	0.3	0.2	4.3	1.5	1.6	0.5	0.0	3.3	0.2	3.5	2.7	0.0	1.4	0.0	2.2	0.0	3.8	9.6	2.8	0.3	0.3	3.4	0.0	1.2	13.1	0.5	2.2	0.0	0.9	0.9	6.0	1.0	0.9	0.0	0.4	0.5	0.6	1.0	0.1	0.3	0.1	0.0	5.0	3.8	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.5	0.0	0.4	0.0	21.2	0.6	0.1	0.0	0.0	0.0	0.5	4.0	0.0	0.0	1.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.3	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	1.5	0.5	1.7	1.5	1.6	3.5	2.7	3.8	2.2	6.0	1.0	0.3	35.3	2.6	1.0	0.3	0.0	0.9	0.1	1.2	0.0	0.3	0.1	4.9	0.0	2.0	0.0	0.0	0.0	0.1	5.5	0.0	0.2	10.3	0.3	0.6	0.1	0.0	8.0	32.6	0.0	0.1	2.5	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	66.1	1.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	12.2	0.1	0.0	0.0	106.6	1.1	0.9	9.2	0.0	0.5	0.8	19.7	0.2	0.8	0.0	0.0	0.1	29.8	0.0	1.3	0.8	0.1	0.0	0.4	0.0	0.7	0.3
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 118.7;granulocytes: 107.0;Langerhans cells: 282.6;Macrophages: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 11.9;memory B-cell: 9.7;naive B-cell: 12.4;non-classical monocyte: 20.6;plasmacytoid DC: 28.0"	"Group enriched"	"Detected in all"	5	"B-cells: 12.4;dendritic cells: 28.0;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;Daudi: 16.1;Karpas-707: 11.1;NTERA-2: 7.9;OE19: 9.2;SCLC-21H: 7.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	13.8	6.4	8.9	11.0	20.1	32.5	8.3	12.8	9.4	8.8	17.0	6.5	13.6	3.5	12.3	11.3	8.0	12.0	4.3	8.0	9.3	9.4	41.8	19.8	10.7	37.6	12.5	2.5	2.8	5.4	7.5	13.0	39.0	4.2	7.1	12.5	9.9	2.1	2.9	24.3	13.9	5.9	10.0	11.2	14.7	2.4	18.4	14.2	3.4	2.3	9.8	6.0	5.3	20.2	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	13.4	0.3	16.1	0.0	0.0	0.1	0.3	1.1	0.1	0.0	0.1	2.5	1.4	1.0	0.6	0.5	0.3	0.7	0.2	0.6	0.0	0.5	0.1	0.0	2.8	0.2	11.1	0.0	0.6	5.5	0.5	7.9	9.2	3.6	1.6	0.1	6.4	0.5	0.2	7.3	0.1	0.0	2.3	0.1	7.3	1.1	0.0	0.0	0.0	0.5	0.5	0.1	0.1	0.0	5.1	1.2	0.2	0.2	0.8	3.0	0.4	1.9	11.9	2.1	9.7	1.6	1.6	2.7	12.4	2.8	2.7	1.1	3.8	20.6	28.0	0.5	1.2	8.9	20.1	12.8	9.4	8.0	9.3	37.6	12.5	39.0	10.0	18.4	20.2	9.6	28.9	15.9	1.3	118.7	58.9	7.9	4.4	23.9	11.7	22.7	13.2	9.1	15.7	11.1	14.7	37.5	33.2	71.2	13.2	13.7	3.1	0.5	44.5	4.8	10.8	26.8	0.0	3.6	4.0	2.4	9.1	30.1	38.0	107.0	0.6	102.1	45.9	39.5	3.3	2.8	12.8	16.2	64.2	282.6	1.5	0.9	141.4	62.2	10.3	2.9	1.0	2.1	26.7	25.5	3.0	9.6	1.9	33.5	10.2	9.2	12.9	34.0	4.9	0.0	5.9	17.7	0.8	3.2	10.4	56.7	11.2	56.3	0.5	8.1	11.5
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	147.4	114.7	61.9	207.3	61.6	377.7	155.5	83.7	89.1	167.3	68.4	153.6	169.8	176.6	137.1	155.5	152.0	98.7	122.7	60.7	81.0	144.2	140.6	129.0	290.2	61.0	61.7	180.6	146.7	134.1	117.0	167.8	59.2	138.6	164.4	188.1	147.1	125.4	169.7	151.8	177.2	140.1	54.1	184.6	164.6	97.7	61.6	335.1	122.8	103.4	310.7	159.8	145.7	69.2	661.7	257.5	1073.5	344.2	138.9	179.1	508.9	506.2	384.6	566.7	484.9	461.1	565.7	1332.6	357.1	343.3	301.9	318.2	863.8	376.6	883.9	250.1	450.8	957.4	345.2	630.7	282.1	1283.9	475.2	221.0	164.7	459.6	459.5	290.2	521.2	637.3	1076.0	446.6	487.7	254.3	1569.2	887.2	897.8	487.2	236.1	1149.2	1089.0	556.7	478.0	394.8	540.9	583.3	496.5	426.0	262.2	497.0	319.7	504.9	443.7	435.3	595.3	339.7	661.7	472.5	403.1	1516.3	334.6	651.6	508.9	26.1	11.3	12.4	13.3	12.5	15.1	20.3	16.2	17.0	13.5	13.9	17.5	14.6	13.6	14.1	14.1	23.6	19.7	7.2	61.9	61.6	83.7	89.1	60.7	81.0	61.0	61.7	59.2	54.1	61.6	69.2	152.4	102.5	143.5	63.6	128.0	261.3	227.8	139.0	111.0	128.4	124.6	121.9	202.6	125.8	149.0	112.2	62.6	299.7	163.4	71.6	70.5	204.3	35.3	136.2	218.9	162.3	146.6	182.6	65.3	210.6	355.2	134.7	98.4	204.5	92.3	191.5	114.9	114.4	156.6	107.7	72.9	158.9	85.5	125.6	172.7	21.8	124.8	134.5	90.7	63.7	169.3	187.8	130.7	84.9	105.8	157.4	56.7	102.3	151.0	208.3	91.3	80.9	115.7	118.8	111.7	185.5	154.5	106.7	133.7	147.0	229.7	272.0	133.6	149.1	169.3	228.8
HNRNPDL	"HNRPDL, JKTBP, laAUF1, LGMD1G"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422565-82430462	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	267.9	192.7	133.9	221.1	162.3	404.9	259.1	143.9	214.8	288.6	126.4	296.5	151.4	283.6	157.2	209.6	275.4	147.3	229.0	137.8	162.8	220.1	181.2	292.4	247.8	161.6	155.2	368.8	248.8	111.9	231.2	161.5	163.9	218.2	153.2	210.6	200.3	155.8	395.5	232.4	246.1	205.0	140.4	243.2	233.4	119.5	153.1	199.1	245.4	168.8	188.5	233.3	266.4	197.4	405.2	208.8	762.2	151.9	282.0	152.2	249.8	426.5	460.4	371.3	351.5	289.2	324.8	745.8	263.5	467.3	191.2	306.5	582.9	395.3	433.5	165.3	421.1	432.9	354.2	524.9	133.0	745.8	309.1	271.1	112.3	417.2	370.3	294.6	299.6	467.5	572.4	300.4	365.7	169.3	701.6	519.6	526.6	363.9	244.4	624.1	615.1	342.2	437.2	259.4	322.5	556.0	265.6	339.6	262.3	344.7	354.3	418.2	253.4	371.2	462.1	246.3	519.7	351.6	363.7	828.3	325.4	428.8	320.2	44.5	36.8	32.3	60.4	59.6	49.9	63.3	54.0	56.7	29.1	61.4	74.6	66.0	15.3	42.9	77.8	46.8	46.0	51.3	133.9	162.3	143.9	214.8	137.8	162.8	161.6	155.2	163.9	140.4	153.1	197.4	314.7	272.4	281.3	104.8	486.6	659.0	612.1	364.2	429.6	223.4	287.0	304.9	201.0	150.2	359.4	152.6	106.3	520.8	472.3	128.1	297.4	338.3	57.7	294.3	410.9	296.7	236.0	260.7	163.9	255.8	629.2	361.5	271.7	432.2	387.7	319.8	127.1	132.7	326.5	176.7	152.9	225.5	240.1	218.2	452.0	50.7	212.5	344.3	311.3	80.6	339.0	303.9	272.9	143.7	298.8	231.5	131.1	202.8	480.6	556.8	173.0	300.2	288.2	188.3	164.3	602.9	397.0	161.8	391.4	433.0	554.2	521.0	488.0	238.7	241.1	478.6
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 134.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	13.1	43.1	12.9	4.6	15.3	1.9	22.0	9.7	16.8	15.1	6.3	7.7	7.4	4.9	134.9	3.6	7.4	6.5	12.7	15.7	12.7	17.3	13.9	6.2	14.7	12.9	15.9	31.5	3.4	5.4	8.4	9.8	14.7	12.6	4.3	4.5	17.0	7.6	6.9	4.3	6.9	6.9	12.0	14.3	5.0	3.2	12.2	9.1	11.4	9.7	12.8	5.0	5.2	12.5	0.1	1.0	8.8	10.9	0.1	0.1	0.4	1.9	4.7	1.3	1.2	0.0	0.6	0.3	0.9	0.3	3.6	0.2	5.0	0.0	1.4	0.4	2.3	0.7	1.2	0.1	0.0	0.0	1.0	4.5	0.6	0.0	0.0	0.8	2.7	5.3	0.0	0.0	0.2	32.2	0.6	0.8	3.9	0.0	0.5	1.0	0.2	1.2	0.2	4.8	20.1	3.5	0.5	0.4	2.8	4.1	0.5	0.2	0.8	0.5	0.3	0.1	1.1	0.1	0.5	0.4	0.6	0.1	2.2	2.6	0.3	0.5	0.2	0.2	0.1	1.0	0.3	0.2	0.1	1.1	0.2	0.2	1.4	0.5	0.3	0.6	0.1	0.1	12.9	15.3	9.7	16.8	15.7	12.7	12.9	15.9	14.7	12.0	12.2	12.5	30.7	0.0	1.1	36.6	0.2	2.4	3.5	1.9	0.6	1.1	19.3	13.6	10.1	5.7	6.1	14.7	2.1	88.6	1.4	0.2	0.0	7.2	5.5	2.6	11.2	24.8	1.2	3.0	35.6	2.5	1.3	13.1	0.5	10.5	6.3	104.7	25.4	20.4	5.7	1.7	24.2	1.1	0.0	1.0	3.6	2.9	14.3	1.8	1.8	7.5	7.8	14.8	0.0	17.6	13.1	1.4	0.2	9.8	1.2	4.9	0.4	2.6	7.1	2.2	0.0	3.9	7.8	1.1	4.1	1.6	1.1	117.3	0.6	1.8	4.3	0.9
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798796	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.7;brain: 353.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 69.2;RPTEC TERT1: 90.1"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	6.8	156.7	226.1	3.7	283.7	2.9	5.7	302.5	260.4	10.6	85.2	12.9	4.5	12.5	97.6	5.8	18.7	9.3	8.1	212.6	277.4	33.1	2.5	15.0	3.0	353.6	272.7	93.7	40.9	18.7	31.4	7.5	291.0	12.7	4.0	70.2	18.0	24.3	1.3	8.2	6.0	12.0	314.1	4.5	10.6	33.3	255.6	10.6	35.5	4.2	4.4	7.7	8.7	316.2	11.2	7.1	36.0	18.6	19.7	12.5	0.6	69.2	33.9	29.7	22.8	0.5	1.7	22.5	23.5	14.5	8.0	19.9	10.6	7.6	37.0	4.4	4.7	1.0	8.1	0.7	2.9	10.0	6.9	10.0	30.6	5.9	5.2	30.5	48.4	25.8	1.3	2.2	15.6	4.4	42.6	2.1	2.6	0.2	5.0	35.6	21.5	17.9	90.1	11.2	20.1	11.5	11.4	0.5	6.8	3.5	1.3	5.0	59.5	31.5	18.1	11.9	18.9	6.0	2.5	2.2	15.3	10.5	9.0	1.9	0.6	0.1	3.9	0.2	2.5	0.2	0.8	2.3	0.3	0.4	0.7	2.6	0.7	1.1	0.4	0.7	0.2	1.2	226.1	283.7	302.5	260.4	212.6	277.4	353.6	272.7	291.0	314.1	255.6	316.2	1.4	44.8	3.9	248.4	0.8	10.7	16.5	16.3	5.7	101.4	6.8	4.8	2.9	27.1	25.7	27.6	25.0	1.9	3.9	0.4	13.7	79.7	115.0	13.5	9.3	7.7	7.7	0.0	84.3	46.9	0.2	16.8	2.6	14.8	0.0	10.5	10.4	0.2	1.1	101.0	107.0	0.3	10.2	1.3	3.3	100.3	55.0	1.8	3.6	23.4	1.9	145.3	4.1	892.7	513.6	8.9	0.0	58.3	0.7	11.3	0.2	20.4	13.0	14.6	6.6	3.6	11.5	2.9	3.7	2.7	7.2	0.1	3.2	137.4	2.0	9.3
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
THAP9	FLJ34093	ENSG00000168152	"THAP domain containing 9"	Q9H5L6	4	82900684-82919969	"Predicted intracellular proteins, Transcription factors"	"DNA integration, DNA recombination"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 40.5;Late spermatids: 52.9;Oligodendrocytes: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037420, HPA037421"	Uncertain		Approved	Mitochondria		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA037420: AB_2675467, HPA037421: AB_10673631"	"unprognostic (7.54e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.64e-3)"	"unprognostic (8.74e-4)"	1.3	1.6	3.0	1.0	3.6	2.0	3.2	3.3	4.5	2.0	2.6	1.5	1.5	2.5	3.6	1.3	1.7	1.3	2.7	3.1	3.3	3.0	3.2	1.6	1.8	3.4	3.2	3.2	2.5	3.2	2.7	2.1	3.6	2.4	1.6	4.3	2.0	1.9	5.2	1.7	1.5	1.4	3.2	1.4	1.4	6.7	3.1	2.5	4.1	6.8	1.7	1.5	1.6	5.8	1.1	1.5	5.7	3.2	1.7	2.0	4.0	1.1	1.8	1.1	1.0	2.3	2.0	6.3	2.0	1.5	2.1	1.4	4.6	1.8	1.3	2.4	1.7	2.7	2.2	2.9	2.0	2.5	2.1	2.1	2.9	0.5	2.8	1.7	1.7	5.1	2.4	4.2	1.4	1.5	6.1	3.0	4.6	2.2	0.8	5.5	2.4	3.7	2.0	1.3	4.8	3.3	2.2	3.0	4.1	4.7	1.8	2.2	1.1	1.4	1.6	1.1	0.8	2.7	1.3	6.0	1.7	1.5	2.2	0.0	0.9	0.1	0.5	1.4	0.7	1.3	0.4	0.5	1.0	1.1	1.2	1.0	0.0	0.6	1.0	0.6	0.2	0.5	3.0	3.6	3.3	4.5	3.1	3.3	3.4	3.2	3.6	3.2	3.1	5.8	3.2	3.2	3.6	8.5	2.8	0.8	2.8	2.3	2.2	2.8	2.4	2.3	5.0	0.0	2.2	1.8	6.2	3.2	3.6	1.3	0.0	1.6	40.5	4.0	2.8	2.0	3.0	2.5	4.6	2.5	2.0	2.3	5.6	4.2	1.3	4.2	1.4	1.3	1.3	0.0	4.7	1.7	2.0	0.8	1.3	52.9	1.8	2.6	0.0	3.7	1.3	4.0	2.1	7.5	20.8	0.9	0.7	0.0	2.3	1.8	1.1	2.5	1.9	4.7	6.6	4.6	2.8	6.1	5.2	2.6	1.7	3.3	2.0	1.4	1.5	2.0
LIN54	"CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1"	ENSG00000189308	"Lin-54 DREAM MuvB core complex component"	Q6MZP7	4	82909973-83012926	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.2;Oligodendrocytes: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056606	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA056606: AB_2683187"	"unprognostic (2.01e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.56e-3)"	"unprognostic (6.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.06e-4)"	"unprognostic (3.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-2)"	3.8	3.4	2.6	4.9	4.4	13.1	4.9	5.4	5.1	5.3	0.2	6.0	5.4	4.4	3.8	10.5	3.7	3.9	4.4	2.9	3.2	6.9	8.2	3.9	6.5	4.7	3.5	5.0	2.7	5.9	2.0	6.2	4.2	3.9	6.9	10.0	3.4	4.4	4.4	5.4	4.3	4.5	3.6	4.7	4.5	6.9	3.1	12.8	10.3	5.8	8.6	4.7	3.4	7.8	16.8	9.8	15.1	17.3	7.8	7.5	11.2	26.7	18.5	19.8	18.9	11.7	18.9	18.3	14.4	27.6	13.0	12.9	20.8	8.7	24.1	19.9	9.1	16.8	14.7	13.2	6.8	20.7	117.8	6.3	5.0	21.7	10.4	6.1	12.2	17.0	18.6	35.5	19.4	11.9	44.3	8.6	6.3	20.6	6.5	23.9	16.8	12.8	9.4	14.3	15.7	8.3	16.2	25.7	10.6	9.4	11.2	13.3	9.6	23.6	17.6	22.1	12.2	17.6	14.0	30.6	13.1	12.8	18.9	3.5	2.5	5.5	3.7	2.0	4.2	1.6	3.7	4.2	1.5	2.1	4.6	3.9	5.4	4.7	6.6	1.1	4.7	2.4	2.6	4.4	5.4	5.1	2.9	3.2	4.7	3.5	4.2	3.6	3.1	7.8	7.5	6.4	5.5	10.7	7.2	12.1	3.6	2.4	9.6	8.5	5.5	5.2	6.1	4.3	3.3	5.5	2.1	4.3	8.9	11.3	0.0	3.1	37.2	7.1	6.0	4.9	4.2	15.2	23.4	3.6	4.8	4.9	6.6	12.9	2.5	5.7	5.7	7.5	6.5	5.0	22.1	4.9	2.0	6.3	7.8	14.2	2.5	8.2	8.8	12.2	4.4	7.3	7.2	18.1	60.3	4.0	3.4	4.9	17.2	3.8	4.7	6.2	4.4	8.6	13.1	6.4	6.9	3.1	3.1	14.0	12.5	3.4	9.1	3.5	5.2	8.2
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036894, HPA042828"	Approved		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: AB_2678191"	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	25.6	38.6	28.4	22.0	30.7	41.0	32.0	26.9	33.5	31.7	26.0	27.4	23.1	30.8	28.8	30.5	26.0	22.5	59.7	30.6	35.0	38.8	29.2	22.2	29.9	28.4	29.9	31.9	24.6	43.7	39.2	30.2	32.0	30.3	25.1	45.6	23.7	30.5	104.8	26.7	22.0	33.3	28.7	22.5	22.4	45.0	30.8	36.2	38.4	84.1	32.7	31.8	23.5	28.9	51.7	30.4	64.1	59.0	56.0	71.7	34.8	67.2	85.7	74.8	66.0	43.7	51.8	86.9	57.3	140.5	41.3	37.7	80.6	68.9	101.1	55.6	56.9	50.4	43.5	42.1	46.3	86.8	135.6	54.4	47.0	55.8	47.8	56.2	101.1	53.5	65.2	48.0	91.9	43.4	105.0	63.6	35.3	81.1	40.6	74.0	48.8	48.1	59.8	47.2	67.7	39.6	45.0	69.4	43.5	43.8	52.7	46.4	66.7	52.2	55.1	39.7	48.6	49.8	32.7	96.8	50.3	55.2	52.8	91.4	37.0	55.2	43.0	50.4	53.9	39.7	47.1	49.7	45.3	38.9	44.7	48.1	8.2	54.6	59.8	29.0	47.6	52.3	28.4	30.7	26.9	33.5	30.6	35.0	28.4	29.9	32.0	28.7	30.8	28.9	25.6	12.8	20.1	21.9	34.1	42.8	42.2	94.5	23.3	38.7	20.1	23.4	81.3	20.0	51.5	20.2	31.3	82.5	36.5	14.5	90.1	42.4	130.6	24.9	27.6	31.9	31.2	26.5	34.7	33.2	62.7	39.9	15.3	21.3	34.2	38.2	20.0	22.4	49.0	26.9	32.9	22.0	67.1	29.2	29.2	38.3	30.7	27.2	33.8	18.7	37.8	62.5	37.0	28.6	32.9	28.2	22.1	42.9	28.6	20.5	22.6	75.7	37.9	44.6	32.9	34.1	42.5	121.2	50.2	29.7	35.2	95.0	32.8	53.3	26.3	34.3
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	9.2	2.0	1.8	81.3	2.0	365.9	3.8	2.8	2.4	32.8	1.4	236.0	78.9	2.7	1.2	92.0	18.7	6.5	2.8	1.5	1.7	2.6	35.4	41.2	93.8	7.8	2.7	1.0	1.6	0.5	2.0	33.7	5.5	3.7	163.3	1.1	6.6	2.3	2.0	1.0	88.5	18.5	2.3	155.1	117.5	0.8	2.4	40.5	2.6	0.8	137.5	11.0	5.8	3.7	183.2	1.3	0.5	1.1	0.0	0.2	28.6	4.6	1.1	11.1	13.7	3.5	510.7	30.7	1.5	52.3	17.0	18.7	3.2	1.4	41.6	0.2	0.6	0.8	33.4	15.2	1.8	329.1	1.7	0.9	3.6	1.8	2.4	0.3	0.8	16.0	0.4	2.6	29.5	0.8	62.6	160.1	1.0	14.4	0.9	8.0	10.6	238.2	0.9	5.4	25.8	0.5	1.2	29.1	0.6	9.0	1.6	187.8	1.3	1.1	31.7	0.9	0.9	1.8	0.4	81.7	2.3	149.7	0.2	49.2	139.2	95.9	392.1	635.8	299.4	523.8	185.1	229.2	129.5	481.1	225.9	263.4	29.7	1053.3	358.9	2310.7	13.8	577.1	1.8	2.0	2.8	2.4	1.5	1.7	7.8	2.7	5.5	2.3	2.4	3.7	4.3	195.5	39.2	0.3	247.4	0.4	1.7	77.3	0.0	0.3	0.9	1.4	0.5	2.8	119.1	0.0	0.0	18.5	1118.2	1514.4	0.0	0.3	0.5	45.6	1.1	95.0	86.8	58.4	0.1	3.6	572.2	3.1	119.8	2.9	26.6	0.6	141.0	8.4	21.7	1.7	0.1	231.2	67.1	384.5	7.4	0.6	0.0	213.3	7.2	1.0	157.3	1.2	1103.0	0.0	0.2	99.0	865.7	0.0	35.7	1.1	374.4	1.4	549.6	0.3	6.6	0.7	8.0	0.2	0.8	10.1	0.1	14.2	150.6	0.1	104.2	9.0
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.2;neutrophil: 18.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.5;monocytes: 27.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.8;OE19: 40.1;TIME: 25.8"	"Region enhanced"	"Detected in some"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		6500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	3.4	4.5	0.8	6.6	0.9	2.3	1.0	0.6	1.7	2.4	0.4	5.9	2.1	2.7	0.2	9.9	3.9	2.7	0.8	0.9	0.9	1.6	2.4	3.2	4.5	1.8	1.0	4.5	0.8	5.6	1.2	2.1	1.3	0.6	6.4	0.2	9.7	0.6	0.3	5.3	2.8	1.9	1.8	6.0	2.0	5.7	2.7	2.0	0.7	0.3	3.9	3.0	3.3	3.6	13.5	0.6	0.1	1.7	3.2	0.9	0.1	1.5	8.2	3.6	16.5	0.0	11.0	0.4	2.3	4.2	20.8	12.3	16.8	2.5	6.5	1.4	1.7	4.2	9.0	0.2	1.4	2.5	8.4	1.8	5.1	2.4	15.4	1.4	18.1	2.4	0.1	39.8	1.5	2.8	0.2	0.3	0.7	40.1	2.6	0.0	0.4	0.6	10.2	0.3	9.3	0.0	17.7	9.8	1.4	2.6	1.5	3.8	25.8	1.5	4.6	1.4	1.7	0.5	6.2	0.2	9.9	11.4	2.7	0.4	27.2	0.0	1.4	10.1	1.0	0.2	2.7	1.0	3.0	0.3	1.7	1.6	18.5	2.3	1.5	0.1	5.2	7.9	0.8	0.9	0.6	1.7	0.9	0.9	1.8	1.0	1.3	1.8	2.7	3.6	0.3	6.4	4.4	0.0	0.7	3.4	3.0	3.3	2.8	0.0	0.3	0.5	0.6	0.0	5.6	1.8	0.0	0.5	2.4	10.1	0.0	1.9	0.6	2.3	3.7	1.0	6.6	2.7	0.8	1.3	2.9	1.4	4.1	13.2	0.0	0.4	2.9	0.6	16.4	0.0	3.8	2.8	0.0	41.5	3.0	0.3	0.6	20.2	0.0	7.5	33.9	0.0	3.1	0.0	0.1	1.1	6.7	0.0	0.7	1.7	4.1	0.0	2.8	0.0	0.0	0.1	1.2	0.2	1.0	4.0	3.7	1.5	6.2	1.4	4.6	3.7
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
MRPS18C	"CGI-134, FLJ11146, FLJ22967, MRPS18-1"	ENSG00000163319	"Mitochondrial ribosomal protein S18C"	Q9Y3D5	4	83455932-83469735	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050404	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA050404: AB_2681115"	"unprognostic (4.53e-3)"	"unprognostic (7.58e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.25e-2)"	"unprognostic (8.26e-3)"	"prognostic favorable (2.90e-5)"	"unprognostic (1.52e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.31e-3)"	26.5	33.6	27.1	24.0	28.1	26.7	25.1	29.6	42.7	23.2	27.1	26.2	24.8	24.5	17.7	33.6	25.2	14.4	46.7	27.6	29.6	36.4	44.3	21.6	24.6	28.2	27.7	22.3	22.0	20.0	20.1	20.7	28.5	16.8	25.9	19.6	21.1	14.8	85.2	24.2	25.4	21.0	28.2	25.0	24.7	19.5	27.6	25.1	19.4	53.4	32.5	22.7	23.3	29.5	74.4	76.2	58.9	45.3	36.3	24.1	56.9	78.1	39.6	60.5	51.6	136.2	66.8	69.8	86.8	38.5	68.9	39.4	61.0	47.3	71.2	62.7	48.8	59.6	105.6	136.5	49.3	143.2	74.5	25.3	41.0	49.4	58.4	34.9	39.8	86.1	86.5	55.7	39.8	142.9	95.3	87.6	35.4	109.7	53.3	53.6	51.0	55.8	46.4	66.8	61.7	33.2	41.9	82.9	68.0	57.4	36.1	85.7	47.8	53.5	82.5	53.3	104.7	50.7	70.3	158.5	51.1	73.2	67.4	126.2	122.9	196.1	105.9	139.5	108.6	174.7	126.3	117.2	142.5	164.4	130.8	116.5	56.0	117.2	117.3	164.7	195.5	113.5	27.1	28.1	29.6	42.7	27.6	29.6	28.2	27.7	28.5	28.2	27.6	29.5	102.2	51.3	61.3	4.6	67.8	68.1	73.7	169.1	47.8	33.3	54.3	87.2	81.3	90.1	93.3	77.3	37.5	132.4	62.7	57.1	229.0	139.1	117.0	75.9	59.6	77.3	33.6	117.0	8.7	187.8	119.7	57.2	33.1	54.5	109.5	57.1	77.1	180.6	112.6	32.0	8.0	59.3	91.6	65.4	46.8	25.2	82.0	58.1	62.2	6.5	72.9	80.7	96.8	8.0	9.7	134.6	84.1	77.5	63.6	62.7	101.8	211.0	124.7	47.7	59.2	71.2	93.7	109.0	71.6	70.4	64.1	96.2	55.7	70.3	79.9	61.9
ABRAXAS1	"ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614"	ENSG00000163322	"Abraxas 1, BRCA1 A complex subunit"	Q6UWZ7	4	83459517-83523348	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037654	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"HPA037654: AB_2675588"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.24e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.57e-2)"	4.4	3.9	2.9	3.9	2.0	7.9	3.8	7.7	3.0	5.1	12.0	3.3	3.7	6.4	2.1	5.2	4.8	5.7	3.7	2.4	1.4	4.1	2.2	3.8	8.0	2.2	2.2	14.8	3.4	2.2	1.1	2.9	2.4	2.7	2.8	3.6	3.5	2.2	6.4	5.7	3.1	2.9	0.5	4.1	3.6	10.8	2.6	4.8	7.4	2.0	3.8	3.8	3.5	5.1	5.6	3.4	6.8	8.2	6.1	25.2	3.6	4.1	5.1	1.9	2.9	7.6	9.0	22.1	3.3	4.3	4.2	2.9	3.7	2.9	3.5	8.8	2.4	12.9	4.6	9.1	4.9	15.3	11.1	10.9	2.5	2.7	2.4	10.2	8.7	12.9	36.7	13.2	4.7	3.7	17.2	5.6	11.5	6.3	5.0	9.3	7.6	5.5	4.2	4.6	6.3	5.1	5.3	2.2	9.6	5.5	6.3	6.3	11.5	7.4	7.6	7.4	6.0	11.5	8.4	16.1	6.7	12.8	5.3	4.0	2.5	2.1	2.0	2.3	2.6	2.1	3.5	2.4	1.9	3.3	5.4	4.2	3.2	5.0	2.3	1.5	3.2	1.9	2.9	2.0	7.7	3.0	2.4	1.4	2.2	2.2	2.4	0.5	2.6	5.1	14.3	16.0	12.4	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	13.0	0.0	0.0	8.6	12.9	0.0	5.2	8.8	0.0	43.0	9.2	0.0	11.9	20.7	5.7	0.0	0.0	0.0	6.5	6.9	9.1	0.0	5.9	6.3	12.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	1.7	0.0	0.0	30.1	21.9	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	2.9	6.2	26.8	0.0	0.0
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 60.0;Early spermatids: 82.3;Macrophages: 60.5;Proximal enterocytes: 56.2;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 157.6;GAMG: 116.4;HMC-1: 57.4;U-87 MG: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029414	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	14.0	1.0	0.9	5.7	1.1	11.9	6.5	3.9	2.7	5.5	8.9	13.7	39.9	3.7	1.2	8.3	3.6	8.6	25.3	1.0	2.8	88.4	18.1	4.2	2.0	5.5	3.4	16.1	1.2	23.2	5.0	1.5	5.5	1.6	11.1	1.2	3.5	3.6	37.6	2.6	35.6	3.5	2.0	4.7	15.2	7.4	2.7	1.7	19.8	12.5	2.1	6.0	6.3	1.8	30.6	29.6	0.0	0.4	1.5	3.7	0.6	2.4	4.3	0.6	0.6	2.2	157.6	0.0	3.2	5.9	116.4	6.8	14.3	2.8	0.5	2.1	6.7	0.0	9.2	29.7	4.2	8.9	57.4	2.0	0.2	1.1	3.5	11.5	15.0	8.5	25.1	23.7	0.6	3.1	2.3	2.2	0.7	45.6	12.5	0.3	6.7	11.6	29.8	2.0	0.7	0.0	5.8	6.1	17.3	1.6	1.2	1.6	0.7	6.9	12.3	6.9	28.9	1.1	2.2	0.0	66.4	17.6	52.2	182.5	33.2	4.0	0.6	27.8	6.0	0.1	3.5	2.0	81.4	0.1	2.5	1.2	91.1	1.6	23.6	0.3	2.3	10.4	0.9	1.1	3.9	2.7	1.0	2.8	5.5	3.4	5.5	2.0	2.7	1.8	4.8	6.4	6.8	0.0	1.3	0.0	60.0	0.0	8.0	0.8	10.2	4.1	0.0	4.3	5.0	11.0	0.0	0.4	0.8	18.6	15.6	4.8	82.3	1.0	1.1	5.4	1.2	6.1	0.0	6.8	1.3	5.5	34.7	2.4	7.6	0.8	7.5	13.2	14.8	5.0	0.0	9.9	0.0	11.3	0.0	21.7	1.2	60.5	0.0	0.0	28.7	0.1	1.0	0.0	0.0	10.4	6.7	0.7	1.2	32.4	56.2	67.4	1.5	0.3	6.6	5.8	1.7	10.6	1.9	5.2	0.0	1.0	7.3	4.9	3.6	28.9
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491985-84499292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.2;esophagus: 9.2;pancreas: 6.4"	"Group enriched"	"Detected in some"	5	"Ductal cells: 9.3;Early spermatids: 25.8;Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.4;HAP1: 6.2;HEK 293: 5.0;HMC-1: 4.1;PC-3: 3.0;U-2197: 6.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Group enriched"	"Detected in many"	5	"hypothalamus: 2.5;medulla oblongata: 3.4;midbrain: 3.8;pons: 3.8;spinal cord: 7.9"	"HPA036774, CAB070169"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.0	0.0	0.7	0.0	1.0	0.0	0.2	0.6	0.6	0.0	0.6	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.1	0.0	4.2	14.2	0.1	6.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.7	2.2	1.6	0.0	3.2	0.0	0.0	0.0	0.0	1.3	0.2	0.1	4.4	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	2.0	0.0	6.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	3.0	0.0	2.0	0.0	0.0	0.3	1.1	0.0	0.7	0.0	0.0	1.3	0.0	0.5	0.0	0.0	1.8	6.8	2.0	0.0	0.0	0.0	1.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.6	0.6	0.6	2.8	4.2	14.2	4.0	4.2	1.6	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	25.8	0.2	1.0	0.1	0.0	0.0	0.0	0.4	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	16.7	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84583127-84651334	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 129.8;Respiratory ciliated cells: 210.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.1;hTCEpi: 56.9;OE19: 45.5;SK-BR-3: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	1.0	6.1	8.8	1.5	9.5	0.6	10.2	11.1	17.8	6.3	19.0	20.0	40.2	3.0	29.0	20.1	32.2	8.0	0.5	8.9	11.6	14.9	0.5	10.7	0.6	15.9	11.2	5.2	4.7	28.3	4.8	7.2	16.6	9.4	21.3	22.4	12.5	4.7	0.1	15.4	34.4	1.2	9.9	1.6	18.4	7.4	14.7	3.5	30.4	0.1	5.1	6.7	9.2	8.2	26.5	0.6	1.5	0.3	0.1	0.0	26.5	0.0	0.4	0.6	0.5	11.2	46.1	0.0	2.0	0.0	5.4	27.2	8.5	23.2	0.3	1.8	12.6	0.0	3.8	2.7	0.0	0.8	1.8	0.2	56.9	0.0	8.2	1.0	0.0	1.5	0.1	0.0	0.1	18.8	0.2	0.1	3.8	45.5	1.8	0.1	0.0	5.7	12.7	20.0	10.6	0.2	2.9	62.1	0.1	4.9	19.0	0.5	0.0	0.0	1.4	2.8	3.5	0.0	0.0	0.0	2.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	9.5	11.1	17.8	8.9	11.6	15.9	11.2	16.6	9.9	14.7	8.2	0.8	16.0	42.3	33.3	0.4	29.1	27.7	26.4	26.7	16.7	26.6	13.6	1.4	24.3	39.5	40.5	10.4	60.0	0.4	63.0	3.9	26.4	12.1	129.8	3.8	3.3	22.3	0.0	43.1	22.8	12.1	3.5	41.3	45.2	0.0	15.4	1.4	0.7	12.7	21.9	64.6	53.9	48.8	3.5	13.9	4.5	0.6	3.5	0.0	9.4	1.2	29.0	0.0	3.5	2.4	40.8	30.4	0.4	0.1	30.8	80.0	15.9	210.7	32.0	0.0	1.2	4.3	13.1	6.6	41.1	54.1	57.3	1.6	4.8	51.6	38.3
WDFY3	"ALFY, KIAA0993, ZFYVE25"	ENSG00000163625	"WD repeat and FYVE domain containing 3"	Q8IZQ1	4	84669597-84966690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Developmental protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 241.0;Excitatory neurons: 231.0;Inhibitory neurons: 248.7;Microglial cells: 209.9;Oligodendrocyte precursor cells: 262.9;Oligodendrocytes: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"TIME: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042734, HPA048572"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042734: AB_2678135, HPA048572: AB_2680447"	"unprognostic (7.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.64e-5)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.95e-2)"	8.6	8.6	14.8	7.6	31.7	14.4	8.7	26.8	22.9	8.5	4.7	5.7	3.6	8.2	6.4	7.4	8.2	8.8	5.7	16.3	15.6	20.1	5.6	7.4	2.6	30.6	30.4	13.6	9.0	16.3	6.5	11.8	28.7	8.6	5.6	26.2	7.2	7.4	5.9	10.8	4.7	8.5	21.7	7.8	5.6	8.1	25.6	3.4	11.7	13.2	2.3	8.7	5.7	44.9	11.9	7.8	14.3	7.9	24.8	19.3	9.0	11.2	11.8	11.5	10.3	9.1	9.6	0.0	11.3	18.8	12.3	5.9	15.4	12.3	14.6	7.9	4.9	7.5	9.0	5.5	9.4	5.9	13.7	14.2	10.9	15.0	15.1	13.9	37.1	6.0	7.5	35.3	21.4	8.5	5.7	1.4	7.4	11.4	4.0	8.4	11.4	1.8	19.6	15.6	16.8	7.8	13.8	15.1	7.5	13.5	7.9	14.4	57.0	15.1	14.9	8.5	14.1	0.1	0.0	0.0	10.2	5.0	16.9	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.1	14.8	31.7	26.8	22.9	16.3	15.6	30.6	30.4	28.7	21.7	25.6	44.9	28.5	19.2	12.9	241.0	1.0	14.7	9.1	12.4	11.4	46.6	13.8	11.3	18.2	20.0	14.7	16.5	35.5	11.8	0.5	6.5	1.9	8.6	6.7	27.1	27.8	20.1	9.1	1.3	231.0	7.3	6.9	19.5	15.3	43.4	0.0	31.0	17.9	8.1	20.5	28.6	248.7	7.8	20.3	43.1	14.1	10.1	18.3	29.9	7.2	209.9	19.7	28.7	0.0	262.9	440.4	10.7	6.5	24.5	0.2	13.6	4.8	18.4	15.5	41.9	26.3	30.0	22.8	11.4	7.3	14.1	16.1	14.5	1.8	15.0	6.7	13.6
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475150-86002668	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 99.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1364.3;Microglial cells: 905.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7"	"Group enriched"	"Detected in many"	5	"B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"		"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	14.6	2.2	6.5	7.5	5.1	18.7	9.2	6.2	5.8	5.5	3.9	7.4	7.3	9.4	4.6	6.1	4.1	10.9	27.3	5.7	6.6	99.8	9.5	15.7	10.5	15.7	11.5	5.5	30.1	8.1	5.4	22.4	17.2	5.4	6.1	8.4	10.6	7.2	10.2	7.0	10.3	14.1	12.1	16.4	26.0	3.4	10.4	7.5	27.8	7.7	15.5	9.1	5.6	19.1	3.0	6.2	4.4	0.1	109.0	65.5	4.8	21.5	28.5	5.2	8.4	0.1	0.0	2.8	7.4	48.8	6.4	0.0	0.2	9.0	11.0	0.0	1.2	3.6	0.6	0.2	63.6	0.4	0.0	48.4	0.9	10.3	4.7	23.9	121.9	0.0	6.6	0.4	46.1	0.0	0.1	0.0	0.3	1.5	11.3	0.6	22.4	11.8	67.2	0.0	2.3	2.3	2.5	3.5	7.8	4.7	0.4	0.2	87.0	59.9	1.2	4.4	0.3	0.3	0.0	3.9	10.1	2.2	19.9	0.0	15.9	0.0	0.0	3.0	0.0	47.3	0.0	0.0	3.8	36.8	0.0	0.0	5.5	0.0	2.3	12.7	0.0	3.1	6.5	5.1	6.2	5.8	5.7	6.6	15.7	11.5	17.2	12.1	10.4	19.1	14.0	57.7	28.8	1364.3	142.1	8.2	3.9	35.6	10.2	6.6	1.2	4.7	26.4	47.1	18.3	46.0	6.2	54.8	9.9	1.0	226.9	9.4	30.5	1.2	12.9	9.5	2.4	0.0	12.2	11.8	26.2	24.7	25.0	1.4	1.3	6.7	4.2	9.5	10.5	111.0	51.3	3.3	6.1	33.7	21.3	8.8	16.8	26.3	19.6	905.0	34.0	27.7	0.0	27.2	21.8	7.4	2.9	12.4	2.0	2.3	0.2	205.9	24.8	6.6	6.6	50.0	21.3	8.1	5.9	4.0	6.3	232.9	4.1	18.4	5.0	1.9
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 902.0;Excitatory neurons: 1018.9;Inhibitory neurons: 727.8;Late spermatids: 400.5;Oligodendrocyte precursor cells: 596.6;Oligodendrocytes: 302.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"AF22: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favorable (5.57e-4)"	26.1	15.6	45.2	5.1	61.6	14.5	7.4	25.4	91.3	17.5	23.5	5.7	3.6	14.5	18.8	9.8	15.8	13.8	6.9	60.4	24.9	20.4	3.2	8.6	5.2	29.0	36.2	14.7	7.4	10.3	25.5	4.3	31.4	22.4	5.4	18.3	4.7	24.2	2.6	4.6	5.1	15.5	24.9	7.4	6.6	26.4	39.2	3.4	20.5	4.2	4.6	14.0	18.4	55.6	2.9	4.9	155.0	4.8	4.1	3.6	5.6	3.2	2.9	2.7	1.2	3.3	4.4	7.1	5.1	1.9	3.8	9.4	1.8	4.2	4.3	4.9	4.0	5.7	7.3	4.6	3.6	2.7	3.1	4.1	1.9	3.7	5.0	5.5	3.5	4.8	5.2	27.9	1.7	3.5	4.4	3.1	8.8	0.7	3.2	4.9	4.0	2.5	10.7	16.9	9.2	8.4	3.3	5.9	2.2	5.0	8.8	3.3	7.5	6.3	6.4	3.0	2.7	8.2	5.1	4.4	9.9	3.5	3.8	3.3	0.7	1.2	0.8	0.7	1.0	1.3	0.7	1.0	0.6	1.1	1.0	1.4	4.4	1.2	0.7	1.2	1.2	0.9	45.2	61.6	25.4	91.3	60.4	24.9	29.0	36.2	31.4	24.9	39.2	55.6	4.3	22.4	33.8	902.0	1.6	0.8	15.7	5.5	4.0	26.1	3.2	3.7	1.6	8.6	12.8	22.0	6.2	0.3	0.1	0.0	11.7	2.4	219.5	61.1	25.1	1.3	2.4	0.0	1018.9	0.0	0.5	16.9	2.0	7.1	2.5	6.2	1.1	0.0	0.3	38.7	727.8	0.0	4.1	0.3	0.0	400.5	26.4	1.5	1.8	185.5	0.0	15.7	0.0	596.6	302.8	2.0	0.0	54.9	0.1	7.6	0.0	22.6	68.9	10.8	6.6	7.2	18.5	10.5	5.5	1.3	1.0	0.1	0.9	28.5	0.0	22.6
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 124.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 117.6;RT4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	14.0	6.7	9.9	3.0	16.6	0.3	11.7	8.1	10.8	18.8	22.4	5.2	0.8	13.1	25.5	22.2	13.0	7.7	6.1	14.2	10.6	26.6	1.4	22.9	5.2	16.7	13.1	28.7	4.9	17.5	16.8	3.3	10.5	11.0	2.4	124.3	6.6	10.6	1.0	55.9	2.6	7.9	8.2	4.0	4.1	15.8	13.8	7.6	20.8	5.0	11.5	20.7	22.7	20.4	13.8	6.8	117.6	11.5	48.2	41.9	0.0	25.0	51.0	9.4	11.7	0.1	6.8	0.0	5.3	28.0	3.3	44.4	20.6	37.9	18.0	0.3	15.1	11.4	14.6	0.0	5.9	20.5	0.1	27.2	11.8	6.8	22.4	19.7	0.0	0.0	0.0	19.2	0.0	6.2	1.8	7.4	26.5	0.0	5.1	4.1	0.0	0.0	35.6	57.2	6.8	9.8	7.4	16.4	13.3	18.8	9.6	0.7	0.0	9.1	6.9	0.2	3.3	19.8	0.0	0.0	9.5	0.0	4.0	0.0	0.1	0.0	0.1	1.3	0.9	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.9	16.6	8.1	10.8	14.2	10.6	16.7	13.1	10.5	8.2	13.8	20.4	5.3	48.1	223.1	165.2	0.6	109.4	25.6	26.3	79.1	11.6	11.2	8.9	1.8	11.5	52.0	47.8	91.8	0.2	0.3	0.1	3.9	5.0	23.2	16.9	49.4	3.7	4.8	0.8	67.0	3.7	0.1	28.8	4.1	7.7	5.1	7.5	3.6	0.1	0.3	1.7	39.3	1.1	8.2	1.4	10.6	20.8	45.7	4.5	19.6	51.5	0.5	20.3	0.0	75.4	200.2	6.2	2.7	32.7	3.0	16.0	0.1	10.9	27.3	179.0	13.1	10.1	20.8	25.4	20.5	97.8	99.4	0.3	6.6	14.0	0.7	52.5
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849384	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1;skin 1: 13.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 59.5;Late spermatids: 191.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.2;HaCaT: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016662	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	5.2	0.3	0.1	0.7	0.3	0.0	2.8	0.1	0.2	3.1	0.0	0.4	0.1	0.5	0.3	9.1	0.6	1.0	0.7	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.3	0.1	0.7	0.6	0.2	0.1	0.3	0.4	0.3	0.0	1.5	0.2	0.7	13.4	0.2	1.0	0.1	0.2	0.3	4.3	0.9	0.3	1.0	1.1	1.2	0.9	4.7	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.1	0.9	0.7	9.3	0.0	0.0	6.2	0.0	13.8	0.0	0.8	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	1.7	1.0	2.6	0.0	0.0	2.5	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.2	191.7	1.5	0.1	0.0	2.8	0.0	0.0	0.0	3.5	4.8	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.2	1.2	0.6	6.0	24.9	0.0	0.0	0.0	0.0	0.2
C4orf36	MGC26744	ENSG00000163633	"Chromosome 4 open reading frame 36"	Q96KX1	4	86876205-86892422	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.7"	"Group enriched"	"Detected in many"	12	"Early spermatids: 129.5;Late spermatids: 349.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.8;CAPAN-2: 2.1;hTCEpi: 1.7;hTERT-HME1: 2.4"									HPA057434	Uncertain		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Focal adhesion sites"	Cytosol	"HPA057434: AB_2683438"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.76e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.69e-5)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.75e-2)"	0.4	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.4	1.0	0.0	0.1	0.1	0.3	0.0	0.7	0.2	0.0	0.1	0.1	0.2	0.4	0.1	0.4	0.0	0.1	0.1	0.6	0.2	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.4	0.1	0.0	1.5	0.1	0.2	0.1	0.1	0.1	10.7	0.1	0.0	0.4	0.0	0.1	0.3	0.6	0.3	2.8	0.2	0.1	0.1	0.0	0.1	0.6	1.4	0.4	0.3	0.0	0.1	2.1	0.0	0.2	0.0	0.0	1.2	0.2	1.2	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.4	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.8	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.3	1.1	0.3	0.8	0.3	0.2	0.0	0.2	0.5	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	2.6	2.3	5.0	8.9	9.6	4.0	5.4	0.2	0.0	19.2	15.7	5.1	0.0	10.4	0.9	4.0	13.0	0.0	0.1	129.5	0.1	0.4	5.9	3.0	4.8	1.4	0.0	2.9	4.3	11.7	0.2	0.0	0.1	7.9	3.1	3.3	1.7	1.6	9.1	8.2	6.2	5.8	349.7	5.3	3.5	1.8	1.0	1.4	6.4	5.2	1.0	3.6	0.2	11.3	3.4	6.9	3.7	10.8	0.0	5.6	6.7	6.6	6.2	2.3	3.9	6.9	6.7	10.2	9.7	2.1	0.0	7.1	4.6
AC093827.5		ENSG00000285458	"Novel protein"		4	86886472-86936178	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 3.1;Distal tubular cells: 5.9;Respiratory ciliated cells: 8.0"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.1"									HPA057434	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Focal adhesion sites"	Cytosol	"HPA057434: AB_2683438"																		1.3	1.2	2.2	0.7	2.5	1.1	1.9	3.6	3.3	1.2	1.3	0.9	1.0	1.1	2.0	1.3	1.0	0.8	2.7	2.6	2.2	1.7	0.7	1.0	0.5	2.0	2.0	1.1	0.9	1.6		0.9	2.1	1.4	1.2	2.0	1.4	0.9	3.4	2.8	1.0	1.0	1.0	0.9	1.3	1.9	2.1	0.6	2.2	3.7	0.4	0.9		3.6	1.6	1.0	0.4	0.7	1.5	1.3	0.6	1.5	1.6	0.5	0.7	0.7	2.6	0.2	1.3	1.0	1.2	1.1	0.7	0.9	0.6	1.2	0.6	1.2	1.3	0.7	0.8	2.1	0.8	0.9	2.3	0.5	1.7	0.8	0.4	0.6	0.9	5.1	0.3	0.5	0.9	0.7	1.0	1.6	0.5	1.6	0.6	1.3	1.5	1.1	0.5	0.8	1.1	1.0	1.3	0.7	2.0	1.3	0.6	1.1	1.5	0.5	0.7	2.3	1.1	2.3	0.9	1.0	0.6	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.2	0.3	0.3	0.3	0.3	0.6	0.4	0.4	0.2	0.5	0.1	0.1	2.2	2.5	3.6	3.3	2.6	2.2	2.0	2.0	2.1	1.0	2.1	3.6	0.7	12.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	5.9	0.4	0.0	1.1	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	8.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 225.2;Microglial cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.2	18.0	10.7	18.1	11.8	35.0	22.8	8.1	13.0	24.8	51.4	25.9	18.2	25.6	11.8	19.1	21.4	19.6	19.6	10.2	10.0	32.8	24.8	20.7	16.3	16.3	9.8	28.8	28.2	31.8	12.5	26.8	11.8	18.2	22.5	63.6	24.0	22.8	55.6	23.4	19.4	31.9	9.1	19.4	19.0	6.9	14.2	22.8	54.9	41.8	13.4	18.5	19.0	12.0	15.3	13.5	11.3	12.0	18.3	21.6	15.9	15.1	22.2	11.3	16.7	14.7	27.8	17.3	20.2	18.7	14.4	6.8	18.0	22.8	15.7	29.8	7.2	36.0	38.3	12.3	14.1	35.0	27.4	17.7	16.1	19.4	17.0	16.4	42.1	14.1	22.5	47.5	4.8	4.1	31.6	10.1	15.0	25.6	4.8	24.7	6.7	22.2	33.1	14.5	25.6	4.7	23.1	15.0	7.2	23.5	9.0	28.9	21.3	20.9	18.8	12.9	8.5	41.0	24.8	29.6	17.1	39.5	7.7	5.4	7.4	17.6	8.8	5.4	9.8	12.0	11.8	8.9	8.5	14.5	6.0	5.8	28.4	7.7	3.3	20.7	11.3	4.2	10.7	11.8	8.1	13.0	10.2	10.0	16.3	9.8	11.8	9.1	14.2	12.0	88.0	41.7	55.6	125.7	29.3	24.1	20.2	17.8	33.6	41.7	20.6	11.6	119.8	40.0	28.4	92.0	225.2	1.4	29.1	40.7	3.9	11.9	7.2	32.4	39.1	50.2	32.3	54.5	69.2	12.6	4.2	36.3	42.8	46.2	25.2	40.3	65.0	34.2	13.0	18.5	47.5	35.8	16.2	41.7	32.8	9.3	29.2	34.8	23.2	202.4	16.5	21.4	16.5	74.4	84.0	13.1	31.4	28.6	53.9	21.9	29.8	50.3	36.0	147.2	26.3	41.9	31.2	3.8	11.3	45.3	31.7	32.8	26.4	13.3	29.0	15.8
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 60.4"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.7	7.3	4.6	6.1	4.7	3.1	9.4	7.0	4.8	8.7	1.9	8.0	7.8	6.8	60.4	4.8	5.4	4.9	4.6	4.1	5.6	12.0	11.2	5.2	5.8	4.1	5.4	6.0	5.2	8.5	3.6	4.2	3.6	5.5	8.9	27.2	7.1	7.4	13.7	4.0	7.6	6.6	4.7	6.3	4.2	4.3	5.9	8.5	18.9	9.7	4.8	6.0	4.2	5.0	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.6	4.7	7.0	4.8	4.1	5.6	4.1	5.4	3.6	4.7	5.9	5.0	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322886	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 573.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.4"	"Not detected"	"Not detected"							HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	9.4	0.3	0.6	0.2	0.6	1.4	6.4	2.4	1.0	2.7	0.1	0.7	0.4	2.7	0.2	0.2	1.0	0.2	0.4	0.6	0.5	0.4	573.7	3.6	0.2	0.8	0.5	0.5	1.8	0.1	0.2	0.8	0.9	4.5	0.4	0.8	0.2	0.2	0.3	6.5	0.7	4.2	0.4	0.7	0.3	0.4	0.5	0.3	0.2	0.1	0.1	1.2	7.8	0.9	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.7	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.1	1.4	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.2	1.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.6	0.6	2.4	1.0	0.6	0.5	0.8	0.5	0.9	0.4	0.5	0.9	100.0	3.2	6.4	1.6	0.0	2.5	22.6	0.3	0.0	0.2	0.2	0.3	0.3	4.3	42.9	1.8	0.0	0.1	0.4	1.0	0.0	0.1	2.7	0.4	0.5	2.4	1.8	5.3	3.7	0.4	0.3	0.8	0.0	0.1	0.0	0.2	1.8	131.3	0.2	0.0	3.0	0.5	0.0	2.4	0.4	2.7	0.0	0.7	0.0	0.0	0.3	0.3	0.0	1.5	2.8	0.1	1.4	0.4	0.1	4.7	0.2	0.5	34.0	0.1	0.0	0.7	0.4	0.0	0.9	0.2	0.4	0.0	0.7	0.2	0.7	57.0
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336515-87391188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 288.6;liver: 241.6"	"Cell type enhanced"	"Detected in all"		"Paneth cells: 498.6;Proximal enterocytes: 1134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 768.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 768.7;monocytes: 202.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 295.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	56.0	64.1	15.0	33.0	15.7	109.9	45.5	19.7	18.6	44.0	18.8	139.6	216.7	57.5	28.2	21.5	44.2	107.7	21.0	15.6	18.4	75.9	241.6	104.4	41.5	20.1	17.5	60.6	54.5	10.9	13.1	47.2	18.9	25.5	145.8	8.2	14.8	34.2	12.1	14.5	288.6	49.4	19.3	42.7	36.6	10.1	16.7	36.3	19.3	26.3	34.9	41.8	33.5	22.8	1.0	45.4	22.2	56.1	66.5	92.4	31.2	23.4	39.3	16.1	29.9	38.2	295.2	0.0	45.8	26.2	14.8	0.9	65.6	5.2	18.0	72.1	13.8	63.3	22.9	131.0	37.6	114.8	114.0	65.3	1.7	22.5	7.4	51.3	31.5	27.4	67.9	32.7	30.1	1.8	24.0	144.8	37.8	146.7	7.6	63.2	20.4	77.7	45.5	70.0	7.2	69.3	47.5	1.6	87.0	28.2	0.1	112.7	24.9	11.0	47.9	43.1	13.0	15.0	6.6	7.1	20.1	80.6	77.0	591.1	202.0	442.9	62.5	142.7	74.8	57.1	62.6	64.6	108.2	47.6	55.8	64.2	768.7	82.3	125.8	36.8	77.4	171.6	15.0	15.7	19.7	18.6	15.6	18.4	20.1	17.5	18.9	19.3	16.7	22.8	169.0	314.1	179.5	13.4	89.0	28.0	77.0	16.0	10.8	1.8	5.0	6.2	5.3	368.9	83.7	44.1	2.1	30.6	63.1	356.8	25.4	53.9	1.2	9.0	28.1	101.8	93.7	68.8	16.8	58.6	59.7	77.3	28.1	18.8	100.1	34.1	112.5	337.3	129.1	18.5	14.7	180.8	18.3	220.4	176.2	5.1	104.1	139.1	67.6	43.1	197.3	36.3	113.3	16.6	19.0	65.9	498.6	59.5	60.8	39.5	1134.9	173.6	62.2	3.9	72.3	77.9	43.0	2.7	15.4	10.4	21.5	14.9	93.8	65.4	281.0	93.9
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422573-87459455	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 160.7"	"Low region specificity"	"Detected in all"							"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9900	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	23.6	36.1	20.8	16.2	21.4	6.7	19.7	25.5	38.5	27.6	39.1	27.0	42.6	24.8	32.2	19.6	24.9	16.2	28.8	21.9	24.7	40.4	46.6	23.0	13.7	21.0	20.5	26.7	67.6	55.3	29.1	19.9	21.9	30.4	27.1	20.1	28.1	23.8	42.1	16.6	40.3	23.8	19.6	14.7	22.3	22.5	22.1	13.4	28.8	45.0	14.8	22.4	24.3	26.0	30.8	25.6	34.0	19.8	67.6	39.6	26.0	59.8	35.6	21.3	21.1	17.1	53.1	47.6	58.9	47.6	41.0	21.1	32.1	38.1	33.2	34.5	24.0	13.4	34.5	31.8	42.4	25.6	21.2	41.5	52.4	25.6	22.6	45.5	41.6	13.7	40.3	30.0	38.7	33.4	39.1	23.2	29.1	68.5	12.0	45.0	31.8	27.0	160.7	24.2	41.3	28.7	37.6	63.0	30.8	44.5	36.8	38.2	43.7	34.7	34.3	25.8	27.8	21.5	18.7	37.9	51.3	21.9	48.2	1.6	17.9	5.9	19.1	21.2	18.2	22.2	18.5	19.5	21.4	18.8	22.5	26.0	1.8	15.6	24.0	20.6	19.0	16.0	20.8	21.4	25.5	38.5	21.9	24.7	21.0	20.5	21.9	19.6	22.1	26.0	32.6	67.3	44.8	20.2	14.9	9.9	40.4	45.0	9.6	15.3	11.3	13.1	40.9	30.0	55.0	23.9	27.1	33.2	13.1	21.0	41.1	44.7	28.6	26.0	26.2	25.8	16.8	6.7	21.7	36.5	32.5	29.4	8.6	27.0	20.8	23.3	18.2	47.5	33.2	6.7	24.0	18.0	40.7	12.7	11.0	11.5	25.4	14.7	10.6	20.6	16.4	26.8	8.2	18.6	24.8	29.4	37.0	26.7	15.8	32.9	55.7	56.2	41.0	18.6	26.3	36.9	23.7	44.5	23.6	15.7	9.5	37.6	12.1	29.8	24.9	27.3
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 4430.9;Endothelial cells: 2372.1;Peritubular cells: 2523.5;Sertoli cells: 4674.1;Skeletal myocytes: 2379.0;Smooth muscle cells: 2781.9"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 24.9;SuSa: 31.4;U-266/70: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		630000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	755.6	129.5	664.6	124.5	810.9	0.5	532.1	612.4	1058.4	732.7	580.4	624.3	125.1	1244.5	443.8	308.1	754.5	487.9	600.2	744.6	723.5	72.5	25.0	481.1	99.1	655.7	730.9	286.8	91.8	128.0	197.8	315.4	663.4	584.2	187.5	95.2	228.3	999.2	244.8	130.2	280.1	1191.2	774.7	157.9	347.7	97.5	694.8	103.2	369.9	594.7	100.0	488.0	466.4	681.2	0.7	0.0	24.9	0.3	0.2	0.1	2.6	0.1	0.1	0.0	0.0	0.0	0.1	0.4	1.8	0.0	0.0	1.4	2.4	0.0	0.0	1.7	0.0	0.3	1.1	0.4	1.1	0.3	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.5	0.2	3.5	0.6	0.0	0.0	0.3	0.4	1.2	0.0	0.1	0.8	1.6	0.1	0.2	0.1	31.4	0.4	0.5	0.0	0.2	0.3	1.5	0.2	9.1	1.4	0.6	3.4	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	664.6	810.9	612.4	1058.4	744.6	723.5	655.7	730.9	663.4	774.7	694.8	681.2	4430.9	12.8	56.4	1155.7	6.2	46.3	187.2	0.6	59.7	10.7	24.4	251.6	334.2	4.3	43.3	7.3	2.1	2.2	8.6	0.0	13.7	0.8	11.8	34.9	935.8	2372.1	0.0	32.0	382.3	0.4	3.2	1413.1	6.1	46.7	7.6	1.4	899.5	9.1	9.2	3.3	450.1	0.0	0.0	5.3	55.2	47.0	659.5	31.6	56.9	261.4	0.0	179.4	0.0	210.6	53.8	0.1	0.0	2523.5	25.2	50.4	0.0	24.6	7.4	34.4	4674.1	2379.0	2781.9	5.7	7.9	56.8	39.9	2.5	26.9	38.8	0.0	124.2
DSPP	"DFNA39, DGI1, DMP3"	ENSG00000152591	"Dentin sialophosphoprotein"	Q9NZW4	4	87608529-87616873	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Deafness, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036230	Uncertain				"Secreted in other tissues"	NA	NA		27000							"HPA036230: AB_10672239"				"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.27e-1)"		"unprognostic (2.21e-2)"				"unprognostic (1.26e-1)"			"unprognostic (1.76e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMP1		ENSG00000152592	"Dentin matrix acidic phosphoprotein 1"	Q13316	4	87650280-87664361	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Early spermatids: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037465	Approved				"Secreted to extracellular matrix"	NA	NA		64000			"Cluster 29: U-266 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA037465: AB_10672492"	"unprognostic (6.77e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.96e-3)"		"unprognostic (7.73e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-2)"		"unprognostic (8.50e-9)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799554-87812435	"Cancer-related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;pituitary gland: 2.0"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 5.8"	"Group enriched"	"Detected in many"	4	"breast cancer: 3.8;glioma: 12.2"	"Region enhanced"	"Detected in single"		"thalamus: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-138 MG: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	2.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.5	0.7	0.7	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	107	"brain: 10.6"	"Cell type enriched"	"Detected in single"	18	"Inhibitory neurons: 12.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"	NA	NA		810000		"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038003: AB_2675780, HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.0	0.0	4.6	0.0	1.1	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	0.0	10.6	0.9	4.0	0.3	0.0	0.9	0.2	0.1	2.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	113.1	24.4	276.0	59.5	490.3	1.0	70.2	652.0	736.4	27.5	265.0	44.9	9.5	131.2	9.8	4.8	52.8	2424.4	37.0	301.6	417.1	3587.6	35.6	18.8	9.1	813.2	645.3	9.9	292.0	19.2	20.6	2791.9	781.8	15.7	7.6	745.5	88.7	22.1	16.0	2.7	14.4	38.3	472.6	9.2	11.0	11.7	633.1	8.4	8.3	0.4	5.7	25.0	6.0	855.0	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	276.0	490.3	652.0	736.4	301.6	417.1	813.2	645.3	781.8	472.6	633.1	855.0	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	30.7	24.2	9.6	13.9	12.2	10.7	18.6	10.0	12.0	40.0	7.3	32.5	10.7	61.1	14.7	12.7	39.3	26.9	19.7	9.0	8.9	48.6	15.0	22.2	11.5	10.4	11.2	47.7	14.8	27.9	9.0	24.5	10.0	23.3	13.2	14.0	9.7	39.2	5.8	10.3	14.8	53.7	9.1	10.9	20.0	10.3	11.9	7.6	16.4	11.7	8.7	20.6	18.4	14.6	7.4	40.8	44.9	23.2	101.8	67.6	13.3	137.2	207.1	62.9	62.2	2.0	12.8	4.0	29.3	166.4	24.0	9.1	8.1	20.4	54.5	21.2	7.1	6.6	21.8	4.3	56.5	16.2	12.9	56.4	9.1	49.4	26.4	85.6	28.8	7.6	0.9	10.9	55.5	14.4	11.4	7.7	23.4	5.3	6.7	21.5	26.8	6.0	55.6	17.2	9.0	20.1	25.5	1.2	32.5	45.0	9.7	12.1	44.7	59.1	12.9	16.8	18.8	8.7	2.9	4.4	35.2	2.5	55.3	1.4	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.3	0.1	0.4	0.1	0.1	9.6	12.2	10.0	12.0	9.0	8.9	10.4	11.2	10.0	9.1	11.9	14.6	14.8	3.2	6.3	59.4	3.5	7.4	5.3	7.4	23.3	16.7	7.4	11.3	7.1	18.6	7.2	69.9	10.4	10.4	2.7	0.6	0.0	14.0	0.3	10.3	41.7	19.2	6.7	13.5	129.1	3.8	3.4	42.0	2.0	11.1	1.3	12.7	21.4	10.6	12.2	26.9	148.6	3.4	4.1	5.0	6.8	1.1	23.0	9.8	23.2	95.5	9.5	17.3	4.1	178.9	219.4	2.2	4.6	50.8	3.1	6.5	3.9	17.0	12.3	1.9	26.3	53.0	31.5	0.8	3.8	13.3	6.7	2.7	6.1	11.5	2.8	3.4
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090150-88231628	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 88.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6"	"Cancer enhanced"	"Detected in many"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.3	4.0	30.8	1.0	29.1	2.3	4.0	30.0	33.1	22.1	17.4	15.7	48.2	23.1	6.8	2.3	9.8	5.1	2.9	25.4	32.3	3.5	36.0	5.1	1.2	40.1	31.3	8.3	0.8	4.4	8.9	11.7	40.1	7.1	13.9	2.5	5.0	33.8	0.3	0.6	88.3	19.8	31.1	1.4	1.9	3.0	40.0	1.3	6.4	0.9	2.0	2.3	4.0	31.9	1.7	43.5	11.9	0.0	0.4	0.0	75.8	1.9	1.3	2.1	3.5	9.8	0.5	0.0	0.4	0.3	5.4	13.2	0.4	1.2	3.1	13.2	1.9	0.6	0.3	13.0	0.0	0.6	0.1	0.2	5.1	4.8	0.3	1.2	4.1	1.0	1.1	0.0	1.3	26.2	6.3	0.2	4.1	58.6	0.0	3.2	0.0	38.9	0.1	9.5	0.2	0.5	8.9	0.9	1.2	26.1	0.3	0.1	0.0	1.7	1.6	0.4	0.2	11.9	4.7	0.0	3.1	0.0	1.8	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.2	0.2	0.0	0.5	0.2	0.1	0.0	1.1	0.1	0.2	0.8	0.2	30.8	29.1	30.0	33.1	25.4	32.3	40.1	31.3	40.1	31.1	40.0	31.9	9.4	3.2	1.1	3.9	0.9	3.8	0.3	0.0	0.0	0.4	24.3	1.9	1.6	1.5	0.2	0.0	0.0	16.8	0.6	106.7	1.9	0.0	3.3	0.4	3.8	45.8	3.0	20.6	1.1	0.2	81.7	2.4	0.5	0.5	5.7	0.2	31.4	23.4	137.4	0.0	0.7	12.0	0.0	1.3	2.5	1.2	1.2	2.8	5.4	185.5	0.1	0.7	2.1	11.1	0.9	0.1	44.3	0.4	2.0	0.2	216.6	7.6	0.8	0.9	0.0	0.4	4.3	1.0	4.3	1.1	0.4	37.6	1.0	4.3	6.1	0.2
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 512.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	5.3	8.5	23.3	14.9	26.3	9.9	14.5	22.5	31.2	19.4	22.0	5.9	4.4	32.7	7.6	11.2	21.5	8.9	92.5	26.5	23.9	17.8	7.6	9.7	25.6	19.9	22.3	32.5	11.1	12.5	9.9	9.7	22.9	16.2	6.0	14.2	11.8	7.1	14.2	2.6	10.4	26.6	22.1	18.9	8.0	19.9	27.7	15.2	7.9	11.5	25.8	8.9	11.7	33.2	4.6	1.5	5.7	10.1	8.3	10.9	2.3	7.2	13.0	23.3	27.4	11.6	1.1	58.0	7.7	4.6	11.5	0.5	17.0	5.4	9.1	44.9	7.1	10.8	5.0	10.8	6.6	14.6	5.3	7.2	2.7	14.5	12.5	4.9	4.2	25.4	15.5	48.6	7.0	6.5	20.3	7.9	3.4	3.5	2.3	10.8	9.3	21.9	8.1	2.0	4.4	3.9	4.6	0.5	5.4	9.6	23.2	3.9	0.8	8.3	4.2	2.8	4.1	15.6	15.0	48.3	9.1	11.7	14.0	24.7	9.9	8.1	39.4	12.0	51.4	102.9	37.1	39.9	18.6	113.5	36.3	44.2	3.2	27.6	3.6	131.3	46.9	24.5	23.3	26.3	22.5	31.2	26.5	23.9	19.9	22.3	22.9	22.1	27.7	33.2	20.7	48.1	12.4	105.4	124.8	9.8	15.8	5.7	29.6	109.5	42.8	25.7	512.1	8.6	13.7	49.7	18.8	11.5	153.0	0.8	156.5	7.0	7.9	9.7	37.2	27.2	9.6	34.3	89.5	6.2	3.2	42.9	8.2	20.0	19.0	32.2	24.7	30.2	28.9	85.8	145.6	16.5	4.1	14.5	16.4	10.5	23.9	27.5	21.4	40.3	75.6	21.8	80.3	100.0	54.7	4.6	9.2	31.6	82.7	32.1	8.2	47.6	19.5	14.8	26.3	38.5	36.4	38.2	22.9	71.4	5.4	2.9	70.1	45.4	4.1	6.7
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443097	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 116.1;BJ hTERT+ SV40 Large T+ RasG12V: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	4.1	5.5	6.5	5.4	7.2	7.9	6.2	5.2	8.8	14.2	4.3	6.1	5.3	8.5	4.2	20.9	9.7	10.7	9.6	7.0	7.6	6.0	4.8	8.1	5.0	8.2	6.6	8.3	5.4	7.1	4.4	5.5	7.3	8.4	6.1	4.4	30.5	5.1	3.0	4.1	5.3	8.0	11.7	8.2	7.2	3.9	6.9	12.3	4.3	4.7	5.3	6.0	11.2	6.8	6.7	4.5	0.3	0.9	0.3	3.8	1.2	0.8	22.1	116.1	85.8	0.4	8.3	0.0	1.5	2.1	18.8	2.5	10.9	5.7	7.6	13.9	2.2	6.3	3.8	0.6	3.7	11.3	4.2	5.2	1.3	9.1	0.3	7.0	3.4	5.2	0.0	1.5	2.6	4.1	5.3	3.6	1.5	6.0	2.2	3.6	0.1	0.5	7.8	8.2	0.3	2.7	8.2	2.7	13.5	5.6	4.8	2.0	1.2	1.6	2.1	0.2	2.1	0.3	0.1	0.0	5.2	2.5	5.4	4.4	3.2	4.7	6.4	3.4	12.8	3.5	8.9	6.3	2.8	3.0	6.9	4.7	1.9	6.0	7.4	0.3	12.5	4.2	6.5	7.2	5.2	8.8	7.0	7.6	8.2	6.6	7.3	11.7	6.9	6.8	11.4	12.8	10.6	14.4	5.8	2.8	5.2	3.3	4.6	18.1	4.9	4.6	13.9	7.2	9.8	5.5	16.7	5.8	5.0	8.3	0.0	7.8	1.3	6.4	3.9	11.5	1.8	4.8	21.5	17.4	1.8	6.6	5.6	5.0	5.7	25.9	5.3	2.2	5.0	1.7	25.8	2.9	4.1	2.2	0.8	1.6	4.4	4.7	5.4	28.1	5.7	3.7	4.1	24.1	2.8	13.3	2.4	5.7	3.8	8.3	6.2	4.1	14.6	1.0	6.6	2.0	3.6	0.8	2.1	18.4	1.1	2.5	8.2	13.3	2.5	8.0
HERC5	CEB1	ENSG00000138646	"HECT and RLD domain containing E3 ubiquitin protein ligase 5"	Q9UII4	4	88457119-88506163	"Predicted membrane proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.5;Spermatocytes: 272.1;Spermatogonia: 431.3"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 89.9;BJ hTERT+ SV40 Large T+ RasG12V: 123.5;SK-MEL-30: 58.1"					"Low region specificity"	"Detected in all"			HPA043929	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA043929: AB_10962492"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-1)"	5.5	6.0	3.1	6.0	3.8	18.8	4.9	2.7	5.1	7.8	4.8	3.9	4.0	15.4	3.3	2.6	5.9	5.8	4.0	2.8	3.0	6.4	9.7	6.5	7.2	4.5	4.0	14.0	7.7	9.6	4.1	10.2	4.1	5.5	2.6	3.7	11.9	5.8	1.5	2.5	4.6	13.4	5.6	12.1	4.8	57.9	3.1	13.9	5.3	3.4	4.3	4.5	4.4	4.6	7.5	3.5	2.0	0.4	0.4	0.8	27.9	0.6	10.7	89.9	123.5	1.1	19.9	0.3	4.9	0.0	40.8	1.4	13.7	2.1	7.6	46.4	8.4	12.1	13.2	0.3	0.8	14.8	5.5	0.8	0.6	22.7	0.0	4.9	0.6	24.4	0.5	28.2	1.7	0.8	45.9	18.2	7.5	0.4	2.4	45.3	35.9	1.9	1.6	1.7	0.5	11.7	15.0	0.3	58.1	23.3	1.2	8.2	0.3	1.1	0.2	0.5	5.9	38.7	36.3	0.3	8.6	10.9	1.1	14.8	7.2	11.6	7.6	8.4	8.6	7.1	8.7	6.3	2.7	4.4	5.4	4.7	25.1	8.0	7.9	8.0	27.7	5.0	3.1	3.8	2.7	5.1	2.8	3.0	4.5	4.0	4.1	5.6	3.1	4.6	26.9	0.0	0.5	5.5	14.8	4.0	5.9	0.8	8.0	7.9	6.4	7.1	2.3	2.8	1.0	1.8	18.8	25.8	19.9	1.1	23.5	2.6	90.5	5.4	2.0	20.6	0.0	3.8	0.4	5.1	12.1	10.9	3.6	3.9	2.5	57.1	14.3	7.8	15.0	0.0	1.1	0.7	0.0	8.1	2.5	19.4	9.9	16.6	7.2	7.5	8.3	9.6	16.5	18.1	1.8	2.8	2.3	9.1	34.5	7.3	2.6	9.8	1.7	2.8	19.7	10.8	7.9	272.1	431.3	2.5	1.8	11.9	19.2	20.2	0.4	1.7
PYURF	PreY	ENSG00000145337	"PIGY upstream reading frame"	Q96I23	4	88520998-88523776	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA036455	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA036455: AB_10673388"	"unprognostic (8.25e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	71.2	72.2	35.1	23.1	37.0	44.5	70.4	38.7	43.4	69.0	33.8	72.0	30.7	74.8	45.6	64.1	65.5	22.5	58.6	34.0	37.3	84.9	81.7	56.4	27.8	36.7	35.6	65.2	59.0	41.9	66.2	28.5	36.5	61.9	31.2	22.9	55.4	33.9	66.9	67.0	53.9	36.2	39.2	54.4	56.8	42.3	36.2	27.3	54.5	42.3	29.4	61.7	62.5	39.3	60.1	19.8	39.1	46.4	76.7	78.3	26.2	43.2	60.6	53.1	44.6	15.5	46.3	0.2	47.3	61.7	36.4	25.2	35.6	54.4	66.6	73.4	61.8	66.2	24.8	59.9	58.0	110.7	40.9	54.4	80.8	34.5	69.5	50.4	88.5	20.4	75.9	64.9	77.8	45.5	68.5	67.6	32.7	70.5	37.5	68.0	36.3	69.8	44.4	33.4	46.7	45.7	54.9	49.4	119.9	38.4	23.0	54.8	60.6	56.1	51.9	55.3	40.6	45.6	40.1	7.5	49.3	55.7	63.1	82.4	92.1	79.0	90.4	94.9	102.2	98.9	103.2	98.3	111.0	80.5	105.4	101.6	18.1	108.9	95.3	68.3	116.8	186.1	35.1	37.0	38.7	43.4	34.0	37.3	36.7	35.6	36.5	39.2	36.2	39.3	136.2	51.3	71.3	0.0	92.0	230.4	176.0	167.2	158.8	28.7	207.2	205.2	5.8	84.4	98.8	86.5	10.4	232.3	106.8	65.5	287.6	118.0	44.0	69.7	103.9	127.0	114.6	98.2	0.0	129.5	120.6	119.6	53.5	51.2	105.8	97.7	114.2	147.3	139.4	26.9	0.0	99.4	101.7	115.9	124.7	98.3	125.9	100.0	348.6	0.0	129.2	113.3	176.1	0.0	0.0	103.4	102.7	120.0	84.6	208.7	128.0	236.9	79.1	33.0	59.2	107.3	109.2	108.1	62.3	189.9	289.0	163.9	119.6	136.5	132.8	142.3
PIGY	MGC14156	ENSG00000255072	"Phosphatidylinositol glycan anchor biosynthesis class Y"	Q3MUY2	4	88520998-88523776	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059018	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"				"HPA059018: AB_2683884"																		35.7	39.6	35.1	23.1	37.0	44.5	48.2	38.7	43.4	32.1	33.8	30.7	30.7	34.0	45.6	28.4	33.8	22.5	32.3	34.0	37.3	41.2	52.0	26.3	27.8	36.7	35.6	34.3	41.3	41.9	3.3	28.5	36.5	32.3	31.2	22.9	43.1	33.9	48.6	27.1	28.3	36.2	39.2	26.1	24.6	22.4	36.2	27.3	32.0	42.3	29.4	28.7	3.7	39.3	60.1	19.8	39.1	46.4	76.7	78.3	26.2	43.2	60.6	53.1	44.6	15.5	46.3	0.2	47.3	61.7	36.4	25.2	35.6	54.4	66.6	73.4	61.8	66.2	24.8	59.9	58.0	110.7	40.9	54.4	80.8	34.5	69.5	50.4	88.5	20.4	75.9	64.9	77.8	45.5	68.5	67.6	32.7	70.5	37.5	68.0	36.3	69.8	44.4	33.4	46.7	45.7	54.9	49.4	119.9	38.4	23.0	54.8	60.6	56.1	51.9	55.3	40.6	45.6	40.1	7.5	49.3	55.7	63.1	82.4	92.1	79.0	90.4	94.9	102.2	98.9	103.2	98.3	111.0	80.5	105.4	101.6	18.1	108.9	95.3	68.3	116.8	186.1	35.1	37.0	38.7	43.4	34.0	37.3	36.7	35.6	36.5	39.2	36.2	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HERC3	KIAA0032	ENSG00000287542	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"		4	88523810-88708450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"retina: 8.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Excitatory neurons: 73.2;Inhibitory neurons: 101.6;Oligodendrocytes: 113.9"					"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA039170	Uncertain		Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA039170: AB_10673414"																		1.0	0.9	1.4	1.4	1.2	2.1	1.3	1.9	1.6	2.1	2.1	1.2	0.8	0.9	0.9	1.5	0.8	0.8	2.4	0.9	1.5	1.5	1.3	1.2	1.4	1.8	1.3	1.1	0.6	5.0		1.1	1.8	2.5	1.6	8.5	1.7	1.8	0.9	1.5	0.7	0.9	1.0	1.7	1.2	0.4	1.3	2.1	1.5	1.9	2.1	1.2		1.4	1.9	0.0	0.3	0.5	0.6	4.5	0.5	1.4	4.1	1.8	1.5	0.4	1.4	2.3	0.3	4.6	1.0	0.3	0.0	1.3	1.9	0.4	0.5	1.6	0.1	0.5	0.6	3.4	2.2	1.8	1.9	1.7	5.1	0.9	3.0	0.6	0.7	0.9	3.6	0.0	1.7	0.3	0.0	0.4	0.3	1.8	1.6	0.9	2.3	0.0	0.4	0.7	0.5	0.6	0.8	0.6	0.3	0.5	3.3	1.8	0.7	0.3	2.1	1.4	0.0	0.7	1.5	1.4	0.9	0.0	0.5	0.3	0.3	0.4	0.4	0.3	0.5	0.3	0.6	0.1	0.7	0.8	0.9	0.4	0.7	0.0	0.8	0.4	1.4	1.2	1.9	1.6	0.9	1.5	1.8	1.3	1.8	1.0	1.3	1.4	8.6	6.4	6.9	35.9	15.5	35.9	10.6	7.6	9.6	23.9	11.3	3.8	0.0	5.7	5.5	9.2	110.5	0.0	11.0	14.6	1.9	4.1	3.6	5.2	7.0	7.3	27.6	8.2	73.2	9.1	0.0	8.1	9.2	9.5	15.8	3.4	7.9	13.5	0.0	32.0	101.6	8.9	8.2	22.3	22.0	3.0	8.4	17.9	14.2	68.4	14.1	14.0	8.2	57.3	113.9	10.9	8.2	13.2	12.3	11.6	10.5	9.2	7.2	70.0	6.6	11.1	8.5	3.5	6.7	16.3	50.7	0.0	16.7	4.9	6.1	11.2
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592434-88708541	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 114.1"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 23.8;Cytotrophoblasts: 7.0;Extravillous trophoblasts: 17.3;Hofbauer cells: 9.3;Syncytiotrophoblasts: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 48.2;hTERT-HME1: 68.6"									HPA039170	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favorable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	11.6	10.2	10.6	13.3	13.4	24.3	14.0	24.5	12.5	13.3	9.4	11.4	11.6	9.9	9.6	16.5	10.2	12.0	21.9	9.6	9.5	14.9	12.1	13.6	17.1	13.6	9.4	12.0	9.3	21.1	9.4	10.1	14.0	19.5	12.1	114.1	12.1	10.9	19.3	18.2	12.1	13.6	7.8	16.1	12.8	3.2	10.0	16.8	14.5	24.4	15.0	11.0	15.3	16.8	12.2	2.4	2.4	3.8	15.3	23.9	9.0	14.5	24.2	13.0	8.5	2.8	14.8	12.0	7.9	48.2	6.1	5.2	4.4	14.1	13.0	7.2	3.4	8.9	6.3	1.9	7.9	22.6	15.7	13.2	15.4	12.7	68.6	8.9	14.2	7.5	7.8	6.2	29.5	3.8	17.8	6.7	0.4	9.6	3.9	19.7	16.5	4.5	8.3	2.6	3.4	3.2	20.4	10.7	4.6	3.9	1.9	12.2	25.7	16.7	9.6	19.9	10.4	11.5	3.1	7.5	11.5	10.2	6.1	7.8	4.9	7.3	3.8	5.6	4.4	4.3	4.7	4.0	5.4	4.2	7.0	4.4	16.2	2.4	9.2	2.4	8.1	2.9	10.6	13.4	24.5	12.5	9.6	9.5	13.6	9.4	14.0	7.8	10.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	17.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0
NAP1L5	DRLM	ENSG00000177432	"Nucleosome assembly protein 1 like 5"	Q96NT1	4	88695913-88697829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 49.6"	"Low region specificity"	"Detected in all"							HPA058227	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA058227: AB_2683644"	"unprognostic (1.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.39e-1)"	9.3	27.7	41.3	4.5	35.7	7.2	5.9	24.1	53.9	7.0	11.6	5.7	2.1	7.9	12.9	4.8	5.8	6.7	7.3	34.1	72.9	7.5	6.2	3.6	3.8	38.0	49.1	9.9	3.3	9.0	23.0	6.0	55.3	8.1	3.5	21.0	2.8	10.4	2.8	2.1	2.8	8.0	25.5	4.4	3.9	6.2	37.6	3.8	11.6	4.0	2.7	7.6	3.5	26.7	0.0	1.9	12.4	7.6	17.7	11.3	0.0	13.5	8.2	6.8	10.5	0.0	1.6	0.0	5.4	7.9	3.0	2.6	22.2	5.4	12.2	4.3	0.0	23.8	7.9	1.9	15.4	12.4	15.0	18.0	1.7	8.0	1.2	8.7	12.2	13.1	6.8	0.1	20.1	0.2	15.3	0.9	5.1	6.6	0.0	8.2	3.6	1.4	4.5	5.7	16.4	49.6	0.0	2.4	10.4	13.2	0.0	3.5	8.8	7.7	1.9	4.9	6.8	3.4	0.0	0.0	16.4	0.0	6.1	0.0	0.1	0.1	1.4	0.1	0.9	0.0	0.6	1.0	0.3	0.2	1.2	1.1	0.2	0.5	0.3	0.3	0.7	0.3	41.3	35.7	24.1	53.9	34.1	72.9	38.0	49.1	55.3	25.5	37.6	26.7	6.4	3.2	6.7	8.5	4.2	1.8	3.8	2.2	5.2	32.4	3.0	5.2	5.3	1.5	4.7	5.5	14.6	16.0	12.2	0.6	15.6	1.8	1.0	2.8	13.0	7.2	17.3	10.5	21.2	2.6	2.2	12.8	4.6	3.3	31.1	5.6	16.8	3.0	5.6	15.2	30.8	2.2	2.0	0.9	3.1	0.7	10.8	2.9	5.4	3.7	1.8	36.8	8.2	5.5	7.6	1.0	1.3	18.0	4.3	2.0	0.1	5.9	1.4	16.1	19.7	9.2	14.5	8.6	3.0	2.2	1.4	22.2	9.0	16.3	0.9	2.2
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
TIGD2		ENSG00000180346	"Tigger transposable element derived 2"	Q4W5G0	4	89111533-89114901	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 25.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 15.9;Hepatocytes: 21.0;Syncytiotrophoblasts: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 11.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054844, HPA071168"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA054844: AB_2682623, HPA071168: AB_2686353"	"unprognostic (7.11e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.47e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.94e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.02e-4)"	2.8	1.9	1.9	3.2	1.9	2.5	10.4	4.7	2.1	3.9	3.9	3.4	6.8	2.4	4.0	2.7	1.7	2.8	1.6	1.7	2.4	5.4	25.4	3.1	4.5	2.0	2.5	2.1	3.6	7.1	3.5	8.6	2.1	3.8	4.1	13.2	10.7	2.5	1.9	2.4	4.8	1.9	1.8	3.5	4.4	3.7	2.4	5.5	5.6	3.1	4.5	3.0	2.7	2.3	15.2	7.0	7.5	9.0	8.1	6.2	3.3	9.0	11.0	8.5	7.1	14.1	14.4	7.3	4.7	3.6	6.1	4.7	8.2	13.8	11.4	12.7	2.6	8.6	7.7	6.8	24.0	4.0	5.9	15.4	13.4	3.4	12.2	7.9	3.2	9.6	11.1	12.3	10.6	5.8	7.6	4.6	9.0	16.2	2.3	11.5	13.1	10.0	7.4	28.7	35.6	7.2	8.8	27.8	11.5	9.9	9.8	8.1	2.5	10.9	10.1	3.5	6.9	19.7	6.4	5.5	9.6	7.0	9.4	11.7	1.3	0.1	1.9	1.9	0.9	1.2	0.9	1.4	1.5	1.0	0.9	1.4	0.0	2.2	1.0	0.2	1.0	0.9	1.9	1.9	4.7	2.1	1.7	2.4	2.0	2.5	2.1	1.8	2.4	2.3	1.9	0.0	0.5	1.3	1.8	0.3	5.9	1.7	7.4	4.5	4.9	3.3	3.5	7.2	5.5	3.7	10.4	15.9	1.3	1.2	1.9	2.7	1.4	6.3	3.0	2.6	2.4	1.7	1.3	5.7	10.5	1.7	4.6	6.3	0.0	2.8	2.2	21.0	4.9	0.0	1.9	2.9	0.0	2.4	1.1	0.8	1.5	3.5	0.0	0.0	4.3	2.7	1.0	1.5	2.3	3.8	1.9	1.2	2.4	2.3	8.3	10.2	1.5	7.2	0.0	1.5	2.7	2.3	8.0	3.6	0.4	39.0	2.5	2.1	3.2	1.6
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236383-89307800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"					"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	2.7	1.2	4.1	9.0	9.5	7.8	1.4	17.8	3.1	2.2	0.9	5.3	6.2	1.4	0.7	0.9	0.9	3.5	4.0	2.2	7.3	3.9	2.0	6.9	10.2	4.3	6.5	3.2	5.1	0.6	2.9	1.0	4.5	0.8	7.1	3.5	1.5	0.6	1.0	0.6	5.3	1.4	4.1	7.1	3.6	0.4	5.0	2.8	1.3	3.2	7.9	2.7	1.0	5.9	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.8	0.1	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	102.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	27.7	0.3	0.1	27.2	0.6	0.0	0.1	1.1	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	15.9	13.2	0.1	0.5	0.0	0.0	0.0	0.3	0.0	2.8	1.0	3.8	0.2	2.7	2.2	0.9	0.0	1.1	1.1	0.0	1.9	1.5	0.0	3.4	1.0	4.1	9.5	17.8	3.1	2.2	7.3	4.3	6.5	4.5	4.1	5.0	5.9	11.1	0.0	22.6	10.1	6.7	1.1	0.9	0.1	0.0	12.2	1.6	1.7	20.3	8.6	5.0	3.7	0.0	0.2	51.2	17.4	1.9	2.0	0.2	5.8	3.4	11.7	78.7	6.5	21.7	9.4	0.1	3.0	15.8	15.0	7.6	12.2	1.8	0.4	18.7	26.9	32.7	38.0	0.0	28.2	29.0	0.0	0.3	53.9	1.8	41.2	7.4	1.0	23.7	26.2	0.5	1.3	11.0	1.2	48.6	0.3	16.3	1.9	0.7	10.8	78.9	3.3	32.7	0.1	0.8	0.3	1.0	0.3	76.9	0.7	26.2	0.5
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89700345-89838315	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 273.6;brain: 128.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 102.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9"	"Cell line enhanced"	"Detected in many"		"HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	16.0	9.9	91.5	10.0	112.2	273.6	7.8	47.2	128.2	26.1	16.1	28.5	3.3	34.3	3.4	8.5	11.2	5.4	20.9	115.2	69.1	12.4	2.9	16.6	2.2	97.5	88.3	29.3	2.2	1.1	28.7	28.3	89.9	17.3	6.9	20.3	15.9	9.7	1.2	16.4	8.6	33.3	36.0	15.2	6.4	3.2	76.2	5.3	10.2	8.5	4.8	9.3	23.2	107.0	0.5	1.0	40.1	0.0	0.7	0.0	0.6	0.4	44.5	1.6	3.0	0.0	0.0	0.2	12.0	0.0	0.0	9.3	53.6	97.7	1.5	0.0	22.6	221.5	115.4	0.5	84.2	0.0	1.4	2.1	38.2	0.0	109.5	117.3	269.8	2.2	2.0	0.6	0.2	0.0	2.1	0.3	10.6	0.2	4.8	0.0	15.8	0.0	0.3	137.3	23.2	15.6	0.2	0.3	271.6	29.0	0.0	0.4	311.4	1.3	8.0	0.1	0.8	0.2	0.2	0.1	8.8	0.2	87.4	51.5	66.9	0.1	0.3	27.7	0.1	4.2	1.9	0.3	84.6	1.7	1.0	0.5	11.1	17.3	8.2	102.9	0.0	63.7	91.5	112.2	47.2	128.2	115.2	69.1	97.5	88.3	89.9	36.0	76.2	107.0	1.8	0.0	0.6	40.1	2.6	76.6	16.3	173.4	101.3	10.4	0.9	14.4	13.4	0.0	21.5	11.0	0.0	10.1	10.1	0.1	1.9	0.0	0.6	0.3	1.1	19.4	1.8	1225.0	251.5	0.2	1.9	32.7	0.0	0.3	0.0	23.9	7.5	0.8	62.3	10.1	53.8	0.0	44.7	17.2	64.2	1.5	2.1	100.7	352.2	76.8	24.4	19.4	4.1	95.5	195.4	0.2	0.0	0.0	0.5	11.3	0.0	2.0	6.6	7.4	13.1	0.5	5.3	19.6	16.9	4.5	22.6	3.4	3.8	43.6	0.0	3.4
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 158.0;Hepatic stellate cells: 146.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"NK-cell: 6.3;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.2;NK-cells: 6.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 1242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	22.6	3.8	0.8	10.9	0.8	1.8	27.3	0.8	1.1	28.5	1.4	9.9	5.4	15.0	2.8	14.5	23.1	21.1	3.6	0.6	0.9	1.1	8.7	16.1	14.0	1.4	1.4	4.9	3.4	0.5	0.7	40.1	1.2	3.8	14.9	0.5	2.7	4.6	1.1	8.2	13.5	16.8	1.1	0.6	5.2	12.7	1.5	3.7	23.1	6.6	7.6	19.6	9.8	1.1	0.0	0.0	94.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1242.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	6.3	0.0	2.2	0.2	1.2	0.8	0.8	0.8	1.1	0.6	0.9	1.4	1.4	1.2	1.1	1.5	1.1	15.4	0.0	12.0	0.3	2.3	4.2	0.1	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.6	0.0	0.0	0.0	3.9	0.0	1.9	0.0	17.7	0.3	0.7	158.0	0.0	25.9	0.2	0.0	0.0	1.9	0.0	0.4	2.5	0.1	146.3	2.4	0.6	0.0	0.1	0.0	0.0	5.7	5.9	7.7	0.3	9.1	1.8	21.5	0.7	0.8	2.1	0.0	0.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	1.5	0.4	0.0	0.3	0.9	15.4	0.0	0.8	4.5	0.0	1.6	0.0	0.0	0.1
CCSER1	"FAM190A, KIAA1680"	ENSG00000184305	"Coiled-coil serine rich protein 1"	Q9C0I3	4	90127535-91601913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 3.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1954.8;Inhibitory neurons: 1639.5;Oligodendrocyte precursor cells: 577.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;OE19: 2.4;RT4: 1.2;SCLC-21H: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041880, HPA054709"	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041880: AB_10796461, HPA054709: AB_2682581"	"unprognostic (4.03e-4)"	"unprognostic (4.21e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.64e-4)"	"unprognostic (6.94e-2)"	0.2	1.3	1.5	0.2	1.5	0.7	0.9	2.1	2.6	0.1	0.1	0.3	0.3	0.3	0.3	0.2	0.8	0.3	1.0	2.1	0.7	1.1	0.1	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.4	0.1	0.5	0.5	0.2	3.6	1.1	0.3	0.0	0.5	0.4	0.2	0.1	0.4	0.4	2.6	0.9	0.3	0.9	0.1	0.2	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.1	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	2.4	0.2	0.0	0.0	0.1	0.1	1.2	1.3	0.4	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	2.1	2.6	2.1	0.7	0.4	0.2	0.5	0.1	0.9	1.9	12.4	6.4	3.2	72.5	21.4	4.5	11.9	0.1	15.9	23.7	5.5	4.4	11.1	1.5	2.2	3.7	177.2	3.6	0.2	9.0	9.8	1.2	261.8	2.4	0.4	3.1	3.5	2.5	1954.8	3.5	5.6	0.9	23.4	4.8	5.1	0.8	3.3	0.2	1.0	5.0	1639.5	10.9	2.0	0.6	8.6	339.4	3.1	5.7	1.8	89.0	2.4	2.6	0.0	577.5	33.7	4.9	7.7	1.2	5.7	8.8	13.0	2.6	0.2	78.8	6.6	0.4	0.5	5.6	4.7	1.6	2.3	1.8	0.5	0.3	5.1	14.9
GRID2	"GluD2, GluR-delta-2"	ENSG00000152208	"Glutamate ionotropic receptor delta type subunit 2"	O43424	4	92303966-93810157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 40.2;testis: 34.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 380.6;Excitatory neurons: 787.2;Inhibitory neurons: 982.0;Late spermatids: 674.2;Microglial cells: 382.2;Oligodendrocyte precursor cells: 2319.7;Oligodendrocytes: 453.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.8"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 7.7;U-266/70: 3.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 68.3"	"HPA056253, HPA058538"	Enhanced					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA056253: AB_2683079, HPA058538: AB_2683747"	"unprognostic (2.78e-1)"			"unprognostic (1.29e-4)"	"unprognostic (7.23e-3)"			"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.38e-3)"		0.0	2.2	5.6	0.0	6.2	0.0	0.0	40.2	4.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	3.1	10.7	0.1	0.0	0.0	0.0	4.6	5.3	2.4	0.0	0.0	0.0	0.0	4.8	0.0	0.0	4.9	0.0	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.1	34.0	14.2	0.0	0.0	0.2	0.0	0.1	0.1	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	3.5	0.0	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.2	40.2	4.0	3.1	10.7	4.6	5.3	4.8	3.4	14.2	3.8	0.0	0.0	0.0	86.8	0.0	0.0	0.0	0.0	2.2	108.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	380.6	0.0	0.1	1.5	0.0	0.0	787.2	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.1	28.6	982.0	0.0	0.0	0.0	0.0	674.2	5.0	0.2	0.0	382.2	0.0	115.3	0.0	2319.7	453.5	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	7.7	6.6	0.0	1.2	3.7	2.9	0.2	0.0	0.0	0.0	6.4	0.0	0.0
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 20.0"	"Cell type enriched"	"Detected in some"	30	"Intestinal goblet cells: 226.1"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	41.7	26.0	20.5	25.6	25.2	59.7	39.5	22.4	22.4	27.4	84.9	34.1	33.3	94.8	11.3	72.3	40.5	47.5	629.5	21.4	27.7	34.9	82.7	22.0	16.2	30.9	30.1	27.2	30.2	12.2	17.5	67.7	25.0	88.5	30.8	18.2	40.2	68.9	1163.5	21.5	34.4	105.9	22.7	24.1	31.0	12.7	26.3	10.9	25.5	576.0	21.1	45.8	27.6	21.0	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	20.5	25.2	22.4	22.4	21.4	27.7	30.9	30.1	25.0	22.7	26.3	21.0	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1;cervix: 24.7;prostate: 22.4"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 480.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	0.7	4.6	13.4	0.3	15.4	0.1	1.0	13.5	15.0	24.7	2.1	0.9	0.1	4.4	2.4	0.2	12.5	2.6	0.8	12.5	16.0	7.8	0.8	1.7	0.0	19.3	20.1	6.2	1.1	0.1	1.9	0.7	17.5	22.4	0.2	8.1	1.0	14.2	3.0	0.8	0.1	0.6	15.3	0.9	2.4	3.7	15.6	6.4	0.5	1.1	0.0	0.2	0.5	12.1	0.0	22.0	5.6	0.0	2.3	4.8	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	1.0	0.0	1.3	3.6	8.4	0.1	0.0	4.9	0.0	1.4	0.0	0.6	0.5	0.1	2.7	9.0	2.8	6.2	0.4	0.1	0.0	0.0	0.0	7.1	11.1	0.6	0.1	2.1	0.1	3.2	0.2	3.4	0.1	4.3	0.1	0.2	18.8	0.3	3.2	3.2	0.8	1.7	0.0	0.0	4.0	3.8	0.2	4.3	0.0	0.0	0.0	1.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	13.4	15.4	13.5	15.0	12.5	16.0	19.3	20.1	17.5	15.3	15.6	12.1	0.0	6.4	0.0	480.6	0.0	2.7	1.3	13.1	1.2	0.4	3.8	1.0	3.4	2.8	33.4	60.7	0.0	0.0	0.0	0.0	1.9	3.0	1.4	28.5	1.4	1.1	18.4	0.0	51.0	0.4	0.3	1.5	0.0	20.8	0.0	38.6	2.9	0.0	0.1	0.0	2.5	0.0	8.2	0.0	1.2	1.4	3.1	0.4	28.4	22.5	0.0	38.5	0.0	10.1	2.8	0.7	0.0	3.8	0.0	28.5	0.0	0.2	15.7	1.6	0.0	1.7	2.9	1.2	10.6	0.4	2.3	0.0	0.5	4.4	0.0	1.6
UNC5C		ENSG00000182168	"Unc-5 netrin receptor C"	O95185	4	95162504-95549206	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 2078.8"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000		"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.55e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.70e-5)"	"unprognostic (1.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.62e-4)"	1.9	9.0	8.9	1.0	17.2	0.0	1.3	7.0	17.4	1.8	0.0	2.9	1.4	2.4	1.7	0.6	1.9	2.0	3.1	6.6	15.4	1.1	1.0	2.5	0.5	18.1	8.7	2.8	0.3	0.1	1.2	1.8	21.4	3.3	3.4	6.4	6.3	3.9	0.1	0.2	1.9	2.0	8.0	4.2	2.1	2.6	16.4	1.9	11.9	0.4	0.3	2.6	1.6	40.5	0.0	0.5	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	4.2	0.0	0.2	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	0.0	0.2	4.8	0.3	12.3	0.0	0.1	1.2	0.0	7.9	0.0	0.0	0.0	0.1	9.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	17.2	7.0	17.4	6.6	15.4	18.1	8.7	21.4	8.0	16.4	40.5	0.7	0.0	0.0	105.4	0.0	0.1	0.1	0.1	0.0	1.9	0.7	1.5	1.7	0.0	0.2	1.8	0.0	0.5	0.0	2.6	0.0	0.0	0.7	0.5	3.4	0.7	1.2	0.0	326.1	0.0	0.1	4.6	0.0	1.2	0.0	20.2	0.4	0.0	1.8	0.0	448.3	0.5	0.0	0.8	0.0	0.8	21.1	0.4	1.8	57.1	0.0	1.3	0.0	308.1	2078.8	0.0	26.9	11.7	0.0	0.3	0.0	0.1	0.0	12.5	6.6	0.3	4.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 subunit alpha 2"	P29803	4	95840093-95841464	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	602	"testis: 60.2"	"Group enriched"	"Detected in some"	71	"Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.3	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	229.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STPG2	"C4orf37, MGC46496"	ENSG00000163116	"Sperm tail PG-rich repeat containing 2"	Q8N412	4	97184093-98143476	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;testis: 1.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 81.6;Excitatory neurons: 34.7;Inhibitory neurons: 38.2;Microglial cells: 36.5;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 150.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059473			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Nucleoli	"HPA059473: "	"unprognostic (3.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.59e-3)"	"unprognostic (8.87e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.55e-3)"	"unprognostic (5.78e-2)"	0.0	0.1	0.5	0.0	1.3	0.0	0.2	0.7	0.5	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.3	1.0	0.6	0.2	0.1	0.1	1.1	0.9	0.1	0.2	0.2	0.4	0.2	1.2	0.1	0.1	0.9	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.1	0.1	1.9	0.7	0.1	0.4	0.0	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.7	0.5	0.3	1.0	1.1	0.9	1.2	0.9	0.7	1.9	0.2	0.0	0.0	81.6	0.7	0.0	0.4	0.0	0.0	0.9	0.4	0.1	0.4	0.0	0.1	0.0	6.2	0.1	0.0	0.0	3.9	0.0	1.8	0.6	0.1	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.7	0.1	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	36.5	0.0	0.8	0.0	21.1	150.4	0.2	0.0	0.0	0.1	0.1	0.3	0.8	0.0	1.8	0.0	0.0	0.0	3.2	1.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2
RAP1GDS1	SmgGDS	ENSG00000138698	"Rap1 GTPase-GDP dissociation stimulator 1"	P52306	4	98261384-98443858	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 434.9;Inhibitory neurons: 176.3;Late spermatids: 245.3;Oligodendrocytes: 357.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019060	Approved		Supported	Cytosol		NA	NA		62000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA019060: AB_1856068"	"unprognostic (8.12e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.44e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.60e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	15.6	12.6	49.3	18.8	54.9	14.3	17.4	56.3	56.7	11.7	25.2	16.5	10.0	12.2	11.2	18.5	9.6	11.6	9.6	48.3	54.1	16.5	21.1	14.0	23.4	59.5	62.6	10.8	19.1	10.3	16.1	13.2	67.6	10.3	18.6	65.7	12.5	15.1	5.8	14.4	14.3	22.1	51.9	18.0	11.2	22.6	64.4	32.4	17.6	5.7	24.4	19.0	12.9	72.4	50.8	30.4	37.8	32.8	47.6	56.4	14.2	86.7	48.6	51.1	40.0	22.7	66.5	61.0	26.3	65.9	24.3	27.8	47.0	80.5	68.7	60.4	17.1	37.0	35.6	29.6	93.8	64.1	25.2	65.7	47.8	45.3	69.5	42.3	67.9	61.9	25.7	51.6	128.3	27.7	104.9	31.3	13.9	43.0	19.0	41.5	22.4	20.8	51.7	40.8	55.0	32.5	36.2	81.2	48.9	20.6	18.5	41.5	67.2	52.7	36.8	23.9	51.7	16.5	30.1	51.1	43.9	47.3	69.7	32.8	17.4	10.4	23.3	24.9	24.2	23.9	24.4	23.5	27.9	17.1	12.3	19.5	2.5	37.0	28.5	60.6	41.2	14.8	49.3	54.9	56.3	56.7	48.3	54.1	59.5	62.6	67.6	51.9	64.4	72.4	17.6	16.0	12.2	88.8	34.7	13.9	10.8	11.7	22.8	48.2	17.1	12.2	11.1	14.3	14.7	16.5	50.1	6.8	45.7	9.7	23.5	17.7	434.9	7.4	16.2	15.7	20.9	19.8	146.4	20.9	16.5	11.5	16.8	11.2	15.2	19.8	13.9	18.5	23.8	15.2	176.3	13.0	12.2	33.4	27.6	245.3	9.3	24.7	17.8	89.0	32.6	16.9	34.0	110.6	357.6	23.4	14.6	10.9	30.4	16.3	14.5	20.4	7.6	77.5	0.0	12.7	17.2	16.7	36.5	26.8	16.8	4.5	34.3	19.8	18.4	15.1
TSPAN5	"NET-4, TM4SF9, Tspan-5"	ENSG00000168785	"Tetraspanin 5"	P62079	4	98470367-98658611	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 175.4;Excitatory neurons: 362.2;Inhibitory neurons: 248.3;Microglial cells: 195.8;Oligodendrocytes: 587.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	37	"B-cells: 3.0;NK-cells: 3.8;T-cells: 6.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 120.8;BJ hTERT+: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.83e-5)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.23e-1)"	2.7	1.2	32.5	3.8	37.2	10.4	15.4	62.0	42.7	13.5	21.6	6.4	1.5	19.9	29.2	12.9	7.2	5.0	3.2	41.4	33.5	5.1	0.6	4.3	6.7	32.8	30.8	46.4	0.9	4.0	5.1	7.9	34.5	5.3	3.8	28.1	10.8	8.7	3.8	20.0	3.0	16.4	32.4	9.9	8.9	12.6	33.7	8.5	18.5	3.2	9.2	8.8	9.7	47.4	27.8	10.8	11.0	0.7	41.2	120.8	3.7	111.9	121.4	39.4	48.3	9.6	14.6	0.0	1.1	40.2	21.6	7.0	9.6	52.6	87.7	34.3	5.2	16.9	1.5	0.4	42.5	9.5	0.9	70.1	1.6	72.5	89.1	60.5	64.5	11.3	6.6	29.1	95.3	0.7	29.1	0.1	7.2	23.8	49.2	8.8	10.5	4.2	3.5	8.1	77.5	14.8	2.0	35.4	0.2	3.7	1.2	1.4	66.4	82.7	37.4	29.8	39.9	20.0	31.8	0.0	32.4	22.5	28.8	0.0	0.0	0.0	3.3	0.0	3.6	1.3	4.7	4.7	0.1	3.0	2.4	1.6	0.1	3.8	0.0	0.0	6.0	1.1	32.5	37.2	62.0	42.7	41.4	33.5	32.8	30.8	34.5	32.4	33.7	47.4	4.6	22.4	9.1	129.3	5.6	22.0	24.8	9.1	10.8	63.9	30.9	26.0	2.3	0.0	9.3	29.5	27.1	1.0	17.2	1.4	5.9	2.3	69.6	8.5	45.9	19.7	80.9	175.4	362.2	7.1	0.9	26.0	10.2	15.1	2.5	11.6	8.2	0.9	2.3	111.0	248.3	4.6	20.3	3.4	15.4	91.4	46.0	7.1	28.4	195.8	0.3	21.5	39.1	94.5	587.2	25.3	0.5	17.0	9.3	45.9	0.4	0.6	3.7	41.9	6.6	9.7	13.1	10.1	4.1	33.0	57.7	2.9	31.4	79.7	3.8	44.8
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98879276-98929133	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 927.0;Late spermatids: 2284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		450000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	38.0	37.4	27.4	37.7	28.5	57.4	35.6	32.5	34.6	28.5	20.9	45.1	35.9	30.5	38.0	51.7	31.7	31.3	37.5	27.8	34.3	47.4	43.3	27.0	44.6	29.2	31.1	29.1	27.0	45.1	17.0	35.9	29.2	31.4	52.2	54.0	31.2	30.7	39.2	24.2	34.4	39.4	36.2	31.5	35.8	62.6	31.4	53.2	52.6	48.1	58.0	54.4	29.8	34.3	101.1	85.2	139.8	96.5	73.4	74.2	87.3	184.6	105.3	137.0	100.5	111.0	122.7	194.7	59.4	104.4	94.3	49.0	181.9	124.9	158.9	133.5	56.2	135.6	52.7	105.8	62.6	199.3	104.8	54.5	78.3	104.8	82.9	81.5	108.3	97.6	226.6	95.2	120.0	82.9	189.2	110.6	115.0	189.2	72.2	119.7	94.4	90.0	122.0	85.3	123.3	80.3	85.5	188.4	65.4	93.3	89.9	85.9	86.5	110.0	121.6	96.9	153.7	71.4	185.4	179.4	99.7	102.7	127.1	39.5	34.7	59.3	38.2	42.1	44.4	50.0	43.2	40.2	39.6	43.6	47.3	47.3	26.3	54.3	54.8	33.5	46.5	50.3	27.4	28.5	32.5	34.6	27.8	34.3	29.2	31.1	29.2	36.2	31.4	34.3	45.2	32.1	42.2	29.7	93.1	362.1	227.5	202.2	149.7	87.9	81.6	41.1	27.5	55.8	106.0	60.7	35.5	105.3	56.2	140.5	256.3	88.9	927.0	76.1	84.0	77.8	64.6	192.8	45.2	67.4	150.0	87.1	80.0	119.0	51.4	28.0	40.0	77.1	121.1	85.8	45.0	77.4	227.9	61.9	327.6	2284.9	50.7	122.1	193.9	25.3	69.8	82.0	57.7	35.2	50.9	83.8	107.1	49.2	113.0	191.1	83.2	189.2	76.8	64.7	52.6	78.7	151.7	98.7	87.1	171.2	370.9	119.0	82.2	39.8	97.3	224.3
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	8.2	41.5	0.3	0.0	0.3	9.2	7.7	0.0	0.0	0.0	52.3	703.8	0.2	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.6	0.0	0.0	0.1	0.0	1.8	22.6	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 598.1;liver: 2062.2;stomach 1: 570.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	22.9	0.8	0.1	29.8	0.1	0.0	19.2	0.1	0.1	4.7	0.0	329.5	598.1	5.1	7.2	5.1	5.8	51.6	5.9	0.1	0.0	19.6	2062.2	2.9	0.6	0.1	0.1	4.0	16.7	0.1	1.6	0.1	0.1	9.4	191.9	0.0	19.3	6.2	23.9	0.7	190.7	16.3	0.1	0.7	570.6	0.8	0.1	0.5	2.9	31.1	0.5	5.9	3.6	0.2	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 196.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 1.0;HaCaT: 1.2"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	196.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.2	0.0	0.0	38.1	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	89.0	21.1	0.0	0.0	0.0	0.2	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	0.0	0.0	26.2	0.0	0.0	0.0	2.3	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	1.0
C4orf17	DKFZP434G072	ENSG00000138813	"Chromosome 4 open reading frame 17"	Q53FE4	4	99511012-99542303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 20.1"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 230.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060374, HPA060564"	Uncertain					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA060374: AB_2684268, HPA060564: AB_2684319"																"unprognostic (1.34e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 99.5;Spermatogonia: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	4.3	3.7	2.0	3.1	2.6	2.2	4.4	2.6	2.9	1.9	1.5	3.6	4.3	2.7	3.9	3.6	5.8	3.4	2.3	1.8	2.5	4.9	9.8	2.4	4.4	2.6	2.5	3.3	5.9	3.7	2.3	3.7	2.9	4.1	3.6	2.8	3.9	2.2	3.9	3.7	4.5	2.7	2.7	3.5	4.4	9.9	2.4	4.3	6.1	2.7	4.4	2.9	2.0	4.3	8.2	5.4	10.1	5.7	6.0	8.4	7.8	9.6	3.7	5.8	4.1	4.9	9.4	10.9	3.7	5.6	5.9	4.4	10.9	5.1	8.6	13.7	5.4	8.0	4.4	7.6	5.5	19.6	7.8	5.4	14.4	5.7	14.0	3.0	6.4	10.0	17.5	9.4	4.5	9.4	16.4	3.5	6.5	13.8	5.0	9.5	10.2	7.2	8.5	6.8	6.3	5.8	5.3	28.3	9.9	8.5	9.3	7.8	4.9	6.9	7.2	5.5	11.1	7.0	12.4	10.0	4.9	10.9	4.7	2.7	3.9	2.1	1.8	3.8	1.7	3.5	3.3	3.3	5.2	5.8	3.5	3.2	4.9	3.3	3.4	3.0	3.9	1.9	2.0	2.6	2.6	2.9	1.8	2.5	2.6	2.5	2.9	2.7	2.4	4.3	7.2	3.2	10.3	8.8	8.7	8.2	5.6	8.4	10.2	4.3	12.1	8.6	6.4	11.5	6.6	11.0	4.2	16.8	6.1	10.6	43.0	13.8	46.8	33.5	12.1	7.2	7.2	2.1	5.3	19.3	16.4	6.9	8.6	21.6	8.2	11.0	8.2	32.6	8.5	5.0	4.6	11.1	12.2	8.1	4.1	17.0	6.5	5.0	5.4	1.9	8.4	8.7	5.2	3.5	19.7	14.1	11.0	7.5	10.4	4.8	19.0	31.9	20.6	5.9	13.1	5.7	8.1	99.5	55.0	10.2	9.5	17.5	5.5	8.1	10.6	6.6
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 275.2;liver: 266.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 244.2;Proximal enterocytes: 605.4"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.8;Hep G2: 12.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		640000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.3	0.1	0.9	0.2	0.9	0.0	0.2	0.8	0.9	0.1	0.3	1.3	243.2	0.1	1.0	0.1	0.6	1.3	0.9	0.8	1.5	12.9	266.6	0.3	0.3	1.1	1.6	2.0	0.0	0.0	0.5	0.0	1.3	0.5	0.3	5.6	0.1	0.2	0.4	0.1	275.2	0.5	1.2	0.0	0.8	9.6	1.2	0.2	0.1	0.3	0.1	0.9	0.0	1.9	0.0	0.2	10.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.2	0.1	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.5	0.1	0.2	0.1	0.1	1.0	0.0	0.0	0.7	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	0.9	0.8	1.5	1.1	1.6	1.3	1.2	1.2	1.9	0.1	0.0	0.0	4.6	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.8	4.3	0.1	1.8	0.0	0.2	0.2	0.2	0.0	0.0	44.2	1.0	0.1	0.1	0.0	2.7	1.6	0.0	0.0	0.8	1.5	0.2	0.0	30.1	3.6	244.2	0.1	0.0	0.7	16.7	2.0	3.5	0.0	12.0	0.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.2	12.5	0.4	0.1	0.0	605.4	23.5	1.0	0.0	6.6	0.5	0.5	32.1	5.7	0.0	0.0	0.0	0.4	12.0	21.0	0.0
C4orf54	"FOPV, LOC285556"	ENSG00000248713	"Chromosome 4 open reading frame 54"	D6RIA3	4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 72.7"	"Cell type enriched"	"Detected in single"	17	"Endometrial ciliated cells: 14.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"							HPA079091			Approved	"Nuclear bodies,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	Cytosol	"HPA079091: "	"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	6.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	72.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.7	0.0	14.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816827-99870190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;Langerhans cells: 188.5;monocytes: 235.5;Respiratory ciliated cells: 88.6;Urothelial cells: 221.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;RPMI-8226: 70.2;SK-BR-3: 30.6;U-698: 46.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					NA	NA		56000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	1.6	1.0	0.5	22.6	0.9	15.5	3.7	0.4	0.5	6.9	0.6	3.1	2.1	8.4	1.0	29.2	5.2	11.9	0.5	0.5	0.6	0.7	1.5	6.3	34.6	1.0	1.0	0.4	0.4	0.2	0.2	6.8	1.1	2.8	3.2	0.1	8.6	0.8	0.9	13.7	6.3	13.5	0.8	16.6	6.5	0.4	0.7	10.2	0.6	1.3	38.5	14.9	12.9	1.5	22.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	22.5	23.8	0.3	0.0	0.1	12.8	0.0	25.3	0.0	61.2	0.0	24.3	0.0	0.0	0.0	9.4	1.0	0.0	11.3	0.0	7.5	0.0	0.0	1.0	1.2	21.7	0.0	0.2	0.1	6.7	0.0	0.0	0.4	0.1	0.1	70.2	4.6	16.3	0.1	0.0	0.0	30.6	0.0	0.2	0.4	10.1	0.0	0.0	0.4	0.0	0.1	8.3	3.2	46.4	0.1	6.5	0.0	25.0	70.2	71.0	2.3	62.6	2.5	90.9	11.4	4.0	75.9	98.7	12.5	4.5	138.1	17.8	57.3	32.4	25.2	65.3	0.5	0.9	0.4	0.5	0.5	0.6	1.0	1.0	1.1	0.8	0.7	1.5	0.3	3.2	3.0	0.0	92.0	61.8	30.2	51.4	16.5	0.1	10.1	5.0	0.8	2.8	43.2	9.2	0.0	2.6	13.3	8.4	0.0	6.2	0.3	37.1	0.8	1.2	1.2	9.4	0.4	3.1	14.1	1.4	14.8	9.0	8.2	0.2	0.7	0.7	25.1	0.0	0.1	1.8	22.4	32.0	188.5	0.9	0.0	86.0	12.4	5.6	235.5	0.0	7.2	0.0	0.1	18.9	17.6	0.0	60.2	24.3	0.2	0.1	88.6	0.2	0.0	0.9	4.2	0.2	0.5	40.4	70.3	3.4	17.2	0.1	2.2	221.2
LAMTOR3	"MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3"	ENSG00000109270	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3"	Q9UHA4	4	99878336-99894428	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026858	Supported					NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026858: AB_1853523"	"unprognostic (7.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.75e-9)"	"unprognostic (5.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-2)"	16.9	25.7	14.6	16.4	15.4	32.5	24.9	17.3	26.7	20.8	14.5	24.9	23.5	23.3	39.5	30.1	19.2	19.4	24.3	15.4	15.8	38.1	21.7	17.5	20.4	15.2	16.4	24.3	17.3	36.4	18.9	22.5	15.5	28.3	26.2	23.3	24.6	17.1	21.0	23.8	23.8	19.1	13.6	16.6	21.3	15.6	15.7	20.1	33.9	20.2	21.0	23.8	21.6	14.8	19.9	6.4	26.1	17.5	36.2	35.1	20.2	18.9	18.6	18.3	15.0	15.0	39.0	17.3	18.6	19.5	17.8	9.3	26.1	23.9	25.4	20.5	14.0	12.0	13.1	28.3	35.0	36.1	34.1	23.1	48.9	13.8	15.4	26.9	20.7	12.9	30.4	21.1	35.2	20.4	30.5	35.4	16.1	42.8	10.7	20.2	14.9	19.5	55.2	22.9	20.2	25.2	12.2	40.6	41.0	26.3	20.9	29.3	20.5	14.2	16.7	24.0	14.8	26.5	30.6	33.8	30.0	20.6	20.5	43.5	17.6	38.5	9.8	26.8	12.9	11.4	12.1	11.1	19.0	9.3	14.0	14.1	58.6	18.8	28.4	13.3	13.5	13.8	14.6	15.4	17.3	26.7	15.4	15.8	15.2	16.4	15.5	13.6	15.7	14.8	38.8	57.7	33.7	8.8	35.6	49.6	60.7	77.8	68.3	28.0	53.9	46.1	35.9	24.3	44.2	35.0	12.5	48.8	30.3	95.7	135.0	50.9	12.0	38.3	29.8	27.6	36.1	46.7	15.2	32.6	55.8	37.4	43.8	61.3	41.8	23.9	22.9	25.2	77.8	18.5	13.7	48.9	52.9	41.5	89.8	9.4	40.0	56.9	37.4	3.7	60.7	50.7	38.1	8.5	12.7	43.9	102.5	42.5	30.7	63.9	53.9	130.2	30.3	26.3	19.7	30.9	30.9	72.6	40.2	86.6	64.6	78.4	32.6	22.8	43.3	78.8
DNAJB14	FLJ14281	ENSG00000164031	"DnaJ heat shock protein family (Hsp40) member B14"	Q8TBM8	4	99896248-99946618	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036016	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"			"HPA036016: AB_10670594"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.12e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	13.4	11.6	9.0	9.6	12.1	17.7	11.6	7.4	15.3	10.8	5.4	13.8	9.4	11.5	10.7	9.8	7.8	10.3	7.8	14.3	13.7	13.8	10.9	12.2	15.3	9.7	11.1	11.9	7.9	14.8	8.5	16.5	11.9	12.0	9.8	18.5	8.3	10.3	5.0	10.2	9.8	10.2	7.7	14.3	12.0	4.4	11.8	11.2	17.3	6.2	10.9	10.8	8.5	13.7	14.4	36.9	12.6	14.0	22.6	23.8	12.5	35.6	21.2	11.2	10.3	25.2	33.0	13.8	19.7	15.5	7.2	12.0	9.5	15.7	18.2	35.2	11.3	22.3	21.8	20.7	20.0	19.6	32.9	19.6	18.2	12.0	12.2	19.6	22.0	14.7	20.2	18.8	26.1	30.2	23.0	11.4	7.0	9.3	18.6	21.6	14.6	12.0	20.5	28.7	7.1	16.4	19.4	28.0	19.4	11.2	15.6	9.2	31.6	19.6	16.6	13.8	12.1	23.4	55.1	18.4	16.4	8.2	23.6	39.0	14.5	17.5	18.6	16.2	16.7	16.8	14.7	17.1	13.1	17.5	16.9	15.5	22.3	16.3	25.6	15.1	20.1	13.6	9.0	12.1	7.4	15.3	14.3	13.7	9.7	11.1	11.9	7.7	11.8	13.7	78.6	64.1	57.5	61.0	76.5	45.0	50.8	40.3	44.9	92.3	36.7	35.1	20.9	37.1	46.5	40.5	54.2	47.2	100.1	50.9	33.2	31.0	4.4	32.2	60.0	55.0	35.4	15.8	125.4	30.1	31.0	54.9	36.2	42.2	41.1	45.0	47.5	30.3	31.5	111.0	114.8	30.3	30.5	52.7	76.8	4.2	49.7	49.4	44.4	53.4	68.3	64.5	64.9	70.9	107.5	32.1	36.5	53.4	55.7	63.5	34.3	41.8	31.5	95.3	26.3	69.0	54.3	20.3	14.1	32.7	36.9	48.2	83.4	43.0	27.4	54.7
H2AZ1	"H2A.Z, H2AFZ, H2AZ"	ENSG00000164032	"H2A.Z variant histone 1"	P0C0S5	4	99948086-99950355	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 621.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	104.6	88.6	104.7	193.5	115.0	621.6	120.9	112.0	156.8	116.8	114.4	206.7	149.4	156.0	99.2	220.9	105.5	110.5	98.8	108.9	113.5	137.5	104.4	137.9	348.0	103.2	105.5	130.2	88.3	79.2	110.5	146.0	106.9	123.6	193.6	123.7	122.5	114.6	127.5	140.1	155.3	207.2	110.6	161.6	155.3	150.3	107.4	545.3	88.9	121.7	385.4	165.3	129.5	113.6	1249.7	864.3	1753.9	911.2	354.8	314.7	581.6	1287.6	930.7	1319.4	1229.9	897.5	1422.2	2205.2	451.5	666.0	862.3	442.9	1558.6	1268.1	1566.7	956.4	1088.7	1130.4	974.2	1029.1	212.4	2028.8	914.6	235.3	549.6	1004.5	561.1	369.3	1322.2	1313.0	1133.0	1293.1	1558.8	1751.0	1710.7	1697.0	1013.0	1402.9	822.1	1443.6	1279.6	928.0	741.0	750.1	1142.6	875.9	796.4	1507.4	1509.1	608.7	772.0	1550.7	686.7	841.6	1589.0	578.0	1674.1	736.1	1208.3	2671.0	939.8	1348.6	1342.7	780.2	689.8	1375.4	351.5	788.5	393.9	493.8	580.9	475.6	590.8	419.7	533.4	437.6	1482.5	453.8	1053.0	379.0	868.9	1555.4	104.7	115.0	112.0	156.8	108.9	113.5	103.2	105.5	106.9	110.6	107.4	113.6	211.4	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	0.0	625.4	147.1	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1438.5	78.5	0.0	0.0	0.0	0.0	0.0	0.0	711.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	403.2	39.0	0.0	0.0	0.0
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 323.5;tongue: 106.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 22.0;Distal tubular cells: 21.5;Extravillous trophoblasts: 18.5;Granulosa cells: 23.5;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.3;BJ: 29.6;fHDF/TERT166: 16.2;HSkMC: 14.7;hTERT-RPE1: 32.8;RPTEC TERT1: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	3.1	1.0	7.0	0.6	21.1	0.4	2.2	8.5	11.0	23.0	7.7	2.0	0.3	1.5	1.7	7.7	2.1	0.6	2.3	10.2	7.6	21.8	0.4	0.8	0.5	11.8	8.8	7.7	0.4	0.6	2.0	3.7	11.1	11.2	0.9	1.2	17.4	6.9	323.5	1.1	0.7	1.6	9.1	1.2	0.5	3.0	8.7	1.2	1.1	106.9	0.4	1.2	2.6	8.9	0.0	2.2	8.5	0.0	3.7	19.3	1.2	29.6	2.5	0.5	0.1	0.1	0.9	0.0	0.7	16.2	0.7	0.0	6.2	0.5	0.5	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	14.7	0.1	0.3	1.5	32.8	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.7	0.0	0.0	0.6	0.0	0.0	20.5	0.1	0.1	0.1	0.6	1.2	4.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	3.9	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.0	21.1	8.5	11.0	10.2	7.6	11.8	8.8	11.1	9.1	8.7	8.9	3.8	0.0	0.0	6.2	0.0	2.7	0.2	4.2	1.8	0.1	1.0	0.9	7.3	0.0	1.3	22.0	0.0	1.9	0.4	0.2	21.5	0.1	0.8	0.5	0.3	3.6	0.0	0.0	0.0	0.0	18.5	5.1	1.5	0.9	0.0	23.5	0.0	0.0	12.0	0.0	0.5	0.3	0.0	0.0	3.0	0.4	0.9	0.3	7.2	0.0	0.0	8.6	0.0	0.5	0.0	0.5	0.0	2.2	0.2	1.1	0.0	2.2	0.1	0.2	19.7	7.3	11.9	4.7	0.8	0.9	1.4	4.0	0.6	8.3	0.4	0.3
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Adipocytes: 409.0;Endothelial cells: 261.7;Hepatic stellate cells: 175.3;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA		470000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	46.3	20.2	6.7	9.6	7.1	0.2	38.2	7.1	11.2	37.1	7.8	10.3	6.8	27.9	9.9	12.7	19.2	31.4	38.5	6.3	7.5	79.7	7.5	48.4	6.6	8.1	7.0	6.9	6.2	19.2	9.6	0.8	9.0	12.7	8.1	1.5	9.2	25.6	18.5	9.0	8.3	38.8	7.0	3.5	8.2	2.3	9.4	8.7	43.6	40.2	4.9	24.9	13.9	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	7.1	7.1	11.2	6.3	7.5	8.1	7.0	9.0	7.0	9.4	7.4	409.0	6.4	6.0	0.3	14.0	16.6	0.5	0.1	6.2	0.1	2.1	3.0	14.1	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.0	0.1	0.7	0.6	0.6	261.7	0.0	8.0	1.3	0.0	0.0	16.2	0.0	0.3	0.0	0.1	175.3	1.1	0.2	0.0	0.2	0.0	0.0	5.5	21.4	1.3	1.2	1.7	16.0	111.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	2.6	1.0	0.0	0.2	0.0	0.4	0.0	5.8	21.4	0.2	0.5	1.1	14.6	0.3	2.4	0.7	0.0	1.0
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.5	3.6	0.6	35.1	0.6	6.2	2.2	1.5	0.9	2.3	0.2	2.8	2.4	0.8	3.2	0.8	2.3	3.0	0.7	0.5	0.7	3.2	0.3	8.1	82.2	0.8	0.8	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.2	2.4	4.7	0.1	0.7	24.2	1.0	0.9	56.1	7.4	3.0	1.0	9.7	12.9	0.2	96.4	7.6	0.7	0.6	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.6	1.5	0.9	0.5	0.7	0.8	0.8	0.9	0.9	1.0	0.6	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 171.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	45.5	3.5	9.6	28.9	10.7	36.5	18.1	10.2	12.1	84.7	9.9	37.8	6.7	11.0	5.7	3.0	11.9	7.8	30.4	8.3	10.5	18.3	40.0	171.1	13.3	14.6	10.7	14.0	54.5	42.0	8.0	13.0	14.4	8.4	43.0	6.4	89.3	6.6	1.1	9.4	7.3	9.1	14.2	6.7	7.8	2.6	13.5	14.4	12.3	2.0	12.3	20.8	6.8	11.6	20.2	19.5	4.4	0.1	15.8	35.4	10.1	2.2	158.9	5.8	9.3	0.9	72.5	19.3	21.0	0.6	20.0	1.4	13.5	4.4	3.4	34.1	39.5	51.0	37.5	0.3	6.3	120.9	16.8	19.1	5.0	3.1	9.1	15.4	2.1	47.1	51.6	171.2	30.7	13.4	43.7	55.9	13.0	26.8	19.0	11.0	0.2	63.8	33.3	7.4	5.6	14.0	55.0	1.0	5.3	3.8	13.4	44.4	11.3	19.3	7.3	39.1	31.6	76.3	34.1	90.4	31.0	77.4	18.2	0.0	1.8	1.4	6.3	1.1	10.9	1.8	11.7	10.0	3.3	3.9	8.6	5.9	0.1	13.7	0.4	1.2	5.0	4.2	9.6	10.7	10.2	12.1	8.3	10.5	14.6	10.7	14.4	14.2	13.5	11.6	16.1	778.8	305.6	15.7	14.5	11.7	9.2	35.9	5.2	2.6	42.8	13.1	21.3	4.3	23.9	5.5	4.2	19.2	14.9	20.3	11.7	1.8	0.7	17.7	5.2	19.8	24.0	46.7	6.6	32.7	217.5	17.4	4.1	40.9	3.8	32.4	5.7	26.1	42.9	3.3	1.5	74.1	6.1	29.8	79.0	0.7	1.2	28.9	28.4	60.9	10.8	5.2	9.2	5.0	1.7	11.8	26.2	1.2	56.0	9.6	2.1	17.7	2.9	1.6	6.6	2.6	8.8	2.3	6.0	2.1	7.0	60.6	23.6	31.0	64.3	6.8
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501331-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 610.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	26.7	16.2	3.9	30.3	7.0	34.6	19.8	6.5	5.7	22.0	5.5	20.4	15.2	18.9	2.7	23.0	19.1	20.8	15.8	4.2	5.8	17.4	16.4	25.0	33.1	7.6	6.1	18.8	16.0	11.7	7.7	21.2	7.8	17.3	19.6	4.9	18.9	17.8	20.9	23.7	20.3	17.0	5.6	23.0	17.5	7.6	6.4	37.0	16.3	10.7	35.1	48.5	19.9	10.1	36.8	19.2	11.2	13.6	27.0	28.5	10.9	20.0	64.2	27.7	27.1	21.5	40.8	58.0	17.6	32.6	39.4	29.5	22.0	34.5	35.2	53.6	10.8	22.7	14.5	15.0	20.0	44.3	44.3	19.7	20.2	22.0	34.4	15.0	34.5	18.1	25.8	34.1	17.6	17.7	4.1	9.1	5.0	24.3	15.4	33.4	25.9	24.0	15.3	38.8	7.1	11.8	38.3	37.2	16.3	8.3	8.6	24.2	40.5	32.5	16.6	14.5	26.4	17.0	13.3	52.0	20.8	19.4	44.1	0.0	2.1	2.6	0.9	3.0	1.9	1.9	3.0	1.6	4.8	1.7	4.5	3.2	1.9	3.7	3.1	1.5	0.8	1.6	3.9	7.0	6.5	5.7	4.2	5.8	7.6	6.1	7.8	5.6	6.4	10.1	32.5	41.7	49.4	42.1	90.0	165.4	91.5	57.1	31.3	6.6	41.5	32.6	19.1	24.3	40.8	20.2	6.2	14.4	119.6	41.1	3.9	28.5	7.6	82.5	62.0	47.6	33.6	13.0	78.4	37.3	16.9	63.1	29.6	207.0	111.1	19.8	23.9	23.9	24.8	20.2	77.2	43.2	18.3	56.2	610.3	2.4	23.9	178.3	55.2	59.0	207.9	9.5	23.7	66.9	127.4	46.3	27.1	34.6	56.3	78.5	21.1	24.4	31.5	6.7	0.0	73.7	41.2	2.5	8.1	35.3	150.3	14.2	88.2	16.7	35.4	90.2
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	182.7	171.7	85.7	172.0	92.6	478.3	141.9	101.1	120.6	127.1	93.4	154.9	154.0	125.3	113.8	173.4	125.9	142.5	149.4	92.1	103.9	172.2	251.4	175.3	189.6	102.5	96.0	131.5	154.2	133.5	98.4	159.0	99.8	106.8	144.4	129.0	116.7	102.1	243.6	136.4	158.3	129.9	101.4	149.5	144.4	127.0	95.6	198.5	159.2	197.9	197.0	185.6	128.0	113.7	301.6	169.1	275.4	223.4	286.2	408.0	235.9	301.2	395.1	260.1	243.6	257.4	416.4	319.3	190.6	304.4	336.8	168.6	294.7	400.8	352.5	299.6	149.8	292.0	165.8	209.6	300.3	415.5	240.4	314.0	247.9	288.6	398.9	334.3	343.4	258.7	372.9	316.4	350.9	243.1	613.4	235.1	200.2	341.0	167.1	318.4	269.9	231.5	261.5	283.7	275.6	232.1	183.5	464.8	349.6	318.2	193.0	241.0	318.4	270.0	231.1	179.2	276.3	277.9	389.8	491.3	288.2	227.2	297.0	614.9	253.7	394.0	163.5	256.0	216.3	165.9	203.4	194.4	217.6	139.2	205.8	190.5	817.2	215.7	271.9	149.8	229.6	422.1	85.7	92.6	101.1	120.6	92.1	103.9	102.5	96.0	99.8	101.4	95.6	113.7	303.4	166.7	193.1	98.9	291.7	844.0	693.9	408.2	233.9	133.7	251.5	166.9	229.8	193.0	242.3	139.8	125.1	311.5	317.4	336.1	547.8	361.0	779.4	257.1	246.7	344.0	240.8	348.7	159.7	382.2	561.6	286.0	202.3	371.3	224.9	154.8	193.1	235.7	392.9	122.8	145.8	283.8	303.2	403.0	825.6	635.1	164.7	415.1	357.5	111.5	399.4	160.0	280.2	104.5	185.0	454.4	347.2	149.0	296.4	612.3	335.8	428.8	242.4	170.6	105.2	270.6	531.9	217.2	180.7	258.2	813.3	638.4	382.5	172.3	268.2	784.3
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	11.2	19.1	2.4	5.5	2.7	6.0	9.0	3.9	3.2	9.5	4.1	11.5	1.7	9.5	5.3	12.5	8.8	4.3	10.5	2.6	3.2	17.9	46.0	10.7	5.5	2.9	2.9	8.9	20.0	5.4	12.8	3.1	3.0	9.5	3.8	6.1	12.0	1.9	7.4	9.7	10.9	3.0	2.7	14.7	11.4	6.5	3.0	4.0	13.6	1.7	3.5	9.8	10.1	4.0	16.8	5.5	5.8	7.2	14.2	15.2	3.7	12.6	4.6	5.4	8.2	6.5	27.7	12.1	10.9	12.2	12.9	8.1	28.2	10.1	24.8	10.7	4.2	10.5	3.6	6.7	10.1	18.7	16.1	5.9	15.1	23.0	17.8	5.2	9.8	6.7	22.7	21.3	14.7	4.6	16.5	5.4	11.2	5.7	4.0	6.7	5.9	22.2	13.6	5.3	13.4	7.8	7.5	12.8	12.8	6.6	8.5	4.0	4.4	15.8	17.8	21.3	7.8	16.3	23.5	24.2	11.2	5.7	12.6	4.6	2.8	5.8	2.6	2.7	2.7	2.5	2.6	2.7	2.7	2.1	1.7	2.2	2.0	4.4	3.1	3.5	3.5	2.3	2.4	2.7	3.9	3.2	2.6	3.2	2.9	2.9	3.0	2.7	3.0	4.0	24.2	25.6	26.1	10.1	65.3	85.7	45.3	131.0	60.3	33.5	61.2	51.3	27.8	58.6	70.4	77.3	20.9	74.2	52.7	52.9	72.4	101.8	12.2	39.9	41.8	35.8	43.0	256.8	17.5	77.2	131.0	39.6	39.8	48.3	57.8	24.2	26.0	159.9	110.9	30.3	22.1	94.2	146.5	93.5	128.9	6.9	23.9	66.4	69.4	12.2	78.4	36.9	45.3	17.6	25.9	74.3	88.5	33.8	194.3	63.7	82.7	203.9	63.1	33.1	32.9	22.1	41.6	41.7	36.7	56.4	90.1	56.8	54.0	33.4	68.6	53.9
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019719	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.8;Late spermatids: 106.0;Spermatocytes: 224.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.0	0.8	1.7	0.6	2.6	0.6	0.5	2.0	2.1	0.4	0.0	0.4	0.7	1.3	2.1	0.3	0.6	1.5	0.8	1.2	1.8	0.5	0.2	0.5	1.0	2.5	2.3	1.4	1.2	0.7	0.5	0.8	2.9	0.9	0.7	1.7	0.2	0.7	0.2	1.8	0.5	0.6	2.5	0.9	0.4	40.4	2.3	1.1	1.0	0.0	1.0	0.8	0.2	4.1	0.1	0.0	0.9	1.5	1.9	1.4	0.3	0.3	0.4	0.0	0.1	0.0	0.1	0.7	0.2	0.8	0.3	0.0	0.7	0.4	0.6	1.5	0.9	1.2	1.0	0.0	0.0	0.4	0.2	0.2	0.4	0.0	0.8	0.4	0.5	2.0	0.5	0.8	0.7	0.6	0.4	1.0	0.4	0.2	0.0	1.3	0.8	0.2	0.4	0.2	0.9	2.3	0.2	0.3	1.1	0.6	0.2	0.8	0.3	0.4	0.1	0.5	0.5	2.5	1.9	0.7	0.5	0.4	1.0	0.2	0.2	0.0	0.4	0.1	0.5	0.5	0.3	0.6	0.2	0.5	1.5	0.9	0.1	0.1	0.1	0.6	0.6	0.2	1.7	2.6	2.0	2.1	1.2	1.8	2.5	2.3	2.9	2.5	2.3	4.1	1.3	3.2	1.5	26.1	3.4	1.3	0.5	1.8	1.8	1.8	1.0	0.6	0.9	1.5	0.4	0.0	16.7	0.6	1.1	0.2	1.9	0.3	177.8	0.8	1.1	1.7	0.0	0.4	6.0	0.4	0.4	2.3	0.0	0.6	0.0	1.9	1.4	0.2	1.3	3.3	8.3	0.1	6.1	3.9	3.1	106.0	5.3	1.3	1.8	4.7	1.5	2.5	1.0	24.1	40.5	1.1	0.0	3.0	1.8	0.9	0.4	0.9	0.2	5.0	0.0	6.4	1.8	224.8	9.5	0.7	0.6	0.5	2.9	2.0	0.3	0.6
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.9;Exocrine glandular cells: 68.5;Inhibitory neurons: 57.2;Pancreatic endocrine cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.8"	"Group enriched"	"Detected in many"	5	"B-cells: 5.1;NK-cells: 11.8;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.8	6.0	11.2	5.2	11.7	4.6	5.7	10.9	12.8	6.2	3.2	6.2	1.1	6.8	2.3	3.4	5.6	7.6	6.2	12.5	11.1	2.5	38.7	3.6	5.9	11.4	9.1	6.7	2.4	0.3	8.5	3.9	12.7	4.1	2.7	12.8	2.4	5.0	3.0	3.0	3.7	7.7	7.0	3.6	4.9	3.6	10.0	3.6	2.9	3.5	5.6	6.5	4.9	11.2	4.9	2.1	5.2	10.5	26.0	20.7	0.0	22.0	7.8	3.2	3.0	2.5	3.0	29.3	3.7	24.3	5.1	1.4	12.2	9.3	4.8	24.7	7.5	30.2	7.5	21.8	13.5	22.5	8.8	18.7	10.8	7.7	27.3	11.1	15.3	8.3	10.1	22.1	10.7	1.7	15.3	10.8	4.4	0.1	6.4	0.0	6.0	12.2	9.0	2.4	17.5	14.9	10.0	2.3	6.0	1.4	2.6	13.4	17.6	7.5	4.3	11.6	6.9	16.8	14.2	21.7	8.7	17.5	3.0	0.0	0.1	0.0	4.9	0.0	6.4	5.1	5.1	4.1	0.9	3.0	3.1	3.8	0.0	11.8	0.1	1.6	2.4	1.8	11.2	11.7	10.9	12.8	12.5	11.1	11.4	9.1	12.7	7.0	10.0	11.2	13.9	0.0	0.5	15.0	15.6	4.8	3.4	2.0	6.2	9.7	3.1	2.8	2.5	8.6	1.1	0.0	27.1	0.5	6.5	0.2	0.0	14.1	12.1	1.1	8.6	17.8	3.0	17.2	57.9	68.5	2.3	13.2	22.4	0.9	1.3	10.3	6.1	39.5	1.4	8.4	57.2	1.1	4.1	1.3	5.3	6.9	5.6	3.4	10.6	5.6	3.9	0.7	0.0	32.6	17.6	94.7	0.3	5.3	12.0	4.9	0.0	1.4	1.1	2.3	6.6	16.5	11.5	5.8	4.2	5.6	3.8	0.3	7.9	4.8	0.3	1.3
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103077592-103099870	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 162.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Proximal tubular cells: 795.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	45.0	96.6	23.3	4.3	25.8	3.5	39.7	27.0	27.3	46.6	27.1	31.8	39.4	31.2	16.6	27.2	43.4	14.9	46.6	20.3	27.8	162.1	70.5	35.9	6.7	28.4	26.5	54.8	23.2	30.8	29.2	7.7	27.0	31.9	10.3	8.5	32.8	14.1	24.6	26.1	39.6	9.6	25.2	21.2	38.9	14.8	28.2	17.5	62.9	16.7	7.3	37.1	37.3	26.5	3.1	5.3	26.5	10.0	30.4	29.4	3.4	6.7	17.8	6.9	10.6	3.4	11.8	12.4	11.1	10.2	2.1	1.5	17.3	10.1	8.2	8.2	8.5	1.5	6.4	8.1	15.0	7.4	2.1	24.8	9.1	10.6	2.6	23.0	20.7	14.3	8.0	5.5	24.1	1.0	37.2	6.3	9.6	2.0	2.1	24.5	30.7	7.9	46.4	3.6	4.5	12.0	12.8	6.7	7.9	9.6	5.7	5.3	9.9	10.7	3.4	5.5	3.7	8.1	7.9	12.5	11.8	8.9	5.4	2.6	2.5	0.2	7.6	1.4	8.8	4.8	6.6	6.0	3.2	6.7	9.8	10.4	0.4	6.5	0.2	5.0	10.2	4.0	23.3	25.8	27.0	27.3	20.3	27.8	28.4	26.5	27.0	25.2	28.2	26.5	37.7	32.1	57.8	33.6	10.2	30.3	47.1	59.4	36.5	2.5	31.9	36.1	9.6	64.3	46.9	108.5	0.0	7.9	19.0	18.0	211.3	58.2	1.9	60.6	45.5	30.3	22.9	16.4	1.2	21.3	18.5	75.2	41.8	27.9	19.6	39.1	27.8	71.6	20.4	3.3	3.8	24.4	46.8	10.9	16.9	4.8	69.9	12.5	23.2	14.0	14.9	50.4	14.4	3.5	21.8	23.0	18.6	77.8	8.0	18.9	162.3	795.7	48.7	3.8	13.1	40.9	36.5	0.9	4.0	25.9	26.7	3.4	18.2	52.6	37.6	37.5
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
TACR3	"NK3R, NKR, TAC3R"	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719985	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;retina: 2.7;urinary bladder: 1.9"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 13.1;Excitatory neurons: 6.7;Extravillous trophoblasts: 4.5;Oligodendrocytes: 10.5;Skeletal myocytes: 11.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"BEWO: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.0	0.0	2.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	1.9	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.4	0.3	2.4	1.4	1.5	8.4	1.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.0	4.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468308-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 16.1;retina: 7.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 48.0;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 102.1;Horizontal cells: 45.4;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;AN3-CA: 9.7;Karpas-707: 9.0;RPMI-8226: 5.5;SCLC-21H: 12.0;U-266/70: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	0.6	1.3	4.9	0.1	3.9	0.0	1.4	3.0	16.1	0.7	0.2	1.3	1.8	0.4	1.7	0.1	2.3	0.3	1.9	4.3	10.1	0.4	0.8	0.6	0.0	5.0	6.1	1.8	3.0	0.7	4.4	0.3	4.5	0.5	0.8	7.3	2.9	0.4	0.3	0.2	1.9	0.4	4.4	0.4	1.3	1.6	11.9	0.5	2.4	0.1	0.0	0.2	0.3	4.8	0.0	0.2	7.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	9.0	0.0	0.0	2.7	0.0	2.5	0.1	0.1	0.0	0.0	5.5	0.0	0.1	12.0	2.2	0.0	0.6	0.0	2.8	0.3	0.0	0.0	0.0	1.5	0.0	0.1	9.7	2.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.9	3.0	16.1	4.3	10.1	5.0	6.1	4.5	4.4	11.9	4.8	12.4	0.0	6.4	10.4	0.1	0.3	1.0	0.8	1.2	48.0	8.4	5.6	15.9	2.8	2.2	0.0	31.3	0.2	0.8	0.4	0.0	0.1	0.3	13.0	0.9	2.9	102.1	0.0	23.8	3.3	0.0	1.0	0.0	0.6	0.0	1.2	1.1	2.7	0.1	45.4	27.5	6.2	0.0	0.3	0.3	0.9	0.3	0.1	1.8	0.0	0.0	13.8	1.0	64.3	30.8	1.5	1.2	10.9	0.3	0.6	10.2	1.1	12.6	26.7	0.0	15.6	0.9	0.0	4.8	0.1	0.0	0.3	0.5	0.1	2.6	0.5
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 55.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	4.3	3.1	2.9	10.1	4.4	22.4	5.4	2.5	2.7	6.3	5.8	5.2	6.1	7.2	6.0	7.7	4.9	5.0	3.3	2.1	4.6	4.1	4.2	5.4	5.6	5.3	4.4	4.3	3.7	4.6	1.8	10.2	5.3	4.4	5.9	6.6	4.7	3.3	2.8	11.0	6.0	5.7	2.9	7.2	5.3	1.3	4.1	5.4	4.2	5.2	7.0	5.5	4.5	5.6	5.1	3.1	10.9	11.1	2.1	3.7	4.2	3.1	4.8	4.8	4.7	3.1	6.4	0.5	4.0	4.0	2.1	4.9	9.3	6.1	5.3	6.7	2.9	7.0	6.5	1.6	4.9	15.5	11.8	3.8	7.9	4.5	5.6	8.6	6.4	4.1	7.7	13.6	4.4	3.1	2.5	4.7	2.5	6.2	2.2	8.4	4.7	1.0	4.7	9.4	7.5	5.9	4.2	9.1	0.8	5.9	4.5	11.8	9.1	7.8	6.7	2.1	5.3	9.5	6.8	6.8	4.8	3.8	7.2	30.1	13.6	14.7	3.9	10.4	1.6	5.3	2.3	2.2	10.2	6.3	1.9	2.9	55.5	5.9	13.6	8.9	3.1	3.3	2.9	4.4	2.5	2.7	2.1	4.6	5.3	4.4	5.3	2.9	4.1	5.6	24.5	25.6	29.1	58.8	28.3	14.4	11.0	14.2	12.5	22.8	15.6	13.6	27.9	5.7	23.9	9.2	16.7	23.1	34.1	19.0	7.9	7.0	0.4	22.1	38.3	20.3	23.3	10.9	48.4	7.5	5.7	18.0	21.4	33.2	27.8	15.5	13.6	8.5	14.5	35.3	89.7	15.8	32.6	48.8	93.3	0.9	8.1	98.3	5.4	90.9	48.1	5.8	34.0	112.6	128.3	8.2	18.7	7.2	22.5	12.1	16.3	2.8	22.3	24.3	13.1	47.0	21.7	0.2	1.3	28.4	35.9	34.2	18.9	24.7	14.0	27.5
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 7.8;pancreas: 6.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	7.8	0.0	0.0	2.5	0.0	2.6	1.9	0.2	5.5	0.1	0.6	3.2	0.0	0.0	0.0	3.9	0.1	3.6	0.0	0.0	0.0	0.0	6.5	0.0	2.0	0.0	0.0	5.7	4.2	0.0	4.9	0.4	0.3	0.5	2.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	48.5	0.0	0.2	0.0	1.1	1.1	0.0	0.0	17.9	6.1	1.8	4.3	12.6	12.9	0.0	0.2	0.2	9.8	9.8	6.8	1.9	12.6	0.5	0.3	8.4	0.0	0.3	5.8	0.1	0.3	9.2	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	14.8	10.2	0.0	0.2	0.4	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	2.4	6.4	0.0	0.1	9.4	4.8	0.5	31.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.8
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: AB_2677687"	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	15.2	11.1	12.8	10.9	13.3	30.4	20.2	14.9	18.0	14.1	12.0	14.7	18.1	14.6	17.8	13.5	13.2	12.7	18.9	12.4	14.9	18.7	22.6	16.4	14.0	12.3	14.0	11.6	12.6	17.2	10.3	11.9	12.5	18.1	15.6	17.2	14.4	13.4	26.5	14.0	15.5	17.1	12.7	12.6	15.0	13.9	14.3	19.9	19.9	26.0	17.0	15.6	11.2	13.7	24.4	12.8	28.5	29.8	27.5	32.6	20.8	28.2	29.1	34.7	35.9	18.1	26.9	34.9	15.4	31.9	26.9	13.8	31.7	40.7	42.8	36.9	19.0	26.3	19.6	25.7	44.3	46.7	23.0	31.0	51.7	34.5	51.4	22.5	32.3	29.1	39.8	26.7	37.8	25.6	55.3	28.9	12.4	35.3	19.5	28.0	31.0	26.8	32.5	16.3	30.7	24.6	19.8	32.6	31.0	22.4	26.4	27.2	21.3	22.7	23.3	24.8	30.5	40.8	40.9	52.2	25.3	31.5	46.0	64.0	23.7	38.5	25.7	26.6	28.9	33.0	29.4	29.4	27.7	32.1	30.6	28.3	17.9	42.9	28.3	42.6	34.8	21.9	12.8	13.3	14.9	18.0	12.4	14.9	12.3	14.0	12.5	12.7	14.3	13.7	19.0	12.8	11.8	14.0	15.1	11.0	11.8	25.8	15.4	10.5	12.1	11.7	18.7	11.5	12.9	3.7	10.4	16.1	13.6	8.3	43.0	25.2	35.8	8.1	11.2	16.8	6.0	15.6	13.8	20.3	18.6	10.8	8.6	8.7	24.7	9.9	11.7	9.3	17.8	10.1	15.7	5.2	30.5	9.0	9.5	28.4	12.2	9.8	7.2	9.4	15.5	14.0	21.6	27.2	19.1	20.5	6.8	8.2	18.9	14.2	16.5	17.1	6.2	9.3	0.0	12.9	20.1	13.4	16.2	14.1	10.4	18.3	13.0	14.9	10.2	11.0
GSTCD	FLJ13273	ENSG00000138780	"Glutathione S-transferase C-terminal domain containing"	Q8NEC7	4	105708778-105847725	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046160, HPA061782"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046160: AB_10961048, HPA061782: AB_2797265"	"unprognostic (4.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.44e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.02e-2)"	2.6	2.4	1.7	3.8	2.1	5.3	5.5	3.8	2.1	3.6	5.7	3.7	2.6	3.6	2.7	5.0	4.3	3.6	2.3	1.6	2.0	4.4	2.5	2.6	4.6	2.0	2.3	2.9	3.2	3.5	2.3	3.7	2.0	3.9	4.0	7.3	2.2	3.5	2.1	3.3	3.0	4.1	1.7	2.8	3.3	10.8	1.9	4.7	5.3	2.7	5.2	2.4	2.2	3.2	11.2	10.0	22.2	19.5	5.8	7.4	16.6	15.5	7.9	18.6	16.6	9.2	21.0	13.2	7.7	6.5	10.8	8.9	25.8	16.0	26.3	19.9	7.2	10.7	9.5	12.6	2.5	20.7	7.4	4.0	8.0	17.2	13.1	7.0	11.6	13.2	22.0	11.7	16.0	9.1	21.9	7.7	12.2	16.4	11.5	14.9	13.1	7.4	20.4	8.0	18.0	8.1	11.9	17.2	6.6	19.5	15.3	8.3	8.8	13.8	14.4	8.6	12.2	4.4	10.1	7.4	8.6	10.4	19.4	0.7	0.8	0.4	0.9	1.1	1.0	1.0	0.8	0.3	1.0	1.1	0.9	1.5	5.5	1.4	1.4	1.3	0.1	0.7	1.7	2.1	3.8	2.1	1.6	2.0	2.0	2.3	2.0	1.7	1.9	3.2	5.8	6.4	3.9	32.7	5.2	2.5	3.6	2.4	2.2	22.3	10.4	4.8	3.3	8.6	1.9	9.2	27.1	6.1	2.6	5.6	3.9	5.8	120.2	7.7	8.1	4.6	4.2	12.8	32.0	5.0	8.1	5.0	6.6	9.9	2.5	9.3	3.6	8.0	7.7	21.9	32.2	4.4	2.0	5.1	3.1	52.4	8.4	4.2	5.4	9.4	4.2	7.3	3.1	53.8	35.4	6.8	1.3	4.5	7.1	3.8	1.7	5.0	2.4	21.4	0.0	5.4	4.9	11.2	7.5	6.4	4.3	3.3	2.9	6.3	6.1	2.0
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106316683	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Excitatory neurons: 196.6;Inhibitory neurons: 221.1;Microglial cells: 128.4;Oligodendrocyte precursor cells: 147.2;Oligodendrocytes: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 44.0;BJ hTERT+ SV40 Large T+ RasG12V: 81.7;HBF TERT88: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: AB_2681550"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	7.4	5.2	5.6	3.0	5.3	1.3	3.4	11.0	6.1	4.5	8.3	3.2	2.3	4.3	6.0	4.2	5.3	5.6	2.8	6.1	7.0	6.3	4.4	4.1	3.0	5.2	5.3	6.4	5.8	4.8	3.9	5.5	6.0	4.7	3.1	7.6	3.6	6.0	1.6	4.1	3.3	4.7	3.5	3.6	3.5	6.1	6.9	4.7	5.5	4.3	2.6	5.2	3.0	10.1	1.4	5.9	9.0	2.7	36.7	19.1	1.1	8.1	8.9	44.0	81.7	10.9	6.4	2.3	13.0	28.0	7.0	5.4	5.7	8.1	59.3	5.1	1.8	14.1	4.5	10.3	9.7	2.7	6.3	20.9	5.9	4.1	7.1	14.5	11.1	6.0	7.2	3.8	10.2	7.7	5.2	3.7	2.0	14.4	2.0	4.1	3.7	6.8	11.1	9.0	4.4	4.1	8.2	4.0	5.6	7.6	4.8	8.5	8.3	7.7	4.3	2.4	4.4	2.5	6.1	6.8	10.1	5.6	5.0	14.1	5.1	5.1	4.7	5.7	5.6	4.8	4.9	6.4	4.8	7.9	5.6	5.2	0.4	5.2	3.8	4.4	5.5	4.0	5.6	5.3	11.0	6.1	6.1	7.0	5.2	5.3	6.0	3.5	6.9	10.1	7.7	19.2	25.2	134.8	13.9	2.3	6.4	9.0	17.1	20.7	8.2	6.9	8.2	5.7	15.5	14.7	20.9	11.5	9.0	3.5	3.9	4.3	45.7	10.2	15.9	8.9	5.4	9.2	196.6	0.9	6.6	12.5	15.3	21.1	11.4	21.5	8.6	4.6	6.8	11.8	221.1	5.7	10.2	6.2	1.6	28.2	11.1	7.7	5.4	128.4	4.6	8.1	10.3	147.2	188.8	2.2	8.0	12.8	10.4	4.3	4.8	8.0	11.9	15.3	0.0	10.6	9.6	14.5	8.2	14.2	2.4	7.4	10.6	13.9	5.5	4.5
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349456	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000	35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	32.5	33.4	23.3	31.4	25.9	60.1	44.4	25.8	32.9	32.2	25.2	42.1	39.9	34.5	35.1	37.7	32.1	32.1	34.4	23.2	25.0	40.3	35.8	29.0	38.6	25.8	25.7	42.3	32.4	37.8	25.6	30.1	25.7	33.1	41.6	36.0	35.0	35.1	65.3	29.4	37.8	32.3	24.3	33.5	34.8	23.5	24.8	35.4	38.9	50.4	39.2	40.9	30.7	27.8	66.7	46.1	47.3	60.3	51.0	78.0	68.1	80.8	69.7	73.9	87.7	81.9	97.8	109.4	61.6	79.6	50.5	61.4	69.6	86.6	98.8	62.1	47.4	64.2	63.8	134.0	101.3	147.4	75.4	62.9	100.2	74.5	117.5	56.3	64.3	68.2	120.8	58.0	82.4	58.5	99.2	78.2	51.4	94.6	46.5	81.1	86.3	101.5	94.7	60.5	72.9	56.9	52.7	158.1	86.4	61.7	75.2	107.8	50.5	87.9	73.1	66.1	105.9	71.5	98.9	110.0	74.6	112.7	97.0	60.6	54.7	55.0	42.9	61.8	51.7	57.4	54.0	43.9	58.5	55.8	55.8	51.0	7.7	51.9	73.4	74.7	72.2	34.9	23.3	25.9	25.8	32.9	23.2	25.0	25.8	25.7	25.7	24.3	24.8	27.8	87.4	70.5	55.2	18.6	72.7	50.2	147.0	166.1	50.7	49.7	71.3	87.8	95.4	82.9	130.2	66.2	35.5	124.5	58.1	83.3	156.5	121.1	79.0	75.4	83.8	60.8	73.8	66.7	17.3	126.6	144.8	66.0	48.9	130.8	79.3	64.2	61.4	109.8	109.6	25.2	20.4	144.4	116.0	90.1	53.3	19.4	99.1	68.8	32.0	16.9	117.2	56.0	74.2	24.6	38.3	118.3	93.7	85.4	40.9	141.8	146.8	166.1	105.6	45.5	59.2	77.5	128.4	127.2	74.3	66.4	50.2	150.9	68.9	74.3	142.2	173.1
GIMD1		ENSG00000250298	"GIMAP family P-loop NTPase domain containing 1"	P0DJR0	4	106357392-106368778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 27.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 15.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7"	"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: AB_2732576"	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	1.4	0.8	0.4	0.4	1.4	0.0	3.0	0.0	1.5	15.2	1.2	1.7	0.0	1.0	0.4	1.2	0.5	0.7	2.2	0.7	0.6	0.2	0.2	5.3	0.7	0.9	4.5	4.4	0.2	0.6	1.5	2.8	0.3	2.3	0.5	0.4	1.3	1.7	1.9	4.7	0.3	0.6	0.2	1.3	0.1	0.1	2.3	1.0	0.9	1.2	3.0	0.2	0.8	0.8	0.0	0.0	3.6	0.0	0.6	0.3	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	1.5	0.7	0.6	0.9	4.5	0.3	0.2	2.3	0.8	2.6	0.0	0.0	0.3	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.1	5.4	0.0	0.0	5.2	0.0	0.2	18.7	0.0	0.1	0.0	0.0	3.3	0.0	16.8	0.0	32.5	0.0	0.0	0.3	11.8	0.0	4.1	0.3	7.2	2.8	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	7.4	0.0	0.8	2.0	0.0	0.0
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720234	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 321.8;eosinophil: 359.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 359.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		13000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	26.3	14.2	36.8	30.8	43.9	26.0	49.9	46.4	50.0	49.6	26.5	20.4	16.0	47.1	43.0	36.2	48.4	26.4	15.9	41.9	40.8	31.7	10.3	44.4	32.9	53.2	41.4	29.2	49.3	26.9	15.8	17.2	51.8	41.1	24.7	22.3	66.0	25.9	6.1	49.7	15.8	33.6	51.1	17.4	62.8	17.0	41.8	35.4	20.3	9.9	51.7	31.7	23.7	66.3	33.6	29.7	49.1	62.1	59.1	74.0	39.6	42.4	77.2	39.4	53.1	45.7	46.7	51.3	26.0	76.1	30.4	40.7	46.8	81.6	50.5	124.2	35.5	60.4	62.6	103.0	32.3	93.0	99.8	61.7	41.2	45.7	37.1	95.2	88.7	63.9	13.6	97.0	111.6	50.7	77.3	28.2	52.6	35.3	33.1	62.4	78.0	15.0	59.6	45.6	55.5	81.4	42.9	63.3	51.9	61.9	37.9	14.1	52.9	49.3	51.0	33.6	35.4	76.9	57.2	48.7	60.1	69.3	79.2	321.8	49.9	359.8	15.6	56.2	18.8	44.8	21.2	18.0	51.4	26.4	13.2	14.9	55.5	27.6	60.8	9.8	39.9	36.7	36.8	43.9	46.4	50.0	41.9	40.8	53.2	41.4	51.8	51.1	41.8	66.3	19.7	96.1	20.2	41.4	25.4	32.0	36.3	73.2	33.6	19.9	48.4	41.5	7.4	50.1	92.3	57.0	10.4	20.6	7.0	10.5	17.6	36.8	6.2	124.2	84.6	25.1	23.4	15.3	112.2	44.7	48.7	35.2	62.2	444.3	42.5	25.0	20.3	10.2	55.1	30.3	64.7	17.5	32.6	46.5	27.8	6.7	18.0	53.5	60.5	29.0	37.4	35.0	10.3	100.0	150.3	33.6	9.1	25.6	86.4	29.1	6.9	28.8	110.0	13.3	26.3	45.2	29.1	19.6	14.7	62.9	40.9	8.9	22.2	19.2	14.8	29.4
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.6;Basal prostatic cells: 167.4;Endometrial ciliated cells: 172.1;Glandular and luminal cells: 147.8;Urothelial cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.7;eosinophil: 2.4;intermediate monocyte: 1.5;myeloid DC: 4.2;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 4.2;granulocytes: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	8.6	3.0	5.2	9.0	15.3	4.6	5.2	10.1	7.8	12.7	36.7	12.3	19.5	8.8	4.6	16.4	12.5	39.6	9.1	3.3	6.5	14.5	20.4	27.8	1.1	13.9	14.3	1.1	11.7	3.6	4.7	5.1	13.0	9.6	10.6	0.8	9.2	4.6	2.5	3.6	16.5	29.1	10.2	1.1	13.8	9.6	10.6	0.8	18.0	3.4	2.9	13.9	4.2	21.6	20.8	7.7	1.1	5.8	12.9	29.9	0.4	25.0	18.8	11.6	12.1	3.5	42.1	1.5	9.7	40.0	10.1	7.6	14.5	22.1	20.7	5.9	5.7	0.9	16.5	1.2	14.8	14.2	0.1	10.4	15.1	22.7	27.4	24.2	26.1	0.3	0.2	0.5	18.6	6.9	0.5	0.1	0.7	12.1	8.6	0.5	9.9	2.9	30.7	10.0	2.0	0.1	19.1	26.9	3.3	3.0	14.5	0.4	44.7	13.9	21.9	20.1	11.7	1.4	0.5	0.8	18.7	3.4	5.9	0.0	3.7	2.4	0.0	1.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	1.0	5.2	15.3	10.1	7.8	3.3	6.5	13.9	14.3	13.0	10.2	10.6	21.6	3.4	86.6	126.6	7.2	1.0	56.0	167.4	12.8	18.2	0.5	20.9	10.4	17.8	28.6	88.0	16.5	0.0	1.0	2.9	32.3	3.9	19.8	71.4	172.1	13.5	10.7	8.9	0.0	8.0	19.5	0.9	26.6	58.1	147.8	10.1	2.8	11.4	25.0	5.5	1.7	10.0	26.0	14.2	22.1	43.0	11.1	2.5	28.2	8.8	1.9	23.3	0.2	2.1	0.5	18.5	37.9	60.5	0.4	0.4	96.9	33.5	12.4	104.0	0.1	0.0	46.1	22.0	0.9	3.1	38.1	72.9	13.8	3.3	0.1	21.8	159.7
CYP2U1	"SPG49, SPG56"	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931549-107953461	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 84.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.2;Inhibitory neurons: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	7.7	6.4	6.6	4.0	8.3	0.5	4.5	7.6	7.3	5.1	10.1	5.8	3.4	6.6	3.6	3.5	7.8	5.6	7.7	6.5	8.7	5.3	5.9	5.7	6.3	9.0	7.9	9.5	2.3	10.7	4.7	2.4	8.2	9.9	3.9	5.8	3.4	8.7	3.6	2.7	4.7	10.2	8.1	7.6	3.2	3.0	8.0	84.9	3.6	7.2	4.7	4.7	3.8	9.5	4.0	1.9	5.2	9.5	28.6	13.4	0.8	16.8	25.3	10.2	15.7	0.1	2.5	10.8	1.1	10.1	7.8	0.2	8.1	6.4	15.4	3.0	2.5	2.3	3.5	0.5	11.3	3.2	0.0	15.3	5.3	4.7	3.2	20.8	4.0	12.0	0.1	5.0	8.4	2.9	11.8	0.0	5.4	0.4	4.7	6.5	6.3	0.1	3.3	6.7	10.0	7.6	4.2	7.3	18.6	4.3	3.6	1.5	10.6	6.5	0.8	9.3	6.9	21.1	21.2	3.4	5.5	0.0	7.4	0.0	0.1	0.3	0.4	0.5	0.3	0.8	0.3	0.4	0.9	1.1	0.7	0.5	0.0	0.7	2.8	1.1	0.0	0.2	6.6	8.3	7.6	7.3	6.5	8.7	9.0	7.9	8.2	8.1	8.0	9.5	5.5	3.2	3.9	18.6	12.9	1.1	4.6	2.2	15.4	4.1	2.8	5.8	6.2	1.5	2.4	9.2	4.2	0.4	10.1	1.4	0.0	0.9	13.2	6.9	6.3	5.8	3.0	1.7	30.2	2.0	0.3	12.6	3.1	6.2	4.5	2.5	8.6	7.3	2.3	1.7	34.3	1.2	0.0	6.2	3.3	9.5	17.7	4.7	19.6	5.6	3.7	9.5	1.0	20.1	12.1	0.4	0.1	17.7	4.2	1.5	9.9	3.0	8.6	3.1	0.0	20.0	8.1	1.0	4.2	2.0	1.4	0.3	3.6	5.1	3.1	0.8
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035174	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Oxidoreductase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 280.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.4;Proximal enterocytes: 383.0;Proximal tubular cells: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Enhanced		Supported	Mitochondria		No	Yes		1000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	143.0	54.1	23.2	20.9	23.8	27.4	74.9	24.6	26.3	37.9	33.5	101.2	84.4	49.8	24.9	34.2	56.2	24.0	175.6	22.9	27.2	140.2	225.5	22.8	22.2	24.7	26.3	54.3	42.1	40.2	18.0	13.7	26.0	35.4	90.8	10.4	55.9	42.4	249.7	28.0	89.1	72.7	26.0	18.0	60.7	27.9	24.9	76.0	37.7	280.3	28.5	34.1	28.7	28.0	32.2	27.9	64.3	46.2	149.2	48.2	27.0	43.1	68.5	49.6	48.9	21.2	60.9	185.0	23.5	38.8	34.6	42.0	85.5	64.5	55.5	49.6	37.2	39.9	50.5	48.9	24.3	88.2	17.0	50.4	34.1	35.1	32.3	41.4	34.4	127.1	53.1	98.7	57.3	58.9	163.6	36.7	29.0	147.8	30.1	113.5	84.3	89.2	54.5	129.4	73.2	43.1	41.1	161.9	45.6	37.0	77.4	70.8	20.6	35.5	18.9	48.5	26.7	52.1	63.3	80.6	47.0	60.2	27.0	0.0	11.1	11.4	17.2	14.2	22.1	31.4	19.5	20.7	36.8	27.1	22.4	22.2	1.2	36.7	20.1	41.7	17.7	16.3	23.2	23.8	24.6	26.3	22.9	27.2	24.7	26.3	26.0	26.0	24.9	28.0	17.3	28.9	33.8	11.1	25.7	15.6	54.2	65.8	41.5	6.9	46.5	56.1	225.6	52.9	48.1	35.0	4.2	41.0	18.3	164.7	160.4	43.3	196.8	41.4	22.6	17.5	32.4	65.6	15.1	32.2	44.7	28.2	52.5	26.1	10.8	63.9	21.0	272.4	116.5	6.7	18.9	93.3	36.7	37.8	11.8	108.5	46.3	25.3	21.4	12.2	15.3	26.8	8.2	9.5	9.9	23.0	100.8	35.3	32.0	33.9	383.0	318.8	70.8	6.8	39.5	21.7	38.2	22.4	20.3	64.0	18.2	17.0	19.6	66.3	194.2	49.1
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 349.2"	"Cell type enhanced"	"Detected in many"		"Melanocytes: 33.8;Microglial cells: 145.2;T-cells: 70.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 142.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 142.6"	"Group enriched"	"Detected in many"	5	"JURKAT: 579.6;MOLT-4: 569.0;REH: 454.8"	"Region enhanced"	"Detected in all"		"thalamus: 22.6"	"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	1.0	12.7	10.7	13.8	7.6	11.6	2.0	6.1	7.9	4.2	14.3	1.5	0.7	8.0	4.8	3.2	5.1	3.9	0.2	5.7	9.9	2.5	0.3	3.3	31.3	8.9	11.2	1.1	0.1	0.3	1.0	11.0	9.4	3.7	1.4	0.5	1.0	1.0	0.1	2.8	4.1	3.9	5.9	9.8	1.5	12.3	18.2	349.2	3.0	0.1	22.8	5.5	3.0	5.5	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.2	7.2	1.8	4.7	27.1	0.0	0.0	0.1	0.0	2.5	0.2	7.9	0.0	3.7	0.3	17.6	6.9	0.0	0.0	0.0	23.6	2.9	0.4	0.4	0.0	0.7	3.5	0.0	579.6	14.2	0.0	2.6	1.0	569.0	0.0	1.7	6.3	1.4	454.8	9.1	0.2	2.4	1.3	3.0	5.2	0.0	0.5	83.8	6.7	2.4	0.2	0.0	11.9	10.3	0.0	15.3	38.3	17.0	100.9	7.8	0.0	48.4	0.3	0.2	0.0	8.2	0.0	1.6	0.6	68.3	29.9	0.1	0.9	142.6	102.2	1.9	32.9	0.3	0.5	97.7	36.8	10.7	7.6	6.1	7.9	5.7	9.9	8.9	11.2	9.4	5.9	18.2	5.5	1.4	3.2	1.9	2.0	4.4	3.3	1.4	1.0	24.5	0.1	0.4	5.0	1.6	0.0	0.7	0.0	0.0	0.1	6.2	0.0	13.7	0.0	4.2	5.8	22.3	22.0	0.0	9.2	0.2	0.0	0.2	2.1	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	4.1	0.3	1.4	7.9	0.6	2.0	33.8	145.2	3.5	0.6	10.3	0.5	0.6	0.1	0.0	0.0	5.4	1.8	0.0	0.5	2.3	0.3	0.0	0.6	9.0	16.1	6.6	11.3	1.3	0.4	70.3	0.0	0.9	0.4
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620569-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	2425.0	1591.7	1002.0	785.6	1018.3	2268.5	2730.5	987.4	1524.6	3162.1	962.2	2061.8	823.2	1963.6	1544.1	2142.7	2352.9	621.4	1521.5	956.2	997.4	1752.0	1479.4	1498.1	1670.2	1010.6	982.1	4574.1	4126.6	561.6	1616.2	716.9	1015.1	2107.6	914.8	439.0	1967.4	729.0	1791.6	2675.3	1965.7	686.3	1052.9	2223.5	2008.0	507.9	1033.0	1276.7	1700.7	739.6	1511.2	2044.7	2481.9	1055.4	825.0	541.4	1026.2	1485.8	2018.1	3044.8	1023.2	1230.1	1393.2	916.9	752.8	1358.5	1395.7	2413.4	723.7	1117.5	499.4	564.9	1064.4	1792.9	1160.3	927.5	1680.3	1034.0	1087.0	2109.6	1708.0	2628.2	1118.4	2837.7	2381.1	773.6	1701.2	1839.1	1618.7	1345.9	1731.4	1357.1	1479.3	1452.6	1625.9	3123.7	1214.4	1794.1	1095.2	1473.5	1112.4	1478.1	1929.2	1234.1	1099.4	1409.8	510.1	2915.7	1881.3	805.7	957.1	2348.2	1357.7	674.5	926.3	711.3	1121.6	1020.7	1327.3	1913.0	924.1	1533.2	859.0	1744.5	3024.8	943.1	2796.0	2242.1	4811.7	7783.4	5669.6	3854.8	3005.0	6460.3	7498.4	5716.8	610.2	3571.6	1985.1	3793.7	4557.8	12314.4	1002.0	1018.3	987.4	1524.6	956.2	997.4	1010.6	982.1	1015.1	1052.9	1033.0	1055.4	3354.3	1413.4	2496.4	19.9	8040.6	12566.5	10934.5	14134.5	6505.0	343.4	12055.8	16944.0	1156.9	4838.4	5399.5	2164.7	75.0	6443.9	5150.7	1717.5	6914.3	3577.3	1527.0	2002.3	4683.1	4313.0	2720.0	3488.0	31.4	8680.5	7464.2	3471.8	2274.2	2664.1	3308.2	3093.0	5696.3	5781.3	4151.7	154.8	29.1	6030.2	3912.2	6966.0	11139.9	2023.8	7477.3	4326.2	5839.5	43.1	7738.0	1718.3	4866.1	18.1	28.5	5645.0	4899.2	4032.5	3437.1	5962.5	5302.3	9409.4	2362.8	535.0	1913.0	6558.2	3975.1	787.2	678.5	6369.9	15308.7	6380.6	7015.5	2344.3	6469.6	8608.5
OSTC	DC2	ENSG00000198856	"Oligosaccharyltransferase complex non-catalytic subunit"	Q9NRP0	4	108650585-108667820	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 628.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.26e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (6.46e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (2.31e-8)"	"unprognostic (2.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-2)"	72.6	74.1	22.8	84.2	23.7	98.9	99.8	24.1	29.8	118.6	35.0	85.1	96.2	87.1	180.0	77.5	72.7	82.4	51.6	22.3	26.5	74.6	193.9	64.6	87.8	25.9	24.1	69.7	132.9	51.1	82.8	105.4	24.7	64.6	98.4	22.6	83.5	59.6	24.3	47.8	89.1	82.7	25.1	70.1	87.1	39.2	26.4	91.6	106.2	30.6	80.9	92.5	60.4	26.8	123.2	75.5	200.2	138.2	419.3	556.1	158.0	328.3	316.8	166.9	203.0	161.6	274.7	258.5	236.0	388.7	101.2	81.6	159.8	133.5	192.8	108.8	117.4	133.0	99.7	357.0	336.8	304.0	124.1	362.8	253.7	137.4	280.2	349.9	379.6	160.1	255.0	295.1	329.5	152.2	213.1	264.7	137.2	332.2	95.7	216.2	217.5	284.6	292.1	85.9	99.9	123.4	111.8	265.0	262.9	245.2	122.4	246.5	298.5	175.4	185.3	132.2	135.9	168.0	183.1	254.0	225.1	183.9	195.7	146.4	136.2	76.4	130.4	145.5	202.4	120.2	138.0	143.0	204.0	91.5	128.3	139.2	18.6	152.7	125.9	375.9	105.5	227.2	22.8	23.7	24.1	29.8	22.3	26.5	25.9	24.1	24.7	25.1	26.4	26.8	123.1	38.5	48.5	11.8	128.4	97.3	114.1	413.8	86.6	15.1	178.3	197.1	34.2	124.4	235.4	84.6	16.7	276.9	199.9	54.6	88.0	221.7	9.4	105.4	337.0	120.0	58.0	105.5	9.4	159.5	628.6	200.2	120.8	180.5	122.4	169.5	111.4	187.1	256.1	11.8	13.3	274.2	209.5	139.9	196.7	10.1	164.1	138.5	161.9	6.5	140.0	50.2	140.1	12.1	17.5	160.3	90.4	109.1	424.4	183.7	166.5	173.9	126.9	17.3	72.3	108.8	175.3	74.5	72.4	134.9	117.9	365.4	117.2	197.4	178.5	145.2
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;retina: 24.7;testis: 19.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 107.1;Inhibitory neurons: 275.3;Late spermatids: 39.2;Rod photoreceptor cells: 71.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HeLa: 47.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	6.1	0.5	13.4	0.1	10.3	0.0	2.8	0.0	30.0	1.1	0.3	0.4	2.9	0.6	1.6	0.4	0.9	2.2	0.5	17.8	13.7	1.9	2.2	0.2	0.1	6.5	9.4	1.0	0.2	1.3	7.0	0.3	1.0	0.5	0.3	24.7	4.9	0.5	1.0	0.7	2.5	0.8	6.9	0.8	0.3	19.1	8.9	0.5	2.8	0.3	0.1	0.7	1.0	1.7	0.0	0.0	5.3	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	2.7	0.0	0.1	0.0	3.2	5.9	47.6	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.2	0.0	0.1	1.2	0.2	5.6	0.0	0.8	0.0	1.6	0.0	0.1	0.0	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.2	1.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	10.3	0.0	30.0	17.8	13.7	6.5	9.4	1.0	6.9	8.9	1.7	8.2	0.0	0.0	12.4	0.1	0.0	0.1	0.0	2.2	2.1	0.4	0.6	1.0	0.0	0.6	1.8	4.2	0.0	0.0	0.0	0.0	0.0	107.1	6.5	2.0	1.6	0.0	0.0	20.5	0.0	0.0	0.7	0.0	18.9	0.0	0.5	0.7	0.0	0.0	1.7	275.3	0.0	0.0	0.0	0.4	39.2	0.6	0.2	0.0	10.3	0.0	2.8	0.0	16.6	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	71.5	0.0	4.7	24.6	7.8	1.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 88.1;Oligodendrocytes: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	19.3	13.7	7.2	13.2	7.5	28.0	17.4	14.7	9.9	16.3	15.0	15.7	14.1	16.9	12.9	17.2	15.0	13.8	15.6	6.8	7.6	16.7	46.2	14.8	13.9	7.5	6.9	21.4	18.6	21.9	11.2	20.6	7.8	15.6	16.1	32.6	14.3	16.1	28.1	19.8	12.7	17.9	7.3	14.7	13.3	11.3	7.4	27.2	18.5	22.9	16.7	17.5	16.0	9.6	21.1	18.9	29.3	22.1	34.9	34.7	16.8	27.0	32.8	22.5	19.8	17.4	23.8	19.4	13.8	41.1	19.3	17.4	33.2	26.9	33.0	24.0	16.6	20.3	16.6	19.2	23.4	27.0	22.9	34.4	33.7	25.8	30.8	31.8	33.7	19.7	31.5	17.3	33.6	17.1	39.2	12.5	11.2	26.1	15.0	25.1	25.9	11.3	27.1	25.8	20.6	16.5	20.8	43.8	16.0	30.0	12.9	10.3	31.3	26.2	17.6	23.1	19.5	16.6	22.3	18.1	23.3	10.7	21.5	6.1	9.5	11.5	8.6	10.4	9.5	10.3	9.5	9.0	11.8	8.9	10.8	9.3	9.2	11.5	10.5	4.6	9.1	9.0	7.2	7.5	14.7	9.9	6.8	7.6	7.5	6.9	7.8	7.3	7.4	9.6	25.1	25.6	15.4	63.0	23.0	35.4	20.1	11.8	28.5	27.0	12.9	10.8	30.5	14.3	17.4	5.5	6.2	13.3	13.2	22.7	5.9	10.4	4.4	18.7	14.6	22.5	15.6	11.6	71.1	13.1	9.2	16.4	19.9	21.9	11.4	15.9	16.8	29.9	12.3	16.8	84.1	15.6	4.1	17.6	16.8	7.9	20.5	18.7	17.8	88.1	14.5	20.3	13.4	76.9	91.6	12.6	18.7	21.8	21.3	22.5	16.5	9.6	19.6	22.0	13.1	16.3	16.8	14.7	13.6	22.2	36.7	16.1	17.0	9.9	14.4	30.3
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative subunit beta"	Q9NWR8	4	109560209-109688719	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 127.7;Exocrine glandular cells: 111.4;Extravillous trophoblasts: 91.9;Hofbauer cells: 106.8;Pancreatic endocrine cells: 67.9;Syncytiotrophoblasts: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	10.2	2.0	2.6	18.4	3.0	10.6	7.6	2.1	3.4	7.0	3.5	5.3	3.8	8.8	1.5	6.8	5.8	7.8	10.5	2.7	4.6	3.5	2.2	7.2	32.2	4.3	3.0	5.6	1.5	1.2	3.7	6.1	3.2	3.0	6.3	3.7	4.9	2.1	1.4	6.2	7.8	8.2	3.7	13.5	4.6	3.0	5.2	31.4	3.3	3.5	25.7	9.2	7.5	4.6	26.9	11.7	6.4	32.6	6.9	18.1	23.9	23.3	14.2	24.9	22.1	0.6	21.6	93.0	4.6	20.2	13.8	7.6	24.1	14.0	21.9	59.2	18.4	11.3	11.6	1.6	12.1	23.6	0.4	11.7	3.8	15.1	13.0	17.7	33.9	35.0	3.3	59.4	19.2	34.0	54.1	0.4	28.2	4.8	15.6	20.4	47.7	10.8	29.6	12.1	25.6	11.1	24.2	73.4	7.7	5.3	9.2	1.2	23.9	9.8	12.6	51.8	40.2	22.3	16.4	22.7	29.9	4.9	6.9	0.4	51.4	0.8	18.9	32.2	26.6	43.6	79.1	56.5	49.8	50.7	114.7	66.2	3.6	65.0	24.4	35.1	74.9	92.2	2.6	3.0	2.1	3.4	2.7	4.6	4.3	3.0	3.2	3.7	5.2	4.6	21.5	9.6	5.2	0.0	19.5	0.0	0.0	0.0	0.0	0.0	12.7	9.9	0.0	0.0	2.5	5.5	0.0	127.7	36.0	0.0	0.0	25.2	0.0	7.0	5.9	11.7	0.0	0.0	0.0	111.4	91.9	15.1	0.0	8.9	1.3	9.1	0.0	0.0	106.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	14.5	0.0	0.0	0.0	0.0	67.9	0.0	0.0	5.8	0.0	0.0	0.9	2.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	73.5	28.2	7.4	0.0	0.0
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	6.5	6.7	3.9	8.4	4.0	10.8	10.5	4.3	5.4	7.6	4.0	35.3	40.8	7.7	5.1	7.4	7.6	9.3	5.6	3.8	4.0	11.5	18.1	7.8	9.6	3.7	3.7	8.3	13.3	4.8	4.2	4.8	3.8	9.1	31.5	3.0	8.6	6.5	3.3	10.7	36.8	7.4	3.8	8.0	15.8	1.8	3.7	11.5	8.5	2.4	7.7	8.1	7.0	4.3	26.6	8.4	16.5	14.8	11.0	11.2	24.3	15.3	9.2	12.4	13.4	13.8	50.3	2.7	16.4	14.7	17.3	12.1	19.7	21.8	8.4	43.5	13.0	22.8	7.1	12.9	9.4	23.5	15.7	12.6	15.1	12.4	2.8	17.1	22.9	30.1	29.9	76.1	19.2	13.7	62.0	14.4	12.7	17.1	16.1	20.5	10.8	13.3	39.6	24.8	17.2	13.2	15.0	25.7	8.8	19.6	11.0	8.0	20.3	12.8	14.6	6.6	16.7	11.4	23.0	2.8	17.1	26.9	7.1	16.3	6.9	8.9	6.3	6.9	7.0	6.1	23.8	12.3	8.8	8.6	28.0	16.1	1.4	7.5	11.2	11.6	24.8	9.4	3.9	4.0	4.3	5.4	3.8	4.0	3.7	3.7	3.8	3.8	3.7	4.3	10.5	16.0	14.6	5.2	7.7	10.8	10.2	26.7	12.0	6.9	23.6	16.0	4.1	28.6	23.2	20.2	6.2	20.9	7.6	54.0	9.8	40.8	2.6	19.8	9.5	12.2	59.2	19.7	6.4	46.4	41.1	13.4	18.3	23.3	10.1	112.3	9.7	20.4	19.8	0.0	7.3	53.9	32.6	8.7	9.3	1.7	12.8	14.5	1.8	2.8	17.9	16.0	6.2	5.5	5.8	45.9	52.5	9.8	8.8	7.4	71.7	35.7	18.6	1.3	6.6	7.6	12.3	1.9	8.6	10.8	11.6	5.7	17.5	12.4	74.2	8.0
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730070	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	10.0	9.0	11.4	3.4	12.7	6.2	12.0	12.6	13.8	8.4	11.9	11.5	10.5	8.1	7.3	11.4	8.4	7.3	16.0	10.4	12.2	14.7	21.2	7.4	4.0	13.9	14.4	10.5	34.5	23.0	12.5	3.7	13.1	15.1	10.8	15.5	11.8	7.1	22.1	9.3	10.6	7.0	14.2	5.2	9.8	5.0	12.7	4.9	17.8	19.3	4.6	7.0	7.6	15.1	17.2	6.2	4.8	7.4	15.0	14.9	9.4	14.9	11.0	8.5	8.9	15.6	29.1	24.5	11.6	11.1	14.0	9.3	14.9	20.1	13.0	8.3	22.8	8.7	17.5	11.5	14.2	19.2	5.9	15.1	22.9	8.6	21.3	14.3	7.7	22.5	48.8	10.7	14.7	30.3	15.7	8.6	8.6	39.0	24.1	9.3	14.3	19.5	16.2	25.0	30.8	10.1	13.7	35.5	11.9	12.3	21.3	4.0	10.4	12.4	10.1	12.9	10.8	18.5	36.0	17.8	13.5	11.0	15.5	5.4	4.1	2.7	6.2	2.7	5.7	3.7	7.8	6.0	8.2	4.3	8.7	8.0	1.8	5.0	4.5	7.0	8.3	12.1	11.4	12.7	12.6	13.8	10.4	12.2	13.9	14.4	13.1	14.2	12.7	15.1	11.7	25.6	21.8	14.4	11.7	36.7	36.3	39.7	25.0	52.5	27.5	18.3	56.8	30.0	24.9	22.0	50.1	42.7	8.3	31.5	27.4	15.0	26.7	15.1	9.5	17.1	107.7	48.4	24.1	25.9	53.4	29.3	32.6	14.0	14.0	147.4	23.9	103.1	19.4	26.9	28.6	52.8	34.6	22.4	17.1	8.7	33.2	64.6	30.2	18.7	6.1	47.7	13.4	16.6	20.1	13.9	38.9	34.6	20.6	67.8	78.9	19.2	16.4	42.3	19.7	38.2	21.1	62.7	47.5	39.0	42.6	34.5	14.3	28.6	58.9	44.9
AC126283.1		ENSG00000285330	"Novel protein"		4	109713916-109801999	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.4;Breast myoepithelial cells: 1.5;Collecting duct cells: 3.7;Endometrial ciliated cells: 3.4"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 38.1;HDLM-2: 7.8;Hep G2: 8.4;RPTEC TERT1: 11.2"									"HPA001143, HPA024061, HPA035909"	Uncertain					NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074"																		1.5	3.5	0.3	3.4	0.3	0.1	1.5	0.3	0.8	1.9	0.5	1.6	6.2	2.1	0.0	3.4	2.1	3.1	4.1	0.3	0.4	3.6	9.7	2.3	1.8	0.8	0.2	3.2	9.0	1.2		3.6	0.4	2.1	2.1	3.5	2.5	1.2	3.4	0.7	5.3	2.1	0.4	2.4	2.3	1.4	0.3	1.3	1.9	4.1	1.5	4.1		0.6	0.0	1.0	0.0	0.3	0.2	0.4	0.0	1.5	2.9	0.0	0.3	0.2	38.1	0.2	6.5	0.7	0.6	0.1	0.2	0.1	0.0	7.8	0.7	0.1	0.5	8.4	5.8	0.4	0.0	6.0	0.0	0.0	0.1	1.9	4.8	0.1	0.5	2.5	0.1	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.3	0.2	11.2	1.1	0.2	0.3	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.1	6.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.8	0.3	0.4	0.8	0.2	0.4	0.4	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	14.7	16.4	10.0	13.5	10.1	31.7	15.9	9.8	13.0	12.3	10.1	16.0	11.3	13.7	11.4	23.0	13.3	6.4	12.7	10.0	10.3	20.1	16.5	9.6	13.5	10.1	10.1	15.5	14.7	9.3	11.8	11.5	10.3	12.2	15.2	7.1	13.2	8.0	12.2	23.2	13.2	11.7	9.9	15.5	12.9	15.1	10.3	13.8	10.7	6.6	16.0	16.3	13.5	10.6	45.7	65.5	34.3	49.7	19.3	26.8	34.1	47.1	24.1	35.3	30.1	100.6	60.2	103.5	27.5	38.9	39.5	22.2	68.8	47.7	66.5	31.2	68.3	57.7	57.1	113.1	46.6	150.8	35.2	27.0	49.5	48.6	37.6	27.9	44.5	48.1	146.8	34.6	50.0	121.7	78.5	115.4	59.5	78.4	68.7	58.0	57.2	41.2	55.3	79.3	51.2	55.7	26.3	80.6	46.2	29.5	25.1	48.4	39.3	38.5	51.1	27.2	61.4	42.0	70.7	132.2	26.3	69.7	43.2	7.5	4.0	2.9	6.1	6.7	6.5	8.4	5.9	6.2	6.3	7.9	6.7	6.2	0.7	7.3	6.3	6.8	6.8	2.6	10.0	10.1	9.8	13.0	10.0	10.3	10.1	10.1	10.3	9.9	10.3	10.6	25.2	3.2	17.0	4.6	29.0	57.9	40.9	42.7	27.3	11.9	36.3	37.2	13.8	14.3	33.1	16.5	14.6	69.9	23.4	18.5	25.4	49.2	1.3	54.0	39.9	30.9	18.6	62.1	6.6	53.8	65.8	24.7	30.1	36.9	19.0	38.1	18.2	19.6	35.8	5.0	6.3	40.7	10.2	13.3	17.2	4.3	22.1	16.0	17.8	5.6	16.1	39.2	17.5	5.5	7.4	49.5	22.7	18.8	24.7	68.5	14.5	40.4	35.6	9.3	6.6	35.2	27.7	45.0	38.3	40.2	60.0	87.8	24.8	44.6	46.1	40.6
RRH	peropsin	ENSG00000180245	"Retinal pigment epithelium-derived rhodopsin homolog"	O14718	4	109827972-109849123	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	112	"retina: 75.6"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 40.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.18e-2)"	0.1	0.2	0.5	0.1	0.4	0.0	0.2	0.4	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.2	0.3	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	75.6	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.4	0.6	0.4	0.2	0.3	0.2	0.4	0.2	0.2	0.5	0.1	0.0	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	2.5	3.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848107-109872315	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"retina: 17.6"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 33.3;Muller glia cells: 10.2;Rod photoreceptor cells: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.2	0.2	0.4	0.0	0.5	0.1	0.3	0.3	0.6	0.4	0.2	0.2	0.0	0.2	0.3	0.2	0.3	0.0	0.1	0.4	0.2	0.7	0.3	0.2	0.1	0.3	0.3	0.2	0.3	0.0	0.2	0.0	0.4	0.3	0.0	17.6	0.2	0.1	0.3	0.6	0.2	0.0	0.2	0.3	0.2	0.5	0.3	0.1	0.3	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.6	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	33.3	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	10.2	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912883-110013766	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 110.2;pancreas: 89.5;skeletal muscle: 29.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.9;Breast myoepithelial cells: 8.1;Cardiomyocytes: 8.2;Distal tubular cells: 7.9;Excitatory neurons: 8.5;Inhibitory neurons: 11.2;Muller glia cells: 26.2;Skeletal myocytes: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;SK-BR-3: 11.6;U-251 MG: 3.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA	209000	680000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.0	0.0	1.0	0.1	1.0	0.2	14.7	0.2	0.8	0.0	0.2	0.8	0.0	0.4	2.4	0.7	0.3	1.0	2.8	0.9	2.0	110.2	0.0	0.5	0.0	1.4	0.9	0.0	89.5	0.2	0.4	0.0	1.5	1.4	1.1	13.6	15.7	0.4	29.6	0.7	0.2	0.5	1.2	0.1	0.0	0.1	0.7	0.0	3.0	17.4	0.0	0.4	0.1	1.8	0.2	0.2	1.9	0.0	0.0	0.1	0.0	0.4	1.1	0.5	0.4	0.1	0.0	0.0	6.4	0.6	1.6	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.6	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.1	0.6	0.1	0.0	0.0	2.3	0.0	0.4	0.1	0.1	0.5	0.4	0.2	0.0	0.0	0.0	11.6	0.4	1.2	2.8	0.0	0.0	0.9	1.3	0.0	3.6	0.0	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.0	1.0	0.2	0.8	0.9	2.0	1.4	0.9	1.5	1.2	0.7	1.8	0.1	0.0	0.0	3.3	0.0	1.0	0.2	0.1	0.0	1.0	12.9	8.1	8.2	0.0	0.5	0.0	0.0	0.0	0.2	2.0	7.9	0.2	5.6	0.2	0.1	0.6	0.0	0.0	8.5	5.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.7	11.2	0.1	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.3	26.2	0.0	1.5	0.3	1.0	0.4	0.0	0.0	1.1	0.1	1.2	1.0	1.2	0.0	8.2	0.2	0.5	0.4	0.0	1.4	0.0	0.1	0.1	1.6	0.3
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.4;Hepatocytes: 102.0;Inhibitory neurons: 78.5;Oligodendrocytes: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.4;MAIT T-cell: 2.6;memory CD4 T-cell: 1.0;memory CD8 T-cell: 1.3;naive CD8 T-cell: 1.0;NK-cell: 3.3"	"Group enriched"	"Detected in many"	21	"NK-cells: 3.3;T-cells: 2.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	12.2	8.7	4.6	2.9	5.2	4.0	7.4	5.2	7.9	4.2	1.5	11.5	8.5	3.1	2.1	18.0	2.1	3.2	4.2	4.9	5.0	4.0	36.2	3.1	0.7	5.8	5.4	1.5	2.0	6.4	4.0	1.7	6.0	1.9	10.2	12.1	4.1	2.3	1.0	15.3	6.3	3.7	5.8	1.6	13.6	0.9	5.3	1.8	1.8	0.5	2.3	6.8	5.7	7.8	24.1	14.5	57.8	12.9	31.6	32.6	24.6	16.8	9.5	6.4	16.4	7.6	45.5	2.5	1.3	13.3	22.0	21.5	46.8	52.2	13.6	9.5	14.8	33.9	17.3	17.9	19.6	30.4	18.8	30.0	10.2	34.9	13.5	21.5	11.9	3.4	33.8	57.0	12.6	10.5	7.1	2.6	25.0	15.3	7.2	4.3	24.1	7.2	37.2	20.3	11.0	23.3	9.9	57.9	9.1	24.3	10.0	0.3	5.9	13.2	15.5	20.4	21.4	2.7	11.3	57.9	20.8	0.0	2.8	0.1	0.0	0.0	2.4	0.0	2.6	0.0	1.0	1.3	0.0	0.0	0.3	1.0	0.1	3.3	0.0	0.0	0.1	0.4	4.6	5.2	5.2	7.9	4.9	5.0	5.8	5.4	6.0	5.8	5.3	7.8	2.1	0.0	7.8	51.2	1.6	1.8	3.0	8.6	2.8	24.4	3.8	2.8	3.2	8.6	9.8	11.0	37.5	2.5	8.9	38.1	5.9	13.0	7.6	3.5	11.1	2.2	3.0	34.9	83.4	8.2	26.8	6.9	30.5	6.3	6.3	8.3	4.2	102.0	1.9	26.9	78.5	14.4	8.2	3.0	0.3	3.9	1.2	0.7	0.0	18.7	0.1	5.5	18.6	56.3	77.3	16.6	24.8	1.2	2.9	2.5	7.1	6.9	2.9	16.3	6.6	6.4	7.5	0.2	1.5	19.9	7.0	2.1	9.6	11.8	22.4	5.1
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.0;skeletal muscle: 43.2;urinary bladder: 29.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 19.2;Fibroblasts: 69.6;Paneth cells: 20.6;Proximal enterocytes: 39.7;Skeletal myocytes: 49.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"hypothalamus: 17.8;thalamus: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.8;HEK 293: 10.5;LHCN-M2: 25.1;RH-30: 20.5"					"Group enriched"	"Detected in some"	25	"hypothalamus: 5.4;midbrain: 1.5"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.2	0.0	0.0	7.8	0.2	0.0	0.4	0.0	0.0	1.6	0.0	3.8	0.0	0.1	0.0	2.6	0.2	1.1	2.0	0.0	17.8	0.2	0.0	0.0	0.0	0.1	2.8	0.0	0.5	0.0	16.1	42.0	0.2	0.9	0.2	0.0	13.5	0.1	43.2	1.5	3.1	0.5	0.2	0.0	0.5	0.5	6.8	0.0	0.0	12.3	0.0	29.8	3.8	0.0	1.4	2.6	0.0	1.0	2.4	2.1	4.0	0.8	0.4	2.6	2.0	24.8	0.0	0.0	5.2	5.1	3.2	0.4	0.1	0.0	1.4	0.0	10.5	0.0	2.0	0.0	8.8	0.0	5.0	2.5	0.2	0.5	0.0	0.8	0.0	2.7	0.6	0.0	25.1	0.7	2.7	0.0	0.4	0.0	0.5	0.0	20.5	0.0	0.4	3.4	0.0	0.0	2.0	3.3	0.3	0.4	0.2	0.0	0.0	3.1	7.5	0.0	4.1	0.1	0.1	1.0	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.8	0.1	2.8	0.2	0.2	6.8	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.2	0.0	0.1	0.3	19.2	0.0	0.1	0.0	0.0	5.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.4	5.7	69.6	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	9.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.2	39.7	2.3	0.0	0.0	0.0	49.8	5.4	2.3	7.0	1.7	0.1	10.5	0.0	0.0	14.1	0.1
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145454-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 41.3;HUVEC TERT2: 28.0"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	16.7	4.1	7.7	5.3	8.6	7.2	11.2	16.6	15.5	2.8	0.5	2.8	2.9	3.8	3.8	4.3	2.3	5.1	7.2	6.7	1.7	4.5	4.6	5.1	5.2	1.6	2.3	2.8	2.2	3.9	1.5	10.8	2.9	3.8	2.8	10.5	8.8	2.9	6.0	6.3	3.4	5.1	0.4	5.0	7.3	6.0	3.9	3.2	4.2	5.0	4.1	5.1	2.5	13.7	6.3	2.4	2.5	2.1	12.5	7.1	3.7	5.3	1.2	1.0	1.6	1.9	7.9	41.3	4.9	2.9	3.5	3.1	3.9	5.5	1.8	19.7	6.6	4.4	6.4	3.4	7.4	10.3	2.7	7.8	8.7	1.5	9.1	2.0	28.0	5.8	8.4	19.6	3.1	6.5	3.8	7.4	3.2	10.3	5.9	8.6	4.2	8.5	4.2	6.1	4.6	3.8	5.0	9.0	2.7	3.6	6.5	4.4	17.9	3.2	9.7	2.1	1.9	8.2	11.3	19.1	7.3	5.1	4.1	2.8	0.6	0.6	0.5	0.5	0.4	0.6	0.5	0.4	0.3	0.9	0.5	0.6	1.5	0.6	0.6	1.0	0.6	0.3	7.7	8.6	16.6	15.5	6.7	1.7	1.6	2.3	2.9	0.4	3.9	13.7	272.0	60.9	69.9	0.0	4.9	0.0	0.0	0.0	0.0	0.0	87.0	42.2	0.0	0.0	36.5	33.1	0.0	1.6	9.2	0.0	7.9	12.0	0.0	4.6	3.9	44.0	0.0	0.0	0.0	17.3	2.8	13.8	0.0	12.0	32.8	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	28.2	0.0	0.0	4.0	0.0	0.0	3.5	42.3	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	2.5	9.8	1.3	0.0	0.0
AP1AR	"2C18, C4orf16, gamma-BAR, PRO0971"	ENSG00000138660	"Adaptor related protein complex 1 associated regulatory protein"	Q63HQ0	4	112231740-112273110	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035863, HPA058115"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA035863: AB_10672098, HPA058115: AB_2683610"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (6.15e-2)"	"prognostic favorable (4.05e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-3)"	"prognostic favorable (7.79e-4)"	9.0	15.7	6.4	12.6	7.6	3.7	16.9	9.4	9.7	8.4	5.7	18.0	22.2	11.3	8.2	13.3	6.5	12.8	7.9	8.7	8.4	22.1	20.5	9.1	12.1	6.2	7.2	11.6	8.3	40.9	4.8	12.0	6.5	9.0	16.3	7.6	12.1	10.0	7.4	14.2	23.8	9.8	5.9	13.2	13.0	14.5	7.6	10.9	10.8	7.5	12.1	13.0	9.9	7.9	20.7	10.1	24.5	23.8	20.7	15.2	22.3	18.9	45.9	13.6	16.2	10.0	39.0	46.0	15.3	12.7	16.2	9.2	24.4	14.5	23.2	53.1	13.3	15.5	13.6	32.8	31.9	38.0	23.9	16.9	32.3	11.9	33.7	11.1	21.2	24.2	16.7	38.5	13.5	19.6	34.7	23.5	18.2	47.0	10.8	30.0	26.2	23.5	26.4	14.5	24.5	32.1	12.7	45.2	34.5	12.2	14.9	12.8	19.0	18.1	23.1	27.4	15.2	34.5	68.0	56.2	19.0	14.4	16.3	6.7	7.4	2.6	4.0	10.0	5.6	6.8	6.3	6.4	9.5	5.9	8.5	8.9	1.1	9.0	8.4	4.4	7.5	5.2	6.4	7.6	9.4	9.7	8.7	8.4	6.2	7.2	6.5	5.9	7.6	7.9	21.3	9.6	19.5	9.4	12.9	21.0	8.9	7.0	22.2	8.9	34.2	22.7	20.5	17.2	14.9	16.5	2.1	5.5	14.5	38.4	11.7	9.8	91.7	21.3	17.2	17.7	31.7	6.3	24.8	10.1	3.8	15.2	18.3	29.5	6.3	8.2	9.3	27.3	15.7	10.1	20.6	16.0	6.1	20.1	16.5	59.9	4.7	17.4	23.2	15.0	12.0	12.3	1.0	13.6	16.3	12.7	24.0	10.1	6.8	13.1	24.9	28.6	16.0	8.0	0.0	16.0	20.4	9.6	12.2	28.2	31.3	3.1	12.5	15.2	20.8	14.7
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274537-112285904	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 86.6;Syncytiotrophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 137.4;U-698: 123.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	6.4	6.3	2.0	19.9	1.8	40.6	13.7	4.3	2.1	7.7	4.3	7.0	6.7	5.6	2.1	15.6	6.8	7.5	10.7	2.3	2.4	5.2	11.3	10.2	32.2	2.3	2.1	9.3	41.3	11.5	2.1	14.2	2.5	6.7	6.9	2.8	34.8	3.7	3.8	9.3	8.8	5.3	2.1	11.7	10.3	2.1	2.3	15.4	21.1	6.4	34.6	11.6	7.7	2.3	21.9	5.5	7.9	13.4	9.5	7.7	15.9	17.0	32.0	10.6	18.1	2.8	19.1	66.3	13.5	6.8	15.5	6.3	10.9	13.0	22.1	54.1	6.4	6.6	12.4	6.2	6.4	21.2	8.8	10.4	7.0	11.4	12.3	18.0	17.0	18.1	6.8	137.4	14.3	11.0	37.3	11.5	1.6	13.4	7.0	63.7	19.9	44.7	23.6	14.7	18.1	18.6	13.7	28.2	6.6	3.4	12.2	29.9	12.7	16.7	19.8	14.2	13.6	85.3	84.8	123.8	15.7	13.8	12.6	6.8	7.2	4.0	11.1	5.2	18.1	38.2	20.4	19.4	13.2	40.4	9.0	11.6	21.4	17.4	6.8	12.3	33.9	11.3	2.0	1.8	4.3	2.1	2.3	2.4	2.3	2.1	2.5	2.1	2.3	2.3	35.7	19.2	27.4	0.0	44.8	21.3	15.7	27.8	43.9	1.4	31.6	30.9	15.4	12.8	15.7	12.9	0.0	47.9	23.4	4.4	19.6	16.5	0.1	10.0	9.6	31.8	9.0	7.6	1.4	24.4	20.9	22.3	14.8	21.0	3.8	5.4	6.4	10.7	17.8	0.0	0.6	8.4	28.5	13.0	29.7	1.4	9.0	13.1	33.8	2.8	7.1	12.5	11.3	0.5	0.1	11.4	8.0	10.9	86.6	29.2	11.0	9.5	8.8	0.6	6.6	27.2	10.5	2.5	3.8	39.2	26.0	79.4	35.9	5.7	7.0	15.1
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442621	"Enzymes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027435, HPA027443"	Approved		Approved	Centrosome		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.17e-4)"	4.8	5.3	1.7	4.4	2.0	10.7	5.1	1.9	2.7	5.4	3.2	4.3	2.4	3.7	3.7	4.4	5.3	4.2	3.1	4.5	1.6	7.2	4.5	5.1	5.4	1.4	1.1	5.4	3.5	4.2	2.5	3.6	1.8	4.9	4.2	2.1	5.4	3.1	1.8	6.9	5.0	4.2	0.5	8.7	4.0	2.1	1.8	5.2	4.2	2.3	6.1	6.0	4.4	2.5	1.6	5.0	1.5	0.3	6.4	10.1	2.1	1.7	3.6	2.6	3.3	0.5	7.8	5.3	3.3	3.3	5.2	1.0	1.7	3.2	3.7	6.7	1.9	3.6	2.0	0.4	10.1	2.2	2.0	12.8	8.3	3.7	7.8	5.7	0.9	2.7	0.9	9.1	5.0	3.1	1.3	2.0	0.3	3.7	1.2	0.6	1.1	1.6	3.9	1.8	0.5	0.8	1.7	6.4	2.8	0.2	2.9	4.1	1.8	2.3	2.0	3.8	1.3	2.2	0.7	4.5	5.8	5.3	2.1	1.6	3.7	1.7	0.2	4.7	0.6	0.9	0.6	0.1	3.7	0.9	0.8	0.6	18.7	0.4	2.2	0.5	0.0	1.4	1.7	2.0	1.9	2.7	4.5	1.6	1.4	1.1	1.8	0.5	1.8	2.5	10.8	12.8	26.8	11.4	7.3	2.9	10.9	11.5	12.5	0.5	8.7	10.7	4.0	4.3	15.5	5.5	0.0	4.9	2.9	10.0	0.0	8.0	11.1	12.0	13.7	8.2	1.2	5.0	5.9	6.7	3.0	9.6	16.3	10.9	6.3	10.9	7.1	7.4	10.1	0.0	1.2	8.6	8.2	13.5	4.6	2.6	3.7	18.7	7.2	73.1	16.1	10.7	1.0	0.5	0.7	7.1	9.0	7.5	2.4	8.8	8.0	5.3	25.7	0.2	6.6	8.4	10.8	0.9	0.7	10.3	4.5	7.3	4.0	7.0	6.4	12.4
NEUROG2	"Atoh4, bHLHa8, Math4A, ngn-2, NGN2"	ENSG00000178403	"Neurogenin 2"	Q9H2A3	4	112513516-112516180	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.3;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast myoepithelial cells: 3.4;Early spermatids: 1.9;Late spermatids: 1.1;Muller glia cells: 8.1;Spermatocytes: 1.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 203.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	10	"hippocampal formation: 12.3"	CAB012342	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"CAB012342: "	"unprognostic (1.09e-1)"	"unprognostic (2.52e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.75e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.13e-3)"						"unprognostic (1.02e-1)"	"unprognostic (3.30e-1)"		0.0	0.0	0.8	0.0	1.2	0.0	0.2	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	2.0	203.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	1.2	2.1	3.3	0.2	0.2	0.1	0.1	0.1	0.2	0.7	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZGRF1	"C4orf21, FLJ11331"	ENSG00000138658	"Zinc finger GRF-type containing 1"	Q86YA3	4	112539333-112636995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.0;Microglial cells: 17.8;Oligodendrocytes: 27.5;Spermatocytes: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA030704, HPA030706"	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA030704: AB_2673577, HPA030706: AB_10601784"	"unprognostic (8.48e-2)"	"unprognostic (6.17e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.83e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.72e-3)"	"unprognostic (7.60e-10)"	"unprognostic (3.45e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-4)"	1.0	0.7	0.9	2.0	1.4	7.8	1.3	2.2	1.5	0.9	0.1	1.1	1.2	1.2	0.3	1.0	0.8	0.5	0.7	0.8	0.7	0.5	0.6	0.9	2.5	1.3	0.9	1.1	0.7	0.3	1.3	1.7	1.3	0.9	1.4	4.3	0.9	0.4	1.2	1.4	1.5	0.9	1.0	1.8	0.9	3.6	1.0	5.2	0.8	0.6	2.9	0.7	0.8	2.1	5.0	3.6	12.1	8.6	0.9	1.6	4.7	8.8	3.7	8.7	7.8	6.9	7.3	13.2	2.5	2.7	3.6	4.0	12.7	4.7	10.0	7.3	3.1	8.3	5.8	2.1	0.4	18.5	5.3	0.8	0.6	11.0	3.0	1.2	3.5	13.6	12.0	14.3	6.0	8.2	25.0	6.7	6.3	5.2	4.2	13.8	18.1	4.5	1.5	4.4	5.6	9.5	3.9	5.3	1.7	8.8	2.5	5.4	4.2	10.9	10.6	5.9	7.1	5.5	10.1	17.0	4.9	6.3	6.3	0.0	0.1	0.3	0.2	0.7	0.1	0.3	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.2	0.1	0.7	0.2	0.1	0.9	1.4	2.2	1.5	0.8	0.7	1.3	0.9	1.3	1.0	1.0	2.1	3.3	0.0	1.3	10.4	5.4	0.0	1.3	0.0	0.6	10.4	2.1	1.7	2.4	0.0	3.7	1.8	8.4	3.5	10.4	2.1	0.0	1.0	2.9	1.8	3.5	1.9	1.2	11.1	18.0	0.5	2.7	2.3	4.6	2.8	2.5	12.2	1.1	0.6	1.8	5.0	14.5	1.8	0.0	1.6	0.0	2.8	0.6	4.1	0.0	17.8	1.3	1.6	6.2	17.6	27.5	0.6	1.4	2.2	10.5	0.8	0.7	0.3	0.7	17.6	0.0	3.1	2.7	22.1	15.6	3.6	0.0	0.8	5.0	2.2	2.5	0.9
LARP7	"DKFZP564K112, HDCMA18P, PIP7S"	ENSG00000174720	"La ribonucleoprotein 7, transcriptional regulator"	Q4G0J3	4	112637107-112657592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation"	RNA-binding	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026842, HPA027930"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA026842: AB_10611116, HPA027930: AB_10601233"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	37.2	31.6	26.3	32.8	28.3	44.6	35.7	28.6	34.6	28.0	28.0	36.2	33.8	33.3	29.8	31.7	25.8	30.5	59.6	24.9	33.5	40.2	44.1	28.1	44.9	30.2	30.2	34.2	18.3	29.9	20.1	34.1	31.0	32.1	36.7	31.5	23.2	27.2	46.6	30.6	33.2	29.5	28.3	36.9	31.5	24.6	29.1	42.2	38.7	45.3	40.3	33.0	21.8	30.8	42.9	34.9	77.7	44.3	50.7	61.6	44.0	55.3	40.6	45.3	42.0	27.9	62.0	95.4	43.7	46.9	42.2	29.6	75.1	45.2	60.2	86.8	52.1	56.4	35.2	41.9	41.0	131.6	84.6	49.3	50.7	40.4	25.1	62.6	40.4	47.6	71.4	51.1	55.3	35.2	107.4	56.7	182.2	67.5	28.2	62.9	66.2	44.3	68.8	44.8	46.5	64.4	32.0	83.4	55.4	131.4	35.1	61.0	43.7	42.4	49.5	47.7	57.6	34.7	62.5	97.6	57.7	52.4	49.2	70.1	28.1	49.9	32.8	43.1	30.3	48.1	33.9	34.2	25.3	47.4	32.3	31.3	33.2	38.7	60.7	64.0	37.9	20.8	26.3	28.3	28.6	34.6	24.9	33.5	30.2	30.2	31.0	28.3	29.1	30.8	66.1	96.1	79.2	45.1	68.8	24.9	66.5	102.6	34.1	61.3	48.3	50.4	113.2	95.8	91.6	47.8	29.2	79.0	88.7	83.2	111.6	69.3	17.6	78.7	70.5	63.2	38.9	43.6	18.0	64.4	70.2	60.6	32.1	58.8	104.4	51.5	81.4	160.9	70.4	58.9	19.9	79.7	61.1	93.7	27.1	14.9	94.4	67.2	24.9	32.8	96.0	107.1	107.1	20.6	43.1	62.0	85.6	100.1	39.1	38.8	73.1	117.0	109.8	54.1	118.3	74.5	68.3	83.5	87.8	33.3	20.9	100.4	65.9	74.2	75.6	47.9
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 159.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 272.6"					"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	28.6	25.6	52.7	26.6	45.1	5.7	21.0	45.8	52.0	18.9	1.6	36.4	28.8	23.5	9.8	29.7	18.8	30.7	159.3	60.2	23.9	19.3	37.3	22.9	35.2	11.8	33.9	25.4	15.2	56.5	9.1	19.8	12.6	32.2	39.1	79.2	13.4	41.7	105.1	15.8	34.1	24.9	21.0	18.4	37.1	19.8	46.7	16.3	23.7	60.0	31.4	27.4	19.7	22.9	4.8	62.5	67.5	22.8	144.0	272.6	24.0	145.4	96.3	56.0	48.0	42.3	17.6	91.2	20.7	102.3	70.7	2.1	42.6	22.8	56.6	35.1	10.8	0.0	22.0	49.2	73.0	0.1	0.2	176.3	30.5	43.5	107.1	88.5	50.6	11.3	3.6	39.4	106.8	17.1	9.3	3.6	9.8	60.3	22.8	17.9	79.0	0.4	57.3	42.7	18.2	18.3	20.0	29.3	19.5	55.9	0.6	23.7	30.7	146.9	34.8	63.6	29.1	30.4	16.5	76.7	75.7	5.5	70.8	0.0	12.7	0.0	6.7	7.0	12.7	11.2	6.6	7.5	15.7	22.6	7.4	6.5	0.9	9.7	2.5	0.1	13.2	7.7	52.7	45.1	45.8	52.0	60.2	23.9	11.8	33.9	12.6	21.0	46.7	22.9	43.7	41.7	37.6	128.3	55.1	18.4	16.6	8.3	22.8	83.3	14.0	17.1	272.9	62.9	24.7	29.5	87.6	0.5	19.0	70.9	5.9	8.4	3.2	18.2	35.2	27.2	103.8	3.6	182.9	20.1	0.4	50.1	71.9	47.0	10.1	13.0	24.3	57.2	18.6	72.3	200.0	88.1	14.2	17.3	22.3	6.2	20.2	31.5	5.4	187.4	16.0	35.9	28.8	203.1	128.0	11.6	57.3	19.9	20.4	36.2	52.4	23.1	21.7	74.0	6.6	32.8	44.4	3.1	3.4	37.1	31.8	1.1	27.8	12.3	48.6	27.5
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Astrocytes: 44.1;Basal prostatic cells: 60.3;Prostatic glandular cells: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 46.4;HUVEC TERT2: 42.2;LHCN-M2: 42.8;TIME: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	1.8	1.3	1.5	1.3	1.1	0.0	1.0	5.0	1.4	4.5	0.2	2.4	0.6	2.0	0.9	3.1	2.8	3.6	2.5	1.2	0.9	2.7	1.7	3.3	0.6	0.9	1.1	2.0	1.1	3.0	0.7	4.3	0.7	3.9	3.3	0.6	5.8	2.2	0.2	0.7	0.7	2.2	0.6	0.2	3.5	0.1	1.9	1.5	0.7	0.6	0.3	3.8	2.1	1.1	2.7	5.3	0.6	0.0	10.1	20.5	0.0	46.4	35.5	29.0	11.3	1.3	3.4	0.0	5.7	22.6	10.3	5.0	0.2	11.7	36.2	0.0	2.1	0.0	4.2	0.0	30.6	0.0	0.0	12.7	11.5	19.7	40.0	20.5	42.2	0.0	0.0	0.0	42.8	0.4	0.0	0.0	1.5	0.0	8.4	0.0	5.1	0.0	38.0	0.0	0.0	1.7	3.1	0.5	2.2	7.5	0.2	0.0	53.6	33.3	8.7	5.0	22.3	0.0	0.0	0.0	16.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	5.0	1.4	1.2	0.9	0.9	1.1	0.7	0.6	1.9	1.1	0.7	35.3	9.8	44.1	0.2	2.9	60.3	23.7	15.9	0.2	4.7	2.9	1.3	11.5	10.8	25.8	0.0	0.3	0.1	7.0	0.0	9.2	0.0	6.2	21.1	4.3	23.4	0.0	27.1	0.9	0.2	13.6	4.6	8.2	0.0	0.0	4.2	1.2	0.5	1.7	1.5	17.3	16.2	0.3	1.6	0.3	2.5	0.3	3.6	7.5	0.0	6.8	1.0	3.0	0.5	5.2	5.0	1.5	0.0	49.6	0.1	4.1	4.6	0.2	0.0	8.6	10.5	0.1	0.3	16.9	1.1	0.4	0.6	3.3	4.1	25.6
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 266.4"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	58.6	4.6	153.7	1.1	4.6	166.2	94.5	7.0	9.7	26.8	30.3	3.8	0.3	1.5	4.4	11.0	0.3	66.2	94.7	31.0	0.2	1.1	4.9	220.9	132.8	0.4	8.5	0.2	0.2	0.2	200.6	0.5	27.7	2.2	7.3	0.7	0.5	2.2	27.7	1.6	139.2	1.7	16.8	5.0	132.4	0.6	13.5	0.4	5.0	0.6	0.6	266.4	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	58.6	153.7	166.2	94.5	66.2	94.7	220.9	132.8	200.6	139.2	132.4	266.4	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 9.0"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 29.3;Oligodendrocyte precursor cells: 15.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"hypothalamus: 2.3;medulla oblongata: 8.3;midbrain: 3.5;pons: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;CACO-2: 3.7;RH-30: 14.5;T-47d: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011129	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	8.3	3.5	1.5	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.7	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.2	0.6	2.3	8.3	3.5	9.0	0.6	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	15.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0
MTRNR2L13		ENSG00000270394	"MT-RNR2 like 13"	S4R3P1	4	116298876-116300320	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;choroid plexus: 1.7;skeletal muscle: 1.5"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 176.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	6	"HeLa: 4.3;Hep G2: 1.8"														"Secreted - unknown location"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"								"unprognostic (6.40e-2)"					"unprognostic (2.88e-1)"			"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"				0.2	0.6	1.8	0.0	1.8	0.1	0.0	1.8	3.0	0.0	1.7	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.9	1.9	1.8	0.6	0.3	0.1	0.0	1.8	1.8	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	1.5	0.1	0.2	0.0	1.8	0.0	0.1	0.1	1.8	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.1	0.4	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	4.3	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	1.8	1.8	1.8	3.0	1.9	1.8	1.8	1.8	1.8	1.8	1.8	1.8	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.0	176.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.8	0.0	0.0	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.7
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.8;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 13.5;Spermatogonia: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.0;U-138 MG: 11.0;U-266/70: 9.1"	"Low region specificity"	"Detected in all"							HPA044560	Uncertain		Uncertain	Mitochondria		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	1.2	2.4	4.7	0.5	6.0	0.0	4.2	5.4	7.0	2.5	2.9	1.2	0.4	1.9	6.0	0.8	3.9	1.7	1.0	4.9	6.1	6.9	0.1	1.6	0.5	5.7	5.5	2.2	2.9	2.4	3.2	0.6	6.1	4.3	1.1	5.5	1.4	2.5	0.3	2.4	0.6	2.0	5.5	0.6	1.9	3.6	6.0	0.2	4.9	0.6	0.4	1.1	0.8	6.5	1.4	0.9	4.2	2.1	0.0	0.0	0.0	0.6	0.4	0.9	2.5	0.1	5.0	0.0	0.5	1.1	5.4	0.1	2.0	2.3	3.4	0.0	0.1	1.2	1.2	0.5	1.2	1.3	0.0	4.5	1.9	1.1	0.0	3.5	0.0	0.0	0.0	2.6	7.0	0.3	2.3	0.0	0.3	0.0	1.1	0.0	5.5	0.0	0.7	0.3	2.4	9.0	0.0	3.6	4.5	2.2	6.2	1.3	3.0	11.0	4.8	0.1	1.7	9.1	2.1	0.0	4.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	6.0	5.4	7.0	4.9	6.1	5.7	5.5	6.1	5.5	6.0	6.5	0.6	0.0	1.5	2.6	0.5	0.9	0.3	0.3	1.8	6.8	2.8	2.0	0.7	0.0	1.6	1.8	4.2	1.9	0.0	0.0	1.9	2.3	0.3	0.5	2.2	2.0	0.0	0.0	3.0	0.7	0.4	2.5	0.0	0.5	0.0	1.5	0.0	0.0	0.3	5.0	3.8	0.3	2.0	0.0	0.4	0.1	0.9	0.1	3.6	0.0	0.0	3.3	0.0	8.0	13.5	0.6	0.0	1.9	0.0	0.9	0.0	2.1	2.3	3.1	0.0	1.7	0.8	1.9	6.2	1.5	1.4	0.3	0.1	1.8	0.1	0.1
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 4.8;liver: 1.3;lymphoid tissue: 2.9;retina: 2.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 299.6;Inhibitory neurons: 128.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.0	0.5	1.2	0.0	4.8	0.0	0.0	3.3	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	1.0	0.1	1.3	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.4	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.8	3.3	2.8	1.5	1.0	0.6	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	299.6	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.6	0.1	6.7	128.6	0.2	0.0	42.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.1	18.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.6	0.5	1.4	1.6	0.9	0.1	2.2	0.6	1.3	14.5	14.4	6.7	2.7	1.9	0.6	3.2	10.5	9.8	0.0	2.7	0.5	0.8	0.6	7.6	0.1	0.5	1.9	1.6	7.7	0.1	0.6	10.6	0.7	1.4	6.4	0.3	2.5	2.0	0.2	5.9	4.8	1.3	0.5	0.0	9.2	10.0	1.2	1.0	0.2	1.2	5.7	3.8	12.6	0.5	5.2	0.2	1.8	0.0	0.2	13.3	0.1	46.0	41.5	9.7	16.1	0.1	18.7	0.0	0.2	70.2	4.9	0.8	31.1	9.5	12.7	0.2	7.2	0.0	3.6	0.0	1.4	0.0	0.2	4.1	17.5	3.4	9.9	31.2	0.1	0.6	0.0	0.0	8.0	0.3	0.5	9.6	2.2	36.4	2.9	0.0	38.7	0.0	0.0	7.0	5.1	215.4	0.0	0.2	3.0	30.9	0.0	100.6	0.0	19.2	2.8	12.2	9.1	1.0	0.1	0.0	1.0	3.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.6	1.3	2.7	0.5	0.5	1.9	0.7	0.5	1.2	0.5	0.3	6.4	4.6	0.7	0.2	8.4	0.8	16.4	2.2	0.6	0.8	0.8	1.4	10.0	34.3	1.8	0.0	48.0	0.0	26.8	0.0	0.4	9.9	19.7	16.8	0.9	5.3	0.0	10.5	10.2	4.5	7.1	17.9	2.6	7.0	3.3	0.0	0.4	3.8	0.0	14.3	2.7	10.2	0.0	4.2	18.3	0.0	0.4	5.4	7.5	0.0	0.0	0.0	0.5	0.2	8.1	12.8	0.0	0.2	0.4	9.4	0.6	76.1	0.2	0.0	0.6	4.9	10.1	13.3	3.6	4.3	11.9	0.7	21.8	5.3	4.7
METTL14	KIAA1627	ENSG00000145388	"Methyltransferase like 14"	Q9HCE5	4	118685392-118715433	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038002	Supported		Supported	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA038002: AB_10672401"	"unprognostic (4.48e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (7.76e-3)"	8.9	8.8	5.2	8.6	6.0	19.5	11.5	6.8	6.3	8.8	5.5	8.8	8.8	11.7	10.7	8.9	8.8	7.7	8.3	4.8	6.3	10.2	14.9	9.1	11.6	5.5	5.2	12.7	7.8	10.9	8.2	9.0	6.3	9.7	8.2	11.7	7.6	8.0	8.4	10.9	9.2	9.2	5.4	10.8	7.9	15.1	5.7	12.5	10.6	7.7	11.0	8.5	7.9	7.4	19.6	8.9	19.0	17.8	11.7	14.7	13.8	17.1	13.0	12.6	14.4	12.9	22.8	22.0	9.8	12.0	12.6	9.4	16.2	14.1	16.1	17.5	9.8	18.5	11.4	14.4	13.3	30.2	21.2	13.1	15.8	14.6	9.6	16.5	11.5	17.4	20.1	18.2	17.5	13.2	29.7	24.7	16.2	16.7	7.7	16.8	23.7	11.2	13.8	12.7	15.4	17.3	12.0	22.0	17.2	17.2	10.0	28.5	15.8	18.1	16.6	16.3	13.7	15.2	17.0	24.9	12.9	16.5	15.1	37.7	12.8	29.0	17.0	19.6	19.3	24.3	17.8	17.7	15.3	25.3	21.0	19.0	10.3	21.8	23.7	12.1	20.8	13.7	5.2	6.0	6.8	6.3	4.8	6.3	5.5	5.2	6.3	5.4	5.7	7.4	18.6	25.6	25.9	14.7	20.6	10.8	18.3	10.6	16.5	16.8	13.4	12.6	15.7	17.2	20.8	23.9	22.9	18.7	28.3	13.7	11.7	11.9	96.9	14.5	21.7	17.3	12.1	8.4	18.7	15.6	10.2	16.8	9.2	18.0	22.1	18.3	16.4	32.1	12.1	8.4	17.0	15.2	6.1	17.9	7.6	16.7	18.6	13.3	7.2	14.0	14.0	13.4	25.7	14.1	26.9	14.8	13.0	13.9	8.2	17.1	15.4	20.6	15.2	25.4	13.1	15.3	15.5	42.2	28.1	12.4	11.9	15.3	20.6	17.0	12.8	16.0
SEC24D	KIAA0755	ENSG00000150961	"SEC24 homolog D, COPII coat complex component"	O94855	4	118722823-118838683	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041626, HPA053486"	Approved		Approved	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA041626: AB_10796348, HPA053486: AB_2682166"	"unprognostic (9.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (3.42e-6)"	"unprognostic (1.09e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	21.1	13.3	2.7	27.2	3.3	17.6	19.4	1.1	4.4	49.0	4.5	24.4	37.5	26.4	36.9	12.4	20.7	31.9	20.1	5.5	4.6	9.5	52.0	22.9	18.4	1.3	2.3	15.3	35.8	10.2	23.3	36.8	1.6	22.0	32.3	1.6	22.9	26.4	5.8	9.9	40.8	41.3	0.6	18.0	29.6	18.4	2.8	14.6	35.6	6.1	21.9	28.9	16.7	2.6	29.6	15.4	35.3	28.6	98.0	130.2	24.8	124.5	136.8	62.1	73.5	16.9	21.3	23.2	17.3	198.7	32.1	10.0	19.4	39.2	66.8	19.4	10.5	25.7	22.8	70.6	99.8	68.6	46.0	77.9	21.6	54.9	89.2	110.3	103.9	15.8	6.7	69.1	98.5	20.6	33.2	20.4	33.3	66.5	24.8	20.1	25.8	41.2	55.6	14.7	20.9	41.8	17.8	89.1	15.3	50.9	12.6	53.9	113.9	48.0	15.3	69.7	28.6	53.1	21.1	38.6	104.5	42.8	68.5	5.8	5.6	16.3	3.1	6.0	6.3	1.7	3.2	4.4	5.8	1.5	2.1	2.7	4.8	5.0	7.4	2.9	4.7	2.6	2.7	3.3	1.1	4.4	5.5	4.6	1.3	2.3	1.6	0.6	2.8	2.6	13.0	3.2	15.3	4.9	19.4	21.0	15.2	19.4	25.6	4.5	19.0	10.2	5.9	17.2	25.5	14.7	0.0	24.3	24.2	18.2	0.0	10.3	101.3	17.4	61.3	23.2	41.3	6.1	57.4	25.3	54.2	49.7	37.2	39.4	8.2	14.2	21.8	70.0	28.1	1.7	6.5	81.0	12.2	34.0	54.4	84.6	45.7	25.1	17.8	48.7	18.3	1.3	13.4	37.7	3.7	13.0	13.6	38.4	118.8	30.7	48.1	4.2	23.0	2.9	26.3	17.5	38.7	14.5	9.7	10.4	17.6	45.0	16.3	34.2	19.1	40.1
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
MYOZ2	"C4orf5, CS-1, FATZ-2"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135832-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 771.4;skeletal muscle: 225.5;tongue: 173.4"	"Cell type enriched"	"Detected in some"	51	"Cardiomyocytes: 2275.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	0.6	0.3	0.2	0.0	0.3	0.0	2.1	0.1	0.5	0.7	0.0	1.0	0.0	2.0	0.3	1.0	1.0	0.3	771.4	0.2	0.3	0.7	0.1	0.9	0.3	0.2	0.2	0.6	0.1	0.0	0.2	0.2	0.1	4.8	0.1	0.0	1.8	0.3	225.5	0.5	0.4	0.8	0.2	0.6	0.6	1.0	0.3	0.3	0.3	173.4	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2275.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	20.8	0.0	0.0	3.4	2.2	0.0	44.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.7	0.0	0.2	0.0	2.9	0.0	0.0	6.6	6.9	22.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 586.8;Microglial cells: 269.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 327.9;SK-MEL-30: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	37.8	14.4	5.6	5.7	5.8	0.9	25.3	6.1	6.2	18.5	11.8	16.3	5.7	13.1	13.1	17.0	30.6	10.2	24.0	4.9	7.3	19.9	7.3	29.4	12.4	9.4	8.1	9.4	24.6	8.1	10.3	10.5	7.3	9.2	16.1	3.4	12.7	11.5	33.5	11.7	9.7	10.2	6.5	7.2	15.1	7.8	8.6	5.4	10.5	51.7	8.0	12.7	12.0	5.5	11.4	6.8	2.4	0.0	60.5	60.4	13.6	70.6	327.9	6.2	8.1	7.4	10.4	46.1	2.5	21.1	12.1	5.5	5.5	5.3	16.1	6.1	4.5	3.1	5.2	2.6	47.2	3.9	0.7	20.3	15.0	21.9	31.0	11.7	29.8	3.0	7.3	1.7	8.4	2.5	2.9	5.2	6.7	7.0	3.8	0.9	11.4	9.2	16.4	7.2	3.8	3.0	3.9	27.5	102.4	13.3	7.0	2.7	32.3	2.0	7.0	26.3	6.4	3.3	5.2	7.8	31.4	1.7	7.9	1.3	0.0	0.0	0.4	0.0	0.5	0.7	1.0	0.8	0.1	0.7	1.9	1.0	0.2	0.9	0.0	0.3	0.9	0.3	5.6	5.8	6.1	6.2	4.9	7.3	9.4	8.1	7.3	6.5	8.6	5.5	27.6	35.3	44.5	80.6	18.5	61.8	73.6	21.2	48.3	17.8	74.1	46.6	99.0	32.9	33.9	119.5	29.2	48.4	15.1	207.8	45.0	33.4	5.6	167.2	45.9	35.7	34.6	4.8	32.4	62.7	17.3	86.0	41.8	586.8	70.8	19.8	23.9	30.5	9.3	25.2	32.5	80.4	52.9	21.3	76.4	7.3	19.0	36.5	14.2	269.8	45.6	25.0	12.3	11.6	11.9	110.6	214.5	10.9	18.6	138.6	46.0	20.1	27.3	31.5	6.6	91.8	32.9	18.0	4.0	62.6	42.3	49.8	26.8	14.8	62.6	124.8
C4orf3	"ALN, HCVFTP1"	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	80.0	67.8	96.4	54.1	107.1	34.1	69.4	103.1	148.1	123.2	83.3	80.2	60.5	79.7	77.9	268.2	68.9	65.1	107.8	90.1	99.6	97.9	110.8	70.3	61.3	107.9	104.9	85.5	51.5	55.5	56.6	60.3	106.4	71.8	43.6	74.7	89.6	69.8	79.6	89.3	67.3	70.6	109.6	63.1	49.6	39.8	109.2	64.8	71.4	59.7	56.8	75.9	150.2	112.8	116.8	13.7	58.4	49.8	107.1	97.0	34.1	59.3	31.6	35.3	62.6	15.6	44.5	95.9	36.6	87.3	31.0	24.8	29.6	54.1	61.8	57.1	21.3	40.9	33.5	67.9	35.9	64.7	42.8	96.4	64.5	30.0	14.4	120.6	52.8	29.1	33.8	50.4	137.6	41.8	50.9	64.0	24.2	60.7	20.9	32.9	62.6	27.3	53.5	32.2	38.4	54.8	46.4	58.5	43.2	56.9	32.6	37.5	55.7	80.3	34.6	52.5	21.4	51.3	59.8	37.2	156.7	36.7	40.9	257.8	110.0	145.4	85.1	132.6	92.9	126.7	109.6	101.5	95.1	104.8	120.4	114.4	239.4	109.6	128.0	131.6	112.9	157.1	96.4	107.1	103.1	148.1	90.1	99.6	107.9	104.9	106.4	109.6	109.2	112.8	213.2	157.0	150.5	11.4	211.3	315.5	292.0	809.1	132.1	79.1	198.4	191.9	544.4	158.7	456.3	222.5	25.0	321.5	228.9	117.0	383.5	288.5	38.1	272.5	148.7	245.6	68.4	78.6	22.2	179.1	403.9	215.0	46.4	134.3	186.1	108.0	234.9	446.4	317.4	153.1	21.6	170.2	408.9	303.5	298.4	31.0	167.4	244.9	199.3	16.9	423.9	233.4	253.3	6.6	16.3	207.6	196.8	215.5	239.0	392.5	500.1	1070.2	542.7	78.9	197.2	145.8	246.0	182.7	67.0	245.9	346.6	445.7	203.2	150.3	135.8	428.1
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055623-120066858	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.9;lymphoid tissue: 5.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	0.3	0.4	0.5	2.1	0.6	5.9	1.2	0.8	0.7	0.5	0.2	2.2	1.8	0.7	0.3	1.6	1.4	0.4	0.5	0.5	0.5	0.4	0.5	0.4	4.0	0.4	0.4	0.5	0.2	0.4	0.1	1.4	0.5	0.6	2.6	1.0	0.3	0.5	0.2	1.0	1.9	0.8	0.4	0.8	0.9	2.3	0.4	5.7	0.4	0.2	3.6	0.7	0.5	0.6	27.2	11.6	26.9	17.5	2.8	3.4	11.5	21.0	11.8	21.5	16.5	15.7	16.3	39.6	6.8	7.6	9.5	7.1	27.1	16.1	30.0	18.8	18.8	22.0	10.5	14.9	0.8	36.3	12.0	1.9	2.3	14.6	9.1	5.4	12.6	16.4	26.7	22.0	11.4	12.0	35.0	15.6	18.3	14.1	13.0	17.8	35.9	16.2	8.7	10.3	28.4	20.1	10.5	12.8	6.5	12.9	8.4	13.0	7.8	14.2	16.1	14.6	27.0	20.1	23.2	25.7	13.3	18.4	19.1	0.9	0.1	0.1	0.4	0.1	0.6	0.5	1.2	1.0	0.1	0.4	1.1	1.1	0.3	0.9	0.2	0.7	1.3	0.5	0.5	0.6	0.8	0.7	0.5	0.5	0.4	0.4	0.5	0.4	0.4	0.6	2.4	0.0	1.3	1.0	11.5	17.3	7.3	23.5	4.0	9.7	7.2	8.3	3.4	1.5	6.0	7.3	2.1	52.0	7.6	7.5	0.0	3.4	2.4	31.3	6.0	5.4	1.8	81.8	1.3	1.5	119.2	13.7	8.6	7.8	15.2	34.6	3.9	2.9	27.9	20.2	1.2	13.7	36.7	7.3	13.4	4.8	4.7	6.1	8.8	0.0	3.1	12.3	5.2	0.5	1.0	1.6	3.7	1.5	33.1	5.0	3.7	7.2	12.9	3.8	13.1	7.3	14.9	127.8	76.2	26.0	8.9	10.8	20.1	11.9	29.2	8.7
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"eosinophil: 7.5;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	3.0	4.0	1.8	1.6	2.0	3.5	3.0	3.2	2.0	5.2	4.2	3.2	1.3	6.0	2.8	2.2	4.6	2.4	3.0	1.6	3.2	1.9	0.4	4.2	0.9	4.1	4.0	10.3	4.8	8.6	3.9	3.5	4.0	4.1	2.9	4.7	1.8	4.3	1.6	1.5	1.8	4.4	4.7	2.4	2.1	3.6	2.9	1.4	5.8	3.0	0.8	2.9	3.3	4.4	2.2	3.4	7.8	0.1	4.5	9.3	9.2	4.7	9.9	4.7	4.2	4.4	1.2	0.4	1.2	6.2	4.5	0.1	0.0	1.0	6.0	0.0	1.4	2.9	3.1	0.3	4.9	10.0	0.1	6.6	2.9	3.3	4.1	4.3	3.4	1.2	0.0	14.2	5.7	0.4	1.5	0.1	5.7	0.8	2.7	0.0	9.3	6.1	1.6	0.0	1.4	6.2	0.0	0.1	0.9	4.0	6.4	4.1	1.4	0.2	2.7	4.8	4.6	13.0	19.7	0.1	3.6	0.1	3.6	0.1	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	1.8	2.0	3.2	2.0	1.6	3.2	4.1	4.0	4.0	4.7	2.9	4.4	7.1	12.8	5.6	51.2	0.5	1.7	2.7	2.4	9.1	9.1	1.1	2.4	8.2	2.8	3.8	1.8	8.4	1.0	0.2	1.5	1.9	2.3	75.6	1.4	9.4	6.3	3.6	0.0	25.0	2.5	2.6	9.6	2.6	1.4	2.5	15.5	3.6	0.0	0.8	0.0	31.9	3.6	4.1	0.3	0.7	31.0	8.7	0.6	1.8	23.4	0.2	7.6	0.0	52.8	8.0	1.5	0.8	9.4	0.7	2.6	0.1	0.2	1.8	7.5	6.6	10.1	6.6	8.2	3.5	4.6	1.7	0.5	1.2	14.9	3.0	0.7
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Disease related genes, Predicted secreted proteins"	Neurogenesis		"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 106.5;placenta: 60.1;retina: 57.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Bipolar cells: 69.8;Early spermatids: 217.1;Late spermatids: 221.7"	"Cancer enriched"	"Detected in many"	4	"lung cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 48.5;U-266/70: 20.8;U-266/84: 85.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 11.1;olfactory bulb: 34.0"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	4.8	2.6	1.1	0.9	1.7	0.0	3.2	4.7	1.2	14.2	9.3	6.5	2.9	6.0	4.3	7.7	20.4	9.4	5.2	1.8	2.6	27.1	0.4	106.5	0.3	8.8	12.9	42.5	0.5	0.7	5.3	60.1	15.2	16.7	8.3	57.4	2.2	4.4	4.3	1.7	4.7	3.5	7.6	0.3	4.1	10.4	3.7	2.4	1.3	14.0	0.2	9.0	1.9	5.4	0.2	0.0	10.6	0.0	13.9	11.3	0.2	0.2	0.5	0.2	0.5	1.6	0.0	0.0	0.0	48.5	0.8	0.0	0.0	0.0	1.1	0.9	1.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	14.3	1.0	0.0	0.2	0.1	0.9	7.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.6	0.2	0.0	0.0	11.5	0.0	0.2	0.5	20.8	85.8	0.0	3.9	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	4.7	1.2	1.8	2.6	8.8	12.9	15.2	7.6	3.7	5.4	10.9	246.8	48.3	1.6	0.0	1.1	0.0	0.0	0.0	69.8	0.2	0.1	1.6	8.6	28.6	12.9	18.8	0.3	0.0	5.3	0.0	0.0	217.1	0.9	4.7	11.7	1.8	0.0	0.0	0.2	0.0	14.9	0.0	0.1	2.5	0.1	2.9	0.0	0.1	1.7	8.0	0.8	0.0	0.0	0.8	221.7	3.4	0.4	5.4	6.5	0.0	12.2	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.0	12.5	20.0	0.0	1.2	3.6	6.4	5.0	0.3	0.9	0.5	0.3	13.0	1.2	0.1
TNIP3	"ABIN-3, FLJ21162, LIND"	ENSG00000050730	"TNFAIP3 interacting protein 3"	Q96KP6	4	121131408-121227466	"Predicted intracellular proteins"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.4;urinary bladder: 4.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.7;Distal enterocytes: 19.1;Early spermatids: 13.8;Late spermatids: 46.2;T-cells: 17.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 6.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;hTEC/SVTERT24-B: 8.0;U-138 MG: 30.9;U-266/70: 8.8;U-266/84: 9.3;U-87 MG: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043063	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA043063: AB_10793989"	"unprognostic (2.89e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.23e-3)"	"unprognostic (8.75e-5)"	"unprognostic (9.62e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.84e-7)"	"unprognostic (3.35e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.78e-2)"	0.7	0.1	0.6	6.4	0.6	1.0	0.1	0.4	0.9	1.3	0.0	0.5	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.9	0.5	0.2	0.4	1.6	2.6	1.9	0.4	0.1	0.2	0.0	0.0	0.0	2.2	0.1	0.4	0.9	0.7	0.0	0.5	0.2	0.9	0.5	0.1	0.9	0.7	0.6	0.4	1.9	0.1	0.0	3.2	4.2	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.3	0.1	0.4	0.5	0.1	0.1	1.1	0.1	0.1	0.2	2.8	4.6	0.0	0.0	0.7	0.9	7.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	8.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	30.9	0.6	2.5	0.1	8.8	9.3	0.2	6.3	0.3	1.0	0.6	0.1	0.0	2.5	0.0	1.8	0.0	1.1	6.2	0.0	0.1	0.5	2.8	0.3	0.0	0.1	0.0	0.7	0.6	0.6	0.6	0.4	0.9	0.9	0.5	1.9	0.4	2.2	0.1	0.4	0.8	0.2	3.2	21.7	0.7	1.8	0.1	0.2	5.7	0.0	0.0	0.4	0.1	0.6	0.0	4.9	0.0	6.2	0.0	2.4	19.1	0.0	0.2	13.8	0.0	0.1	1.4	0.0	0.0	1.5	1.1	0.0	0.3	2.0	0.2	7.0	0.0	0.0	0.0	0.3	0.0	0.4	0.5	4.1	0.8	2.7	46.2	0.3	9.5	0.0	0.0	0.1	0.3	2.1	0.5	0.1	0.7	3.7	0.0	2.4	0.1	0.0	0.1	1.7	1.3	0.0	0.7	1.1	0.4	0.4	0.0	0.4	0.0	17.8	0.0	9.8	0.1
QRFPR	GPR103	ENSG00000186867	"Pyroglutamylated RFamide peptide receptor"	Q96P65	4	121328642-121381059	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.2;Early spermatids: 2.1;Endothelial cells: 3.1;Excitatory neurons: 5.9;Inhibitory neurons: 10.9;Microglial cells: 2.8"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.6;hTERT-HME1: 4.7;RPTEC TERT1: 2.6;SCLC-21H: 1.7;U-2 OS: 3.7;WM-115: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA050236	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050236: "	"unprognostic (1.24e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.93e-2)"		"unprognostic (3.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.09e-4)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"		0.1	0.2	0.9	0.1	0.7	0.2	0.1	0.2	1.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.6	5.9	1.2	0.0	0.0	0.0	2.7	0.9	0.1	0.0	0.1	0.3	0.0	3.2	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.2	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.5	1.5	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.1	0.4	0.1	0.2	0.1	0.1	0.9	0.7	0.2	1.1	0.6	5.9	2.7	0.9	3.2	0.3	3.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	3.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667946-121696995	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1156.8;Extravillous trophoblasts: 1125.1;Syncytiotrophoblasts: 1140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		5000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	490.6	286.5	111.7	241.7	126.3	96.2	314.0	136.9	144.7	429.1	137.7	181.9	96.5	288.7	162.6	135.1	225.0	273.1	213.9	106.4	134.7	216.2	149.5	299.0	136.2	151.2	129.6	224.7	162.9	133.7	176.7	466.0	150.4	211.7	155.5	78.1	273.8	250.5	85.2	132.5	130.9	370.3	134.3	175.7	186.0	110.4	154.3	63.3	182.9	114.8	135.2	298.1	178.6	157.3	463.5	339.6	438.0	256.1	2094.3	1645.5	503.4	1582.7	1464.9	841.3	744.8	246.2	200.6	35.7	282.9	2224.8	581.7	165.4	287.3	727.6	762.2	335.1	171.2	105.0	281.6	647.4	1213.9	221.1	178.3	945.5	344.7	705.1	665.9	927.4	1120.9	25.2	106.0	271.8	2133.5	306.7	225.5	75.1	231.9	417.7	718.5	8.2	1014.5	72.6	1368.9	66.3	117.1	141.4	579.7	227.6	1515.2	872.3	201.5	261.2	830.6	1322.1	632.1	955.2	478.0	240.8	308.6	76.0	847.8	123.5	1586.2	122.2	725.8	359.9	104.8	830.5	136.0	127.3	158.8	131.9	745.6	89.5	51.3	74.6	157.9	48.4	798.0	91.2	289.9	773.3	111.7	126.3	136.9	144.7	106.4	134.7	151.2	129.6	150.4	134.3	154.3	157.3	286.5	243.6	233.9	13.7	85.0	199.3	266.4	395.9	76.2	6.8	101.6	107.4	88.3	265.9	257.2	132.4	25.0	1156.8	53.2	15.6	297.4	703.5	16.2	239.7	318.1	287.7	48.6	29.0	15.4	338.2	1125.1	564.7	91.3	312.6	148.7	177.5	186.4	54.8	753.2	13.5	7.1	110.9	187.2	446.5	705.1	41.4	379.9	544.0	352.2	45.0	412.5	161.4	13.4	23.1	26.8	501.1	31.2	366.3	203.1	473.8	15.3	194.3	268.9	30.0	295.9	443.1	377.2	15.9	28.6	101.1	140.8	1140.8	122.0	185.7	43.2	188.2
SMIM43		ENSG00000164112	"Small integral membrane protein 43"	Q4W5P6	4	121758881-121765427	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 8.3"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 16.7;Syncytiotrophoblasts: 4.5"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 8.3;cerebral cortex: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"MOLT-4: 3.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 24.8"											NA	NA					"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.0	0.0	0.4	0.0	8.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.3	0.0	2.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
BBS7	"BBS2L1, FLJ10715"	ENSG00000138686	"Bardet-Biedl syndrome 7"	Q8IWZ6	4	121824329-121870487	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 56.6"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 65.1;Inhibitory neurons: 58.6;Rod photoreceptor cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044592	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044592: AB_10795882"	"unprognostic (6.36e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.15e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.33e-1)"	6.9	6.4	7.3	5.3	7.7	2.1	6.1	9.8	12.4	7.9	2.6	6.3	5.0	10.5	4.9	6.2	7.9	5.9	4.7	7.7	6.4	6.7	2.4	5.3	5.0	8.9	7.8	12.4	3.7	9.1	9.1	4.7	8.7	6.8	6.3	56.6	4.8	6.6	3.8	6.8	5.3	10.3	5.1	4.6	4.8	9.1	8.4	6.4	5.5	5.5	4.8	5.8	6.9	8.9	13.7	6.6	14.9	10.9	18.8	27.2	5.4	18.3	14.6	15.5	14.2	5.2	7.4	15.0	5.1	21.7	11.6	7.1	15.5	14.8	17.6	14.4	12.1	8.9	10.0	6.2	16.7	12.7	8.0	14.0	10.6	17.7	13.3	20.2	16.8	10.0	6.0	14.8	22.1	4.3	21.3	6.1	7.9	8.3	8.2	9.7	19.3	4.6	15.7	4.8	16.4	7.0	17.5	7.7	14.0	19.7	6.5	4.7	16.9	11.6	12.5	16.2	11.8	13.9	10.3	13.1	13.4	10.0	11.6	0.6	1.0	1.7	1.9	1.1	1.5	0.9	1.5	1.8	1.2	0.9	1.2	1.6	0.2	2.0	1.2	1.2	1.6	1.0	7.3	7.7	9.8	12.4	7.7	6.4	8.9	7.8	8.7	5.1	8.4	8.9	15.7	6.4	8.4	12.7	6.9	8.7	10.8	13.7	5.7	16.6	6.0	9.3	8.4	4.3	13.0	11.0	47.9	8.5	6.6	6.4	13.7	14.6	22.2	14.4	19.9	11.2	6.1	9.5	65.1	9.8	21.5	14.4	6.1	10.6	15.2	9.2	8.6	5.0	11.4	16.8	58.6	8.2	16.2	6.3	6.1	12.9	13.1	7.7	8.8	16.9	6.3	12.6	5.2	30.7	26.4	15.6	5.1	11.3	5.6	9.3	6.0	15.1	16.5	68.9	19.7	12.2	15.2	39.6	22.4	10.9	8.5	5.7	10.7	11.4	8.4	8.6
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121874481-121952060	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.4;pituitary gland: 7.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 18.1;Inhibitory neurons: 82.7;Oligodendrocyte precursor cells: 33.7;Rod photoreceptor cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.3;Karpas-707: 2.6;U-2 OS: 1.5;U-251 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 57.8"	"Low region specificity"	"Detected in many"									NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	0.3	0.0	2.3	0.1	4.0	0.0	0.2	4.6	5.8	0.8	0.1	0.2	0.1	0.4	0.2	0.0	0.5	0.8	0.2	0.8	3.2	0.1	0.1	0.9	0.1	10.4	2.8	0.1	0.0	0.2	7.4	1.1	2.2	0.2	0.1	3.9	0.1	0.6	0.4	0.1	0.5	2.6	1.6	0.2	0.2	0.4	4.6	0.0	0.1	0.2	0.0	1.7	0.7	1.7	0.0	0.0	0.8	0.1	0.1	0.1	0.0	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.4	0.0	0.1	0.0	1.3	2.3	0.2	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	2.6	0.5	0.1	0.8	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	1.2	1.5	0.1	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.3	4.0	4.6	5.8	0.8	3.2	10.4	2.8	2.2	1.6	4.6	1.7	0.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.3	0.2	0.0	0.0	18.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.1	4.6	0.0	33.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	32.0	0.0	0.3	1.4	0.5	0.8	0.0	0.0	0.0	0.5	0.5	0.0	0.1
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152331-122362758	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 245.2;Inhibitory neurons: 246.5;Oligodendrocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	29.3	24.9	39.5	13.7	48.4	60.3	31.7	41.7	42.8	29.8	62.3	29.6	18.8	27.6	29.8	17.5	27.2	19.8	22.9	36.0	38.5	27.8	21.3	28.2	19.8	48.4	39.1	41.6	24.8	56.3	47.1	17.5	44.6	21.9	22.1	82.4	22.4	21.7	55.5	28.7	28.3	22.1	35.4	26.4	23.3	26.6	44.0	23.1	31.5	42.2	16.8	24.5	25.6	60.5	30.5	9.5	22.3	14.8	36.3	46.7	11.6	13.5	25.3	13.6	14.9	7.2	15.7	15.9	7.6	32.2	18.4	11.2	13.7	16.7	22.0	12.1	8.8	17.7	18.4	13.7	18.9	16.7	9.4	27.2	19.6	16.4	22.3	37.2	29.3	17.0	11.6	18.8	28.5	10.3	14.5	13.0	7.4	14.6	10.7	8.2	30.8	4.1	24.1	22.6	13.0	11.6	8.4	9.7	18.8	35.8	10.6	13.5	39.8	16.8	16.7	14.0	14.0	18.1	12.5	11.5	17.8	14.4	12.6	1.8	0.7	4.3	1.6	1.8	1.7	1.2	1.1	1.1	0.7	1.8	0.9	1.1	3.3	1.0	0.9	1.1	1.6	0.4	39.5	48.4	41.7	42.8	36.0	38.5	48.4	39.1	44.6	35.4	44.0	60.5	94.6	86.6	42.8	245.2	36.0	20.9	22.0	19.8	26.2	126.0	36.2	27.6	69.2	22.8	35.9	42.3	125.1	12.0	59.6	42.4	1.9	13.8	35.1	34.3	52.8	47.2	21.6	27.1	194.0	17.5	7.0	41.2	59.7	47.2	21.5	64.4	35.0	24.1	12.7	92.5	246.5	27.3	20.3	30.1	17.5	27.7	51.3	41.0	16.0	153.6	32.5	60.9	26.8	161.9	239.9	20.7	34.9	50.8	47.9	19.3	50.0	10.3	33.1	145.0	32.9	63.1	54.9	63.2	33.9	28.9	24.4	13.0	52.0	34.0	32.0	23.0
ADAD1	Tenr	ENSG00000164113	"Adenosine deaminase domain containing 1"	Q96M93	4	122378966-122429802	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	573	"testis: 119.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 1043.4;Late spermatids: 988.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"																		"unprognostic (1.37e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	119.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1043.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	988.3	8.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	248.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Melanocytes: 3.6;T-cells: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300					"Cluster 7: Non-specific - Mitochondria"			"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.4	0.0	0.0	0.0
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122610108-122621066	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"lymphoid tissue: 5.9"	"Group enriched"	"Detected in some"	18	"Early spermatids: 13.7;Late spermatids: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	55700			"Cluster 16: Immune cells - Immune response"		"Cluster 34: Spermatids - Unknown function"											"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0
BBS12	"C4orf24, FLJ35630, FLJ41559"	ENSG00000181004	"Bardet-Biedl syndrome 12"	Q6ZW61	4	122732702-122744942	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.0;Rod photoreceptor cells: 37.1;Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061856	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA061856: AB_2684626"	"unprognostic (9.59e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (5.69e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (9.89e-6)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	2.6	2.5	2.6	1.4	3.0	0.3	2.7	1.8	3.1	3.0	4.6	2.4	2.5	2.7	4.7	1.5	5.0	1.9	3.7	2.7	3.5	9.4	0.9	2.3	1.5	2.3	2.7	2.7	1.7	7.9	3.7	2.0	2.5	1.7	1.9	17.6	1.8	2.9	0.6	1.3	2.5	2.6	2.3	1.8	1.5	7.8	3.4	1.8	9.3	0.9	1.6	1.9	1.5	2.2	1.8	1.8	2.8	3.3	8.3	10.1	1.1	2.5	4.6	3.3	3.4	1.2	2.9	1.1	2.0	3.7	3.6	1.4	2.2	3.2	3.3	4.0	1.9	0.4	2.6	1.2	5.6	1.2	1.8	7.2	8.2	4.3	6.1	11.4	3.6	2.0	4.2	1.3	4.5	1.2	2.3	0.8	1.6	1.2	1.5	1.4	7.7	0.6	7.8	0.5	1.7	3.2	3.7	0.8	2.9	5.8	1.1	1.1	3.4	2.8	1.5	2.6	1.4	2.2	1.2	0.8	4.2	0.9	4.6	0.9	1.2	2.0	1.4	1.6	1.7	2.1	1.8	2.1	1.2	0.9	1.9	1.8	0.0	1.2	2.1	1.2	1.9	1.2	2.6	3.0	1.8	3.1	2.7	3.5	2.3	2.7	2.5	2.3	3.4	2.2	1.3	6.4	1.1	1.6	0.7	1.0	1.2	1.9	0.6	6.1	1.5	1.4	3.9	1.5	2.5	0.0	2.1	6.8	0.4	3.5	3.9	5.5	57.0	7.5	3.1	2.4	3.0	2.7	5.4	2.7	1.7	2.4	1.5	1.9	1.3	3.4	3.3	0.9	1.9	3.3	4.1	2.0	4.1	1.6	1.4	12.0	4.1	0.9	5.4	1.9	1.4	11.7	1.0	4.5	0.9	4.5	5.9	6.8	0.6	1.0	7.4	17.4	12.7	37.1	6.6	1.2	2.3	33.2	4.4	0.9	1.0	4.4	1.2	5.8	2.0	0.7
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	24.3	2.6	14.8	5.3	16.1	0.1	9.5	12.2	14.7	8.7	14.2	14.1	1.7	14.2	4.5	4.7	8.0	7.1	5.0	12.2	18.8	4.0	2.0	8.3	1.8	18.6	20.5	12.6	1.5	4.7	3.2	6.4	15.6	7.6	4.0	3.4	3.5	8.7	1.4	1.9	3.7	12.6	16.8	1.1	6.2	1.9	18.3	1.6	2.4	4.8	1.8	14.8	6.1	13.3	4.7	14.1	7.8	30.5	18.8	31.1	0.0	243.8	148.4	104.3	60.2	0.2	0.4	0.0	20.5	278.2	81.8	0.7	8.1	0.5	104.3	12.3	3.3	0.0	28.7	0.2	55.3	1.4	0.1	16.8	1.7	103.6	147.6	52.0	11.8	0.0	6.9	8.4	27.4	0.1	0.1	0.2	21.6	0.1	5.4	0.0	3.9	0.1	33.0	0.0	4.4	4.0	48.4	0.1	2.0	44.7	0.1	0.5	10.6	85.7	12.2	32.0	20.0	8.6	10.3	0.0	24.7	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	16.1	12.2	14.7	12.2	18.8	18.6	20.5	15.6	16.8	18.3	13.3	33.7	6.4	0.0	111.0	0.3	1.7	1.6	0.8	2.8	4.6	4.5	8.9	4.7	0.0	1.3	7.3	0.0	2.7	0.4	0.0	3.9	8.2	10.9	1.5	40.6	11.5	1.8	0.4	1.8	1.0	0.1	77.1	0.0	1.6	0.0	5.7	17.2	1.3	0.5	0.0	6.6	0.0	0.0	0.0	2.4	3.8	9.9	1.7	5.4	15.9	0.6	9.3	0.0	42.3	5.8	11.0	0.0	8.2	1.6	16.0	0.0	0.6	0.0	2.0	0.0	15.2	14.2	4.7	1.1	0.3	1.3	4.8	0.5	0.1	0.0	2.0
NUDT6	"FGF-AS, FGF2AS, gfg, gfg-1"	ENSG00000170917	"Nudix hydrolase 6"	P53370	4	122888697-122922968	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 37.2;Early spermatids: 36.7;Proximal tubular cells: 46.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039202, HPA066115"	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039202: AB_10795032, HPA066115: AB_2685620"	"unprognostic (7.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.91e-6)"	"unprognostic (1.13e-5)"	"unprognostic (2.32e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-1)"	4.9	10.7	8.2	2.8	9.4	2.2	5.3	5.8	10.6	4.2	6.6	7.7	4.4	4.1	7.1	3.3	6.7	3.6	13.0	8.4	8.2	19.4	27.3	3.2	3.9	6.0	7.3	4.2	4.0	7.4	6.4	3.2	6.1	3.7	6.2	8.3	5.2	4.3	10.0	4.2	3.7	3.5	5.9	4.5	3.3	7.1	9.0	4.8	7.3	10.9	2.3	3.2	3.2	7.8	5.4	7.9	11.5	10.3	10.3	10.7	4.1	6.1	8.1	5.3	7.3	3.4	12.1	5.6	4.5	3.3	11.7	2.7	5.1	4.8	5.4	13.5	3.4	5.0	7.6	9.2	3.8	10.4	3.0	6.6	2.1	4.6	4.0	9.8	7.0	9.7	12.8	13.8	9.0	6.3	14.5	11.2	4.3	20.8	9.9	4.9	14.6	6.4	12.7	3.2	6.1	7.6	6.3	8.5	12.5	13.3	5.6	8.3	4.4	12.8	6.7	11.2	5.6	15.4	12.9	10.7	7.7	15.4	5.8	0.0	2.0	0.0	1.5	2.8	1.9	4.0	2.0	2.6	4.4	1.2	1.5	1.7	0.3	1.3	2.5	1.7	2.3	1.8	8.2	9.4	5.8	10.6	8.4	8.2	6.0	7.3	6.1	5.9	9.0	7.8	7.0	16.0	7.8	10.7	2.0	0.9	3.1	9.3	4.6	12.5	4.7	6.9	5.3	4.3	5.4	5.5	0.0	16.4	1.3	4.1	37.2	6.2	36.7	8.9	7.4	5.4	7.2	3.0	8.9	5.6	3.7	5.3	5.6	3.4	1.3	12.8	4.6	21.3	8.7	15.2	9.6	6.0	6.1	4.6	2.0	6.1	6.2	5.0	5.4	4.7	1.5	14.0	0.0	13.6	10.8	4.7	5.2	9.1	3.8	1.2	2.5	46.2	10.4	11.9	0.0	6.3	5.0	28.5	3.7	3.9	1.8	4.0	3.3	20.8	10.1	2.1
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923070-123319433	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	1.3	0.8	0.8	0.9	1.1	1.4	1.6	2.3	1.0	1.3	1.2	1.0	0.6	1.3	0.8	1.0	1.0	0.8	0.9	0.6	1.2	1.1	1.1	0.9	1.2	1.2	1.1	1.2	0.8	1.5	0.7	1.4	1.2	1.1	1.2	2.2	1.0	1.1	1.3	1.2	0.7	1.3	1.0	1.3	2.3	3.6	1.0	2.0	1.5	1.2	1.2	1.0	1.1	1.3	2.3	3.2	2.9	7.1	2.4	1.7	1.9	4.0	1.6	3.3	3.3	1.5	3.2	3.7	2.4	2.4	2.4	2.0	5.0	2.2	5.6	6.2	0.9	3.8	5.7	2.5	1.1	5.2	4.0	1.2	1.1	3.8	3.3	1.7	3.4	2.4	7.7	6.2	4.6	2.4	10.1	3.2	2.1	3.6	1.3	3.3	7.2	2.4	1.9	1.9	4.8	3.1	3.2	2.3	1.7	4.2	2.2	2.0	2.6	6.9	5.2	4.6	4.2	3.9	5.0	3.3	3.3	4.4	6.2	0.5	0.2	0.2	0.6	0.6	0.4	0.5	0.5	0.5	0.1	0.5	0.5	0.5	0.3	0.5	0.2	0.7	0.3	0.2	0.8	1.1	2.3	1.0	0.6	1.2	1.2	1.1	1.2	1.0	1.0	1.3	10.7	16.0	5.0	34.6	9.1	5.1	5.6	2.6	6.2	6.2	4.2	3.2	4.3	11.5	7.4	1.8	14.6	5.1	6.7	2.9	0.0	3.1	207.9	4.5	9.6	8.5	2.4	11.2	48.8	3.6	4.3	5.1	14.3	5.2	5.1	8.6	4.2	3.2	3.5	3.3	59.0	2.6	0.0	4.1	5.3	25.0	7.2	5.3	0.0	104.0	1.8	4.0	4.1	79.9	91.4	4.2	2.1	4.5	10.6	3.9	1.5	3.1	6.4	11.3	0.0	12.5	6.6	14.7	10.6	5.0	5.4	2.2	9.9	4.7	4.1	3.0
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 238.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 61.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	238.1	38.4	6.5	22.3	7.9	22.7	154.3	7.6	9.0	71.9	26.6	46.6	15.7	40.9	24.1	42.5	81.2	83.8	73.1	7.5	8.4	35.6	21.5	58.3	13.0	5.5	5.4	30.0	31.8	37.4	27.3	49.6	5.8	52.0	27.5	19.0	45.2	24.7	49.9	79.8	25.2	57.7	5.6	17.0	35.1	10.2	7.6	29.2	92.7	49.9	10.1	74.4	71.0	6.0	6.3	1.8	95.4	194.1	76.5	51.6	6.4	0.4	4.9	0.3	2.0	5.8	10.3	0.0	42.4	2.9	0.4	1.2	2.6	4.6	0.7	0.1	10.0	2.2	0.0	31.0	21.7	14.2	0.1	21.1	2.5	0.7	2.1	10.5	8.1	2.2	1.7	1.9	4.7	0.7	16.4	34.8	22.8	22.6	32.0	7.1	10.3	0.2	13.2	14.5	14.5	12.3	0.1	19.4	19.6	10.1	1.9	0.0	20.2	1.2	0.2	0.4	2.9	1.0	0.1	0.2	1.4	2.6	3.2	0.1	0.4	6.5	1.1	0.2	33.1	29.8	4.0	9.2	0.1	61.2	5.7	6.4	0.4	14.2	0.1	1.7	0.0	2.0	6.5	7.9	7.6	9.0	7.5	8.4	5.5	5.4	5.8	5.6	7.6	6.0	771.3	28.9	28.3	14.4	16.2	49.6	17.3	37.3	68.9	86.2	22.8	69.6	16.9	32.9	20.6	27.6	33.3	12.7	21.6	10.4	80.3	5.0	2.5	45.9	41.9	352.8	26.5	5.7	5.0	10.9	1.7	222.3	8.2	67.4	9.5	0.2	166.3	5.9	10.1	6.7	2.2	15.0	14.2	15.3	37.9	10.5	448.0	17.1	46.2	5.6	0.7	158.3	0.0	7.5	0.3	7.0	6.3	57.9	6.1	16.8	8.1	38.7	11.7	84.5	151.2	245.0	81.6	6.2	9.6	37.0	43.3	3.1	57.3	1.8	17.9	13.5
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664048-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	6.0	2.6	3.2	4.2	4.5	4.5	5.7	1.3	3.1	11.4	2.6	4.7	3.1	7.6	2.5	6.4	2.8	8.5	5.0	3.7	6.2	4.4	5.8	9.6	2.3	4.3	4.2	6.5	3.3	5.7	1.0	14.8	3.8	8.9	5.6	1.8	3.9	6.2	1.4	11.0	3.9	8.9	2.1	3.1	7.4	15.1	7.2	4.6	7.4	3.6	1.9	14.2	5.6	2.0	6.3	11.6	32.0	14.9	25.0	15.8	3.2	15.9	13.4	8.1	5.2	5.0	8.1	0.0	4.8	22.8	7.3	5.7	21.3	12.3	14.1	0.0	4.6	5.3	15.3	5.0	17.8	8.8	6.6	16.0	16.4	12.8	56.8	15.2	58.2	5.7	9.6	11.0	15.5	14.3	11.1	3.2	6.7	9.2	16.9	9.0	9.9	1.4	10.2	25.7	9.2	11.5	11.0	6.9	12.9	13.3	7.4	7.4	147.7	17.1	13.3	8.5	13.8	8.0	0.1	2.1	7.8	3.7	20.0	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.0	0.1	3.2	4.5	1.3	3.1	3.7	6.2	4.3	4.2	3.8	2.1	7.2	2.0	18.3	32.1	24.6	10.7	0.9	40.4	21.7	17.9	24.5	2.8	12.2	7.1	9.0	12.8	12.5	5.5	0.0	2.9	2.7	7.3	0.0	9.3	41.0	6.6	14.2	21.5	8.4	5.0	15.1	20.1	29.0	16.5	11.7	7.7	5.1	20.4	29.6	8.8	5.3	21.9	42.2	3.7	18.3	13.4	13.0	55.6	6.8	12.6	10.6	30.9	12.8	2.7	0.0	30.7	13.4	15.1	2.8	12.0	0.6	11.7	3.7	4.7	11.0	0.9	0.0	10.9	17.5	17.2	11.2	33.0	30.7	4.1	1.2	33.7	5.3	18.0
FAT4	"CDHF14, CDHR11, FAT-J"	ENSG00000196159	"FAT atypical cadherin 4"	Q6V0I7	4	125314918-125492932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Endothelial cells: 18.0;Fibroblasts: 17.9;Hepatic stellate cells: 33.2;Inhibitory neurons: 35.0;Microglial cells: 23.4;Oligodendrocytes: 54.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;ASC TERT1: 11.2;fHDF/TERT166: 11.4;HSkMC: 13.6;HUVEC TERT2: 14.3;TIME: 21.9"	"Low region specificity"	"Detected in many"							HPA052819	Approved		Approved	Cytosol		NA	NA		2300000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA052819: AB_2681963"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.81e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-3)"	3.3	1.0	3.2	1.4	4.1	0.0	2.7	1.2	2.7	4.0	0.7	6.4	0.9	3.0	1.3	2.3	1.9	4.3	4.0	3.8	2.0	2.8	2.5	4.5	0.8	3.1	2.8	4.9	0.9	3.0	0.6	2.9	2.8	3.7	2.3	0.5	1.0	2.6	1.6	1.4	2.2	3.5	3.5	2.7	2.0	0.7	3.3	1.1	4.0	4.8	0.8	2.5	1.8	4.8	0.0	0.9	7.4	0.8	15.5	11.2	0.0	2.6	3.0	1.2	1.2	0.0	0.4	0.0	3.1	11.4	1.5	0.0	2.8	3.2	0.7	0.0	1.3	1.7	3.3	0.1	5.4	1.1	0.0	13.6	1.9	0.7	7.0	9.1	14.3	0.0	0.0	1.9	6.7	0.1	0.5	0.0	0.5	0.0	0.3	0.9	1.5	0.0	0.1	0.0	0.2	1.5	0.4	0.0	0.0	0.4	0.0	0.0	21.9	7.8	2.2	2.7	1.1	0.3	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	4.1	1.2	2.7	3.8	2.0	3.1	2.8	2.8	3.5	3.3	4.8	19.3	6.4	0.0	8.8	0.0	1.7	0.2	1.5	0.0	3.7	0.3	1.3	6.9	0.0	0.3	5.5	0.0	0.1	0.9	0.0	0.0	0.7	0.9	0.6	8.8	18.0	0.0	0.0	9.4	0.2	0.0	17.9	1.1	1.0	0.0	1.2	33.2	7.4	0.2	0.0	35.0	0.0	0.0	2.2	2.2	0.2	5.9	0.3	3.6	23.4	0.0	1.1	1.0	6.0	54.4	0.3	0.0	4.9	1.4	0.4	0.0	0.7	0.1	0.2	0.0	5.3	4.1	0.1	0.6	0.5	0.6	0.0	0.3	5.7	0.0	0.1
INTU	"CPLANE4, KIAA1284, PDZD6, PDZK6"	ENSG00000164066	"Inturned planar cell polarity protein"	Q9ULD6	4	127623271-127726737	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 13.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Cone photoreceptor cells: 137.6;Endometrial ciliated cells: 81.4;Oligodendrocytes: 78.0;Respiratory ciliated cells: 84.0;Rod photoreceptor cells: 181.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036714, HPA036715, HPA061467"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: "	"unprognostic (1.09e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.33e-2)"	1.5	1.6	6.0	1.2	5.9	2.6	2.9	4.0	7.0	1.4	4.9	1.2	2.1	2.6	5.1	1.3	2.4	1.5	0.9	4.6	3.2	1.9	0.7	1.6	1.1	1.0	3.1	3.3	1.2	1.1	2.8	1.0	1.3	1.8	1.6	13.2	1.8	1.2	1.1	3.8	1.0	1.3	0.3	1.3	2.1	2.3	6.3	0.6	2.7	2.5	0.7	1.2	1.6	5.9	2.5	1.7	8.7	3.1	1.1	2.7	0.7	1.4	0.7	1.0	1.9	1.2	2.2	1.8	2.1	1.2	2.8	1.5	7.0	1.3	2.9	0.8	2.1	2.6	3.3	3.0	1.1	2.3	1.2	1.2	1.5	2.9	0.7	2.6	2.7	0.9	3.4	2.0	1.4	1.2	0.8	1.2	4.0	0.9	1.6	0.8	2.0	0.5	1.8	1.8	4.1	2.9	2.9	1.6	1.0	4.3	1.8	1.3	2.1	2.5	1.9	2.2	2.0	1.2	1.9	0.6	2.1	1.0	1.5	1.1	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.4	0.3	0.2	0.4	0.1	0.0	6.0	5.9	4.0	7.0	4.6	3.2	1.0	3.1	1.3	0.3	6.3	5.9	8.9	22.4	15.4	133.5	0.6	6.0	10.4	7.2	12.0	56.3	13.7	24.8	15.6	10.0	18.8	3.7	137.6	8.3	0.4	2.7	7.9	7.6	10.2	81.4	30.5	8.2	11.5	3.8	36.0	5.1	6.2	18.7	10.2	15.8	5.1	22.9	6.4	2.5	3.0	37.0	36.6	5.9	10.2	1.6	9.6	11.9	14.0	3.0	7.2	23.4	0.5	16.5	0.0	19.6	78.0	3.4	1.5	11.7	0.0	6.9	1.1	11.2	84.0	181.8	0.0	17.8	10.9	8.7	20.4	7.9	6.1	1.9	1.7	12.9	7.0	6.4
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730400-127774292	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Spermatogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	272	"testis: 47.3"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 198.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.2	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	4.3	4.2	2.4	5.3	3.0	5.8	4.0	6.5	3.3	4.3	2.0	5.3	7.1	4.0	4.2	4.0	4.5	2.4	13.5	2.5	3.7	4.6	8.4	3.9	5.8	2.4	2.2	5.1	8.9	3.3	5.2	2.9	2.6	3.6	5.1	5.4	4.8	2.2	10.9	5.5	7.0	3.2	1.8	4.8	4.6	1.9	2.9	5.9	4.8	11.7	4.9	4.1	4.1	3.2	4.2	3.5	4.1	5.3	3.2	4.4	6.1	4.0	3.2	3.5	4.6	7.8	7.7	11.1	6.5	2.0	3.3	4.0	8.7	4.7	3.8	9.2	2.8	8.2	5.1	6.7	4.4	13.9	10.1	3.4	3.2	3.7	2.4	4.1	6.3	8.4	13.8	8.0	3.3	7.4	18.7	6.8	4.3	8.7	3.1	10.2	1.4	7.2	5.2	4.2	9.4	3.4	4.1	6.8	4.1	5.8	6.0	5.7	5.4	2.3	3.1	5.7	4.0	14.8	15.4	13.2	4.0	14.7	3.7	13.6	5.7	8.7	5.0	5.0	3.9	6.3	6.3	6.0	4.7	7.8	7.2	7.1	12.1	4.5	3.7	7.8	7.2	2.9	2.4	3.0	6.5	3.3	2.5	3.7	2.4	2.2	2.6	1.8	2.9	3.2	8.4	6.4	15.4	0.0	17.6	0.0	8.7	0.0	17.1	13.5	5.9	3.7	0.0	8.6	5.6	7.3	20.9	5.5	13.5	7.9	0.0	5.1	3.5	6.3	5.7	6.9	6.1	27.3	0.0	7.3	4.7	4.8	23.4	8.2	1.3	10.6	11.4	23.4	7.8	18.5	0.0	9.6	0.0	17.6	0.0	1.6	6.2	12.9	0.0	0.0	15.9	5.1	12.3	0.0	0.0	7.5	5.6	5.7	21.3	10.2	13.9	8.5	3.6	19.8	13.1	8.0	4.2	9.2	4.8	12.0	0.0	9.2	14.5	7.8	8.4	9.4
LARP1B	"DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2"	ENSG00000138709	"La ribonucleoprotein 1B"	Q659C4	4	128061286-128222931	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.1;Late spermatids: 449.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036280	Approved		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA036280: AB_10673126"	"unprognostic (1.84e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.13e-5)"	"unprognostic (8.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.50e-2)"	10.5	8.2	5.1	8.0	6.1	14.4	11.5	8.5	9.7	11.5	2.1	14.8	14.6	8.9	24.1	11.1	9.6	9.1	11.6	5.9	5.4	14.2	50.7	9.9	6.3	3.5	4.2	10.3	35.6	16.3	12.9	10.5	4.4	11.0	16.3	11.0	13.8	11.7	18.2	11.1	15.5	8.3	2.1	6.2	15.4	55.8	6.0	6.5	13.6	13.3	9.3	13.2	9.9	8.6	21.5	7.4	13.2	16.7	13.7	15.5	26.8	18.0	19.9	16.7	10.7	16.9	16.5	26.1	24.6	17.8	12.7	8.3	32.7	19.9	19.9	24.7	20.9	20.9	13.0	41.5	29.7	40.3	8.2	8.1	28.7	13.4	49.0	16.0	19.8	19.4	37.1	42.4	9.6	25.1	35.2	23.1	15.2	33.0	11.9	19.4	20.3	29.8	19.1	16.4	39.1	15.5	15.6	35.7	16.8	17.5	10.5	17.4	16.1	10.7	11.8	17.5	18.1	55.9	22.7	30.1	13.8	30.7	11.5	0.2	2.1	1.3	1.7	1.6	3.1	1.6	1.9	2.2	2.5	1.4	1.5	1.7	0.5	2.6	1.7	4.6	1.7	0.8	5.1	6.1	8.5	9.7	5.9	5.4	3.5	4.2	4.4	2.1	6.0	8.6	18.4	35.3	35.6	46.0	19.9	27.8	25.7	11.7	10.8	37.0	34.9	18.7	30.2	40.0	32.5	20.2	52.1	31.4	15.2	52.2	13.7	22.1	393.1	41.9	32.3	17.3	34.0	25.0	139.1	29.9	23.2	23.4	29.6	62.6	20.8	12.5	15.0	154.6	11.9	23.5	115.6	115.2	18.3	15.7	16.3	449.5	36.4	15.5	17.8	19.7	16.7	17.5	20.6	55.8	51.8	31.3	36.2	19.9	54.5	46.4	37.4	63.2	29.0	71.5	19.7	20.7	23.1	138.3	21.9	25.3	34.7	51.4	14.3	8.4	55.1	30.6
PGRMC2	"DG6, PMBP"	ENSG00000164040	"Progesterone receptor membrane component 2"	O15173	4	128269237-128288829	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041172, HPA058652"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		76000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear bodies, Plasma membrane, Cytosol"		"HPA041172: AB_2677345, HPA058652: AB_2683786"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (6.03e-2)"	"unprognostic (6.57e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.03e-2)"	107.3	51.9	23.8	38.1	25.6	41.7	76.6	25.8	29.8	58.4	34.1	68.1	127.3	52.3	51.3	57.5	44.2	53.4	50.7	25.0	30.2	96.0	173.8	42.7	30.6	25.6	29.6	57.9	74.2	80.5	49.0	85.3	27.7	53.0	65.2	55.1	55.3	73.2	54.4	98.2	121.9	67.4	26.6	32.5	95.8	39.5	28.5	28.0	65.6	44.0	40.8	56.3	51.0	29.8	123.3	44.4	80.3	64.9	339.8	177.6	80.5	164.6	182.7	119.4	158.3	46.4	123.6	86.3	187.8	213.4	138.8	70.1	74.3	81.6	149.3	49.7	42.7	58.0	111.3	88.3	429.1	84.7	41.7	140.9	161.3	100.3	123.3	277.0	109.1	55.0	98.2	105.6	173.7	38.2	78.9	39.2	63.1	148.5	39.7	62.5	64.2	59.8	176.8	42.9	63.3	59.7	92.4	103.1	97.3	131.2	79.7	38.0	203.5	100.0	81.4	103.8	77.3	121.0	106.0	91.3	109.9	74.4	70.1	2.2	1.0	2.0	1.5	0.9	0.7	1.2	1.8	1.5	0.6	0.9	1.6	1.5	0.9	1.1	0.7	2.4	2.0	0.6	23.8	25.6	25.8	29.8	25.0	30.2	25.6	29.6	27.7	26.6	28.5	29.8	95.9	54.5	41.0	16.6	27.0	100.1	49.7	27.8	54.1	22.4	49.2	32.8	60.7	58.6	35.9	44.1	10.4	85.4	41.2	68.2	29.4	57.3	80.9	42.2	59.1	50.0	35.5	104.2	20.4	74.2	146.6	69.9	53.0	64.2	12.0	31.0	47.2	125.1	35.3	11.8	19.1	67.8	40.7	15.7	39.5	49.5	46.3	22.1	67.6	13.1	19.0	98.6	21.6	13.6	25.0	69.7	50.6	37.6	48.9	58.0	177.3	111.0	27.4	41.1	13.1	63.3	53.1	33.3	27.3	51.9	111.8	274.9	32.4	39.4	58.8	34.4
JADE1	"JADE-1, PHF17"	ENSG00000077684	"Jade family PHD finger 1"	Q6IE81	4	128809700-128875224	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020016	Approved		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA020016: AB_1855292"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.93e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (8.22e-6)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.68e-1)"	25.3	21.6	11.7	10.3	12.8	46.2	20.1	21.6	12.4	16.4	10.0	16.3	8.6	12.3	8.7	12.2	18.5	12.6	17.7	10.2	15.9	24.7	11.7	15.9	15.2	13.6	14.1	27.9	70.8	16.5	15.0	11.2	14.8	18.0	6.2	20.4	18.9	17.2	14.9	13.4	12.3	12.7	12.0	15.4	19.1	9.7	15.8	17.8	31.4	11.5	12.3	19.5	12.9	12.1	13.5	25.8	25.2	18.6	33.7	23.7	32.9	21.0	12.5	22.4	20.4	22.8	22.9	40.8	24.3	12.1	9.8	4.5	29.8	7.4	24.9	31.9	13.5	22.8	35.9	20.9	57.9	37.5	17.6	26.5	11.5	27.3	20.2	18.5	24.5	26.1	36.7	54.3	17.5	16.2	47.8	28.0	67.8	13.5	13.1	35.0	17.3	22.0	35.7	6.5	32.7	23.7	20.1	16.2	16.5	35.0	13.1	20.9	17.1	21.9	36.3	16.9	24.8	35.9	32.0	46.0	23.7	36.8	18.3	31.4	10.7	35.9	17.2	17.2	21.1	13.4	18.3	19.2	10.4	18.6	25.5	19.9	13.8	31.1	23.6	4.9	14.6	16.3	11.7	12.8	21.6	12.4	10.2	15.9	13.6	14.1	14.8	12.0	15.8	12.1	24.5	38.5	25.4	17.6	35.4	14.9	16.1	4.3	32.5	40.3	25.8	32.3	33.9	42.9	13.7	49.7	50.1	25.2	42.0	3.1	19.6	30.1	3.6	45.5	21.7	21.7	10.2	48.8	24.5	48.7	16.5	36.7	25.5	37.0	17.7	34.3	18.2	37.3	10.1	28.6	31.8	8.3	46.8	28.5	14.3	4.2	36.1	16.3	21.4	12.2	27.5	26.7	107.1	17.1	19.2	44.0	7.8	48.2	41.2	12.6	12.6	34.7	29.7	28.4	85.5	33.0	59.0	6.6	21.9	20.9	13.4	4.0	40.9	8.9	10.8	5.9
SCLT1	"FLJ30655, hCAP-1A"	ENSG00000151466	"Sodium channel and clathrin linker 1"	Q96NL6	4	128864921-129093600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 110.0;Excitatory neurons: 111.1;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 109.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 66.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 66.0;monocytes: 31.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036560, HPA036561"	Approved		Uncertain	Microtubules,Cytosol		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Microtubules, Cytosol"		"HPA036560: AB_2675190, HPA036561: AB_10673658"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.86e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.05e-2)"	"unprognostic (8.92e-2)"	3.6	3.0	3.7	6.4	4.5	14.4	3.5	7.4	4.8	3.7	0.9	3.7	4.3	3.5	2.2	3.9	3.1	4.6	3.6	2.4	2.8	2.7	3.5	3.5	7.3	4.5	4.3	4.5	3.3	2.9	2.9	4.6	3.5	2.4	4.4	2.9	2.6	2.7	1.5	3.2	3.4	3.6	4.7	7.5	3.5	4.9	5.3	8.8	3.0	1.8	6.7	4.4	3.4	3.9	19.9	5.3	18.8	12.4	6.5	10.5	10.3	16.5	14.8	17.8	16.3	5.7	17.1	17.0	10.4	9.3	12.4	7.4	12.5	12.2	18.5	38.9	10.0	22.7	10.2	6.5	8.9	27.1	17.0	6.7	4.3	14.2	14.2	8.5	14.0	8.6	25.7	39.8	15.6	8.8	20.8	13.0	8.4	14.2	10.5	12.2	19.2	10.6	11.4	5.5	28.1	8.2	12.7	11.5	11.1	8.2	6.8	10.8	13.2	14.5	17.6	19.7	22.3	19.3	15.5	29.0	8.1	29.7	22.2	18.3	16.9	36.8	3.8	24.6	2.2	3.9	2.6	2.7	9.5	3.7	2.5	3.4	66.0	10.2	31.1	4.4	3.7	6.5	3.7	4.5	7.4	4.8	2.4	2.8	4.5	4.3	3.5	4.7	5.3	3.9	16.1	12.8	9.8	110.0	18.0	11.1	8.9	5.8	8.0	15.2	6.1	7.4	21.2	15.7	9.0	1.8	29.2	13.8	34.8	9.1	3.9	6.5	63.2	20.3	18.4	11.9	5.4	9.0	111.1	6.3	21.5	16.3	28.1	14.3	12.0	16.5	9.3	1.6	13.3	16.8	116.0	8.1	8.2	21.6	18.0	51.8	10.8	28.4	8.8	87.1	33.8	8.9	82.4	109.1	90.5	9.0	9.8	9.1	24.0	2.7	8.2	3.1	16.7	21.6	13.1	14.4	16.5	19.6	12.1	13.1	13.9	9.3	21.2	30.5	10.6	5.6
C4orf33	FLJ33703	ENSG00000151470	"Chromosome 4 open reading frame 33"	Q8N1A6	4	129093317-129116640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA061199	Uncertain		Approved	"Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nuclear bodies"	"HPA061199: AB_2684450"	"unprognostic (7.27e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.49e-5)"	7.8	10.3	4.6	6.4	5.2	16.1	9.5	11.6	5.6	5.5	3.9	20.5	17.0	4.8	9.4	9.1	8.4	9.2	5.8	4.7	5.4	14.2	9.9	8.4	6.5	6.3	6.5	11.1	9.4	6.0	12.2	9.4	7.0	4.6	16.7	13.4	6.7	4.1	2.6	6.8	15.1	5.7	6.2	7.9	16.2	5.6	5.5	8.9	12.0	2.7	5.8	9.9	5.8	7.0	7.7	4.3	9.7	9.8	7.8	7.5	15.7	7.2	10.0	8.4	10.8	2.2	36.1	6.4	17.8	10.4	13.0	4.8	11.2	11.5	6.8	38.3	8.6	15.7	11.4	3.0	9.5	7.8	16.0	7.6	10.2	10.0	4.0	15.5	6.9	22.9	20.5	26.9	8.6	3.1	12.7	6.2	0.5	16.2	5.4	5.3	10.3	8.3	23.7	8.7	12.4	2.8	5.5	13.1	8.7	2.2	12.2	5.9	5.0	7.4	2.7	5.5	5.8	14.4	6.8	11.3	15.4	20.4	6.4	18.7	11.7	30.3	3.3	11.6	2.5	5.6	2.6	4.0	11.8	2.7	2.7	4.3	5.7	9.3	12.3	6.4	4.8	4.9	4.6	5.2	11.6	5.6	4.7	5.4	6.3	6.5	7.0	6.2	5.5	7.0	10.7	6.4	14.1	11.8	9.2	10.5	7.4	22.9	10.8	15.1	13.4	8.3	4.2	18.6	16.3	12.9	8.4	21.5	19.8	24.7	50.9	10.4	6.9	34.8	7.4	7.9	4.9	8.2	12.8	9.3	18.9	8.3	18.8	17.5	14.5	5.9	8.6	5.2	14.2	1.7	11.2	14.7	22.4	18.1	16.7	3.0	2.1	18.6	12.4	10.3	13.3	11.8	7.2	12.1	21.5	8.1	17.9	2.2	9.6	2.7	25.6	30.9	36.9	11.5	0.0	5.0	12.9	4.6	5.4	13.5	9.2	18.9	12.2	15.5	16.4	8.9
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149294-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA		88000		"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	0.5	5.1	20.5	0.2	35.4	0.0	0.1	0.9	23.9	1.5	0.0	0.5	0.1	1.6	0.5	0.3	1.2	0.5	1.2	19.6	15.2	2.1	0.1	0.7	0.0	7.7	24.9	2.3	0.2	0.0	1.4	25.9	11.3	10.6	0.2	3.0	0.5	17.3	0.0	0.0	0.4	0.7	3.7	0.0	0.4	1.4	16.8	0.1	0.5	0.0	0.0	1.8	2.8	19.1	0.0	0.7	8.7	0.0	0.3	0.0	0.0	8.6	4.6	0.7	0.4	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.9	0.0	4.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	11.5	27.4	0.0	0.3	0.0	4.2	0.0	24.1	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	55.4	14.5	0.0	0.1	12.9	0.0	0.0	0.0	1.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	35.4	0.9	23.9	19.6	15.2	7.7	24.9	11.3	3.7	16.8	19.1	1.4	0.0	0.6	58.1	0.0	0.1	0.5	0.1	1.2	15.0	1.2	2.7	2.3	0.0	0.7	0.0	0.0	0.8	0.0	0.9	1.9	0.0	5.6	26.5	4.6	4.0	0.0	0.0	64.9	0.0	0.9	15.5	0.0	29.1	0.0	5.0	0.0	0.0	1.8	0.0	57.7	0.2	0.0	0.0	0.0	1.7	0.0	0.5	0.0	6.5	0.0	8.6	0.0	46.8	59.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.1	2.7	0.0	4.3	11.5	17.4	0.9	0.0	0.3	2.9	0.2	3.9	0.1	0.4
PABPC4L		ENSG00000254535	"Poly(A) binding protein cytoplasmic 4 like"	P0CB38	4	134196333-134201789	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 10.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 5.7;Fibroblasts: 5.5;Glandular and luminal cells: 12.2;Leydig cells: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 11.4;HeLa: 15.8;REH: 8.1;RH-30: 8.5;U-2 OS: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 20: HeLa - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (1.11e-5)"	"unprognostic (4.41e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-3)"	1.5	0.4	0.6	0.5	0.7	0.0	0.8	0.5	0.8	2.4	0.5	0.4	0.3	3.7	1.4	0.7	2.0	1.1	1.7	0.4	0.5	1.0	0.1	0.5	0.2	0.5	0.5	2.2	0.3	5.3	0.3	10.3	0.6	2.9	0.3	0.0	2.1	4.2	0.2	0.3	0.3	2.4	0.5	0.1	0.3	0.5	1.1	0.9	2.0	0.9	0.5	0.7	0.8	0.6	0.0	0.1	2.8	0.0	0.0	0.0	0.0	3.4	2.3	1.6	1.9	0.0	0.0	0.0	3.5	0.0	0.0	0.3	11.4	0.1	2.3	0.0	2.6	4.5	15.8	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.6	0.0	2.3	0.0	1.3	0.0	0.1	0.0	0.0	0.0	1.4	8.1	8.5	0.0	0.5	0.0	3.4	0.9	0.0	0.7	0.2	2.9	0.0	1.5	0.2	2.9	8.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.8	0.4	0.5	0.5	0.5	0.6	0.5	1.1	0.6	5.3	3.2	1.1	0.0	0.0	0.3	0.4	0.0	1.2	0.0	0.2	0.9	1.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	7.4	5.7	4.3	0.0	0.0	0.0	0.0	0.4	5.5	0.0	12.2	0.0	3.8	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	2.3	5.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.7	1.4	3.1	1.3	0.8	0.1	0.8	0.3	4.5	0.0	0.1
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 368.6;Microglial cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 84.2;TIME: 95.2;WM-115: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	0.2	0.1	18.8	2.2	17.5	1.0	0.4	16.5	16.5	0.9	7.2	0.7	0.4	0.3	6.7	2.6	4.5	1.6	1.7	16.2	26.5	0.1	0.2	1.7	0.4	24.3	22.8	0.5	2.7	0.3	0.8	0.7	19.0	0.6	1.0	4.2	0.7	0.1	0.0	0.6	0.4	0.1	19.8	0.4	4.9	0.8	20.1	0.3	4.6	0.0	0.8	2.7	0.5	20.1	5.2	42.1	18.4	14.5	3.9	5.0	5.1	23.2	15.9	5.2	11.8	4.7	17.7	9.7	29.5	80.8	27.6	6.7	10.0	19.8	21.7	18.5	2.1	6.9	37.7	10.7	59.6	18.1	6.3	11.9	84.2	14.6	64.6	7.6	65.1	9.6	9.5	24.4	27.3	3.7	2.5	1.7	3.6	25.1	11.9	2.8	6.1	11.5	3.1	20.1	7.6	1.5	10.1	2.9	35.4	3.9	4.4	38.1	95.2	6.7	18.8	10.2	18.3	20.5	10.3	9.7	11.4	9.7	138.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	18.8	17.5	16.5	16.5	16.2	26.5	24.3	22.8	19.0	19.8	20.1	20.1	0.5	0.0	8.4	368.6	2.5	4.6	7.5	8.8	1.8	7.3	2.2	1.3	5.4	1.5	8.1	0.0	2.1	3.6	28.5	7.9	0.0	4.4	3.2	3.2	2.3	27.8	27.0	0.8	12.5	25.1	0.7	5.7	65.2	18.3	4.5	1.0	2.9	0.4	0.6	1.7	7.3	19.8	22.4	0.3	63.5	0.8	2.5	18.3	5.4	148.9	51.7	47.9	0.0	12.1	8.6	30.4	1.5	2.2	4.1	58.5	0.4	0.1	7.3	2.0	0.0	2.1	4.0	1.1	0.7	1.9	3.1	1.1	0.9	7.0	4.2	37.6
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	23.7	14.2	12.1	15.2	17.3	47.3	24.5	19.2	16.1	21.8	9.6	24.6	15.0	24.7	18.5	17.3	20.7	17.8	20.1	11.1	15.6	15.5	20.4	19.0	19.9	15.6	14.9	28.2	16.7	20.0	22.6	26.8	15.9	21.5	19.2	30.7	21.4	21.7	36.0	23.2	17.6	23.0	13.2	19.6	17.4	37.4	14.5	32.8	23.0	33.6	21.4	19.2	18.4	20.2	15.9	11.3	27.9	21.4	28.2	31.7	26.9	18.4	31.8	19.6	21.8	22.2	31.2	32.3	18.5	25.7	10.4	16.8	41.2	26.3	20.5	20.2	18.6	28.5	26.4	20.0	20.7	32.1	22.1	31.1	24.8	19.3	23.3	25.7	29.5	18.0	46.8	18.4	17.7	27.8	37.8	28.6	17.0	36.4	13.1	36.0	36.8	30.1	25.1	27.2	28.4	32.6	23.1	28.5	17.6	32.4	19.7	38.5	25.0	18.3	15.9	16.7	12.4	40.8	48.6	28.3	13.5	32.4	17.2	13.3	8.3	14.1	12.0	7.2	13.2	17.5	11.8	10.8	9.9	19.3	14.6	13.5	9.1	12.9	7.9	18.0	9.4	5.3	12.1	17.3	19.2	16.1	11.1	15.6	15.6	14.9	15.9	13.2	14.5	20.2	103.0	48.1	22.5	64.0	57.6	53.2	41.1	36.1	120.1	42.0	50.3	40.4	37.0	40.0	39.1	40.5	75.0	32.6	71.9	31.0	43.0	26.4	26.0	60.0	54.3	67.1	47.3	43.5	73.6	24.2	32.3	63.7	35.7	56.3	34.8	44.0	53.2	46.9	22.2	67.3	75.3	38.1	42.7	52.2	40.1	24.6	52.5	59.5	30.2	98.4	49.2	37.3	77.2	83.9	279.4	24.1	33.5	38.0	51.0	52.6	35.9	23.1	48.2	57.7	39.5	81.4	59.2	59.7	42.0	79.0	47.6	23.7	50.7	33.6	27.7	39.6
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266165-139280225	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 228.0;retina: 116.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 151.3;Granulosa cells: 93.5;Horizontal cells: 208.6;Muller glia cells: 508.9;Theca cells: 474.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 20.4;fHDF/TERT166: 30.7;HHSteC: 23.6;HUVEC TERT2: 61.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	9.4	228.0	3.2	0.3	3.2	0.1	1.8	7.8	4.6	2.0	3.1	1.0	0.2	5.0	1.8	0.4	2.2	0.9	3.0	3.1	4.0	1.8	0.2	0.7	0.9	3.7	4.0	23.9	0.3	0.2	11.8	0.3	3.7	2.6	0.3	116.9	0.4	4.0	0.8	0.4	0.3	3.8	3.2	0.8	0.4	8.6	3.6	0.3	0.8	0.3	0.6	1.1	2.5	3.6	0.0	1.1	0.6	0.5	1.5	0.7	0.1	20.4	0.1	3.0	0.1	0.1	0.2	0.1	0.2	30.7	8.7	0.5	4.4	0.1	1.7	0.0	2.0	0.0	0.1	0.2	23.6	0.2	0.2	7.2	0.7	3.3	0.2	7.1	61.7	0.2	0.4	0.4	5.1	0.1	0.8	0.5	1.1	0.4	0.1	0.1	0.0	0.0	0.7	0.3	0.6	1.2	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.8	0.7	0.5	8.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.2	7.8	4.6	3.1	4.0	3.7	4.0	3.7	3.2	3.6	3.6	0.6	0.0	0.0	0.0	0.2	1.7	0.7	0.4	1.2	151.3	0.7	10.8	3.5	0.0	0.1	0.0	8.4	0.2	0.3	0.1	1.9	0.0	0.3	0.8	1.2	1.1	0.0	0.0	1.3	0.0	0.2	10.7	0.0	0.3	0.0	93.5	0.4	0.4	0.5	208.6	2.5	0.0	0.0	0.0	0.3	0.6	17.1	0.6	0.0	0.0	0.0	508.9	2.1	5.0	0.7	0.1	0.0	24.8	0.3	0.3	0.1	9.2	0.0	32.6	0.0	1.9	3.4	0.8	0.4	0.7	0.9	0.3	0.6	474.8	0.1	0.3
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 83.5;skeletal muscle: 268.3;tongue: 158.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1840.3;Distal tubular cells: 1136.7;Proximal tubular cells: 1449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	9.5	15.3	19.9	8.0	20.4	9.1	11.0	22.4	28.6	7.4	21.3	18.6	23.8	8.1	14.3	10.5	10.5	5.4	83.5	19.6	20.8	26.7	24.1	8.8	10.1	20.3	21.0	10.0	14.8	22.9	15.8	5.9	21.6	9.7	19.0	23.5	18.9	14.4	268.3	13.2	18.6	7.4	19.5	10.4	17.0	12.7	20.5	8.6	14.8	158.5	11.0	8.6	7.9	22.4	21.4	5.9	19.2	30.8	17.7	22.7	20.5	20.1	13.1	11.1	10.4	13.1	23.7	7.7	7.7	15.5	14.9	10.5	38.6	18.2	15.0	13.0	13.5	11.9	13.5	23.0	18.1	11.2	10.1	24.5	18.2	14.4	21.6	16.8	17.5	17.8	25.3	33.8	11.0	17.8	17.8	32.1	16.3	44.1	11.7	14.9	10.6	52.6	24.6	14.2	14.6	14.7	13.8	23.2	10.5	15.6	23.7	23.2	8.1	24.2	6.4	13.0	13.5	23.2	49.5	18.5	18.9	26.7	13.8	26.2	10.1	13.1	8.5	10.3	11.6	7.1	11.7	11.5	8.9	15.9	10.5	11.4	3.0	10.1	14.2	16.2	18.2	10.8	19.9	20.4	22.4	28.6	19.6	20.8	20.3	21.0	21.6	19.5	20.5	22.4	201.8	89.8	145.7	15.7	95.8	140.2	173.3	402.7	185.0	120.4	240.3	349.6	1840.3	221.6	240.1	439.6	33.3	147.4	71.7	343.0	1136.7	270.3	409.9	333.5	115.5	162.7	221.4	175.2	10.9	336.9	166.2	176.9	158.0	196.8	73.3	151.2	133.5	432.9	225.1	119.5	14.3	340.5	276.7	102.0	65.7	70.9	169.3	115.6	266.8	6.5	185.5	446.6	79.3	8.0	13.3	265.3	355.8	206.5	155.6	173.7	471.7	1449.6	297.1	139.1	98.6	159.3	184.4	439.0	197.4	290.1	179.3	118.1	83.5	224.7	343.7	176.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N-alpha-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301505-139420033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		140000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	9.1	8.9	6.5	11.4	7.3	16.4	9.9	12.4	8.3	7.3	7.3	8.4	7.6	8.9	6.0	12.5	7.1	7.0	10.0	6.5	6.7	7.5	10.9	6.4	14.5	7.3	6.8	7.9	7.8	9.7	5.8	10.6	7.7	8.3	9.1	9.2	6.2	7.2	17.0	9.3	7.0	8.7	6.9	8.5	7.9	13.1	6.9	13.4	9.0	16.3	15.5	14.5	7.7	10.5	44.7	32.1	30.4	49.2	21.7	26.4	37.3	42.2	27.6	39.9	30.6	45.3	38.2	91.1	25.3	35.0	34.6	28.1	80.5	51.7	57.2	42.8	29.6	49.0	29.6	29.8	23.0	90.5	30.5	18.7	31.0	50.4	39.1	21.1	40.5	35.2	92.1	38.7	42.9	35.6	86.8	26.8	50.7	83.4	25.0	53.4	40.9	47.0	31.8	37.2	39.3	30.8	28.2	45.7	28.8	30.6	27.8	35.2	35.0	38.3	27.0	36.7	48.7	46.5	89.0	88.7	32.9	64.6	37.4	4.2	3.4	1.1	5.0	3.9	5.9	4.8	5.3	5.9	4.7	5.3	5.1	5.8	2.6	4.5	3.9	4.0	5.5	2.1	6.5	7.3	12.4	8.3	6.5	6.7	7.3	6.8	7.7	6.9	6.9	10.5	28.4	48.1	33.8	28.4	39.7	93.4	69.6	20.7	29.0	34.0	28.1	15.7	46.9	22.8	32.3	20.2	20.9	39.9	22.8	14.4	15.6	28.1	9.0	40.3	38.9	31.5	15.6	34.5	44.0	19.5	50.8	32.9	21.4	40.5	34.8	35.7	16.8	28.1	32.5	40.4	45.9	20.8	18.3	24.1	35.0	11.3	25.4	27.8	28.4	29.0	26.6	27.7	32.0	42.3	57.6	26.5	16.2	29.0	23.4	53.8	10.2	16.4	34.0	36.3	32.9	69.0	47.4	90.0	59.7	44.0	99.3	41.7	31.7	32.1	32.5	70.2
RAB33B	DKFZP434G099	ENSG00000172007	"RAB33B, member RAS oncogene family"	Q9H082	4	139453232-139476609	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 22.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048367	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048367: AB_2680372"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.06e-3)"	"prognostic favorable (9.19e-4)"	8.4	5.2	3.7	5.2	4.4	12.8	7.1	7.0	5.3	8.1	2.2	4.1	3.8	9.5	4.2	6.6	5.6	6.0	6.5	3.3	4.4	5.0	16.7	6.8	6.5	5.5	4.5	9.9	10.0	4.1	2.8	9.0	5.8	6.8	4.1	4.1	4.2	5.6	4.2	4.9	4.2	8.4	4.6	7.5	5.4	3.6	4.8	5.4	6.3	5.2	5.8	5.6	3.1	7.4	5.1	1.9	5.6	7.7	12.6	12.3	9.4	6.1	8.5	5.2	6.4	5.5	8.0	10.7	3.0	7.0	2.6	4.8	6.1	5.4	6.2	10.1	4.0	3.7	4.5	6.4	12.6	6.8	8.4	9.5	5.9	6.6	6.2	9.4	15.3	6.7	4.1	20.6	3.9	3.5	5.8	6.0	3.9	8.5	3.2	7.3	8.4	4.7	7.3	3.4	7.4	7.6	4.3	8.5	10.1	6.2	3.9	4.7	10.7	6.2	4.5	10.6	3.4	10.9	13.3	6.9	6.2	7.3	5.6	4.3	3.4	8.7	3.6	3.5	5.8	4.3	4.5	4.0	2.3	3.6	5.6	5.1	22.6	4.3	3.4	2.8	5.2	3.5	3.7	4.4	7.0	5.3	3.3	4.4	5.5	4.5	5.8	4.6	4.8	7.4	13.9	6.4	7.7	5.2	15.1	9.9	7.2	3.4	18.2	5.0	10.0	6.3	10.1	5.7	4.1	3.7	0.0	6.3	9.1	5.3	1.9	5.3	34.1	13.7	11.3	12.0	8.4	3.8	5.9	4.7	5.7	10.7	7.1	10.6	6.3	3.3	11.4	19.7	6.6	3.3	7.5	8.2	2.0	9.4	8.9	72.1	10.5	7.1	1.8	10.3	8.6	5.9	3.1	10.1	8.9	6.2	5.2	12.8	10.9	6.8	6.3	4.5	6.4	8.5	6.6	12.8	9.9	4.6	4.3	12.9	11.6	16.8	13.2	3.4	6.5	5.9
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 441.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 194.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 276.3;OE19: 558.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010690, HPA010707"	Enhanced		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Endoplasmic reticulum"	"HPA010690: , HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	61.8	92.7	43.5	30.4	42.9	42.6	66.6	45.1	60.6	63.6	54.8	112.5	132.5	39.2	82.1	177.6	70.8	87.6	118.3	42.6	45.7	99.2	393.2	49.0	36.0	46.6	44.6	26.3	66.2	102.0	44.6	75.6	46.5	74.9	121.2	7.8	90.6	50.0	104.2	97.1	143.5	57.4	46.6	60.5	72.5	50.6	45.3	35.1	45.8	118.4	64.6	86.7	78.4	48.9	40.8	58.5	28.7	0.3	4.8	15.4	17.7	7.2	66.1	3.2	10.7	62.3	276.3	0.1	158.2	17.5	13.6	74.8	52.7	81.2	4.9	22.3	47.7	174.9	57.3	251.5	13.3	152.7	130.0	53.0	197.2	2.1	12.5	63.9	166.3	0.3	75.9	25.7	23.3	33.9	0.2	24.7	6.5	558.9	59.4	12.7	33.4	54.0	153.0	87.4	71.9	21.6	53.2	83.2	64.8	2.0	52.9	202.2	104.9	5.6	27.3	7.8	6.4	29.7	22.5	9.7	3.8	254.8	12.6	43.8	103.8	30.4	4.1	64.8	2.9	1.3	7.6	3.5	147.0	2.4	2.3	2.6	17.7	26.4	22.2	194.6	37.7	39.4	43.5	42.9	45.1	60.6	42.6	45.7	46.6	44.6	46.5	46.6	45.3	48.9	327.9	25.6	36.6	5.5	7.7	61.1	295.9	316.7	75.7	7.8	99.1	57.3	100.5	205.9	185.5	95.6	25.0	85.3	71.0	168.3	90.1	121.0	6.3	132.5	27.1	238.4	121.8	60.2	19.4	138.6	62.8	31.8	90.2	172.9	43.2	56.9	203.1	419.3	378.1	6.7	24.2	215.1	170.9	107.8	77.8	12.8	44.4	85.3	39.2	49.6	83.6	14.1	27.8	11.6	4.7	121.8	213.1	33.4	7.1	94.6	441.1	277.2	126.6	3.5	13.1	44.6	49.6	4.6	15.1	264.0	124.9	67.2	15.2	43.6	258.2	344.9
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 16.8"	"Immune cell enhanced"	"Detected in many"		"basophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;NK-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	3.3	3.4	1.5	2.4	0.9	3.2	3.4	16.8	2.1	5.0	0.1	3.8	4.8	6.7	5.3	5.9	5.5	4.1	2.0	2.2	2.8	2.0	2.6	3.8	2.6	3.4	2.3	8.6	6.8	3.3	4.5	5.0	3.4	4.9	3.9	1.7	5.9	4.5	1.7	7.8	4.5	6.0	2.4	3.3	3.4	3.0	2.2	6.0	4.3	2.1	2.3	3.6	5.1	2.2	0.5	8.1	5.4	2.7	2.1	4.4	4.9	1.0	4.4	0.5	0.3	3.2	2.2	1.8	0.4	0.8	0.3	0.1	2.1	1.8	0.3	0.0	1.2	5.9	1.9	0.3	0.4	2.8	8.7	4.3	1.5	0.1	0.9	3.3	15.0	0.1	1.6	0.0	0.3	0.9	0.5	1.2	1.4	3.6	3.5	3.5	0.5	3.6	2.5	11.2	15.7	23.9	0.0	4.2	5.5	4.2	2.3	0.8	13.1	0.6	1.3	0.1	1.7	2.9	3.5	0.1	0.8	9.2	20.2	12.2	1.5	2.9	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.4	0.4	0.4	3.6	3.4	0.9	1.2	0.0	1.2	1.5	0.9	16.8	2.1	2.2	2.8	3.4	2.3	3.4	2.4	2.2	2.2	21.2	3.2	11.5	39.5	3.1	8.0	8.1	4.2	7.4	4.6	12.6	9.3	3.0	11.5	8.7	5.5	18.8	5.8	3.9	13.6	5.9	5.1	3.6	12.6	9.4	11.7	14.9	9.4	60.2	5.1	7.3	5.3	8.6	19.9	19.6	34.4	13.2	17.5	7.5	11.8	125.6	12.1	2.0	22.6	13.3	9.0	4.1	19.6	3.6	355.1	18.3	3.1	1.0	7.5	150.8	3.0	14.0	3.8	2.1	5.7	8.2	6.1	7.2	3.7	0.0	2.9	13.7	0.5	2.2	19.0	13.5	8.2	5.3	8.5	11.0	8.9
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
CLGN		ENSG00000153132	Calmegin	O14967	4	140388453-140427661	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 59.5;testis: 113.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	6.6	0.9	1.0	0.7	2.4	2.7	3.8	1.6	0.9	2.0	2.6	0.5	1.6	0.6	1.2	13.7	0.4	59.5	0.9	2.6	0.4	3.2	0.5	0.7	2.7	1.9	0.3	2.2	0.6	11.2	0.2	2.6	22.5	1.3	17.2	1.0	0.7	0.4	0.2	1.3	1.5	1.2	0.2	2.0	113.6	2.3	2.4	2.7	1.6	1.2	0.6	0.1	0.9	0.2	10.2	10.3	6.9	4.0	21.1	2.4	0.1	9.4	10.0	18.6	0.3	0.9	0.0	27.8	0.9	8.4	0.2	7.5	0.1	16.2	0.4	9.0	3.0	9.8	7.4	41.4	38.9	0.6	2.2	39.2	1.0	0.9	53.0	0.2	9.6	2.0	0.0	0.0	0.5	47.8	0.5	12.0	0.2	28.1	31.5	0.0	0.4	0.0	0.3	16.8	29.8	6.5	4.1	1.8	3.8	1.9	5.6	0.0	27.4	4.7	9.7	73.6	14.4	31.7	19.9	43.4	1.6	2.9	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	3.8	1.6	0.9	2.6	2.7	1.9	2.6	1.2	2.3	0.9	0.8	0.0	2.2	0.3	0.1	0.0	0.9	8.5	1.2	9.2	3.3	1.8	313.3	0.0	6.4	0.0	4.2	0.5	0.0	0.5	0.0	1.2	162.4	93.4	1.3	11.9	5.3	8.6	7.2	4.2	0.1	10.2	0.0	11.3	0.0	10.1	0.7	3.7	0.1	25.2	6.7	0.4	30.5	0.0	0.0	60.2	5.0	0.7	1.8	0.0	0.1	176.4	0.0	6.6	0.6	0.9	3.9	4.5	0.1	33.8	0.2	0.1	24.6	16.3	0.0	0.6	2.0	465.5	23.9	2.8	0.1	0.3	0.7	0.2	0.8	1.3
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"testis: 22.7"	"Group enriched"	"Detected in some"	19	"Early spermatids: 19.5;Late spermatids: 26.7;Spermatocytes: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524168-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: AB_2680098"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.82e-2)"	10.7	13.8	6.8	8.7	7.4	8.6	14.2	9.7	6.9	9.9	12.3	12.2	12.9	10.9	13.2	8.6	10.7	9.1	11.4	6.0	7.8	14.5	15.6	8.5	8.8	8.3	7.6	8.5	8.8	15.5	7.4	9.6	8.0	13.0	13.0	18.0	9.2	9.7	4.3	9.4	15.3	10.2	8.7	7.6	10.3	8.0	7.2	12.5	16.8	5.3	10.2	9.4	6.0	10.6	11.3	12.4	24.9	19.1	25.4	29.2	16.0	26.3	24.7	14.3	17.1	12.2	23.7	18.5	11.3	16.5	17.3	10.1	23.8	16.7	17.6	18.1	14.2	15.3	10.2	16.0	23.1	23.6	13.0	20.1	27.2	12.2	12.5	22.6	15.9	22.2	19.9	29.6	24.8	8.2	25.6	8.1	13.2	16.4	10.1	29.7	19.2	12.0	20.7	17.9	11.8	43.6	17.3	17.5	19.3	27.7	17.1	9.7	16.3	32.7	11.6	15.5	27.6	30.8	47.1	23.1	23.9	18.2	25.3	2.3	6.6	8.0	6.6	7.1	7.4	3.2	5.8	7.2	5.6	6.0	5.9	5.9	15.3	7.5	5.7	9.8	7.3	4.4	6.8	7.4	9.7	6.9	6.0	7.8	8.3	7.6	8.0	8.7	7.2	10.6	14.6	28.9	17.7	22.5	13.1	9.2	11.0	30.3	11.4	20.7	14.7	10.5	14.3	7.2	26.4	18.4	18.8	23.2	19.9	17.6	1.9	22.2	3.9	29.0	24.4	14.5	9.1	7.4	20.2	26.5	8.7	15.5	9.2	15.7	19.7	17.8	11.4	27.1	19.0	15.2	15.6	10.9	22.4	16.4	11.0	1.5	13.1	13.8	17.8	19.7	14.1	16.3	9.2	20.6	35.3	25.6	12.9	10.9	21.7	10.3	27.1	15.9	44.9	24.7	6.6	10.0	18.3	26.9	19.1	12.4	11.6	20.1	13.9	10.9	12.0	8.6
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559431-140568961	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"adrenal gland: 2.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Syncytiotrophoblasts: 2.3"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 4.7;HAP1: 3.3;JURKAT: 1.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	0.9	2.7	0.0	0.0	0.1	0.0	0.6	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.2	9.2	7.2	15.2	7.9	2.0	48.7	22.5	9.4	12.9	35.2	7.3	8.2	8.3	7.8	9.1	10.0	13.8	8.5	8.4	15.3	15.7	12.6	16.3	15.1	7.9	9.6	15.9	9.1	9.8	6.3	20.5	15.4	14.6	6.6	21.0	8.8	21.3	2.2	3.2	12.8	7.7	6.4	33.7	16.8	3.3	12.9	5.6	5.8	6.9	19.4	15.8	7.1	3.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	7.2	7.9	22.5	9.4	8.4	15.3	7.9	9.6	15.4	6.4	12.9	3.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
RNF150	KIAA1214	ENSG00000170153	"Ring finger protein 150"	Q9ULK6	4	140859807-141212877	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Excitatory neurons: 184.5;Inhibitory neurons: 174.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 285.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.7;fHDF/TERT166: 27.1;SH-SY5Y: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037987	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA037987: AB_10669512"	"prognostic favorable (1.41e-4)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.88e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.41e-2)"	11.3	12.4	6.8	1.7	12.5	0.3	3.1	7.5	7.7	8.0	0.0	16.5	1.0	11.9	10.8	6.8	12.4	3.4	14.9	7.7	8.1	8.3	0.9	1.3	3.3	1.3	1.3	10.8	2.0	0.5	7.8	1.9	6.1	8.3	3.8	31.8	31.7	11.1	18.7	0.9	3.7	12.2	1.9	5.4	4.0	1.4	5.6	2.0	6.2	12.5	3.1	6.5	3.9	2.0	0.3	0.5	4.8	4.2	19.7	1.4	0.2	6.8	3.5	2.5	1.2	0.0	0.1	0.0	0.9	27.1	0.1	0.1	9.8	0.1	1.3	0.1	4.6	0.0	8.9	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.2	1.6	0.0	4.8	0.0	0.1	0.9	0.1	4.7	0.2	2.2	0.0	1.8	2.6	12.4	0.1	2.8	0.0	2.0	37.0	0.7	0.3	1.9	2.5	0.1	0.1	0.1	12.6	5.2	8.7	3.1	0.3	0.1	0.0	0.2	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	12.5	7.5	7.7	7.7	8.1	1.3	1.3	6.1	1.9	5.6	2.0	0.8	0.0	0.5	65.6	0.0	1.1	0.7	0.3	3.4	53.9	3.1	7.4	72.5	1.5	2.2	11.0	112.6	1.3	0.0	0.1	1.9	0.4	4.6	17.8	43.9	2.7	1.8	0.0	184.5	0.5	0.1	10.0	0.0	22.8	0.0	11.4	2.2	0.2	0.7	26.9	174.3	0.0	0.0	0.6	2.9	2.7	28.6	2.0	0.0	114.3	0.0	13.4	0.0	285.5	5.7	0.1	0.0	18.0	0.0	1.1	0.0	1.0	0.2	69.1	13.1	34.5	17.4	0.0	2.0	0.5	0.6	0.4	0.4	47.6	0.0	0.1
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 154.0;Early spermatids: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015705, HPA056325"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	29.1	26.8	11.9	20.3	12.6	35.5	22.8	14.3	15.7	23.1	15.0	30.9	18.5	26.0	17.6	25.2	25.6	19.8	100.3	11.0	12.8	26.0	51.7	25.1	28.6	13.3	12.6	25.1	26.9	23.9	15.5	20.2	13.2	21.0	22.7	25.0	48.1	20.1	67.1	19.0	21.2	32.1	12.9	23.2	22.8	26.3	13.1	21.5	37.4	43.4	26.7	23.4	18.7	14.6	20.7	24.8	29.5	23.4	51.7	46.1	41.3	54.0	31.1	34.1	32.1	33.5	38.6	87.6	32.4	34.3	19.3	16.1	52.6	35.0	51.7	40.8	34.4	40.7	39.2	47.6	55.2	103.8	31.6	46.6	40.3	32.0	46.4	41.4	36.1	53.1	84.3	57.9	43.8	46.4	80.9	48.6	26.3	63.2	46.7	65.0	42.2	55.9	36.7	22.6	51.1	23.8	19.0	42.9	55.7	33.0	21.5	28.1	38.7	43.3	29.4	26.3	39.1	96.1	74.7	83.2	36.2	63.8	31.6	16.3	27.4	16.7	15.9	22.7	22.3	21.6	20.1	20.7	28.9	17.7	21.6	20.0	4.1	20.1	18.8	19.6	25.9	16.3	11.9	12.6	14.3	15.7	11.0	12.8	13.3	12.6	13.2	12.9	13.1	14.6	32.5	54.5	32.4	8.1	31.9	49.2	53.9	22.3	35.3	63.0	21.5	29.1	154.0	27.1	26.2	9.2	14.6	38.2	29.8	21.2	58.7	32.7	197.7	34.9	58.2	31.5	16.8	29.6	13.0	51.0	37.9	35.3	18.8	26.9	22.9	25.7	32.5	70.6	73.5	16.8	13.4	25.7	20.3	56.2	36.0	50.5	39.1	48.2	46.2	20.6	38.1	38.4	14.4	11.6	17.3	43.5	27.8	28.6	27.4	43.6	26.0	78.3	20.3	26.1	13.1	42.4	34.9	46.2	17.7	33.6	51.6	34.3	29.7	38.4	26.9	56.6
IL15	"IL-15, MGC9721"	ENSG00000164136	"Interleukin 15"	P40933	4	141636583-141733987	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.0;monocytes: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.6;Karpas-707: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004457, HPA037738"	Approved		Supported	"Nucleoplasm,Nuclear speckles"	"Secreted to blood"	NA	NA	182000		"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear speckles"		"CAB004457: AB_2124575, HPA037738: AB_2675640"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	7.7	3.4	1.3	7.1	1.4	4.0	6.0	2.1	1.8	5.3	1.4	7.7	6.1	4.5	2.5	4.4	4.5	4.9	5.1	1.2	1.3	7.9	3.6	7.8	9.7	2.3	1.3	1.5	2.7	0.7	3.6	3.1	1.8	4.1	5.3	4.3	3.6	2.7	8.6	3.4	10.0	4.6	1.5	15.4	4.8	2.5	1.8	6.8	15.6	3.4	6.6	4.5	6.4	1.9	2.8	6.3	0.3	0.6	0.9	5.4	1.6	6.7	6.1	6.8	5.5	3.4	8.1	2.5	8.5	6.2	6.0	4.4	0.1	3.4	3.6	17.6	1.7	0.5	16.7	0.5	4.5	1.9	1.3	2.1	1.5	4.4	0.5	13.7	4.3	2.3	4.0	18.8	4.2	0.9	4.2	0.3	3.3	2.3	1.7	1.0	16.0	0.5	9.2	0.8	0.6	1.6	3.1	4.7	3.2	0.8	0.9	0.3	6.6	6.9	4.3	2.0	4.2	13.0	1.8	1.0	7.2	0.8	2.5	10.4	16.1	0.6	2.7	15.1	5.0	4.1	3.3	2.5	5.5	4.0	1.4	1.4	1.2	3.2	16.5	0.2	2.0	6.1	1.3	1.4	2.1	1.8	1.2	1.3	2.3	1.3	1.8	1.5	1.8	1.9	14.8	0.0	2.8	0.3	9.9	6.1	2.5	2.1	2.2	0.6	2.1	1.3	2.9	2.8	5.3	5.5	0.0	1.2	5.0	4.7	0.0	9.4	6.6	6.9	78.0	14.8	0.0	1.3	2.0	14.0	1.6	5.5	4.1	5.9	0.0	0.9	11.4	2.5	4.7	0.0	4.8	5.4	0.0	17.0	22.1	2.5	2.8	16.7	8.8	4.7	72.0	21.1	8.2	3.0	0.2	19.8	8.2	1.2	9.3	6.2	9.9	12.0	3.9	0.9	6.6	7.6	4.0	1.2	0.8	5.6	3.4	0.3	6.0	0.1	2.6	3.0
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 158.7;Early spermatids: 178.1;Excitatory neurons: 196.8;Inhibitory neurons: 614.4;Late spermatids: 291.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 30.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 150.4;SK-MEL-30: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	9.9	4.0	5.2	6.7	6.7	2.1	18.3	3.2	6.4	13.1	0.3	5.8	4.6	5.4	3.9	7.5	7.3	7.9	17.4	5.5	3.4	5.4	1.8	6.5	10.8	1.3	2.7	5.7	2.5	2.0	1.3	5.7	1.9	4.7	5.1	1.7	2.7	4.7	7.9	3.6	5.5	7.3	0.0	6.8	5.8	18.6	7.3	5.9	4.3	5.2	6.9	14.0	8.7	6.0	27.7	11.4	7.3	3.6	5.5	3.4	1.4	32.5	37.9	8.2	15.3	3.1	150.4	0.8	8.9	29.4	12.6	41.1	0.0	37.9	19.1	0.1	1.1	6.6	4.0	0.1	1.8	1.4	5.0	5.9	5.2	5.8	19.4	24.7	4.8	0.0	0.0	1.5	17.9	49.1	1.1	0.0	0.3	16.8	8.1	0.3	24.7	1.4	11.3	50.3	0.6	0.7	3.7	11.2	66.6	4.3	34.2	4.9	3.1	18.8	22.6	28.0	0.3	0.4	0.1	0.1	4.4	29.7	49.5	6.1	0.2	0.0	5.2	0.0	10.1	0.0	30.4	13.6	0.1	0.1	20.6	8.9	0.5	17.0	0.0	0.1	17.4	5.9	5.2	6.7	3.2	6.4	5.5	3.4	1.3	2.7	1.9	0.0	7.3	6.0	13.4	0.0	0.6	158.7	2.6	6.6	9.5	7.0	4.0	7.5	49.0	15.5	42.2	7.2	20.2	9.2	0.0	1.7	8.7	8.7	5.9	12.2	178.1	19.8	58.2	13.2	8.9	6.1	196.8	30.6	5.1	5.1	19.4	5.4	6.3	0.6	6.4	0.3	8.1	6.7	614.4	3.5	4.1	2.8	4.9	291.9	13.7	3.9	72.9	47.8	1.3	0.9	2.1	79.4	57.6	76.3	0.2	6.4	4.5	20.5	10.1	0.9	35.7	0.8	85.5	5.2	84.7	2.5	1.9	1.9	2.6	1.9	60.4	1.8	4.3	42.9
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	6.5	4.4	2.5	6.2	4.3	21.6	4.6	4.3	2.9	6.2	4.3	8.0	7.9	5.5	2.3	7.0	4.3	5.2	6.8	2.2	2.4	7.0	13.2	6.3	6.4	5.9	3.8	3.7	8.2	7.7	3.3	8.1	4.9	5.5	5.7	4.5	5.8	5.6	36.6	5.9	7.2	5.7	4.9	7.4	6.3	6.8	3.2	9.3	7.4	21.3	5.8	6.8	3.9	6.8	8.5	7.9	6.6	11.3	8.4	8.2	5.1	13.0	12.5	11.8	10.1	23.1	11.7	10.5	9.2	11.5	7.8	6.5	15.9	13.5	10.2	26.0	10.5	9.7	8.5	4.7	11.3	19.4	9.4	10.2	11.1	12.0	9.5	8.3	12.2	11.9	21.5	31.5	7.9	13.3	25.6	3.7	6.1	17.7	15.3	16.7	10.2	10.1	7.2	9.2	13.8	12.3	10.5	17.3	10.9	4.9	10.8	7.6	14.6	10.8	9.1	9.6	14.1	35.7	65.3	18.6	10.9	14.4	9.3	13.4	4.5	9.7	5.7	4.6	7.0	4.6	4.9	4.9	6.6	4.5	4.8	4.2	4.3	10.1	4.9	2.7	7.9	4.3	2.5	4.3	4.3	2.9	2.2	2.4	5.9	3.8	4.9	4.9	3.2	6.8	21.5	22.4	19.8	13.7	19.5	53.5	21.0	6.2	25.6	7.4	20.8	13.7	18.4	10.0	12.2	0.0	12.5	12.8	22.2	35.5	1.9	8.3	36.4	20.7	26.1	15.3	30.6	31.5	19.6	7.7	7.1	13.4	26.0	52.1	3.8	9.9	17.9	38.4	10.6	8.4	15.9	20.2	4.1	17.0	16.6	20.3	6.8	21.9	12.4	9.4	10.1	15.1	12.3	18.6	22.8	10.2	13.4	9.4	38.6	16.8	17.0	18.5	10.9	8.9	13.1	15.0	14.1	11.3	4.7	31.5	59.1	26.7	23.2	11.0	17.6	45.4
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513702-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 307.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB005227: AB_2191863, HPA008751: AB_1857268"	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	16.9	26.0	15.1	21.1	20.1	32.7	17.6	17.6	17.3	18.1	13.5	17.2	14.9	20.4	20.5	14.1	14.6	19.3	17.1	13.0	16.6	16.7	16.8	27.9	27.0	17.9	16.8	21.2	16.4	22.6	13.5	22.8	19.1	18.1	17.9	26.4	12.4	17.0	15.3	11.1	16.4	18.4	18.3	22.8	16.2	32.6	16.0	29.9	23.1	15.3	25.7	22.7	11.0	26.0	33.4	25.8	92.5	58.5	53.4	38.4	55.5	41.5	49.4	59.5	50.0	44.3	45.8	90.0	27.9	35.7	23.7	26.0	85.9	38.9	57.1	60.2	30.2	67.7	36.9	36.7	39.3	84.2	38.3	34.0	27.8	42.1	36.0	34.5	46.9	45.1	62.0	55.4	39.2	30.1	98.7	29.4	75.7	55.6	36.6	108.2	59.1	29.4	46.6	40.4	73.6	62.2	54.0	37.9	49.5	69.2	27.4	39.1	50.0	38.9	29.7	41.0	41.2	60.0	77.4	106.8	30.6	69.5	40.3	5.8	10.7	16.0	12.7	12.8	15.3	11.4	13.1	14.2	13.3	11.2	13.4	13.6	9.4	15.8	21.5	10.0	16.7	11.5	15.1	20.1	17.6	17.3	13.0	16.6	17.9	16.8	19.1	18.3	16.0	26.0	77.3	307.7	291.0	30.7	95.7	46.4	78.9	50.6	55.2	93.9	56.4	49.0	104.1	31.5	96.9	44.1	64.6	70.6	125.6	39.8	39.2	77.9	63.2	104.5	127.1	74.3	79.9	85.4	42.5	61.4	66.4	73.8	46.4	94.2	103.1	97.3	39.3	25.4	44.8	85.8	41.7	41.3	69.2	51.9	49.4	27.9	60.3	79.2	30.2	27.2	98.6	84.7	55.6	37.7	85.2	66.0	35.3	62.1	93.9	57.7	36.6	36.8	109.6	116.4	52.6	113.9	88.3	144.4	130.8	47.4	40.9	102.1	107.9	118.7	46.2	71.2
FREM3		ENSG00000183090	"FRAS1 related extracellular matrix 3"	P0C091	4	143577302-143700675	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Excitatory neurons: 9.7;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 2.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.1;hypothalamus: 2.8;thalamus: 4.4"					HPA041641	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041641: AB_2677592"	"unprognostic (1.19e-2)"			"unprognostic (4.09e-9)"	"unprognostic (3.09e-3)"	"unprognostic (2.74e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.24e-1)"	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.3	0.6	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.2	0.6	0.3	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	1.0	0.0	0.0	0.0	4.5	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870864-143905563	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 13.3"	"Cell type enriched"	"Detected in some"	11	"Erythroid cells: 188.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"HEL: 120.9;K-562: 39.8"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	1.4	0.3	0.1	1.4	0.8	13.3	0.7	0.0	1.4	0.7	0.0	0.2	0.0	0.3	0.7	0.3	0.2	0.7	1.4	0.6	0.0	0.4	0.1	2.9	1.1	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.3	0.4	0.2	0.3	0.6	0.1	0.4	0.9	0.4	0.0	3.2	0.3	0.5	0.0	1.1	0.7	0.0	2.5	0.7	0.2	0.1	0.0	0.0	0.0	0.0	6.8	6.6	0.0	2.8	6.4	1.4	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.0	1.6	0.0	0.0	120.9	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	39.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	16.0	1.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	188.4	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.8	0.5	0.3	0.0	0.3	3.6	1.0	0.0	0.0	1.0	6.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0
GYPB	"CD235b, GPB, MNS, SS"	ENSG00000250361	"Glycophorin B (MNS blood group)"	P06028	4	143996104-144019380	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"bone marrow: 63.2"	"Cell type enriched"	"Detected in some"	450	"Erythroid cells: 1351.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 159.0"														"Intracellular and membrane"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"																					0.2	0.0	0.0	0.0	0.3	63.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.1	0.0	1351.4	3.0	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.9	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646156-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;lung: 16.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 175.6;Leydig cells: 136.1;Oligodendrocytes: 413.3;Theca cells: 162.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 322.6;TIME: 376.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	2.3	2.3	10.4	0.4	25.4	0.8	0.3	10.7	19.6	1.3	0.0	3.2	2.6	1.6	3.8	0.0	0.1	1.1	0.2	17.1	11.0	0.8	6.8	16.2	0.0	20.0	20.2	0.6	2.6	0.0	0.3	0.0	13.6	4.7	3.2	0.9	0.3	2.6	0.4	0.2	3.7	0.1	9.4	0.0	5.9	1.5	18.1	2.7	0.6	1.3	0.0	5.0	0.3	37.3	0.0	0.1	4.9	0.1	0.3	1.9	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.0	0.2	0.3	0.0	2.2	0.0	2.0	0.1	0.0	0.1	0.1	0.0	0.0	10.4	7.8	17.2	322.6	29.1	0.1	0.0	4.8	0.0	47.7	0.0	4.4	0.0	2.8	0.4	65.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	376.7	0.4	3.9	0.3	2.5	2.2	0.0	10.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	25.4	10.7	19.6	17.1	11.0	20.0	20.2	13.6	9.4	18.1	37.3	0.3	12.8	175.6	3.9	0.4	0.0	0.0	0.5	0.0	42.7	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.5	6.0	0.6	0.0	0.0	17.6	0.4	0.0	38.9	0.0	0.4	16.5	0.1	9.3	0.1	0.1	0.0	13.9	0.0	2.0	0.0	0.4	4.5	136.1	1.3	1.8	1.0	0.0	0.3	0.0	8.5	413.3	0.1	0.0	44.0	0.0	0.0	0.0	0.0	4.4	3.3	0.0	1.7	0.9	0.3	0.5	0.0	0.6	0.0	1.0	162.7	0.0	0.0
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	11.4	9.4	7.7	6.1	8.2	10.1	14.3	9.6	11.2	11.0	7.9	9.1	4.4	11.6	13.3	7.7	10.7	7.7	13.9	7.9	8.5	12.9	13.6	9.8	10.3	8.3	8.9	11.9	7.5	9.0	7.5	12.3	8.3	8.9	9.8	9.2	8.1	9.2	14.9	8.2	6.6	11.8	8.5	8.4	7.4	19.0	8.4	13.8	11.8	15.1	10.7	11.0	9.0	9.1	14.3	7.8	20.0	7.8	19.5	21.2	13.0	17.1	16.9	21.6	15.7	18.9	18.6	19.6	11.1	11.8	15.6	8.4	17.6	22.6	23.1	19.0	14.0	12.1	6.0	15.6	24.5	23.9	13.7	17.2	15.9	17.7	28.8	18.0	17.1	23.0	32.2	28.2	22.8	10.3	40.5	29.1	14.1	17.0	15.7	20.5	15.5	11.8	24.1	9.0	14.0	10.4	11.1	10.4	23.1	18.6	9.4	19.7	15.6	14.7	8.9	13.7	21.7	22.3	25.2	31.3	19.2	30.2	18.7	25.5	7.8	9.7	13.0	10.3	13.4	15.1	13.5	13.2	11.5	12.4	13.4	13.7	2.2	16.4	9.6	15.6	18.1	7.4	7.7	8.2	9.6	11.2	7.9	8.5	8.3	8.9	8.3	8.5	8.4	9.1	30.7	12.8	17.0	31.3	16.7	16.3	22.0	61.6	10.8	9.9	16.9	26.0	14.8	4.3	34.3	14.7	0.0	38.9	20.2	7.6	46.9	25.8	83.3	26.4	21.0	22.2	3.0	8.6	61.2	26.1	35.8	20.7	9.2	15.6	26.0	15.3	19.6	15.6	35.1	5.0	58.0	13.0	40.7	12.7	18.2	22.8	33.8	17.6	10.6	36.5	27.8	19.0	22.6	55.8	62.3	27.3	15.5	27.1	10.5	26.9	14.3	49.8	27.6	9.8	32.9	21.0	36.2	126.8	41.5	14.2	19.9	29.6	19.5	26.1	13.7	29.4
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145098288-145129524	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Translation regulation"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No		380000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	30.0	21.5	11.2	33.6	12.5	27.2	33.1	13.7	16.0	20.7	10.7	22.7	20.2	24.4	16.0	35.1	22.5	22.4	24.9	12.5	14.3	23.8	39.7	18.5	40.5	12.6	11.2	29.1	29.4	27.0	10.0	28.7	14.4	19.4	27.7	14.4	24.1	16.9	28.0	25.2	17.7	28.9	13.8	26.4	20.1	26.5	11.8	34.2	26.9	30.3	42.1	40.5	15.9	18.1	117.1	61.2	89.5	62.2	74.6	107.5	89.4	124.6	86.4	145.1	101.3	95.5	105.9	187.6	39.3	109.2	77.7	75.4	132.5	157.7	193.1	108.6	82.9	106.9	44.0	80.6	98.3	244.3	81.3	80.0	108.4	153.8	213.7	74.8	157.4	139.1	219.5	136.1	156.3	70.4	234.5	82.2	74.8	177.5	142.9	124.0	107.9	135.7	108.1	79.9	111.1	55.1	74.7	124.6	89.5	66.7	74.2	98.1	105.3	143.3	89.4	101.3	152.5	120.6	209.6	199.5	87.7	214.6	163.7	2.2	10.0	0.9	12.3	13.1	25.4	13.2	15.4	16.0	19.5	13.0	21.0	18.1	0.8	16.4	13.4	10.9	18.5	14.8	11.2	12.5	13.7	16.0	12.5	14.3	12.6	11.2	14.4	13.8	11.8	18.1	56.4	25.6	18.7	15.3	55.9	59.9	109.0	38.7	45.5	37.2	35.0	30.6	24.0	17.2	45.4	25.8	20.9	39.4	44.4	9.8	39.2	39.4	40.1	29.0	61.8	53.7	20.4	47.5	24.2	28.2	45.1	50.6	35.7	23.4	32.9	50.3	21.4	32.9	41.5	42.1	27.8	22.5	24.4	22.4	40.3	15.4	46.9	34.6	19.6	12.2	33.2	18.1	33.0	18.1	37.5	39.1	10.3	34.6	58.3	112.2	8.0	39.8	28.5	34.9	32.9	71.7	47.5	92.4	79.4	65.5	59.5	26.5	47.2	98.4	36.6	72.2
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180589	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.0	12.8	9.6	13.8	12.3	32.0	12.6	13.0	12.5	12.2	11.0	11.6	11.5	13.6	14.2	13.4	16.1	12.3	11.8	9.9	8.7	11.9	20.2	15.3	16.2	9.1	9.1	14.5	12.2	17.1	9.7	15.1	9.5	10.2	12.1	17.0	11.0	11.4	40.4	15.4	11.2	13.7	8.7	16.2	10.8	31.9	9.4	16.4	13.6	40.4	14.3	18.7	12.1	14.9	28.2	15.7	18.3	17.1	21.3	25.8	24.5	24.0	26.9	30.2	23.9	16.9	33.8	51.2	10.6	33.8	18.5	16.6	31.9	33.6	39.3	22.0	15.0	24.7	20.1	15.8	24.9	52.3	17.7	20.3	33.5	36.9	48.3	25.4	27.1	22.0	41.5	37.3	30.1	16.8	32.4	22.7	20.5	27.0	17.7	26.3	20.0	12.1	29.4	20.1	17.7	14.6	22.2	33.0	24.3	24.1	11.0	21.2	33.1	33.8	21.5	17.7	32.2	27.2	28.7	33.0	23.4	36.5	33.4	0.0	0.4	0.8	0.9	0.6	0.6	0.8	0.6	0.7	0.4	0.6	0.6	0.6	0.1	0.5	0.8	0.7	0.5	0.3	9.6	12.3	13.0	12.5	9.9	8.7	9.1	9.1	9.5	8.7	9.4	14.9	24.8	64.1	23.5	27.7	19.6	63.2	55.3	13.9	18.2	16.1	20.3	11.8	20.2	22.8	20.5	27.6	25.0	21.5	28.2	16.3	9.8	12.7	185.2	52.8	29.1	44.7	15.1	21.4	36.4	14.7	21.4	30.3	14.8	45.7	20.3	19.6	21.0	24.0	12.7	6.7	30.8	15.2	20.3	20.8	42.4	82.4	20.2	23.6	32.0	30.0	17.7	8.3	11.3	40.2	53.7	23.9	11.7	30.1	20.1	64.7	13.1	7.7	45.3	20.9	0.0	39.4	24.2	27.9	48.5	27.4	54.4	16.0	22.9	20.7	15.6	60.4
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145559176	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 195.9;Endothelial cells: 76.3;Late spermatids: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 46.2;non-classical monocyte: 22.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 46.2;monocytes: 22.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	19.6	5.3	16.7	10.9	21.9	5.8	15.9	15.3	18.2	20.4	6.9	20.4	15.4	29.0	32.7	16.3	24.4	17.1	13.1	13.2	16.6	12.6	20.2	12.3	17.6	14.6	18.3	11.7	13.3	29.1	6.0	11.4	14.5	12.5	20.8	6.5	12.9	17.2	20.7	24.4	15.7	30.4	13.6	14.0	10.6	13.9	16.4	18.3	17.4	17.8	13.7	17.9	8.9	13.6	9.6	12.6	23.5	27.3	8.7	12.8	11.5	13.9	32.6	22.0	16.4	6.2	34.0	9.8	8.0	31.8	9.7	14.1	26.6	30.2	12.8	0.0	13.5	0.0	10.0	13.1	23.2	15.8	2.4	17.6	35.2	11.8	22.9	17.9	110.7	20.7	11.1	0.4	27.0	9.6	24.4	0.3	21.8	15.3	14.6	47.0	21.1	28.5	25.9	17.1	35.3	17.6	18.8	40.3	9.6	14.1	14.0	0.2	32.4	10.5	14.5	11.3	8.6	31.1	0.0	56.1	16.7	0.3	11.1	46.2	3.6	1.5	0.0	9.4	0.0	0.0	0.6	0.0	6.8	0.1	0.3	0.0	0.0	2.4	22.2	0.0	1.3	1.3	16.7	21.9	15.3	18.2	13.2	16.6	14.6	18.3	14.5	13.6	16.4	13.6	62.9	9.6	10.9	54.9	0.1	11.5	17.5	22.0	45.5	6.6	8.6	9.3	3.6	12.8	16.3	14.7	14.6	5.2	0.8	13.2	7.9	12.6	195.9	19.5	12.1	76.3	9.1	8.4	47.7	18.5	2.7	11.5	12.2	24.8	0.0	10.0	10.4	12.0	2.5	10.1	43.2	10.4	28.5	6.5	2.7	80.7	4.4	4.5	1.8	26.2	3.2	5.3	0.0	66.9	22.0	12.0	10.2	5.7	0.3	17.5	6.6	11.5	12.7	5.9	0.0	19.0	10.6	8.3	16.8	19.9	12.6	2.2	1.2	6.9	8.8	17.2
MMAA	cblA	ENSG00000151611	"Metabolism of cobalamin associated A"	Q8IVH4	4	145599042-145660033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 24.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Supported	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	4.1	3.2	1.4	3.0	1.9	1.7	4.2	2.7	2.3	3.0	1.3	5.8	7.4	2.4	4.0	4.1	2.7	3.8	3.3	1.5	1.4	7.3	24.5	3.7	3.1	1.3	1.5	2.3	2.0	4.2	0.7	2.8	1.3	2.3	5.3	1.9	3.5	2.8	4.7	3.8	6.2	2.6	1.2	3.5	3.6	4.5	1.3	5.2	3.1	6.0	3.7	4.7	0.8	1.6	2.5	1.4	4.0	2.1	8.4	9.8	1.1	7.1	4.0	2.3	1.4	1.7	4.3	12.1	2.1	4.4	1.1	2.2	2.0	4.4	1.7	7.5	0.8	4.0	1.3	1.5	6.5	5.6	3.3	5.5	6.1	2.6	5.8	3.7	7.2	8.1	1.1	4.6	5.1	3.4	7.2	1.4	1.5	6.2	2.7	3.7	2.2	1.4	13.3	1.3	1.9	1.4	3.5	6.0	3.3	2.4	3.9	1.5	7.0	2.8	1.4	5.0	1.6	2.2	2.0	3.3	4.4	5.5	2.8	3.9	3.1	3.0	4.5	6.1	4.0	3.1	5.3	4.6	3.2	2.6	4.0	5.3	0.5	4.8	7.4	3.3	5.2	2.3	1.4	1.9	2.7	2.3	1.5	1.4	1.3	1.5	1.3	1.2	1.3	1.6	3.6	12.8	5.6	5.5	3.6	2.9	10.4	7.7	5.7	3.4	3.0	2.4	7.6	14.3	13.0	11.0	2.1	7.9	6.5	7.7	15.6	11.1	10.5	5.0	4.5	4.1	2.4	1.7	5.7	12.5	2.8	4.8	7.1	5.7	8.2	3.4	7.9	31.8	4.9	0.0	5.7	6.5	8.2	4.1	1.6	6.3	4.7	3.6	1.8	3.7	5.6	2.3	9.2	8.0	7.4	8.4	7.3	3.0	2.8	6.5	10.9	21.1	6.8	1.6	0.0	4.2	3.8	8.7	5.2	4.4	1.1	7.7	4.5	5.7	6.7	12.2
C4orf51		ENSG00000237136	"Chromosome 4 open reading frame 51"	C9J302	4	145680146-145771032	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.7"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"		"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.37e-1)"		"unprognostic (1.32e-1)"		"unprognostic (2.19e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.7	0.9	0.0	0.1	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	9.1	1.5	0.0	0.0	1.9	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF827		ENSG00000151612	"Zinc finger protein 827"	Q17R98	4	145757627-145938823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 96.3;Excitatory neurons: 77.5;Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 96.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021166	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA021166: AB_2670608"	"unprognostic (2.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.88e-2)"	2.9	7.1	2.4	3.2	5.5	2.2	4.5	9.1	4.3	5.7	0.0	6.4	5.2	8.1	2.9	2.2	6.1	3.7	4.8	3.0	2.4	4.7	0.6	2.7	3.8	2.3	2.2	7.4	3.0	7.0	8.3	1.3	1.0	15.8	3.9	1.3	10.7	4.8	7.9	2.8	6.4	6.0	0.8	4.0	3.8	3.5	2.2	7.3	7.7	5.3	4.4	6.5	3.8	4.0	4.4	3.5	12.8	7.3	5.2	5.4	0.0	7.7	7.6	5.7	4.2	1.3	10.5	0.6	2.0	12.9	4.4	2.2	6.9	4.9	4.6	7.3	2.5	3.9	4.8	3.7	4.1	3.1	0.0	8.1	4.3	4.6	11.7	10.9	9.2	2.1	0.4	5.6	4.8	0.0	3.0	0.0	5.1	0.0	7.5	10.6	6.0	1.9	5.1	4.7	10.5	9.0	6.0	9.4	13.3	5.6	5.5	0.1	17.8	13.9	10.9	1.0	8.1	4.6	0.1	3.4	4.7	11.7	49.2	2.9	0.0	0.0	1.8	0.0	0.9	1.6	0.9	1.8	0.0	1.2	0.9	1.7	0.0	1.9	0.0	1.5	0.0	0.6	2.4	5.5	9.1	4.3	3.0	2.4	2.3	2.2	1.0	0.8	2.2	4.0	7.3	12.8	19.8	96.3	12.3	6.4	8.3	16.2	22.8	12.7	19.2	19.2	22.4	2.8	16.9	23.9	10.4	2.3	10.3	14.9	3.9	12.1	17.1	11.9	10.8	8.7	25.8	5.9	77.5	7.1	0.5	7.8	14.3	14.6	2.5	17.4	8.2	1.3	1.3	18.5	64.3	18.6	10.2	1.2	0.8	7.8	9.0	1.2	1.8	8.4	0.7	4.7	8.2	174.9	96.6	14.2	9.5	17.0	13.7	30.7	20.1	12.3	19.3	1.5	6.6	20.6	7.1	2.1	5.0	5.8	4.8	1.4	9.4	18.7	19.5	11.6
LSM6	YDR378C	ENSG00000164167	"LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62312	4	146175703-146200000	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing, tRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045079	Approved		Approved	"Actin filaments"		NA	NA		30000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Actin filaments"		"HPA045079: AB_10961320"	"unprognostic (5.04e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.36e-1)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.08e-3)"	11.2	6.2	6.2	10.0	6.7	11.4	6.9	9.6	13.5	5.3	4.5	10.1	5.8	5.5	5.8	5.2	5.4	4.6	4.4	5.4	7.1	7.9	9.9	6.2	18.3	6.9	7.3	6.8	6.4	3.9	4.3	9.1	6.8	7.4	7.6	8.3	6.8	4.5	4.3	4.8	8.2	4.9	6.9	10.4	8.9	7.5	6.9	12.5	4.2	5.7	14.2	8.5	4.4	6.6	21.1	11.1	28.0	11.3	9.4	9.7	19.2	17.7	17.8	17.2	18.9	12.1	23.7	27.9	6.3	10.3	16.3	8.8	22.7	10.8	27.5	35.1	15.7	18.4	8.9	32.2	16.0	50.1	16.1	7.0	15.9	17.2	7.8	10.5	16.6	19.7	25.4	31.0	13.7	17.5	56.4	37.0	21.7	21.9	14.3	29.9	14.8	14.3	13.4	23.2	23.8	11.3	9.7	12.6	22.0	15.3	9.8	37.1	12.2	16.2	17.9	11.8	29.9	17.7	23.5	32.9	20.2	16.0	18.6	3.5	27.4	18.4	18.2	43.9	24.1	32.3	23.8	21.6	26.6	33.3	26.6	24.1	16.2	26.8	59.6	21.3	28.3	30.8	6.2	6.7	9.6	13.5	5.4	7.1	6.9	7.3	6.8	6.9	6.9	6.6	143.3	22.4	34.1	11.8	86.7	69.3	91.2	141.8	56.9	22.5	55.3	88.0	25.1	51.5	55.9	27.6	2.1	132.7	53.5	38.2	68.4	67.2	3.6	53.4	44.9	68.7	23.4	82.6	12.3	67.1	183.4	65.6	30.1	33.1	56.4	52.1	54.7	65.8	124.9	18.5	13.3	66.2	61.1	96.2	98.0	13.8	76.1	98.2	51.6	7.5	171.2	33.7	74.2	16.6	13.1	53.1	83.6	57.9	60.6	162.8	92.7	111.5	64.3	25.0	32.9	47.5	82.2	107.3	196.2	78.0	71.7	73.7	77.1	71.6	85.5	99.8
REELD1		ENSG00000250673	"Reeler domain containing 1"	A0A1B0GV85	4	146214515-146230878	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"Respiratory ciliated cells: 1.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	88	"HDLM-2: 9.6"					"Low region specificity"	"Detected in single"									NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (6.26e-3)"	"unprognostic (1.40e-1)"		"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-6)"	"unprognostic (2.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.13e-2)"	0.8	0.2	0.3	0.2	0.3	0.1	0.7	0.3	0.5	0.3	0.3	0.2	0.0	0.2	0.3	0.1	0.5	0.0	0.4	0.3	0.3	1.1	0.6	0.4	0.0	0.3	0.3	0.2	0.4	0.0	0.1	0.0	0.5	0.6	0.0	0.4	0.3	0.0	0.4	0.6	0.6	0.0	0.3	1.3	0.2	0.5	0.3	0.0	0.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC10A7	"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043"	ENSG00000120519	"Solute carrier family 10 member 7"	Q0GE19	4	146253975-146521964	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Microglial cells: 50.6;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039996	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039996: AB_10673266"	"unprognostic (9.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.69e-2)"	"unprognostic (9.57e-2)"	5.4	4.6	2.6	4.9	4.0	6.0	6.0	3.2	2.6	7.2	1.7	7.0	4.6	4.9	12.0	5.8	4.4	5.6	2.9	2.9	3.6	3.8	7.2	5.9	5.6	4.6	3.8	5.6	6.5	3.7	3.6	8.9	4.9	6.3	9.2	3.9	6.9	3.3	2.2	3.7	5.4	5.9	3.8	5.3	9.7	3.4	3.5	6.5	7.0	3.2	5.9	4.7	4.8	5.1	5.2	1.7	12.2	5.0	8.6	10.3	5.8	6.3	8.2	5.7	5.8	4.7	21.6	9.6	4.4	6.9	3.6	5.2	7.2	8.6	6.8	11.1	3.5	11.8	4.2	8.5	5.5	20.5	18.3	4.9	6.8	6.9	8.7	3.1	10.2	10.2	13.2	25.6	4.3	3.6	15.6	5.2	2.2	11.4	8.6	8.6	8.9	13.7	4.0	3.8	3.7	3.1	4.3	12.8	5.3	6.4	7.5	8.1	5.8	5.1	5.4	7.8	4.4	20.7	24.9	13.4	7.0	8.2	7.4	10.9	3.0	4.5	3.7	4.8	3.8	3.9	3.7	3.3	4.0	2.8	3.5	3.4	0.3	5.1	3.9	2.7	4.9	2.2	2.6	4.0	3.2	2.6	2.9	3.6	4.6	3.8	4.9	3.8	3.5	5.1	10.8	3.2	3.9	44.4	7.9	3.3	4.2	2.0	2.8	6.8	5.2	3.7	2.1	8.6	3.2	1.8	4.2	6.4	8.2	6.2	1.9	4.0	2.3	4.8	6.2	5.4	4.8	9.9	34.3	5.1	13.2	6.1	11.2	6.0	22.9	5.8	8.9	10.3	5.8	8.4	37.1	14.7	2.0	7.3	3.1	1.2	7.5	6.1	0.0	50.6	4.9	3.4	6.2	62.4	82.0	3.6	3.4	4.9	15.8	3.3	4.2	1.9	7.3	11.8	0.0	4.0	5.5	7.0	4.5	5.2	4.8	6.2	8.6	2.3	7.6	4.1
POU4F2	"Brn-3b, BRN3B"	ENSG00000151615	"POU class 4 homeobox 2"	Q12837	4	146638893-146642474	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 7.2"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"medulla oblongata: 4.7;midbrain: 7.2;pons: 5.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.8"	"Region enriched"	"Detected in single"	6	"midbrain: 4.4"	"Region enhanced"	"Detected in some"		"midbrain: 2.9"							NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"								"unprognostic (4.18e-2)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	7.2	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	7.2	5.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706617-146945882	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"fallopian tube: 20.0;testis: 71.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 697.9;Late spermatids: 445.9;Respiratory ciliated cells: 97.7;Spermatocytes: 157.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;hTERT-HME1: 1.4;U-266/70: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA037006: AB_10670379, HPA061473: AB_2684534"	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.1	0.0	1.1	0.0	0.8	0.0	0.1	0.5	0.5	0.5	4.6	0.0	0.0	0.2	2.2	0.0	20.0	0.0	0.0	0.9	1.3	0.2	0.0	2.0	0.0	3.8	4.2	0.0	0.0	0.7	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	71.8	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	1.4	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.5	0.5	0.9	1.3	3.8	4.2	2.9	3.4	1.1	2.1	0.2	0.0	1.8	7.8	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	697.9	48.9	0.3	0.7	0.0	0.0	5.3	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	2.0	0.0	0.0	445.9	7.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	4.9	0.0	0.1	0.0	0.1	97.7	0.0	0.0	0.0	1.4	157.6	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 113.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	14.0	5.5	2.1	3.3	2.8	0.0	8.3	2.7	4.2	57.0	2.1	3.2	3.4	44.7	23.3	4.4	18.4	12.7	26.0	2.2	2.2	4.2	3.1	22.7	3.8	2.9	3.1	37.5	1.1	3.4	2.8	12.1	2.9	30.7	3.4	0.3	6.4	113.9	4.0	4.6	2.9	45.1	2.5	8.4	5.4	6.2	2.9	4.9	6.8	5.5	2.6	11.8	24.0	3.0	0.0	1.2	5.2	0.0	9.4	18.2	0.0	2.9	3.8	0.4	0.1	0.2	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.7	0.2	0.0	1.9	0.0	2.8	0.0	9.3	0.0	0.0	6.9	0.6	0.5	0.0	3.4	0.0	0.0	0.0	1.4	22.7	0.3	0.0	0.1	1.5	0.0	1.1	0.0	0.9	0.1	1.3	1.0	0.0	16.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.7	0.0	0.0	1.3	0.4	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	2.7	4.2	2.2	2.2	2.9	3.1	2.9	2.5	2.9	3.0	7.7	3.2	5.3	1.0	0.0	3.1	0.8	1.7	27.3	0.1	0.8	5.2	24.9	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.9	3.4	117.1	8.0	0.0	0.0	5.3	0.0	0.1	15.9	0.0	2.7	0.0	14.3	0.0	0.0	0.6	0.0	22.5	0.0	0.0	0.0	3.9	3.5	43.8	0.8	3.6	9.4	0.0	0.1	0.0	2.0	1.0	0.2	0.0	68.1	0.0	1.4	0.0	0.5	0.0	0.5	52.6	0.6	108.6	0.7	0.7	7.1	2.7	0.1	0.9	0.3	0.0	0.4
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617386-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 131.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	14.0	20.7	7.8	12.4	10.0	7.9	12.8	10.0	15.9	16.1	10.3	14.8	17.2	14.2	11.2	12.9	13.6	13.4	14.3	10.6	8.9	20.3	20.4	12.7	11.4	8.1	8.7	16.5	15.4	131.7	7.1	19.6	8.7	16.7	16.4	16.2	17.3	16.7	14.7	11.8	16.9	14.3	9.2	11.2	15.3	12.0	9.9	12.6	32.6	16.4	13.8	14.5	7.6	11.2	17.4	27.3	33.7	25.6	45.0	44.6	22.3	32.6	37.5	23.7	26.9	22.7	32.7	16.3	15.7	25.1	23.2	20.5	28.4	24.6	25.8	36.4	16.2	21.1	19.8	16.2	36.3	28.8	29.8	33.2	33.0	26.3	26.9	34.9	30.7	18.4	27.2	44.1	33.6	27.0	24.8	10.2	21.7	40.4	15.7	24.3	11.6	28.2	26.3	32.6	25.8	33.4	18.3	27.0	28.5	25.8	26.8	17.5	31.5	29.2	15.7	24.3	21.0	47.9	68.0	21.5	34.9	17.0	32.7	20.5	12.9	14.7	15.3	16.5	19.4	10.4	13.9	13.9	15.8	12.1	13.0	12.4	10.0	14.6	17.9	10.8	14.3	11.0	7.8	10.0	10.0	15.9	10.6	8.9	8.1	8.7	8.7	9.2	9.9	11.2	8.3	9.6	9.3	7.8	9.5	4.6	8.0	6.3	6.8	8.6	8.3	5.7	19.8	8.6	11.5	5.5	12.5	14.3	12.5	9.8	1.9	12.8	34.6	8.0	11.1	10.0	5.4	8.2	10.4	12.7	12.0	10.6	7.7	9.9	21.5	7.3	8.2	11.8	10.4	11.8	12.7	7.7	6.1	11.9	5.1	13.7	10.8	9.1	5.4	6.5	6.4	8.5	7.2	8.5	14.1	8.6	6.7	14.7	9.0	7.8	9.7	5.8	5.2	6.5	6.6	9.5	8.8	6.5	5.4	10.6	3.4	8.6	12.0	10.6	11.3	7.0
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	3.2	9.9	1.4	2.8	1.8	8.5	4.1	3.1	2.4	2.8	1.8	2.3	1.4	4.6	3.1	2.9	3.3	3.0	2.8	2.0	1.8	4.3	3.4	3.2	3.5	1.4	1.6	11.3	3.3	6.1	3.6	3.0	1.5	3.4	2.6	5.2	2.7	3.3	3.3	2.8	1.8	2.7	1.6	2.8	3.1	7.1	1.7	4.5	5.7	2.5	3.0	2.5	2.3	1.6	2.8	1.8	4.3	3.3	3.3	5.6	3.8	3.1	4.9	4.6	4.8	1.4	3.1	9.8	1.3	2.7	2.3	1.9	5.1	2.6	6.3	3.5	3.0	5.4	3.6	2.3	2.5	8.0	2.8	3.9	2.7	2.8	2.5	3.7	3.9	4.8	5.4	5.5	3.9	1.6	6.8	3.1	2.2	2.7	3.2	4.5	3.7	3.6	3.7	2.2	2.7	4.1	4.9	3.8	2.5	2.8	1.6	1.7	3.3	2.9	2.4	3.3	3.4	6.2	5.3	6.1	3.3	4.8	2.2	6.1	4.2	8.6	4.7	4.7	4.6	7.4	5.7	5.8	3.0	7.2	7.1	6.2	2.8	4.3	3.5	4.4	5.5	2.1	1.4	1.8	3.1	2.4	2.0	1.8	1.4	1.6	1.5	1.6	1.7	1.6	8.7	0.0	5.3	9.8	40.4	0.0	4.2	0.0	26.7	56.5	11.7	21.8	5.9	7.2	0.6	35.0	112.6	14.5	51.6	6.2	5.9	7.0	73.1	9.2	9.5	8.4	17.4	10.3	29.8	6.5	14.8	12.9	11.2	13.0	33.7	15.6	12.8	6.9	17.2	50.5	29.8	7.2	0.0	36.5	0.0	13.4	18.0	63.7	0.0	17.8	10.9	48.1	16.5	20.6	16.3	7.4	6.2	17.0	18.4	4.1	7.4	5.5	1.5	81.1	13.1	6.2	18.5	36.5	19.6	4.3	0.0	15.2	61.2	18.5	6.3	2.0
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072776	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 80.2"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	35.0	11.4	4.6	7.0	6.3	3.3	22.6	2.0	7.1	35.1	9.8	47.0	4.9	16.9	9.8	35.7	35.1	13.0	38.7	6.0	2.6	9.7	7.9	15.1	5.8	3.1	4.7	33.4	9.2	16.0	6.2	10.7	3.5	26.0	8.0	14.4	11.1	20.0	38.6	22.2	16.6	13.3	3.6	9.8	26.3	11.8	5.5	11.3	16.9	33.1	6.7	44.2	30.8	4.1	21.0	8.3	4.4	9.2	33.2	45.1	46.0	28.3	23.5	17.9	13.8	21.6	11.8	0.0	4.7	24.4	15.0	10.1	16.4	23.4	21.5	11.4	10.9	7.2	6.2	0.7	51.2	7.1	8.0	23.4	17.9	22.3	19.0	22.7	22.0	6.0	1.0	38.3	32.3	25.5	4.5	0.0	4.1	13.9	4.0	8.1	12.7	24.5	12.3	19.0	10.7	5.1	7.4	29.6	7.9	19.0	3.7	0.6	21.9	16.8	12.9	10.3	13.8	14.2	1.8	0.1	25.5	0.9	15.1	0.0	1.7	16.7	5.3	0.1	10.5	0.0	4.1	6.2	3.0	0.0	1.2	6.0	0.2	5.3	0.1	0.1	5.4	2.4	4.6	6.3	2.0	7.1	6.0	2.6	3.1	4.7	3.5	3.6	5.5	4.1	18.5	3.2	4.1	5.5	1.5	14.4	7.9	7.0	16.5	7.1	13.0	15.4	64.8	5.7	3.5	1.8	43.8	29.0	11.1	0.2	0.0	5.8	13.6	16.3	83.5	11.8	0.0	1.3	63.3	16.0	48.2	45.6	11.2	31.8	1.3	21.7	4.2	13.0	20.9	3.3	26.7	0.4	0.0	6.2	33.7	10.2	137.6	24.2	5.4	46.9	58.4	8.2	8.2	124.7	2.1	14.0	0.1	121.1	3.2	4.5	0.8	15.0	1.3	132.9	144.7	22.7	107.3	4.7	13.3	15.7	10.2	12.7	16.0	9.1	1.1	3.1
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.6	4.5	4.5	3.7	5.6	1.0	4.8	9.2	11.7	5.6	4.0	21.8	8.7	6.2	3.8	3.1	5.9	5.8	9.4	13.7	3.5	12.1	8.5	7.3	3.1	3.0	5.9	14.7	7.6	12.5	5.5	1.8	3.0	3.7	26.2	8.5	10.7	4.3	12.1	3.0	15.3	4.9	3.2	5.2	8.3	4.3	6.1	2.9	19.7	14.1	2.1	5.9	3.3	4.8	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.6	1.0	0.2	0.0	1.3	0.7	0.1	0.2	2.3	0.2	0.6	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	9.7	6.0	0.9	0.0	6.9	2.0	0.0	0.0	0.0	0.1	1.2	6.1	0.5	0.0	0.1	7.8	0.1	0.1	0.0	0.0	1.4	0.6	0.1	0.7	0.0	8.7	4.3	2.5	0.1	0.8	0.0	0.0	0.1	1.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.8	0.1	0.7	0.4	0.0	0.2	1.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	4.5	5.6	9.2	11.7	13.7	3.5	3.0	5.9	3.0	3.2	6.1	4.8	11.9	28.9	13.9	265.8	5.1	2.0	2.2	0.4	6.2	10.3	6.2	5.8	20.3	7.2	6.7	11.0	18.8	0.9	1.0	76.1	9.8	3.0	68.2	2.1	1.1	8.2	18.0	0.0	275.7	5.8	0.5	5.9	13.7	2.6	5.7	6.4	8.6	7.0	0.6	13.5	269.9	44.6	6.1	2.9	2.4	41.8	4.4	1.7	7.2	176.1	1.2	8.1	1.0	230.2	95.7	3.2	26.8	3.8	0.8	1.8	26.4	2.3	4.7	9.6	0.0	14.7	5.1	1.8	5.6	2.6	1.7	0.1	4.9	1.8	21.5	2.1
IQCM		ENSG00000234828	"IQ motif containing M"	A0A1B0GVH7	4	149351709-149896233	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"testis: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 83: Testis - Spermatogenesis"								"unprognostic (3.22e-1)"			"unprognostic (1.17e-3)"		"unprognostic (2.18e-1)"						"unprognostic (2.85e-2)"	"unprognostic (1.91e-1)"		"unprognostic (8.47e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078445-150257438	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0"	"Group enriched"	"Detected in many"	6	"Astrocytes: 501.1;Excitatory neurons: 189.8;Inhibitory neurons: 173.2;Oligodendrocyte precursor cells: 172.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.6;BJ: 11.8;BJ hTERT+: 24.9;fHDF/TERT166: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	1.7	2.8	45.8	0.9	42.0	0.5	1.4	34.6	43.6	2.0	7.7	5.6	1.4	2.7	2.0	1.5	1.9	2.5	12.2	59.0	41.2	2.3	0.6	2.1	0.4	41.2	46.6	2.9	2.2	0.6	8.3	1.5	38.4	2.7	2.0	18.4	0.8	2.0	1.2	1.0	2.2	4.7	46.6	1.2	2.3	2.8	42.7	0.2	2.6	1.4	0.3	2.6	1.3	46.8	1.2	4.2	23.6	3.7	0.0	1.1	0.4	11.8	24.9	3.5	0.9	0.1	0.0	0.0	0.4	11.0	3.6	0.1	3.5	0.0	4.4	5.1	2.1	0.0	7.0	0.0	5.0	0.7	0.7	0.6	0.0	2.2	0.2	2.2	1.2	0.6	0.0	0.1	2.5	0.2	0.4	0.0	0.5	0.3	1.6	0.0	2.8	1.0	0.1	1.0	9.2	9.1	4.7	3.4	1.0	2.0	0.0	0.1	2.1	3.3	1.3	2.2	1.3	1.1	0.0	0.1	3.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	45.8	42.0	34.6	43.6	59.0	41.2	41.2	46.6	38.4	46.6	42.7	46.8	10.7	0.0	0.0	501.1	0.6	0.5	0.1	0.0	0.6	26.2	2.8	2.2	10.5	1.5	0.7	3.7	16.7	0.0	0.0	0.8	0.0	0.4	0.1	0.4	4.6	7.6	3.0	0.0	189.8	0.7	0.0	3.4	1.1	0.5	4.5	5.7	7.5	0.0	1.6	35.3	173.2	0.3	0.0	0.6	3.4	0.3	1.8	0.7	5.4	43.1	0.2	31.2	0.0	172.4	37.6	0.1	0.4	3.8	0.3	0.6	0.0	0.4	0.1	9.6	13.1	5.6	9.2	0.1	2.0	0.1	0.6	0.3	0.9	6.6	1.4	0.2
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150582151-150584693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 174.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.0;Cholangiocytes: 28.6;Horizontal cells: 25.2;Muller glia cells: 7.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3;pancreatic cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTERT-RPE1: 101.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.9	4.1	0.7	8.7	0.7	0.0	0.1	1.0	1.0	0.0	7.5	174.2	9.0	0.1	1.3	1.4	0.1	1.0	1.1	0.5	1.8	0.0	0.9	0.0	0.0	16.8	10.4	0.0	0.1	0.0	0.2	0.0	17.0	0.1	10.2	7.4	5.8	0.3	0.2	0.2	38.7	20.3	5.7	0.0	0.5	0.0	2.0	0.7	3.3	0.0	0.0	0.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.5	0.0	0.0	0.0	101.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	1.0	1.0	0.5	1.8	16.8	10.4	17.0	5.7	2.0	3.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	1.4	28.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	25.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099624-151104642	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	2233.9	1361.3	1032.4	1357.8	1063.0	4321.5	4603.8	1034.9	1672.3	3236.5	1041.5	1964.3	1314.5	1964.8	2303.4	2250.6	2307.9	1186.8	1430.3	992.0	1052.4	1657.2	1371.0	1471.0	3341.7	1038.8	1025.1	4877.7	3514.8	1107.6	1325.8	1372.7	1059.4	1982.7	1778.1	861.8	2107.7	1322.9	1967.9	2992.3	1848.5	1337.8	1102.5	2038.6	1898.7	586.2	1056.2	2991.3	1965.5	1499.1	2764.4	1969.9	2486.8	1089.1	2090.9	1501.8	2780.1	2751.6	3524.5	6867.8	2849.1	2150.7	3334.5	3006.4	1848.2	2933.6	2944.4	9381.3	1048.4	2383.2	1050.5	1339.3	2877.1	3624.3	2840.5	2075.6	2762.0	2023.6	1589.8	3421.2	4067.8	4855.0	1999.1	5125.5	7353.9	1849.5	4874.5	4195.4	3639.4	3417.8	3320.0	4722.3	3632.8	3124.8	5289.7	5604.8	2624.1	3296.7	1147.0	3798.0	2719.3	3175.4	3505.2	2487.1	2668.0	2635.2	971.4	3495.1	5019.9	1954.5	2341.0	5780.5	2212.2	1451.6	1915.8	1618.1	2424.7	3626.8	6367.6	5820.6	1863.4	3508.9	1758.5	1918.8	3362.4	977.5	3828.9	2626.4	6462.8	7155.1	6390.5	5052.0	5393.2	6165.0	8750.8	7174.2	495.2	5199.2	2256.0	6377.8	5103.3	18540.3	1032.4	1063.0	1034.9	1672.3	992.0	1052.4	1038.8	1025.1	1059.4	1102.5	1056.2	1089.1	2387.5	971.2	1605.1	15.0	5574.2	6158.3	8280.0	5535.6	4255.3	412.4	6080.4	8681.6	381.3	2194.8	2530.5	825.8	120.9	4538.4	4799.4	1188.9	4284.8	2316.3	1754.6	1570.1	3613.3	2564.2	2154.3	3366.6	17.8	3732.2	7502.1	2388.6	1599.9	1895.7	1468.6	3424.3	2653.9	1441.0	3403.7	163.2	18.6	4137.0	1454.6	4309.4	5658.7	4012.5	4428.4	3332.7	3260.3	20.6	5502.6	1760.6	4551.0	23.6	22.4	2788.3	3029.1	2592.3	2412.5	6111.5	2682.0	5073.3	1084.8	593.9	1768.4	4410.8	3918.5	834.4	820.8	5042.0	6756.0	4591.7	4520.4	4186.2	5049.9	7641.8
SH3D19	"DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19"	ENSG00000109686	"SH3 domain containing 19"	Q5HYK7	4	151102751-151325605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 360.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 190.3;ASC TERT1: 161.0;HSkMC: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016424, HPA058562"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA016424: AB_1856814, HPA058562: AB_2683758"	"unprognostic (1.09e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.64e-2)"	70.8	15.7	9.8	12.8	14.9	0.2	31.5	6.0	9.6	22.5	104.9	44.2	44.4	23.2	10.7	40.8	23.7	63.7	64.1	6.8	11.6	27.2	49.9	36.2	5.1	8.8	10.3	42.9	15.2	19.9	5.0	27.9	8.8	27.1	48.3	12.8	17.3	40.5	17.7	30.0	49.0	41.4	5.1	7.4	22.6	12.4	11.5	3.9	25.1	33.8	7.9	33.3	20.6	18.6	26.3	19.2	12.1	9.5	190.3	161.0	26.0	31.8	34.0	13.9	14.4	24.9	31.6	0.0	12.5	29.9	22.7	19.2	12.8	36.6	13.5	0.1	10.1	0.0	22.2	26.7	46.0	0.1	0.1	129.1	27.6	20.9	32.0	23.9	81.9	0.0	0.0	0.1	36.9	10.9	0.0	0.4	24.3	40.3	27.6	0.0	0.9	0.4	17.3	18.3	0.9	16.3	22.7	23.0	18.5	24.7	7.5	0.1	59.9	43.6	15.6	19.5	12.9	0.1	0.0	0.1	22.6	0.1	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.8	14.9	6.0	9.6	6.8	11.6	8.8	10.3	8.8	5.1	11.5	18.6	36.7	22.4	32.5	8.1	2.9	28.6	14.1	12.3	18.8	6.6	20.5	25.0	88.5	34.3	29.2	16.5	14.6	25.9	5.0	103.5	5.9	11.9	4.4	17.6	38.1	29.1	18.6	7.0	55.8	15.4	20.7	77.9	38.7	13.7	21.5	37.5	21.8	46.4	7.4	6.7	30.0	35.6	10.2	4.6	20.2	6.7	62.1	4.8	26.6	74.0	1.2	20.8	5.2	263.9	360.1	21.3	55.9	48.2	3.2	41.5	88.2	27.2	52.4	11.0	13.1	46.0	26.3	2.9	6.0	16.7	38.5	27.2	5.5	20.3	54.0	41.2
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"choroid plexus: 18.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 2.2;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 3.7;Sertoli cells: 6.6;Spermatocytes: 3.1;Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	1.6	0.0	2.2	0.0	0.0	2.8	1.6	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	2.8	1.6	1.0	2.8	2.9	1.0	3.4	0.8	1.9	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.1	0.0	3.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409176-151670503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 32.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 11.9;Excitatory neurons: 15.8;Oligodendrocyte precursor cells: 19.1;Suprabasal keratinocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	11	"cerebellum: 13.8"	"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 8.6;HeLa: 10.0;hTERT-HME1: 9.2;SiHa: 8.9;SK-BR-3: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	0.6	1.3	0.8	0.3	0.7	1.8	4.4	13.8	1.2	3.2	32.3	3.3	1.9	1.6	4.0	7.8	2.7	0.9	3.4	1.2	0.0	3.4	0.7	1.9	0.2	0.6	0.6	2.4	10.2	8.3	1.3	0.5	0.8	2.2	3.4	6.7	4.7	1.5	34.5	13.4	2.0	1.1	0.3	0.5	2.5	3.4	0.4	1.5	6.8	16.5	2.3	2.2	3.4	0.2	8.6	0.7	0.0	0.2	0.0	0.1	2.9	0.3	1.4	0.8	0.2	3.6	3.0	0.0	0.8	0.3	2.6	7.4	2.1	6.1	0.9	0.0	3.3	0.0	10.0	0.9	0.0	0.0	0.2	0.2	7.0	0.0	9.2	2.4	0.2	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.8	2.8	0.8	0.0	2.0	0.2	5.1	5.5	1.2	0.4	8.9	7.8	0.2	2.2	3.3	0.0	0.0	0.4	3.7	0.2	1.4	0.0	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	13.8	1.2	1.2	0.0	0.6	0.6	0.8	0.3	0.4	0.2	0.1	3.2	2.0	1.3	0.0	11.9	6.6	2.9	10.8	0.1	2.7	1.9	1.8	0.0	5.2	0.0	0.0	0.3	0.5	5.9	0.0	1.6	3.3	5.9	0.6	0.4	0.0	0.0	15.8	1.8	0.6	0.6	6.1	10.8	1.3	0.3	0.0	0.5	0.3	8.4	2.4	2.3	0.0	0.0	2.1	1.5	0.0	0.6	0.0	1.0	0.0	2.5	0.0	19.1	1.3	1.9	0.3	0.0	1.4	7.9	2.2	0.7	1.3	4.7	0.0	1.0	0.4	6.1	5.8	11.6	14.5	1.6	0.2	0.3	1.8	8.6
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.8	15.6	15.4	5.6	17.5	9.5	8.3	18.0	20.4	6.7	14.9	9.8	5.8	5.5	8.3	10.3	8.7	5.5	33.3	16.3	16.9	21.6	22.2	5.3	7.6	17.4	16.5	11.3	5.3	18.3	5.2	8.6	17.1	5.5	9.6	17.0	7.9	6.4	23.0	9.4	6.4	8.0	17.7	6.5	8.2	8.0	17.2	12.2	7.5	40.3	9.7	6.9	6.1	20.4	14.9	11.6	16.1	15.7	22.9	21.7	13.9	19.3	24.9	33.3	25.8	19.5	23.8	20.2	5.0	20.1	20.3	13.7	34.5	36.6	35.3	11.4	21.1	9.4	15.2	40.7	22.4	19.1	9.0	22.8	23.1	32.0	11.2	19.2	25.1	28.0	36.8	17.1	26.0	16.7	24.1	20.8	16.6	12.4	21.1	20.4	15.5	16.1	30.2	12.3	16.5	18.5	15.8	21.1	23.1	15.4	17.9	13.7	14.1	16.8	9.1	11.7	13.4	20.3	28.2	16.8	23.7	16.9	12.5	0.9	11.6	2.0	4.5	16.9	7.3	11.4	6.1	6.5	20.9	9.9	7.8	7.3	1.1	8.7	12.1	8.1	7.0	10.8	15.4	17.5	18.0	20.4	16.3	16.9	17.4	16.5	17.1	17.7	17.2	20.4	4.3	9.6	4.8	11.4	6.7	0.0	6.0	0.0	5.7	9.8	6.3	7.1	64.8	1.5	3.7	11.0	8.4	23.4	2.9	3.2	27.4	11.2	8.0	6.7	7.3	4.4	2.4	15.6	28.4	7.4	16.6	8.8	6.6	7.1	1.3	12.3	2.5	17.2	17.1	10.1	16.4	4.2	0.0	7.3	0.0	10.6	5.3	7.6	0.0	15.9	10.8	333.3	1.0	14.1	27.5	6.9	4.9	4.5	5.6	3.1	6.3	22.7	1.5	17.1	6.6	6.5	5.9	14.3	14.0	10.6	0.0	13.4	3.6	12.5	7.1	4.5
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536092	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 201.8;Excitatory neurons: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	14.2	9.5	37.9	15.0	43.1	19.8	14.2	54.3	66.9	8.7	6.7	9.5	7.8	8.6	24.3	14.3	15.6	9.2	24.7	48.2	23.0	6.7	11.2	11.4	16.1	17.1	20.9	9.1	12.8	7.8	9.2	9.4	18.1	7.8	10.3	18.0	11.8	7.5	26.0	63.1	10.4	9.1	11.8	16.2	13.0	22.8	29.4	14.7	10.3	19.7	20.3	11.9	10.7	47.4	9.8	8.0	19.1	14.2	12.2	9.4	16.2	13.4	12.9	8.5	8.1	15.7	12.0	24.7	3.9	13.7	6.5	5.2	16.9	30.9	12.1	16.2	8.0	11.9	10.7	10.9	12.7	29.2	10.6	14.8	45.7	15.2	24.4	8.4	15.2	20.5	19.2	25.7	10.8	13.7	34.9	10.6	9.7	8.0	6.1	32.2	8.0	5.3	9.8	17.0	12.7	10.2	8.5	11.3	7.5	21.6	6.4	12.6	15.6	11.3	12.6	5.4	8.2	79.0	47.5	24.4	9.4	9.2	8.3	23.5	2.7	1.6	4.0	3.0	2.7	2.8	3.1	2.7	1.6	1.8	3.4	2.5	4.8	7.1	2.2	2.1	2.9	1.3	37.9	43.1	54.3	66.9	48.2	23.0	17.1	20.9	18.1	11.8	29.4	47.4	29.5	9.6	22.9	80.0	48.1	201.8	36.5	29.9	120.1	74.9	32.1	30.9	61.8	12.8	15.1	9.2	31.3	10.9	54.7	22.2	3.9	14.3	17.4	37.7	37.3	36.1	14.5	30.1	529.6	13.5	39.9	27.2	21.4	61.6	15.8	19.1	17.9	18.3	10.5	11.8	186.5	16.4	32.6	18.8	47.0	10.2	15.2	33.7	28.4	172.4	28.0	37.0	35.0	102.5	99.8	18.7	18.2	11.3	174.5	36.3	8.9	7.5	11.9	41.4	13.1	33.2	25.5	74.1	87.2	57.0	174.9	31.2	46.2	18.7	14.9	70.5
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618628-152680012	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 58.3;skin 1: 58.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 6.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 477.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	3.1	0.5	0.3	17.2	0.7	18.6	4.3	0.6	1.7	5.7	0.5	3.1	2.6	1.6	0.7	58.3	1.4	5.1	0.8	0.4	0.7	0.6	5.9	5.1	14.3	0.8	0.6	0.2	1.0	0.3	0.8	3.8	1.1	2.0	2.6	0.2	6.9	2.3	0.4	58.5	3.6	1.8	0.7	12.4	5.9	0.2	1.0	6.2	3.6	1.9	26.4	11.6	7.9	1.0	32.1	0.1	0.3	0.1	0.5	8.7	14.1	8.0	29.1	8.5	16.2	0.4	4.2	32.5	3.3	7.6	9.3	22.8	0.0	63.0	15.5	0.1	0.1	1.8	0.5	0.0	8.9	25.7	71.1	8.3	29.7	27.1	23.4	0.0	21.4	19.7	0.1	55.6	0.7	2.3	10.1	8.0	1.6	0.1	7.8	1.2	0.1	0.2	47.5	19.4	0.1	1.2	2.2	6.2	1.0	8.4	1.0	17.8	8.6	1.2	5.1	0.7	11.1	69.7	26.0	18.1	11.7	56.6	6.6	403.7	37.8	305.7	4.9	38.2	9.2	51.6	10.9	7.9	19.6	45.1	10.7	7.4	477.5	0.8	43.7	2.5	22.5	17.2	0.3	0.7	0.6	1.7	0.4	0.7	0.8	0.6	1.1	0.7	1.0	1.0	6.5	12.8	19.3	0.0	108.6	74.2	9.0	23.6	20.5	0.1	8.8	4.8	1.7	0.0	20.9	22.0	2.1	25.0	9.8	0.9	0.0	6.4	0.1	31.9	13.4	6.7	1.2	6.6	0.5	3.7	14.5	5.2	8.2	75.0	101.2	0.1	0.7	4.6	4.5	3.3	0.3	0.7	14.2	9.8	15.7	0.2	0.6	28.2	5.4	15.9	82.1	0.1	5.2	3.5	0.1	21.5	7.1	0.0	45.7	5.4	0.0	0.3	60.5	0.7	0.0	3.0	3.6	0.1	0.5	119.2	194.4	25.9	28.6	0.5	2.6	27.2
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779730	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 22.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 107.6;Rod photoreceptor cells: 30.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.1;U-266/70: 4.5;U-266/84: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035649, HPA073768"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Nucleoplasm	"HPA035649: AB_10670956, HPA073768: "	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.2	0.3	0.6	0.2	0.7	0.0	0.4	0.6	0.7	0.8	1.3	0.2	0.3	0.7	1.2	0.1	2.0	0.2	0.3	0.5	0.9	0.7	0.1	0.4	0.1	1.1	1.2	0.5	0.2	1.5	1.2	0.1	0.8	0.4	0.2	22.1	0.7	0.3	0.4	0.4	0.2	0.2	1.0	0.2	0.3	4.9	0.8	0.3	0.7	0.8	0.1	0.2	0.1	0.8	0.4	0.4	2.0	0.8	0.1	0.2	0.2	0.0	0.4	0.2	0.4	0.3	0.9	0.7	0.1	0.1	0.9	0.4	0.8	0.3	0.3	0.7	0.1	1.0	0.6	0.2	0.1	0.4	0.2	0.0	0.3	0.3	0.2	0.4	0.1	1.5	0.3	3.1	0.2	0.2	2.0	0.2	0.9	0.3	0.3	0.3	0.4	0.0	1.3	0.1	0.9	1.0	0.1	0.2	1.9	0.9	0.5	0.1	0.0	0.2	0.4	0.3	0.4	4.5	9.4	0.4	0.6	1.1	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.8	0.4	0.0	1.5	8.5	0.6	0.0	0.4	0.6	0.6	7.9	0.8	0.8	0.1	0.0	0.3	1.8	12.5	0.2	0.8	0.2	0.0	0.7	107.6	6.9	0.6	0.7	1.2	0.4	6.5	1.1	0.2	0.4	1.1	1.4	0.0	0.2	0.0	0.1	0.5	1.7	6.3	0.4	0.0	0.3	0.0	14.0	0.3	0.5	0.0	5.6	0.0	14.1	0.0	5.5	2.1	0.4	1.1	0.4	0.0	0.4	0.4	2.0	9.3	30.3	0.0	1.0	0.5	8.3	3.2	0.0	0.0	0.3	0.6	0.1	0.4	0.3
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	16.8	14.8	7.9	15.8	8.7	3.7	23.4	9.9	10.8	22.5	9.9	28.1	23.2	21.7	20.5	20.9	18.5	19.9	10.2	7.3	9.3	19.8	15.4	16.8	15.1	9.3	8.0	17.6	10.5	22.4	10.5	18.0	9.5	21.1	27.8	20.2	13.7	17.2	6.6	17.3	21.3	19.8	9.4	18.3	22.7	12.1	8.3	12.0	20.1	10.4	14.8	23.5	15.2	11.4	25.8	18.4	25.1	25.7	37.2	37.9	30.6	29.5	40.5	28.7	26.9	21.3	51.3	20.6	9.9	40.5	22.7	18.1	26.3	29.1	35.3	16.9	16.2	20.0	18.0	20.5	26.1	38.2	41.7	26.6	30.9	24.8	23.8	30.7	26.4	11.8	23.5	43.3	39.8	28.6	22.7	19.8	21.8	29.9	18.5	12.6	14.7	19.2	50.7	32.1	32.8	26.0	22.1	40.7	30.2	23.5	37.7	19.6	17.3	27.8	20.1	26.8	21.4	48.2	42.8	28.1	35.3	38.2	40.0	31.5	27.3	42.2	14.5	31.1	14.6	19.0	11.2	12.2	24.8	17.7	8.7	11.8	81.6	29.1	30.7	3.1	18.5	18.7	7.9	8.7	9.9	10.8	7.3	9.3	9.3	8.0	9.5	9.4	8.3	11.4	28.5	6.4	31.8	40.5	20.3	29.6	18.4	30.7	34.1	17.2	26.2	19.7	10.2	20.0	29.1	38.6	0.0	28.6	15.6	40.9	27.4	27.4	46.3	42.2	33.0	23.8	38.9	12.0	44.5	18.3	27.0	28.8	40.2	50.7	22.8	14.2	17.2	19.8	22.1	18.5	42.8	39.1	34.6	23.8	18.0	21.6	22.4	24.5	21.4	89.9	19.5	35.9	23.7	76.4	75.6	24.4	28.2	21.8	11.8	23.6	23.8	34.2	31.9	24.2	32.9	20.6	27.8	31.7	29.5	31.9	34.0	43.9	17.7	89.2	31.7	30.3
FHDC1	"INF1, KIAA1727"	ENSG00000137460	"FH2 domain containing 1"	Q9C0D6	4	152936323-152979671	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7;parathyroid gland: 17.6;thyroid gland: 15.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 85.9;Erythroid cells: 71.1;Syncytiotrophoblasts: 80.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.6;RT4: 10.5;SK-BR-3: 14.4;WM-115: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008527	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA008527: AB_2104099"	"unprognostic (5.42e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.95e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.30e-1)"	0.7	0.3	1.0	1.2	3.7	14.7	2.1	2.1	2.2	1.6	0.5	3.9	3.5	0.6	1.2	4.9	1.4	1.8	0.3	0.5	1.7	2.0	0.4	8.6	0.8	2.4	1.5	0.3	1.0	17.6	1.5	6.7	2.4	7.2	4.7	1.0	3.9	0.8	0.3	7.9	4.1	0.6	0.7	3.5	4.7	1.2	2.8	0.4	15.7	0.3	2.1	1.6	2.8	1.2	5.7	0.5	1.0	0.8	0.4	0.3	30.6	0.4	1.1	1.2	0.1	0.3	3.4	0.2	0.2	0.5	1.0	1.1	0.3	2.3	0.4	0.6	0.3	0.6	3.5	0.4	0.1	0.2	0.9	0.2	2.8	0.0	0.7	1.2	0.0	0.5	1.4	0.6	0.4	3.5	0.1	0.1	6.3	0.5	0.4	0.1	0.3	0.1	5.6	10.5	5.5	0.2	1.9	14.4	2.1	6.9	2.2	0.4	0.2	0.4	0.9	2.6	1.3	0.8	0.5	0.1	0.2	0.1	10.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.0	3.7	2.1	2.2	0.5	1.7	2.4	1.5	2.4	0.7	2.8	1.2	0.5	16.0	85.9	5.5	0.5	5.9	2.8	16.3	3.4	0.1	4.8	4.1	0.9	2.8	18.8	3.7	2.1	11.9	0.3	11.1	0.0	0.9	2.0	4.5	2.4	2.0	13.8	71.1	10.7	3.1	13.1	2.6	15.3	15.6	3.8	0.5	0.0	0.0	2.1	0.0	13.7	9.3	4.1	0.0	0.8	0.2	0.9	0.6	0.0	7.5	0.0	0.0	0.0	13.0	8.7	7.5	6.2	0.7	0.1	4.7	7.7	0.1	9.3	0.1	0.0	0.5	1.2	1.1	0.8	4.7	7.1	80.0	0.6	1.5	7.6	3.2
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152163-153339319	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 116.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 47.0;SK-MEL-30: 46.8"									"HPA035853, HPA035854"	Supported		Uncertain	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	5.8	11.8	29.5	4.8	64.4	0.1	11.8	38.6	46.2	23.6	0.0	21.6	17.4	9.9	8.0	10.7	15.2	12.6	8.4	48.0	34.8	24.2	7.9	7.2	2.2	40.1	33.2	12.8	12.7	1.0	21.6	2.5	56.3	13.1	19.3	19.4	42.9	13.4	2.1	7.1	17.3	7.0	35.3	10.6	27.4	1.9	37.9	2.9	50.6	3.0	3.9	12.0	11.5	116.2	10.2	0.2	47.0	24.2	22.0	27.2	0.5	12.7	15.4	3.6	4.5	4.1	0.2	0.1	7.7	21.7	8.5	6.4	24.7	4.7	3.2	0.0	5.4	0.1	4.6	0.5	24.7	0.1	0.1	13.5	2.3	5.4	4.7	12.9	3.4	0.4	0.2	0.0	4.9	0.4	2.4	0.1	37.4	27.5	8.8	1.0	9.4	0.0	37.0	11.8	14.5	27.3	4.4	2.7	46.8	6.9	1.7	0.5	2.8	12.7	3.0	10.8	3.9	0.0	0.0	0.1	20.9	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	29.5	64.4	38.6	46.2	48.0	34.8	40.1	33.2	56.3	35.3	37.9	116.2	11.2	6.4	33.7	189.0	2.6	7.0	15.3	40.2	9.1	67.7	40.5	29.1	39.6	17.2	82.1	58.8	29.2	2.0	0.7	59.4	101.8	9.6	3.3	113.3	16.3	17.3	62.3	0.4	266.4	26.1	0.5	22.0	80.0	95.6	1.3	4.8	21.0	12.4	1.4	111.0	211.2	64.1	54.9	0.8	7.7	2.4	29.5	2.2	64.0	21.5	3.2	86.9	0.0	237.2	1132.8	22.5	41.4	32.7	1.5	17.8	62.9	14.7	106.0	23.4	26.3	14.7	16.2	0.4	1.3	5.0	4.0	0.7	2.8	8.7	90.8	33.7
AC013477.1		ENSG00000288637	"Novel protein"		4	153152435-153415081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 2.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;AN3-CA: 1.0;CACO-2: 1.1;RPTEC TERT1: 1.4;SH-SY5Y: 1.0"									"HPA035853, HPA035854, HPA043499"	Uncertain		Approved	Centrosome		NA	NA					"Cluster 35: RPTEC-TERT1 - Kidney processes"		Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659, HPA043499: AB_2732506"																		0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.3	1.8	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.7	1.4	0.1	0.0	0.0	0.0	2.1	1.0	0.1	0.8	0.0		0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	1.5	0.0	0.5	0.0	0.0	0.1		2.7	0.1	0.0	1.0	1.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	1.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.3	1.8	0.7	1.4	2.1	1.0	1.0	0.5	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MND1	GAJ	ENSG00000121211	"Meiotic nuclear divisions 1"	Q9BWT6	4	153344649-153415118	"Predicted intracellular proteins"	"DNA recombination, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.3;lymphoid tissue: 26.7;testis: 15.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.9;Erythroid cells: 30.9;Spermatocytes: 55.5;Spermatogonia: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.3;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043499	Supported					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA043499: AB_2732506"	"unprognostic (2.21e-2)"	"unprognostic (6.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.71e-8)"	"unprognostic (7.65e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.84e-2)"	"unprognostic (7.64e-2)"	0.5	0.5	1.1	4.7	1.2	13.3	2.5	1.0	2.0	0.7	0.7	4.4	3.0	0.7	1.2	3.3	0.5	1.0	0.4	1.1	1.3	0.6	1.3	0.8	12.0	1.4	1.1	0.3	0.3	0.0	0.3	2.4	1.2	0.5	5.1	0.0	0.9	0.9	1.3	2.1	2.6	1.5	1.1	1.8	1.6	15.9	1.3	26.7	0.4	0.5	14.0	1.3	1.3	1.7	38.6	17.7	52.7	30.6	0.7	7.2	20.9	35.1	15.4	31.4	25.6	32.8	26.1	74.4	5.8	8.5	29.5	15.7	52.3	15.8	39.9	47.7	19.9	39.1	17.3	42.9	1.1	88.2	17.9	1.9	3.3	24.4	21.1	7.8	10.7	86.0	71.0	91.9	26.8	21.5	124.1	116.0	39.1	17.9	17.8	74.1	18.2	35.8	19.3	9.7	26.5	23.3	15.7	17.7	30.0	26.5	14.7	72.1	2.6	24.1	34.8	28.1	32.6	79.0	96.0	58.8	24.1	69.6	28.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.0	0.4	0.0	0.1	1.7	0.1	1.1	1.2	1.0	2.0	1.1	1.3	1.4	1.1	1.2	1.1	1.3	1.7	0.2	0.0	0.5	2.6	1.9	2.8	1.8	5.1	0.0	0.0	2.2	4.6	0.6	2.8	0.7	0.0	0.0	14.5	1.0	4.1	1.9	0.3	25.9	3.5	1.6	1.3	0.0	30.9	1.6	0.5	20.6	3.6	2.0	5.7	0.0	11.8	1.4	1.0	12.5	0.0	2.6	4.3	4.1	2.5	5.0	20.5	0.9	2.4	3.6	1.9	0.1	0.0	1.0	2.0	23.3	0.6	1.6	2.2	7.7	1.2	0.7	0.1	1.0	0.0	6.6	0.9	8.6	55.5	96.3	10.2	1.4	2.5	2.5	1.5	10.3	2.7
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.4;lymphoid tissue: 48.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.6;Alveolar cells type 2: 9.6;B-cells: 9.9;dendritic cells: 13.2;Exocrine glandular cells: 9.3;monocytes: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 105.2;MOLT-4: 99.9;U-698: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli fibrillar center"	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"	9.8	1.7	1.6	20.9	4.0	49.4	7.2	1.0	2.7	5.6	1.0	6.4	2.3	6.3	9.4	6.7	5.0	4.9	8.7	1.5	1.6	3.5	20.7	6.6	47.8	1.9	1.4	4.6	31.2	1.1	3.9	3.9	1.9	5.9	4.6	0.4	8.1	4.8	24.5	6.9	10.9	6.9	1.0	24.6	6.1	4.4	2.0	48.3	4.1	6.2	45.4	6.1	6.0	2.8	5.8	3.7	15.7	16.5	9.1	7.9	0.3	8.3	4.0	5.6	7.1	25.8	3.7	105.2	2.0	11.1	6.2	5.7	12.1	14.3	8.5	9.7	8.7	20.6	7.0	6.7	5.9	22.9	1.2	7.3	8.7	7.4	6.9	6.3	14.4	19.1	19.7	0.4	5.7	10.7	99.9	16.6	14.0	0.2	5.4	34.3	15.2	6.8	3.8	2.4	11.7	9.1	6.5	14.2	8.6	8.0	5.5	16.6	11.6	7.5	13.2	9.1	6.9	11.2	12.1	122.4	2.2	13.5	6.2	11.8	19.4	21.1	12.3	36.8	16.7	28.2	15.5	11.7	20.9	27.3	25.8	17.5	21.0	24.3	31.6	2.1	20.9	17.6	1.6	4.0	1.0	2.7	1.5	1.6	1.9	1.4	1.9	1.0	2.0	2.8	13.6	6.4	9.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	5.5	4.3	0.0	0.0	1.8	0.0	0.0	0.5	13.2	0.0	1.9	2.0	0.0	1.3	8.2	3.2	0.0	0.0	0.0	9.3	0.2	3.7	0.0	1.1	5.1	5.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	16.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	4.8	0.0	0.0	1.5	5.8	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	7.2	5.1	0.0	0.0
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	1.5	2.5	18.8	2.9	19.2	6.1	0.8	15.0	27.6	3.0	10.8	0.6	0.1	0.2	0.9	0.6	0.5	1.0	4.0	18.3	21.8	0.2	0.4	1.4	1.2	17.7	15.3	0.1	0.3	0.0	4.0	0.1	17.6	2.4	0.1	3.5	1.4	3.4	0.1	0.7	0.5	0.1	14.1	2.5	0.3	1.6	18.0	0.1	0.2	0.5	0.6	0.5	1.5	17.5	0.2	0.0	8.8	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	7.6	0.0	0.0	0.2	0.1	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	2.4	0.0	2.1	0.0	0.6	0.6	18.8	19.2	15.0	27.6	18.3	21.8	17.7	15.3	17.6	14.1	18.0	17.5	0.1	0.0	0.5	6.8	0.0	0.4	0.1	0.6	0.6	0.7	0.1	0.6	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.2	0.0	0.4	91.4	0.0	0.0	2.9	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	95.7	0.0	0.0	5.9	2.9	14.6	0.0	1.5	1.8	2.8	0.7	0.8	0.0	38.7	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	1.6	0.0	0.0	0.3	1.5	1.3	0.0	0.3	0.0	0.6	0.0	0.0	0.2
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780591-153789083	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 318.8;urinary bladder: 306.7"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 806.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	188.2	16.0	4.9	84.6	4.0	0.3	154.9	3.6	6.3	23.2	11.2	72.2	18.4	12.0	22.2	212.7	62.1	318.8	6.2	12.3	13.8	4.5	0.3	62.5	11.8	4.5	3.7	8.3	45.1	7.0	72.5	0.4	4.6	56.5	44.3	2.3	83.4	70.5	6.5	80.5	57.3	89.5	3.8	0.7	34.4	1.5	2.2	9.6	92.3	38.7	3.6	306.7	63.0	12.3	0.0	0.0	229.1	0.2	85.2	15.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	140.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	318.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	0.1	0.0	8.1	0.2	0.0	0.0	0.4	0.1	0.0	12.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.0	3.6	6.3	12.3	13.8	4.5	3.7	4.6	3.8	2.2	12.3	15.5	3.2	0.6	9.4	0.5	115.5	0.8	0.0	5.7	0.0	3.7	7.9	0.3	0.0	1.9	0.0	0.0	0.1	2.0	0.0	0.0	0.2	0.0	0.1	0.1	11.8	0.0	0.0	0.7	0.0	0.2	806.1	38.7	0.3	1.3	0.0	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.0	175.0	0.5	4.1	5.0	119.2	0.0	0.6	0.0	0.0	0.5	0.1	0.1	0.0	7.2	4.1	0.7	0.0	0.1	2.9	0.0	0.0	6.7	59.4	0.0	0.1	6.9	106.0	0.1	8.6	0.0	0.0	0.9
DCHS2	"CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ"	ENSG00000197410	"Dachsous cadherin-related 2"	Q6V1P9	4	154231742-154491799	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 63.0;Early spermatids: 20.7;Excitatory neurons: 30.3;Horizontal cells: 25.2;Inhibitory neurons: 13.2;Late spermatids: 19.4;Microglial cells: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"U-2 OS: 4.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA064159	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Plasma membrane"		"HPA064159: AB_2685201"	"unprognostic (1.38e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-3)"	0.0	0.1	0.6	0.0	0.8	0.0	0.1	0.3	0.5	0.9	0.0	1.7	0.0	1.4	0.0	0.0	0.9	0.1	0.0	0.4	0.8	0.1	0.0	0.1	0.0	0.5	1.3	0.7	0.0	0.0	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.2	0.3	0.1	0.7	0.0	1.2	1.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.5	0.4	0.8	0.5	1.3	0.3	0.7	1.1	1.4	0.0	0.0	0.0	63.0	0.0	0.4	0.2	0.8	0.0	0.4	0.8	0.6	1.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.7	0.1	0.5	0.3	6.7	0.0	30.3	0.0	0.0	1.8	3.6	0.0	0.0	1.2	0.0	0.0	0.1	25.2	13.2	0.1	0.0	0.0	0.7	19.4	0.6	0.0	0.0	13.1	0.0	0.2	0.0	6.6	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.2	0.0	0.3	0.5	1.7	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535005-154550400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	29.4	21.9	22.8	24.9	26.3	31.1	38.7	26.0	24.3	32.8	20.8	30.9	24.8	34.0	28.6	33.9	34.2	24.8	25.9	22.6	32.6	38.1	43.8	27.3	35.2	30.5	26.8	34.0	19.6	41.1	16.0	28.3	30.7	27.4	34.2	26.4	25.8	33.7	31.7	26.4	25.8	44.6	33.5	27.7	26.4	21.4	25.3	40.4	38.0	39.5	51.2	34.8	22.7	39.2	73.2	58.6	73.7	79.4	85.1	73.5	62.3	91.6	111.2	121.9	98.9	69.3	62.7	79.1	45.7	109.1	80.3	52.4	97.2	122.1	134.5	80.2	48.7	95.1	45.1	67.8	87.0	96.0	76.4	79.7	110.8	144.6	112.6	73.0	106.1	85.3	98.9	98.2	107.2	52.3	73.9	45.7	56.1	57.5	62.7	72.2	38.5	48.2	84.8	46.1	43.0	48.6	55.9	59.3	91.7	69.4	57.1	66.4	69.3	72.4	81.9	64.6	82.9	50.9	72.0	100.6	68.1	45.6	98.8	53.0	37.0	29.7	41.6	43.3	49.9	47.0	43.5	45.7	47.6	36.2	45.9	43.2	9.4	67.6	63.9	46.4	55.7	49.4	22.8	26.3	26.0	24.3	22.6	32.6	30.5	26.8	30.7	33.5	25.3	39.2	26.9	25.6	18.1	29.0	26.9	16.3	31.2	98.7	18.2	26.2	19.6	22.9	24.7	20.0	50.7	22.0	12.5	49.1	23.6	18.0	15.6	48.0	31.7	22.7	33.0	27.5	27.1	30.5	23.6	34.7	37.9	30.9	17.9	20.3	45.7	27.0	16.1	26.8	34.2	62.2	21.7	15.9	73.2	19.3	12.0	5.8	28.0	17.2	14.2	17.8	36.8	31.2	28.8	14.1	25.0	32.6	20.9	35.0	21.8	14.9	33.7	35.0	45.2	21.4	19.7	31.2	40.8	36.4	30.2	25.0	17.3	44.3	26.9	36.8	22.3	20.6
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			2.0	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	1.3	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.4	0.0	0.0	48.0	17944.9	0.5	0.1	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.1	6.8	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16556.3"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.7	34.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.0	1.2	0.0	0.0	8.8	16556.3	50.2	0.1	0.0	0.0	1.4	15.8	0.0	0.4	6.3	0.0	0.4	0.0	0.0	0.4	0.3	0.4	0.5	0.6	0.0	0.0	9.1	8.7	3.0	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753120	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.2	0.2	0.6	0.2	0.7	0.5	0.4	0.7	2.6	0.2	1.6	0.5	1.2	0.1	0.3	0.0	0.2	0.5	0.1	0.7	1.2	0.1	2.1	0.3	0.1	1.0	1.1	0.3	0.8	0.2	0.2	0.1	1.3	0.4	0.1	1.0	0.1	0.5	0.8	0.4	1.6	0.1	0.7	0.1	0.3	0.8	0.7	0.0	1.5	0.0	0.1	0.1	0.1	0.9	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.1	1.4	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.6	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.5	0.2	0.1	0.1	0.8	0.2	0.2	0.2	0.1	2.2	0.6	0.7	0.7	2.6	0.7	1.2	1.0	1.1	1.3	0.7	0.7	0.9	0.2	0.0	4.4	4.6	0.1	1.1	4.4	4.0	0.6	0.5	8.6	9.1	0.3	11.5	1.7	0.0	0.0	0.1	0.3	0.8	3.9	1.2	15.2	0.9	0.5	0.3	0.0	0.0	2.2	0.8	0.1	1.5	2.0	2.2	0.0	104.4	1.4	2.2	0.1	0.0	0.6	0.9	2.0	0.8	2.8	3.2	0.0	0.3	5.4	0.0	0.0	3.9	0.0	1.0	2.2	1.2	0.0	0.0	0.0	2.4	12.3	1.0	0.9	0.8	0.0	1.4	8.1	10.5	4.7	1.4	1.1	0.3	0.6	0.0	1.2	0.6
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 27.6"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 135.7;Spermatogonia: 82.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	8	"spinal cord: 12.9"	HPA037746			Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA037746: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	27.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.6	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	4.3	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	9.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	135.7	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPY2R		ENSG00000185149	"Neuropeptide Y receptor Y2"	P49146	4	155208636-155217078	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.3;breast: 1.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.8;Excitatory neurons: 6.7;Leydig cells: 21.1;Oligodendrocytes: 13.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;ASC diff: 2.1;HSkMC: 1.0;SH-SY5Y: 7.5"	"Group enriched"	"Detected in many"	5	"amygdala: 12.9;basal ganglia: 12.3;hippocampal formation: 46.7;hypothalamus: 23.7"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 14.2"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (7.14e-2)"				"unprognostic (4.36e-3)"					"unprognostic (7.08e-2)"		"unprognostic (5.50e-2)"			"unprognostic (9.35e-2)"			0.3	0.2	2.0	0.2	1.1	0.0	1.6	0.1	2.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.5	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.5	0.2	0.7	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.1	2.4	5.3	3.5	1.5	0.6	0.6	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP9	"ASAP, FLJ21159"	ENSG00000164114	"Microtubule associated protein 9"	Q49MG5	4	155342658-155376970	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;parathyroid gland: 33.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 114.4;Respiratory ciliated cells: 125.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (8.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.54e-2)"	4.2	5.8	20.5	3.9	21.4	1.8	4.4	26.4	46.3	5.8	26.2	3.1	0.9	7.3	7.6	2.9	9.6	7.9	7.0	23.5	35.1	9.7	0.7	5.0	3.2	31.6	23.9	6.0	5.5	33.9	7.8	5.1	31.3	12.4	1.8	16.3	2.4	8.9	0.2	0.5	1.6	5.7	20.9	2.4	6.1	12.8	28.7	3.4	15.5	0.8	2.4	3.2	1.6	22.1	0.0	10.3	11.0	9.6	11.7	14.0	2.2	11.3	10.2	6.6	5.7	0.1	0.0	7.5	14.7	8.3	24.6	0.0	11.7	12.0	10.8	0.0	9.4	4.7	0.1	0.0	8.6	0.0	0.0	12.0	6.5	9.3	5.7	20.2	0.0	2.9	0.1	0.0	7.5	4.6	8.8	0.1	8.7	3.7	13.3	0.0	0.0	0.2	22.2	8.9	15.1	43.4	0.0	19.4	0.6	7.3	15.7	0.1	1.6	8.8	15.6	0.2	8.4	9.1	0.0	8.2	25.8	0.0	14.3	0.0	0.0	0.0	2.7	0.3	2.1	2.9	1.5	2.5	0.1	4.8	1.3	1.8	0.1	0.8	0.0	2.6	1.0	0.5	20.5	21.4	26.4	46.3	23.5	35.1	31.6	23.9	31.3	20.9	28.7	22.1	3.8	16.0	37.4	34.6	17.0	1.3	13.4	18.7	12.5	67.0	15.2	20.8	33.1	17.2	25.7	25.8	79.2	9.0	10.2	0.4	33.2	35.4	39.3	114.4	44.8	3.5	21.1	5.0	59.0	16.0	3.4	24.5	13.7	24.7	2.5	16.5	1.8	0.6	1.0	72.3	58.3	0.7	26.4	0.9	0.8	14.1	45.7	2.0	5.4	14.0	1.3	53.5	9.2	23.6	27.4	15.9	0.2	49.2	3.8	11.7	0.0	49.1	125.0	92.5	13.1	28.0	31.1	69.4	53.1	2.8	1.1	2.3	14.2	40.1	0.6	4.1
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866277	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"intestine: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 797.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1174.2"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3"	"Group enriched"	"Detected in some"	7	"cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9"	"Low region specificity"	"Detected in all"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.3	1.6	0.3	16.8	0.5	0.0	0.1	0.2	1.2	0.2	0.2	1.2	3.5	0.4	0.6	0.7	0.3	1.9	0.0	0.5	0.3	0.6	797.8	3.2	3.1	0.2	1.1	0.1	0.3	0.1	4.0	0.6	0.2	0.2	1.4	0.0	0.4	0.2	0.2	0.0	5.9	2.5	0.3	1.9	1.6	0.4	0.3	0.2	0.2	0.0	2.6	7.6	0.1	0.7	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.2	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.5	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.5	0.0	3.4	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	1.2	0.5	0.3	0.2	1.1	0.2	0.3	0.3	0.7	0.8	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.6	158.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.5	0.1	1.1	2.4	0.0	32.0	4.1	0.0	0.0	1.7	3.6	0.1	0.0	0.0	29.6	1174.2	0.9	0.0	0.4	0.0	0.0	31.7	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.0	11.3	0.4	1.1	0.0	0.0	0.3	2.3	0.3	0.0	0.1
CTSO	CTSO1	ENSG00000256043	"Cathepsin O"	P43234	4	155921580-155953912	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1;HSkMC: 44.6;Karpas-707: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002041	Approved				"Intracellular and membrane"	NA	NA		25000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002041: AB_1078408"	"unprognostic (3.96e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	19.1	31.5	8.0	17.8	8.0	5.0	31.9	6.2	11.8	36.7	7.9	19.6	32.8	37.2	36.1	16.7	36.9	40.7	20.2	7.8	7.6	34.5	98.8	36.8	24.5	7.1	7.5	28.0	19.9	24.5	9.6	41.2	6.9	29.8	23.2	5.2	22.1	32.2	6.7	10.0	34.0	30.7	7.0	39.7	15.5	9.4	7.4	14.1	34.5	17.8	17.9	28.0	15.4	7.6	0.8	0.6	4.1	3.7	17.3	37.1	0.2	1.6	18.3	3.3	5.7	0.4	14.4	0.2	1.2	6.8	1.2	0.1	0.2	0.1	2.6	1.6	0.1	0.4	0.5	0.2	18.1	1.4	0.2	44.6	3.5	2.2	1.8	25.6	3.5	0.7	0.3	85.8	11.7	0.7	1.1	0.4	0.7	0.6	0.7	4.8	0.5	1.0	16.8	7.5	0.5	4.3	2.4	9.3	2.3	2.0	4.2	2.6	3.0	13.3	0.7	0.4	2.3	8.3	0.2	0.2	24.4	0.3	18.6	5.3	0.9	0.6	1.2	0.7	3.0	1.2	1.4	0.8	0.4	1.5	1.6	2.0	0.7	3.0	0.9	1.0	3.3	1.4	8.0	8.0	6.2	11.8	7.8	7.6	7.1	7.5	6.9	7.0	7.4	7.6	29.3	38.5	20.8	15.0	19.9	10.5	13.1	11.3	12.0	10.4	20.1	13.0	5.0	44.3	14.3	25.8	2.1	20.5	19.6	15.6	13.7	24.6	0.4	20.9	34.6	28.2	6.7	8.6	1.7	20.7	7.7	51.5	8.6	27.3	8.8	25.0	43.2	58.1	16.3	5.0	1.7	7.9	8.2	29.2	23.7	1.5	30.4	21.4	30.2	7.5	26.5	17.0	22.6	36.7	5.4	12.7	6.3	25.2	7.0	17.5	21.1	10.7	14.5	1.9	19.7	34.0	24.6	0.3	2.1	5.9	9.1	10.5	14.5	14.3	6.6	9.5
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971799	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.6;Granulosa cells: 124.1;Microglial cells: 85.3;Oligodendrocyte precursor cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 60.0;hTERT-RPE1: 56.8;U-138 MG: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		37000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	4.8	4.0	0.9	1.3	1.0	0.6	7.5	0.4	1.0	9.2	0.7	2.3	2.0	9.9	2.1	3.3	6.7	4.8	2.6	1.0	0.8	5.5	5.1	3.1	1.1	0.8	0.7	7.7	4.3	20.3	0.4	4.5	0.7	8.7	2.0	0.7	8.4	7.0	1.2	1.6	2.8	9.4	0.9	1.3	2.8	0.9	1.1	2.0	6.5	1.2	1.0	3.2	1.2	1.0	2.5	3.7	38.6	25.4	7.0	13.4	1.0	21.5	21.5	12.0	16.1	2.2	9.4	0.0	3.8	60.0	9.2	2.6	10.8	13.4	16.5	0.0	5.0	25.5	3.2	2.4	18.3	3.9	0.3	14.2	6.6	30.6	21.7	56.8	6.0	0.1	0.1	0.1	30.2	0.1	0.0	0.0	0.4	0.0	1.7	0.0	8.1	0.0	22.5	0.9	0.0	0.0	0.0	0.2	0.4	6.0	3.1	1.3	28.3	41.7	0.4	10.9	17.3	0.0	0.0	0.0	16.1	0.0	1.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	1.0	0.4	1.0	1.0	0.8	0.8	0.7	0.7	0.9	1.1	1.0	2.4	6.4	14.2	98.6	0.7	49.6	22.7	12.4	25.0	2.0	14.7	13.6	16.8	58.6	7.8	12.9	0.0	0.6	3.4	0.5	0.0	15.4	30.5	6.9	15.0	7.3	0.0	5.5	64.4	7.1	0.3	18.6	8.2	11.4	1.3	124.1	10.0	15.9	13.0	0.0	32.1	2.1	4.1	34.4	21.6	23.8	5.3	32.1	10.6	85.3	14.2	6.3	0.0	233.2	3.0	18.0	0.5	23.0	1.4	8.7	2.4	18.6	3.5	0.5	6.6	34.8	18.2	0.7	2.9	3.4	13.5	0.5	0.9	13.8	2.1	4.8
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076125-157172090	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;parathyroid gland: 33.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 168.6;Inhibitory neurons: 110.7;Oligodendrocyte precursor cells: 110.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.6;hTERT-RPE1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.7	7.0	16.5	1.1	17.7	0.2	10.6	7.4	35.5	9.0	4.5	3.3	0.6	2.9	5.2	1.0	7.3	3.2	11.1	18.0	12.9	3.8	1.2	3.1	0.3	9.4	6.9	1.2	15.2	33.0	7.5	2.6	10.8	6.2	0.9	8.5	19.5	4.7	3.3	1.8	1.4	3.7	5.7	0.0	2.9	1.6	9.8	1.1	1.0	4.9	0.2	1.4	1.5	13.5	8.0	3.4	9.5	28.6	18.0	7.2	0.0	16.0	10.1	7.6	14.4	0.0	24.0	0.0	3.7	16.2	9.4	0.0	7.2	2.5	14.3	0.0	9.7	5.0	3.8	0.3	8.1	6.2	0.0	6.4	2.2	13.4	1.9	37.8	6.9	5.1	0.0	0.0	14.1	0.0	0.8	0.0	0.6	0.0	2.3	0.0	13.0	0.0	20.6	1.5	10.3	6.1	0.0	7.3	1.2	1.4	6.8	1.6	10.5	4.5	13.2	7.6	15.3	0.0	0.0	0.0	10.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.5	17.7	7.4	35.5	18.0	12.9	9.4	6.9	10.8	5.7	9.8	13.5	0.5	0.0	1.1	26.1	0.0	1.1	0.9	3.1	1.2	10.8	7.8	4.8	13.9	4.3	3.5	0.0	2.1	0.4	0.4	0.1	0.0	8.8	0.3	6.9	3.4	2.1	0.0	1.7	168.6	1.8	0.0	3.9	0.0	2.0	1.3	7.0	3.3	0.0	0.1	1.7	110.7	0.0	4.1	0.3	1.9	0.3	0.3	0.1	3.6	15.9	0.6	13.2	0.0	110.1	31.5	1.5	0.0	3.4	0.0	0.6	0.0	0.5	10.4	2.2	0.0	8.5	2.2	1.3	3.3	0.4	0.3	0.1	0.1	1.3	0.1	0.2
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;retina: 29.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	6.9	32.8	0.2	60.2	0.0	1.1	11.4	77.4	9.2	0.0	0.2	0.1	17.0	11.5	0.1	11.0	0.0	0.1	78.4	11.3	0.4	0.0	0.2	0.0	0.0	7.4	0.6	1.4	0.0	21.7	0.1	0.0	0.8	0.1	29.0	4.1	2.3	0.2	1.6	0.1	6.2	1.4	0.2	1.2	1.4	37.3	0.1	0.0	0.6	0.0	0.1	0.4	43.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	60.2	11.4	77.4	78.4	11.3	0.0	7.4	0.0	1.4	37.3	43.2	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GASK1B	"C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155"	ENSG00000164125	"Golgi associated kinase 1B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 206.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0"	"Group enriched"	"Detected in many"	41	"dendritic cells: 15.1;monocytes: 50.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA		13000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	73.9	206.2	29.0	39.8	29.2	2.8	47.3	21.8	23.3	47.0	11.9	23.4	13.3	77.7	21.8	17.2	19.4	37.1	77.9	28.7	29.6	9.5	8.6	14.1	11.2	51.7	33.0	140.3	14.2	11.5	2.8	29.0	26.9	23.6	23.3	0.8	23.6	30.0	12.4	7.3	18.5	70.2	34.1	20.8	11.8	10.4	35.5	5.7	17.7	16.7	6.8	43.2	9.2	33.0	12.5	9.9	6.1	1.1	77.0	143.3	11.4	3.1	2.4	0.6	3.7	13.3	4.9	0.1	0.3	5.0	5.1	0.2	70.7	18.9	1.8	0.1	0.2	1.0	0.0	37.0	51.4	0.6	0.3	166.4	4.6	24.2	2.6	8.0	193.3	0.0	13.0	0.0	35.7	0.8	0.0	0.2	0.4	43.4	0.2	0.1	0.5	0.2	0.0	27.5	0.4	0.1	0.0	27.8	8.2	33.4	5.4	0.3	9.3	16.0	17.1	9.6	6.1	0.0	0.1	44.8	2.5	0.3	74.3	0.1	50.6	0.0	0.1	28.8	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.7	0.1	14.0	0.6	0.0	17.8	29.0	29.2	21.8	23.3	28.7	29.6	51.7	33.0	26.9	34.1	35.5	33.0	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	1.2	14.5	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255416	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 418.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 994.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.1;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.2;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA063554: AB_2685039"	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	8.6	12.9	91.0	3.6	235.8	3.1	15.4	164.3	134.4	7.6	15.3	14.4	29.4	6.1	15.6	5.4	6.8	12.5	14.9	101.1	122.5	3.8	3.2	6.3	2.3	204.2	158.6	13.5	7.4	4.6	1.3	6.5	201.8	9.0	15.9	0.6	5.9	10.9	2.8	3.4	20.7	7.1	133.8	4.0	11.2	27.0	163.9	1.9	16.9	2.6	1.6	6.6	2.6	418.0	4.7	12.1	0.2	2.6	8.6	11.8	36.5	1.9	3.9	1.7	2.8	15.1	17.8	0.0	2.8	0.6	10.0	2.2	5.1	16.7	2.4	0.0	5.5	8.5	3.0	13.5	2.8	10.7	2.3	8.9	20.0	7.0	3.0	0.5	9.7	1.7	5.5	0.2	12.8	5.1	0.0	0.0	3.2	15.1	2.9	0.0	0.0	0.4	4.2	12.3	1.9	0.0	0.5	19.6	4.2	7.1	12.6	2.4	1.8	3.9	2.7	0.7	2.1	0.0	1.1	0.9	5.4	1.4	3.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.3	2.2	0.0	0.3	91.0	235.8	164.3	134.4	101.1	122.5	204.2	158.6	201.8	133.8	163.9	418.0	2.9	9.6	9.1	53.2	0.3	3.1	7.7	5.2	2.8	0.9	12.4	10.7	12.7	12.8	8.4	0.0	0.0	13.7	1.5	36.6	0.0	15.4	231.8	14.5	8.6	4.8	4.9	3.0	10.9	13.3	6.5	4.4	14.8	24.5	4.5	14.6	4.6	1.2	29.0	0.0	12.5	21.4	8.2	20.8	5.0	98.2	10.5	12.9	3.6	12.2	10.6	1.3	0.0	5.5	994.4	9.0	18.9	9.1	0.2	3.5	44.1	6.4	8.8	0.2	0.0	8.5	2.6	3.0	2.2	5.8	5.1	8.8	0.9	6.8	18.6	6.4
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 7.6;endometrium 1: 6.2"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6"	"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	4	"amygdala: 4.6;basal ganglia: 5.3;cerebral cortex: 7.6;hippocampal formation: 4.6;white matter: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 11.8;hippocampal formation: 7.8"	HPA027067	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.1	5.3	4.6	0.2	5.3	0.0	0.1	0.0	7.6	2.7	0.0	0.2	0.1	6.2	1.0	0.1	0.8	0.7	0.0	4.6	1.2	2.1	1.4	3.8	0.4	0.0	0.0	0.3	0.1	0.2	0.1	2.7	0.0	0.4	0.1	0.0	0.1	2.8	0.0	0.0	0.2	0.8	0.0	0.3	0.4	0.2	0.0	0.0	1.3	0.0	0.3	0.1	0.8	3.5	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.3	0.0	7.6	4.6	1.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.4	23.5	4.2	0.0	1.7	167.9	0.0	0.0	0.2	0.0	174.6	0.0	0.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	7.5	0.0	0.0	0.0	10.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.6	0.8	0.0	0.1	0.1	0.6	0.0	0.0	0.0
C4orf46	"LOC201725, RCDG1"	ENSG00000205208	"Chromosome 4 open reading frame 46"	Q504U0	4	158666675-158672255	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047287, HPA052670"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA047287: AB_2680011, HPA052670: "	"unprognostic (2.71e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.06e-3)"	2.5	2.4	1.9	4.1	2.4	14.5	2.9	2.4	2.8	2.7	1.3	3.3	3.0	5.0	2.1	2.9	2.4	2.8	3.7	1.9	1.9	1.9	1.5	2.6	6.0	2.3	2.2	4.2	2.4	1.7	1.1	4.5	2.3	2.4	4.2	9.4	1.7	2.2	2.1	2.9	2.8	4.0	2.1	3.2	2.6	12.8	2.0	10.2	4.3	6.0	5.4	2.6	2.0	2.9	16.6	9.9	23.7	35.0	10.3	10.6	11.8	27.5	18.9	31.5	27.4	8.9	14.6	29.3	4.3	14.0	11.6	9.0	20.6	14.2	40.3	40.5	10.7	44.5	10.4	11.9	3.5	33.9	23.7	6.2	5.0	25.6	11.2	10.4	22.7	29.3	19.7	72.1	43.2	8.9	65.8	29.7	16.3	10.6	13.0	47.0	13.5	13.0	9.6	8.1	12.8	38.5	12.1	10.9	10.1	11.9	9.3	26.9	12.0	48.0	22.1	27.0	23.2	16.5	22.3	37.0	12.1	29.8	18.9	2.4	1.9	1.7	1.9	1.6	1.4	1.7	1.5	1.9	2.1	1.4	2.1	2.3	0.6	3.4	2.2	1.8	1.8	1.3	1.9	2.4	2.4	2.8	1.9	1.9	2.3	2.2	2.3	2.1	2.0	2.9	10.3	3.2	1.8	1.3	7.8	24.1	5.1	5.8	14.2	7.5	6.5	5.2	7.6	1.5	3.2	1.8	4.2	9.8	8.2	2.9	7.9	3.6	0.8	7.6	10.8	6.9	7.7	11.2	1.2	3.0	11.8	14.5	4.6	15.0	7.0	8.7	5.0	2.0	9.7	10.1	1.8	5.1	6.1	10.3	25.8	1.8	4.7	7.6	19.6	0.0	18.9	6.5	5.2	1.0	6.2	3.8	3.1	6.0	18.1	6.6	3.2	2.8	3.3	28.2	6.6	7.7	10.6	49.1	15.2	30.1	15.6	3.3	9.6	2.5	5.8	7.2
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease variant, FDA approved drug targets, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 196.4;tongue: 186.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favorable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	34.6	38.0	13.3	10.7	14.8	9.4	16.0	13.9	15.1	10.2	25.5	32.6	63.7	10.4	8.4	25.0	9.3	11.1	93.3	12.8	14.5	46.5	196.4	9.2	8.7	12.3	13.8	10.8	20.4	32.8	9.8	13.0	12.8	13.7	26.9	15.8	21.8	13.2	111.0	18.7	51.4	14.8	12.5	9.5	26.9	11.2	15.0	9.4	13.2	186.9	14.3	12.9	12.8	15.1	13.2	9.2	12.2	21.4	47.2	28.8	6.6	21.3	19.4	13.9	14.3	3.7	24.6	27.8	4.6	24.1	15.8	13.8	22.1	20.9	19.2	51.5	20.3	26.5	17.3	8.0	20.8	24.0	23.4	26.5	23.8	15.8	12.8	20.8	27.3	20.7	15.6	53.8	22.2	14.7	22.7	11.0	5.0	33.2	19.4	18.4	4.3	21.9	21.2	10.6	18.7	8.0	21.0	39.5	21.8	10.0	30.4	17.6	13.6	11.9	6.7	18.5	12.2	31.3	42.1	20.3	24.6	19.2	13.5	3.7	21.5	41.5	10.1	22.6	12.7	10.3	9.8	10.4	18.3	9.6	11.6	9.9	7.8	10.5	20.9	13.1	16.1	9.5	13.3	14.8	13.9	15.1	12.8	14.5	12.3	13.8	12.8	12.5	15.0	15.1	18.1	12.8	10.3	55.2	18.5	33.0	46.0	27.2	29.6	29.2	12.6	13.8	146.6	14.3	22.8	18.4	64.6	24.9	18.0	34.4	29.4	14.4	4.2	12.5	12.5	17.7	18.0	30.7	43.2	11.7	9.9	23.9	44.4	14.2	5.1	19.2	12.8	85.7	13.4	25.2	71.9	22.5	30.5	14.4	15.8	4.7	23.0	13.3	8.8	15.0	12.2	13.9	10.3	55.8	58.0	11.7	29.4	23.7	30.1	21.3	58.3	26.8	13.1	43.9	32.9	27.4	30.4	43.2	29.8	32.7	36.9	43.0	19.7	15.7	26.2	38.7
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709127-158723396	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		480000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	26.8	38.3	38.0	24.4	40.2	25.1	22.8	40.4	77.6	25.4	46.4	33.9	50.6	24.2	19.0	27.7	24.1	18.8	49.6	40.1	44.2	39.5	87.6	19.8	28.6	39.0	39.4	24.2	31.7	17.0	28.6	21.6	40.2	23.5	20.3	36.2	23.3	18.7	88.9	36.1	45.3	18.9	39.6	29.1	29.0	24.1	42.2	24.3	23.9	45.5	25.8	27.4	24.0	46.9	46.7	42.3	41.8	57.7	60.7	45.2	63.1	44.9	24.3	40.3	30.4	55.4	30.9	48.9	19.7	42.0	63.4	35.1	127.9	51.5	48.8	162.9	44.4	87.5	36.5	76.9	46.8	55.6	63.0	28.9	41.2	34.6	51.5	52.0	44.6	81.9	111.0	84.4	45.5	44.6	80.0	49.9	57.9	75.5	55.8	35.9	20.7	41.7	44.6	23.0	70.2	47.1	33.8	69.2	65.6	60.0	31.9	52.2	43.7	40.1	45.3	44.7	60.2	48.3	107.2	62.0	51.1	59.4	41.1	68.8	23.9	55.2	31.1	35.4	36.0	22.3	30.2	29.1	26.4	25.4	30.9	32.0	32.9	40.5	37.7	26.9	37.0	28.0	38.0	40.2	40.4	77.6	40.1	44.2	39.0	39.4	40.2	39.6	42.2	46.9	29.2	6.4	13.4	13.1	24.8	10.1	29.7	17.5	9.1	30.2	19.1	20.8	59.7	25.8	27.9	27.6	22.9	41.5	38.7	17.1	37.2	39.2	39.0	66.1	39.9	25.1	19.6	17.4	24.3	23.0	49.5	24.3	14.3	28.5	32.3	24.4	17.2	18.5	41.9	75.7	28.6	28.3	22.4	17.0	14.7	23.1	20.5	26.0	14.2	9.4	51.6	23.3	48.4	15.1	28.3	29.5	27.4	22.6	22.3	31.6	39.7	33.7	62.3	32.3	6.6	17.7	58.2	96.0	77.5	16.9	11.8	47.6	33.7	33.7	32.0	20.2
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769026-158908050	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.3;myeloid DC: 2.1;non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 179.0;U-266/70: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200"	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	26.3	7.7	6.7	10.1	13.2	8.9	12.1	6.5	12.8	12.7	4.4	21.8	7.4	11.1	9.3	14.5	8.0	20.4	25.3	12.3	8.3	47.8	58.3	24.9	7.7	10.3	10.1	10.7	19.4	15.9	3.2	30.1	8.8	10.8	22.3	8.8	13.9	11.3	11.4	10.1	9.3	17.9	7.3	13.3	22.8	10.0	22.5	7.2	18.5	20.0	5.5	13.6	5.2	18.6	4.0	4.5	19.2	10.1	14.1	8.9	21.0	8.6	9.1	8.7	9.8	5.3	4.0	0.2	2.1	31.2	10.7	3.7	18.4	8.9	10.5	179.0	6.6	18.7	2.5	7.3	8.8	7.9	36.0	6.5	7.3	5.9	7.7	12.8	9.9	9.8	11.4	0.8	14.6	1.3	18.4	1.0	6.1	12.7	4.6	10.8	9.5	5.1	7.0	10.2	12.3	10.9	4.7	3.2	19.5	6.1	4.0	4.3	12.5	14.0	8.7	9.6	6.5	57.3	26.0	3.8	13.9	9.5	10.0	0.4	0.7	0.2	0.5	3.3	0.3	0.0	0.3	0.2	2.1	0.0	0.2	0.6	0.1	0.6	7.2	0.4	0.1	0.4	6.7	13.2	6.5	12.8	12.3	8.3	10.3	10.1	8.8	7.3	22.5	18.6	93.7	19.2	129.2	20.9	6.5	35.6	30.9	7.2	14.2	17.7	18.4	16.4	55.4	58.6	23.2	40.5	54.2	13.1	17.8	80.9	23.5	38.5	17.6	51.6	13.8	78.1	62.4	25.4	109.0	79.9	7.4	35.1	30.1	82.0	27.9	15.7	95.3	114.7	65.4	10.1	95.5	44.9	8.2	90.6	288.0	9.9	13.4	101.5	40.9	64.6	28.4	4.9	11.3	56.8	151.8	80.5	77.2	9.8	5.4	55.7	11.1	72.9	15.3	27.9	52.6	72.3	34.0	25.8	22.8	13.6	36.8	8.2	13.0	10.4	46.8	41.2
C4orf45	FLJ25371	ENSG00000164123	"Chromosome 4 open reading frame 45"	Q96LM5	4	158893134-159038760	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 10.6"	"Group enriched"	"Detected in some"	18	"Early spermatids: 363.5;Late spermatids: 93.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.64e-1)"				"unprognostic (1.14e-1)"			"unprognostic (2.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.45e-2)"		0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	363.5	0.0	0.1	0.1	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	93.0	2.5	0.0	0.0	1.9	0.0	1.5	0.0	4.5	4.1	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	8.6	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 456.2;Inhibitory neurons: 264.1;Microglial cells: 238.9;Oligodendrocyte precursor cells: 199.0;Oligodendrocytes: 236.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.9;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	22.7	9.4	8.7	13.4	19.8	87.5	24.1	4.1	32.1	16.7	0.0	21.8	15.9	16.1	9.8	13.8	14.0	20.1	23.2	27.4	0.3	22.7	30.5	26.6	11.9	0.0	0.7	13.5	19.5	23.5	15.3	38.5	0.3	12.2	20.8	35.1	25.3	12.6	21.7	17.5	17.0	19.7	0.6	29.7	19.3	9.8	6.0	17.5	39.5	31.4	11.5	14.8	11.8	18.6	8.9	11.9	55.4	17.2	21.4	23.9	84.9	17.0	21.3	15.2	10.9	36.7	19.4	50.7	6.1	17.0	22.0	8.0	19.1	21.8	18.0	8.6	13.2	79.0	25.3	21.4	15.5	9.7	104.5	14.1	12.1	36.5	12.9	32.0	44.1	20.7	17.6	46.0	19.0	15.6	24.1	1.5	23.7	10.4	11.8	19.7	14.0	2.0	13.6	20.2	15.7	21.0	24.9	12.1	20.0	26.5	6.0	6.3	47.0	23.9	25.2	30.7	14.2	51.0	32.9	0.8	28.3	4.1	14.8	2.2	1.0	0.7	0.5	0.5	0.6	0.2	0.4	0.3	0.5	0.2	0.6	0.3	5.9	3.3	0.6	1.0	1.0	0.3	8.7	19.8	4.1	32.1	27.4	0.3	0.0	0.7	0.3	0.6	6.0	18.6	66.7	57.7	30.1	110.7	12.9	20.4	11.2	7.5	9.6	19.7	23.5	11.9	39.0	11.5	13.8	7.3	41.7	11.1	20.2	24.8	0.0	9.2	5.3	43.5	19.5	49.2	14.4	38.9	456.2	12.6	9.6	16.9	7.7	59.2	51.8	22.9	32.2	30.5	10.8	33.7	264.1	12.0	2.0	24.6	20.1	5.3	7.8	29.5	33.8	238.9	15.6	30.2	2.1	199.0	236.2	22.1	17.7	8.6	40.5	17.6	7.1	8.7	18.7	22.4	52.6	28.1	37.2	3.5	8.9	10.7	20.0	5.9	12.9	7.2	7.9	15.1
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164004	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 68.6;retina: 94.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 306.0;Cone photoreceptor cells: 462.9;Excitatory neurons: 184.7;Inhibitory neurons: 517.7;Rod photoreceptor cells: 139.6"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	5	"cerebellum: 68.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 75.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 57.3"						"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"					"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.0	6.0	7.4	0.0	6.9	0.0	0.0	68.6	3.7	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.1	15.2	0.0	0.0	0.0	0.0	12.7	9.9	0.0	0.3	0.0	1.2	0.1	14.4	0.0	0.1	94.8	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.6	9.6	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.0	0.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	75.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	10.8	0.0	0.0	0.7	0.1	0.0	0.3	0.1	0.0	0.0	16.2	0.0	6.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	6.9	68.6	3.7	3.1	15.2	12.7	9.9	14.4	6.2	9.6	5.1	0.0	0.0	0.0	47.7	0.0	0.3	0.0	0.0	0.0	306.0	0.0	0.0	0.1	0.0	0.0	0.0	462.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	184.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	28.6	517.7	0.0	0.0	0.3	0.3	4.5	0.6	0.0	1.8	7.5	0.0	20.7	0.0	8.0	75.3	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	139.6	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166890	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	9.5	8.1	4.7	7.6	5.9	7.6	8.3	3.9	7.1	8.7	9.2	7.2	4.7	10.4	6.1	7.0	12.3	7.0	6.5	6.2	3.5	6.8	7.1	7.0	8.7	2.4	3.7	10.9	7.7	10.7	4.8	6.6	1.8	8.5	8.1	13.5	7.6	8.6	19.4	8.3	4.9	8.7	3.1	7.3	6.0	13.3	2.5	7.1	10.2	10.3	7.9	9.5	4.8	4.0	15.2	12.7	16.0	16.4	9.2	14.5	18.8	17.6	11.7	15.1	15.0	14.4	17.8	39.4	5.0	10.9	12.2	12.5	32.7	18.9	19.7	17.5	20.2	41.7	11.4	12.3	16.1	27.2	14.3	13.7	16.5	18.5	14.9	15.6	13.6	12.5	47.7	20.3	20.4	15.0	31.8	15.5	20.9	11.5	12.5	26.1	11.8	20.7	15.0	6.9	17.3	13.1	11.6	20.9	13.0	13.9	11.3	11.8	14.4	18.0	15.6	14.1	20.2	12.7	19.1	30.2	17.1	15.6	18.2	0.0	0.5	0.0	0.7	0.5	0.2	0.6	0.7	1.0	0.8	0.7	1.0	0.7	0.0	0.4	0.5	0.8	0.2	0.5	4.7	5.9	3.9	7.1	6.2	3.5	2.4	3.7	1.8	3.1	2.5	4.0	15.2	6.4	16.7	24.8	25.9	32.4	23.6	10.5	19.4	10.9	10.7	12.8	4.0	11.5	8.0	9.2	18.8	14.3	19.0	4.2	3.9	9.8	48.0	35.7	13.3	9.2	19.2	11.1	44.8	6.8	15.6	25.1	9.2	22.1	10.8	10.2	12.1	5.0	11.7	8.4	30.9	8.2	4.1	17.9	13.3	19.1	6.8	32.8	8.8	19.7	6.0	10.3	4.1	31.7	29.8	7.8	4.0	5.3	16.4	14.4	2.8	8.9	30.3	14.7	32.9	29.8	24.7	23.6	16.2	14.8	41.1	21.3	24.9	13.0	8.0	13.1
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323962-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 119.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 32.8;Excitatory neurons: 39.8;Hepatic stellate cells: 160.6;Sertoli cells: 46.0;Smooth muscle cells: 34.1"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HEL: 128.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"prognostic favorable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	30.5	31.0	10.4	2.9	13.1	0.0	32.4	0.0	13.7	7.8	0.0	5.8	1.0	7.3	10.2	1.8	8.4	4.5	4.8	9.1	19.7	32.3	14.7	2.1	17.3	0.3	0.8	2.8	28.7	3.6	3.0	5.2	0.4	2.5	4.5	4.4	21.4	8.3	2.9	9.8	1.5	5.7	5.7	119.6	1.8	4.1	2.2	1.1	7.9	2.6	0.9	1.8	4.9	9.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	7.0	0.0	0.0	0.0	0.0	128.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.9	0.0	0.1	0.4	0.0	0.0	1.2	0.0	4.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.2	0.0	0.6	0.1	0.0	0.0	1.4	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.4	13.1	0.0	13.7	9.1	19.7	0.3	0.8	0.4	5.7	2.2	9.0	2.1	0.0	0.5	1.3	0.7	2.8	0.7	0.0	3.4	11.6	19.2	3.3	0.9	1.5	0.0	0.0	2.1	0.0	0.0	3.4	13.7	12.5	5.0	0.0	0.4	10.8	32.8	0.0	39.8	0.0	0.0	5.1	0.0	0.1	0.0	3.7	160.6	0.9	0.1	0.0	18.8	1.6	0.0	7.2	0.9	2.4	11.5	0.1	5.4	4.7	0.0	1.1	0.0	2.0	1.4	0.1	15.9	0.4	0.0	0.5	0.1	0.1	0.0	2.1	46.0	1.1	34.1	0.5	0.6	0.1	1.7	0.0	0.6	0.5	2.1	0.3
NPY5R	NPYR5	ENSG00000164129	"Neuropeptide Y receptor Y5"	Q15761	4	163343892-163351934	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;lymphoid tissue: 8.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Granulosa cells: 1.4;Inhibitory neurons: 3.5;Smooth muscle cells: 3.1;Spermatocytes: 3.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (4.63e-6)"		"unprognostic (3.00e-1)"		"unprognostic (2.79e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"			"unprognostic (3.74e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-1)"	7.2	3.3	0.9	0.3	2.2	0.0	1.7	0.0	1.5	0.7	0.0	0.3	0.0	0.7	1.0	0.2	0.8	0.5	0.7	1.1	2.8	4.6	1.0	0.3	2.4	0.2	0.4	0.2	1.0	0.7	0.3	2.9	0.2	0.2	0.3	0.2	3.7	0.9	0.1	0.8	0.1	0.7	1.1	8.8	0.2	5.1	0.8	0.1	0.7	0.4	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.0	1.5	1.1	2.8	0.2	0.4	0.2	1.1	0.8	0.6	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.5	0.0	0.0	4.6	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	3.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TKTL2	"DKFZP434L1717, FLJ32975"	ENSG00000151005	"Transketolase like 2"	Q9H0I9	4	163471095-163473754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	375	"testis: 57.8"	"Group enriched"	"Detected in some"	26	"Early spermatids: 76.3;Late spermatids: 40.8;Spermatocytes: 156.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"			"unprognostic (8.62e-2)"			"unprognostic (2.05e-2)"		"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"		"unprognostic (7.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	3.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.6;Late spermatids: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.4	11.9	4.4	17.9	4.6	12.5	18.0	5.4	6.7	10.8	5.1	13.0	11.0	15.8	6.9	14.3	11.4	9.9	9.2	4.4	5.1	12.1	13.5	8.9	22.0	4.8	4.7	16.8	14.8	9.5	5.3	14.0	5.0	11.8	11.8	5.7	14.4	9.9	9.6	14.4	10.1	13.0	4.9	16.1	12.8	26.7	4.5	19.1	11.6	7.6	20.0	13.9	10.8	6.2	49.1	24.1	43.0	37.3	20.1	32.6	41.3	56.3	29.8	34.2	28.5	23.4	65.4	108.1	22.7	34.0	27.0	25.2	54.6	43.0	43.0	58.1	42.6	154.3	23.3	41.3	39.6	120.2	46.7	22.6	40.0	27.1	36.4	29.5	34.5	39.4	55.1	79.9	39.7	47.2	74.9	68.4	45.6	28.4	43.0	67.7	38.3	68.9	26.2	23.8	22.5	35.2	36.8	46.3	43.4	25.7	30.3	51.3	59.3	23.5	46.0	22.9	61.2	55.8	75.8	124.7	47.3	64.0	72.3	11.7	37.0	3.5	18.4	58.8	26.1	55.6	32.4	23.5	42.3	51.7	29.8	26.1	1.3	35.3	48.4	74.8	31.3	19.4	4.4	4.6	5.4	6.7	4.4	5.1	4.8	4.7	5.0	4.9	4.5	6.2	25.7	22.4	31.2	3.3	51.2	32.9	36.3	52.0	29.6	15.4	42.9	40.5	37.6	47.1	31.7	33.1	4.2	53.8	25.6	16.4	64.6	53.2	165.6	19.0	61.4	30.0	30.5	28.8	8.8	71.0	92.3	37.9	15.3	17.9	29.1	41.6	36.0	55.6	36.4	15.2	7.3	37.5	20.3	43.3	23.4	179.2	55.6	25.4	26.6	6.5	44.4	15.8	16.5	11.6	11.0	54.9	30.6	32.0	30.0	57.8	11.9	71.7	19.0	14.3	39.5	30.4	33.7	103.9	42.1	28.5	39.6	30.5	24.1	43.7	44.0	28.9
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"	A0A1B0GVY4	4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 7.8;intestine: 24.6;prostate: 11.0"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 93.3;Pancreatic endocrine cells: 139.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.1	0.1	0.3	1.4	0.3	1.0	1.0	0.6	0.5	5.0	0.3	15.4	22.0	0.3	0.9	0.1	0.1	7.8	0.1	0.3	0.1	0.1	0.1	0.4	0.3	0.4	0.2	0.1	0.4	0.1	0.0	0.1	0.4	11.0	15.5	0.2	1.2	0.1	0.2	0.2	24.6	0.7	0.1	0.1	0.6	0.1	0.4	0.0	0.1	0.0	0.1	1.7	0.0	0.9	0.1	0.8	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.0	0.3	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.2	0.4	0.1	0.4	0.9	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.1	0.0	0.0	9.3	3.7	0.0	0.1	0.0	0.0	0.0	3.8	0.0	2.5	2.2	0.3	0.0	0.0	0.0	93.3	0.0	0.2	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.8	10.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877178-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.2;prostate: 4.2"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 28.2;Proximal tubular cells: 28.5;Syncytiotrophoblasts: 40.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 41.7;SuSa: 25.1"														"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	2.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.2	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	3.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.7	4.3	0.3	0.0	0.0	1.8	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	28.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	40.9	0.1	0.1	0.0	0.3
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 34.5;Late spermatids: 14.0;Spermatocytes: 50.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 15.1;SuSa: 10.2;U-266/70: 17.2"	"Not detected"	"Not detected"							HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.1	3.6	1.9	2.2	2.2	3.7	1.3	2.2	2.3	2.9	0.3	1.3	1.9	1.5	2.1	1.0	3.5	2.9	3.0	1.8	3.1	1.0	1.1	2.2	3.2	2.4	2.6	5.0	1.4	1.1	1.0	1.7	2.3	1.8	1.4	2.7	0.9	2.0	0.9	1.1	1.4	2.2	1.7	2.1	1.3	8.9	2.5	2.6	5.6	1.4	2.9	2.3	0.2	2.7	0.9	0.8	2.0	2.1	1.1	1.1	1.2	4.2	1.3	0.9	0.8	0.7	1.4	0.9	1.1	5.3	1.0	1.0	1.4	1.5	0.9	1.6	0.8	1.6	1.5	0.9	15.1	1.6	1.4	9.0	1.3	3.7	1.4	8.5	0.8	1.3	1.8	3.6	0.8	1.0	1.4	1.0	6.5	1.0	0.7	1.4	1.1	1.2	0.6	2.6	1.7	1.1	1.0	1.5	1.2	10.2	0.5	1.6	0.9	2.7	1.8	0.9	1.7	17.2	8.2	2.3	1.0	0.9	1.9	5.4	1.4	0.1	2.9	1.2	3.3	3.5	1.8	3.3	1.5	5.8	4.4	3.6	0.3	8.0	1.1	4.1	0.8	1.4	1.9	2.2	2.2	2.3	1.8	3.1	2.4	2.6	2.3	1.7	2.5	2.7	0.2	0.0	3.3	1.0	3.8	0.3	1.2	0.4	0.0	1.1	0.1	0.1	2.3	0.0	0.2	3.7	4.2	0.3	2.3	0.0	0.0	0.3	34.5	0.4	2.1	0.9	0.0	1.3	1.9	0.7	0.0	1.6	0.5	0.1	0.0	4.8	0.0	0.4	1.1	1.7	1.4	0.0	0.0	0.6	0.7	14.0	1.2	0.9	0.0	0.0	1.7	2.7	1.0	3.5	4.3	0.1	0.1	1.5	6.4	0.6	0.0	3.7	0.1	0.4	0.0	1.5	1.3	50.1	3.7	0.2	0.0	0.3	2.2	2.8	0.0	0.6
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165016458-165041749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 1.5;testis: 1.5"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 5.1;Early spermatids: 3.0;Extravillous trophoblasts: 10.6;Spermatocytes: 9.6;Spermatogonia: 8.2;Syncytiotrophoblasts: 5.6"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 14.2"	"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540"															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	0.2	0.3	0.2	0.3	0.0	0.4	0.5	0.9	0.7	0.0	0.1	0.0	0.0	5.1	0.6	0.0	0.0	0.0	3.0	0.8	0.9	0.7	0.0	0.0	0.2	0.0	10.6	0.3	0.0	1.5	0.0	0.2	0.0	1.1	0.5	0.0	0.3	0.0	0.0	1.3	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	0.7	0.3	0.0	0.1	0.8	0.5	0.0	0.0	0.3	9.6	8.2	0.0	0.3	5.6	0.7	0.2	0.0	0.1
TRIM75P	TRIM75	ENSG00000250374	"Tripartite motif containing 75, pseudogene"	A6NK02	4	165053864-165060554	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"BEWO: 1.7"															NA	NA					"Cluster 28: BEWO - Transcription regulation"									"unprognostic (8.51e-2)"					"unprognostic (2.81e-2)"			"unprognostic (1.94e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.78e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
KLHL2	MAV	ENSG00000109466	"Kelch like family member 2"	O95198	4	165207561-165323156	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 125.4;Oligodendrocytes: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051637			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA051637: "	"unprognostic (1.14e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.67e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.81e-1)"	11.8	11.8	35.3	12.1	50.9	21.4	13.0	26.7	55.8	5.9	14.3	7.2	5.3	7.7	13.5	19.7	9.9	10.7	5.5	78.4	34.7	15.4	27.1	14.2	11.2	33.2	35.7	4.1	7.8	9.5	16.3	7.7	30.8	8.2	6.7	8.8	20.0	10.0	4.7	6.4	6.5	10.7	33.3	14.6	8.3	6.1	35.5	6.3	12.3	6.8	9.5	15.2	8.8	45.2	16.1	14.7	9.8	10.1	14.1	12.9	10.2	21.3	16.7	10.7	11.7	8.9	11.5	16.3	5.1	10.9	19.2	10.5	16.1	10.4	13.9	27.2	6.0	14.1	12.8	12.9	12.9	14.2	19.3	10.7	30.5	9.8	37.1	18.5	25.9	6.1	6.4	33.0	16.1	6.0	0.4	4.0	6.0	8.9	6.5	5.6	7.0	5.1	18.1	14.9	49.1	8.1	13.5	4.5	13.0	18.1	3.3	15.1	37.0	8.4	17.6	9.6	14.0	21.5	16.3	13.2	10.1	9.7	16.9	1.8	0.9	1.3	0.5	1.0	0.3	0.3	0.3	0.3	0.8	0.8	0.9	1.0	7.2	0.3	1.2	0.4	0.5	0.4	35.3	50.9	26.7	55.8	78.4	34.7	33.2	35.7	30.8	33.3	35.5	45.2	19.0	6.4	17.9	33.3	10.7	6.0	13.1	8.0	4.6	8.9	13.2	10.9	4.7	8.6	9.7	22.0	14.6	4.3	8.3	7.5	27.4	8.7	1.9	8.3	6.6	14.6	15.5	2.1	125.4	12.9	9.4	5.2	8.2	13.5	9.5	4.0	25.7	35.6	8.3	32.0	33.0	6.2	8.2	42.5	13.9	1.7	4.1	22.7	5.4	39.4	13.5	5.8	1.0	43.2	144.5	9.6	7.4	4.5	6.3	11.9	5.4	19.0	10.9	7.3	0.0	11.9	7.2	3.3	7.4	7.7	7.5	3.7	9.2	3.9	3.9	20.1
GK3P	"GKP3, GKTB"	ENSG00000229894	"Glycerol kinase 3 pseudogene"	Q14409	4	165277812-165279679	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 13.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Distal tubular cells: 1.9;Excitatory neurons: 1.3;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060687	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 11: Alveolar cells - Smell perception"			"HPA060687: AB_2684343"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.19e-2)"			"unprognostic (6.99e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.56e-1)"	"unprognostic (3.34e-4)"	0.0	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	1.2	1.8	0.0	0.2	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327667-165343164	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 575.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 532.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 416.2;Karpas-707: 412.3;RPTEC TERT1: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055073, HPA056127"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA055073: , HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	18.3	95.2	36.7	20.9	48.2	10.4	66.2	45.1	47.5	57.1	37.4	39.2	75.7	19.1	97.0	145.7	20.9	21.7	18.5	43.9	59.2	52.6	575.6	70.3	20.7	90.5	58.4	25.7	22.6	42.9	18.4	22.9	78.6	58.9	32.9	26.1	34.7	12.1	5.5	82.5	38.1	16.5	45.0	11.0	31.5	52.8	48.4	13.4	22.4	6.5	27.0	20.2	67.0	61.1	89.1	21.7	198.8	36.4	97.7	312.0	37.5	35.3	159.0	44.7	123.4	41.5	372.9	43.4	20.6	43.1	416.2	71.7	101.6	366.3	49.4	37.7	63.0	20.0	20.0	127.6	194.9	35.8	26.8	192.6	237.6	163.6	100.6	61.1	58.8	55.7	35.3	412.3	74.6	45.7	32.6	58.2	115.6	46.9	21.0	16.8	21.8	132.3	399.5	102.5	39.7	30.0	54.5	77.9	33.9	121.7	36.1	44.7	67.6	20.6	36.1	18.5	24.7	75.9	86.5	58.6	43.9	36.0	28.5	13.7	8.6	8.8	34.0	11.6	25.4	40.6	31.8	31.4	15.0	37.6	34.3	35.6	6.1	24.9	20.5	19.3	31.0	29.2	36.7	48.2	45.1	47.5	43.9	59.2	90.5	58.4	78.6	45.0	48.4	61.1	16.9	51.3	168.0	70.5	28.9	36.1	70.1	189.2	21.6	33.8	81.9	23.0	10.7	40.0	160.0	69.9	27.1	55.6	20.7	130.8	35.2	67.9	6.4	27.6	12.2	30.4	60.7	53.9	33.6	71.7	87.0	24.1	35.2	44.4	47.7	83.0	27.8	532.0	28.3	35.3	22.8	72.8	170.9	28.0	11.5	7.0	24.8	18.3	32.0	10.3	23.6	27.2	17.5	42.7	49.6	86.8	85.7	18.8	10.9	138.3	46.0	38.4	103.2	50.4	19.7	5.6	35.1	8.7	15.4	84.6	115.1	123.0	22.3	136.1	36.9	129.0
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.0;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000		"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.1	0.5	0.7	1.0	5.9	0.0	2.7	20.0	8.9	1.8	0.0	1.2	0.6	1.1	0.3	0.7	1.3	2.4	0.7	9.9	5.4	1.6	0.1	1.2	1.0	3.5	6.9	0.3	2.3	0.8	0.9	6.4	4.4	0.9	0.9	1.8	0.8	0.8	0.4	1.4	1.8	1.4	0.0	0.0	0.7	0.4	3.0	0.3	1.4	0.4	0.8	1.6	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.9	20.0	8.9	9.9	5.4	3.5	6.9	4.4	0.0	3.0	1.1	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
SPOCK3	testican-3	ENSG00000196104	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.9;parathyroid gland: 175.0;prostate: 73.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 1010.6;Oligodendrocyte precursor cells: 399.1;Oligodendrocytes: 1851.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 1.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;hTERT-RPE1: 6.5;PC-3: 2.7;RH-30: 7.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	0.3	24.7	51.4	0.6	87.2	0.1	0.3	73.0	97.3	0.9	18.7	0.9	0.8	2.9	18.8	0.2	1.1	0.3	0.3	48.4	63.8	0.2	0.4	0.4	0.5	83.2	64.9	17.4	0.7	175.0	0.3	0.0	79.4	73.9	0.5	14.3	0.3	34.9	0.2	0.0	1.3	2.8	72.8	0.4	0.7	0.5	68.4	0.3	0.2	24.0	0.3	1.7	0.2	143.9	0.0	1.6	0.2	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.4	0.1	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	6.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	2.7	0.0	7.1	0.4	0.0	1.1	2.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	51.4	87.2	73.0	97.3	48.4	63.8	83.2	64.9	79.4	72.8	68.4	143.9	0.0	0.0	0.0	12.7	0.1	0.0	1.5	8.1	0.0	43.7	0.0	0.0	1.6	0.0	10.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	15.0	0.0	0.2	1.6	0.0	1.3	106.7	0.0	0.1	15.7	2.0	0.0	1.3	3.2	0.0	0.0	0.1	15.2	1010.6	0.0	6.1	0.0	0.0	2.9	0.9	0.5	0.0	98.4	0.2	1.3	0.0	399.1	1851.1	0.1	0.0	0.4	0.0	3.3	0.0	0.1	6.7	6.3	0.0	0.0	2.5	0.5	0.7	0.0	0.0	0.1	0.0	55.4	0.0	0.8
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092537-168187736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 486.3"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 172.6;Gastric mucus-secreting cells: 667.7;Pancreatic endocrine cells: 315.0"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 284.8;PC-3: 125.5;RT4: 172.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	19.6	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	486.3	0.9	0.0	0.0	0.0	0.0	0.0	89.6	0.1	0.0	0.0	4.6	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.4	0.1	9.7	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	284.8	125.5	0.0	0.6	0.0	0.0	172.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.5	0.0	0.5	15.5	0.0	0.4	0.1	0.0	0.2	7.2	3.2	0.0	2.1	0.0	0.0	0.1	0.0	21.1	11.0	0.1	0.1	0.3	0.0	2.7	0.2	172.6	0.0	0.4	667.7	0.1	0.0	0.0	1.8	72.6	0.0	0.0	0.2	0.5	0.0	2.8	0.0	0.8	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	315.0	1.1	0.0	1.4	0.6	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	14.7
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216291-168318883	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	8.2	6.0	2.3	9.8	2.6	5.6	7.2	2.0	2.4	9.6	2.6	17.4	13.3	7.7	4.8	3.5	7.1	9.7	5.9	1.9	2.4	6.7	9.4	11.4	9.8	4.8	2.3	11.0	4.0	6.4	4.0	11.5	2.9	6.0	15.7	3.3	21.3	5.8	2.4	6.5	12.3	6.1	5.1	17.4	40.8	3.4	3.2	15.4	6.3	3.5	6.8	6.8	5.6	3.1	8.3	1.1	4.2	1.4	2.9	10.4	5.3	2.3	14.9	27.4	26.1	0.0	20.2	0.0	1.4	3.1	12.6	6.6	0.5	4.1	8.7	6.1	0.3	12.9	7.3	0.0	9.9	3.8	3.3	7.2	1.7	6.7	1.2	7.1	10.1	4.8	0.0	2.0	3.4	0.3	6.2	2.5	0.4	0.4	2.1	5.1	1.5	0.0	5.3	4.6	0.8	0.7	5.4	1.3	18.8	0.3	1.0	5.1	8.9	2.1	1.5	0.9	2.0	1.6	0.3	0.0	6.6	6.1	6.1	1.6	1.2	1.2	4.2	2.5	4.8	1.4	3.2	4.1	1.1	1.4	3.3	3.7	0.6	3.7	3.0	0.0	3.0	1.8	2.3	2.6	2.0	2.4	1.9	2.4	4.8	2.3	2.9	5.1	3.2	3.1	32.4	35.3	6.5	14.0	12.2	4.2	4.8	6.2	5.7	0.8	3.9	3.2	8.6	11.5	11.5	12.9	0.0	7.6	13.4	57.6	5.9	8.2	3.3	11.8	10.5	22.8	3.0	8.4	0.7	6.8	10.4	11.6	90.2	10.2	27.3	16.2	14.3	4.0	6.2	0.0	1.3	22.4	2.0	4.1	2.8	2.2	8.1	13.5	3.6	25.3	9.3	7.4	17.5	27.6	1.3	12.0	14.9	9.4	3.1	4.1	11.0	4.2	15.3	2.9	6.6	10.0	9.0	1.1	1.0	2.2	2.7	2.9	17.2	18.4	6.0	3.7
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 32.8;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 44.0"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	6.9	2.8	2.9	15.8	3.1	51.1	5.8	2.4	4.4	6.6	3.5	9.1	8.7	6.7	2.1	3.2	5.4	9.2	3.5	2.4	5.0	2.2	8.2	10.1	9.6	9.6	3.9	5.3	3.1	3.0	0.4	20.7	5.5	3.8	9.0	6.3	9.0	3.2	1.0	3.0	11.0	7.4	9.3	12.8	13.5	2.2	7.8	15.5	3.5	3.6	7.3	5.9	0.7	5.7	12.3	7.1	2.7	1.1	6.9	19.9	13.3	12.0	25.3	44.0	30.4	0.1	28.0	0.2	0.6	12.2	23.9	4.7	1.2	7.3	12.8	7.0	1.0	27.0	8.1	0.7	8.4	11.1	6.5	5.6	2.1	15.9	1.4	9.2	31.5	6.0	0.5	0.3	28.6	0.3	10.0	7.0	0.6	1.1	5.9	5.4	6.1	0.0	4.2	7.1	0.5	3.6	21.4	2.6	12.2	0.5	1.9	15.3	34.1	2.4	15.6	5.6	4.2	11.2	1.9	0.1	7.8	32.2	3.4	2.4	5.9	5.4	3.7	9.1	5.1	1.2	3.7	3.8	3.6	2.0	2.9	3.3	32.8	2.7	13.1	0.0	5.5	2.5	2.9	3.1	2.4	4.4	2.4	5.0	9.6	3.9	5.5	9.3	7.8	5.7	29.0	9.6	6.7	11.4	14.7	1.0	2.6	3.9	3.4	1.7	11.2	3.3	8.3	2.8	5.1	3.7	22.9	6.1	16.0	24.0	0.0	7.6	15.7	8.5	15.6	18.9	0.0	5.9	1.5	10.1	39.4	13.0	44.4	7.1	8.8	20.3	6.1	6.6	26.1	0.0	5.5	14.1	10.2	23.8	6.0	4.4	3.4	46.2	0.0	33.7	35.6	2.9	24.7	28.6	2.4	26.4	31.5	4.1	6.0	2.1	13.2	3.7	11.5	19.4	6.6	7.1	5.7	0.7	1.4	4.3	2.4	7.1	24.1	12.2	4.5	2.0
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497052-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 527.9;Cardiomyocytes: 591.7;Peritubular cells: 399.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 304.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Mitochondria,Cytosol"		No	No		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	"Plasma membrane, Mitochondria, Cytosol"	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	65.0	35.5	31.7	49.7	27.3	0.9	43.6	11.1	19.9	146.1	0.0	303.3	29.0	301.5	21.9	122.6	118.4	71.0	180.4	27.9	36.2	42.1	12.4	71.7	16.9	29.8	25.9	62.1	13.2	55.6	11.3	62.1	25.1	137.0	74.9	12.8	40.8	205.7	127.7	34.7	64.1	303.1	21.4	60.5	94.8	35.1	24.7	23.3	38.7	47.3	16.6	280.2	85.3	22.7	82.1	39.6	87.9	53.4	77.2	83.9	123.6	53.7	137.6	47.2	66.7	1.1	4.6	36.6	14.4	23.7	29.0	17.0	54.1	138.8	60.5	73.9	16.6	0.8	112.5	10.4	135.5	0.4	1.0	132.8	84.4	85.5	125.4	115.0	20.8	19.7	0.1	0.5	304.5	3.8	23.8	1.4	24.9	20.8	24.1	8.3	81.4	0.8	5.3	16.4	9.0	46.4	102.8	8.1	7.3	151.2	48.6	0.5	64.4	50.3	192.1	20.7	90.1	47.8	0.7	1.7	41.6	1.0	14.2	13.7	3.1	0.0	4.6	1.8	0.2	0.1	0.5	2.4	2.1	0.1	0.6	1.6	0.7	0.6	1.2	0.2	0.8	1.8	31.7	27.3	11.1	19.9	27.9	36.2	29.8	25.9	25.1	21.4	24.7	22.7	22.7	32.1	9.4	167.8	1.5	93.6	527.9	56.8	76.8	6.0	46.0	107.9	591.7	20.0	58.7	44.1	18.8	52.1	8.1	20.9	1.9	27.6	133.1	52.8	181.2	27.7	44.8	0.8	27.8	51.3	115.6	130.5	59.7	51.0	52.6	21.0	47.8	11.2	24.5	26.9	108.4	30.7	18.3	28.9	23.8	146.4	130.1	36.7	23.2	16.9	52.9	55.1	17.5	182.4	6.5	83.0	18.6	399.4	2.6	167.6	9.8	23.4	85.2	4.0	177.5	115.4	227.8	81.0	7.6	34.1	49.3	22.3	9.2	13.4	29.3	113.0
CBR4	"FLJ14431, SDR45C1"	ENSG00000145439	"Carbonyl reductase 4"	Q8N4T8	4	168863770-169010275	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037499	Supported					NA	NA		51000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA037499: AB_10672386"	"unprognostic (1.60e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.64e-14)"	"unprognostic (1.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.38e-3)"	9.1	14.1	11.2	7.9	13.1	6.7	14.1	13.1	14.4	9.4	12.4	12.1	12.8	9.9	20.1	8.3	9.3	8.1	17.8	11.1	12.4	27.3	49.6	7.3	11.0	12.8	12.3	11.0	10.0	11.7	9.9	8.1	13.4	11.7	13.9	17.5	13.2	11.2	17.3	15.7	11.8	8.8	11.7	9.4	10.8	7.5	12.7	9.7	15.6	15.9	11.5	8.4	8.4	15.9	9.0	6.6	20.2	12.8	17.2	20.3	4.1	6.3	8.6	7.5	6.9	7.9	9.3	18.3	3.4	4.9	7.0	9.4	18.8	20.1	8.2	7.0	9.3	32.3	16.9	10.7	10.3	12.9	10.9	13.4	17.1	5.4	9.1	17.8	22.4	15.3	17.8	14.4	12.0	4.6	13.5	21.0	7.3	6.2	10.0	11.6	7.1	8.0	26.5	9.4	17.9	13.4	7.7	10.9	16.7	16.7	11.7	8.2	13.4	7.8	4.2	8.8	6.4	14.2	10.2	8.8	13.6	15.6	4.9	7.9	4.0	6.4	6.6	3.6	3.9	5.7	4.5	6.4	3.5	7.5	4.9	6.4	3.0	5.8	5.3	4.8	4.0	2.1	11.2	13.1	13.1	14.4	11.1	12.4	12.8	12.3	13.4	11.7	12.7	15.9	16.1	0.0	9.4	86.2	24.2	23.1	32.2	27.7	10.8	37.3	20.7	12.1	30.0	28.6	19.9	49.7	39.6	40.6	19.8	24.2	50.9	66.5	16.1	22.5	17.5	20.5	29.3	34.9	68.0	42.9	27.5	17.8	16.8	15.8	2.5	36.0	24.7	81.6	24.9	62.2	82.3	26.5	34.6	26.6	8.9	34.6	44.4	16.8	35.6	61.8	26.1	28.3	46.4	150.3	135.8	37.6	39.8	31.2	8.7	24.6	31.7	93.4	19.8	51.3	59.2	18.5	16.3	56.6	41.6	15.3	20.2	20.2	15.9	38.3	27.4	29.6
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094259-169270956	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 146.3;Oligodendrocytes: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.5;monocytes: 6.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	9.8	3.7	8.7	4.4	10.0	3.4	8.2	7.6	13.1	5.7	5.9	15.1	13.8	4.3	5.7	5.9	5.6	11.9	5.7	18.2	8.6	12.2	8.0	9.4	3.3	8.8	9.7	8.5	10.4	3.7	3.7	7.4	9.4	14.3	13.6	2.4	15.8	8.4	9.4	5.1	13.1	4.0	8.2	3.9	24.7	6.1	9.5	2.0	19.9	10.0	3.2	9.3	4.4	13.0	15.2	12.2	11.0	31.9	11.5	14.3	14.1	40.5	19.7	30.0	13.8	12.5	17.8	0.0	1.9	43.1	8.1	9.8	8.9	16.2	32.4	0.1	5.2	8.7	27.4	6.5	26.0	3.1	0.3	8.5	8.6	25.7	19.9	37.3	18.7	3.3	0.1	0.0	27.8	6.0	3.1	2.9	5.6	19.2	10.5	4.5	3.6	0.6	13.6	11.8	8.3	9.9	10.4	15.7	4.2	4.7	5.2	1.3	17.1	14.2	11.0	23.6	14.7	1.1	0.0	0.1	16.0	3.0	17.3	0.0	1.0	0.0	0.0	4.2	0.0	0.3	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	6.7	0.2	0.0	0.6	8.7	10.0	7.6	13.1	18.2	8.6	8.8	9.7	9.4	8.2	9.5	13.0	28.0	64.1	37.7	146.3	3.4	34.3	48.3	11.9	13.6	3.5	21.1	15.6	11.2	44.3	34.4	27.6	0.0	12.7	0.4	69.3	11.7	42.2	5.5	28.5	14.2	13.0	31.3	2.1	54.9	63.7	22.1	16.5	65.7	46.5	10.2	5.6	11.4	12.4	7.4	0.0	54.9	27.1	12.2	9.3	5.3	3.5	12.2	11.1	3.6	52.5	3.9	11.3	0.0	89.5	213.0	68.4	37.2	12.0	2.4	63.2	28.9	18.4	31.7	1.2	65.7	24.1	36.9	5.4	10.7	9.4	12.6	13.1	1.7	6.5	34.4	72.0
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392809-169612627	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 126.3;Inhibitory neurons: 170.5;Oligodendrocytes: 196.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	6.0	6.1	5.1	4.9	6.8	4.2	5.2	7.1	5.3	7.6	2.7	4.0	3.2	7.3	2.8	4.6	9.3	6.1	6.9	3.5	8.8	5.9	4.2	4.6	5.3	7.5	7.7	9.4	4.0	6.5	2.9	4.3	7.6	6.7	4.4	8.7	4.2	6.0	3.3	2.3	3.5	6.6	7.6	5.1	4.9	11.8	5.3	6.8	7.9	4.6	4.6	5.6	2.8	7.7	5.8	2.5	10.0	11.0	15.5	17.1	3.3	11.9	10.6	9.3	8.8	3.3	6.7	15.4	2.2	10.4	9.0	1.9	9.7	10.1	10.5	16.9	6.5	10.3	10.4	3.9	9.0	10.6	7.9	13.7	5.9	9.5	16.7	19.1	9.3	14.5	18.6	28.2	12.1	3.7	13.6	4.6	3.3	3.6	6.0	8.4	6.5	4.9	9.7	6.8	11.0	12.5	8.6	4.2	8.1	7.7	5.3	4.6	11.2	6.0	5.4	6.2	8.1	11.3	18.6	11.6	9.7	5.1	10.7	5.1	0.9	0.9	1.9	1.5	2.2	2.0	1.5	1.2	0.7	2.0	2.2	2.3	0.6	1.1	0.7	1.6	1.6	0.7	5.1	6.8	7.1	5.3	3.5	8.8	7.5	7.7	7.6	7.6	5.3	7.7	12.2	12.8	16.4	162.6	34.2	9.6	15.8	12.1	21.1	21.8	11.3	12.7	37.2	4.3	17.8	18.4	29.2	20.8	17.0	6.4	17.6	10.4	109.7	67.2	21.6	13.2	7.2	26.7	126.3	6.2	8.6	25.0	17.3	23.7	18.3	20.1	9.7	7.8	10.7	18.5	170.5	5.6	20.3	7.0	7.4	48.2	23.6	14.5	5.4	53.4	6.6	26.1	15.5	115.1	196.1	8.9	4.0	31.6	23.2	6.9	5.3	9.6	68.4	24.9	13.1	32.8	25.5	67.9	37.3	21.3	6.3	29.6	22.0	26.0	6.3	9.2
CLCN3	"ClC-3, CLC3"	ENSG00000109572	"Chloride voltage-gated channel 3"	P51790	4	169612633-169723673	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044723	Approved		Supported	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA044723: AB_10959733"	"unprognostic (1.92e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.38e-3)"	21.1	34.5	20.1	20.6	28.7	12.3	31.9	29.1	30.2	23.9	20.5	47.5	30.1	18.7	29.4	40.7	26.4	38.0	35.3	22.8	30.5	36.4	25.7	21.2	17.3	32.3	41.0	23.1	41.0	37.2	18.2	24.1	32.1	32.7	52.6	78.3	78.0	21.8	24.7	29.1	29.8	17.8	32.3	16.7	41.2	33.3	26.5	21.0	37.0	22.1	24.5	37.4	17.1	42.0	32.6	33.2	48.7	62.1	96.1	80.8	24.0	42.9	53.5	28.3	34.3	23.7	72.2	40.0	26.1	35.9	32.7	27.2	61.2	26.6	46.9	35.9	24.4	33.8	50.6	27.3	65.8	41.0	54.2	56.6	59.7	50.5	49.5	117.4	51.7	55.2	85.1	88.0	49.7	11.8	56.2	9.4	20.0	56.2	22.4	25.0	21.5	31.6	58.1	66.6	51.9	51.5	38.4	40.9	66.9	39.3	27.9	19.2	43.5	22.5	25.3	36.5	33.7	39.3	64.3	35.5	67.6	15.4	60.8	3.8	4.1	2.9	5.0	4.8	6.5	5.0	3.7	4.7	5.7	3.8	5.7	5.2	2.9	4.5	4.0	7.1	4.7	4.7	20.1	28.7	29.1	30.2	22.8	30.5	32.3	41.0	32.1	32.3	26.5	42.0	35.5	32.1	26.2	58.8	30.7	11.3	25.7	21.5	20.5	90.3	54.6	27.9	66.5	42.9	25.3	62.5	131.3	23.8	23.1	118.3	7.9	37.2	88.1	46.9	35.9	35.2	66.9	83.1	102.4	44.3	18.7	29.5	51.5	51.8	113.0	32.3	38.6	39.3	18.6	60.6	126.1	64.2	20.3	32.9	9.8	67.4	24.5	47.8	32.0	44.0	17.1	136.7	28.8	139.7	141.5	31.9	55.3	21.1	21.4	45.3	37.1	17.9	67.8	115.1	6.6	34.6	21.5	17.2	15.5	42.8	26.1	71.1	21.0	67.0	65.4	34.0
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729470-169757944	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	19.3	18.6	18.6	16.4	19.9	16.8	21.2	19.6	26.0	19.6	22.0	22.0	12.2	23.3	24.8	15.7	17.1	13.1	22.5	19.2	19.7	18.1	22.1	14.3	21.1	20.2	19.3	22.7	14.4	16.0	19.5	16.8	20.9	17.3	17.7	21.3	13.2	15.7	21.3	19.6	12.8	24.8	19.6	17.5	15.8	14.1	19.6	26.9	18.8	20.9	21.1	16.8	16.8	22.2	33.7	21.0	71.2	37.7	42.6	52.4	30.3	59.9	58.8	72.8	76.7	14.3	35.5	17.5	15.7	39.2	53.3	14.7	49.5	43.6	76.7	55.1	33.7	57.0	30.0	20.5	29.9	48.7	20.1	34.1	43.2	47.1	14.5	44.1	64.1	59.1	43.7	66.2	64.4	27.3	102.7	42.4	29.2	32.2	27.0	44.7	33.8	21.2	41.9	21.9	17.2	63.1	39.7	17.2	56.3	49.1	34.0	43.1	31.3	24.8	39.2	58.4	54.3	31.3	49.8	52.4	68.3	47.0	40.3	19.3	20.0	22.4	28.7	24.0	34.6	22.0	33.0	35.1	26.1	18.1	32.1	33.3	5.3	25.4	23.7	17.9	38.1	21.9	18.6	19.9	19.6	26.0	19.2	19.7	20.2	19.3	20.9	19.6	19.6	22.2	41.6	44.8	26.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	19.9	29.6	0.0	0.0	17.3	27.6	0.0	71.0	14.3	0.0	92.0	45.7	0.0	31.9	36.9	20.1	0.0	0.0	0.0	46.3	61.2	26.1	0.0	21.9	17.7	56.4	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	31.1	0.0	0.0	1.6	0.0	0.0	63.9	15.3	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.3	10.5	56.0	0.0	0.0
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.5;choroid plexus: 88.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.0	3.4	32.9	0.9	61.0	3.2	12.0	49.1	34.4	13.0	88.8	2.7	0.6	5.1	38.9	0.8	4.2	2.6	1.7	35.2	40.1	30.0	37.4	2.7	0.9	46.3	58.3	0.6	1.5	6.5	4.1	3.0	48.5	2.8	2.0	25.0	2.1	12.8	5.1	24.5	1.0	4.1	38.8	1.5	1.3	46.3	54.9	0.6	2.8	2.3	0.5	10.1	1.8	65.5	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	32.9	61.0	49.1	34.4	35.2	40.1	46.3	58.3	48.5	38.8	54.9	65.5	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 67.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Extravillous trophoblasts: 71.3;Hepatocytes: 29.3;Spermatogonia: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.3	2.8	6.2	1.9	6.8	0.3	4.7	3.8	9.8	9.8	11.3	6.2	1.6	10.5	5.9	2.6	6.3	3.9	2.7	6.5	6.7	6.8	67.1	4.9	0.7	5.8	5.6	4.7	5.6	6.0	6.1	1.9	6.5	14.4	5.0	11.8	1.7	5.3	4.0	1.4	2.3	7.3	4.8	1.7	3.6	8.2	6.1	1.5	7.5	2.4	0.8	6.4	5.7	8.7	3.5	8.5	25.0	0.0	4.9	18.9	9.0	8.7	4.2	4.9	5.0	8.4	1.0	0.1	1.4	9.8	6.5	2.9	11.3	4.1	3.4	0.0	9.7	0.0	10.0	14.0	3.9	0.1	3.8	7.7	2.5	4.0	5.1	13.5	4.7	11.4	1.5	0.1	19.0	8.9	4.3	0.1	19.0	9.6	7.6	0.0	7.8	0.0	4.4	15.3	20.1	23.5	7.0	1.7	8.5	8.0	0.1	1.7	3.2	12.5	13.4	14.3	13.9	0.1	0.0	0.1	12.5	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	6.8	3.8	9.8	6.5	6.7	5.8	5.6	6.5	4.8	6.1	8.7	0.9	0.0	5.9	22.2	0.3	0.9	2.8	0.9	6.2	6.0	3.9	1.0	1.2	1.5	2.1	0.0	2.1	2.8	0.0	0.7	0.0	1.6	0.5	3.7	7.4	0.7	6.7	0.0	15.4	2.2	71.3	3.2	3.1	6.0	0.0	6.2	0.7	29.3	1.6	0.0	13.6	2.8	0.0	0.3	0.9	1.4	1.2	0.4	1.8	5.6	0.0	2.7	0.0	17.6	14.0	1.1	1.6	2.2	0.0	4.0	0.2	8.4	8.5	9.1	6.6	3.9	4.2	14.5	27.1	3.0	0.4	5.6	0.3	3.3	3.1	1.8
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;lymphoid tissue: 2.5"	"Group enriched"	"Detected in some"	17	"Excitatory neurons: 424.4;Inhibitory neurons: 1567.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031019	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.0	0.2	3.6	0.4	2.8	0.4	0.2	0.5	4.0	1.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.1	6.0	7.8	0.0	0.1	0.1	0.3	0.2	5.3	0.0	0.1	0.0	0.0	0.0	2.3	0.7	0.2	1.3	0.3	0.0	0.3	0.1	0.5	0.0	1.1	2.5	1.0	2.4	4.0	0.0	0.1	1.4	0.1	0.1	0.4	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.5	4.0	6.0	7.8	0.2	5.3	2.3	1.1	4.0	0.6	0.0	0.0	1.5	10.4	2.4	0.3	0.1	0.0	0.0	1.6	0.3	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	424.4	4.1	0.0	0.3	2.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1567.9	2.6	0.0	1.6	0.0	21.1	0.3	0.9	5.4	13.1	0.0	0.1	0.0	57.3	9.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	1.2	0.2	1.6	1.6	0.0	0.3	0.0	0.0	0.1	0.4	0.1
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168811-173323967	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		6200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	6.4	6.4	6.4	16.3	8.8	11.5	23.3	34.2	8.3	25.1	3.5	47.8	29.1	16.9	7.0	14.9	9.8	15.6	5.9	6.6	7.8	7.8	2.9	9.6	12.2	12.6	8.3	11.2	22.2	8.7	5.2	13.0	11.7	39.7	52.8	22.4	27.4	8.1	1.4	3.9	33.7	16.7	10.1	11.0	65.7	11.9	8.4	60.0	13.5	3.9	9.8	17.0	5.9	16.0	71.1	37.2	35.0	11.2	18.6	27.1	50.3	18.1	20.5	16.7	23.0	11.5	109.9	39.4	13.3	16.6	45.2	59.2	15.0	32.0	22.7	154.3	29.1	47.8	72.2	0.4	12.2	71.6	32.8	17.5	28.3	37.6	18.9	63.4	112.3	28.2	32.6	59.3	86.0	23.5	52.7	39.4	34.8	70.2	24.0	52.1	32.4	10.2	123.2	32.8	28.2	21.5	8.5	50.4	25.4	45.3	20.2	21.0	135.6	11.9	52.3	0.6	40.0	17.2	0.2	20.8	48.6	42.3	43.6	13.2	14.3	18.9	5.1	7.5	7.2	6.2	5.7	5.3	12.4	3.3	4.4	3.3	21.3	7.5	8.0	5.0	9.2	6.4	6.4	8.8	34.2	8.3	6.6	7.8	12.6	8.3	11.7	10.1	8.4	16.0	10.0	6.4	38.0	72.8	12.1	1.8	9.0	12.3	4.0	47.9	41.1	19.8	9.6	8.6	36.0	20.2	2.1	1.4	16.4	143.4	0.0	14.4	2.5	28.3	13.3	11.3	22.8	12.0	74.4	48.9	3.7	12.1	102.4	52.9	24.1	14.8	12.1	0.2	10.3	10.1	172.0	126.8	24.4	17.9	6.2	4.2	9.3	17.2	8.8	62.8	16.3	8.1	5.2	71.4	54.1	39.9	50.0	5.3	6.6	52.8	63.7	10.0	17.4	25.5	13.1	16.1	11.7	3.8	5.5	14.9	1.1	0.8	9.9	13.1	48.6	19.4
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331376-173334432	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"bone marrow: 2347.2;lymphoid tissue: 939.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 798.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 2454.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	NA	Yes		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	90.3	31.0	36.3	146.1	38.4	2347.2	89.1	35.4	49.9	79.0	33.0	117.1	93.2	92.3	47.3	115.6	78.8	43.5	85.8	33.2	38.3	74.3	37.8	83.8	390.4	37.5	36.8	118.9	27.2	18.3	35.4	111.0	38.0	46.9	122.2	134.1	59.8	35.2	72.4	75.1	108.7	65.5	36.3	159.5	66.0	136.0	36.1	939.2	56.4	57.0	388.9	68.2	86.1	40.1	498.2	114.6	976.8	444.4	118.2	118.2	375.1	366.3	271.3	386.7	345.7	329.0	673.6	1645.5	79.2	203.0	207.4	190.3	645.0	196.1	601.0	1004.0	303.4	1823.2	308.8	487.8	115.7	1642.8	683.4	114.7	59.2	194.2	439.1	211.5	402.8	866.1	703.9	2282.4	358.9	409.9	2454.9	1513.7	355.4	289.4	199.3	1226.7	499.7	620.4	227.0	208.8	838.6	759.0	365.5	209.6	166.6	340.8	291.1	1173.2	236.0	175.5	513.6	219.0	554.9	734.8	437.1	1869.4	149.1	1178.4	464.4	798.0	135.9	407.0	94.1	57.6	86.2	72.5	137.8	131.1	112.8	57.6	88.4	85.3	316.7	83.0	49.1	43.2	266.4	107.6	36.3	38.4	35.4	49.9	33.2	38.3	37.5	36.8	38.0	36.3	36.1	40.1	167.0	28.9	64.1	5.9	153.2	158.8	141.5	131.8	75.1	48.9	75.3	107.8	229.0	38.6	78.3	55.2	35.5	472.6	222.9	116.5	142.8	25.9	30.4	71.2	71.7	128.0	74.7	1915.4	2.7	16.1	872.5	121.5	63.2	76.5	110.6	210.5	171.7	26.5	210.1	45.4	4.7	191.2	109.9	295.0	142.9	33.1	105.3	233.9	67.6	6.5	241.9	81.8	132.8	1.0	4.8	11.3	75.2	57.6	268.6	114.2	65.4	51.0	149.8	143.5	78.9	71.7	134.4	493.6	400.9	233.6	134.0	128.7	289.5	42.3	284.7	89.0
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 77.2;Macrophages: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB022627: , HPA059012: AB_2683880"	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	17.4	12.9	17.4	13.3	19.7	23.4	12.8	18.4	21.6	13.9	16.1	25.6	9.5	13.2	9.6	9.9	16.9	8.6	20.4	17.0	18.2	6.2	9.0	12.8	8.0	19.3	18.2	14.6	7.3	4.5	8.1	7.1	19.2	11.4	7.0	16.3	11.6	9.7	10.5	8.5	12.5	12.4	18.7	15.7	18.4	24.7	17.6	10.3	10.6	7.4	6.6	19.5	12.6	25.3	49.0	16.3	46.3	45.2	29.0	17.9	10.1	22.5	19.3	24.7	30.4	7.0	19.4	43.9	10.3	26.3	31.1	12.0	37.8	19.1	18.9	49.6	35.9	58.7	39.6	20.0	27.5	34.0	35.9	29.8	9.2	21.1	21.2	34.7	29.3	31.5	30.8	181.4	32.2	20.9	48.4	38.0	20.5	21.7	31.3	38.9	16.5	31.6	15.1	7.8	37.5	79.1	31.8	31.9	14.9	11.8	13.5	20.0	29.1	17.6	23.9	41.4	52.8	101.5	39.1	41.8	56.8	81.6	51.2	0.4	1.3	0.0	0.6	0.7	0.2	0.1	0.3	0.4	1.0	0.2	0.0	0.2	0.5	0.0	0.4	0.0	0.4	0.2	17.4	19.7	18.4	21.6	17.0	18.2	19.3	18.2	19.2	18.7	17.6	25.3	42.1	0.0	2.3	11.1	7.2	51.7	6.6	3.9	16.5	26.2	25.5	29.3	28.9	4.3	3.7	7.3	22.9	2.1	22.5	4.8	0.0	2.2	23.1	23.6	34.3	27.3	19.7	20.2	12.5	3.5	9.3	19.9	19.4	7.4	7.0	13.5	14.6	9.0	9.3	25.2	14.6	10.5	0.0	77.2	13.8	6.2	10.2	77.0	33.8	3.7	15.2	57.7	2.1	7.1	15.4	2.4	2.7	6.4	17.6	8.6	6.4	6.2	9.9	46.3	52.6	12.5	31.7	63.7	15.2	16.1	53.0	1.2	27.0	12.3	11.1	4.1
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.5"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5;stomach cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"SH-SY5Y: 410.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.9	28.0	0.0	5.4	0.0	0.0	2.1	0.5	0.0	22.2	0.0	60.5	2.5	33.4	0.3	1.0	16.0	16.2	36.8	0.0	0.0	0.1	5.5	0.0	0.2	0.0	0.0	15.3	4.1	0.0	0.1	20.9	0.2	1.3	4.4	0.0	0.8	1.0	0.2	1.5	11.0	27.3	0.0	1.1	22.1	0.4	0.0	0.4	1.5	1.1	0.8	12.4	5.3	0.0	0.0	0.1	0.0	0.0	16.6	7.7	0.3	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.3	0.0	0.1	1.7	0.0	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	410.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	4.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.2	0.0	0.1	0.1	100.3	2.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.2	9.0	317.1	2.7	0.0	0.0	0.0	0.4	1.4	30.4	0.0	5.3	0.0	0.0	6.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	2.3	0.9	39.4	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.9	0.1	0.3	0.2	0.3	2.3	1.3	0.6	0.0	0.0
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174283667	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	15.7	18.6	13.8	10.5	15.3	10.2	17.8	15.7	17.5	14.3	13.8	18.4	16.3	12.5	19.9	17.0	15.5	15.5	21.2	13.5	16.6	22.9	47.5	14.0	12.9	15.8	14.7	17.0	14.2	21.2	14.2	30.9	16.1	14.7	16.1	17.8	15.2	12.6	6.7	16.1	16.4	16.3	15.1	13.0	15.0	11.2	14.8	15.8	22.2	10.1	12.6	16.0	13.7	17.8	10.0	6.3	12.3	4.3	31.5	33.2	9.8	18.8	19.2	13.3	13.6	5.2	19.9	6.9	19.5	15.7	12.2	6.7	9.2	11.7	13.8	22.5	20.9	7.2	10.4	7.4	23.5	8.5	7.5	19.1	24.5	12.9	13.4	20.5	13.4	8.0	14.9	40.5	18.3	7.9	9.8	8.6	4.4	15.4	7.6	4.9	8.2	12.5	17.8	4.1	13.9	80.8	8.7	16.1	22.4	11.8	11.0	11.0	17.0	9.1	7.3	23.5	11.3	18.5	9.7	6.2	25.2	6.4	13.0	29.4	6.5	14.0	12.1	8.4	15.2	13.2	13.7	12.1	9.0	11.9	12.7	11.6	6.6	10.5	10.0	9.1	16.6	8.4	13.8	15.3	15.7	17.5	13.5	16.6	15.8	14.7	16.1	15.1	14.8	17.8	18.9	3.2	10.0	6.5	15.8	20.6	17.0	26.0	19.4	13.2	16.9	11.4	10.8	15.7	19.5	22.0	6.2	36.6	10.1	20.3	50.9	19.0	20.5	24.9	13.2	15.8	12.1	11.2	10.1	10.9	60.6	32.7	14.8	16.3	2.5	5.3	21.0	58.1	21.2	18.5	13.0	21.5	28.5	19.6	8.2	5.5	17.4	12.2	10.6	11.2	16.3	29.1	9.2	9.0	17.8	12.4	21.4	26.4	9.1	16.8	21.5	44.6	26.2	18.1	13.1	14.9	18.4	34.7	17.6	19.8	31.4	89.6	14.3	10.3	13.7	22.7
CEP44	KIAA1712	ENSG00000164118	"Centrosomal protein 44"	Q9C0F1	4	174283730-174333380	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 73.9;SH-SY5Y: 142.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041515, HPA041835"	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA041515: AB_10795638, HPA041835: AB_10794637"	"unprognostic (2.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (8.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.72e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	6.1	8.7	5.7	7.8	8.2	11.1	9.7	11.5	7.6	7.9	7.4	9.2	7.6	10.5	9.2	8.7	7.6	8.1	8.7	7.8	6.0	5.9	7.8	7.1	10.2	7.5	6.5	10.8	6.3	9.2	8.1	11.5	8.5	8.4	8.6	12.6	7.6	6.1	5.8	13.0	8.6	7.6	6.6	8.8	8.7	13.4	6.6	11.0	9.0	6.2	8.5	7.3	7.3	13.2	12.5	11.4	19.2	9.6	12.1	17.3	10.7	18.7	7.1	12.1	12.5	6.9	27.1	19.0	18.1	4.8	11.5	10.1	20.4	9.3	15.5	30.9	32.2	23.2	33.1	8.0	8.3	17.7	16.6	9.2	14.4	9.9	10.6	12.0	10.6	14.7	30.9	73.9	14.6	4.9	20.7	13.7	10.0	9.4	9.8	15.4	18.2	15.6	10.8	5.0	34.5	142.6	16.1	12.8	14.2	17.6	13.8	12.7	11.5	9.6	10.5	23.1	11.8	18.7	14.0	24.0	18.6	15.7	19.6	5.9	3.1	2.3	3.9	3.7	3.9	5.6	4.1	3.4	3.2	5.6	5.2	4.5	2.3	2.8	4.6	3.0	8.7	2.7	5.7	8.2	11.5	7.6	7.8	6.0	7.5	6.5	8.5	6.6	6.6	13.2	12.6	9.6	16.4	24.5	14.4	9.9	9.0	10.1	14.8	22.8	10.7	8.0	17.1	8.6	11.9	1.8	33.3	6.6	14.2	8.0	5.9	7.8	6.6	25.4	15.8	9.1	7.7	27.4	24.0	8.0	10.3	14.2	10.2	20.0	12.0	19.4	6.1	7.8	6.6	15.2	25.5	7.8	8.2	9.5	6.0	7.9	16.4	12.3	8.8	10.3	7.9	11.1	8.2	39.2	58.4	9.5	4.9	10.1	13.7	7.2	9.2	4.9	31.5	30.3	13.1	21.1	14.6	44.8	15.0	8.8	11.1	6.7	13.0	9.3	8.1	10.1
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 10.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.0	0.8	4.2	0.0	3.4	0.0	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.2	0.8	3.6	0.0	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	10.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.4	0.0	3.0	2.6	4.5	0.8	3.6	0.6	0.9	10.5	0.0	0.0	0.0	0.6	1.3	1.6	0.0	1.3	0.0	0.0	5.0	25.3	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.1	0.4	0.0	0.0	52.4	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.0	1.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	1.0	0.3	0.7	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.4
ADAM29	"CT73, svph1"	ENSG00000168594	"ADAM metallopeptidase domain 29"	Q9UKF5	4	174829668-174978180	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"testis: 41.1"	"Group enriched"	"Detected in some"	25	"Early spermatids: 429.2;Late spermatids: 280.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.40e-3)"				"unprognostic (2.03e-2)"			"unprognostic (4.72e-3)"			"unprognostic (4.93e-2)"		"unprognostic (1.16e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	429.2	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	280.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	14.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 577.8;choroid plexus: 249.3;retina: 147.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 34.8;naive B-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 34.8"	"Group enriched"	"Detected in some"	10	"AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	3.8	4.2	366.9	1.4	455.6	0.5	2.5	422.6	577.8	6.8	249.3	25.4	1.9	7.7	2.9	1.9	7.5	4.4	2.8	469.8	268.7	7.1	13.4	20.1	2.6	225.0	265.4	12.3	1.8	0.7	7.7	0.3	222.4	5.7	6.0	147.3	0.9	6.9	0.6	0.8	3.4	11.1	257.9	15.8	1.1	1.5	281.9	0.3	11.9	0.6	1.3	2.6	2.9	336.4	0.3	0.7	49.9	0.5	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.1	0.7	43.0	0.2	0.2	1.8	0.9	17.4	1.5	0.1	0.2	4.0	0.5	3.7	1.4	0.1	0.4	0.7	0.1	0.0	0.1	0.2	2.0	0.0	0.1	0.4	1.7	0.0	1.2	1.6	0.6	1.2	0.0	0.6	0.2	0.2	0.3	0.1	2.1	0.5	0.4	0.2	0.9	0.2	0.3	0.6	0.1	0.2	0.9	0.6	0.6	50.8	1.6	0.1	2.6	1.8	0.4	1.1	0.8	0.1	0.1	0.1	0.1	0.1	34.8	0.1	0.0	0.2	16.6	0.1	0.1	0.4	0.1	0.2	2.9	0.1	0.8	366.9	455.6	422.6	577.8	469.8	268.7	225.0	265.4	222.4	257.9	281.9	336.4	0.6	96.1	8.7	3712.4	9.6	1.8	5.3	0.0	0.0	220.3	0.2	0.1	0.7	1.5	0.6	0.0	14.6	0.0	0.0	0.1	1.9	0.0	11.7	0.4	0.1	29.0	0.0	5.3	833.0	0.2	0.2	2.4	0.0	0.2	0.0	0.2	116.0	2.1	0.3	124.5	581.3	0.0	0.0	4.4	0.4	3.6	3.4	1.6	0.0	208.0	0.0	459.6	0.0	1341.6	37.3	0.0	0.0	1.5	0.1	9.0	0.0	3.4	0.0	30.5	0.0	15.3	3.3	0.5	0.4	0.2	0.9	0.1	1.2	3.0	0.0	6.5
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065841-176182818	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 11.5;retina: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 183.1;Cone photoreceptor cells: 64.6;Excitatory neurons: 222.8;Inhibitory neurons: 127.6;Oligodendrocyte precursor cells: 125.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 5.6;SCLC-21H: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	0.8	2.9	4.5	0.9	7.9	0.6	1.3	2.9	7.6	1.4	0.0	2.5	0.5	1.8	2.4	0.6	1.9	1.1	0.8	8.5	2.5	2.5	0.3	1.4	0.6	0.0	0.0	1.8	2.2	7.0	11.5	0.1	0.8	0.8	1.1	28.6	0.8	0.8	0.2	0.4	1.2	1.0	0.0	1.1	1.3	1.9	2.3	0.3	4.3	0.3	0.5	1.4	1.0	3.4	0.0	2.5	5.6	0.0	0.1	0.4	0.2	0.1	0.0	0.6	1.9	0.2	0.0	3.7	0.0	0.1	3.0	0.0	2.4	1.4	0.5	0.0	2.0	0.0	0.5	0.0	0.2	2.0	2.8	0.8	0.7	0.1	0.3	0.7	0.0	4.3	0.0	0.3	0.5	1.1	2.4	0.1	1.2	0.0	1.4	0.0	2.5	0.0	0.2	0.0	7.6	4.8	0.0	1.4	3.8	0.7	0.4	0.0	0.0	0.8	1.0	0.0	3.4	2.7	1.8	2.3	4.2	0.0	1.4	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	4.5	7.9	2.9	7.6	8.5	2.5	0.0	0.0	0.8	0.0	2.3	3.4	0.3	0.0	5.8	183.1	2.4	0.1	0.5	0.1	3.4	16.9	0.6	0.9	0.9	1.5	1.3	0.0	64.6	0.0	0.0	0.1	1.9	0.3	1.5	0.5	0.6	0.7	4.8	1.7	222.8	0.6	0.0	2.0	0.0	0.0	3.8	0.1	2.2	0.1	0.2	21.9	127.6	0.1	0.0	0.6	0.6	1.5	0.9	1.3	1.8	23.4	0.6	10.2	0.0	125.2	40.0	0.2	0.0	1.5	0.2	0.4	0.0	11.6	7.7	36.6	0.0	3.0	1.9	2.7	5.2	0.4	0.0	0.0	0.3	1.4	0.1	0.3
SPATA4	"CFAP178, FAP178, SPEF1B, TSARG2"	ENSG00000150628	"Spermatogenesis associated 4"	Q8NEY3	4	176184579-176195585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 139.5"	"Group enriched"	"Detected in some"	12	"Early spermatids: 1074.2;Late spermatids: 496.7;Spermatocytes: 460.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.4;U-87 MG: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019220	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA019220: AB_1857420"	"unprognostic (1.97e-3)"	"unprognostic (6.08e-2)"		"unprognostic (2.83e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-2)"		"unprognostic (1.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-3)"	"unprognostic (9.77e-2)"	"unprognostic (4.38e-6)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.59e-1)"	0.0	0.4	0.8	0.0	0.9	0.1	0.6	0.9	1.0	0.3	1.4	0.4	0.0	0.3	3.6	0.1	8.7	0.2	0.4	0.8	1.0	2.2	0.0	1.2	0.0	1.6	1.9	0.2	0.4	0.4	1.0	0.0	1.1	0.2	0.0	2.3	0.3	0.5	1.1	0.1	0.1	0.2	1.2	0.0	0.1	139.5	1.1	0.0	1.7	0.4	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.9	0.9	1.0	0.8	1.0	1.6	1.9	1.1	1.2	1.1	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.1	2.2	0.0	0.5	1.0	1.4	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.9	0.5	1074.2	20.0	0.3	0.7	0.0	0.0	1.1	0.0	0.0	0.2	2.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.0	2.0	0.0	0.0	496.7	11.5	1.3	0.0	0.0	0.0	1.9	0.0	1.0	0.5	1.5	0.0	8.2	0.0	0.1	0.0	10.7	52.3	3.1	0.0	0.5	1.3	460.1	11.3	0.0	0.0	0.0	0.1	0.5	0.1	0.1
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 217.2;tongue: 67.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 52.7;Late spermatids: 293.6;Skeletal myocytes: 79.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.5;prostate cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 1184.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA028870: AB_10611679"					"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	0.1	0.0	0.4	0.9	0.5	0.0	0.0	1.3	1.0	1.0	0.2	11.1	0.3	0.6	0.1	10.5	0.1	1.2	3.9	0.5	0.4	0.7	0.0	0.2	0.0	0.9	1.5	0.0	0.0	0.1	0.4	0.0	0.8	12.9	3.3	0.0	23.9	0.3	217.2	0.2	1.2	2.5	0.8	0.0	4.7	7.3	0.5	0.1	0.0	67.0	0.0	19.2	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	29.1	0.0	25.9	54.7	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	61.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1184.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.3	1.0	0.5	0.4	0.9	1.5	0.8	0.8	0.5	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.7	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	293.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	11.6	0.8	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	79.6	0.6	0.9	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1
SPCS3	"FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W"	ENSG00000129128	"Signal peptidase complex subunit 3"	P61009	4	176319966-176332245	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 670.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 374.4"					"Low region specificity"	"Detected in all"			HPA053180	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053180: AB_2682071"	"unprognostic (4.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.20e-3)"	"prognostic favorable (8.89e-6)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.44e-1)"	33.0	24.6	13.9	50.6	16.0	68.1	36.0	15.5	18.0	46.6	15.1	37.0	34.5	38.5	47.5	25.0	25.5	32.0	37.6	17.3	17.1	34.1	43.6	36.1	50.3	15.9	25.6	21.6	72.8	31.3	30.1	45.5	16.1	32.9	37.5	13.5	99.1	30.0	24.1	26.9	36.9	34.8	18.1	46.5	48.9	10.7	16.3	34.8	62.2	26.4	48.2	41.1	25.6	21.2	64.9	21.5	57.8	47.8	80.9	142.5	61.0	125.2	119.1	71.4	61.4	23.5	139.1	124.2	25.1	72.7	37.6	43.6	55.3	92.1	108.0	84.2	24.3	107.6	32.2	53.5	82.5	162.3	90.9	86.9	99.4	63.4	60.9	79.8	107.1	59.4	70.2	374.4	99.4	39.7	100.1	61.4	39.5	45.6	21.0	48.7	89.8	109.3	87.7	46.5	46.1	42.2	130.6	96.4	58.8	49.8	31.1	75.1	100.2	52.5	52.8	47.4	58.2	172.3	54.7	153.8	112.0	80.6	74.1	43.0	16.1	14.2	15.2	19.3	20.2	10.0	14.0	13.9	12.2	6.8	11.6	14.5	16.2	16.6	16.1	22.6	11.9	19.2	13.9	16.0	15.5	18.0	17.3	17.1	15.9	25.6	16.1	18.1	16.3	21.2	121.4	54.5	86.3	19.2	150.0	57.2	67.4	111.8	25.0	31.3	62.9	52.1	79.5	32.9	84.1	29.5	27.1	64.1	170.0	55.2	21.5	76.4	66.8	49.3	130.6	109.3	44.9	61.4	40.9	136.1	205.1	66.2	70.3	102.2	91.2	36.3	88.9	123.8	153.2	23.5	37.3	102.1	89.5	100.8	98.4	14.4	22.4	127.9	110.3	29.0	105.8	31.2	74.2	41.2	59.1	157.0	36.0	17.0	670.6	173.8	48.1	71.6	54.5	31.0	13.1	46.4	64.8	95.4	56.4	58.7	65.1	184.4	107.0	51.8	53.3	147.1
VEGFC	"VEGF-C, VRP"	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792922	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.3;Endothelial cells: 22.0;Leydig cells: 13.7;Microglial cells: 36.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 146.5;HBF TERT88: 114.4;hTEC/SVTERT24-B: 116.5;LHCN-M2: 129.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 7.0"						"Secreted to blood"	NA	NA	383000	340000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	25.0	6.9	2.6	4.2	2.5	0.2	16.7	2.7	2.8	9.7	2.1	4.7	2.4	7.3	1.8	4.0	8.5	6.8	12.7	2.4	2.4	6.7	4.2	16.8	8.0	3.1	2.8	5.9	1.8	2.7	1.5	19.3	2.9	5.1	3.3	1.2	7.4	5.0	3.1	5.1	6.8	6.6	2.6	3.9	3.2	1.4	3.7	1.1	27.7	4.1	3.4	10.3	7.6	2.5	5.9	2.8	1.8	0.0	25.5	25.3	0.0	146.5	87.3	79.2	62.5	0.0	0.7	0.0	0.0	82.7	33.1	4.4	1.3	54.8	114.4	0.1	2.8	0.0	3.8	0.0	13.9	0.0	0.0	27.0	2.5	116.5	80.5	79.3	49.7	0.0	0.0	0.0	129.9	2.1	0.0	0.0	1.3	0.0	47.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	2.3	3.3	0.1	0.7	0.7	0.2	24.2	83.6	9.2	20.8	42.1	0.2	0.0	0.0	34.9	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	2.5	2.7	2.8	2.4	2.4	3.1	2.8	2.9	2.6	3.7	2.5	39.3	3.2	0.0	10.1	0.1	2.4	1.3	3.2	0.0	1.0	3.2	1.7	1.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	3.1	8.3	10.9	22.0	0.0	0.0	2.0	0.0	0.0	9.1	0.0	11.0	0.0	8.5	10.0	0.0	0.3	1.7	2.0	0.0	4.1	0.3	2.2	1.2	13.7	0.4	3.6	36.5	0.0	3.4	0.0	1.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.2	0.0	1.9	11.7	0.2	2.0	0.3	2.0	0.0	0.2	1.9	0.0	3.6
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309874-177362936	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.6;lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	HPA065761			Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.1	0.0	0.0	1.7	0.0	6.6	0.3	0.0	0.1	0.2	0.0	1.1	1.1	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	2.3	1.3	0.5	0.0	0.4	0.6	1.5	0.1	23.6	0.0	0.0	3.5	0.4	0.4	0.0	19.3	15.8	16.4	8.2	1.8	3.3	8.0	23.4	8.6	25.3	14.9	5.8	16.5	21.2	3.4	6.2	25.1	8.8	17.4	9.3	36.6	72.1	11.4	14.7	11.9	15.2	0.5	79.1	9.7	0.3	0.5	26.2	5.6	5.2	9.9	53.9	15.3	99.1	16.7	8.4	80.7	30.2	7.5	5.7	11.5	16.2	11.2	6.8	6.8	2.6	12.8	8.9	11.7	13.4	6.3	7.2	10.9	20.4	4.7	15.2	11.8	7.8	24.0	6.8	4.8	33.5	10.1	27.8	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.4	1.2	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	2.6	1.6	0.5	0.0	0.0	0.1	0.1	0.6	0.3	0.0	14.7	0.1	0.2	3.3	0.9	0.0	0.5	0.0	4.8	0.4	0.0	1.5	0.0	0.1	1.0	0.0	1.3	0.4	0.2	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	6.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.5	2.7	2.4	4.5	1.3	0.3	1.0	0.5	1.2	0.2
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430774-177442437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 77.5;Karpas-707: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		36000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	9.4	13.3	8.1	9.1	10.4	15.4	21.1	9.8	12.0	9.2	16.2	13.1	9.6	8.6	30.2	15.9	8.4	13.1	7.5	8.4	9.9	15.3	18.7	11.6	12.2	11.4	9.1	10.2	15.1	17.1	6.1	8.4	11.4	11.8	13.1	6.6	14.9	9.8	9.0	20.6	12.4	9.5	9.5	10.3	16.2	13.2	8.6	11.1	15.8	5.8	15.6	10.9	8.2	13.7	5.4	11.9	13.3	18.8	14.9	13.2	9.0	39.5	77.5	20.1	24.8	6.2	26.2	26.9	7.2	30.0	9.7	6.5	11.3	13.0	39.4	17.3	7.5	11.2	11.9	17.3	10.0	19.6	7.4	9.6	22.5	14.7	6.5	18.0	18.7	11.4	10.3	111.6	8.0	14.6	15.9	12.0	5.2	10.5	12.2	5.0	5.4	4.0	20.5	12.9	7.3	16.4	11.9	10.3	32.2	9.9	23.3	39.8	6.1	13.9	12.3	6.6	15.2	21.2	17.4	14.0	22.3	22.0	16.0	26.4	15.3	23.9	15.6	27.5	17.9	13.9	16.6	18.8	14.8	12.9	14.8	21.3	3.3	12.7	35.8	15.8	17.8	15.1	8.1	10.4	9.8	12.0	8.4	9.9	11.4	9.1	11.4	9.5	8.6	13.7	12.6	12.8	13.5	2.6	20.5	24.0	17.4	26.9	12.5	3.9	19.8	16.9	7.5	15.7	21.7	14.7	2.1	26.3	17.6	8.4	5.9	28.2	13.6	8.9	8.5	10.9	5.4	7.8	3.7	31.3	32.0	16.0	13.7	12.5	14.0	13.9	8.2	23.5	23.1	6.7	2.3	18.2	14.2	15.4	23.3	9.2	11.1	15.9	39.2	2.8	23.8	19.1	11.3	3.5	19.3	21.4	9.1	9.8	48.8	13.4	15.1	22.1	10.5	4.8	0.0	8.4	14.1	35.8	36.6	23.7	27.3	22.7	22.5	14.1	13.6	17.7
TENM3	"KIAA1455, ODZ3, Ten-M3, TEN3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 13.1"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 635.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047043	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	5.0	5.1	12.0	1.6	18.4	0.0	2.0	0.0	12.3	1.5	0.0	4.3	0.8	2.9	0.6	0.8	1.0	2.4	1.4	21.8	8.1	0.9	0.3	0.8	0.8	2.8	7.3	3.8	1.2	5.1	4.5	13.1	0.0	3.7	0.8	3.9	0.6	3.6	2.1	0.4	0.9	2.3	0.8	2.2	0.7	2.1	7.4	2.8	6.1	4.3	1.2	1.6	1.4	2.0	0.3	2.6	66.3	0.4	13.2	23.5	63.3	7.8	2.7	6.9	6.1	33.9	17.6	0.0	0.9	52.6	28.6	3.3	16.0	3.4	6.8	90.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	31.2	1.2	21.5	15.0	15.4	9.6	0.0	0.0	0.4	10.6	2.3	0.1	0.1	21.4	0.0	2.8	0.0	17.1	0.2	0.1	0.1	27.2	25.2	4.0	0.5	0.1	35.8	86.0	3.4	21.2	53.7	38.2	0.2	39.6	0.0	0.0	0.0	28.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	18.4	0.0	12.3	21.8	8.1	2.8	7.3	0.0	0.8	7.4	2.0	0.1	0.0	0.0	23.8	0.0	0.4	0.2	0.7	1.8	50.8	1.6	2.2	3.9	0.0	0.1	3.7	4.2	112.7	0.0	0.0	1.9	0.1	12.4	0.1	4.5	0.7	5.3	0.0	115.6	1.8	54.6	4.1	0.0	0.6	0.0	7.7	1.1	0.7	10.4	5.0	635.6	0.0	0.0	0.0	0.7	3.2	8.4	0.0	1.8	8.4	0.0	10.6	0.0	12.1	24.4	0.4	0.0	2.6	0.0	0.4	0.0	0.3	0.0	3.1	0.0	4.8	3.2	3.8	7.2	1.8	0.0	133.4	0.1	4.1	0.1	0.1
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	50.8	83.8	39.0	41.6	40.3	29.5	46.7	40.1	44.8	48.9	51.1	41.4	33.1	47.8	29.7	61.2	49.0	54.7	40.6	39.8	43.6	48.9	79.8	41.2	45.2	43.0	42.8	65.8	54.9	61.8	46.9	36.7	40.2	39.9	40.9	25.1	44.6	41.7	41.7	39.3	36.3	46.4	43.8	50.3	54.1	21.8	42.6	42.2	100.8	32.9	49.6	50.1	45.6	46.0	97.8	87.4	88.4	81.3	129.6	176.7	115.0	184.1	163.0	128.7	79.7	89.2	183.0	33.5	44.3	179.9	87.1	47.3	65.5	114.9	117.1	163.8	50.4	155.9	50.4	109.1	139.5	153.3	93.3	149.8	120.8	113.6	117.8	129.6	112.2	73.1	157.4	324.5	175.6	71.5	100.1	94.7	70.0	39.8	79.3	107.3	62.2	65.8	107.9	115.1	86.7	54.3	86.7	73.8	87.4	81.2	56.7	78.8	131.7	105.7	81.7	52.0	142.0	124.5	72.9	42.8	117.4	98.5	127.1	68.6	47.9	45.2	61.0	58.8	76.8	71.0	52.6	62.7	55.0	48.6	51.6	54.6	3.3	73.7	60.2	42.4	50.6	55.6	39.0	40.3	40.1	44.8	39.8	43.6	43.0	42.8	40.2	43.8	42.6	46.0	31.6	12.8	19.5	8.8	31.7	25.4	34.4	35.4	37.5	4.9	39.4	34.2	24.3	38.6	21.5	33.1	4.2	19.0	26.6	16.8	37.2	68.8	7.0	19.7	41.6	30.9	14.5	27.1	10.7	54.5	26.8	42.3	15.8	22.3	22.8	36.2	30.0	45.2	53.8	3.3	11.7	28.5	18.3	38.8	32.1	18.0	44.1	29.4	26.6	9.4	34.8	37.4	25.7	3.0	3.1	75.5	18.5	35.3	27.6	46.1	19.3	45.8	18.7	5.5	32.9	25.8	34.6	10.2	15.4	54.5	23.0	7.3	27.6	42.4	31.3	42.3
WWC2	"BOMB, FLJ22029"	ENSG00000151718	"WW and C2 domain containing 2"	Q6AWC2	4	183099257-183320777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Microglial cells: 129.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 84.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044005	Uncertain		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Microtubules		"HPA044005: AB_10960552"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (7.16e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.22e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (3.27e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.52e-2)"	9.0	5.5	4.7	4.6	5.9	0.6	7.8	5.5	4.4	7.7	10.0	5.0	2.0	8.9	3.3	5.2	6.9	6.9	12.1	4.4	4.4	18.8	19.2	28.2	2.3	7.3	5.8	11.5	12.6	9.7	1.8	14.5	6.3	7.9	2.9	21.3	6.1	8.8	4.2	4.1	2.1	9.9	6.6	6.3	6.8	15.5	5.4	1.0	15.9	5.5	2.2	6.2	3.8	7.7	26.0	10.9	23.1	20.7	16.9	18.8	26.7	34.5	27.1	37.2	26.6	48.2	24.7	0.0	16.9	55.7	13.0	9.2	35.7	14.3	46.9	0.0	11.0	26.3	25.4	24.9	17.5	12.5	27.6	14.3	10.7	24.6	22.9	30.8	25.1	3.7	18.9	1.4	28.6	7.5	0.0	8.3	22.0	0.7	9.3	0.0	21.1	14.0	52.7	6.9	1.5	11.7	84.2	72.7	11.1	36.5	17.6	4.2	37.8	13.8	38.2	8.2	25.1	0.0	0.0	0.3	13.5	5.7	24.7	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	4.7	5.9	5.5	4.4	4.4	4.4	7.3	5.8	6.3	6.6	5.4	7.7	27.8	262.8	65.4	23.2	0.4	24.0	9.3	6.3	8.6	5.4	15.0	11.4	30.0	37.1	24.0	7.3	64.6	15.4	1.4	0.7	27.4	16.3	36.9	26.7	26.6	27.4	1.2	3.6	62.1	14.6	9.8	25.0	9.2	35.4	19.0	39.5	17.2	39.0	10.5	0.0	98.1	0.2	4.1	15.6	7.7	26.9	17.7	9.0	12.4	129.3	7.6	11.7	0.0	52.3	44.0	30.3	0.1	21.1	0.8	29.3	0.0	24.7	11.5	58.6	26.3	34.2	24.2	41.8	19.7	7.7	15.3	6.6	3.2	19.9	0.4	12.2
CLDN22	CLDN21	ENSG00000177300	"Claudin 22"	Q8N7P3	4	183318100-183320276	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 4.9"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 34.1;Glandular and luminal cells: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 44: Endometrium - Transcription"																					0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CLDN24	CLDN21	ENSG00000185758	"Claudin 24"	A6NM45	4	183321764-183322426	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (1.49e-1)"				"unprognostic (9.27e-2)"		"unprognostic (1.89e-1)"					"unprognostic (4.93e-3)"					0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444635-183449064	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 207.0;Glandular and luminal cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 161.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	11.7	11.7	10.1	11.9	10.7	38.0	15.5	13.4	13.4	12.8	9.9	14.3	19.0	15.7	12.3	22.2	11.8	12.9	10.3	9.8	10.4	18.3	17.5	11.2	19.8	10.2	10.2	22.6	18.5	15.4	11.4	13.9	10.1	12.8	13.6	13.1	12.8	13.0	9.0	12.0	17.3	9.7	10.9	14.3	17.8	20.1	10.8	24.0	13.5	14.2	18.8	11.8	12.3	12.3	14.4	8.1	23.2	16.8	19.0	14.0	17.7	23.9	19.9	23.9	16.0	11.9	13.5	47.1	4.9	16.1	10.0	11.3	21.0	17.3	25.1	19.4	12.6	49.7	39.4	15.9	14.8	37.3	19.5	16.3	15.6	14.3	18.7	12.6	19.1	18.0	25.1	50.4	16.5	7.8	41.6	30.5	17.0	5.5	16.2	36.1	11.2	19.5	161.1	13.5	23.9	20.7	17.2	72.0	29.9	14.9	10.5	32.0	11.0	8.5	12.3	7.9	19.6	24.4	10.9	25.0	13.3	31.4	13.9	61.0	8.0	18.6	14.4	9.7	14.9	12.2	17.4	15.4	7.7	14.1	22.6	20.8	9.7	15.0	10.3	5.2	19.2	14.6	10.1	10.7	13.4	13.4	9.8	10.4	10.2	10.2	10.1	10.9	10.8	12.3	49.6	16.0	33.1	3.6	58.9	35.9	38.5	9.1	130.3	21.2	35.5	40.1	18.9	17.2	24.2	16.5	10.4	21.8	51.8	36.4	17.6	12.5	150.8	207.0	48.9	33.5	30.4	32.0	5.8	15.5	14.7	38.8	62.2	333.9	62.1	29.7	16.4	13.5	15.7	21.9	5.8	25.5	20.3	12.6	24.2	70.5	21.1	25.7	21.4	7.5	13.2	24.3	22.6	7.5	9.9	17.6	21.1	17.3	47.2	31.5	37.8	13.1	28.8	21.2	13.1	60.8	37.5	36.6	40.3	124.7	39.8	18.7	55.3	22.4	33.3	60.9
ING2	"ING1L, p33ING2"	ENSG00000168556	"Inhibitor of growth family member 2"	Q9H160	4	183505058-183512429	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019486, HPA021517"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA019486: AB_1851780, HPA021517: AB_10601914"	"prognostic favorable (5.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (7.47e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.30e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.82e-2)"	9.5	42.3	5.2	5.2	5.8	21.7	8.7	6.8	6.8	7.2	5.5	9.4	10.6	5.2	10.2	14.6	8.8	8.9	7.5	5.0	9.6	12.2	10.5	8.6	5.9	6.4	6.4	37.4	15.8	6.1	23.3	6.1	6.0	8.7	6.7	8.6	10.7	4.5	26.1	12.1	14.3	4.6	4.6	9.1	11.5	33.3	8.0	12.5	9.3	14.8	6.7	11.4	9.9	5.3	19.1	11.4	15.5	12.3	28.1	16.4	12.7	20.1	17.4	15.6	13.3	10.4	20.2	13.5	5.2	14.7	12.7	8.3	10.4	15.6	19.8	10.4	7.6	23.4	11.4	13.5	8.5	19.3	25.1	12.7	14.3	17.0	7.1	12.8	7.5	13.0	13.2	49.8	11.5	18.8	24.7	19.6	12.5	5.5	11.1	10.3	8.6	22.5	18.8	8.7	15.3	11.5	13.3	17.6	5.3	10.0	8.3	13.9	6.4	10.5	16.5	7.2	13.0	10.7	8.6	9.1	19.3	14.3	7.6	15.2	6.3	19.7	3.2	6.6	5.0	11.9	6.3	5.7	7.8	8.4	8.8	7.6	6.4	3.8	8.5	7.6	5.4	3.7	5.2	5.8	6.8	6.8	5.0	9.6	6.4	6.4	6.0	4.6	8.0	5.3	18.7	6.4	21.0	6.2	20.1	49.3	20.5	20.7	105.9	25.7	36.3	41.8	12.1	25.8	18.2	16.5	12.5	26.1	18.8	32.7	74.3	20.9	68.4	93.0	26.3	21.7	18.6	26.7	7.1	34.9	94.9	29.1	11.7	82.9	40.0	85.4	15.4	24.1	30.0	25.2	5.3	24.2	16.2	24.2	43.3	35.2	82.6	27.3	26.6	1.0	13.9	40.5	6.2	3.5	5.1	33.3	28.3	53.8	19.5	34.2	112.9	47.8	39.8	23.6	19.7	23.7	28.0	95.3	74.9	71.6	46.2	21.2	25.6	50.4	23.0	39.3
RWDD4	"FAM28A, MGC10198, RWDD4A"	ENSG00000182552	"RWD domain containing 4"	Q6NW29	4	183639635-183659203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036501, HPA036502"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Intermediate filaments"		"HPA036501: AB_2675159, HPA036502: AB_10670800"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (1.01e-6)"	"unprognostic (6.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.65e-2)"	11.9	52.1	9.2	8.9	9.6	14.7	19.1	10.9	12.5	12.3	14.5	12.0	11.0	12.1	14.3	14.5	13.7	12.7	16.2	9.2	11.7	23.7	15.9	9.6	10.7	9.8	10.2	40.4	26.2	11.8	19.0	11.6	9.5	15.2	12.1	6.2	20.6	11.0	44.9	11.2	10.0	10.7	9.5	9.8	13.7	10.0	10.9	15.9	22.2	32.2	12.5	14.0	10.4	10.1	25.6	14.6	22.0	27.2	35.1	36.5	16.7	31.8	25.4	38.9	24.7	9.5	32.8	38.6	7.1	26.6	18.8	11.8	31.1	29.7	40.8	25.5	14.0	27.7	16.4	24.4	24.7	42.5	20.3	24.2	30.0	21.6	24.0	30.2	29.8	29.7	27.0	48.5	42.0	10.8	44.7	36.7	14.7	9.8	19.2	30.7	17.0	24.8	38.5	12.1	21.0	29.6	29.9	34.4	29.0	16.9	17.3	25.8	20.9	16.3	8.0	17.6	24.9	16.2	13.1	13.1	30.6	31.8	23.7	3.2	3.4	6.8	4.4	4.5	4.4	3.8	4.0	4.2	4.4	2.5	3.7	3.9	2.9	6.5	5.5	4.7	5.7	3.5	9.2	9.6	10.9	12.5	9.2	11.7	9.8	10.2	9.5	9.5	10.9	10.1	29.4	22.4	19.5	7.2	25.6	33.6	35.4	32.0	27.3	17.9	39.2	40.8	11.5	37.1	25.3	18.4	6.2	25.9	32.9	19.7	74.3	38.8	10.6	38.4	28.6	27.3	21.7	30.3	10.3	77.5	42.4	33.4	28.1	28.2	35.5	35.9	26.4	35.6	36.1	10.1	9.5	21.6	38.7	30.1	21.9	9.9	74.0	23.8	56.9	6.5	34.7	30.9	32.0	6.6	7.7	55.8	17.1	70.7	32.5	90.3	19.6	116.1	32.0	22.1	19.7	44.5	27.4	47.7	59.7	46.0	35.5	27.1	26.7	70.2	25.4	59.1
TRAPPC11	"C4orf41, FLJ12716, foigr, gry"	ENSG00000168538	"Trafficking protein particle complex 11"	Q7Z392	4	183659267-183713594	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038173			Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA038173: "	"unprognostic (2.24e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.14e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.92e-2)"	12.1	15.9	4.3	13.4	5.5	11.4	15.5	8.3	6.4	12.4	15.4	13.2	11.0	14.1	11.8	13.8	12.4	11.0	12.4	5.5	4.8	14.8	16.9	13.6	14.9	3.4	4.1	20.8	14.2	19.1	6.8	13.8	3.7	14.1	15.0	13.8	14.8	12.1	15.1	12.1	11.7	15.7	4.4	14.2	13.5	16.0	4.9	17.8	14.8	18.7	17.6	13.6	8.0	6.0	15.1	14.4	23.2	23.1	28.5	31.3	17.6	21.6	21.7	17.8	16.2	9.0	19.1	20.7	6.0	21.8	13.9	10.8	21.2	20.5	20.4	23.1	9.3	26.0	12.0	12.8	26.2	28.3	24.8	24.2	21.5	17.8	20.6	23.2	26.5	23.9	21.1	41.8	22.5	10.8	34.1	13.8	8.7	10.2	10.7	23.4	13.8	15.8	22.8	15.3	15.6	20.7	21.1	21.6	21.4	20.5	16.6	31.0	26.7	10.1	11.9	9.7	12.4	21.8	12.7	12.4	20.6	18.7	18.0	3.8	12.9	8.2	5.7	14.9	7.6	4.7	6.2	6.1	12.8	3.4	5.7	5.9	3.7	10.0	25.6	3.3	5.4	7.6	4.3	5.5	8.3	6.4	5.5	4.8	3.4	4.1	3.7	4.4	4.9	6.0	9.5	3.2	14.5	33.0	12.3	4.5	3.1	7.4	9.1	11.0	5.7	6.2	14.8	8.6	9.1	7.3	8.4	7.9	10.0	9.8	3.9	7.4	57.7	8.2	13.3	9.1	13.1	12.0	47.5	9.3	8.4	12.0	12.2	8.0	7.6	18.7	9.3	8.5	11.6	8.4	47.4	7.2	0.0	16.0	6.8	7.3	13.4	16.1	3.6	30.0	19.5	6.4	11.3	37.2	35.2	9.0	7.1	11.3	10.6	5.5	11.7	4.6	12.9	13.6	0.0	9.9	8.6	7.7	14.9	10.4	6.1	7.0	9.4	12.4	7.9	5.9
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	1.8	1.6	8.3	0.7	8.2	6.0	1.8	4.2	13.3	2.1	2.3	1.7	0.9	1.9	3.4	5.0	2.7	1.3	3.6	11.1	3.1	2.7	2.0	2.1	0.6	2.7	3.9	3.3	4.9	4.0	7.0	1.4	3.9	2.3	0.9	3.8	7.3	2.3	2.1	3.9	1.3	1.8	2.0	4.1	2.3	0.9	6.6	4.1	5.8	2.1	1.1	2.5	3.3	11.5	2.1	4.3	13.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.3	1.7	0.0	2.6	0.0	2.7	0.2	7.4	1.2	0.0	0.0	5.9	0.0	12.7	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.8	0.0	0.6	0.0	0.1	16.8	0.0	0.6	0.1	4.8	0.0	3.1	4.1	6.8	15.8	3.2	0.0	0.0	4.7	0.2	0.4	0.0	0.0	2.8	0.0	0.1	0.1	3.8	2.1	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.2	4.2	13.3	11.1	3.1	2.7	3.9	3.9	2.0	6.6	11.5	12.7	12.8	22.1	39.2	0.4	4.2	6.0	3.7	8.6	28.2	3.8	4.6	20.7	5.7	8.7	7.3	0.0	2.7	0.0	0.2	3.9	5.4	1.2	7.2	0.7	18.5	1.8	0.0	181.7	3.1	2.1	5.8	3.1	3.7	0.0	0.3	21.4	5.6	1.1	33.7	192.3	0.4	2.0	2.2	1.5	2.6	0.6	0.8	1.8	72.1	0.0	12.4	0.0	91.0	153.5	2.1	0.0	4.5	1.3	5.2	0.0	4.0	16.8	3.4	0.0	4.8	4.5	0.6	2.0	17.8	3.3	0.7	0.7	3.6	0.4	3.4
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4;kidney: 30.6;ovary: 12.5"	"Cell type enhanced"	"Detected in some"		"Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		290000		"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.2	0.3	2.7	0.8	11.8	0.9	0.8	14.2	5.5	0.2	2.3	1.0	1.7	0.2	6.1	1.0	0.3	0.5	0.2	2.7	6.1	30.6	0.1	0.3	0.9	20.4	9.6	12.5	0.0	0.0	4.2	0.1	18.1	2.2	1.0	0.1	0.7	6.1	0.2	0.1	2.2	0.1	12.5	1.0	1.2	2.4	11.1	1.9	0.1	1.3	2.8	0.6	0.3	29.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	2.7	11.8	14.2	5.5	2.7	6.1	20.4	9.6	18.1	12.5	11.1	29.4	0.5	0.0	0.0	5.9	0.1	0.0	0.2	0.9	0.6	0.0	0.1	0.5	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	3.9	1.1	1.0	0.0	0.0	0.5	0.0	0.0	4.3	0.2	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.4	4.1	0.6	1.8	4.7	1.1	0.0	0.0	6.6	119.9	0.0	0.0	35.3	0.5	0.1	0.0	31.3	0.2	0.0	0.0	5.1	0.6	0.1	1.6	0.0	0.0	0.0	0.3	23.9	0.0	0.3
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 571.0;eosinophil: 408.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 571.0"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		94000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	16.3	12.1	11.3	26.6	10.9	32.8	16.3	18.6	11.4	12.7	10.0	34.2	54.1	12.7	12.9	27.7	9.2	19.9	14.7	10.8	12.2	8.5	22.0	12.8	43.4	10.8	11.5	8.9	13.4	9.0	8.8	26.1	11.4	11.3	33.9	12.7	13.2	10.6	13.9	16.1	41.8	15.3	11.6	23.0	31.2	9.3	11.3	39.0	10.6	14.1	41.9	24.4	12.0	13.0	31.0	16.7	65.3	31.6	39.4	52.2	37.6	90.2	67.7	61.9	35.4	30.7	25.2	42.4	13.9	44.1	29.2	25.5	52.1	32.1	69.7	109.9	28.7	68.2	12.9	71.4	47.3	55.9	62.3	71.7	38.3	39.3	31.4	44.4	77.6	43.1	57.2	259.8	64.5	13.2	89.1	51.8	65.1	33.7	20.9	63.6	30.8	41.2	52.9	49.3	37.1	40.5	39.1	35.1	52.1	64.3	19.2	35.9	54.1	28.2	25.9	21.1	42.4	118.9	121.6	29.2	34.2	38.5	40.9	571.0	26.1	408.6	32.1	43.3	34.4	26.0	29.5	46.3	33.3	18.6	22.2	32.8	35.6	62.0	71.0	26.5	64.1	47.5	11.3	10.9	18.6	11.4	10.8	12.2	10.8	11.5	11.4	11.6	11.3	13.0	28.6	19.2	15.8	26.4	32.3	48.7	22.2	34.1	35.9	18.6	21.7	17.0	17.5	5.7	36.3	12.9	0.0	46.9	54.8	37.4	13.7	18.4	9.6	24.9	17.1	26.6	18.0	62.3	9.6	23.7	33.6	19.5	24.5	24.9	17.7	24.8	21.0	15.3	23.9	13.5	12.6	37.6	44.7	27.0	17.4	4.0	7.5	33.3	30.2	13.1	41.5	15.4	37.0	11.1	18.4	25.0	18.8	7.5	118.6	20.1	26.6	8.4	30.4	11.3	13.1	19.0	20.8	7.9	16.4	34.6	28.6	51.4	43.8	23.1	24.4	36.7
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649667-184694963	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 24.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	7.2	8.0	4.0	6.0	4.9	5.5	8.9	7.6	4.2	8.5	4.4	7.9	4.7	10.7	8.2	7.0	8.9	6.9	7.0	3.6	4.1	5.7	6.8	7.5	7.9	4.3	4.1	12.1	4.8	6.8	4.6	6.6	4.3	7.1	8.6	7.2	4.7	8.2	4.7	6.6	6.7	9.2	4.2	8.6	5.9	5.5	4.3	8.6	7.6	5.3	6.4	6.4	5.3	5.6	13.1	5.7	13.2	15.0	17.5	23.2	8.9	13.8	21.8	22.9	19.9	4.4	13.3	7.5	5.0	10.6	12.6	7.9	11.3	14.6	24.0	15.9	5.3	7.8	7.8	5.3	11.4	6.4	11.5	14.5	11.4	21.2	13.7	13.4	12.6	20.7	16.5	24.0	16.5	4.4	13.3	5.4	4.3	5.8	4.6	12.3	9.4	9.0	11.8	7.8	9.4	11.9	8.3	2.1	15.2	10.4	6.6	12.3	6.8	7.5	9.7	5.9	8.9	13.4	10.2	3.8	11.1	8.5	18.6	11.2	2.5	24.0	3.8	2.4	5.6	3.6	3.6	3.9	3.2	3.7	3.0	3.0	1.2	4.7	5.6	2.7	4.6	3.1	4.0	4.9	7.6	4.2	3.6	4.1	4.3	4.1	4.3	4.2	4.3	5.6	7.7	6.4	8.6	23.5	6.7	9.6	9.5	10.0	9.1	6.2	10.1	6.3	2.6	7.2	10.4	5.5	0.0	14.3	8.1	5.9	5.9	7.7	5.5	9.0	11.1	7.3	6.7	17.5	13.9	5.2	10.0	9.7	8.2	6.3	15.2	12.0	8.9	7.5	9.7	8.4	26.9	58.8	6.1	14.8	6.4	5.7	12.5	9.5	8.8	19.7	6.5	11.1	6.2	27.2	28.1	3.7	10.4	9.1	8.6	4.0	7.2	5.7	15.4	8.2	13.1	11.1	9.0	18.8	13.1	6.9	9.8	4.9	8.9	5.7	8.0	5.4
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694085-184734130	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.6;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.7;Late spermatids: 900.3;Spermatocytes: 490.2;Spermatogonia: 215.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 20.7;eosinophil: 14.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 157.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	1.5	1.1	0.1	5.4	0.3	62.6	5.7	0.6	0.3	2.4	0.1	7.8	5.1	1.5	0.7	10.5	0.9	1.1	1.5	0.2	0.2	0.7	3.7	1.7	16.2	0.2	0.2	0.6	1.0	1.4	0.2	4.8	0.6	1.3	8.0	1.5	2.7	0.4	0.9	15.3	5.4	2.7	0.2	2.3	3.7	29.5	0.4	12.8	1.3	0.1	13.6	2.1	3.9	0.5	57.8	17.1	67.9	35.8	4.3	6.4	37.6	40.8	19.4	32.2	21.2	24.8	32.1	45.9	3.8	18.7	20.2	23.0	52.4	33.2	30.6	23.4	23.0	50.4	17.5	12.6	0.7	71.1	29.3	2.7	2.1	33.3	8.4	9.4	32.1	53.9	44.1	157.3	51.1	38.2	111.4	53.0	33.8	12.7	21.5	74.5	24.3	15.6	17.1	26.7	52.0	49.0	31.4	39.4	23.9	25.0	44.1	50.2	20.9	23.8	31.3	23.5	39.7	26.5	29.5	37.6	37.2	55.4	94.5	20.7	0.7	14.2	0.5	2.0	0.4	0.9	0.7	0.8	0.4	0.9	0.6	0.8	0.1	3.5	2.8	1.9	2.5	0.6	0.1	0.3	0.6	0.3	0.2	0.2	0.2	0.2	0.6	0.2	0.4	0.5	1.4	9.6	3.2	0.3	6.5	13.9	6.0	11.5	3.4	0.9	11.5	7.9	2.3	4.3	8.7	1.8	0.0	31.5	5.4	8.9	3.9	4.8	489.7	9.5	4.0	3.8	0.0	115.7	0.4	2.5	48.4	7.3	9.2	6.6	8.9	27.1	1.1	0.9	21.6	0.0	0.4	10.0	10.2	5.1	7.3	900.3	9.0	15.3	0.0	1.0	5.3	0.2	4.1	0.5	1.9	3.0	1.0	6.8	28.3	2.6	0.9	0.7	5.6	1.4	19.7	2.0	7.2	490.2	215.1	29.1	21.5	7.5	6.3	4.4	18.1	11.6
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 770.4;liver: 1319.0;skeletal muscle: 731.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 355.8;Hepatocytes: 1170.0;Late spermatids: 456.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 475.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 475.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1124.0;ASC TERT1: 275.2;HSkMC: 609.5;RPTEC TERT1: 358.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011317, HPA011964"	Enhanced		Uncertain	Vesicles		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA011316: AB_1844536, HPA011317: , HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	770.4	43.3	32.5	94.8	43.9	337.9	316.7	45.2	70.2	62.1	60.7	34.0	32.4	41.6	78.2	66.0	50.6	36.2	172.7	34.4	39.1	218.7	1319.0	173.7	20.7	63.2	44.4	15.5	49.3	57.0	39.6	30.0	56.2	91.3	16.3	28.4	84.2	30.1	731.8	173.0	34.5	42.8	45.2	132.8	54.2	41.9	63.2	12.2	51.3	442.0	24.7	73.2	57.7	70.8	51.6	15.9	9.7	24.6	1124.0	275.2	8.3	29.1	13.8	16.1	11.2	3.9	14.0	22.2	3.0	32.8	38.4	29.7	43.1	17.8	13.3	107.1	17.7	16.6	13.1	40.5	183.4	41.9	37.2	609.5	140.7	13.6	67.1	27.6	21.1	3.6	7.5	59.4	77.0	26.9	3.1	55.1	2.0	32.5	23.3	8.0	8.6	27.0	358.4	135.9	36.3	35.1	25.4	70.8	86.5	3.9	26.9	39.8	25.1	13.8	16.8	34.5	8.7	24.5	13.5	8.9	45.6	56.3	22.4	16.5	54.7	17.7	3.3	30.9	2.8	3.3	2.3	1.5	13.1	3.4	2.5	2.2	475.2	4.4	23.0	2.4	4.9	20.8	32.5	43.9	45.2	70.2	34.4	39.1	63.2	44.4	56.2	45.2	63.2	70.8	7.5	25.6	121.0	6.5	15.7	21.0	16.0	14.0	5.2	6.6	49.7	10.3	119.1	25.8	33.5	31.3	18.8	10.2	7.1	4.3	93.9	4.6	355.8	9.8	25.0	9.8	0.0	34.1	15.2	12.8	2.2	19.4	36.2	24.6	24.1	1.5	18.2	1170.0	41.8	3.3	22.8	4.7	85.5	140.7	14.6	456.6	19.3	170.1	32.0	6.5	40.5	3.1	1.0	8.5	89.8	8.6	1.6	16.6	8.6	51.3	1.5	111.1	26.8	11.4	13.1	11.1	12.4	10.5	16.7	26.4	41.1	3.4	10.6	1.8	3.2	23.1
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.5"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	14.0	1.6	15.3	0.4	4.6	22.6	30.6	3.4	6.8	21.0	3.0	5.9	3.5	10.1	5.8	3.9	245.1	16.7	11.8	10.4	7.3	4.5	1.5	11.6	10.7	4.9	5.2	7.8	9.5	1.7	11.8	8.9	3.9	19.9	9.0	12.6	190.8	3.3	6.8	8.1	9.4	3.1	15.7	4.7	12.5	1.4	5.2	346.6	1.2	9.8	3.6	18.2	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	14.0	15.3	22.6	30.6	16.7	11.8	11.6	10.7	11.8	9.4	12.5	18.2	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
CFAP97	"DKFZp434F1728, hmw, KIAA1430"	ENSG00000164323	"Cilia and flagella associated protein 97"	Q9P2B7	4	185159665-185209504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 276.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049446, HPA053335"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA049446: AB_2680770, HPA053335: AB_2682117"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.29e-1)"	17.0	11.8	6.6	14.6	7.7	5.2	20.8	9.4	10.0	17.6	10.4	11.2	7.5	18.8	9.4	19.1	15.8	15.1	9.0	6.5	7.6	16.2	18.8	13.6	17.5	7.5	7.1	22.1	10.2	20.3	6.4	13.9	8.6	17.6	11.3	18.0	12.2	17.5	6.7	11.4	9.7	17.3	7.1	18.6	11.2	37.4	6.8	11.8	27.3	7.0	16.2	14.6	9.7	11.1	29.5	17.9	23.6	40.8	27.1	47.8	14.2	38.3	34.7	28.1	22.2	11.2	36.2	73.1	12.6	44.2	21.0	15.8	26.9	33.3	37.2	65.3	17.7	29.5	10.5	26.1	33.5	40.5	22.4	31.0	45.9	30.6	66.6	34.9	24.6	33.7	53.1	66.8	39.9	14.0	21.5	20.0	13.6	9.1	14.2	31.9	11.7	45.8	34.4	15.6	15.8	42.3	28.3	27.2	53.9	13.6	18.2	24.4	35.8	26.4	16.4	10.4	30.4	26.4	12.5	22.4	33.0	34.5	53.8	9.5	6.4	2.9	27.8	11.5	32.8	30.7	27.0	27.4	8.5	29.7	27.0	18.9	1.3	19.9	18.9	29.3	21.0	10.0	6.6	7.7	9.4	10.0	6.5	7.6	7.5	7.1	8.6	7.1	6.8	11.1	84.0	64.1	41.3	17.0	50.5	0.0	64.7	0.0	58.6	61.5	68.5	75.4	29.6	52.9	22.9	46.0	52.1	29.5	54.4	2.8	70.5	57.2	276.4	66.9	81.7	49.9	12.2	30.1	10.8	51.5	33.8	53.0	34.7	39.3	27.8	39.7	41.4	65.1	20.7	69.0	19.3	11.6	0.0	26.3	0.0	156.3	81.7	25.7	0.0	15.0	41.0	61.9	63.8	26.2	20.3	49.1	6.6	87.6	41.9	73.0	15.0	109.2	36.5	69.6	72.3	75.5	51.4	171.7	109.3	48.3	0.0	15.7	47.7	122.0	14.8	37.8
SNX25	SBBI31	ENSG00000109762	"Sorting nexin 25"	Q9H3E2	4	185204237-185370185	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 128.9;Astrocytes: 50.6;Excitatory neurons: 57.7;Inhibitory neurons: 60.7;Oligodendrocyte precursor cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036928			Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA036928: AB_10669720"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.89e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.55e-3)"	7.6	8.0	7.0	7.3	8.4	2.0	9.5	17.3	7.9	6.0	23.9	12.3	3.5	6.9	6.3	7.1	9.7	8.5	8.7	7.5	8.9	11.3	9.1	29.1	11.5	9.6	10.0	7.4	10.0	13.3	10.5	11.8	9.7	14.9	6.7	25.5	6.7	8.6	10.2	6.2	7.9	7.0	8.1	9.5	6.2	12.7	8.8	2.9	16.7	8.6	12.9	7.2	5.4	7.3	11.9	6.2	7.8	11.0	20.5	15.0	11.5	35.6	17.1	17.9	14.9	5.3	8.1	33.6	3.8	26.0	12.4	4.6	8.9	7.8	20.0	55.9	14.5	5.7	7.5	12.8	11.9	3.8	8.0	10.4	8.3	15.6	8.6	36.0	15.7	6.3	12.0	33.3	23.9	3.5	1.5	6.9	6.3	1.6	5.9	4.9	9.0	8.6	43.0	4.5	16.5	11.9	7.4	2.0	30.3	10.8	4.2	4.9	30.0	10.2	6.5	9.8	15.7	29.3	12.8	7.1	16.7	2.8	12.9	0.0	0.0	0.0	0.1	0.0	0.3	0.7	0.3	0.4	0.0	1.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	7.0	8.4	17.3	7.9	7.5	8.9	9.6	10.0	9.7	8.1	8.8	7.3	9.5	25.6	128.9	50.6	12.6	4.8	4.2	2.3	4.6	15.9	7.0	3.4	6.8	0.0	7.3	5.5	31.3	4.8	5.5	5.4	0.0	4.8	5.9	11.5	8.1	9.6	0.0	0.0	57.7	2.6	4.9	4.9	5.1	10.3	1.3	3.9	12.5	8.8	2.0	6.7	60.7	4.0	2.0	3.2	2.5	4.8	9.6	2.2	21.4	32.8	0.6	5.6	3.1	55.3	21.4	3.9	1.6	9.8	11.3	9.4	5.6	2.3	6.7	15.7	0.0	4.8	5.7	9.0	16.2	2.3	6.1	5.6	7.0	10.3	3.3	5.5
LRP2BP	DKFZp761O0113	ENSG00000109771	"LRP2 binding protein"	Q9P2M1	4	185363872-185395924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Cone photoreceptor cells: 33.3;Early spermatids: 62.1;Inhibitory neurons: 34.2;Late spermatids: 42.3;Oligodendrocyte precursor cells: 40.2;Oligodendrocytes: 34.9;Rod photoreceptor cells: 34.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036664, HPA036665"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036664: AB_10672361, HPA036665: AB_10673660"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.15e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-4)"	"unprognostic (2.17e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-4)"	1.7	2.1	6.7	0.7	6.9	0.4	1.6	15.0	7.9	2.7	9.8	3.6	0.3	1.8	2.3	1.0	6.9	0.9	3.6	6.5	7.5	4.8	1.6	4.4	0.7	11.4	10.0	8.5	3.2	0.2	17.4	0.6	8.7	3.7	0.4	28.9	1.5	0.5	3.0	1.5	1.9	0.3	9.8	2.7	1.7	10.7	8.1	0.2	3.5	0.7	0.1	2.1	1.7	10.8	0.5	0.4	0.5	1.1	0.3	0.1	1.0	1.5	0.4	0.0	0.3	0.5	0.5	1.8	0.1	0.1	0.5	0.3	0.3	0.2	0.2	1.7	0.9	0.4	1.5	1.6	0.2	0.3	0.5	0.3	0.2	0.7	0.2	1.5	0.4	1.3	0.6	1.4	0.4	0.1	0.6	1.2	0.6	0.0	0.2	0.3	0.3	0.4	0.4	0.3	1.2	0.8	0.3	0.4	1.0	0.7	0.4	0.1	1.4	0.8	0.6	0.2	0.8	5.3	0.5	0.3	1.3	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.2	0.0	0.5	0.3	0.2	0.1	0.1	0.1	0.5	0.2	0.0	6.7	6.9	15.0	7.9	6.5	7.5	11.4	10.0	8.7	9.8	8.1	10.8	3.1	9.6	2.6	57.5	3.5	2.4	4.1	1.3	2.8	28.8	3.0	2.4	5.5	0.0	1.8	0.0	33.3	1.2	3.3	1.7	0.0	1.5	62.1	17.6	3.1	3.2	7.8	0.0	28.0	0.9	2.5	2.1	2.6	4.4	0.0	1.9	1.4	0.3	0.5	26.9	34.2	2.4	4.1	1.2	1.4	42.3	2.8	1.9	5.4	3.7	0.8	10.4	0.0	40.2	34.9	1.0	0.2	3.8	2.5	4.3	2.6	1.6	14.1	34.0	0.0	5.4	2.8	8.4	1.9	0.8	3.1	1.6	3.1	2.1	1.0	2.1
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 93.7"	"Cell type enhanced"	"Detected in all"		"Club cells: 257.6;Endometrial ciliated cells: 271.9;Respiratory ciliated cells: 263.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	16.9	10.3	30.7	4.3	31.7	3.3	13.4	32.2	58.7	36.6	45.2	11.2	7.8	6.1	3.7	69.5	11.7	6.7	27.4	31.5	31.9	14.3	26.2	9.9	4.1	33.7	32.9	29.1	17.5	1.4	21.8	15.1	32.1	35.2	9.5	93.7	31.2	5.7	30.2	14.9	6.4	4.4	33.9	7.1	9.0	11.2	34.7	5.1	23.9	13.3	7.5	10.8	29.6	32.4	12.6	1.6	1.1	5.4	7.4	4.5	4.9	4.8	3.7	3.7	6.8	2.9	3.4	4.3	2.4	8.4	6.4	4.3	6.5	6.2	4.2	12.4	0.7	2.8	5.8	8.3	3.3	2.4	7.6	1.2	6.4	3.0	3.6	23.8	3.9	2.9	5.0	8.2	9.4	2.6	2.6	12.1	1.7	1.1	8.3	0.5	1.5	13.4	4.5	1.1	7.2	12.9	3.7	4.1	14.4	4.6	4.1	2.3	5.1	6.6	5.0	4.2	5.1	13.3	5.2	2.2	20.9	2.8	6.9	0.5	3.3	8.3	4.1	3.2	3.9	6.8	3.6	6.7	2.0	6.9	2.4	3.4	1.2	3.9	3.3	3.4	4.5	2.5	30.7	31.7	32.2	58.7	31.5	31.9	33.7	32.9	32.1	33.9	34.7	32.4	39.3	22.4	28.7	9.1	104.2	59.4	41.8	197.9	42.7	29.9	66.9	92.3	1.8	11.5	257.6	9.2	29.2	25.0	69.8	93.8	25.4	25.2	6.2	271.9	18.9	44.7	119.9	8.4	8.0	23.3	43.0	28.6	142.2	96.5	61.7	7.7	12.1	25.8	15.4	10.1	7.9	186.6	89.5	8.1	170.2	3.2	9.3	53.3	142.3	12.2	17.7	99.8	1.0	4.0	4.6	32.3	53.3	11.7	223.5	38.5	60.9	31.5	263.3	115.2	6.6	27.3	38.7	32.1	28.4	54.0	48.2	84.4	65.8	7.4	50.8	20.2
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399537-185425979	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	21.2	24.9	19.9	9.5	21.7	5.7	24.3	25.2	24.1	21.6	29.6	19.5	13.0	19.9	28.1	25.8	17.7	15.6	32.1	20.4	21.9	37.3	24.1	17.1	11.9	20.4	20.2	31.4	19.7	23.8	10.0	14.0	20.9	19.8	15.3	56.4	20.3	19.2	48.5	21.6	12.0	20.2	20.7	14.5	17.5	21.0	21.3	14.3	25.9	40.6	16.1	16.2	10.1	25.3	17.5	11.9	28.8	24.3	25.8	25.6	15.3	20.3	20.5	19.3	19.3	18.4	23.2	17.9	9.0	19.7	14.7	16.1	20.4	32.2	17.4	21.8	12.4	11.8	13.0	23.3	30.2	15.3	12.3	14.7	26.8	16.5	16.7	26.7	35.7	21.9	24.8	34.3	28.2	16.3	22.0	16.4	8.7	11.8	16.7	20.2	11.5	20.4	31.9	11.4	18.6	14.8	11.3	25.6	23.1	17.6	15.4	13.6	27.3	9.5	16.8	7.5	17.2	34.6	14.8	9.5	30.5	11.0	25.3	10.8	12.3	7.6	21.2	10.4	25.7	22.0	21.7	24.1	14.1	15.4	23.2	22.9	0.7	21.5	11.1	19.9	20.6	12.5	19.9	21.7	25.2	24.1	20.4	21.9	20.4	20.2	20.9	20.7	21.3	25.3	33.8	6.4	23.9	14.7	30.1	22.0	28.7	35.1	33.0	47.6	20.9	25.5	27.0	15.7	31.1	20.2	66.7	26.0	23.4	8.3	111.6	28.3	190.5	16.4	28.9	24.1	19.3	24.0	12.2	33.1	29.7	34.2	20.4	19.2	29.7	21.9	21.8	17.3	27.2	18.5	17.8	18.6	28.5	22.1	18.8	52.9	35.4	18.5	35.6	12.2	17.3	71.8	21.6	23.6	33.2	19.7	14.6	42.2	53.0	15.4	22.2	100.9	23.7	87.9	65.7	31.8	38.9	89.3	56.7	22.6	18.9	41.9	27.1	35.6	14.8	19.6
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.3;fallopian tube: 13.6;retina: 15.1;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.3;Endometrial ciliated cells: 50.0;Excitatory neurons: 36.6;Respiratory ciliated cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;hTERT-RPE1: 4.9;U-87 MG: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.5	0.3	3.2	0.2	4.4	0.3	2.1	3.8	2.9	1.0	24.3	0.3	0.1	1.2	3.8	0.3	13.6	0.9	0.9	3.3	3.6	2.7	0.4	2.0	0.1	7.2	8.2	0.7	0.7	0.6	2.9	0.2	5.5	0.6	0.2	15.1	0.5	0.6	0.1	1.0	0.2	0.3	7.1	0.2	0.3	13.3	3.9	0.2	4.6	0.1	0.2	0.3	0.3	3.9	2.4	0.0	0.2	1.2	0.4	2.3	0.7	0.0	0.1	0.2	0.3	0.3	1.4	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0.5	0.5	0.4	0.0	0.1	0.3	0.5	0.0	0.1	0.5	0.5	0.5	0.2	4.9	0.0	0.5	0.3	0.1	1.8	0.3	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.7	0.0	1.3	0.6	0.4	0.0	1.5	0.5	0.1	0.4	0.7	0.4	0.1	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.0	3.2	4.4	3.8	2.9	3.3	3.6	7.2	8.2	5.5	7.1	3.9	3.9	0.6	3.2	1.5	21.5	2.0	0.6	0.9	8.7	4.6	0.9	2.2	3.9	0.6	1.5	13.2	3.7	10.4	0.1	0.4	0.4	1.9	2.8	191.3	50.0	1.5	1.3	0.0	0.0	36.6	0.6	1.5	2.4	6.6	3.4	0.0	0.3	1.1	0.1	0.2	1.7	26.3	0.0	2.0	0.6	0.4	20.9	0.6	0.7	1.8	4.7	0.1	3.6	0.0	18.6	13.4	1.0	0.0	0.7	9.6	0.6	0.0	3.7	106.6	14.8	0.0	3.0	3.1	12.6	5.0	2.6	0.6	0.3	1.5	0.5	0.0	0.3
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 30.7;testis: 100.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.6	1.0	1.8	1.0	3.4	0.0	3.6	2.6	2.1	2.6	1.6	1.8	0.9	1.4	5.1	1.8	2.9	1.2	1.1	1.2	1.2	2.5	0.8	0.9	1.2	2.0	1.6	4.5	30.7	2.0	2.9	0.8	2.4	2.2	1.9	7.9	6.2	2.0	2.1	1.1	0.8	1.4	0.8	0.6	2.5	100.0	1.7	0.4	7.7	0.9	0.7	1.3	0.5	0.9	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	2.6	2.1	1.2	1.2	2.0	1.6	2.4	0.8	1.7	0.9	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 4781.7;tongue: 1519.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.78e-3)"	36.3	11.5	12.7	25.7	13.3	0.0	34.5	16.8	14.8	22.7	10.9	201.2	20.8	235.3	59.1	216.2	97.5	40.1	314.0	12.0	15.7	13.9	7.7	55.2	10.7	19.9	14.2	38.1	18.7	0.8	20.7	18.8	13.8	87.0	32.5	11.2	56.3	148.1	4781.7	12.1	69.0	127.6	17.9	24.5	95.8	8.2	14.6	4.1	32.7	1519.6	26.2	141.1	40.8	14.2	0.0	0.0	0.9	0.0	0.3	0.0	0.8	0.0	0.0	0.3	1.0	1.2	0.4	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	0.0	15.1	0.0	0.8	4.7	13.5	0.0	0.0	8.7	0.0	2.6	0.0	12.3	9.1	0.0	0.0	0.0	115.6	0.0	0.0	0.1	2.4	0.0	1.0	0.0	26.9	0.3	0.0	0.0	17.6	13.3	0.0	0.0	7.3	2.8	0.6	0.0	7.9	0.0	7.6	0.1	7.1	111.2	34.8	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	13.3	16.8	14.8	12.0	15.7	19.9	14.2	13.8	17.9	14.6	14.2	22.4	9.6	6.0	37.2	2.6	8.9	11.4	0.7	12.5	12.1	72.8	105.7	228.9	5.7	2.2	0.0	12.5	2.5	0.6	0.2	0.0	332.7	0.4	1.4	0.8	39.0	3.5	0.0	2.5	16.7	2.7	82.9	1.1	1.1	0.0	1.3	67.5	0.9	1.6	5.0	0.5	0.5	2.0	1.8	11.7	2.6	19.6	2.3	124.5	1.0	3.2	36.4	0.0	6.6	2.6	31.2	0.0	196.0	7.3	12.2	0.0	0.2	3.2	44.3	105.2	428.3	131.4	4.0	12.6	2.4	7.1	12.2	2.5	2.4	0.3	3.9
SORBS2	"ARGBP2, KIAA0777"	ENSG00000154556	"Sorbin and SH3 domain containing 2"	O94875	4	185585444-185956652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 575.3;thyroid gland: 277.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 557.8;Cone photoreceptor cells: 771.5;Excitatory neurons: 397.4;Rod photoreceptor cells: 815.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 241.1;TIME: 133.1;WM-115: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (3.30e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (1.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.51e-2)"	27.4	166.6	32.3	11.5	62.5	0.1	38.9	0.0	40.3	31.8	14.1	85.9	10.5	17.6	34.3	36.5	37.0	29.0	575.3	38.0	2.1	32.4	126.5	19.2	5.3	16.1	0.9	17.6	117.3	100.5	29.1	69.0	18.2	56.1	25.9	156.1	74.4	62.3	6.9	8.1	16.1	31.6	1.9	26.2	40.5	3.0	2.8	31.1	277.6	12.8	11.3	50.1	16.3	26.7	0.4	0.5	241.1	0.2	33.6	59.4	12.0	0.5	0.2	0.0	0.6	6.8	19.4	0.0	25.8	2.2	1.6	0.0	0.0	9.1	0.2	0.1	3.6	3.8	18.4	16.0	0.0	0.0	0.2	22.0	2.7	37.1	2.9	31.7	44.8	6.7	0.1	0.2	2.7	0.0	0.0	0.7	23.4	0.0	0.0	23.9	0.0	0.2	32.8	5.9	30.2	9.0	0.0	0.1	14.9	23.3	7.3	0.0	133.1	18.2	2.4	0.3	9.4	0.3	0.4	0.3	39.3	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.3	62.5	0.0	40.3	38.0	2.1	16.1	0.9	18.2	1.9	2.8	26.7	71.1	22.4	41.4	18.9	2.4	6.5	18.5	44.1	21.6	99.7	81.4	45.6	557.8	228.8	85.5	64.4	771.5	12.8	1.9	8.5	5.9	166.1	3.2	80.8	4.0	69.6	41.9	5.3	397.4	110.1	2.6	30.7	30.1	75.3	2.5	102.4	26.7	206.6	1.6	5.0	247.3	14.0	61.1	4.1	8.0	6.9	5.6	2.5	19.6	150.9	3.1	265.7	12.3	204.1	7.2	57.7	27.1	3.8	5.3	25.8	15.8	25.8	149.3	815.8	118.3	4.4	297.8	0.3	1.4	12.4	5.5	10.9	1.8	13.2	26.8	19.3
TLR3	CD283	ENSG00000164342	"Toll like receptor 3"	O15455	4	186069155-186088073	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Receptor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.7;Early spermatids: 70.2"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 10.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 5.5;memory CD8 T-cell: 5.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 20.0;BJ hTERT+ SV40 Large T+ RasG12V: 30.2;CAPAN-2: 48.4;HDLM-2: 19.3;HSkMC: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025658	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025658: "	"unprognostic (2.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.83e-1)"	7.3	5.5	0.8	3.3	0.8	0.3	6.7	1.3	1.1	5.4	1.7	11.7	18.2	6.1	3.3	9.0	10.1	11.3	3.3	0.9	1.6	11.8	14.7	11.5	0.9	3.0	1.2	8.8	5.8	4.1	0.5	17.3	2.7	7.6	12.5	1.6	10.5	10.9	1.0	3.3	16.8	8.3	2.2	5.2	10.9	5.4	1.1	2.5	7.5	3.3	2.0	8.4	2.7	2.5	3.5	0.9	0.5	0.0	19.3	20.0	1.6	0.1	14.4	8.8	30.2	0.0	48.4	0.1	2.0	2.1	17.2	4.9	0.0	10.3	1.5	19.3	0.2	3.1	0.7	0.0	8.6	3.2	1.2	20.0	3.9	11.8	0.5	5.3	4.2	3.3	0.0	0.0	5.1	0.0	3.7	0.0	1.5	0.0	0.6	4.6	0.0	0.2	8.2	5.0	0.0	0.1	2.6	2.1	4.0	0.2	0.6	0.0	3.0	1.5	1.0	0.0	2.1	0.0	0.0	0.0	4.1	2.0	3.4	0.5	0.0	0.0	5.5	0.0	3.1	0.0	1.2	5.9	2.0	0.0	0.8	2.7	0.2	0.6	0.0	0.0	0.1	0.9	0.8	0.8	1.3	1.1	0.9	1.6	3.0	1.2	2.7	2.2	1.1	2.5	12.9	19.2	7.8	0.3	0.8	3.8	5.2	8.1	9.1	0.1	4.0	3.4	1.4	12.8	13.2	14.7	0.0	20.5	2.0	33.7	0.0	10.3	70.2	8.5	5.4	5.8	1.2	4.4	0.1	10.1	4.2	10.8	8.6	19.7	2.5	5.0	6.1	7.9	2.6	0.0	0.0	6.4	4.1	0.6	5.0	6.4	8.4	3.6	0.0	10.3	0.0	4.8	4.1	0.5	0.0	5.8	8.4	3.8	0.5	2.2	20.7	4.9	7.5	0.6	0.0	6.7	3.3	0.1	0.4	7.3	1.0	19.6	1.3	3.1	4.6	5.2
FAM149A	"DKFZP564J102, MST119, MSTP119"	ENSG00000109794	"Family with sequence similarity 149 member A"	A5PLN7	4	186104419-186172667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Microglial cells: 41.2;Muller glia cells: 29.1;Rod photoreceptor cells: 35.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.1;JURKAT: 8.3;MOLT-4: 8.5;RT4: 9.6;SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044019, HPA055004"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA044019: AB_2732513, HPA055004: AB_2682667"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.64e-2)"	"prognostic favorable (2.67e-6)"	"unprognostic (7.08e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.36e-1)"	11.8	5.1	22.7	1.6	25.5	0.1	6.0	20.1	26.5	7.4	25.9	13.0	5.7	7.4	11.9	11.2	13.7	14.8	7.2	28.7	22.0	35.7	50.4	5.4	1.4	23.4	22.7	7.5	25.7	9.4	5.7	2.2	23.2	9.5	7.6	26.6	9.9	16.0	10.0	2.7	5.2	7.2	23.0	2.3	14.8	5.2	24.7	2.1	3.4	11.4	1.7	11.1	5.4	23.2	0.0	3.3	2.9	0.1	11.1	4.5	0.1	0.0	0.0	0.3	0.3	0.0	1.9	0.0	1.6	1.5	2.9	0.0	5.3	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.7	0.1	0.2	2.0	0.3	0.2	0.0	1.1	0.0	8.3	0.0	2.5	1.3	1.7	8.5	0.4	5.1	0.0	0.0	0.3	0.0	2.1	1.7	9.6	14.2	3.9	0.1	0.0	4.7	0.9	1.0	0.0	0.9	0.2	1.6	0.0	1.7	0.0	0.1	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.2	0.0	22.7	25.5	20.1	26.5	28.7	22.0	23.4	22.7	23.2	23.0	24.7	23.2	1.8	0.0	1.5	8.1	0.5	0.5	2.4	0.4	1.2	11.8	0.6	1.0	8.5	22.8	4.4	5.5	45.9	0.7	0.0	1.6	5.9	9.5	15.3	17.4	3.7	1.8	9.5	2.7	8.8	5.4	0.9	5.0	4.1	16.7	0.0	0.4	1.4	13.8	0.2	1.7	12.4	3.7	2.0	1.3	1.8	5.6	3.4	2.6	3.6	41.2	0.0	29.1	0.0	7.5	0.5	5.0	4.0	4.1	2.9	2.3	0.8	8.5	11.1	35.5	6.6	2.5	3.3	1.0	4.7	1.6	0.3	0.8	1.1	0.1	3.3	2.8
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191567-186213463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;SK-MEL-30: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	7.4	16.4	5.1	5.2	6.8	2.1	5.7	5.6	5.0	8.6	17.9	9.6	16.5	5.6	2.6	5.0	6.1	14.7	9.2	4.8	5.1	33.9	113.5	10.8	5.6	5.3	6.0	5.7	15.6	33.4	3.7	3.5	5.3	8.2	11.9	14.2	7.0	7.5	4.5	1.3	16.7	7.1	5.4	11.2	6.2	3.2	5.6	6.5	17.3	5.0	4.9	6.4	2.3	6.3	3.4	1.8	0.8	0.0	15.2	6.3	0.2	4.4	9.9	1.7	1.9	0.0	13.0	1.1	0.5	3.5	5.9	1.6	1.9	1.7	0.3	6.0	2.2	4.7	0.8	0.5	5.6	2.6	1.9	5.8	0.8	1.9	1.0	5.9	0.1	6.4	1.4	14.3	6.8	2.9	3.6	1.3	1.5	1.6	0.0	3.1	0.7	1.0	7.4	6.1	4.0	4.9	1.1	0.0	27.5	0.3	2.6	4.6	4.1	3.6	0.7	3.5	1.6	0.1	0.0	0.5	10.9	11.0	4.7	0.0	0.6	0.0	1.8	1.9	1.0	0.4	1.4	1.8	0.7	1.0	1.3	1.3	0.0	0.8	3.1	1.3	1.1	0.9	5.1	6.8	5.6	5.0	4.8	5.1	5.3	6.0	5.3	5.4	5.6	6.3	9.0	6.4	11.5	31.3	13.8	2.5	4.5	5.1	9.6	33.6	9.3	7.2	18.8	42.9	8.7	14.7	31.3	2.0	9.6	14.7	9.8	24.2	2.7	6.7	5.1	7.7	16.9	16.4	15.4	22.4	2.1	14.2	12.8	7.6	7.0	6.5	8.9	103.7	13.5	5.0	23.4	16.5	2.0	14.8	6.0	2.1	5.0	11.3	3.6	6.5	3.5	52.2	4.1	15.6	11.0	9.6	9.0	6.4	12.3	3.8	47.2	28.5	11.9	27.4	0.0	10.1	10.6	8.9	6.3	6.8	3.1	1.0	17.2	6.7	10.5	5.7
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 328.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 280.5"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	28900000000	5300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.6	1.8	5.9	0.3	6.5	0.0	0.6	6.0	7.6	1.4	9.3	2.3	2.8	0.6	1.0	0.4	1.3	2.5	2.6	6.3	6.2	7.7	328.4	1.0	0.7	7.0	6.5	0.7	4.8	1.0	3.6	0.2	6.4	1.7	1.4	13.1	0.7	0.6	2.4	0.3	2.6	0.6	6.1	2.4	0.8	2.0	6.0	0.4	1.9	1.8	0.4	1.5	0.9	6.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.5	6.0	7.6	6.3	6.2	7.0	6.5	6.4	6.1	6.0	6.3	0.1	0.0	0.0	48.3	0.7	0.0	0.1	0.2	0.6	5.1	0.3	0.5	4.3	14.3	0.1	1.8	16.7	0.0	0.5	0.6	0.0	1.8	2.8	0.6	0.2	1.0	3.0	2.7	10.2	0.5	0.0	0.4	0.0	0.4	0.0	0.2	5.7	280.5	0.2	0.0	15.6	0.4	0.0	4.4	0.0	2.2	0.6	0.3	0.0	6.5	0.1	10.6	2.1	8.0	7.7	0.4	1.4	0.0	0.1	0.0	2.6	1.6	1.1	5.1	0.0	0.6	0.3	1.3	1.3	0.1	0.0	0.0	0.6	0.1	0.7	0.1
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 243.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 27.6;Hepatocytes: 75.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	17.1	0.2	0.1	0.0	0.0	13.1	0.0	0.2	0.0	27.6	243.2	8.4	0.0	0.0	0.3	0.3	58.9	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	27.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	2.5	1.8	0.0	0.0	0.2	0.3	11.7	2.3	0.0	0.0	0.0	0.1	0.0	5.3	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
AC018709.1		ENSG00000272297	"Novel protein"		4	186426546-186555328	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	15	"testis: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 2.6;OE19: 1.3;T-47d: 1.3"															NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"																						0.0	0.0	1.4	0.1	0.9	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.3	0.0	1.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	30.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.1	1.4	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.0;intestine: 1.2;kidney: 2.1;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAT1	"CDHF7, CDHR8, FAT"	ENSG00000083857	"FAT atypical cadherin 1"	Q14517	4	186587794-186726722	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 119.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 285.7;LHCN-M2: 206.7"	"Low region specificity"	"Detected in all"							"HPA001869, HPA023882"	Enhanced				"Intracellular and membrane"	NA	NA		4600000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA001869: AB_1078818, HPA023882: AB_1848429"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.80e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.25e-3)"	"unprognostic (4.27e-2)"	20.1	1.3	14.5	7.2	20.2	0.8	21.9	31.1	12.4	20.0	119.2	35.0	25.9	23.4	16.0	13.3	9.8	23.5	24.8	14.3	27.0	22.1	10.0	12.9	2.4	40.1	42.3	10.4	12.6	11.4	9.7	17.0	24.4	21.4	31.4	3.4	18.7	24.2	3.5	17.5	24.2	25.7	22.1	2.2	16.8	9.7	22.2	6.0	14.6	3.9	4.4	32.0	11.0	22.0	22.2	83.5	80.9	0.3	79.1	94.5	19.9	110.9	181.9	52.8	33.5	50.0	49.0	0.0	26.0	285.7	34.1	40.4	32.0	136.7	71.6	0.2	13.2	0.0	30.5	50.8	39.4	37.3	29.2	34.5	48.4	98.7	63.5	72.4	1.1	44.8	0.6	0.0	206.7	27.1	66.2	0.1	18.1	42.2	13.9	0.3	22.3	1.8	79.2	79.0	8.6	32.3	19.2	32.2	12.7	54.9	0.3	13.3	23.8	149.8	57.9	2.0	69.8	0.4	0.2	0.5	34.1	0.1	52.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	20.2	31.1	12.4	14.3	27.0	40.1	42.3	24.4	22.1	22.2	22.0	6.1	16.0	6.7	55.2	0.3	85.0	27.2	115.4	27.3	5.2	26.5	27.6	27.6	38.6	40.7	53.3	0.0	1.6	0.2	71.2	5.9	25.2	0.7	25.7	17.2	5.0	14.5	0.0	5.8	26.5	3.6	28.8	54.0	29.6	16.5	75.0	1.1	26.1	0.4	0.0	30.3	56.4	18.3	0.8	7.3	0.9	14.6	1.7	12.4	5.6	0.0	4.5	0.0	14.1	12.4	30.3	30.0	37.2	0.2	55.8	78.2	26.7	37.0	0.4	39.5	23.1	65.1	1.5	10.4	10.2	46.9	1.6	1.9	11.7	45.1	38.9
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 44.8;Extravillous trophoblasts: 59.3"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	13	"BEWO: 115.5;SuSa: 77.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.0	0.1	0.4	0.2	0.4	0.4	0.1	0.6	0.5	0.0	0.4	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.7	0.4	0.1	0.2	0.1	0.1	0.1	0.7	0.5	0.1	0.1	0.1	0.5	0.2	2.1	0.5	0.2	0.1	0.0	0.2	0.1	0.0	1.0	0.3	0.0	0.1	0.2	0.0	0.0	115.5	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.2	7.5	0.2	0.0	0.4	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.4	0.1	0.1	0.5	0.3	0.0	0.4	0.2	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.1	77.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.4	0.2	0.2	1.6	0.2	0.3	0.5	0.2	0.4	0.5	0.4	0.3	0.1	0.5	0.4	0.4	1.3	0.7	0.2	0.3	0.4	0.1	0.4	0.4	0.6	0.5	0.4	0.1	0.6	0.2	0.4	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	9.4	0.1	0.0	0.0	0.2
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.1;testis: 2.6"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	33.8	0.0	0.0	0.0	0.1	18.3	0.2	1.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.5	0.9	6.4	0.1	0.0	2.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	145.3	0.0	0.0	0.2	0.1	7.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	6.4	0.0	0.0	8.9	0.1	0.0	0.0	0.3
TRIML1	"FLJ36180, RNF209"	ENSG00000184108	"Tripartite motif family like 1"	Q8N9V2	4	188139441-188147743	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	121	"testis: 12.0"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 138.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"BEWO: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"									"unprognostic (6.99e-2)"									"unprognostic (5.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	138.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	29.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0
FRG1	"FRG1A, FSG1"	ENSG00000109536	"FSHD region gene 1"	Q14331	4	189940870-189963202	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing"	"Actin-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA075683	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA075683: "	"unprognostic (1.67e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.84e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.01e-1)"	36.8	25.7	6.0	6.4	6.0	16.6	33.9	6.1	13.0	29.5	6.1	35.0	6.6	32.9	9.6	30.7	27.6	5.9	31.9	6.0	6.1	29.2	24.8	23.5	7.9	6.0	6.0	32.0	30.6	13.1	18.5	5.9	6.0	21.7	7.7	3.6	24.9	7.5	31.1	28.6	26.7	8.6	6.0	29.0	30.0	19.8	6.0	13.0	23.4	9.4	8.4	28.8	28.3	6.1	12.2	8.5	21.5	19.0	11.0	16.4	14.6	18.0	13.4	23.3	15.6	6.1	20.1	21.9	8.5	13.5	8.8	7.3	20.3	13.8	24.6	13.3	9.6	39.4	9.3	4.3	18.8	28.9	14.9	12.1	15.5	12.9	4.2	15.8	15.5	19.1	25.4	42.4	19.0	6.9	38.6	42.7	4.4	5.4	12.8	27.2	4.9	14.4	16.3	6.9	15.8	15.7	11.4	13.0	21.1	11.8	6.7	20.3	15.4	8.8	11.6	6.5	13.4	15.4	12.8	17.6	15.7	18.7	13.1	30.7	13.4	19.7	13.6	18.0	13.8	16.9	16.0	15.1	12.1	15.4	13.6	14.8	13.3	16.9	19.1	13.4	20.1	13.6	6.0	6.0	6.1	13.0	6.0	6.1	6.0	6.0	6.0	6.0	6.0	6.1	69.3	80.1	52.9	6.5	61.9	33.4	42.5	62.9	18.2	43.1	47.6	56.9	70.6	64.3	52.9	33.1	16.7	77.0	82.2	45.6	131.0	106.0	50.4	42.4	51.4	61.1	44.9	94.1	12.5	121.9	65.2	50.9	18.8	40.9	84.2	34.8	83.6	133.8	68.1	32.0	11.6	53.9	50.8	92.6	46.7	20.4	76.1	57.4	21.4	4.7	107.6	61.1	124.6	12.5	17.0	88.4	48.9	72.6	41.9	20.7	60.8	126.2	51.7	52.0	52.6	50.7	84.6	75.9	70.6	27.5	28.1	53.5	64.6	42.8	52.9	32.4
FRG2	FRG2A	ENSG00000205097	"FSHD region gene 2"	Q64ET8	4	190024367-190027257	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039264, HPA047769"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"			"Cluster 39: Non-specific - Basic cellular processes"			"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Group enriched"	"Detected in some"	26	"Early spermatids: 4.9;Late spermatids: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5"	"Low region specificity"	"Detected in some"							HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.4	0.0	4.7	6.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0